
<html lang="en"     class="pb-page"  data-request-id="d84bbeea-9975-4991-8c14-ad37849fe94f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm300087j;issue:issue:10.1021/jmcmar.2012.55.issue-12;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications" /></meta><meta name="dc.Creator" content="Pier Giovanni  Baraldi" /></meta><meta name="dc.Creator" content="Delia  Preti" /></meta><meta name="dc.Creator" content="Pier Andrea  Borea" /></meta><meta name="dc.Creator" content="Katia  Varani" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 17, 2012" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300087j" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300087j" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300087j" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300087j" /></link>
        
    
    

<title>Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300087j" /></meta><meta property="og:title" content="Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300087j"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300087j">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300087j&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300087j&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300087j&amp;href=/doi/10.1021/jm300087j" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5676-5703</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2004706" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm2011657" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Medicinal Chemistry of A<sub>3</sub> Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pier+Giovanni++Baraldi">Pier Giovanni Baraldi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Delia++Preti">Delia Preti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pier+Andrea++Borea">Pier Andrea Borea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katia++Varani">Katia Varani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Dipartimento di Scienze Farmaceutiche and <sup>‡</sup>Dipartimento di Medicina Clinica e Sperimentale-Sezione di Farmacologia, Università di Ferrara, 44121 Ferrara, Italy</span></div><div class="corresp-info"><strong>*</strong>For P.G.B.: phone, +39-0532-455921; fax, +39-0532-455921; e-mail, <a href="/cdn-cgi/l/email-protection#e98b889b88858d80a99c87808f8cc7809d"><span class="__cf_email__" data-cfemail="b6d4d7c4d7dad2dff6c3d8dfd0d398dfc2">[email protected]</span></a>. For D.P.: phone, +39-0532-455302; e-mail, <a href="/cdn-cgi/l/email-protection#e4949690808881a4918a8d8281ca8d90"><span class="__cf_email__" data-cfemail="2b5b595f4f474e6b5e45424d4e05425f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300087j&amp;href=/doi/10.1021%2Fjm300087j" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5676–5703</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 2, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 January 2012</li><li><span class="item_label"><b>Published</b> online</span>17 April 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300087j" title="DOI URL">https://doi.org/10.1021/jm300087j</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5676%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPier%2BGiovanni%2BBaraldi%252C%2BDelia%2BPreti%252C%2BPier%2BAndrea%2BBorea%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D12%26contentID%3Djm300087j%26title%3DMedicinal%2BChemistry%2Bof%2BA3%2BAdenosine%2BReceptor%2BModulators%253A%2BPharmacological%2BActivities%2Band%2BTherapeutic%2BImplications%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5703%26publicationDate%3DJune%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300087j"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2290</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300087j" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pier&quot;,&quot;last_name&quot;:&quot;Giovanni Baraldi&quot;},{&quot;first_name&quot;:&quot;Delia&quot;,&quot;last_name&quot;:&quot;Preti&quot;},{&quot;first_name&quot;:&quot;Pier&quot;,&quot;last_name&quot;:&quot;Andrea Borea&quot;},{&quot;first_name&quot;:&quot;Katia&quot;,&quot;last_name&quot;:&quot;Varani&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;5676-5703&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300087j&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300087j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300087j" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300087j&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300087j" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300087j&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300087j" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300087j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300087j&amp;href=/doi/10.1021/jm300087j" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300087j" /></input><a href="/doi/pdf/10.1021/jm300087j" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300087j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300087j%26sid%3Dliteratum%253Aachs%26pmid%3D22468757%26genre%3Darticle%26aulast%3DBaraldi%26date%3D2012%26atitle%3DMedicinal%2BChemistry%2Bof%2BA3%2BAdenosine%2BReceptor%2BModulators%253A%2BPharmacological%2BActivities%2Band%2BTherapeutic%2BImplications%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D12%26spage%3D5676%26epage%3D5703%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jmcmar.2012.55.issue-12/production/jmcmar.2012.55.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>§</span> Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The purine nucleoside adenosine is identified as a ubiquitous molecule regulator of different tissues and cell functions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Adenosine is generated in the extracellular space by the breakdown of adenosine 5′-triphosphate (ATP) through a series of ectoenzymes, including apyrase and ecto-5′-nucleotidase.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Inside the cell, adenosine is phosphorylated to adenosine 5′-monophosphate (AMP) by adenosine kinase or degraded to inosine by adenosine deaminase.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Adenosine production from the hydrolysis of AMP is mediated by a cytosolic 5′-nucleotidase or by the hydrolysis of <i>S</i>-adenosylhomocysteine.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The levels of adenosine in the interstitial fluid are in the range 20–200 nM even if dramatically increased under metabolically unfavorable conditions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Adenosine effects are widespread and closely associated with the expression of different adenosine receptor (AR) subtypes which can be coexpressed and serve as active modulators in the cell signaling transduction.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> ARs are characterized by seven transmembrane domains connected by different intracellular and extracellular loops.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A<sub>1</sub>AR stimulation through the interaction with various members of pertussis toxin-sensitive family of G proteins modulates different cellular effectors as adenylate cyclase (AC) and phospholypase C (PLC).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The A<sub>2A</sub> and A<sub>2B</sub>ARs through coupling with Gs proteins activate AC and increase cyclic AMP levels.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A<sub>3</sub>ARs, via the interaction with Gi proteins, inhibit adenylate cyclase, decreasing cyclic AMP accumulation and protein kinase A (PKA) activity. In addition, A<sub>3</sub>ARs, by coupling with Gq proteins, stimulate PLC, causing an increase of calcium levels from intracellular stores, and modulate the protein kinase C (PKC) activity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> From the molecular point of view, the presence of histidine residues at the C-terminus of A<sub>3</sub>ARs is responsible for the cell signaling transduction mechanisms. In addition, the presence of serine and threonine residues is involved in the desensitization and down-regulation of the receptors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> There is considerable evidence for A<sub>3</sub>ARs to modulate the regulatory pathways of the mitogen-activated kinases (MAPKs) that consist of the extracellular signal regulated kinases (ERKs), the c-Jun N-terminal kinases (JNKs), and the p38 kinases.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Different effects of A<sub>3</sub>AR activation on the Akt/Ras/Raf/MEK/ERK signaling pathway modulation in different cells have been reported (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> A strong link is well evident between A<sub>3</sub>ARs and hypoxia inducible factor 1α (HIF-1α), signaling that represents the main transcription factor regulating the cellular responses in hypoxia.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It is well reported that the MAPK pathway is regulated by A<sub>3</sub>ARs through a feedback mechanism that controls G-protein-coupled receptor kinase 2 (GRK2) activity and involves a specific receptor phosphorylation.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The activation of A<sub>3</sub>ARs causes the accumulation of arrestin 3 in plasma membranes through the translocation correlated with receptor sensitivity to GRK-mediated phosphorylation.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a>It has been reported that a short time, about 10 min, of agonist exposure results in a rapid A<sub>3</sub>AR internalization and in a functional desensitization as observed by the reduction of the inhibition of forskolin-stimulated AC.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A prolonged treatment, about 20 h, with the A<sub>3</sub>AR agonists induces uncoupling of the receptor and functional desensitization associated with the receptor down-regulation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Despite this A<sub>3</sub>AR desensitization, the adenylate cyclase activity is not reduced as observed from experiments performed in the presence of forskolin stimulation. In addition, the removal of the agonists mediates, in about 35 min, a restoration of the receptor functionality and recycling to plasma membrane.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Among the four ARs, A<sub>3</sub>ARs are the latest cloned and pharmacologically characterized: the amino acid sequence of the human A<sub>3</sub>ARs (hA<sub>3</sub>ARs) is 54%, 48%, and 44% identical in sequence to hA<sub>1</sub>, hA<sub>2A</sub>, hA<sub>2B</sub>ARs, respectively.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Among the various species, rat A<sub>3</sub>ARs (rA<sub>3</sub>ARs) are significantly different from human, having 74% of identical sequence whereas 85% homology is shown between sheep and human A<sub>3</sub>ARs. Moreover, while A<sub>3</sub>ARs mRNA were found in rat testis, heart, and lung and at low levels in various brain areas,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> a significant expression of human A<sub>3</sub>ARs mRNA has been observed in many peripheral tissues with lower levels in the central nervous system and testis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> As a consequence, the pronounced species-dependent differences of A<sub>3</sub>ARs in tissue distribution and in the pharmacology hamper the evaluation of the potential therapeutic characteristics in animal models.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The tissue distribution of A<sub>3</sub>ARs has been well investigated and suggests that these receptors are primarily expressed in lung, liver, and immune cells. A minor expression of A<sub>3</sub>ARs is reported in kidney, heart, brain, and gastrointestinal tissues.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The widespread distribution in different cells and tissues of the A<sub>3</sub>ARs could suggest their potential involvement in various pathologies and the possible use as a selective pharmacological target (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of signaling pathways mediated by A<sub>3</sub>AR activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic diagram illustrating the functional role of A<sub>3</sub>ARs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The presence of A<sub>3</sub>ARs has been studied by using different experimental approaches as radioligand binding, mRNA, Western blotting analysis, and functional assays in a variety of primary cell cultures, native tissues, and cell lines.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19">(15-19)</a> In binding assays, several agonist or antagonist radioligands have been widely used in the characterization of A<sub>3</sub>ARs (see the related section below). From a thermodynamic point of view all ARs have been analyzed adding important findings as the thermodynamic discrimination of agonists from antagonists and the enthalpy–entropy compensation.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> In particular, the thermodynamic discrimination of ARs is also confirmed for A<sub>3</sub>ARs, showing that agonist binding is entropy-driven probably because of the disorganization of a solvation area around the ligand–receptor interaction.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Moreover, the antagonist binding is mainly enthalpy driven for hydrogen bond formation and van der Waals interactions occurring between the ligands and the binding pocket.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Knowledge of the thermodynamic parameters could help the discovery and characterization of novel selective A<sub>3</sub>AR agonists or antagonists.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">A<sub>3</sub> Adenosine Receptor Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The vast majority of A<sub>3</sub>AR agonists reported to date reflects the nucleoside structure of the endogenous orthosteric ligand, adenosine (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref7 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref7 ref24 ref25 ref26">(7, 24-26)</a> The most successful structural manipulations of the adenosine skeleton in enhancing A<sub>3</sub>AR potency and selectivity involve <i>N</i><sup>6</sup>-, <i>C</i><sup>2</sup>-, and 5′-substitutions or suitable combinations of these. The ribose pentacycle has also been recognized as a possible object of structural modifications affecting both A<sub>3</sub>AR binding affinity and efficacy. Recently, few examples of non-adenine nucleosides and non-nucleoside derivatives able to activate A<sub>3</sub>ARs have been as well reported. In this section we intend to expand on and update our earlier reviews<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and book chapters<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> on the examined topic.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative collection of <i>N</i><sup>6</sup>-substituted (<b>2</b>, <b>3</b>), <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup>-disubstituted (<b>4</b>, <b>5</b>), <i>N</i><sup>6</sup>-5′-disubstituted (<b>6a</b>, <b>7</b>–<b>9</b>), and <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup>-5′-trisubstituted (<b>6b</b>, <b>10</b>–<b>15</b>) adenosine derivatives as A<sub>3</sub>AR agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> <i>N</i><sup>6</sup>-Substituted Adenosine Derivatives</h3><div class="NLM_p">A large series of <i>N</i><sup>6</sup>-substituted adenosines has been reported by Gao et al. in 2003.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Addition of small groups such as a methyl or ethyl appeared preferred over larger or branched alkyl chains. <i>N</i><sup>6</sup>-Cyclobutyl and <i>N</i><sup>6</sup>-phenyl substitution resulted in potent A<sub>3</sub>AR agonists even with higher affinity toward A<sub>1</sub>AR subtype. <i>N</i><sup>6</sup>-Benzyl or <i>N</i><sup>6</sup>-phenylethyl substitution, although beneficial in terms of A<sub>3</sub>AR vs A<sub>1</sub>AR selectivity, determined a lower relative efficacy<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> at the A<sub>3</sub>AR (55% and 84%, respectively). Among <i>N</i><sup>6</sup>-phenylethyl derivatives, the efficacy was partially or completely restored with modifications of the ethylenic bridge such as in compound <b>2a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) showing the best binding/activity profile of the series (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Further SAR studies based on this molecule<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> led to the identification of <i>N</i><sup>6</sup>-(<i>trans</i>-2-(3-trifluoromethyl)phenyl)-1-cyclopropyl (<b>2b</b>) and <i>N</i><sup>6</sup>-(9-fluorenylmethyl) (<b>3</b>) as potent A<sub>3</sub>AR agonists. Interestingly, the efficacy of these series was strictly dependent on the conformation properties of the <i>N</i><sup>6</sup>-substituent, as testified by the observation that <i>N</i><sup>6</sup>-(2,2-diphenylethyl)adenosine, unconstrained analogue of <b>3</b>, completely lost efficacy, behaving as an A<sub>3</sub>AR antagonist (see compound <b>72</b> among the antagonists reported below).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Paremeters Expressed As Affinity Values (<i>K</i><sub>i</sub>, nM) and Selectivities of the Most Representative A<sub>3</sub>AR Agonists</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" colspan="2" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">A<sub>1</sub>AR</th><th class="colsep0 rowsep0" align="center">A<sub>2A</sub>AR</th><th class="colsep0 rowsep0" align="center">A<sub>3</sub>AR</th><th class="colsep0 rowsep0" align="center">A<sub>1</sub>/A<sub>3</sub></th><th class="colsep0 rowsep0" align="center">A<sub>2A</sub>/A<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td><td class="colsep0 rowsep0" align="left">124 (h)</td><td class="colsep0 rowsep0" align="left">2530 (h)</td><td class="colsep0 rowsep0" align="left">0.86 (h)</td><td class="colsep0 rowsep0" align="left">144 (h)</td><td class="colsep0 rowsep0" align="left">2942 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10 (r)</td><td class="colsep0 rowsep0" align="left">2980 (r)</td><td class="colsep0 rowsep0" align="left">399 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.5 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td><td class="colsep0 rowsep0" align="left">104 (h)</td><td class="colsep0 rowsep0" align="left">2370 (h)</td><td class="colsep0 rowsep0" align="left">1.9 (h)</td><td class="colsep0 rowsep0" align="left">55 (h)</td><td class="colsep0 rowsep0" align="left">1247 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">16 (r)</td><td class="colsep0 rowsep0" align="left">459 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td><td class="colsep0 rowsep0" align="left">14 (h)</td><td class="colsep0 rowsep0" align="left">145 (h)</td><td class="colsep0 rowsep0" align="left">0.91 (h)</td><td class="colsep0 rowsep0" align="left">15 (h)</td><td class="colsep0 rowsep0" align="left">161 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.4 (r)</td><td class="colsep0 rowsep0" align="left">33 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td><td class="colsep0 rowsep0" align="left">70 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">3.4 (h)</td><td class="colsep0 rowsep0" align="left">21 (h)</td><td class="colsep0 rowsep0" align="left">>2941 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></td><td class="colsep0 rowsep0" align="left">3800 (h)</td><td class="colsep0 rowsep0" align="left">>5000 (h)</td><td class="colsep0 rowsep0" align="left">2 (h)</td><td class="colsep0 rowsep0" align="left">1900 (h)</td><td class="colsep0 rowsep0" align="left">>2500 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b><a onclick="showRef(event, 'ref32 ref54'); return false;" href="javascript:void(0);" class="ref ref32 ref54">(32, 54)</a></td><td class="colsep0 rowsep0" align="left">51 (h)</td><td class="colsep0 rowsep0" align="left">2900 (h)</td><td class="colsep0 rowsep0" align="left">1.0 (h)</td><td class="colsep0 rowsep0" align="left">51 (h)</td><td class="colsep0 rowsep0" align="left">2900 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">54 (r)</td><td class="colsep0 rowsep0" align="left">56 (r)</td><td class="colsep0 rowsep0" align="left">1.1 (r)</td><td class="colsep0 rowsep0" align="left">49 (r)</td><td class="colsep0 rowsep0" align="left">51 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b><a onclick="showRef(event, 'ref37 ref54'); return false;" href="javascript:void(0);" class="ref ref37 ref54">(37, 54)</a></td><td class="colsep0 rowsep0" align="left">222 (h)</td><td class="colsep0 rowsep0" align="left">5360 (h)</td><td class="colsep0 rowsep0" align="left">1.4 (h)</td><td class="colsep0 rowsep0" align="left">159 (h)</td><td class="colsep0 rowsep0" align="left">3828 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">820 (r)</td><td class="colsep0 rowsep0" align="left">470 (r)</td><td class="colsep0 rowsep0" align="left">0.33 (r)</td><td class="colsep0 rowsep0" align="left">2485 (r)</td><td class="colsep0 rowsep0" align="left">1424 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td><td class="colsep0 rowsep0" align="left">325 (h)</td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">8.0 (h)</td><td class="colsep0 rowsep0" align="left">44 (h)</td><td class="colsep0 rowsep0" align="left">>125 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></td><td class="colsep0 rowsep0" align="left">245 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">2.3 (h)</td><td class="colsep0 rowsep0" align="left">106 (h)</td><td class="colsep0 rowsep0" align="left">>4348 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="left">9140 (h)</td><td class="colsep0 rowsep0" align="left">16300 (h)</td><td class="colsep0 rowsep0" align="left">1.9 (h)</td><td class="colsep0 rowsep0" align="left">4810 (h)</td><td class="colsep0 rowsep0" align="left">8579 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="left">53800 (h)</td><td class="colsep0 rowsep0" align="left">10400 (h)</td><td class="colsep0 rowsep0" align="left">2.5 (h)</td><td class="colsep0 rowsep0" align="left">21520 (h)</td><td class="colsep0 rowsep0" align="left">4160 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="left">32800 (h)</td><td class="colsep0 rowsep0" align="left">41700 (h)</td><td class="colsep0 rowsep0" align="left">0.44 (h)</td><td class="colsep0 rowsep0" align="left">75545 (h)</td><td class="colsep0 rowsep0" align="left">94773 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="left">10200 (h)</td><td class="colsep0 rowsep0" align="left">7030 (h)</td><td class="colsep0 rowsep0" align="left">0.33 (h)</td><td class="colsep0 rowsep0" align="left">30909 (h)</td><td class="colsep0 rowsep0" align="left">21303 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">558 (h)</td><td class="colsep0 rowsep0" align="left">4963 (h)</td><td class="colsep0 rowsep0" align="left">0.75 (h)</td><td class="colsep0 rowsep0" align="left">744 (h)</td><td class="colsep0 rowsep0" align="left">6617 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></td><td class="colsep0 rowsep0" align="left">1640 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">1.8 (h)</td><td class="colsep0 rowsep0" align="left">911 (h)</td><td class="colsep0 rowsep0" align="left">>5555 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">7300 (h)</td><td class="colsep0 rowsep0" align="left">>50000 (h)</td><td class="colsep0 rowsep0" align="left">5.8 (h)</td><td class="colsep0 rowsep0" align="left">1259 (h)</td><td class="colsep0 rowsep0" align="left">>8620 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td><td class="colsep0 rowsep0" align="left">1330 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">0.28 (h)</td><td class="colsep0 rowsep0" align="left">4750 (h)</td><td class="colsep0 rowsep0" align="left">>35714 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td><td class="colsep0 rowsep0" align="left">193 (h)</td><td class="colsep0 rowsep0" align="left">223 (h)</td><td class="colsep0 rowsep0" align="left">0.38 (h)</td><td class="colsep0 rowsep0" align="left">508 (h)</td><td class="colsep0 rowsep0" align="left">586 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" align="left">20.2 (h)</td><td class="colsep0 rowsep0" align="left">475 (h)</td><td class="colsep0 rowsep0" align="left">0.25 (h)</td><td class="colsep0 rowsep0" align="left">81 (h)</td><td class="colsep0 rowsep0" align="left">1900 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.86 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></td><td class="colsep0 rowsep0" align="left">260 (h)</td><td class="colsep0 rowsep0" align="left">2300 (h)</td><td class="colsep0 rowsep0" align="left">0.29 (h)</td><td class="colsep0 rowsep0" align="left">896 (h)</td><td class="colsep0 rowsep0" align="left">7931 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.0 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">766 (h)</td><td class="colsep0 rowsep0" align="left">2.1 (h)</td><td class="colsep0 rowsep0" align="left">>4761 (h)</td><td class="colsep0 rowsep0" align="left">365 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b><a onclick="showRef(event, 'ref29 ref60'); return false;" href="javascript:void(0);" class="ref ref29 ref60">(29, 60)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">5740 (h)</td><td class="colsep0 rowsep0" align="left">9.6 (h)</td><td class="colsep0 rowsep0" align="left">>1041 (h)</td><td class="colsep0 rowsep0" align="left">598 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></td><td class="colsep0 rowsep0" align="left">37300 (r)</td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">229 (r)</td><td class="colsep0 rowsep0" align="left">162 (r)</td><td class="colsep0 rowsep0" align="left">>44 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></td><td class="colsep0 rowsep0" align="left">7.0 (h)</td><td class="colsep0 rowsep0" align="left">214 (h)</td><td class="colsep0 rowsep0" align="left">24 (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.9 (h)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values are evaluated in human (h) or rat (r) tissues or cells. For detailed experimental conditions see the cited references.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup>-Disubstituted Adenosine Derivatives</h3><div class="NLM_p last">Ohno et al. scrutinized different combination of <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup> disubstitution of the adenosine skeleton, evaluating the effect on ARs binding.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This study also highlighted the importance of <i>C</i><sup>2</sup> substitution in modulating A<sub>3</sub>AR activation efficacy. In particular, the introduction of a 2-CN group exerted opposite effect in relation to the kind of <i>N</i><sup>6</sup>-substitution. 2-Cyano-<i>N</i><sup>6</sup>-methyladenosine (<b>4</b>) was shown, indeed, to be a full agonist with improved affinity if compared with its <i>C</i><sup>2</sup> unsubstituted analogue, while the same group at 2-position of derivative <b>2a</b> completely abolished A<sub>3</sub>AR activation, resulting in a relatively potent antagonist. Other small groups, at the 2 position of <i>N</i><sup>6</sup>-methyladenosine (i.e., NH<sub>2</sub> or CF<sub>3</sub>), instead decreased selectivity and affinity toward the A<sub>3</sub>AR. Elzein et al. synthesized a series of 2-pyrazolyl-<i>N</i><sup>6</sup>-substituted adenosine derivatives as very potent and selective ligands for the A<sub>3</sub>AR,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> among which compound <b>5</b> (<i>K</i><sub>i</sub> = 2 nM) showed relevant selectivity for the A<sub>3</sub> versus A<sub>1</sub> and A<sub>2A</sub> ARs (selectivity ratios of 1900 and >2500, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and was claimed for use in the treatment of cancer and neutropenia by CV Therapeutics.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> <i>N</i><sup>6</sup>-5′-Disubstituted Adenosine Derivatives</h3><div class="NLM_p last">Potent and selective A<sub>3</sub>AR agonists have been identified combining <i>N</i><sup>6</sup>-substitution with a 5′-uronamide function. The first A<sub>3</sub>AR selective compounds combined a 5′-<i>N</i>-alkyluronamide with an <i>N</i><sup>6</sup>-benzyl group.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> One of the most representative compound of this series, <i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine-5′-<i>N</i>-methyluronamide (IB-MECA, <b>6</b>a), was discovered in 1994.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> After these findings, our research group prepared a series of <i>N</i><sup>6</sup>-arylcarbamoyl derivatives of NECA (5′-<i>N</i>-ethylcarboxamidoadenosine) with general structure <b>7</b> that exhibited good binding profiles as A<sub>3</sub>AR agonists.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> The most recent components of this series were functionalized at the <i>N</i><sup>6</sup>-position with a 4-(substituted)sulfonamidophenylcarbamoyl moiety such as in compound <b>8</b>, which displayed good affinity and selectivity for the A<sub>3</sub>AR.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The best results were observed with disubstitution of the sulfonamide group with small alkyl chains because of a slight enhancement of A<sub>3</sub>AR vs A<sub>1</sub>AR selectivity. The cardioprotective effects of a number of <i>N</i><sup>6</sup>-substituted adenosine-5′-<i>N</i>-methylcarboxamides, among them compound <b>9</b>, were recently demonstrated.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Although the exact nature of such cardioprotection mechanism would need further investigation, it has been observed that the pharmacologic effect was reversed by a selective A<sub>3</sub>AR antagonist.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup>-5′-Trisubstituted Adenosine Derivatives</h3><div class="NLM_p">The effect of different combinations of substitutions at the <i>N</i><sup>6</sup>- and <i>C</i><sup>2</sup>- positions of the adenine core of 5′-<i>N</i>-alkylcarbamoyladenosine derivatives has been largely investigated. The introduction of small groups (i.e., halogens, methylamino, or thiomethyl functions) at the <i>C</i><sup>2</sup>-position of <b>6a</b> generally increased both affinity and selectivity at the A<sub>3</sub>AR subtype and led to the discovery of <i>C</i><sup>2</sup>-chloro-<i>N</i><sup>6</sup>-(3-iodobenyl)-5′-<i>N</i>-methylcarboxamidoadenosine (Cl-IB-MECA, <b>6b</b>) as a highly selective ligand, currently considered as the prototypical A<sub>3</sub>AR agonist.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This compound has a <i>K</i><sub>i</sub> of 0.33 nM at the rA<sub>3</sub>AR, with a <i>K</i><sub>i</sub> of 820 and 470 nM at rA<sub>1</sub> and rA<sub>2A</sub> ARs, respectively. Cl-IB-MECA is known to be more selective for the rA<sub>3</sub>AR than the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> values at the hARs: hA<sub>1</sub>AR = 222 nM, A<sub>2A</sub>AR = 5360 nM, and A<sub>3</sub>AR = 1.4 nM).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> A further important contribution to the study of the effect of <i>C</i><sup>2</sup>-substitution has been furnished by Cristalli and co-workers who synthesized a wide series of 2-(ar)alkynyl derivatives of adenosine with variable affinity/selectivity profile at the ARs.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The best results in terms of affinity, selectivity, and intrinsic activity toward A<sub>3</sub>AR have been achieved combining 2-arylalkynyl substitution with a methylcarboxamido function at the 4′-position of the ribose nucleus and small groups, such as a methyl<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> or a methoxy,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> at the <i>N</i><sup>6</sup>-position (compounds <b>10</b>–<b>13</b>). <i>N</i>-Ethylcarboxamido derivatives of this series showed lower selectivity vs A<sub>1</sub>AR and A<sub>2A</sub>AR subtypes if compared to the corresponding MECA-related compounds. <i>N</i><sup>6</sup>-Methyl substitution increased A<sub>3</sub>ARs affinity from 3- to 8-fold if compared to unsubstitution, reaching subnanomolar values. Compound <b>12</b> stands out as one of the most potent and selective hA<sub>3</sub>AR agonists so far reported. The authors highlighted the presence of an alkylcarboxamido group in the 4′-position to be essential to obtain full agonists at the A<sub>3</sub>AR subtype, as adenosine-related analogues presented a profile from partial agonists to antagonists (see compound <b>71</b>of the antagonists section).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Molecular modeling studies of these derivatives have been recently performed.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> A series of <i>N</i><sup>6</sup>-ethyl-2-alkynyl NECA derivatives has been later reported by Zhu et al. of which compound <b>14</b> exhibited hA<sub>3</sub>AR affinity similar to that of <b>6a</b> or <b>6b</b> but with significantly improved hA<sub>3</sub>/hA<sub>1</sub>AR selectivity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p last">Strictly in agreement with Cristalli’s work, Cosyn et al. found relevant affinity for the A<sub>3</sub>AR in a series of 2-triazolyl-<i>N</i><sup>6</sup>-methyladenosines,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> although associated with reduced relative efficacy (see compound <b>75</b> of the antagonists section). Also this study confirmed that in order to maintain efficacy, a 5′-ethyluronamide was necessary such as in compound <b>15</b> displaying full agonism (efficacy of 90%) at the hA<sub>3</sub>AR with a <i>K</i><sub>i</sub> of 1.8 nM and good selectivity over hA<sub>1</sub> (<i>K</i><sub>i</sub> = 1640) and hA<sub>2A</sub>ARs (displacement at 10 μM of 45%).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> 3′-OH Modification</h3><div class="NLM_p">Different studies highlighted the importance of both the 2′- and 3′-hydroxyl groups of the ribose nucleus to ensure efficacy and affinity of adenosine-related molecules at the hA<sub>3</sub>AR. As a matter of fact, the replacement of either these moieties, especially the 2′-OH, with fluorine atoms determined a marked worsening of the binding profile.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> DeNinno et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> reinforced the hypothesis of a role of the 3′-OH group as a hydrogen bond donor, since 3′-NH<sub>2</sub> adenosine analogues, if properly modified at the 5′ and <i>N</i><sup>6</sup> positions, preserved good affinity and selectivity at the A<sub>3</sub>AR. The 3′-NH<sub>2</sub> group promoted as well as water solubility. Of this series, <b>CP608039</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (<b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) was chosen for clinical development as a full agonist and was able to bind hA<sub>3</sub>ARs with a <i>K</i><sub>i</sub> of 5.8 nM with over 1000-fold selectivity versus the hA<sub>1</sub>AR. Even greater selectivity was observed over the hA<sub>2A</sub> and hA<sub>2B</sub>AR subtypes (<i>K</i><sub>i</sub> > 50 μM). Essentially, only small hydrogen bonding donors, like a hydroxyl or amino group, at the 3′-position of adenosine can be tolerated, since a series of 3′-acetamidoadenosine derivatives was shown to be totally devoid of affinity at the A<sub>3</sub>AR.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative collection of 3′-OH (<b>16</b>) or ribose (<b>17</b>–<b>22</b>) modified adenosine derivatives, nonadenine nucleosides (<b>23</b>), and non-nucleosides (<b>24</b>) as A<sub>3</sub>AR agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Modification of the Pentose Ring: 4′-Thio Derivatives</h3><div class="NLM_p last">The bioisosteric replacement of the endocyclic oxygen of the pentose ring with a sulfur atom led Jeong at al. to the discovery of a series of <i>N</i><sup>6</sup>-substituted (2-Cl)-4′-thioadenosine-5′-uronamides<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> and <i>N</i><sup>6</sup>-substituted 4′-thioadenosines<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> as highly potent and selective agonists. Among all the synthesized 5′-uronamides, the 5′-methyluronamide function was the most helpful to promote A<sub>3</sub>AR affinity and potency. LJ-530<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (<b>17</b>, <i>K</i><sub>i</sub> = 0.28 nM) is one the most potent and selective compound of the series. The <i>N</i><sup>6</sup>-3-iodobenzyl analogues <b>18</b> also showed potent in vitro and in vivo anticancer activity.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> The removal of the 2-Cl atom led to thio-IB-MECA (<b>19</b>), which is the most potent compound of the 4′-thioadenosine series, with high A<sub>3</sub>AR affinity across species (<i>K</i><sub>i</sub> for the rat A<sub>3</sub>AR of 1.86 nM), although such structural modification determined a decrease of A<sub>3</sub>AR vs A<sub>1</sub>AR selectivity.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Larger 5′-uronamide substituents occasionally led to reduction of efficacy, which was also observed in the 4′-thioadenosine series when a substituted benzyl group at the <i>N</i><sup>6</sup> position was present.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> For these regions, 4′-thioadenosines were also scrutinized as a source of adenosine-related antagonists for the A<sub>3</sub>ARs (see the relevant section below).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Modification of the Pentose Ring: Methanocarba(bicyclo[3.1.0]hexane) Ring Systems</h3><div class="NLM_p last">Nucleoside analogues containing a rigid scaffold in place of the ribose ring have been explored as ligands for the ARs. A structure widely investigated by Jacobson and co-workers, for this purpose, is the methanocarba (bicyclo[3.1.0]hexane) ring system,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> which is in line with receptor docking of the ribose ring, indicating that the endocyclic oxygen would not be required for interaction with ARs. In methanocarba analogues, a fused cyclopropane ring constrains the accompanying cyclopentane moiety to mimic the conformation of a rigid furanose ring held in either a Northern (N) or Southern (S) conformation. These ribose modifications were combined with modifications that had been previously shown to support A<sub>3</sub>AR affinity. (N)-Methanocarba-adenosine was favored in A<sub>3</sub>AR binding by 150-fold over the (S)-conformation and by 2.5-fold over adenosine. The (N)-methanocarba-<i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine and its 2-chloro derivative had <i>K</i><sub>i</sub> values of 4.1 and 2.2 nM at A<sub>3</sub>ARs, respectively, and were highly selective partial agonists. 5′-Alkyluronamide modification of the (N)-methanocarba nucleus increased by 6-fold the hA<sub>3</sub>AR affinity. Of this series, MRS3558<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (<b>20</b>) has the pharmacological profile of a full agonist with subnanomolar A<sub>3</sub>AR potency. The utility of <b>20</b>in treating lung injury was shown in a model of ischemia reperfusion lung injury.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Gao et al. synthesized a radioiodinated form of the 3-iodobenzyl analogues of <b>20</b>, which was selected for radiolabeling because of its high A<sub>3</sub>AR affinity across species, with nanomolar affinity at both rat and human A<sub>3</sub>ARs.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Further SAR extension on <b>20</b>-related molecules<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> confirmed that a 5′-uronamide moiety would be essential to promote full agonism at the A<sub>3</sub>AR, since 5′-OH substitution has been exploited to develop A<sub>3</sub>AR antagonists. Moreover, 5′-uronamide in the (N)-methanocarba series, as in the ribose series, proved to counter the loss of efficacy associated with substitutions of the <i>N</i><sup>6</sup>-position. The introduction of 2-alkynyl chains of varying length gave rise to potent and selective agonists such as compound <b>21</b>.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The terminal reactive carboxylates, esters, or amino groups on the <i>C</i><sup>2</sup>-alkynyl chain of such derivatives have been exploited for conjugation with biotin or fluorescent cyanine dye in view of possible imaging employments. To the same purpose, a series of 2-dialkynyl (N)-methanocarba adenosines were later prepared<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> in which the distal alkyne was shown to react selectively with alkyl-/arylazides by click cycloaddition to form triazole derivatives of general structure <b>22</b>. These molecules displayed functional properties from partial to full agonists at the A<sub>3</sub>AR. Among the latter, the substitution of the triazole nitrogen with a 4-(α-bromophenacyl) group led to the most potent and selective compound (MRS5226,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a><i>K</i><sub>i</sub> = 9.6 nM).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Non-Adenine Nucleosides and Non-Nucleosides as A<sub>3</sub> Adenosine Receptor Agonists</h3><div class="NLM_p last">The substitution of the adenine ring of MECA with a 1,3-disubstituted xanthine, as in compound <b>23</b> (<i>N</i>-ethyl-1,3-dibutylxanthine-7-β-<span class="smallcaps smallerCapital">d</span>-ribofuronamide) led to the discovery of non-adenine A<sub>3</sub>AR agonist with fair selectivity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Moreover, a series of non-nucleoside agonist ligands with variable selectivity profile at the ARs were reported,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> among which the pyridine-3,5-dicarbonitrile <b>24</b>, although having higher affinity at the A<sub>1</sub>AR and potency at the A<sub>2B</sub>AR, displayed an interesting affinity also at the A<sub>3</sub>AR, which could be considered for the development of more selective A<sub>3</sub>AR ligands in this series.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">A<sub>3</sub> Adenosine Receptor Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initial attempts to obtain A<sub>3</sub>AR antagonists focused on broad screening of different heterocyclic systems. Some xanthine or purine analogues were examined first, but none of the tested compounds showed significant affinity or selectivity at rA<sub>3</sub>AR.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> During subsequent evaluations, a large number of compounds with high potency and selectivity in antagonizing the hA<sub>3</sub>AR were recognized as being generally characterized by remarkable structural diversity as nitrogen-containing aromatic monocyclic/bicyclic/tricyclic systems and, more recently, nucleoside-derived antagonists. The SAR of adenosine antagonists at the A<sub>3</sub>AR was recently reviewed.<a onclick="showRef(event, 'ref24 ref25 ref26 ref62'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref62">(24-26, 62)</a> In this section, we summarized the leading achievements of the field expanding on and updating our earlier reviews<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and book chapters<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> on the examined topic.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Monocyclic Systems</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Pyridine Derivatives</h4><div class="NLM_p">After the first evidence that 1,4-dihydropyridines exerted affinity to ARs, Jacobson and co-workers exploited this nucleus as a template for probing SAR profile at A<sub>3</sub>AR.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The replacement of the methyl ester at the 5-position of nifedipine with the larger 4-NO<sub>2</sub>-benzyl ester, combined with the introduction of a phenyl ring and a phenylethynyl moiety at the 6- and 4-positions, respectively, led to compound <b>25</b> (MRS1334,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) in which the antagonism at L-type calcium channels was shifted to the A<sub>3</sub>AR. The AR binding profile of 3,5-diacyl-2,4-dialkylpyridines obtained from the oxidation of the corresponding 1,4-dihydropyridines has also been examined.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The most potent compounds of this series, unlike the dihydropyridines, were substituted at the 4-position with small alkyl groups (<b>26</b>, MRS1505).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Potent fluorinated and hydroxylated pyridine derivatives have also been reported, and an extension of this research performed by Jacobson and co-workers led to a series of <i>N</i>-alkylpyridinium salts with improved water solubility.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Monocyclic systems as A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding, Selectivities, and Functional Parameters of the Most Representative A<sub>3</sub>AR Antagonists<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">A<sub>1</sub>AR</th><th class="colsep0 rowsep0" align="center">A<sub>2A</sub>AR</th><th class="colsep0 rowsep0" align="center">A<sub>3</sub>AR</th><th class="colsep0 rowsep0" align="center">A<sub>3</sub>AR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">A<sub>1</sub>/A<sub>3</sub></th><th class="colsep0 rowsep0" align="center">A<sub>2A</sub>/A<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="center">Monocyclic System</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>100000 (r)</td><td class="colsep0 rowsep0" align="left">>100000 (r)</td><td class="colsep0 rowsep0" align="left">2.69 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>26 (r)</td><td class="colsep0 rowsep0" align="left">>26 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3850 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">41400 (r)</td><td class="colsep0 rowsep0" align="left">24100 (r)</td><td class="colsep0 rowsep0" align="left">7.9 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">51 (r)</td><td class="colsep0 rowsep0" align="left">30 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">814 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></td><td class="colsep0 rowsep0" align="left">2443 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">1.8 (h)</td><td class="colsep0 rowsep0" align="left">2.7 (h)</td><td class="colsep0 rowsep0" align="left">1357 (h)</td><td class="colsep0 rowsep0" align="left">>5555 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></td><td class="colsep0 rowsep0" align="left">>100 (h)</td><td class="colsep0 rowsep0" align="left">>100 (h)</td><td class="colsep0 rowsep0" align="left">3.6 (h)</td><td class="colsep0 rowsep0" align="left">3.6 (h)<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>28 (h)</td><td class="colsep0 rowsep0" align="left">>28 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">0.79 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>12658 (h)</td><td class="colsep0 rowsep0" align="left">>12658</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b><a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">0.41 (h)</td><td class="colsep0 rowsep0" align="left">9.6 (h)<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>24390 (h)</td><td class="colsep0 rowsep0" align="left">>24390 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b><a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></td><td class="colsep0 rowsep0" align="left">>666 (h)</td><td class="colsep0 rowsep0" align="left">>826 (h)</td><td class="colsep0 rowsep0" align="left">0.36 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>1850 (h)</td><td class="colsep0 rowsep0" align="left">>2294 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.6 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="center">Bicyclic System</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">561 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>1.8 (r)</td><td class="colsep0 rowsep0" align="left">>1.8 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5500 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a onclick="showRef(event, 'ref26 ref123'); return false;" href="javascript:void(0);" class="ref ref26 ref123">(26, 123)</a></td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">17 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>588 (h)</td><td class="colsep0 rowsep0" align="left">>588 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4200 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">4.0 (h)</td><td class="colsep0 rowsep0" align="left">7.9 (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b><a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">0.78 (h)</td><td class="colsep0 rowsep0" align="left">8.3 (h)</td><td class="colsep0 rowsep0" align="left">>12820 (h)</td><td class="colsep0 rowsep0" align="left">>12820 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">8000 (h)</td><td class="colsep0 rowsep0" align="left">833 (h)</td><td class="colsep0 rowsep0" align="left">26 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">308 (h)</td><td class="colsep0 rowsep0" align="left">32 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></td><td class="colsep0 rowsep0" align="left">430 (h)</td><td class="colsep0 rowsep0" align="left">8050 (h)</td><td class="colsep0 rowsep0" align="left">6.0 (h)</td><td class="colsep0 rowsep0" align="left">148 (h)</td><td class="colsep0 rowsep0" align="left">72 (h)</td><td class="colsep0 rowsep0" align="left">1342 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">47 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>213 (h)</td><td class="colsep0 rowsep0" align="left">>213 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td><td class="colsep0 rowsep0" align="left">1037 (h)</td><td class="colsep0 rowsep0" align="left">3179 (h)</td><td class="colsep0 rowsep0" align="left">0.18 (h)</td><td class="colsep0 rowsep0" align="left">2.4 (h)</td><td class="colsep0 rowsep0" align="left">5761 (h)</td><td class="colsep0 rowsep0" align="left">17661 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">2.9 (h)</td><td class="colsep0 rowsep0" align="left">8.2 (h)</td><td class="colsep0 rowsep0" align="left">>3448 (h)</td><td class="colsep0 rowsep0" align="left">>3448 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">1.2 (h)</td><td class="colsep0 rowsep0" align="left">5.2 (h)</td><td class="colsep0 rowsep0" align="left">>833 (h)</td><td class="colsep0 rowsep0" align="left">>833 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="center">Tricyclic System</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">231 (h)</td><td class="colsep0 rowsep0" align="left">25 (h)</td><td class="colsep0 rowsep0" align="left">0.59 (h)</td><td class="colsep0 rowsep0" align="left">1.7 (h)<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">391 (h)</td><td class="colsep0 rowsep0" align="left">42 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">53 (r)</td><td class="colsep0 rowsep0" align="left">10 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.2 (h)<a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)<a class="ref internalNav" href="#t2fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)<a class="ref internalNav" href="#t2fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">8.2 (h)<a class="ref internalNav" href="#t2fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>1219 (h)</td><td class="colsep0 rowsep0" align="left">>1219 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">2.1 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>4762 (h)</td><td class="colsep0 rowsep0" align="left">>4762 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">9.0 (h)</td><td class="colsep0 rowsep0" align="left">34 (h)</td><td class="colsep0 rowsep0" align="left">>111 (h)</td><td class="colsep0 rowsep0" align="left">>111 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (b)</td><td class="colsep0 rowsep0" align="left">4.7 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>2128 (h)</td><td class="colsep0 rowsep0" align="left">>2128 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000(h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">0.80 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>12500 (h)</td><td class="colsep0 rowsep0" align="left">>12500 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">2.1 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>4762 (h)</td><td class="colsep0 rowsep0" align="left">>4762 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b><a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></td><td class="colsep0 rowsep0" align="left">2700 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">1.6 (h)</td><td class="colsep0 rowsep0" align="left">3.1 (h)</td><td class="colsep0 rowsep0" align="left">1687 (h)</td><td class="colsep0 rowsep0" align="left">>6250 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td><td class="colsep0 rowsep0" align="left">114 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">3.3 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">34 (h)</td><td class="colsep0 rowsep0" align="left">>3030 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></td><td class="colsep0 rowsep0" align="left">1100 (h)</td><td class="colsep0 rowsep0" align="left">140 (h)</td><td class="colsep0 rowsep0" align="left">0.29 (h)</td><td class="colsep0 rowsep0" align="left">4.5 (h)</td><td class="colsep0 rowsep0" align="left">3793 (h)</td><td class="colsep0 rowsep0" align="left">483 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left">1990 (r)</td><td class="colsep0 rowsep0" align="left">>10000 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td><td class="colsep0 rowsep0" align="left">350 (h)</td><td class="colsep0 rowsep0" align="left">100 (h)</td><td class="colsep0 rowsep0" align="left">0.01 (h)</td><td class="colsep0 rowsep0" align="left">0.7 (h)</td><td class="colsep0 rowsep0" align="left">35000 (h)</td><td class="colsep0 rowsep0" align="left">10000 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">>30000 (h)</td><td class="colsep0 rowsep0" align="left">>100000 (h)</td><td class="colsep0 rowsep0" align="left">2.1 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>14286 (h)</td><td class="colsep0 rowsep0" align="left">>47619 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">562 (h)</td><td class="colsep0 rowsep0" align="left">778 (h)</td><td class="colsep0 rowsep0" align="left">0.11 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">5109 (h)</td><td class="colsep0 rowsep0" align="left">7072 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">>30000 (h)</td><td class="colsep0 rowsep0" align="left">>100000 (h)</td><td class="colsep0 rowsep0" align="left">0.24 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>125000 (h)</td><td class="colsep0 rowsep0" align="left">>416667 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td><td class="colsep0 rowsep0" align="left">>100000 (h)</td><td class="colsep0 rowsep0" align="left">>100000 (h)</td><td class="colsep0 rowsep0" align="left">2.1 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>47619 (h)</td><td class="colsep0 rowsep0" align="left">>47619 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57a</b><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td><td class="colsep0 rowsep0" align="left">800 (h)</td><td class="colsep0 rowsep0" align="left">500 (h)</td><td class="colsep0 rowsep0" align="left">15 (h)</td><td class="colsep0 rowsep0" align="left">75 (h)</td><td class="colsep0 rowsep0" align="left">53 (h)</td><td class="colsep0 rowsep0" align="left">33 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57b</b><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td><td class="colsep0 rowsep0" align="left">743 (h)</td><td class="colsep0 rowsep0" align="left">200 (h)</td><td class="colsep0 rowsep0" align="left">10 (h)</td><td class="colsep0 rowsep0" align="left">50 (h)</td><td class="colsep0 rowsep0" align="left">74 (h)</td><td class="colsep0 rowsep0" align="left">20 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td><td class="colsep0 rowsep0" align="left">923 (h)</td><td class="colsep0 rowsep0" align="left">222 (h)</td><td class="colsep0 rowsep0" align="left">110 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">8.4 (h)</td><td class="colsep0 rowsep0" align="left">2 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td><td class="colsep0 rowsep0" align="left">129 (h)</td><td class="colsep0 rowsep0" align="left">68 (h)</td><td class="colsep0 rowsep0" align="left">61 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2.1 (h)</td><td class="colsep0 rowsep0" align="left">1.1 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">0.95 (h)</td><td class="colsep0 rowsep0" align="left">0.61 (h)</td><td class="colsep0 rowsep0" align="left">>10526 (h)</td><td class="colsep0 rowsep0" align="left">>10526 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td><td class="colsep0 rowsep0" align="left">50 (h)</td><td class="colsep0 rowsep0" align="left">119 (h)</td><td class="colsep0 rowsep0" align="left">4 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">12 (h)</td><td class="colsep0 rowsep0" align="left">30 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">35 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>286 (h)</td><td class="colsep0 rowsep0" align="left">>286 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">2.2 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>4545 (h)</td><td class="colsep0 rowsep0" align="left">>4545 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">0.80 (h)</td><td class="colsep0 rowsep0" align="left">5.0 (h)</td><td class="colsep0 rowsep0" align="left">>1250 (h)</td><td class="colsep0 rowsep0" align="left">>1250 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">>1000 (h)</td><td class="colsep0 rowsep0" align="left">3.5 (h)</td><td class="colsep0 rowsep0" align="left">18 (h)</td><td class="colsep0 rowsep0" align="left">>286 (h)</td><td class="colsep0 rowsep0" align="left">>286 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></td><td class="colsep0 rowsep0" align="left">1640 (h)</td><td class="colsep0 rowsep0" align="left">1280 (h)</td><td class="colsep0 rowsep0" align="left">2.3 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">713 (h)</td><td class="colsep0 rowsep0" align="left">556 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">440 (r)</td><td class="colsep0 rowsep0" align="left">2100 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></td><td class="colsep0 rowsep0" align="left">1800 (h)</td><td class="colsep0 rowsep0" align="left">470 (h)</td><td class="colsep0 rowsep0" align="left">0.20 (h)</td><td class="colsep0 rowsep0" align="left">270 (h)<a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">9000 (h)</td><td class="colsep0 rowsep0" align="left">2350 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td><td class="colsep0 rowsep0" align="left">2525 (h)</td><td class="colsep0 rowsep0" align="left">>5000 (h)</td><td class="colsep0 rowsep0" align="left">1.5 (h)</td><td class="colsep0 rowsep0" align="left">23 (h)</td><td class="colsep0 rowsep0" align="left">1329 (h)</td><td class="colsep0 rowsep0" align="left">>3333 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td><td class="colsep0 rowsep0" align="left">3023 (h)</td><td class="colsep0 rowsep0" align="left">1520 (h)</td><td class="colsep0 rowsep0" align="left">1.9 (h)</td><td class="colsep0 rowsep0" align="left">15 (h)</td><td class="colsep0 rowsep0" align="left">1591 (h)</td><td class="colsep0 rowsep0" align="left">800 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="center">Nucleoside-Derived A<sub>3</sub>AR Antagonist</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">>100000 (h)</td><td class="colsep0 rowsep0" align="left">>100000 (h)</td><td class="colsep0 rowsep0" align="left">650 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>154 (h)</td><td class="colsep0 rowsep0" align="left">>154 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></td><td class="colsep0 rowsep0" align="left">437 (h)</td><td class="colsep0 rowsep0" align="left">2960 (h)</td><td class="colsep0 rowsep0" align="left">2.3 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">190 (h)</td><td class="colsep0 rowsep0" align="left">1287 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td><td class="colsep0 rowsep0" align="left">50 (h)</td><td class="colsep0 rowsep0" align="left">510 (h)</td><td class="colsep0 rowsep0" align="left">3.9 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">12.8 (h)</td><td class="colsep0 rowsep0" align="left">131 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">44 (r)</td><td class="colsep0 rowsep0" align="left">75 (r)</td><td class="colsep0 rowsep0" align="left">538 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12 (r)</td><td class="colsep0 rowsep0" align="left">7.2 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></td><td class="colsep0 rowsep0" align="left">4640 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">75 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">61 (h)</td><td class="colsep0 rowsep0" align="left">>133 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1350 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b><a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">32 (h)</td><td class="colsep0 rowsep0" align="left">0.16 (h)</td><td class="colsep0 rowsep0" align="left">>312 (h)</td><td class="colsep0 rowsep0" align="left">>312 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></td><td class="colsep0 rowsep0" align="left">335 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">1.3 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">258 (h)</td><td class="colsep0 rowsep0" align="left">>7692 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></td><td class="colsep0 rowsep0" align="left">1000 (h)</td><td class="colsep0 rowsep0" align="left">16 (h)</td><td class="colsep0 rowsep0" align="left">16 (h)</td><td class="colsep0 rowsep0" align="left">5.0 (h)</td><td class="colsep0 rowsep0" align="left">62 (h)</td><td class="colsep0 rowsep0" align="left">1 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b><a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></td><td class="colsep0 rowsep0" align="left">12100 (h)</td><td class="colsep0 rowsep0" align="left">29800 (h)</td><td class="colsep0 rowsep0" align="left">29 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">417 (h)</td><td class="colsep0 rowsep0" align="left">1028 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></td><td class="colsep0 rowsep0" align="left">>3000 (h)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.2 (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></td><td class="colsep0 rowsep0" align="left">>3000 (h)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12 (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td><td class="colsep0 rowsep0" align="left">5870 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">29 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">202 (h)</td><td class="colsep0 rowsep0" align="left">>345 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td><td class="colsep0 rowsep0" align="left">6220 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">16 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">389 (h)</td><td class="colsep0 rowsep0" align="left">625 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">321 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b><a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">9.3 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>1075 (h)</td><td class="colsep0 rowsep0" align="left">>1075 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">1.7 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>5882 (h)</td><td class="colsep0 rowsep0" align="left">>5882 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6.2 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td><td class="colsep0 rowsep0" align="left">2490 (h)</td><td class="colsep0 rowsep0" align="left">341(h)</td><td class="colsep0 rowsep0" align="left">4.2 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">593 (h)</td><td class="colsep0 rowsep0" align="left">81 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.9 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td><td class="colsep0 rowsep0" align="left">1150 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">13 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">88 (h)</td><td class="colsep0 rowsep0" align="left">>769 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">83 (r)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="left">110 (h)</td><td class="colsep0 rowsep0" align="left">>10000 (h)</td><td class="colsep0 rowsep0" align="left">4.3 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">26 (h)</td><td class="colsep0 rowsep0" align="left">>2325 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></td><td class="colsep0 rowsep0" align="left">3040 (h)</td><td class="colsep0 rowsep0" align="left">1080 (h)</td><td class="colsep0 rowsep0" align="left">1.4 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2171 (h)</td><td class="colsep0 rowsep0" align="left">771 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></td><td class="colsep0 rowsep0" align="left">1760 (h)</td><td class="colsep0 rowsep0" align="left">1600 (h)</td><td class="colsep0 rowsep0" align="left">0.73 (h)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2411 (h)</td><td class="colsep0 rowsep0" align="left">2192 (h)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">The values are evaluated in human (h), bovine (b), rat (r) tissues or cells. For detailed experimental conditions see the cited references.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> (nM) from competition binding experiments, unless otherwise specified.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last">IC<sub>50</sub> (nM) from cyclic AMP assays, unless otherwise specified.</p></div><div class="footnote" id="t2fn3"><sup>d</sup><p class="last"><i>K</i><sub>B</sub> value from cyclic AMP assays.</p></div><div class="footnote" id="t2fn4"><sup>e</sup><p class="last">IC<sub>50</sub> (nM) from GTPγS assays.</p></div><div class="footnote" id="t2fn5"><sup>f</sup><p class="last">IC<sub>50</sub> (nM) from competition binding experiments.</p></div></div></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Pyrimidines</h4><div class="NLM_p">As a part of the endogenous ligand (adenosine), the pyrimidine core has been particularly exploited, as such or within bi- and tricyclic systems displaying ARs antagonism.</div><div class="NLM_p last">A series of 4-amino-6-hydroxy-2-mercaptopyrimidine derivatives has been synthesized and biologically evaluated as A<sub>3</sub>AR antagonists.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The stepwise lead optimization resulted in compounds with very potent affinity and selectivity at the hA<sub>3</sub>AR such as <b>27</b>. Several important attractive interactions have been highlighted when representative molecules were docked into a model of A<sub>3</sub>AR. Compound <i>N</i>-[2,6-bis(4-methoxyphenyl)pyrimidin-4-yl]acetamide (<b>28</b>) was recently identified as a potent hA<sub>3</sub>AR antagonist among two regioisomeric series of diaryl-2- or 4-amidopyrimidines. The structural determinants supporting the binding profiles of the series were evaluated through an exhaustive computational investigation.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a></div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Thiazoles and Thiadiazoles</h4><div class="NLM_p last">These derivatives were originally identified by simplifying the bicyclic heterocyclic ring system of isoquinolines and quinazolines (see below) with several monocyclic rings.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Derivative <i>N</i>-[3-(4-methoxyphenyl)[1,2,4]thiadiazol-5-yl]acetamide (<b>29</b>) was later claimed as a potent A<sub>3</sub>AR antagonist with a <i>K</i><sub>i</sub> of 0.79 nM.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The SAR studies revealed that a 5-(pyridine-4-yl) moiety on a 2-aminothiazole ring was also optimal for enhancing receptor potency and selectivity.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Compound <i>N</i>-[4-(3,4,5-trimethoxyphenyl)-5-pyridin-4-ylthiazol-2-yl]acetamide <b>30</b> showed subnanomolar affinity at the hA<sub>3</sub>AR with over 20000-fold selectivity against hA<sub>1</sub>AR and hA<sub>2A</sub>AR and 8000-fold selectivity versus hA<sub>2B</sub>AR. The introduction of an aromatic acyl substituent at the 2-position of the thiazole ring, such as benzoyl, nicotinoyl (compound <b>31</b>), or isonicotinoyl, led to compounds with good human and rat A<sub>3</sub>AR affinity as well as selectivity over hA<sub>1</sub>AR and hA<sub>2A</sub>AR. Note that 5-(pyridine-4-yl)-2-aminothiazoles (<b>30</b> and <b>31</b>) are among the few molecules that display potent antagonist activity against both rat and human A<sub>3</sub>ARs. Compound <b>30</b> was shown to selectively block the rat A<sub>3</sub>AR in vivo.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In addition, in an in vivo rat model, compound <b>31</b> inhibited IB-MECA-induced plasma protein extravasation in the skin of rats, demonstrating a good oral absorption profile and bioavailability.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> It also increased the antiasthmatic effect of dexamethasone by combination therapy, and these results suggested that the A<sub>3</sub>AR antagonist could become a new type of antiasthma drug as an enhancer of steroids.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Bicyclic Systems</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Flavonoid Derivatives</h4><div class="NLM_p">Some flavonoids revealed micromolar affinity at hA<sub>3</sub>AR after binding screening of different phytochemicals.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> MRS1067 (<b>32</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) resulted from SAR optimization of the flavone nucleus as the most potent and selective compound of this series at hA<sub>3</sub>AR subtype, while none of the tested derivatives showed significant affinity at the rA<sub>3</sub>AR .</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bicyclic systems as A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Isoquinolines, Quinazolines, Phthalazines, and Quinoxalines</h4><div class="NLM_p">In 1998 Ijzerman and co-workers identified a series of 3-(2-pyridinyl)isoquinoline derivatives with A<sub>3</sub>AR affinity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>Different substituents at the 1- and 3-positions were introduced, and the best results were obtained with the 3-(2-pyridinyl)-1-(4-methoxybenzoylamino)-derivative VUF8504<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<b>33</b>). Later, the effect of an additional endocyclic nitrogen was estimated by synthesizing bioisosteric quinazoline derivatives. An increased affinity was obtained by substitution of the 1-amide spacer with a urea moiety. VUF5574<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<b>34</b>) showed affinity at hA<sub>3</sub>AR in the nanomolar range, while it was ineffective at A<sub>1</sub>AR and A<sub>2A</sub>AR subtypes.</div><div class="NLM_p last">In 2007, Morizzo et al. reported a new series of 2-amino/2-oxoquinazoline-4-carboxamido derivatives resulting from an in silico molecular simplification approach of the 1,2,4-triazolo[4,3-<i>a</i>]quinoxalin-1-one template, extensively investigated by the same authors in the search for A<sub>3</sub>AR antagonists (see the relevant section below).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Very recently, an analogous strategy, applied to the same tricyclic skeleton, was confirmed to be effective for the identification of structurally simplified A<sub>3</sub>AR antagonists with the advantage of less complex synthetic routes.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> This study promoted the 2-phenylphthalazin-1(2<i>H</i>)-one ring system to a new versatile core suitable for molecular manipulation. Substitution of the 4-position with different amido and ureido moieties led to compound <b>35</b> possessing the best binding profile of the series. The 2-(4-methyl-1<i>H</i>-benzoimidazol-2-yl)quinoxaline <b>36</b> deserves to be mentioned for the novelty of the design strategy applying a 3D database searching approach.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Adenines and Adenine-like Derivatives</h4><div class="NLM_p">The first class of A<sub>3</sub>AR selective antagonists with a bicyclic structure strictly related to adenine was claimed in 2005 by Biagi and co-workers.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The authors described the synthesis of a series of <i>N</i><sup>6</sup>-ureido-substituted-2-phenyl-9-benzyl-8-azaadenines whose adenine-like structure was responsible for the antagonist activity while a <i>N</i><sup>6</sup>-phenylcarbamoyl group ensured selectivity at the A<sub>3</sub>AR. The structure–activity relationship studies were performed on the systematic optimization of substituents at the 2-, 6-, and 9-positions of the bicyclic scaffold and guided the desired enhancement of A<sub>1</sub>/A<sub>3</sub>AR selectivity (compound <b>37</b>).</div><div class="NLM_p">On the basis of the finding that the known differentiation agent “reversine” (2-(4-morpholinoanilino)-<i>N</i><sup>6</sup>-cyclohexyladenine) exerted a moderate antagonist activity at the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> of 0.66 μM), Jacobson and co-workers developed a series of reversine analogues, focusing the attention on the substitution pattern at the 2- and <i>N</i><sup>6</sup>-position of the adenine scaffold.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> One of most interesting compounds in terms of hA<sub>3</sub>AR affinity and selectivity combines the <i>N</i><sup>6</sup>-cyclohexyl moiety of reversine with a 2-phenyloxy group (compound <b>38</b>). Few derivatives tested in binding assays to the rA<sub>3</sub>AR seemed to reflect the species dependence of the affinity typical of most known A<sub>3</sub>AR antagonists, shown to be inactive at 10 μM.</div><div class="NLM_p last">The pyrazolo[3,4-<i>d</i>]pyrimidine nucleus represents a novel bicyclic scaffold structurally related to adenine, which has been recently examined in view of identifying A<sub>3</sub>AR antagonists.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The SAR profile of this series would indicate that amido (<b>39</b>) or ureido moieties (<b>40</b>) at the 4-position along with a phenyl ring at the 6-position are essential for promoting A<sub>3</sub>AR affinity and selectivity. The <i>N</i><sup>2</sup>-position seems to be characterized by a good degree of steric tolerance, since both the small methyl group (<b>39</b>) and the bulkier benzyl moiety (<b>40</b>) are well tolerated. Compound <b>39</b>, standing out for the subnanomolar affinity at the A<sub>3</sub>AR and the high selectivity versus the remaining AR subtypes, has been suggested as a promising lead compound for the development of adjuvant agents in glioma chemotherapy. The compound proved, indeed, to counter the A<sub>3</sub>AR selective agonist-mediated proliferation (i.e., Cl-IB-MECA and IB-MECA) in human glioma U87MG cells. A series of junction isomers of <b>39</b> and <b>40</b> (i.e., 2-arylpyrazolo[4,3-<i>d</i>]pyrimidin-7-one derivatives), originating from the molecular simplification of the tricyclic pyrazolo[3,4-<i>c</i>]quinolin-4-one skeleton (see tricyclic systems), was reported by Lenzi and co-workers in 2009.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Aryl/arylalkyl substitution at the 5-position of such derivatives was poorly tolerated for A<sub>3</sub>AR binding affinity, while small groups at the same position were shown to enhance ligand–receptor interaction. In addition, the substitution of the 2-phenyl ring with a 4-methoxy group led to the most potent compounds of the series (<b>41</b>).</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Tricyclic Systems</h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Triazoloquinazoline</h4><div class="NLM_p">Jacobson and co-workers first demonstrated that the acylation of the 5-amino group of the AR antagonist 9-chloro-2-(2-furanyl)[1,2,4]triazolo[1,5-<i>c</i>]quinazoline-5-amine (CGS15943, hA<sub>1</sub><i>K</i><sub>i</sub> = 3.5 nM; hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.4 nM; hA<sub>2B</sub> IC<sub>50</sub> = 44 nM; hA<sub>3</sub><i>K</i><sub>i</sub> = 95 nM) enhances both hA<sub>3</sub>AR affinity and selectivity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound MRS1220<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<b>42</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) showed subnanomolar affinity at the hA<sub>3</sub>AR with ∼400- and ∼40-fold selectivity vs A<sub>1</sub>AR and A<sub>2A</sub>AR subtypes, respectively. The removal of the 9-Cl atom along with the replacement of the 5-phenylacetamido and the 2-furyl moieties with a linear alkyl chain and a 4-Br-phenyl ring, respectively, led Okamura et al. to the discovery of derivative <b>43</b> as a potent and selective A<sub>3</sub>AR antagonist.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative collection of tricyclic systems as A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Pyrazolo[3,4-<i>c</i>]/[4,3-<i>c</i>]quinolines</h4><div class="NLM_p last">The binding affinity at bovine A<sub>1</sub>AR and A<sub>2A</sub>AR and at human cloned A<sub>3</sub>ARs of some 2-arylpyrazolo[3,4-<i>c</i>]quinolin-4-ones, 4-amines, and 4-substituted amino derivatives have been reported by Colotta et al. in 2000.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The 4-benzoylamido derivative <b>44</b> exhibited one of the best binding profiles of the series as A<sub>3</sub>AR antagonist. The same group reported some extensions of the SAR study about this class of compounds, highlighting that bulky and lipophilic (hetero)aroylamino groups or a benzylcarbamoyl residue at the 4-position was quite tolerated for hA<sub>3</sub>AR binding potency and selectivity.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a> Although displaying micromolar affinity at the rA<sub>3</sub>AR, selected compounds of these series were tested in an in vitro rat model of cerebral ischemia and proved to prevent the irreversible failure of synaptic activity induced by oxygen and glucose deficiency in the hippocampus, thus confirming that A<sub>3</sub>AR antagonists may substantially increase the tissue resistance to ischemic damage. The synthesis and the affinity profile at ARs of a series of 2-phenyl-2,5-dihydropyrazolo[4,3-<i>c</i>]quinolin-4-ones, conceived as structural isomers of the parent 2-arylpyrazolo[3,4-<i>c</i>]quinoline derivatives, have also been reported.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Some of the compounds synthesized showed A<sub>3</sub>AR affinity in the nanomolar range and good selectivity as evaluated in radioligand binding assays at hARs. In particular, substitution at the 4-position of the 2-phenyl ring with a methyl, methoxy, or chlorine group and the presence of a 4-oxo functionality gave good activity and selectivity (compound <b>45</b>).</div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Triazolo[4,3-<i>a</i>]/[1,5-<i>a</i>]quinoxalines</h4><div class="NLM_p">Interesting studies performed in the past decade by Colotta and co-workers highlighted that the 1,2,4-triazolo[4,3-<i>a</i>]quinoxalin-1-one is an attractive scaffold for obtaining potent and selective hA<sub>3</sub>AR antagonists.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> An intensive synthetic work based on the systematic substitution of the 2-, 4-, and 6-positions of the tricyclic template along with molecular modeling investigations performed to rationalize the experimental SAR findings led to the identification of the optimal structural requirements for A<sub>3</sub>AR affinity and selectivity. In particular, introduction in the triazoloquinoxaline moiety of a 4-oxo (compound <b>46</b>) or 4-<i>N</i>-amido (compound <b>47</b>) function afforded selective and/or potent A<sub>3</sub>AR antagonists, indicating that a C═O group, either extranuclear or nuclear, was necessary for A<sub>3</sub>AR affinity. This suggested the probable engagement of this site of the molecule in a hydrogen bond with the A<sub>3</sub>AR binding site. Hindering and lipophilic 4-acylamino moieties were shown to enhance A<sub>3</sub>AR affinity (compound <b>47</b>). Substitution of the 4′-position of the 2-phenyl ring with a methoxy or a nitro group and 6-nitro substitution, as well as the combination of these substituents, afforded nanomolar A<sub>3</sub>AR affinity and selectivity. For these reasons, 1-oxo, 6-nitro, and 4-amino groups have been supposed to be involved in hydrogen bond anchoring to the binding site.</div><div class="NLM_p last">Some 2-aryl-8-chloro-1,2,4-triazolo[1,5-<i>a</i>]quinoxaline derivatives have been synthesized and tested in radioligand binding assays at bA<sub>1</sub> (bovine A<sub>1</sub>) and bA<sub>2A</sub> adenosine receptors and at hA<sub>1</sub> and hA<sub>3</sub> adenosine receptors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The SAR profiles of these compounds were in agreement with those previously reported for 2-aryl-1,2,4-triazolo[4,3-<i>a</i>]quinoxalines and 2-arylpyrazolo[3,4/4,3-<i>c</i>]quinolines, suggesting similar AR binding modes. These studies provided some interesting compounds, among them the 2-(4-methoxyphenyl)-1,2,4-triazolo[1,5-<i>a</i>]quinoxalin-4-one (<b>48</b>), which is the most potent and selective hA<sub>3</sub>AR antagonist of this series.</div></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1,2,3-Triazolo[1,2-<i>a</i>][1,2,4]benzotriazinones</h4><div class="NLM_p last">The structural manipulation of tricyclic ligands of the central benzodiazepine receptor led Da Settimo and co-workers to the identification of a series of 2-phenyl[1,2,3]triazolo[1,2-<i>a</i>][1,2,4]benzotriazin-1-ones, among which compound <b>49</b> stands out for its remarkable potency and selectivity at the A<sub>3</sub>AR (<i>K</i><sub>i</sub> values at the A<sub>1</sub>AR, A<sub>2A</sub>AR, A<sub>3</sub>AR of 2700, >10000, 1.6 nM, respectively, and IC<sub>50</sub> from cAMP assay at the A<sub>2B</sub>AR of > 1000 nM).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Interestingly, also the triazolobenzotriazinone nucleus presents isomeric analogy with the above-described triazoloquinoxalinone series (compounds <b>46</b>–<b>48</b>).</div></div><div id="sec3_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Pyrido[2,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>a</i>]pyrazines</h4><div class="NLM_p last">A series of 2-arylpyrido[2,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>a</i>]pyrazin-1-one derivatives, both 4-oxo- and 4-amino-substituted, was designed applying the isosteric replacement of the typical nitrobenzene moiety of the 1,2,4-triazolo[4,3-<i>a</i>]quinoxalin-1-one derivatives with a pyridine ring.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Thus, by replacement of the 6-NO<sub>2</sub> group of compound <b>46</b> with an endocyclic nitrogen, still capable of hydrogen bonding but devoid of unfavorable steric hindrance, compound <b>50</b> was identified.</div></div><div id="sec3_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</h4><div class="NLM_p">The importance of the pyrazolotriazolopyrimidine (PTP) nucleus for the development of AR antagonists has been widely reviewed.<a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79-81)</a> The first example of AR antagonist, containing the PTP scaffold, was reported by Gatta and co-workers.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> A large number of compounds originated from the structure–activity optimization work based on the systematic substitution at the <i>C</i><sup>2</sup>, <i>C</i><sup>5</sup>, <i>C</i><sup>9</sup>, <i>N</i><sup>7</sup>, and <i>N</i><sup>8</sup> positions.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The most potent and selective compounds at the hA<sub>3</sub>AR subtype were derived from the combination of a small alkyl chain at the <i>N</i><sup>8</sup>-pyrazole position with a (substituted)phenylcarbamoyl residue at the <i>N</i><sup>5</sup>-position. Compound <b>51</b> is one of the most representative components of this class with high affinity (<i>K</i><sub>i</sub> = 0.29 nM against [<sup>125</sup>I]AB-MECA binding to human receptors expressed in HEK293 cells) and good selectivity over the other hARs and has been also developed into a specific radioligand.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The bioisosteric replacement of the phenyl ring of the 5-phenylcarbamoyl moiety with a 4-pyridyl moiety<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> provided high water solubility while enhancing hA<sub>3</sub>AR affinity. Compound MRE-3005-F20<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> (<b>52</b>) and the corresponding HCl salt indeed showed an excellent binding profile with <i>K</i><sub>i</sub> values at hA<sub>3</sub>AR in the picomolar range (40 and 10 pM, respectively). Receptor modeling ascribed this increase of affinity, compared to neutral aryl carbamate derivatives, to strong electrostatic interactions between the pyridinium moiety and the side chain carbonyl oxygen atoms of Asn274 and Asn278, both located on TM7. Additional studies suggested the involvement of Tyr254 in an H-bond with the pyridyl ring to explain enhancement of receptor affinity and selectivity.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Several modeling investigations have been performed in the past years in order to elucidate the binding motif for PTPs and to identify key ligand–receptor interactions.<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83-85)</a></div><div class="NLM_p last">Recently, some interesting extensions of SAR studies about PTPs have been reported, the most innovative regarding substitution at the 2-position where a 2-furyl group has been for a long time considered as essential for the binding at all AR subtypes.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Cheong et al. evaluated the effect of the replacement of the 2-furyl ring, often responsible for epatotoxicity (due to its metabolic cleavage by the cytochrome P450 enzymes in the liver), with a 4-(substituted)phenyl ring, known to be safer from a metabolic point of view.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> This study demonstrated for the first time that a phenyl ring at the 2-position of PTPs induces better affinity and/or selectivity toward hA<sub>3</sub> receptor if compared to the 2-furyl congeners. Consistent with the previous SAR studies, the presence of the <i>N</i><sup>8</sup>-methyl group was shown to be preferred over bulkier substituents and <i>N</i><sup>5</sup>-benzoyl/phenylacetyl/phenylcarbamoyl substitutions induced higher A<sub>3</sub>AR affinity/selectivity than observed in the case of <i>N</i><sup>5</sup>-unsubstitution (see compounds <b>53</b>–<b>56</b>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> A predictive QSAR study (CoMFA) on the new series of 2-aryl PTP derivatives provided new insights on the steric and electrostatic factors, especially related to the <i>C</i><sup>2</sup>-position, affecting hA<sub>3</sub> AR affinity.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> In order to explore the role of the nitrogen at the 7-position of PTPs, we recently performed a new synthetic strategy for the preparation of pyrrolo[3,4-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine derivatives, which can be considered as 7-deaza analogues of the parent PTPs (see compounds <b>57a</b>,<b>b</b>). We also synthesized a novel series of <i>N</i><sup>8</sup>/<i>N</i><sup>9</sup>-substituted-pyrazolo[3,4-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidines as junction isomers of the reference compounds (see compounds <b>58</b> and <b>59</b>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The removal of the nitrogen at the 7-position significantly affected both A<sub>2A</sub>AR and A<sub>3</sub>AR affinities. The introduction of a 5-phenylcarbamoyl moiety, to promote A<sub>3</sub>AR affinity and selectivity, appeared somewhat effective only in the pyrrole series of which the urea derivatives <b>57a</b> and <b>57b</b> were distinguished as relatively high affinity (<i>K</i><sub>i</sub> of 15 and 10 nM, respectively) and potent (IC<sub>50</sub> = 75 and 50 nM, respectively) hA<sub>3</sub>AR antagonists. The comparison between the new <i>N</i><sup>8</sup>-substituted pyrazolo[3,4-<i>e</i>]triazolopyrimidines (general structure <b>58</b>) and their structural isomers <i>N</i><sup>8</sup>-substituted pyrazolo[4,3-<i>e</i>]triazolopyrimidines showed how the shift of the pyrazole nitrogen from the 7- to the 9-position exerted, as a main effect, a remarkable decrease of hA<sub>3</sub>AR affinity and selectivity of the 5-urea derivatives. When small alkyl chains were shifted from the <i>N</i><sup>8</sup>- to <i>N</i><sup>9</sup>-position (general structure <b>59</b>), the general effect was a random increase of affinity/potency at the AR subtypes. In contrast, <i>N</i><sup>9</sup>-arylalkyl substitution appeared generally detrimental for AR affinity. Thus, steric hindrance around this position seems poorly tolerated, in accordance with previous findings.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div></div><div id="sec3_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Triazolopurines</h4><div class="NLM_p last">Okamura at al.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> reported a series of 1,2,4-triazolo[5,1-<i>i</i>]purines as A<sub>3</sub>AR antagonists highlighting the structural similarity between the new class of compounds and the previously identified triazoloquinazoline derivatives (see above). These investigations led to potent and selective hA<sub>3</sub> ligands, the most representative of which, OT-7999<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> (<b>60</b>), demonstrated significant reduction of intraocular pressure in cynomolgus monkeys at 2–4 h following topical application (500 μg).</div></div><div id="sec3_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> “Tricyclic” Xanthines</h4><div class="NLM_p">Natural xanthines (caffeine and theophylline) show in general low affinity for the A<sub>3</sub>AR subtype; nevertheless, the annulation of xanthine derivatives as a successful approach for the development of AR antagonists has been extensively argued.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Some pyrido[2,1-<i>f</i>]purine-2,4-dione derivatives, which could be considered as tricyclic xanthine derivatives, have been reported to exert low nanomolar hA<sub>3</sub> affinity.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The most potent compound of this series is the 1-benzyl-3-propyl-1<i>H</i>,3<i>H</i>-pyrido[2,1-<i>f</i>]purine-2,4-dione derivative <b>61</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) with a <i>K</i><sub>i</sub> of 4.0 ± 0.3 nM at hA<sub>3</sub>ARs. The replacement of the benzyl nucleus at the 1-position with a methyl moiety determined a dramatic loss of both affinity and selectivity. The series<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> of 1<i>H</i>,3<i>H</i>-pyrido[2,1-<i>f</i>]purine-2,4-diones carrying a methoxy group at the 8-position, a cyclopropylmethyl group at the <i>N</i><sup>3</sup>-position, and substituted benzyl groups at the 1-position revealed a general preservation of hA<sub>3</sub>AR affinity and a relevant enhancement of the overall selectivity (compound <b>63</b>). The effect of the replacement of the pyridine ring of the pyrido[2,1-<i>f</i>]purine-2,4-dione core with different five-membered heterocycles (i.e., pyrrole or imidazole) was later examined by our group.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Among the evaluated tricycles, the imidazo[2,1<i>-f</i>]purine-2,4-dione derivatives were 2- to 10-fold more potent than the corresponding pyrrolo[2,1<i>-f</i>]purine-2,4-dione derivatives. The best results were obtained with the introduction of small alkyl chains at the 7 position (<b>64</b>, <b>65</b>). A SAR extension of this project has been next realized performing new substitutions alternatively at the 1-, 3-, and 8-positions of the reference compound <b>64</b>, and the binding disposition of these molecules was analyzed by means of a docking approach using a mixed pharmacophoric–molecular modeling procedure.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The synthesis and biological evaluation of an analogue series of fused xanthine derivatives (imidazo[2,1-<i>i</i>]purin-5-ones) have been investigated by Müller and co-workers.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Compound <b>66</b> exhibited a <i>K</i><sub>i</sub> of 2.3 nM for the hA<sub>3</sub>AR and good selectivity vs the other AR subtypes. The radiolabeled derivative of this compound exhibited a <i>K</i><sub>D</sub> of 4.9 nM (<i>B</i><sub>max</sub> = 3500 fmol/mg of protein).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> An important innovation of such series, in comparison with xanthines, is a significant increase of water solubility due to the introduction of a basic nitrogen atom which can be protonated in physiological conditions. The analogue (8<i>R</i>)-ethyl-4-methyl-2-(2,3,5-trichlorophenyl)-4,5,7,8-tetrahydro-1<i>H</i>-imidazo[2,1-<i>i</i>]purin-5-one<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> (PSB-10), showed inverse agonist activity in binding studies in hA<sub>3</sub> CHO cells (IC<sub>50</sub> = 4 nM). The 2-(4-bromophenyl) derivative named KF-26777<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> (<b>67</b>) with subnanomolar affinity at the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> = 0.2 nM) and high selectivity over A<sub>1</sub>, A<sub>2A</sub>, and A<sub>2B</sub> ARs (9000-, 2350-, 3100-fold, respectively) was indicated to be of potential interest for the treatment of brain ischemia and inflammatory diseases such as asthma. In a recent study<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> we evaluated the effect of the replacement of the 2-phenyl ring of <b>66</b> and congeners with differently substituted five-membered heterocycles, in particular 1,3- and 1,5-disubstituted pyrazoles or 3-substituted isoxazoles (<b>68</b> and <b>69</b>). The 2-heterocyclic substitution proved to induce excellent affinity and selectivity toward hA<sub>3</sub>AR subtype. Docking of the most potent compound (<b>68</b>) in complex with hA<sub>3</sub>AR furnished a general survey of the hypothetical binding mode of the newly described derivatives.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Fused xanthine derivatives as tricyclic antagonists of A<sub>3</sub>ARs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Nucleoside-Derived A<sub>3</sub> Adenosine Receptor Antagonists</h3><div class="NLM_p">The attempts of the scientific community focused on the design of A<sub>3</sub>AR antagonists with nucleoside structure are aroused by a general limitation in characterizing non-purine heterocyclic antagonists, most of which, although having high affinity and selectivity for the hA<sub>3</sub>AR, show low or no affinity toward the rA<sub>3</sub>AR (with the exception of 5-(pyridine-4-yl)-2-aminothiazoles;<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> see above). This hampers drug development, considering the difficulty of employing animal models for drug testing. The structural manipulation at different positions of adenosine provided a large number of ligands of the A<sub>3</sub>AR exerting different levels of potency, selectivity, and intrinsic efficacy. The exact combination of modifications was shown to affect the balance between full agonism, partial agonism, and antagonism.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Some nucleoside-derived antagonists (i.e., compounds <b>83</b>–<b>85</b>; see below) were shown to display affinity toward human and rat A<sub>3</sub>AR in the same range of concentration, thus allowing the use of small animal models for future drug development.</div><div class="NLM_p">A series of 8-alkynyladenosines reported by Volpini et al. in 2001<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> represents the first example of adenosine analogues, with the intact ribose moiety, which behave as selective antagonists at hA<sub>3</sub>AR (compound <b>70</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). The same group recently reported a series of 2-arylalkynyl-<i>N</i><sup>6</sup>-methoxyadenosine derivatives, among which the 2-pyridyl derivative <b>71</b> showed a profile as an hA<sub>3</sub>AR antagonist.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Nucleoside-derived A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It has been demonstrated that the introduction of a benzyl or a 3-iodobenzyl moiety at the <i>N</i><sup>6</sup>- position and a Cl atom at the 2-position of adenosine synergistically contribute to reduction of intrinsic efficacy of the corresponding nucleoside derivatives. Thus, <i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine acts as partial agonist (46% A<sub>3</sub>AR efficacy) while the 2-chloro-<i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine behaves as a potent but nonselective A<sub>3</sub>AR antagonist (<i>K</i><sub>i</sub>(A<sub>3</sub>AR) = 1.8 nM, EC<sub>50</sub>(A<sub>2B</sub>AR) > 10 000 nM, <i>K</i><sub>i</sub>(A<sub>2A</sub>AR) = 197 nM, <i>K</i><sub>i</sub>(A<sub>1</sub>AR) = 16.8 nM).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> As mentioned above, the efficacy of the latter compound is completely restored by the replacement of the 4′-hydroxymethylene group with a 5′-methyluronamide function (Cl-IB-MECA). <i>N</i><sup>6</sup>-Substitution of adenosine affected intrinsic efficacy, as adenosine was shown to reverse its agonistic activity into antagonism when a <i>N</i><sup>6</sup>-2,2-diphenylethyl moiety was introduced (MRS3310, <b>72</b>).<a onclick="showRef(event, 'ref29 ref56'); return false;" href="javascript:void(0);" class="ref ref29 ref56">(29, 56)</a></div><div class="NLM_p">Some 2′- and 3′-fluoro substituted adenosines have been investigated as A<sub>3</sub>AR ligands.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> While the introduction of a fluorine atom at the 2′-position compromised both A<sub>3</sub>AR binding and activation, the 3′-fluoro substitution generally resulted in partial agonism. Compound <b>73</b> is one of the few ligands of the series in which the presence of the fluorine at the 3′-position led to a total loss of hA<sub>3</sub>AR efficacy.</div><div class="NLM_p">A patent by Solvay<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> claimed the possibility of treating allergic diseases with a series of new nucleoside derivatives that are high affinity A<sub>3</sub>AR antagonists. One of the most important compounds is compound <b>74</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), which showed low nanomolar affinity for A<sub>3</sub>AR with high selectivity over the other ARs, and its potent antagonistic activity has been assessed in functional models (p<i>A</i><sub>2</sub> = 9.8). These findings highlight the importance of substitutions at the 2- and 6-positions of adenosine for receptor activation. Interestingly, these molecules are the only examples of A<sub>3</sub>AR antagonists structurally related to adenosine in which the 6-amino group was completely removed and replaced by a trifluoromethyl moiety. A further example of <i>N</i><sup>6</sup>-<i>C</i><sup>2</sup>-disubstituted adenosine antagonist is represented by 2-(4-cyclopentylmethyl-1,2,3-triazol-1-yl)-<i>N</i><sup>6</sup>-methyladenosine <b>75</b>, displaying hA<sub>3</sub>AR affinity with 260-fold binding selectivity versus the hA<sub>1</sub>AR. This corroborates the assessment according to which hindered groups at the 2-position promote A<sub>3</sub>AR binding preventing receptor activation.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Researchers at GlaxoSmithKline recently confirmed this observation with the identification of the novel ligand (2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2-(6-amino-2-{[(1<i>S</i>)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9<i>H</i>-purin-9-yl)-5-(2-ethyl-2<i>H</i>-tetrazol-5-yl)tetrahydro-3,4-furandiol, <b>76</b>.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> This compound displayed comparable affinity in binding assays at the A<sub>2A</sub>AR and A<sub>3</sub>AR (<i>K</i><sub>i</sub> = 15.8 nM), behaving, however, as a potent agonist at hA<sub>2A</sub>AR subtype (pEC<sub>50</sub> = 9.0 ± 0.2) and as a competitive antagonist at hA<sub>3</sub>AR (p<i>A</i><sub>2</sub> = 8.3 ± 0.04). Lower affinity for A<sub>1</sub>AR and A<sub>2B</sub>AR has been detected (p<i>K</i><sub>i</sub> ≤ 6). In addition, potent inhibitory effects on the generation of reactive oxygen species from human neutrophils and eosinophils and on the degranulation of human granulocytes subsequent to treatment with compound <b>76</b> have been as well described. These findings provide a useful tool for the understanding of the involvement of A<sub>2A</sub> and A<sub>3</sub> ARs in inflammation processes. While in <b>76</b> the typical 4′-CH<sub>2</sub>OH was replaced by a substituted tetrazole ring, MRS1292<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> (<b>77</b>) was obtained by the introduction of spirolactam moiety at the same position. This compound behaves as an A<sub>3</sub>AR antagonist with a <i>K</i><sub>i</sub> from binding assays of 29.3 nM.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The presence of the additional ring induced a conformational restriction which could affect the capacity of the endocyclic 5′-uronamide to realize a hydrogen bond required for the receptor activation.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Compound <b>77</b> was shown to inhibit A<sub>3</sub>AR-mediated shrinkage of human nonpigmented ciliary epithelial cells and reduce mouse intraocular pressure acting as a cross-species A<sub>3</sub>AR antagonist. This would suggest the possible employment of such ligands in the treatment of glaucoma.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Further examples of conformationally constrained analogues of known nucleoside-based A<sub>3</sub>AR agonists have been synthesized and tested for their binding affinity as well as for their agonist and/or antagonist activity at the ARs.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Among these, 2′-<i>O</i>,4′-<i>C</i>-methylene-β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl nucleosides (locked nucleic acid, LNA nucleosides) and 2′-amino-LNA nucleosides derivatives containing the 2-oxa-5-azabicyclo[2.2.1]heptane scaffold were distinguished as potent A<sub>3</sub>AR antagonists (compounds <b>78</b> and <b>79</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Nucleoside-derived A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The fundamental role of the flexibility and H-bonding ability of the 4′-hydroxymethylene or 5′-uronamide moieties of nucleoside derivatives for full activation of the A<sub>3</sub>AR has been lately confirmed by both molecular modeling studies<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and the identification of <span class="smallcaps smallerCapital">d</span>-4′-thioadenosine derivatives.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The highly selective A<sub>3</sub>AR agonists Cl-IB-MECA and its 4′-thio analogue were indeed successfully converted into selective antagonists simply by adding a second <i>N</i>-methyl group on the 5′-uronamide position (compounds MRS3771, <b>80</b>, and LJ-1256, <b>81</b>, respectively).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> 5′-<i>N</i>,<i>N</i>-Dimethyluronamide derivatives exhibited higher binding affinity than larger 5′-<i>N</i>,<i>N</i>-dialkyl or 5′-<i>N</i>,<i>N</i>-cycloalkylamide derivatives, indicating that steric factors are crucial in binding to the hA<sub>3</sub>AR.<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111, 112)</a> The <i>N</i><sup>6</sup>-(3-Br-benzyl) derivative <b>82</b> showed the highest A<sub>3</sub> binding affinity (<i>K</i><sub>i</sub> = 9.32 nM) of this series. The removal of the 4′-substituent of the thionucleoside skeleton led Jacobson and co-workers to the identification of even more potent and selective A<sub>3</sub>AR antagonists, the most effective of which have been depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a> (<b>83</b> and <b>84</b>). Compounds <b>83</b> and <b>84</b> also demonstrated high affinity at the rA<sub>3</sub>AR expressed in CHO cells (<i>K</i><sub>i</sub> of 6.2 and 3.9 nM, respectively), indicating the possibility of evaluation in small animal models for future drug development, and were inactive as agonists or antagonists in a cyclic AMP functional assay at the hA<sub>2B</sub>AR. The removal of the 2-Cl atom did not affect hA<sub>3</sub>R affinity while significantly reducing selectivity versus the remaining AR subtypes.<a onclick="showRef(event, 'ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref113 ref114">(113, 114)</a> The <span class="smallcaps smallerCapital">l</span>-enantiomers of 4′-thioadenosines were shown to be totally devoid of AR affinity.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> A recent series of 4′-oxo bioisosters of <b>84</b> were shown to be generally less potent than the corresponding 4′-thio nucleosides although still exerting considerable potency both as human and rat AR antagonists (see compound <b>85</b>).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Moreover, truncated thioadenosines, substituted at the <i>C</i><sup>2</sup>-position with suitable alkynyl or alkenyl chains, showed a very interesting pharmacological profile as a mixed A<sub>2A</sub>AR agonist/A<sub>3</sub>AR antagonist which might be advantageous for potential antiasthmatic activity.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The involvement of the 5′-position of the ribose moiety in receptor activation has been confirmed by recent findings indicating that the shifting of the <i>N</i><sup>6</sup>-(3-iodobenzyl)adenine moiety from the 1′ to the 4′ position of the ribose ring proved to induce A<sub>3</sub>AR potent antagonism in the full agonist 4′-thio analogue of Cl-IB-MECA (see compound MRS3057, <b>86</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p last">As above-described, the replacement of the flexible ribose scaffold of prototypical A<sub>3</sub>AR agonists with a bicyclo[3.1.0]hexane ring system resulted in (N)-methanocarbaadenosine agonists possessing high potency and selectivity for the A<sub>3</sub>AR subtype. A new series of A<sub>3</sub>AR partial agonists/antagonists belonging to the (N)-methanocarba family has been recently developed because of the removal of the <i>N</i>-methylcarboxamide function (see <b>87</b> and <b>88</b>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The partial agonist <b>88</b> was labeled with <sup>76</sup>Br for use as a PET ligand of high affinity.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Compound <b>87</b> appeared to be an antagonist by Schild analysis of [<sup>35</sup>S]GTPγS binding to membranes from CHO cells expressing the hA<sub>3</sub>AR.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> However, further analysis determined that it is a high affinity and selective partial agonist, stimulating cAMP production with 45% efficacy compared with NECA. This compound was later radioiodinated and characterized pharmacologically.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> The substitution of the 3′-hydroxyl group of these derivatives with a 3′-amino group proved to drastically compromise hA<sub>3</sub> binding affinity.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">A<sub>3</sub> Adenosine Receptor Allosteric Modulators</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Allosteric ligands interact with receptor domains that are distinct from the orthosteric binding site (the primary binding site of the endogenous ligand on a receptor) of classical ligands. The binding of an allosteric ligand to its site causes conformational change in the receptor protein that is transmitted to the orthosteric site (and vice versa), inducing the formation of a modified GPCR with its own binding and functional properties.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The simplest expression of an allosteric interaction arises when the binding of the allosteric modulator either enhances or inhibits the affinity of the orthosteric ligand for the receptor; thus, in the absence of the orthosteric ligand, the modulator is assumed not to mediate any effect on its own. In this case, allosteric ligands have little or no overlap with the orthosteric site. Therefore, allosteric and orthosteric ligands can both bind simultaneously. More complex is the case of a small molecule behaving both as an agonist on its own and as allosteric modulator through the recognition of a domain that is distinct from the orthosteric one (allosteric agonist). Allosteric modulation of GPCRs now represent one of the most exciting areas in modern drug discovery.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> This kind of approach has been associated with higher receptor subtype selectivity because of the observation that allosteric sites may be less conserved within a receptor class in comparison with orthosteric sites. Moreover, allosteric modulators are thought to address their action only in the anatomical district in which the production of the endogenous ligands is stimulated as a consequence of a pathologic condition. Allosteric agonist enhancers of the A<sub>3</sub>AR are of considerable interest as therapeutic agents and as pharmacological tools to explore various signaling pathways. Allosteric modulation of the A<sub>3</sub>AR was first observed byGao et al.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> with a number of 3-(2-pyridinyl)isoquinoline derivatives, previously reported as A<sub>3</sub>AR antagonists (see above). This study described VUF5455<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> (<b>89</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) as a first generation A<sub>3</sub>AR allosteric enhancer, still suffering from low water solubility and antagonistic properties. Nevertheless, a clear indication of distinct structural requirements for modulating allosteric enhancement and competitive antagonistic activity at the A<sub>3</sub>AR stimulated the same author to examine new chemical entities, among which are 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolines known as non-xanthine AR antagonists.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Of this class, DU124183<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> (<b>90</b>) was then claimed as second generation A<sub>3</sub>AR enhancer with potency comparable to that of <b>89</b> but, in contrast to this, able to potentiate the maximum agonist efficacy by approximately 30%. Compound <b>90</b> also displayed some orthosteric activity with moderate affinity (<i>K</i><sub>i</sub> = 820 nM) to hA<sub>3</sub>AR. Later, structure–activity optimization led to compound LUF6000<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> (<b>91</b>) capable of enhancing the maximum efficacy of Cl-IB-MECA (by 45–50%) and other A<sub>3</sub>AR agonists,<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126, 127)</a>as well as able to convert an A<sub>3</sub>AR antagonist into a specific agonist. Compound <b>92</b>, bearing an adamantyl moiety at the 2-position, exerts allosteric enhancer activity similar to that of <b>91</b>,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> thus demonstrating a high steric tolerance around this position. The molecular simplification of <b>91</b> allowed the identification of a series of 2,4-disubstituted quinolines as allosteric enhancers of the A<sub>3</sub>AR.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Compound LUF6096<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (<b>93</b>), which can be considered the direct bicyclic analogue of <b>91</b>, was the most potent compound of this series with reduced orthosteric effect toward A<sub>1</sub>AR and A<sub>3</sub>AR subtypes if compared to <b>91</b>.</div><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. A<sub>3</sub>AR allosteric modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Very recently, 2-arachidonylglycerol and other cannabinoid ligands were tested for their potential effect as hA<sub>3</sub>AR modulators. Interestingly, 2-arachidonylglycerol proved to increase the rate of [<sup>125</sup>I]AB-MECA dissociation, behaving as a negative allosteric modulator.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">A<sub>3</sub> Adenosine Receptor Radioligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the past, a well-known A<sub>3</sub>AR agonist radioligand as [<sup>125</sup>I]AB-MECA was introduced in saturation and competition binding experiments performed in native tissues and in transfected cells.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Other radioligands have been characterized as [<sup>125</sup>I]MRS5127 (see compound <b>87</b>) or [<sup>125</sup>I]MRS1898 (the iodinated analogue of <b>20</b>) which display both r- and hA<sub>3</sub>ARs affinity in the nanomolar range.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> More recently, a selective agonist radioligand [<sup>3</sup>H]HEMADO ([<sup>3</sup>H]2-hexyn-1-yl-<i>N</i><sup>6</sup>-methyladenosine) has been studied with high affinity and selectivity versus hA<sub>3</sub>ARs.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> An antagonist radioligand as [<sup>3</sup>H]MRE3008F20 (see compound <b>51</b>) has been used in different human cells or tissues showing a high affinity and selectivity for hA<sub>3</sub>ARs.<a onclick="showRef(event, 'ref16 ref17 ref133 ref134 ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref133 ref134 ref135 ref136">(16, 17, 133-136)</a> It has also been introduced as an A<sub>3</sub>AR positron emission tomography ligand for in vivo imaging named as [<sup>18</sup>F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5e181b1e0d0b0e0e07">[email protected]</a> (5-(2-fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate)<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> that exhibits high affinity and selectivity for A<sub>3</sub>ARs.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> In addition, another antagonist radioligand named as [<sup>3</sup>H]PSB11 (see compound <b>66</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) has been used to characterize the allosteric binding site for A<sub>3</sub>ARs.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">A<sub>3</sub> Adenosine Receptors in the Central Nervous System</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A<sub>3</sub>ARs are widely distributed in the central nervous system but at low levels and with a reduced affinity. The role of A<sub>3</sub>ARs in several pathophysiological conditions is often controversial even if they may contribute to neurotransmission.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> A proconvulsant effect of A<sub>3</sub>ARs has been observed in the immature brain, suggesting the possibility of facilitating seizure-induced neuronal damage.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> It has been reported that A<sub>3</sub>AR agonists have depressant effects on locomotor activity, suggesting a possible inhibition of excitatory neurotransmission in cortical neurons.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> A nociceptive role for A<sub>3</sub>ARs involving both central nervous system and proinflammatory effects in peripheral tissues has been highlighted.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Major evidence for A<sub>3</sub>ARs in neurodegenerative phenomena emerges from studies performed in vivo and in vitro models of hypoxia/ischemia. It has been hypothesized that A<sub>3</sub>ARs play a protective role in the first phase of ischemia by decreasing synaptic transmission.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a>Moreover, prolonged A<sub>3</sub>AR stimulation is able to transform the effects from protective to injurious, increasing the excitotoxicity.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Glial A<sub>3</sub>AR activation by high adenosine levels, caused by a brain injury, may be implicated in neuroinflammatory tissue responses.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> An up-regulation of A<sub>3</sub>ARs has been reported in the hippocampus of a transgenic mouse model of Alzheimer’s disease where an altered oxidative phosphorylation was detected prior to amyloid deposition.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> It has been reported that the stimulation of A<sub>3</sub>ARs rapidly enhances the activity of antidepressant-sensitive serotonin transporters (SERTs) and that the stimulation of SERT activity is lost in A<sub>3</sub>AR knockout mice.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> A<sub>3</sub>AR-stimulated SERT activity is primarily mediated by p38 MAPK-linked pathways, supporting the potential use of agents that block A<sub>3</sub>ARs and selectively diminish SERT surface expression and activation and suggesting their use for the treatment of mood disorders characterized by hyposerotonergic states.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Recently, the presence of ARs has been evaluated in lymphocytes from Parkinson’s disease (PD) patients, revealing that A<sub>1</sub>AR, A<sub>2B</sub>AR, and A<sub>3</sub>AR did not change while A<sub>2A</sub>ARs were significantly up-regulated in PD if compared with healthy subjects.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> As a consequence, further in vitro and/or in vivo studies aimed at verifying the A<sub>3</sub>AR modulation effect of agonists versus antagonists will help to better clarify their role in these neurodegenerative diseases.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">A<sub>3</sub> Adenosine Receptors in Cardiovascular System</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The different effects of adenosine on electrical and mechanical properties of the heart have been reported.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Generally the actions of adenosine are protective and serve to shelter the heart during conditions of inadequate blood flow or during increased cardiac work.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Vasoconstriction mediated by A<sub>3</sub>ARs may involve indirect signaling through nonvascular cell types such as mast cells, which may reside within the vascular wall, via the release of factors such as histamine and thromboxane.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Also the vasoconstriction response is due to A<sub>3</sub>ARs being closely dependent on the inhibition of cyclic AMP accumulation in smooth muscle and in cultured aorta.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> It is also reported that A<sub>3</sub>ARs mediate vascular protection and contribute to limitations in infarct size and in postischemic myocardium by a mechanism that involves PKC, K<sub>ATP</sub> channel activation, phosphorylation of p38MAPKs, and glycogen synthase kinase (GSk-3β).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Moreover, A<sub>3</sub>ARs enhance cellular antioxidant capacity that contributes to vasoprotection and reduces cardiac myocyte death, suggesting a strong support for an A<sub>3</sub>-dependent cardioprotective response including the reduction in infarct size, inhibition of apoptosis, and improvements in postischemic contractile function.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> It has also been reported that a low expression of A<sub>3</sub>ARs confers substantial resistance to ischemic insult, while only a 5-fold increase in expression leads to cardiomyopathy.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> The activation of the A<sub>3</sub>ARs increases the vascular permeability depending on mast cell activity<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and stimulates vascular growth, acting with A<sub>2B</sub>ARs to promote angiogenesis via the expression of angiogenic factors in mast cells or stimulate HIF-1α and vascular endothelium growth factor (VEGF) expression.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></div><div class="NLM_p">It was reported that ischemia and reperfusion can cause significant injury of skeletal muscle, which is the most vulnerable tissue in the extremities.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Trauma, autogenous skeletal muscle transplantation, surgical incision, and vascular surgery can also induce skeletal muscle damage with deleterious systemic consequences. The protection of skeletal muscle from ischemia and reperfusion injury is an important therapeutic aim to ameliorate muscle and organ injury.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> It has been observed that A<sub>3</sub>ARs induce protection of the skeletal muscle, modulating the expression of different metalloproteinases that are able to degrade collagens, gelatins, and stromelysins and metallothioneins that, reducing reactive oxygen species (ROS), render tissue protection.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">Atherosclerosis, a multifactorial disease of the large arteries, is the major cause of heart disease and stroke worldwide. Epidemiological studies have discovered several relevant environmental and genetic risk factors associated with this pathology.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Recently, it has been shown that adenosine in hypoxic foam cells stimulates HIF-1α accumulation by activating ERK 1/2 pathway. Further, adenosine through the activation of A<sub>3</sub>ARs stimulates VEGF secretion in a HIF-1α dependent way. Adenosine stimulates foam cell formation, and this effect is strongly reduced by A<sub>3</sub>AR antagonists and by HIF-1α silencing. So as a consequence, the potential use of A<sub>3</sub>AR antagonists could be of interest to block important steps in the atherosclerotic plaque development.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><div class="NLM_p last">In the cardiovascular system, A<sub>3</sub>AR modulation appears to have an important role even if extensive evidence reveals an elevated complexity of signaling pathways causing cardioprotection.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">A<sub>3</sub> Adenosine Receptors in Immune System</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A<sub>3</sub>ARs are present in immune cells and are involved in the pathophysiological regulation of inflammatory and immune processes. The cells of the immune system express all ARs and are responsive to the adenosine modulatory effects in an inflammatory environment. Different animal models of asthma, ischemia, arthritis, sepsis, inflammatory bowel disease, and wound healing have helped to elucidate the regulatory roles of the various ARs in the development and progression of disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The increasing knowledge of the control of immune and inflammatory systems by adenosine has generated different hypotheses regarding the potential use of therapies based on ARs in the treatment of infection and/or autoimmunity. Several results from in vitro and in vivo studies suggest that the activation of A<sub>3</sub>ARs can be both pro- or anti-inflammatory depending on the cell type examined or on the animal species considered.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Binding and functional studies have shown that human neutrophils expressed A<sub>3</sub>ARs primarily coupled to the AC inhibition and calcium signaling, mediating the inhibition of oxidative burst representative of anti-inflammatory activity.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> A<sub>3</sub>ARs are also responsible for inhibition of superoxide production and chemiotaxis of mouse bone marrow neutrophils.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> It has been reported that A<sub>3</sub>ARs are present on human eosinophils, coupled to signaling pathways linked to cell activation, and are able to protect eosinophils from apoptosis and to inhibit the chemotaxis process.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> An overexpression of A<sub>3</sub>ARs has also been detected in lymphocytes and in Jurkat cells, a human leukemic cell line, where they are associated with inhibition of AC activity and calcium modulation.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> The effects produced by A<sub>3</sub>AR activation of macrophages seem to indicate an anti-inflammatory effect of this receptor subtype.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> All the data derived from in vitro and in vivo studies suggest that the activation of A<sub>3</sub>ARs can cause pro- and anti-inflammatory effects primarily depending on the cell type examined (neutrophil, eosinophil, macrophage, T cell, or dendritic cell) or on the cellular model used as in vitro or ex vivo or the use of transgenic animals. Other differences that could be very important are the species considered (human or animal) or the functional response investigated, as degranulation, oxidative burst, migration, maturation, and cytokine production. In addition, the presence and the opposite functional role of other AR subtypes could hamper the identification of the specific role of A<sub>3</sub>ARs in cell damage.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">A<sub>3</sub> Adenosine Receptors in the Respiratory System</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The role of adenosine in regulating the respiratory system is well-known, and elevated levels of adenosine have been found in bronchoalveolar lavage (BAL), blood and exhaled breath condensate of patients with asthma, and chronic obstructive pulmonary disease (COPD). In the past, A<sub>3</sub>ARs have been implicated in inflammatory processes, playing an important role in both pro- or anti-inflammatory responses, strictly depending on different cell type involved.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> In particular, the strongest evidence of an A<sub>3</sub>AR functional role in mast cell activation comes from the use of genetic knockout mice where the mast cell degranulation in the absence or in the presence of allergen appears to be dependent on A<sub>3</sub>AR activation. Likewise, adenosine failed to induce histamine release from lung mast cells obtained from A<sub>3</sub>AR knockout mice and adenosine-induced airway hyperresponsiveness by both A<sub>3</sub>AR dependent and independent mechanisms in rodents.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> The airway hyperresponsiveness was abolished in A<sub>3</sub>AR deficient mice, and the reconstitution in these animals of wild type mast cells restored the hyperresponsiveness.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> In contrast, mice treated with selective A<sub>3</sub> antagonists showed a marked attenuation of pulmonary inflammation, reduced eosinophil infiltration into the airways, and decreased airway mucus production.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> The involvement of the A<sub>3</sub>ARs in a bleomycin model of pulmonary inflammation and fibrosis was investigated in A<sub>3</sub>AR-deficient mice that exhibit enhanced pulmonary inflammation and up-regulation in eosinophils related to an increase of chemokines and cytokines. These results suggest that the A<sub>3</sub>ARs supply anti-inflammatory functions in the bleomycin model and regulate the production of mediators involved in fibrosis.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> There is no evidence of A<sub>3</sub>AR protein in human lung mast cells, but a high density of the functionally active form of these receptors is expressed in human eosinophils where the inhibition of the proinflammatory functions by A<sub>3</sub>AR agonist has been reported.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, the A<sub>3</sub>ARs are expressed in human lymphocytes and neutrophils where they are involved in the immunological responses in T cells and in the reduction of superoxide anion production.<a onclick="showRef(event, 'ref17 ref135'); return false;" href="javascript:void(0);" class="ref ref17 ref135">(17, 135)</a> Transcript levels for the A<sub>3</sub>ARs are elevated in lung biopsies of patients with asthma or COPD where they mediated the inhibition of eosinophil chemotaxis.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> In asthmatic inflammation, elevated concentrations are present of activated eosinophils that are widely reduced by the A<sub>3</sub>AR agonist.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> In peripheral lung from COPD patients, a decrease of A<sub>2B</sub>AR density and an increase of A<sub>2A</sub>AR and A<sub>3</sub>AR if compared to smokers with normal lung function were observed.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Moreover, in BAL macrophages from COPD patients was found an increase of A<sub>3</sub>ARs closely associated with the presence of high levels of proinflammatory cytokines.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> In the human leukemic monocyte lymphoma cell line (U937), interleukin 1β (IL-1β) and tumor necrosis factor (TNFα) were significantly increased in both A<sub>2A</sub>AR and A<sub>3</sub>AR density. The addition of hydrogen peroxide, a condition present in the COPD lung, to the proinflammatory stimulus did not affect A<sub>2A</sub>AR or A<sub>3</sub>AR expression, although it induced a significant reduction in A<sub>2B</sub>AR expression. These data suggest the potential use of A<sub>2B</sub> and/or A<sub>3</sub>AR antagonists in pathophysiological conditions related to pulmonary diseases in which inflammation is an important feature.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">A<sub>3</sub> Adenosine Receptors in Arthritis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder of unknown etiology that affects approximately 1% of the population worldwide.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Recently, data have become available suggesting that the pharmacogenetic characterization may help to predict the efficacy and safety in clinical practice.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> It is widely accepted that RA must be treated early with effective therapy in order to prevent an unfavorable outcome. No effective and safe pharmacological treatment is available, even though progress has been done in the past years by using biological drugs. Knowledge of the adenosine mechanism has revealed that ARs could represent a useful target of therapy in RA. The stimulation of A<sub>2A</sub>AR and/or A<sub>3</sub>AR mediates a reduction of inflammation via NF-kB signaling pathway and a decrease of proinflammatory cytokines, suggesting their utilization as biomarkers and as predictors of clinical response linked to the available pharmacological therapies. At present, the precise cause of RA remains elusive even if a variety of cells that play a role in RA disease progression, such as macrophages and synoviocytes, could be of particular importance.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Clinical evidence in RA patients shows that treatment with an A<sub>3</sub> agonist leads to an improvement in signs and symptoms.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Recently it has been shown that A<sub>2A</sub>AR and A<sub>3</sub>AR are up-regulated in untreated RA patients and in methotrexate (MTX) treated RA patients. Treatment with anti-TNF-α normalized A<sub>2A</sub>AR and A<sub>3</sub>AR expression and functionality.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> The overexpression of A<sub>3</sub>ARs in RA has been directly correlated to high levels of proinflammatory cytokines acting via an up-regulation of NF-kB, which is a key player in the pathogenesis of arthritic diseases.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> In RA patients, adenosine suppressed the elevated levels of proinflammatory cytokines such as TNF-α and IL-1β.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> It has been reported that A<sub>3</sub>AR agonists prevent cartilage damage, osteoclast/osteophyte formation, and bone destruction and markedly reduce pannus formation and lymphocyte formation.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> A<sub>3</sub>ARs were also identified as a novel anti-inflammatory target that was up-regulated in RA and psoriasis, if compared with healthy subjects, and was associated with an altered PI3K-PKB/Akt signaling pathway and NF-kB activation.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> The presence of cyclic AMP mediates a number of various anti-inflammatory pathways resulting in inhibition of TNF-α and/or IL-1β and ameliorates the symptoms of joint inflammation.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Adenosine production and signaling have emerged as an important cell mechanism to regulate inflammation due to an increase of the receptor density and/or functionality. Novel ligands interacting with ARs that are safe and selective in humans allow us to better understand their role in several conditions of inflammation essential for successful drug discovery in RA.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> In fact, oral treatment with the selective A<sub>3</sub>AR agonist IB-MECA (CF101) led to a marked decrease in RA clinical manifestations. IB-MECA treatment reduced inflammation, pannus formation, cartilage destruction, bone resorption, and lysis.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> The specificity of the response was evident when an A<sub>3</sub>AR antagonist was introduced into arthritic animals prior to each treatment to neutralize the anti-inflammatory response.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a>In a phase I study in healthy subjects, IB-MECA was found to be safe and well tolerated with dose–linear pharmacokinetics.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a>In a phase II study in RA patients, IB-MECA oral administration twice daily for 12 weeks was shown to be safe, well tolerated and able to mediate an improvement of disease signs and symptoms, suggesting the development of these drugs as antirheumatic agents.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><div class="NLM_p">The anti-inflammatory effect of A<sub>3</sub>ARs was also proven in fibroblast-like synoviocytes derived from synovial fluid of RA patients closely associated with a decrease in NF-kB and TNF-α release.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> In particular, a novel A<sub>3</sub>AR agonist (compound <b>20</b>) induced a dose-dependent inhibitory effect on the proliferation of fibroblast-like synoviocytes via deregulation of NF-kB signaling pathway, suppressing the clinical and pathological manifestations of adjuvant induced arthritis in a rat experimental model. Recently, it was reported that A<sub>2A</sub>AR and A<sub>3</sub>AR activation inhibited the NF-kB pathway, diminished inflammatory cytokines such as TNF-α, IL-1-β, IL-6, and mediated a reduction of the release of the metalloproteinase types 1 and 3. A<sub>2A</sub>AR and A<sub>3</sub>AR density inversely correlated with the clinical disease activity score, suggesting a direct role of the endogenous activation of these receptors in the control of RA joint inflammation.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a></div><div class="NLM_p">Osteoarthritis (OA) is the most common forms of arthritis and is the most important cause of disability in older adults. At present, the current recommended treatment of OA involves weight loss, physical therapy, and the use of pain relievers. However, these drugs do not reverse the OA degenerative process and show some adverse effects on cartilage metabolism.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> It is well-known that p38MAPKs are involved in controlling cellular responses such as the release of proinflammatory cytokines.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The cell signaling pathways initiated by proinflammatory events converge on activation of NF-kB, which drives cytokine transcription and production.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Notably, p38 MAPK is one of the kinases implicated in the phosphorylation of NF-kB inhibitors (IkBs). Once phosphorylated, IkBs undergo polyubiquitination and ultimately proteosomal degradation, allowing NF-kB to enter the nucleus and promote the transcription of inflammatory genes, such as TNF-α and IL-8.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> The role of adenosine and its interaction with ARs in modulating bovine chondrocytes and synoviocytes activity have been documented by using saturation, competition binding experiments, and Western blotting analysis.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> Functional studies have suggested an anti-inflammatory effect due to A<sub>1</sub>AR and A<sub>2A</sub>AR activation in LPS-induced PGE<sub>2</sub> production mediated by a down-regulation of TNF-α and COX-2 mRNA expression.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> Furthermore, it has been demonstrated that in different cells or tissues, adenosine is a regulator of NF-kB and MAPK signaling through the interaction with AR subtypes.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> It has been also reported that the NF-kB signaling pathway is deregulated by the presence of IB-MECA and involved in the OA pathogenesis . In addition, IB-MECA induced apoptosis of inflammatory cells and acted as a cartilage protective agent, suggesting its use as a suitable candidate drug for the OA treatment.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> More recently, ARs have also been characterized by using binding and functional assays, in human synoviocytes that represent key cells closely associated with articular pathologies.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div><div class="NLM_p last">These results strongly suggest a potential role of ARs in chronic inflammatory arthritis and emphasize the utility to better investigate, from a pharmacological point of view, the modulation of the inflammatory conditions closely associated with these diseases.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">A<sub>3</sub>ARs in Gastrointestinal and Renal Disorders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Ulcerative colitis and Crohn’s disease, collectively known as inflammatory bowel disease, are severe and debilitating disorders with a growing incidence in both developing and advanced countries.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Both diseases are characterized by serious inflammation of the enteric mucosa at different levels of the gastrointestinal tract associated with significant alterations of gastrointestinal motor, secretory, and sensory functions.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> It has been observed that activation of T lymphocytes and macrophages is followed by a massive release of several proinflammatory cytokines including IL-1, IL-6, and TNF-α which stimulate the secretion of chemotactic cytokines such as IL-8 and monocyte chemoattractant protein-1 (MCP-1) responsible for the recruitment of leukocytes into inflamed mucosa.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A<sub>3</sub>ARs are also emerging for treatment of bowel inflammation; the well-known A<sub>3</sub>AR agonist IB-MECA was shown in mice to ameliorate intestinal inflammation and spontaneous colitis. In addition, A<sub>3</sub>AR stimulation was able to markedly reduce colonic levels of proinflammatory cytokines such as IL-1, IL-6, and IL-12 and to reduce the local production of macrophage inflammatory proteins such as MIP-1α or MIP-2 with a powerful down-regulation of leukocytes in bowel inflammation.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Different studies have evaluated the effects of A<sub>3</sub>AR agonists on gene dysregulation and tissue injury in a rat model of colitis. It has been demonstrated that A<sub>3</sub>AR agonists prevented the induction of various cytokine/chemokine/inflammatory genes and promoted a marked suppression of ROS production with a significant amelioration of intestinal injury. The effect of adenosine on pain transmission has also been described in an animal model of visceral pain induced by intraperitoneal injection of acetic acid, while the stimulation of ARs induced an inhibitory or facilitatory effect on pain perception.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> It has been reported that in the stomach, jejunum, colon ileum, cecum, and liver, an up-regulation of A<sub>3</sub>ARs was observed during colitis that modulate clear anti-inflammatory processes in intestine and liver.<a onclick="showRef(event, 'ref186 ref188'); return false;" href="javascript:void(0);" class="ref ref186 ref188">(186, 188)</a> More recently, it has been observed that A<sub>3</sub>ARs are overexpressed in different autoimmune pathologies such as Crohn’s disease and psoriasis. The up-regulation observed in these pathologies could be attributed to adenosine, which accumulates in the extracellular environment under stressed conditions. Most transcription factors such as NFkB and CREB that are identified to promote inflammation were inversely associated with A<sub>3</sub>AR up-regulation.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Acute renal failure is a major contributor to perioperative mortality and morbidity. Ischemic–reperfusion injury, toxic nephropathy, and myoglobinuria all can lead to the renal failure, which is frequently complicated by many other life-threatening complications including sepsis and multiorgan failure.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> The preischemic administration of an A<sub>3</sub>AR antagonist or the model of A<sub>3</sub>AR knockout mice showed a high level of protection in the rat kidney against ischemia–reperfusion injury.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> In addition, A<sub>3</sub>AR activation degranulates mast cells, increases plasma histamine in rodents, and decreases the mortality and the renal and/or hepatic injury in murine septic peritonitis. The administration of A<sub>3</sub>AR agonists significantly reduced mortality in mice lacking A<sub>1</sub>AR and A<sub>2A</sub>AR but not A<sub>3</sub>AR, demonstrating the specificity of the A<sub>3</sub>ARs to mediate protection against sepsis-induced mortality.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a></div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">A<sub>3</sub>ARs and Eye Disorders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">It was reported that A<sub>3</sub>ARs have been implicated in many ocular diseases such as dry eye, glaucoma, or uveitis. In the past, the A<sub>3</sub>AR knock out mouse showed lower intracellular pressure, suggesting a role for A<sub>3</sub>AR antagonists in the therapy of glaucoma.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In addition, the use of A<sub>3</sub>AR antagonists may be an alternative approach for treating ocular hypertension in patients affected by the pseudoexfoliation syndrome in open angle glaucoma, which is typically associated with anterior chamber hypoxia and elevated intraocular pressure.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> On the other hand, A<sub>3</sub>AR mRNA and protein have been found to be consistently increased in the nonpigmented ciliary epithelium of the eye in pseudoexfoliation syndrome with glaucoma, compared to normal eye.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> A<sub>3</sub>AR overexpression has also been reported in retinal ganglion cells, which upon agonist treatment showed reduced calcium levels and cell rescue from apoptosis.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> The anti-inflammatory and the protective effects mediated via A<sub>3</sub>AR prompted us to examine the effect of IB-MECA in a model of experimental autoimmune uveitis that represents human uveitis with an autoimmune etiology. IB-MECA inhibited the clinical and pathological manifestations of interphotoreceptor retinoid-binding protein-induced uveitis.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a></div></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">A<sub>3</sub>ARs and Cancers</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Adenosine is present at high concentrations in cancer tissues and in the interstitial fluid of several tumors, at concentrations sufficient to interact with ARs.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In particular, A<sub>3</sub>ARs are present in different types of tumor cells, such as HL60 and K562 human leukemia,<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Jurkat lymphoma,<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> U937 monocytic–macrophagic human cell line,<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Nb2 rat lymphoma,<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> A375 human melanoma,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> PGT-β mouse pineal gland tumor cells,<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> human glioblastoma,<a onclick="showRef(event, 'ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref197 ref198">(197, 198)</a> and human prostatic cells.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> A<sub>3</sub>ARs are involved in the tumor growth and in the regulation of cell cycle and mediate both pro- and antiapoptotic effects closely associated with the level of receptor activation.<a onclick="showRef(event, 'ref161 ref200'); return false;" href="javascript:void(0);" class="ref ref161 ref200">(161, 200)</a> A<sub>3</sub>ARs are able to mediate the inhibition of telomerase activity and arrest at the G0/Gi phase of the cell cycle leading to a cytostatic effect in Nb2-11C lymphoma cells.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> In addition, it was demonstrated that A<sub>3</sub>ARs inhibit tumor growth by regulation of the WNT pathway, which mediates cell cycle progression and cell proliferation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a><i>N</i><sup>6</sup>-(3-Iodobenzyl)adenosine-5′-<i>N</i>-methyluronamide (IB-MECA) treatment induced down-regulation of the expression of NF-kB, known to regulate the transcription of cyclin D1 and c-Myc.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> The A<sub>3</sub>ARs reduced the ability of prostate cancer cells to migrate in vitro and metastasize in vivo. In particular, it has been reported that activation of the A<sub>3</sub>ARs in prostate cancer cells reduced PKA-mediated stimulation of ERK1/2, leading to lower NADPH oxidase activity and cancer cell invasiveness.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> In prostate cancer cells, IB-MECA inhibited cell proliferation and induced G1 cell cycle arrest and/or apoptosis via a mitochondrial signaling pathway.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> It has been found that inhibition of cell proliferation or induction of apoptosis with A<sub>3</sub>AR agonists was only obtained at micromolar doses.<a onclick="showRef(event, 'ref9 ref52 ref203'); return false;" href="javascript:void(0);" class="ref ref9 ref52 ref203">(9, 52, 203)</a> In fact, IB-MECA, at micromolar doses in breast cancer cells, inhibited cell proliferation through interaction with receptors such as the estrogen α subtype.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Moreover, Cl-IB-MECA at micromolar doses interacts with all ARs, causing different complications to clarify functional cell response associated with a specific receptor subtype. The involvement of the A<sub>3</sub>ARs in hypoxic conditions, in an in vitro model reproducing the microenvironment of solid tumors in vivo, has suggested that the signaling pathway generated by this receptor stimulation involves the MAPK activity that is required for HIF-1α expression. Opposite effects are mediated by A<sub>3</sub>AR activation that in glioblastoma and colon cancer cells stimulate VEGF expression, while in pheochromocytoma cells promote VEGF down regulation.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> The HIF-1α regulation by A<sub>3</sub>AR activation induced an increase in angiopoietin-2 and/or VEGF, depending on the cell model investigated.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Clinical investigations have clearly shown that the prevalence of areas of hypoxic tissue is a specific property of solid tumors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Furthermore, hypoxia appears to induce an increase of intracellular adenosine levels and to stabilize the most important factors involved in hypoxia such as HIF-1α.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> The actions of adenosine are primarily linked to an increase of angiogenesis and to the release of VEGF and HIF-1α.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> So the pharmacologic inhibition of HIF-1α may be useful to improve cancer treatment based on the cooperation between hypoxic and adenosine signaling.<a onclick="showRef(event, 'ref15 ref156 ref198'); return false;" href="javascript:void(0);" class="ref ref15 ref156 ref198">(15, 156, 198)</a> A<sub>3</sub>AR density was up-regulated in colon carcinoma tissues and closely correlated to the disease severity. In addition, the A<sub>3</sub>AR alteration reflected a similar behavior shown in lymphocytes or neutrophils derived from colon cancer patients, suggesting that these receptors may represent an interesting biological marker.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Moreover, Cl-IB-MECA enhanced apoptosis via the modulation of NF-kB signaling pathway in thyroid cancer cells and reduced the ability of prostate cancer cells to migrate in vitro and metastasize in vivo.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Recently, it has been reported that A<sub>3</sub>AR selective agonists induce an anti-inflammatory and anticancer effect in a xenograft animal model utilizing Hep-3B hepatocellular carcinoma cells.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> In this model, the A<sub>3</sub>AR up-regulation was present in inflammatory liver tissues similar to those previously found in other inflammatory conditions.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> It has also been reported that in malignant mesothelioma pleura (MMP), mRNA and protein expression of A<sub>3</sub>ARs was statistically increased with respect to healthy mesothelial pleura (HMP). In particular, A<sub>3</sub>AR density in MMP was increased by 2.5-fold in comparison with HMP. A<sub>3</sub>ARs were also up-regulated in malignant mesothelioma cells (MMC) if compared with human healthy mesothelial cells (HMC). Stimulation of A<sub>3</sub>ARs decreased proliferation and exerted a cytotoxic and proapoptotic effect on MMC and on HMC, exposed to asbestos and TNF-α, but not on HMC with an involvement of the deregulation of Akt/NF-κB cell survival pathway.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> These data suggest that A<sub>3</sub>ARs could represent a biological marker and that A<sub>3</sub>AR modulation could be used in cancer treatment.</div></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Conclusions and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is well-known that the clinical use of exogenous adenosine is limited because it does not possess AR specificity and is rapidly metabolized by adenosine deaminase. Thus, instead of using adenosine, the synthetic chemical approaches have been concentrated toward the development of receptor-specific adenosine agonists or antagonists. All the pharmacological evidence found in the adenosine research field led to the design of thousands of compounds, few of which are now in clinical trials for treating different pathologies, with the aim to identify new leads potentially useful as novel diagnostic and therapeutic agents. It has been indeed well described that A<sub>3</sub>ARs play an important role in different human pathologies, suggesting the potential use of selective agonists and/or antagonists acting through AR modulation. The chemical development of several classes of hA<sub>3</sub>AR selective agonists and/or antagonists has permitted the identification of clinical candidates with an important impact on the drug discovery process (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Some A<sub>3</sub>AR antagonists are available in preclinical studies as <b>42</b> (National Institutes of Health, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) for stroke,<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a><b>60</b> (Otsuka Pharmaceutical, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) and <b>77</b> (National Institutes of Health, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) as antiglaucoma agents.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Other A<sub>3</sub>AR antagonists, named CGH 2466 (thiazole analogue of <b>30</b>, Novartis)<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> and SSR 161421 and SAR 137272 (Sanofi, structures not disclosed), have been investigated in the treatment of asthma or COPD.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> While none of the examined A<sub>3</sub>AR antagonists have until now gone beyond the preclinical investigation, a few examples of A<sub>3</sub>AR agonists are currently available in specific clinical trials, suggesting their possible using for novel therapeutic treatments. Among dermatological disorders, a phase II/III study in patients with psoriasis has demonstrated that the treatment with IB-MECA was safe, well tolerated, and effective in improving psoriatic area and severity index score.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> Studies from a phase II/III clinical trial revealed that IB-MECA, given orally, induced statistically significant improvements in patients with dry eye syndrome or with glaucoma.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> In these diseases, IB-MECA was well tolerated and exhibited an excellent safety profile with no serious adverse events.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> At present, IB-MECA has also been investigated in phase I clinical trial for uveitis and in phase II clinical trials for keratoconjunctivitis.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> In addition, a phase II clinical study has demonstrated that oral IB-MECA treatment showed an excellent safety profile and induced a statistically significant improvement in the corneal staining, tear breakup time, and tear meniscus with a decrease in intraocular pressure patients with dry eye syndrome.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. A<sub>3</sub>AR Ligands under Preclinical or Clinical Investigation (Data from Thomson Reuters Integrity) </div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">therapeutic group</th><th class="colsep0 rowsep0" align="center">highest phase</th><th class="colsep0 rowsep0" align="center">organization</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Agonist</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b>, IB-MECA</td><td class="colsep0 rowsep0" align="left">glaucoma</td><td class="colsep0 rowsep0" align="left">phase II/III</td><td class="colsep0 rowsep0" align="left">Can-Fite Biopharma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">antineoplastic enhancing agent</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">psoriasis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">colorectal cancer</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dry eye syndrome</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">RA</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">solid tumors</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">osteoarthritis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">oncolytic drugs</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">keratoconjunctivitis</td><td class="colsep0 rowsep0" align="left">phase II</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">uveitis</td><td class="colsep0 rowsep0" align="left">phaseI</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b>, Cl-IB-MECA</td><td class="colsep0 rowsep0" align="left">liver cancer</td><td class="colsep0 rowsep0" align="left">phase I/II</td><td class="colsep0 rowsep0" align="left">Can-Fite Biopharma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">hepatitis C</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">liver and biliary tract disorders</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">angina pectoris</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">Pfizer</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">oncolytic drug</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">U.S. Department of Health & Human Services</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">acute myocardial infarction</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">Can-Fite Biopharma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">arthritis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">National Institutes of Health</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">oncolytic drug</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">stroke</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Antagonist</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30b</b></td><td class="colsep0 rowsep0" align="left">arthritis and COPD</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">Novartis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">stroke</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">National Institutes of Health</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">glaucoma</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">Otsuka Pharmaceutical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAR-137272</td><td class="colsep0 rowsep0" align="left">asthma and COPD</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">Sanofi</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">glaucoma</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">National Institutes of Health</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Allosteric Modulator</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>91</b></td><td class="colsep0 rowsep0" align="left">osteoarthritis</td><td class="colsep0 rowsep0" align="left">preclinical</td><td class="colsep0 rowsep0" align="left">National Institutes of Health</td></tr></tbody></table></div></div><div class="NLM_p">In musculoskeletal and connective tissue disorders, such as RA, IB-MECA is available in a phase IIb clinical study where it has been reported that patients with high A<sub>3</sub>AR expression at baseline responded positively to the drug.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> The compound was well tolerated and effective, with a maximum clinical response observed at a dose of 1 mg in RA patients. IB-MECA has been also evaluated in terms of safety and efficacy in a phase II clinical study with patients suffering from osteoarthritis of the knee.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> These studies have suggested that A<sub>3</sub>AR expression levels could have an important predictive value in determining treatment response. In the past, it has been demonstrated that the small orally bioavailable molecule IB-MECA exerts systemic anticancer, antimetastatic, and myeloprotective effects in colon carcinoma-bearing mice and may serve as an adjuvant treatment to enhance the chemotherapeutic index and prevent myelotoxicity.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> In particular, in colon cancer cell lines the stimulation of A<sub>3</sub>ARs mediates a tonic proliferative effect, suggesting that these receptors could be potentially used as a diagnostic marker or a therapeutic target.<a onclick="showRef(event, 'ref200 ref206'); return false;" href="javascript:void(0);" class="ref ref200 ref206">(200, 206)</a> The inhibition of primary colon carcinoma growth and liver metastasis by IB-MECA has been accurately described showing in a colon carcinoma murine model an increase of the chemotherapic effect of 5-fluorouracil in the presence of the A<sub>3</sub>AR agonist.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> IB-MECA has been in phase II clinical trials for colorectal cancer, given that the anticancer effect of the A<sub>3</sub>AR agonist has been convincingly demonstrated in vitro and in vivo.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Another A<sub>3</sub>AR agonist, Cl-IB-MECA, which is a targeted drug with high affinity and selectivity, has been developed in early phase I/II clinical studies for the treatment of liver disease including hepatocellular carcinoma and hepatitits as well as for liver regeneration.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> Cl-IB-MECA has been also studied in a phase I/II trial for the treatment of chronic hepatitis C and in liver disease to promote liver regeneration.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> Recently, an interim analysis of a phase I/II trial of Cl-IB-MECA has been reported from Can-Fite BioPharma. This study included 18 patients with hepatocellular carcinoma who were treated with three different doses of Cl-IB-MECA, determining the pharmacokinetic behavior and the safety profile of the long-term administration.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a></div><div class="NLM_p last">Taken together, these findings suggest that A<sub>3</sub>ARs could represent a possible target for pharmacological intervention to prevent different pathologies in both the central nervous system and the cardiovascular system, in inflammatory diseases, and in cancer.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm300087j" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pier Giovanni Baraldi</span> - <span class="hlFld-Affiliation affiliation">†Dipartimento
di Scienze Farmaceutiche and ‡Dipartimento di Medicina Clinica e Sperimentale-Sezione
di Farmacologia, Università di Ferrara, 44121 Ferrara, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#482a293a29242c21083d26212e2d66213c68383a3c2c242d083d26212e2d66213c"><span class="__cf_email__" data-cfemail="a1c3c0d3c0cdc5c8e1d4cfc8c7c48fc8d5">[email protected]</span> <span class="__cf_email__" data-cfemail="3a4a484e5e565f7a4f54535c5f14534e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Delia Preti</span> - <span class="hlFld-Affiliation affiliation">†Dipartimento
di Scienze Farmaceutiche and ‡Dipartimento di Medicina Clinica e Sperimentale-Sezione
di Farmacologia, Università di Ferrara, 44121 Ferrara, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f1939083909d9598b1849f989794df9885d1818385959d94b1849f989794df9885"><span class="__cf_email__" data-cfemail="afcdceddcec3cbc6efdac1c6c9ca81c6db">[email protected]</span> <span class="__cf_email__" data-cfemail="d6a6a4a2b2bab396a3b8bfb0b3f8bfa2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pier Andrea Borea</span> - <span class="hlFld-Affiliation affiliation">†Dipartimento
di Scienze Farmaceutiche and ‡Dipartimento di Medicina Clinica e Sperimentale-Sezione
di Farmacologia, Università di Ferrara, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katia Varani</span> - <span class="hlFld-Affiliation affiliation">†Dipartimento
di Scienze Farmaceutiche and ‡Dipartimento di Medicina Clinica e Sperimentale-Sezione
di Farmacologia, Università di Ferrara, 44121 Ferrara, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Pier Giovanni Baraldi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pier Giovanni Baraldi</b> received his degree in Chemistry in 1974 from the University of Ferrara, Italy, where he held a position of Lecturer in the Faculty of Pharmacy (1977–1980) and Associate Professor of Medicinal Chemistry (1980–1987). In 1987, he became Full Professor of Medicinal Chemistry at the University of Bologna, Italy. In 1992, he returned to the University of Ferrara as Full Professor of Medicinal Chemistry. He has published more than 360 research papers including 44 patents in the following areas: synthesis of natural products possessing biological activity, prostaglandins, minor groove alkylating agents with antitumor activity (anthramycins, distamycins, and CC-1065 analogues), ligands for adenosine receptor subtypes (agonists and antagonists for A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> adenosine receptors), and TRP channels modulators.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Delia Preti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Delia Preti</b> received her B.S. in Medicinal Chemistry (2001) and her Ph.D. in Pharmaceutical Sciences (2005) from Ferrara University, Italy. In the following years (2005–2009) she has worked at the Department of Pharmaceutical Sciences of Ferrara University in a postdoctoral research position, focusing her interests in the design and synthesis of adenosine receptors ligands and antitumor compounds inhibiting tubulin polymerization, in collaboration with the company King Pharmaceuticals (North Carolina, U.S.), now part of Pfizer. Since 2009, she has joined a research project based on the design of TRPA1 channel antagonists for the treatment of pain and inflammation at the Department of Preclinical and Clinical Pharmacology of the University of Florence, Italy, in collaboration with the Italian Institute of Technology (Genova, Italy).</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Pier Andrea Borea</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=bio3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pier Andrea Borea</b> received his degree in Chemistry in 1967 at the University of Ferrara, Italy. In 1994 he became Full Professor of Pharmacology at the School of Medicine of the University of Ferrara, Italy. Since 2005 he has been the Director of the Department of Clinical and Experimental Medicine, University of Ferrara, Italy. His main fields of interest are the study at the molecular level of the drug–receptor interaction from a biochemical and thermodynamic point of view and the pharmacological research of adenosine receptors as biomarkers associated with human pathologies. He has published approximately 350 research articles and book chapters in refereed international journals, including several patents in the adenosine research field.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Katia Varani</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=bio4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Katia Varani</b> received her B.Sc. degree and her Ph.D. in Cellular and Molecular Pharmacology at the University of Ferrara, Italy. She is currently Associate Professor in Pharmacology at the University of Ferrara, Italy. Her research interests include (a) characterization at the molecular level of the drug–receptor interaction, (b) in vitro and in vivo studies concerning the evaluation of affinity and potency of novel ligands, and (c) pharmacological research of adenosine receptors in human diseases of the central nervous and peripheral systems. She is coauthor of 160 full scientific publications in refereed international journals.</p></figure></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This paper posted online April 17, 2012. Revisions were made to the first paragraphs of the A<sub>3</sub> Agonist and Antagonist sections, and the corrected version was reposted May 4, 2012.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i50" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i50"> Abbreviations Used</h2><tr><td class="NLM_term">AB-MECA</td><td class="NLM_def"><p class="first last"><i>N</i><sup>6</sup>-(4-aminobenzyl)adenosine-5′-<i>N</i>-methylcarboxamide</p></td></tr><tr><td class="NLM_term">AC</td><td class="NLM_def"><p class="first last">adenylate cyclase</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">adenosine receptor</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary cell</p></td></tr><tr><td class="NLM_term">Cl-IB-MECA</td><td class="NLM_def"><p class="first last">2-chloro-<i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine-5′-<i>N</i>-methylcarboxamide</p></td></tr><tr><td class="NLM_term">GRK2</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor kinase 2</p></td></tr><tr><td class="NLM_term">HEK293</td><td class="NLM_def"><p class="first last">human embryonic kidney 293 cell</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia inducible factor 1α</p></td></tr><tr><td class="NLM_term">HMC</td><td class="NLM_def"><p class="first last">human healthy mesothelial cells</p></td></tr><tr><td class="NLM_term">HMP</td><td class="NLM_def"><p class="first last">healthy mesothelial pleura</p></td></tr><tr><td class="NLM_term">IB-MECA</td><td class="NLM_def"><p class="first last"><i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine-5′-<i>N</i>-methylcarboxamide</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin 1β</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">LNA</td><td class="NLM_def"><p class="first last">locked nucleic acid</p></td></tr><tr><td class="NLM_term">MCP-1</td><td class="NLM_def"><p class="first last">monocyte chemoattractant protein 1</p></td></tr><tr><td class="NLM_term">MECA</td><td class="NLM_def"><p class="first last">5′-(<i>N</i>-methylcarboxamido)adenosine</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">malignant mesothelioma pleura</p></td></tr><tr><td class="NLM_term">NECA</td><td class="NLM_def"><p class="first last">5′-(<i>N</i>-ethylcarboxamido)adenosine</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PLC</td><td class="NLM_def"><p class="first last">phospholypase C</p></td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">pyrazolotriazolopyrimidine</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 217 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Adenosine receptors as drug targets</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.yexcr.2010.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20153317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2010&pages=1284-1288&author=B.+B.+Fredholm&title=Adenosine+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as drug targets</span></div><div class="casAuthors">Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1284-1288</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  There are four adenosine receptors, A1, A2A, A2B and A3, together forming a defined subgroup of G protein coupled receptors.  They are well conserved and widely expressed.  The endogenous agonist, adenosine, has a minimal concn. in body fluids (20-200 nM) that is sufficient to slightly activate the receptors where they are very highly expressed-as in the basal ganglia, on fat cells and in the kidney.  Here adenosine can play a physiol. role and here antagonists such as caffeine can have effects in healthy individuals.  Adenosine levels rise in stress and distress (up to 30 μM in ischemia) and tend to minimize the risk for adverse outcomes by increasing energy supply and decreasing cellular work, by stimulating angiogenesis, mediating preconditioning and having multiple effects on immune competent cells.  These pathophysiol. roles of adenosine also offer some potential drug targets, but the fact that adenosine receptors are involved in so many processes does not simplify drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_KHHZKnJX2bVg90H21EOLACvtfcHk0ljPkHPEntZk9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVart7c%253D&md5=cc440c9c77ef88aa88406c337f9bd666</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2010.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2010.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520receptors%2520as%2520drug%2520targets%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2010%26volume%3D316%26spage%3D1284%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New potent and selective human adenosine A<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=456-459&author=P.+G.+Baraldiauthor=P.+A.+Borea&title=New+potent+and+selective+human+adenosine+A3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%2520potent%2520and%2520selective%2520human%2520adenosine%2520A3%2520receptor%2520antagonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2000%26volume%3D21%26spage%3D456%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhratsky, A.</span><span> </span><span class="NLM_article-title">Adenosine and ATP receptors in the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F156802611795347627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21401499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=973-1011&author=G.+Burnstockauthor=B.+B.+Fredholmauthor=A.+Verkhratsky&title=Adenosine+and+ATP+receptors+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine and ATP receptors in the brain</span></div><div class="casAuthors">Burnstock, Geoffrey; Fredholm, Bertil B.; Verkhratsky, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">973-1011</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  There is a widespread presence of both adenosine (P1) and P2 nucleotide receptors in the brain on both neurons and glial cells.  Adenosine receptors play a major role in presynaptic neuromodulation, while P2X receptors are involved in fast synaptic transmission and synaptic plasticity.  P2Y receptors largely mediate presynaptic activities.  Both P1 and P2 receptors participate in neuron-glia interactions.  Purinergic signaling is involved in control of cerebral vascular tone and remodelling.  Examples of the roles of purinoceptors in neuropathol. involve: A2A receptors in Parkinson's disease and epilepsy, P2 receptors in trauma, ischemia, neuroinflammatory and neuropsychiatric disorders, and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNffIkJPOinbVg90H21EOLACvtfcHk0lgMk2yGLrnQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLg%253D&md5=c7d41568ebcb97044b145db17f9c76ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802611795347627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795347627%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DVerkhratsky%26aufirst%3DA.%26atitle%3DAdenosine%2520and%2520ATP%2520receptors%2520in%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D973%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptor targeting in health and disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1591-1609&author=S.+Gessiauthor=S.+Merighiauthor=D.+Fazziauthor=A.+Stefanelliauthor=K.+Varaniauthor=P.+A.+Borea&title=Adenosine+receptor+targeting+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DFazzi%26aufirst%3DD.%26aulast%3DStefanelli%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptor%2520targeting%2520in%2520health%2520and%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs.%26date%3D2011%26volume%3D20%26spage%3D1591%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AP, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1124%2Fpr.110.003285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21303899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1-34&author=B.+B.+Fredholmauthor=I.+J.+APauthor=K.+A.+Jacobsonauthor=J.+Lindenauthor=C.+E.+M%C3%BCller&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXI.+Nomenclature+and+classification+of+adenosine+receptors-an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Linden, Joel; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-34</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In the 10 years since our previous International Union of Basic and Clin. Pharmacol. report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations.  However, there have been so many other developments that an update is needed.  The fact that the structure of one of the adenosine receptors has recently been solved has already led to new ways of in silico screening of ligands.  The evidence that adenosine receptors can form homo- and hetero-multimers has accumulated, but the functional significance of such complexes remains unclear.  The availability of mice with genetic modification of all the adenosine receptors has led to a clarification of the functional roles of adenosine, and to excellent means to study the specificity of drugs.  There are also interesting assocns. between disease and structural variants in one or more of the adenosine receptors.  Several new selective agonists and antagonists have become available.  They provide improved possibilities for receptor classification.  There are also developments hinting at the usefulness of allosteric modulators.  Many drugs targeting adenosine receptors are in clin. trials, but the established therapeutic use is still very limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqbDC-UZ5sbVg90H21EOLACvtfcHk0lgMk2yGLrnQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D&md5=e184c127e06b800bbcf15402ed27f02a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003285%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DAP%26aufirst%3DI.%2BJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXI.%2520Nomenclature%2520and%2520classification%2520of%2520adenosine%2520receptors-an%2520update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D1%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor: pharmacology and role in disease</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-3-540-89615-9_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19639286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2009&pages=297-327&author=P.+A.+Boreaauthor=S.+Gessiauthor=S.+Bar-Yehudaauthor=P.+Fishman&title=A3+adenosine+receptor%3A+pharmacology+and+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A3 adenosine receptor: pharmacology and role in disease</span></div><div class="casAuthors">Borea, P. A.; Gessi, S.; Bar-Yehuda, S.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">297-327</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The study of the A3 adenosine receptor (A3AR) represents a rapidly growing and intense area of research in the adenosine field.  The present chapter will provide an overview of the expression patterns, mol. pharmacol. and functional role of this A3AR subtype under pathophysiol. conditions.  Through studies utilizing selective A3AR agonists and antagonists, or A3AR knockout mice, it is now clear that this receptor plays a crit. role in the modulation of ischemic diseases as well as in inflammatory and autoimmune pathologies.  Therefore, the potential therapeutic use of agonists and antagonists will also be described.  The discussion will principally address the use of such compds. in the treatment of brain and heart ischemia, asthma, sepsis and glaucoma.  The final part concs. on the mol. basis of A3ARs in autoimmune diseases such as rheumatoid arthritis, and includes a description of clin. trials with the selective agonist CF101.  Based on this chapter, it is evident that continued research to discover agonists and antagonists for the A3AR subtype is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnDJBH5xASa7Vg90H21EOLACvtfcHk0lgyCpydHTXumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FF&md5=3f891ac8c418f8d1050a2c341d53a24e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_10%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DA3%2520adenosine%2520receptor%253A%2520pharmacology%2520and%2520role%2520in%2520disease%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26volume%3D193%26spage%3D297%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cheong, S. L.; Federico, S.; Venkatesan, G.; Mandel, A. L.; Shao, Y. M.; Moro, S.; Spalluto, G.; Pastorin, G.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches</span>.  <span class="citation_source-journal">Med. Res. Rev.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1002/med.20254</span> . Published Online: November 16,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fmed.20254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=22095687" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+L.+Cheong&author=S.+Federico&author=G.+Venkatesan&author=A.+L.+Mandel&author=Y.+M.+Shao&author=S.+Moro&author=G.+Spalluto&author=G.+Pastorin&title=The+A3+adenosine+receptor+as+multifaceted+therapeutic+target%3A+pharmacology%2C+medicinal+chemistry%2C+and+in+silico+approaches&doi=10.1002%2Fmed.20254"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmed.20254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20254%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520as%2520multifaceted%2520therapeutic%2520target%253A%2520pharmacology%252C%2520medicinal%2520chemistry%252C%2520and%2520in%2520silico%2520approaches%26jtitle%3DMed.%2520Res.%2520Rev.%26doi%3D10.1002%2Fmed.20254%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=627-632&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Modulation+of+the+Akt%2FRas%2FRaf%2FMEK%2FERK+pathway+by+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DModulation%2520of%2520the%2520Akt%252FRas%252FRaf%252FMEK%252FERK%2520pathway%2520by%2520A3%2520adenosine%2520receptor%26jtitle%3DPurinergic%2520Signalling%26date%3D2006%26volume%3D2%26spage%3D627%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">19516</span><span class="NLM_x">–</span> <span class="NLM_lpage">19526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19516-19526&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=A3+adenosine+receptor+activation+inhibits+cell+proliferation+via+phosphatidylinositol+3-kinase%2FAkt-dependent+inhibition+of+the+extracellular+signal-regulated+kinase+1%2F2+phosphorylation+in+A375+human+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520inhibits%2520cell%2520proliferation%2520via%2520phosphatidylinositol%25203-kinase%252FAkt-dependent%2520inhibition%2520of%2520the%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520phosphorylation%2520in%2520A375%2520human%2520melanoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19516%26epage%3D19526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuscano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falleni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremigni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabeni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1373</span><span class="NLM_x">–</span> <span class="NLM_lpage">1384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1373-1384&author=M.+L.+Trincavelliauthor=D.+Tuscanoauthor=M.+Marroniauthor=A.+Falleniauthor=V.+Gremigniauthor=S.+Cerutiauthor=M.+P.+Abbracchioauthor=K.+A.+Jacobsonauthor=F.+Cattabeniauthor=C.+Martini&title=A3+adenosine+receptors+in+human+astrocytoma+cells%3A+agonist-mediated+desensitization%2C+internalization%2C+and+down-regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DTuscano%26aufirst%3DD.%26aulast%3DMarroni%26aufirst%3DM.%26aulast%3DFalleni%26aufirst%3DA.%26aulast%3DGremigni%26aufirst%3DV.%26aulast%3DCeruti%26aufirst%3DS.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DCattabeni%26aufirst%3DF.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DA3%2520adenosine%2520receptors%2520in%2520human%2520astrocytoma%2520cells%253A%2520agonist-mediated%2520desensitization%252C%2520internalization%252C%2520and%2520down-regulation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D1373%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuscano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucacchini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">Involvement of mitogen protein kinase cascade in agonist-mediated human A<sub>3</sub> adenosine receptor regulation</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1591</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1591&publication_year=2002&pages=55-62&author=M.+L.+Trincavelliauthor=D.+Tuscanoauthor=M.+Marroniauthor=K.+N.+Klotzauthor=A.+Lucacchiniauthor=C.+Martini&title=Involvement+of+mitogen+protein+kinase+cascade+in+agonist-mediated+human+A3+adenosine+receptor+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DTuscano%26aufirst%3DD.%26aulast%3DMarroni%26aufirst%3DM.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLucacchini%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DInvolvement%2520of%2520mitogen%2520protein%2520kinase%2520cascade%2520in%2520agonist-mediated%2520human%2520A3%2520adenosine%2520receptor%2520regulation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1591%26spage%3D55%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arslan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, W.</span><span> </span><span class="NLM_article-title">Structure and function of adenosine receptors and their genes</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2Fs002100000313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11111830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFCru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2000&pages=364-374&author=B.+B.+Fredholmauthor=G.+Arslanauthor=L.+Halldnerauthor=B.+Kullauthor=G.+Schulteauthor=W.+Wasserman&title=Structure+and+function+of+adenosine+receptors+and+their+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of adenosine receptors and their genes</span></div><div class="casAuthors">Fredholm, Bertil B.; Arslan, Giulia; Halldner, Linda; Kull, Bjorn; Schulte, Gunnar; Wasserman, Wyeth</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">364-374</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review with 130 refs.  Four adenosine receptors have been cloned from many mammalian and some non-mammalian species.  In each case the translated part of the receptor is encoded by two sep. exons.  Two sep. promoters regulate the A1 receptor expression, and a similar situation may pertain also for the other receptors.  The receptors are expressed in a cell and tissue specific manner, even though A1 and A2B receptors are found in many different cell types.  Emerging data indicate that the receptor protein is targeted to specific parts of the cell.  A1 and A3 receptors activate the Gi family of G proteins, whereas A2A and A2B receptors activate the Gs family.  However, other G proteins can also be activated even though the physiol. significance of this is unknown.  Following the activation of G proteins several cellular effector pathways can be affected.  Signaling via adenosine receptors is also known to interact in functionally important ways with signaling initiated via other receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqi7IPIpeDOLVg90H21EOLACvtfcHk0lhQ-5rvSHRhOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFCru7g%253D&md5=26a3b7f257b3748da01ab4ef33a81953</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs002100000313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000313%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DArslan%26aufirst%3DG.%26aulast%3DHalldner%26aufirst%3DL.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DSchulte%26aufirst%3DG.%26aulast%3DWasserman%26aufirst%3DW.%26atitle%3DStructure%2520and%2520function%2520of%2520adenosine%2520receptors%2520and%2520their%2520genes%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D362%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zhou, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of an adenosine receptor: the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">7432</span><span class="NLM_x">–</span> <span class="NLM_lpage">7436</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=7432-7436&author=Q.+Y.+Zhouauthor=C.+Liauthor=M.+E.+Olahauthor=R.+A.+Johnsonauthor=G.+L.+Stilesauthor=O.+Civelli&title=Molecular+cloning+and+characterization+of+an+adenosine+receptor%3A+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520an%2520adenosine%2520receptor%253A%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1992%26volume%3D89%26spage%3D7432%26epage%3D7436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. G.</span><span> </span><span class="NLM_article-title">Molecular-cloning and characterization of the human-A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">10365</span><span class="NLM_x">–</span> <span class="NLM_lpage">10369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=10365-10369&author=C.+A.+Salvatoreauthor=M.+A.+Jacobsonauthor=H.+E.+Taylorauthor=J.+Lindenauthor=R.+G.+Johnson&title=Molecular-cloning+and+characterization+of+the+human-A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DTaylor%26aufirst%3DH.%2BE.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26atitle%3DMolecular-cloning%2520and%2520characterization%2520of%2520the%2520human-A3%2520adenosine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D10365%26epage%3D10369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor: an enigmatic player in cell biology</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.pharmthera.2007.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18029023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=123-140&author=S.+Gessiauthor=S.+Merighiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Mac+Lennanauthor=P.+A.+Borea&title=The+A3+adenosine+receptor%3A+an+enigmatic+player+in+cell+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: An enigmatic player in cell biology</span></div><div class="casAuthors">Gessi, Stefania; Merighi, Stefania; Varani, Katia; Leung, Edward; Mac Lennan, Stephen; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-140</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adenosine is a primordial signaling mol. present in every cell of the human body that mediates its physiol. functions by interacting with 4 subtypes of G-protein-coupled receptors, termed A1, A2A, A2B and A3.  The A3 subtype is perhaps the most enigmatic among adenosine receptors since, although several studies have been performed in the years to elucidate its physiol. function, it still presents in several cases a double nature in different pathophysiol. conditions.  The 2 personalities of A3 often come into direct conflict, e.g., in ischemia, inflammation and cancer, rendering this receptor as a single entity behaving in 2 different ways.  This review focuses on the most relevant aspects of A3 adenosine subtype activation and summarizes the pharmacol. evidence as the basis of the dichotomy of this receptor in different therapeutic fields.  Although much is still to be learned about the function of the A3 receptor and in spite of its duality, at the present time it can be speculated that A3 receptor selective ligands might show utility in the treatment of ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature.  The biggest and most intriguing challenge for the future is therefore to understand whether and where selective A3 agonists or antagonists are the best choice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DycIR5fBxbVg90H21EOLACvtfcHk0lhQ-5rvSHRhOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtLzF&md5=fbdc6b555110a56c3724cab8a116a9ea</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac%2BLennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%253A%2520an%2520enigmatic%2520player%2520in%2520cell%2520biology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D123%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=10779381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVegurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=968-975&author=K.+Varaniauthor=S.+Merighiauthor=S.+Gessiauthor=K.+N.+Klotzauthor=E.+Leungauthor=P.+G.+Baraldiauthor=B.+Cacciariauthor=R.+Romagnoliauthor=G.+Spallutoauthor=P.+A.+Borea&title=%5B3H%5DMRE+3008F20%3A+a+novel+antagonist+radioligand+for+the+pharmacological+and+biochemical+characterization+of+human+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors</span></div><div class="casAuthors">Varani, Katia; Merighi, Stefania; Gessi, Stefania; Klotz, Karl-Norbert; Lfung, Edward; Baraldi, Pier Giovanni; Cacciari, Barbara; Romagnoli, Romeo; Spalluto, Giampiero; Borfa, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-975</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The lack of a radiolabeled selective A3 adenosine receptor antagonist is a major drawback for an adequate characterization of this receptor subtype.  This paper describes the pharmacol. and biochem. characterization of the tritiated form of a new potent A3 adenosine receptor antagonist, the pyrazolo triazolo pyrimidine deriv. [3H]5N-(4-methoxyphenylcarbamoyl)amino-8-propyl-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine ([3H]MRE 3008F20).  [3H]MRE 3008F20 bound specifically to the human adenosine A3 receptor expressed in CHO cells (hA3CHO), and satn. anal. revealed a single high affinity binding site, KD = 0.80 nM, with a Bmax = 300 fmol/mg protein.  This new ligand displayed high selectivity (1294-, 165-, and 2471-fold) in binding assay to human A3 vs. A1, A2A, and A2B receptors, resp., and binds to the rat A3 receptors with a Ki >10 μM.  The pharmacol. profile of [3H]MRE 3008F20 binding to hA3CHO cells was evaluated using known adenosine receptor agonists and antagonists with a rank order of potency consistent with that typically found for interactions with the A3 adenosine receptors.  In the adenylyl cyclase assay the same compds. exhibited a rank order of potency identical with that obsd. in binding expts.  Thermodn. data indicated that [3H]MRE 3008F20 binding to hA3CHO is entropy- and enthalpy-driven in agreement with the typical behavior of other adenosine antagonists to A1 and A2A receptors.  These results show that [3H]MRE 3008F20 is the first antagonist radioligand with high affinity and selectivity for the human A3 adenosine receptor and may be used to investigate the physiopathol. role of A3 adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLUtXnI9zeCbVg90H21EOLACvtfcHk0lhQ-5rvSHRhOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVegurc%253D&md5=f8856e23ba8e4ac4a17eedc9b21dcf5f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3D%255B3H%255DMRE%25203008F20%253A%2520a%2520novel%2520antagonist%2520radioligand%2520for%2520the%2520pharmacological%2520and%2520biochemical%2520characterization%2520of%2520human%2520A3%2520adenosine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D968%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavioli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Expression of A<sub>3</sub> adenosine receptors in human lymphocytes: up-regulation in T cell activation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=711-719&author=S.+Gessiauthor=K.+Varaniauthor=S.+Merighiauthor=E.+Cattabrigaauthor=A.+Avitabileauthor=R.+Gavioliauthor=C.+Fortiniauthor=E.+Leungauthor=S.+Mac+Lennanauthor=P.+A.+Borea&title=Expression+of+A3+adenosine+receptors+in+human+lymphocytes%3A+up-regulation+in+T+cell+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DAvitabile%26aufirst%3DA.%26aulast%3DGavioli%26aufirst%3DR.%26aulast%3DFortini%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac%2BLennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520A3%2520adenosine%2520receptors%2520in%2520human%2520lymphocytes%253A%2520up-regulation%2520in%2520T%2520cell%2520activation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D711%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A glance at adenosine receptors: novel target for antitumor therapy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0163-7258%2803%2900084-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=14550503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=31-48&author=S.+Merighiauthor=P.+Mirandolaauthor=K.+Varaniauthor=S.+Gessiauthor=E.+Leungauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=P.+A.+Borea&title=A+glance+at+adenosine+receptors%3A+novel+target+for+antitumor+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A glance at adenosine receptors: novel target for antitumor therapy</span></div><div class="casAuthors">Merighi, Stefania; Mirandola, Prisco; Varani, Katia; Gessi, Stefania; Leung, Edward; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-48</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Adenosine can be released from a variety of cells throughout the body, as the result of increased metabolic rates, in concns. that can have a profound impact on the vasculature, immunoescaping, and growth of tumor masses.  It is recognized that the concns. of this nucleoside are increased in cancer tissues.  Therefore, it is not surprising that adenosine has been shown to be a crucial factor in detg. the cell progression pathway, either during apoptosis or during cytostatic state.  From the perspective of cancer, the most important question then may be "Can activation and/or blockade of the pathways downstream of the adenosine receptor contribute to tumor development".  Rigorous examns. of the role of adenosine in in vivo and in vitro systems need to be investigated.  The present review therefore proposes multiple adenosine-sustained ways that could prime tumor development together with the crit. combinatorial role played by adenosine receptors in taking a choice between proliferation and death.  This review proposes that adenosine acts as a potent regulator of normal and tumor cell growth.  It is hypothesized that this effect is dependent on extracellular adenosine concns., cell surface expression of different adenosine receptor subtypes, and signal transduction mechanisms activated following the binding of specific agonists.  We venture to suggest that the clarification of the role of adenosine and its receptors in cancer development may hold great promise for the treatment of chemotherapy in patients affected by malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhMpzNAaZAUbVg90H21EOLACvtfcHk0liPjE_0_IhtXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVOgsLY%253D&md5=98ba1341e13fb77842485b69c4e3ada3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900084-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900084-6%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA%2520glance%2520at%2520adenosine%2520receptors%253A%2520novel%2520target%2520for%2520antitumor%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D100%26spage%3D31%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor ligands: history and perspectives</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C103%3A%3AAID-MED1%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=10723024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=103-128&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=R.+Romagnoliauthor=S.+Merighiauthor=K.+Varaniauthor=P.+A.+Boreaauthor=G.+Spalluto&title=A3+adenosine+receptor+ligands%3A+history+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A3 adenosine receptor ligands: history and perspectives</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Cacciari, Barbara; Romagnoli, Romeo; Merighi, Stefania; Varani, Katia; Borea, Pier Andrea; Spalluto, Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-128</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 92 refs.  Adenosine regulates many physiol. functions through specific cell membrane receptors.  On the basis of pharmacol. studies and mol. cloning, four different adenosine receptors have been identified and classified as A1, A2A, A2B, and A3.  These adenosine receptors are members of the G-protein-coupled receptor family.  While adenosine A1 and A2A receptor subtypes have been pharmacol. characterized through the use of selective ligands, the A3 adenosine receptor subtype is presently under study to better understand its physio-pathol. functions.  Activation of adenosine A3 receptors has been shown to stimulate phospholipase C and D and to inhibit adenylate cyclase.  Activation of A3 adenosine receptors also causes the release of inflammatory mediators such as histamine from mast cells.  These mediators are responsible for processes such as inflammation and hypotension.  It has also been suggested that the A3 receptor plays an important role in brain ischemia, immunosuppression, and bronchospasm in several animal models.  Based on these results, highly selective A3 adenosine receptor agonists and/or antagonists have been indicated as potential drugs for the treatment of asthma and inflammation, while highly selective agonists have been shown to possess cardioprotective effects.  The updated material related to this field of research has been rationalized and arranged to offer an overview of the topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKZMvY-RWf3bVg90H21EOLACvtfcHk0liPjE_0_IhtXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVeisL0%253D&md5=afc7dbccbfd5273cddd9009bb22c49a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C103%3A%3AAID-MED1%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200003%252920%253A2%253C103%253A%253AAID-MED1%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DSpalluto%26aufirst%3DG.%26atitle%3DA3%2520adenosine%2520receptor%2520ligands%253A%2520history%2520and%2520perspectives%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D103%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuzzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Full and partial agonistic behaviour and thermodynamic binding parameters of adenosine A<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2F0922-4106%2894%2990224-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=8206130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1994&pages=55-61&author=P.+A.+Boreaauthor=K.+Varaniauthor=A.+Dalpiazauthor=A.+Capuzzoauthor=E.+Fabbriauthor=A.+P.+Ijzerman&title=Full+and+partial+agonistic+behaviour+and+thermodynamic+binding+parameters+of+adenosine+A1+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Full and partial agonistic behavior and thermodynamic binding parameters of adenosine A1 receptor ligands</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Dalpiaz, Alessandro; Capuzzo, Antonio; Fabbri, Elena; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The inhibitory effect of forskolin-stimulated 3',5'-cyclic monophosphate (cAMP) synthesis in isolated rat adipocytes has been measured for eight typical adenosine receptor agonists.  The percent inhibition was evaluated using concns. of each compd. corresponding to 100 times their Ki, inhibitory binding consts., detd. in parallel by [3H]N6-cyclohexyladenosine binding to adenosine A1 receptors on rat adipocyte membranes which guaranteed full receptor occupancy.  Some drugs were able to inhibit the forskolin-induced c-AMP accumulation by 100% (full agonists, intrinsic activity = 1) but others only to a lesser extent, ranging from 80% to 50% (partial agonists, intrinsic activities in the 0.8-0.5 interval).  These efficacy data were correlated with the thermodn. binding parameters (free energy, enthalpy and entropy) obtained in rat brain membranes by equil. const. measurements and Van't Hoff plots in the 0-30° range.  The pos. correlation between intrinsic activity and entropy changes (r = 0.88) points to the possibility of obtaining information about the full spectrum of activities of adenosine analogs from in vitro binding assays and suggests some considerations on the possible drug-receptor interaction mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhPGGODVxAvbVg90H21EOLACvtfcHk0liPjE_0_IhtXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKrsLg%253D&md5=09ea8bc79ba54c2c76cac153fdf475ff</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990224-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990224-0%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DCapuzzo%26aufirst%3DA.%26aulast%3DFabbri%26aufirst%3DE.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DFull%2520and%2520partial%2520agonistic%2520behaviour%2520and%2520thermodynamic%2520binding%2520parameters%2520of%2520adenosine%2520A1%2520receptor%2520ligands%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D267%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilli, G.</span><span> </span><span class="NLM_article-title">Binding thermodynamics of adenosine A<sub>2A</sub> receptor ligands</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=461-469&author=P.+A.+Boreaauthor=A.+Dalpiazauthor=K.+Varaniauthor=L.+Guerraauthor=G.+Gilli&title=Binding+thermodynamics+of+adenosine+A2A+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGuerra%26aufirst%3DL.%26aulast%3DGilli%26aufirst%3DG.%26atitle%3DBinding%2520thermodynamics%2520of%2520adenosine%2520A2A%2520receptor%2520ligands%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26spage%3D461%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilli, G.</span><span> </span><span class="NLM_article-title">Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=1549-1556&author=P.+A.+Boreaauthor=A.+Dalpiazauthor=K.+Varaniauthor=P.+Gilliauthor=G.+Gilli&title=Can+thermodynamic+measurements+of+receptor+binding+yield+information+on+drug+affinity+and+efficacy%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGilli%26aufirst%3DP.%26aulast%3DGilli%26aufirst%3DG.%26atitle%3DCan%2520thermodynamic%2520measurements%2520of%2520receptor%2520binding%2520yield%2520information%2520on%2520drug%2520affinity%2520and%2520efficacy%253F%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2000%26volume%3D60%26spage%3D1549%26epage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Binding thermodynamics at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=157-161&author=S.+Merighiauthor=K.+Varaniauthor=S.+Gessiauthor=K.+N.+Klotzauthor=E.+Leungauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Binding+thermodynamics+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DBinding%2520thermodynamics%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D63%26spage%3D157%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliesi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> receptor ligands: past, present and future trends</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F156802610791293109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20370658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFaqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=942-975&author=S.+Talianiauthor=I.+Pugliesiauthor=M.+Bellandiauthor=C.+La+Mottaauthor=F.+Da+Settimo&title=A3+receptor+ligands%3A+past%2C+present+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A3 receptor ligands: past, present and future trends</span></div><div class="casAuthors">Taliani, S.; Pugliesi, I.; Bellandi, M.; La Motta, C.; Da Settimo, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">942-975</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The A3 adenosine receptors (A3 ARs), belonging to the adenosine receptor family of G-protein-coupled receptors (GPCRs), are ubiquitously expressed in a wide variety of tissues in human body, with high levels in peripheral organs and low levels in the brain.  The A3 ARs are involved in a variety of important patho-physiol. processes, including modulation of cerebral and cardiac ischemic damage, inflammation, modulation of intraocular pressure, regulation of normal and tumor cell growth, and immunosuppression.  Consequently, A3 AR selective ligands may represent important pharmacol. tools in the treatment of a variety of diseases.  Indeed, the development of potent and selective A3 AR ligands has been the subject of medicinal chem. research for more than two decades.  Although to date a considerable no. of selective A3 AR agonists and antagonists have been discovered, much is still to be learned about the exact function of this subtype, due to its enigmatic role in several physiol. processes.  In the last two decades, numerous medicinal chem. groups have made intense efforts in searching for ideal ligands for the A3 AR subtype.  The purpose of this review is to summarize the most recent developments made in the field of selective A3 AR ligands, which have been subdivided on the basis of their main chem. structural features.  For each chem. class, attention has been focused on the SARs which det. ligand affinity and selectivity for the target subtype, and on eventually available preclin. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVkLMsN7bZBbVg90H21EOLACvtfcHk0ljC7Ixx0bfGhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFaqs7c%253D&md5=2dca84481eee08b7a00308ef8818d11f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F156802610791293109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791293109%26sid%3Dliteratum%253Aachs%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DPugliesi%26aufirst%3DI.%26aulast%3DBellandi%26aufirst%3DM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26atitle%3DA3%2520receptor%2520ligands%253A%2520past%252C%2520present%2520and%2520future%2520trends%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D942%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine receptor ligands and their potential as novel drugs</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1808</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1290-1308&author=C.+E.+M%C3%BCllerauthor=K.+A.+Jacobson&title=Recent+developments+in+adenosine+receptor+ligands+and+their+potential+as+novel+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520receptor%2520ligands%2520and%2520their%2520potential%2520as%2520novel%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1808%26spage%3D1290%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of the A<sub>3</sub> adenosine receptor: agonists, antagonists, and receptor engineering</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-3-540-89615-9_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19639281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=123-159&author=K.+A.+Jacobsonauthor=A.+M.+Klutzauthor=D.+K.+Toshauthor=A.+A.+Ivanovauthor=D.+Pretiauthor=P.+G.+Baraldi&title=Medicinal+chemistry+of+the+A3+adenosine+receptor%3A+agonists%2C+antagonists%2C+and+receptor+engineering"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering</span></div><div class="casAuthors">Jacobson, Kenneth A.; Klutz, Athena M.; Tosh, Dilip K.; Ivanov, Andrei A.; Preti, Delia; Baraldi, Pier Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">123-159</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A3 adenosine receptor (A3AR) ligands have been modified to optimize their interaction with the A3AR.  Most of these modifications have been made to the N6 and C2 positions of adenine as well as the ribose moiety, and using a combination of these substitutions leads to the most efficacious, selective, and potent ligands.  A3AR agonists such as IB-MECA and Cl-IB-MECA are now advancing into Phase II clin. trials for treatments targeting diseases such as cancer, arthritis, and psoriasis.  Also, a wide no. of compds. exerting high potency and selectivity in antagonizing the human (h)A3AR have been discovered.  These mols. are generally characterized by a notable structural diversity, taking into account that arom. nitrogen-contg. monocyclic (thiazoles and thiadiazoles), bicyclic (isoquinoline, quinozalines, (aza)adenines), tricyclic systems (pyrazoloquinolines, triazoloquinoxalines, pyrazolotriazolopyrimidines, triazolopurines, tricyclic xanthines) and nucleoside derivs. have been identified as potent and selective A3AR antagonists.  Probably due to the "enigmatic" physiol. role of A3AR, whose activation may produce opposite effects (for example, concerning tissue protection in inflammatory and cancer cells) and may produce effects that are species dependent, only a few mols. have reached preclin. investigation.  Indeed, the most advanced A3AR antagonists remain in preclin. testing.  Among the antagonists described above, compd. OT-7999 is expected to enter clin. trials for the treatment of glaucoma, while several thiazole derivs. are in development as antiallergic, antiasthmatic and/or antiinflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1HYJjr1FNxrVg90H21EOLACvtfcHk0ljC7Ixx0bfGhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FM&md5=56f7d3226341b1e49ffe359e7ab81f78</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_5%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26atitle%3DMedicinal%2520chemistry%2520of%2520the%2520A3%2520adenosine%2520receptor%253A%2520agonists%252C%2520antagonists%252C%2520and%2520receptor%2520engineering%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26spage%3D123%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaustein, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=1675-1684&author=Z.+G.+Gaoauthor=J.+B.+Blausteinauthor=A.+S.+Grossauthor=N.+Melmanauthor=K.+A.+Jacobson&title=N-6-Substituted+adenosine+derivatives%3A+selectivity%2C+efficacy%2C+and+species+differences+at+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DBlaustein%26aufirst%3DJ.%2BB.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DN-6-Substituted%2520adenosine%2520derivatives%253A%2520selectivity%252C%2520efficacy%252C%2520and%2520species%2520differences%2520at%2520A3%2520adenosine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D1675%26epage%3D1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rompaey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K.</span><span> </span><span class="NLM_article-title">Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2995</span><span class="NLM_x">–</span> <span class="NLM_lpage">3007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2995-3007&author=M.+Ohnoauthor=Z.+Gaoauthor=P.+Van+Rompaeyauthor=S.+Tchilibonauthor=S.+Kimauthor=B.+A.+Harrisauthor=A.+S.+Grossauthor=H.+T.+Duongauthor=S.+Van+Calenberghauthor=K.+Jacobson&title=Modulation+of+adenosine+receptor+affinity+and+intrinsic+efficacy+in+adenine+nucleosides+substituted+at+the+2-position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DVan%2BRompaey%26aufirst%3DP.%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%26atitle%3DModulation%2520of%2520adenosine%2520receptor%2520affinity%2520and%2520intrinsic%2520efficacy%2520in%2520adenine%2520nucleosides%2520substituted%2520at%2520the%25202-position%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2995%26epage%3D3007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaustein, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Exploring distal regions of the A<sub>3</sub> adenosine receptor binding site: sterically constrained <i>N</i><sup>6</sup>-(2-phenylethyl)adenosine derivatives as potent ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2021-2034&author=S.+Tchilibonauthor=S.+K.+Kimauthor=Z.+G.+Gaoauthor=B.+A.+Harrisauthor=J.+B.+Blausteinauthor=A.+S.+Grossauthor=H.+T.+Duongauthor=N.+Melmanauthor=K.+A.+Jacobson&title=Exploring+distal+regions+of+the+A3+adenosine+receptor+binding+site%3A+sterically+constrained+N6-%282-phenylethyl%29adenosine+derivatives+as+potent+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DBlaustein%26aufirst%3DJ.%2BB.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DExploring%2520distal%2520regions%2520of%2520the%2520A3%2520adenosine%2520receptor%2520binding%2520site%253A%2520sterically%2520constrained%2520N6-%25282-phenylethyl%2529adenosine%2520derivatives%2520as%2520potent%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2021%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maa, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span> </span><span class="NLM_article-title">2-Pyrazolyl-<i>N</i><sup>6</sup>-substituted adenosine derivatives as high affinity and selective adenosine A<sub>3</sub> receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4766</span><span class="NLM_x">–</span> <span class="NLM_lpage">4773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049682h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4766-4773&author=E.+Elzeinauthor=V.+Palleauthor=Y.+Z.+Wuauthor=T.+N.+Maaauthor=D.+W.+Zengauthor=J.+Zablocki&title=2-Pyrazolyl-N6-substituted+adenosine+derivatives+as+high+affinity+and+selective+adenosine+A3+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm049682h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049682h%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DY.%2BZ.%26aulast%3DMaa%26aufirst%3DT.%2BN.%26aulast%3DZeng%26aufirst%3DD.%2BW.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3D2-Pyrazolyl-N6-substituted%2520adenosine%2520derivatives%2520as%2520high%2520affinity%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4766%26epage%3D4773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Elzein, E.; Palle, V.; Varkhedkar, V.; Zablocki, J.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> Receptor Agonists</span>. WO 2003014137,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=E.+Elzein&author=V.+Palle&author=V.+Varkhedkar&author=J.+Zablocki&title=Adenosine+A3+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26atitle%3DAdenosine%2520A3%2520Receptor%2520Agonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegman, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Galen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of <i>N</i><sup>6</sup>-benzyladenosine-5′-uronamides as A<sub>3</sub>-selective adenosine agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00031a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=636-646&author=C.+Gallo-Rodriguezauthor=X.+D.+Jiauthor=N.+Melmanauthor=B.+D.+Siegmanauthor=L.+H.+Sandersauthor=J.+Orlinaauthor=B.+Fischerauthor=Q.+Puauthor=M.+E.+Olahauthor=P.+J.+van+Galenauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=Structure%E2%80%93activity+relationships+of+N6-benzyladenosine-5%E2%80%B2-uronamides+as+A3-selective+adenosine+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm00031a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00031a014%26sid%3Dliteratum%253Aachs%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DSiegman%26aufirst%3DB.%2BD.%26aulast%3DSanders%26aufirst%3DL.%2BH.%26aulast%3DOrlina%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DPu%26aufirst%3DQ.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3Dvan%2BGalen%26aufirst%3DP.%2BJ.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520N6-benzyladenosine-5%25E2%2580%25B2-uronamides%2520as%2520A3-selective%2520adenosine%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D636%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Novel <i>N</i><sup>6</sup>-(substituted-phenylcarbamoyl)adenosine-5′-uronamides as potent agonists for A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950518r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=802-806&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=G.+Spallutoauthor=X.+D.+Jiauthor=M.+E.+Olahauthor=G.+Stilesauthor=S.+Dionisottiauthor=C.+Zocchiauthor=E.+Onginiauthor=K.+A.+Jacobson&title=Novel+N6-%28substituted-phenylcarbamoyl%29adenosine-5%E2%80%B2-uronamides+as+potent+agonists+for+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm950518r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950518r%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DNovel%2520N6-%2528substituted-phenylcarbamoyl%2529adenosine-5%25E2%2580%25B2-uronamides%2520as%2520potent%2520agonists%2520for%2520A3%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D802%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda de Las Infantas, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of a new series of <i>N</i><sup>6</sup>-arylcarbamoyl, 2-(Ar)alkynyl-<i>N</i>-arylcarbamoyl, and <i>N</i><sup>6</sup>-carboxamido derivatives of adenosine-5′-<i>N</i>-ethyluronamide as A<sub>1</sub> and A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3174</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980147p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3174-3185&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=M.+J.+Pineda+de+Las+Infantasauthor=R.+Romagnoliauthor=G.+Spallutoauthor=R.+Volpiniauthor=S.+Costanziauthor=S.+Vittoriauthor=G.+Cristalliauthor=N.+Melmanauthor=K.+S.+Parkauthor=X.+D.+Jiauthor=K.+A.+Jacobson&title=Synthesis+and+biological+activity+of+a+new+series+of+N6-arylcarbamoyl%2C+2-%28Ar%29alkynyl-N-arylcarbamoyl%2C+and+N6-carboxamido+derivatives+of+adenosine-5%E2%80%B2-N-ethyluronamide+as+A1+and+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm980147p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980147p%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DPineda%2Bde%2BLas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520a%2520new%2520series%2520of%2520N6-arylcarbamoyl%252C%25202-%2528Ar%2529alkynyl-N-arylcarbamoyl%252C%2520and%2520N6-carboxamido%2520derivatives%2520of%2520adenosine-5%25E2%2580%25B2-N-ethyluronamide%2520as%2520A1%2520and%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3174%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda de Las Infantas, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel <i>N</i><sup>6</sup>-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5′-uronamides as A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5535</span><span class="NLM_x">–</span> <span class="NLM_lpage">5540</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0408161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5535-5540&author=P.+G.+Baraldiauthor=F.+Fruttaroloauthor=M.+A.+Tabriziauthor=R.+Romagnoliauthor=D.+Pretiauthor=A.+Boveroauthor=M.+J.+Pineda+de+Las+Infantasauthor=A.+Moormanauthor=K.+Varaniauthor=P.+A.+Borea&title=Synthesis+and+biological+evaluation+of+novel+N6-%5B4-%28substituted%29sulfonamidophenylcarbamoyl%5Dadenosine-5%E2%80%B2-uronamides+as+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0408161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0408161%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBovero%26aufirst%3DA.%26aulast%3DPineda%2Bde%2BLas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DMoorman%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520N6-%255B4-%2528substituted%2529sulfonamidophenylcarbamoyl%255Dadenosine-5%25E2%2580%25B2-uronamides%2520as%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5535%26epage%3D5540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Devine, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urmaliya, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouton, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottle, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of new <i>N</i><sup>6</sup>-substituted adenosine-5′-<i>N</i>-methylcarboxamides as A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3078</span><span class="NLM_x">–</span> <span class="NLM_lpage">3087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3078-3087&author=S.+M.+Devineauthor=A.+Greggauthor=H.+Figlerauthor=K.+McIntoshauthor=V.+Urmaliyaauthor=J.+Lindenauthor=C.+W.+Poutonauthor=P.+J.+Whiteauthor=S.+E.+Bottleauthor=P.+J.+Scammells&title=Synthesis+and+evaluation+of+new+N6-substituted+adenosine-5%E2%80%B2-N-methylcarboxamides+as+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DGregg%26aufirst%3DA.%26aulast%3DFigler%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DK.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DPouton%26aufirst%3DC.%2BW.%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DBottle%26aufirst%3DS.%2BE.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520new%2520N6-substituted%2520adenosine-5%25E2%2580%25B2-N-methylcarboxamides%2520as%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3078%26epage%3D3087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">2-Substitution of <i>N</i><sup>6</sup>-benzyladenosine-5′-uromamides enhances selectivity for A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3614</span><span class="NLM_x">–</span> <span class="NLM_lpage">3621</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00047a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3614-3621&author=H.+O.+Kimauthor=X.+D.+Jiauthor=S.+M.+Siddiqiauthor=M.+E.+Olahauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=2-Substitution+of+N6-benzyladenosine-5%E2%80%B2-uromamides+enhances+selectivity+for+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00047a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00047a018%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DSiddiqi%26aufirst%3DS.%2BM.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D2-Substitution%2520of%2520N6-benzyladenosine-5%25E2%2580%25B2-uromamides%2520enhances%2520selectivity%2520for%2520A3%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3614%26epage%3D3621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Design of (N)-methanocarba adenosine 5′-uronamides as species-independent A<sub>3</sub> receptor-selective agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2813-2819&author=A.+Melmanauthor=Z.+G.+Gaoauthor=D.+Kumarauthor=T.+C.+Wanauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=K.+A.+Jacobson&title=Design+of+%28N%29-methanocarba+adenosine+5%E2%80%B2-uronamides+as+species-independent+A3+receptor-selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DDesign%2520of%2520%2528N%2529-methanocarba%2520adenosine%25205%25E2%2580%25B2-uronamides%2520as%2520species-independent%2520A3%2520receptor-selective%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2813%26epage%3D2819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2285</span><span class="NLM_x">–</span> <span class="NLM_lpage">2298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F1381612023392856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12369946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Crurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2285-2298&author=R.+Volpiniauthor=S.+Costanziauthor=C.+Lambertucciauthor=S.+Vittoriauthor=G.+Cristalli&title=Purine+nucleosides+bearing+1-alkynyl+chains+as+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists</span></div><div class="casAuthors">Volpini, Rosaria; Costanzi, Stefano; Lambertucci, Catia; Vittori, Sauro; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2285-2298</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  The synthesis and the pharmacol. activity of alkynyl derivs. of adenosine (Ado) and N-ethylcarboxamidoadenosine (NECA), that have been tested on adenosine receptors from different sources, have been reviewed.  Most of compds. have been characterized in the last ten years by using radioligand binding assays on rat brain membranes and functional studies on different animal models.  More recently, the four human adenosine receptor subtypes have been stably transfected into Chinese hamster ovary (CHO) cells allowing for comparative studies in a similar cellular background, utilizing radioligand binding studies (A1, A2A, A3) or adenylate cyclase activity assays (A2B).  From the whole pattern of studies the following structure-activity relationships have been drawn:.  -The activities of 2-alkynylAdos resulted slightly higher at A1 and lower at A3 and A2B subtypes than the corresponding NECA derivs., whereas the affinities at A2A subtype are similar for the two series of nucleosides.  -The presence of a Me group on N6 of the 2-alkynyladenosines, inducing a contemporary increase in affinity at the human A3 receptor and a decrease at the other subtypes, resulted in a relevant increase in A3 selectivity.  In particular, 2-phenylethynyl-N6-methylAdo showed an A3 affinity in the low nanomolar range (Ki A3 = 3.4 nM), and about 500 fold A1/A3 and about 2500 fold A2A/A3 selectivity.  -The presence of a hydroxyl group in some alkynyl side chains led to potent inhibitors of platelet aggregation induced by ADP.  -Introduction of particular substituents, such as the racemic 2-phenylhydroxypropynyl group, both in adenosine and in NECA analogs, led to highly potent, non selective agonists at all the four subtypes.  -For the potency at A2B receptor it seems to be very important the type of alkynyl chain in 2-position and the presence of the carboxyamido group on the sugar; in fact, the (S)-2-phenylhydroxypropynylNECA [(S)-PHPNECA, EC50 A2B = 220 nM] proved to be one of the most potent A2B agonist reported so far.  -The introduction of alkynyl chain in 8-position of adenosine led to very selective ligands for the A3 receptor subtype.  These nucleosides behave as adenosine antagonists, since they do not stimulate basal [35S]GTPγS binding, but inhibit NECA-stimulated binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNgPJDW6MTF7Vg90H21EOLACvtfcHk0lji7P8T6M0hEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Crurc%253D&md5=c777034885bf8337a9ff09de609d60b4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F1381612023392856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023392856%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DPurine%2520nucleosides%2520bearing%25201-alkynyl%2520chains%2520as%2520adenosine%2520receptor%2520agonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2285%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramadori, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 2-alkynyl-<i>N</i><sup>6</sup>-methyl-5′-<i>N</i>-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7897</span><span class="NLM_x">–</span> <span class="NLM_lpage">7900</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900754g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7897-7900&author=R.+Volpiniauthor=M.+Buccioniauthor=D.+Dal+Benauthor=C.+Lambertucciauthor=C.+Lammiauthor=G.+Marucciauthor=A.+T.+Ramadoriauthor=K.+N.+Klotzauthor=G.+Cristalli&title=Synthesis+and+biological+evaluation+of+2-alkynyl-N6-methyl-5%E2%80%B2-N-methylcarboxamidoadenosine+derivatives+as+potent+and+highly+selective+agonists+for+the+human+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm900754g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900754g%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DLammi%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DRamadori%26aufirst%3DA.%2BT.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25202-alkynyl-N6-methyl-5%25E2%2580%25B2-N-methylcarboxamidoadenosine%2520derivatives%2520as%2520potent%2520and%2520highly%2520selective%2520agonists%2520for%2520the%2520human%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7897%26epage%3D7900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>6</sup>-Methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1230</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060963u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1222-1230&author=R.+Volpiniauthor=D.+Dal+Benauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=K.+N.+Klotzauthor=G.+Cristalli&title=N6-Methoxy-2-alkynyladenosine+derivatives+as+highly+potent+and+selective+ligands+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060963u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060963u%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DN6-Methoxy-2-alkynyladenosine%2520derivatives%2520as%2520highly%2520potent%2520and%2520selective%2520ligands%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1222%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">Molecular modeling study on potent and selective adenosine A<sub>3</sub> receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7923</span><span class="NLM_x">–</span> <span class="NLM_lpage">7930</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bmc.2010.09.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20943397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKrsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7923-7930&author=D.+Dal+Benauthor=M.+Buccioniauthor=C.+Lambertucciauthor=G.+Marucciauthor=A.+Thomasauthor=R.+Volpiniauthor=G.+Cristalli&title=Molecular+modeling+study+on+potent+and+selective+adenosine+A3+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling study on potent and selective adenosine A3 receptor agonists</span></div><div class="casAuthors">Dal Ben, Diego; Buccioni, Michela; Lambertucci, Catia; Marucci, Gabriella; Thomas, Ajiroghene; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7923-7930</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A3 receptor (A3AR) is involved in a variety of key physio-pathol. processes and its agonists are potential therapeutic agents for the treatment of rheumatoid arthritis, dry eye disorders, asthma, as anti-inflammatory agents, and in cancer therapy.  Recently reported MECA (5'-N-methylcarboxamidoadenosine) derivs. bearing a Me group in N6-position and an arylethynyl substituent in 2-position demonstrated to possess sub-nanomolar affinity and remarkable selectivity for the human A3AR, behaving as full agonists of this receptor.  In this study, we made an attempt to get a rationalization of the high affinities and selectivities of these mols. for the human A3AR, by using adenosine receptor (AR) structural models based on the A2AAR crystal structure and mol. docking anal.  Post-docking anal. allowed to evaluate the ability of modeling tools in predicting AA3R affinity and in providing interpretation of compd. substituents effect on the A3AR affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprTrcS5ra1x7Vg90H21EOLACvtfcHk0lgS-6cu3e10Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKrsr%252FE&md5=09d41ebd1533011c05bd28f6afda270e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DMolecular%2520modeling%2520study%2520on%2520potent%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7923%26epage%3D7930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>6</sup>-Ethyl-2-alkynyl NECAs, selective human A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2416-2418&author=R.+Zhuauthor=C.+R.+Frazierauthor=J.+Lindenauthor=T.+L.+Macdonald&title=N6-Ethyl-2-alkynyl+NECAs%2C+selective+human+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DFrazier%26aufirst%3DC.%2BR.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DN6-Ethyl-2-alkynyl%2520NECAs%252C%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2416%26epage%3D2418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Cosyn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaniappan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span> </span><span class="NLM_article-title">2-Triazole-substituted adenosines: a new class of selective A<sub>3</sub> adenosine receptor agonists, partial agonists, and antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7373</span><span class="NLM_x">–</span> <span class="NLM_lpage">7383</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7373-7383&author=L.+Cosynauthor=K.+K.+Palaniappanauthor=S.+K.+Kimauthor=H.+T.+Duongauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=S.+Van+Calenbergh&title=2-Triazole-substituted+adenosines%3A+a+new+class+of+selective+A3+adenosine+receptor+agonists%2C+partial+agonists%2C+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0608208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608208%26sid%3Dliteratum%253Aachs%26aulast%3DCosyn%26aufirst%3DL.%26aulast%3DPalaniappan%26aufirst%3DK.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26atitle%3D2-Triazole-substituted%2520adenosines%253A%2520a%2520new%2520class%2520of%2520selective%2520A3%2520adenosine%2520receptor%2520agonists%252C%2520partial%2520agonists%252C%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7373%26epage%3D7383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Design, synthesis and binding affinity of 3′-fluoro analogues of Cl-IB-MECA as adenosine A<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=817-820&author=M.+H.+Limauthor=H.+O.+Kimauthor=H.+R.+Moonauthor=S.+J.+Leeauthor=M.+W.+Chunauthor=Z.+G.+Gaoauthor=N.+Melmanauthor=K.+A.+Jacobsonauthor=J.+H.+Kimauthor=L.+S.+Jeong&title=Design%2C+synthesis+and+binding+affinity+of+3%E2%80%B2-fluoro+analogues+of+Cl-IB-MECA+as+adenosine+A3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520binding%2520affinity%2520of%25203%25E2%2580%25B2-fluoro%2520analogues%2520of%2520Cl-IB-MECA%2520as%2520adenosine%2520A3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D817%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elhalem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamedova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structural determinants of efficacy at A<sub>3</sub> adenosine receptors: modification of the ribose moiety</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bcp.2003.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15104242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFWmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=893-901&author=Z.+G.+Gaoauthor=L.+S.+Jeongauthor=H.+R.+Moonauthor=H.+O.+Kimauthor=W.+J.+Choiauthor=D.+H.+Shinauthor=E.+Elhalemauthor=M.+J.+Cominauthor=N.+Melmanauthor=L.+Mamedovaauthor=A.+S.+Grossauthor=J.+B.+Rodriguezauthor=K.+A.+Jacobson&title=Structural+determinants+of+efficacy+at+A3+adenosine+receptors%3A+modification+of+the+ribose+moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety</span></div><div class="casAuthors">Gao, Zhan-Guo; Jeong, Lak Shin; Moon, Hyung Ryong; Kim, Hea Ok; Choi, Won Jun; Shin, Dae Hong; Elhalem, Eleonora; Comin, Maria J.; Melman, Neli; Mamedova, Liaman; Gross, Ariel S.; Rodriguez, Juan B.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">893-901</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The authors have found previously that structural features of adenosine derivs., particularly at the N6- and 2-positions of adenine, det. the intrinsic efficacy as A3 adenosine receptor (AR) agonists.  Here, the authors have probed this phenomenon with respect to the ribose moiety using a series of ribose-modified adenosine derivs., examg. binding affinity and activation of the human A3 AR expressed in CHO cells.  Both 2'- and 3'-hydroxyl groups in the ribose moiety contribute to A3 AR binding and activation, with 2'-OH being more essential.  Thus, the 2'-fluoro substitution eliminated both binding and activation, while a 3'-fluoro substitution led to only a partial redn. of potency and efficacy at the A3 AR.  A 5'-uronamide group, known to restore full efficacy in other derivs., failed to fully overcome the diminished efficacy of 3'-fluoro derivs.  The 4'-thio substitution, which generally enhanced A3 AR potency and selectivity, resulted in 5'-CH2OH analogs which were partial agonists of the A3 AR.  Interestingly, the shifting of the N6-(3-iodobenzyl)adenine moiety from the 1'- to 4'-position had a minor influence on A3 AR selectivity, but transformed one analog into a potent antagonist.  This antagonist antagonized human A3 AR agonist-induced inhibition of cAMP with a KB value of 3.0 nM.  A novel apio analog of neplanocin A, was a full A3 AR agonist.  The affinities of selected, novel analogs at rat ARs were examd., revealing species differences.  In summary, crit. structural determinants for human A3 AR activation have been identified, which should prove useful for further understanding the mechanism of receptor activation and development of more potent and selective full agonists, partial agonists and antagonists for A3 ARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAMN3ntd9aerVg90H21EOLACvtfcHk0lgS-6cu3e10Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFWmt74%253D&md5=7463b27f1eb62e0eb7c8dfa9bb301d0c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2003.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2003.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DElhalem%26aufirst%3DE.%26aulast%3DComin%26aufirst%3DM.%2BJ.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DMamedova%26aufirst%3DL.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DJ.%2BB.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520determinants%2520of%2520efficacy%2520at%2520A3%2520adenosine%2520receptors%253A%2520modification%2520of%2520the%2520ribose%2520moiety%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D893%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">DeNinno, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamune, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiRico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etienne, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleynek, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span> </span><span class="NLM_article-title">3′-Aminoadenosine-5′-uronamides: discovery of the first highly selective agonist at the human adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0255724" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=353-355&author=M.+P.+DeNinnoauthor=H.+Masamuneauthor=L.+K.+Chenardauthor=K.+J.+DiRicoauthor=C.+Ellerauthor=J.+B.+Etienneauthor=J.+E.+Ticknerauthor=S.+P.+Kennedyauthor=D.+R.+Knightauthor=J.+Kongauthor=J.+J.+Oleynekauthor=W.+R.+Traceyauthor=R.+J.+Hill&title=3%E2%80%B2-Aminoadenosine-5%E2%80%B2-uronamides%3A+discovery+of+the+first+highly+selective+agonist+at+the+human+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm0255724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255724%26sid%3Dliteratum%253Aachs%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DMasamune%26aufirst%3DH.%26aulast%3DChenard%26aufirst%3DL.%2BK.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DEller%26aufirst%3DC.%26aulast%3DEtienne%26aufirst%3DJ.%2BB.%26aulast%3DTickner%26aufirst%3DJ.%2BE.%26aulast%3DKennedy%26aufirst%3DS.%2BP.%26aulast%3DKnight%26aufirst%3DD.%2BR.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DOleynek%26aufirst%3DJ.%2BJ.%26aulast%3DTracey%26aufirst%3DW.%2BR.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26atitle%3D3%25E2%2580%25B2-Aminoadenosine-5%25E2%2580%25B2-uronamides%253A%2520discovery%2520of%2520the%2520first%2520highly%2520selective%2520agonist%2520at%2520the%2520human%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D353%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Synthesis of 3′-acetamidoadenosine derivatives as potential A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1080%2F15257770801944436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18404574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFSit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=408-420&author=M.+W.+Chunauthor=S.+W.+Choiauthor=T.+K.+Kangauthor=W.+J.+Choiauthor=H.+O.+Kimauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Synthesis+of+3%E2%80%B2-acetamidoadenosine+derivatives+as+potential+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3'-Acetamidoadenosine Derivatives as Potential A3 Adenosine Receptor Agonists</span></div><div class="casAuthors">Chun, Moon Woo; Choi, Sung Wook; Kang, Tae Kyung; Choi, Won Jun; Kim, Hea Ok; Gao, Zhan-Guo; Jacobson, Kenneth A.; Jeong, Lak Shin</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">408-420</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">On the basis of high binding affinity of 3'-aminoadenosine derivs. at the human A3 adenosine receptor (AR), 3'-acetamidoadenosine derivs., e.g. I, were synthesized from 1,2:5,6-di-O-isopropylidene-D-glucose via stereoselective hydroboration as a key step.  Although all synthesized compds. were totally devoid of binding affinity at the human A3AR, our results revealed that 3'-position of adenosine can only be tolerated with small size of a hydrogen bonding donor like hydroxyl or amino group in the binding site of human A3AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfXXuFZXY_F7Vg90H21EOLACvtfcHk0liMsY0jYE_Pww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFSit78%253D&md5=6c7d2f2ef80bf1b3d005aefbaa20f836</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1080%2F15257770801944436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770801944436%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DChoi%26aufirst%3DS.%2BW.%26aulast%3DKang%26aufirst%3DT.%2BK.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DSynthesis%2520of%25203%25E2%2580%25B2-acetamidoadenosine%2520derivatives%2520as%2520potential%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2008%26volume%3D27%26spage%3D408%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>6</sup>-Substituted <span class="smallcaps smallerCapital">d</span>-4′-thioadenosine-5′-methyluronamides: potent and selective agonists at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3775</span><span class="NLM_x">–</span> <span class="NLM_lpage">3777</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3775-3777&author=L.+S.+Jeongauthor=D.+Z.+Jinauthor=H.+O.+Kimauthor=D.+H.+Shinauthor=H.+R.+Moonauthor=P.+Gunagaauthor=M.+W.+Chunauthor=Y.+C.+Kimauthor=N.+Melmanauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=N6-Substituted+d-4%E2%80%B2-thioadenosine-5%E2%80%B2-methyluronamides%3A+potent+and+selective+agonists+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm034098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034098e%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJin%26aufirst%3DD.%2BZ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DN6-Substituted%2520d-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-methyluronamides%253A%2520potent%2520and%2520selective%2520agonists%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3775%26epage%3D3777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of 2-chloro-<i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-uronamides as highly potent and selective agonists at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050595e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=273-281&author=L.+S.+Jeongauthor=H.+W.+Leeauthor=K.+A.+Jacobsonauthor=H.+O.+Kimauthor=D.+H.+Shinauthor=J.+A.+Leeauthor=Z.+G.+Gaoauthor=C.+Luauthor=H.+T.+Duongauthor=P.+Gunagaauthor=S.+K.+Leeauthor=D.+Z.+Jinauthor=M.+W.+Chunauthor=H.+R.+Moon&title=Structure%E2%80%93activity+relationships+of+2-chloro-N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-uronamides+as+highly+potent+and+selective+agonists+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm050595e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050595e%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DD.%2BZ.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%25202-chloro-N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-uronamides%2520as%2520highly%2520potent%2520and%2520selective%2520agonists%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of <i>N</i><sup>6</sup>-substituted-4′-thioadenosines at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4718</span><span class="NLM_x">–</span> <span class="NLM_lpage">4730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4718-4730&author=L.+S.+Jeongauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=J.+Y.+Jungauthor=Z.+G.+Gaoauthor=H.+T.+Duongauthor=S.+Raoauthor=K.+A.+Jacobsonauthor=D.+H.+Shinauthor=J.+A.+Leeauthor=P.+Gunagaauthor=S.+K.+Leeauthor=D.+Z.+Jinauthor=M.+W.+Chunauthor=H.+R.+Moon&title=Design%2C+synthesis%2C+and+biological+activity+of+N6-substituted-4%E2%80%B2-thioadenosines+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJung%26aufirst%3DJ.%2BY.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DD.%2BZ.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520N6-substituted-4%25E2%2580%25B2-thioadenosines%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4718%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Lee, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span> </span><span class="NLM_article-title">A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=918-924&author=E.+J.+Leeauthor=H.+Y.+Minauthor=H.+J.+Chungauthor=E.+J.+Parkauthor=D.+H.+Shinauthor=L.+S.+Jeongauthor=S.+K.+Lee&title=A+novel+adenosine+analog%2C+thio-Cl-IB-MECA%2C+induces+G0%2FG1+cell+cycle+arrest+and+apoptosis+in+human+promyelocytic+leukemia+HL-60+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BJ.%26aulast%3DMin%26aufirst%3DH.%2BY.%26aulast%3DChung%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BK.%26atitle%3DA%2520novel%2520adenosine%2520analog%252C%2520thio-Cl-IB-MECA%252C%2520induces%2520G0%252FG1%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520human%2520promyelocytic%2520leukemia%2520HL-60%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D918%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, G.</span><span> </span><span class="NLM_article-title">The anti-tumor effect of LJ-529, a novel agonist to A<sub>3</sub> adenosine receptor, in estrogen receptor-negative human breast cancer cells via inactivation of Akt and Wnt pathways</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1158%2F1535-7163.MCT-05-0245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16546983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitl2lurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=685-692&author=H.+Y.+Chungauthor=S.+D.+Choauthor=H.+J.+Kimauthor=D.+H.+Shinauthor=L.+S.+Jeongauthor=G.+Kong&title=The+anti-tumor+effect+of+LJ-529%2C+a+novel+agonist+to+A3+adenosine+receptor%2C+in+estrogen+receptor-negative+human+breast+cancer+cells+via+inactivation+of+Akt+and+Wnt+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers</span></div><div class="casAuthors">Chung, Heekyoung; Jung, Ji-Youn; Cho, Sung-Dae; Hong, Kyung-A.; Kim, Hyun-Jun; Shin, Dong-Hui; Kim, Hwan; Kim, Hea Ok; Shin, Dae Hong; Lee, Hyuk Woo; Jeong, Lak Shin; Kong, Gu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Agonists to A3 adenosine receptor (A3AR) have been reported to inhibit cell growth and/or induce apoptosis in various tumors.  We tested the effect of a novel A3AR agonist generically known as LJ-529 in breast cancer cells.  Anchorage-dependent cell growth and in vivo tumor growth were attenuated by LJ-529, independently of its estrogen receptor (ER) α status.  In addn., apoptosis was induced as evidenced by the activation of caspase-3 and c-poly(ADP)ribose polymerase.  Furthermore, the Wnt signaling pathway was down-regulated and p27kip was induced by LJ-529.  In ER-pos. cells, the expression of ER was down-regulated by LJ-529, which might have addnl. contributed to attenuated cell proliferation.  In ER-neg., c-ErbB2-overexpressing SK-BR-3 cells, the expression of c-ErbB2 and its downstream extracellular signal-regulated kinase pathway were down-regulated by LJ-529.  However, such effect of LJ-529 acted independently of its receptor because no A3AR was detected by reverse transcription-PCR in all four cell lines tested.  In conclusion, our novel findings open the possibility of LJ-529 as an effective therapeutic agent against both ER-pos. and ER-neg. breast cancers, particularly against the more aggressive ER-neg., c-ErbB2-overexpressing types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbNhzalVi2rVg90H21EOLACvtfcHk0lhi5KknPC6hAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitl2lurw%253D&md5=4bdab4daedb42542c195f008ce10f2be</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0245%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DKong%26aufirst%3DG.%26atitle%3DThe%2520anti-tumor%2520effect%2520of%2520LJ-529%252C%2520a%2520novel%2520agonist%2520to%2520A3%2520adenosine%2520receptor%252C%2520in%2520estrogen%2520receptor-negative%2520human%2520breast%2520cancer%2520cells%2520via%2520inactivation%2520of%2520Akt%2520and%2520Wnt%2520pathways%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of <i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-uronamides as potent and selective human A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">8003</span><span class="NLM_x">–</span> <span class="NLM_lpage">8011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8003-8011&author=W.+J.+Choiauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=M.+Chinnauthor=Z.+G.+Gaoauthor=A.+Patelauthor=K.+A.+Jacobsonauthor=H.+R.+Moonauthor=Y.+H.+Jungauthor=L.+S.+Jeong&title=Design+and+synthesis+of+N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-uronamides+as+potent+and+selective+human+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DJung%26aufirst%3DY.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-uronamides%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8003%26epage%3D8011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, R. G.</span><span> </span><span class="NLM_article-title">Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2196</span><span class="NLM_x">–</span> <span class="NLM_lpage">2203</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9905965" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFKiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2196-2203&author=K.+A.+Jacobsonauthor=X.+Jiauthor=A.+H.+Liauthor=N.+Melmanauthor=M.+A.+Siddiqiauthor=K.+J.+Shinauthor=V.+E.+Marquezauthor=R.+G.+Ravi&title=Methanocarba+analogues+of+purine+nucleosides+as+potent+and+selective+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Methanocarba Analogues of Purine Nucleosides as Potent and Selective Adenosine Receptor Agonists</span></div><div class="casAuthors">Jacobson, Kenneth A.; Ji, Xiao-duo; Li, An-Hu; Melman, Neli; Siddiqui, Maqbool A.; Shin, Kye-Jung; Marquez, Victor E.; Ravi, R. Gnana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2196-2203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine receptor agonists have cardioprotective, cerebroprotective, and antiinflammatory properties.  The authors report that a carbocyclic modification of the ribose moiety incorporating ring constraints is a general approach for the design of A1 and A3 receptor agonists having favorable pharmacodynamic properties.  While simple carbocyclic substitution of adenosine agonists greatly diminishes potency, methanocarba-adenosine analogs have now defined the role of sugar puckering in stabilizing the active adenosine receptor-bound conformation and thereby have allowed identification of a favored isomer.  In such analogs a fused cyclopropane moiety constrains the pseudosugar ring of the nucleoside to either a Northern (N) or Southern (S) conformation, as defined in the pseudorotational cycle.  In binding assays at A1, A2A, and A3 receptors, (N)-methanocarba-adenosine was of higher affinity than the (S)-analog, particularly at the human A3 receptor (N/S affinity ratio of 150).  (N)-methanocarba analogs of various N6-substituted adenosine derivs., including cyclopentyl and 3-iodobenzyl, in which the parent compds. are potent agonists at either A1 or A3 receptors, resp., were synthesized.  The N6-cyclopentyl derivs. were A1 receptor-selective and maintained high efficacy at recombinant human but not rat brain A1 receptors, as indicated by stimulation of binding of [35S]GTP-γ-S.  The (N)-methanocarba-N6-(3-iodobenzyl)adenosine and its 2-chloro deriv. had Ki values of 4.1 and 2.2 nM at A3 receptors, resp., and were highly selective partial agonists.  Partial agonism combined with high functional potency at A3 receptors (EC50 < 1 nM) may produce tissue selectivity.  In conclusion, as for P2Y1 receptors, at least three adenosine receptors favor the ribose (N)-conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyofQbUPWTtbVg90H21EOLACvtfcHk0lhi5KknPC6hAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFKiu78%253D&md5=e6ea09c4de935777d080f2d48a4f8e8c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm9905965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9905965%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DSiddiqi%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DK.%2BJ.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DRavi%26aufirst%3DR.%2BG.%26atitle%3DMethanocarba%2520analogues%2520of%2520purine%2520nucleosides%2520as%2520potent%2520and%2520selective%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2196%26epage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">(N)-Methanocarba 2,<i>N</i><sup>6</sup>-disubstituted adenine nucleosides as highly potent and selective A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1745</span><span class="NLM_x">–</span> <span class="NLM_lpage">1758</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049580r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1745-1758&author=S.+Tchilibonauthor=B.+V.+Joshiauthor=S.+K.+Kimauthor=H.+T.+Duongauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=%28N%29-Methanocarba+2%2CN6-disubstituted+adenine+nucleosides+as+highly+potent+and+selective+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm049580r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049580r%26sid%3Dliteratum%253Aachs%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D%2528N%2529-Methanocarba%25202%252CN6-disubstituted%2520adenine%2520nucleosides%2520as%2520highly%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1745%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Matot, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiniger, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion</span> <span class="citation_source-journal">Crit. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=R65&author=I.+Matotauthor=C.+F.+Weinigerauthor=E.+Zeiraauthor=E.+Galunauthor=B.+V.+Joshiauthor=K.+A.+Jacobson&title=A3+adenosine+receptors+and+mitogen-activated+protein+kinases+in+lung+injury+following+in+vivo+reperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatot%26aufirst%3DI.%26aulast%3DWeiniger%26aufirst%3DC.%2BF.%26aulast%3DZeira%26aufirst%3DE.%26aulast%3DGalun%26aufirst%3DE.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA3%2520adenosine%2520receptors%2520and%2520mitogen-activated%2520protein%2520kinases%2520in%2520lung%2520injury%2520following%2520in%2520vivo%2520reperfusion%26jtitle%3DCrit.%2520Care%26date%3D2006%26volume%3D10%26spage%3DR65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of [<sup>125</sup>I]-MRS1898, a high-affinity, selective radioligand for the rat A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=31-37&author=Z.+Gaoauthor=B.+Tengauthor=H.+Wuauthor=B.+V.+Joshiauthor=G.+L.+Griffithsauthor=K.+A.+Jacobson&title=Synthesis+and+pharmacological+characterization+of+%5B125I%5D-MRS1898%2C+a+high-affinity%2C+selective+radioligand+for+the+rat+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DTeng%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGriffiths%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520%255B125I%255D-MRS1898%252C%2520a%2520high-affinity%252C%2520selective%2520radioligand%2520for%2520the%2520rat%2520A3%2520adenosine%2520receptor%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D31%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Functionalized congeners of A<sub>3</sub> adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7580</span><span class="NLM_x">–</span> <span class="NLM_lpage">7592</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900426g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7580-7592&author=D.+K.+Toshauthor=M.+Chinnauthor=A.+A.+Ivanovauthor=A.+M.+Klutzauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=Functionalized+congeners+of+A3+adenosine+receptor-selective+nucleosides+containing+a+bicyclo%5B3.1.0%5Dhexane+ring+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm900426g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900426g%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionalized%2520congeners%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%2520containing%2520a%2520bicyclo%255B3.1.0%255Dhexane%2520ring%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7580%26epage%3D7592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">2-Dialkynyl derivatives of (N)-methanocarba nucleosides: “clickable” A<sub>3</sub> adenosine receptor-selective agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=508-517&author=D.+K.+Toshauthor=M.+Chinnauthor=L.+S.+Yooauthor=D.+W.+Kangauthor=H.+Lueckeauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=2-Dialkynyl+derivatives+of+%28N%29-methanocarba+nucleosides%3A+%E2%80%9Cclickable%E2%80%9D+A3+adenosine+receptor-selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DYoo%26aufirst%3DL.%2BS.%26aulast%3DKang%26aufirst%3DD.%2BW.%26aulast%3DLuecke%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D2-Dialkynyl%2520derivatives%2520of%2520%2528N%2529-methanocarba%2520nucleosides%253A%2520%25E2%2580%259Cclickable%25E2%2580%259D%2520A3%2520adenosine%2520receptor-selective%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D508%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Chang, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Frijtag Drabbe Kuenzel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjersberg, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Hout, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beukers, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A.</span><span> </span><span class="NLM_article-title">A series of ligands displaying a remarkable agonistic–antagonistic profile at the adenosine A<sub>1</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2045</span><span class="NLM_x">–</span> <span class="NLM_lpage">2053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049597%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2045-2053&author=L.+C.+Changauthor=J.+Von+Frijtag+Drabbe+Kuenzelauthor=T.+Mulderauthor=R.+F.+Spanjersbergauthor=G.+Van+den+Houtauthor=M.+W.+Beukersauthor=J.+Brusseeauthor=A.+IJzerman&title=A+series+of+ligands+displaying+a+remarkable+agonistic%E2%80%93antagonistic+profile+at+the+adenosine+A1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm049597%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049597%252B%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%2BC.%26aulast%3DVon%2BFrijtag%2BDrabbe%2BKuenzel%26aufirst%3DJ.%26aulast%3DMulder%26aufirst%3DT.%26aulast%3DSpanjersberg%26aufirst%3DR.%2BF.%26aulast%3DVan%2Bden%2BHout%26aufirst%3DG.%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%26atitle%3DA%2520series%2520of%2520ligands%2520displaying%2520a%2520remarkable%2520agonistic%25E2%2580%2593antagonistic%2520profile%2520at%2520the%2520adenosine%2520A1%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2045%26epage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Baraldi, P. G.; Romagnoli, R.; Saponaro, G.; Baraldi, S.; Tabrizi, M. A.; Preti, D.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> Adenosine Receptor Antagonists: History and Future Perspectives</span>. In  <span class="citation_source-book">A<sub>3</sub> Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics</span>; <span class="NLM_contrib-group">Borea, P. A.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-90-481-3144-0_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=121-147&author=P.+G.+Baraldi&author=R.+Romagnoli&author=G.+Saponaro&author=S.+Baraldi&author=M.+A.+Tabrizi&author=D.+Pretiauthor=P.+A.+Borea&title=A3+Adenosine+Receptors+from+Cell+Biology+to+Pharmacology+and+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2F978-90-481-3144-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-90-481-3144-0_7%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26atitle%3DA3%2520Adenosine%2520Receptor%2520Antagonists%253A%2520History%2520and%2520Future%2520Perspectives%26btitle%3DA3%2520Adenosine%2520Receptors%2520from%2520Cell%2520Biology%2520to%2520Pharmacology%2520and%2520Therapeutics%26aulast%3DBorea%26aufirst%3DP.%2BA.%26pub%3DSpringer%26date%3D2010%26spage%3D121%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Cosimelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1764</span><span class="NLM_x">–</span> <span class="NLM_lpage">1770</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701159t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1764-1770&author=B.+Cosimelliauthor=G.+Grecoauthor=M.+Ehlardoauthor=E.+Novellinoauthor=F.+Da+Settimoauthor=S.+Talianiauthor=C.+La+Mottaauthor=M.+Bellandiauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=O.+Ciampiauthor=M.+L.+Trincavelliauthor=C.+Martini&title=Derivatives+of+4-amino-6-hydroxy-2-mercaptopyrimidine+as+novel%2C+potent%2C+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm701159t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701159t%26sid%3Dliteratum%253Aachs%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DEhlardo%26aufirst%3DM.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DBellandi%26aufirst%3DM.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DDerivatives%2520of%25204-amino-6-hydroxy-2-mercaptopyrimidine%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1764%26epage%3D1770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Yaziji, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Maatougui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Mera, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotelo, E.</span><span> </span><span class="NLM_article-title">Divergent solution-phase synthesis of diarylpyrimidine libraries as selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc900044k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVentr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=519-522&author=V.+Yazijiauthor=A.+Coelhoauthor=A.+El+Maatouguiauthor=J.+Breaauthor=M.+I.+Lozaauthor=X.+Garcia-Meraauthor=E.+Sotelo&title=Divergent+solution-phase+synthesis+of+diarylpyrimidine+libraries+as+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent Solution-Phase Synthesis of Diarylpyrimidine Libraries as Selective A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Yaziji, Vicente; Coelho, Alberto; El Maatougui, Abdelaziz; Brea, Jose; Loza, M. Isabel; Garcia-Mera, Xerardo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">519-522</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical and divergent soln.-phase synthetic strategy has been optimized to prep. a highly diverse library of 2,4-diaryl- and 2,6-diarylpyrimidines.  Structural elaboration of the starting heterocyclic scaffolds was accomplished by exploiting the potential for diversity offered by the Suzuki-Miyaura cross-coupling reaction.  These studies enabled the identification of structurally simple, highly potent, and selective A3 adenosine receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5JPXnvRZwQbVg90H21EOLACvtfcHk0ljCLO_e3ulPQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVentr8%253D&md5=14c0f81a8aa0b82138a743dd9d538e40</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fcc900044k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc900044k%26sid%3Dliteratum%253Aachs%26aulast%3DYaziji%26aufirst%3DV.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DGarcia-Mera%26aufirst%3DX.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDivergent%2520solution-phase%2520synthesis%2520of%2520diarylpyrimidine%2520libraries%2520as%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2009%26volume%3D11%26spage%3D519%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Yaziji, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez-de-Teran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caamano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Mera, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadavid, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotelo, E.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives as potent and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100843z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=457-471&author=V.+Yazijiauthor=D.+Rodriguezauthor=H.+Gutierrez-de-Teranauthor=A.+Coelhoauthor=O.+Caamanoauthor=X.+Garcia-Meraauthor=J.+Breaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=E.+Sotelo&title=Pyrimidine+derivatives+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm100843z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100843z%26sid%3Dliteratum%253Aachs%26aulast%3DYaziji%26aufirst%3DV.%26aulast%3DRodriguez%26aufirst%3DD.%26aulast%3DGutierrez-de-Teran%26aufirst%3DH.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DCaamano%26aufirst%3DO.%26aulast%3DGarcia-Mera%26aufirst%3DX.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DPyrimidine%2520derivatives%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D457%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Jung, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=613-623&author=K.+Y.+Jungauthor=S.+K.+Kimauthor=Z.+G.+Gaoauthor=A.+S.+Grossauthor=N.+Melmanauthor=K.+A.+Jacobsonauthor=Y.+C.+Kim&title=Structure%E2%80%93activity+relationships+of+thiazole+and+thiadiazole+derivatives+as+potent+and+selective+human+adenosine+A3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520thiazole%2520and%2520thiadiazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520adenosine%2520A3%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D613%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Press, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span> </span><span class="NLM_article-title">New highly potent and selective adenosine A<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F1568026043451023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15078217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVeju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=863-870&author=N.+J.+Pressauthor=T.+H.+Kellerauthor=P.+Tranterauthor=D.+Beerauthor=K.+Jonesauthor=A.+Faesslerauthor=R.+Hengauthor=C.+Lewisauthor=T.+Howeauthor=P.+Gedeckauthor=L.+Mazzoniauthor=J.+R.+Fozard&title=New+highly+potent+and+selective+adenosine+A3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">New highly potent and selective adenosine A3 receptor antagonists</span></div><div class="casAuthors">Press, Neil J.; Keller, Thomas H.; Tranter, Pamela; Beer, David; Jones, Ken; Faessler, Alexander; Heng, Richard; Lewis, Christine; Howe, Trevor; Gedeck, Peter; Mazzoni, Lazzaro; Fozard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">863-870</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A class of potent, selective adenosine A3 receptor antagonists was obtained via optimization of the screening hit N-[4-(4-methoxyphenyl)-thiazol-2-yl]-acetamide.  Structural modifications of this hit revealed very quickly that a 5-(pyridin-4-yl) substituent on the 2-aminothiazole ring was optimal for high potency at the adenosine A3 receptor.  Structure activity relationship studies led to both potent and selective A3 receptor antagonists, including N-[5-pyridin-4-yl-4-(3,4,5-trimethoxyphenyl)-thiazol-2-yl]-acetamide, a highly potent adenosine A3 receptor antagonist with greater than 100- fold selectivity against the related adenosine receptors.  As well as demonstrating selective in vitro binding on the human A3 adenosine receptor, this compd. was also shown to selectively block the rat A3 receptor in vivo.  This important new compd. can be readily synthesized in four steps from com. available starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoswZrH027jH7Vg90H21EOLACvtfcHk0liwDDuTic0WJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVeju7Y%253D&md5=f3bd9305aa069ae9fae80ccb93205530</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F1568026043451023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043451023%26sid%3Dliteratum%253Aachs%26aulast%3DPress%26aufirst%3DN.%2BJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DTranter%26aufirst%3DP.%26aulast%3DBeer%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DFaessler%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DMazzoni%26aufirst%3DL.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26atitle%3DNew%2520highly%2520potent%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D863%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Miwatashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawa, S.</span><span> </span><span class="NLM_article-title">Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A<sub>3</sub> antagonists</span> <span class="citation_source-journal">Chem. Pharm. Bull. (Tokyo)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1126</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=1126-1137&author=S.+Miwatashiauthor=Y.+Arikawaauthor=T.+Matsumotoauthor=K.+Ugaauthor=N.+Kanzakiauthor=Y.+N.+Imaiauthor=S.+Ohkawa&title=Synthesis+and+biological+activities+of+4-phenyl-5-pyridyl-1%2C3-thiazole+derivatives+as+selective+adenosine+A3+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiwatashi%26aufirst%3DS.%26aulast%3DArikawa%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DImai%26aufirst%3DY.%2BN.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%25204-phenyl-5-pyridyl-1%252C3-thiazole%2520derivatives%2520as%2520selective%2520adenosine%2520A3%2520antagonists%26jtitle%3DChem.%2520Pharm.%2520Bull.%2520%2528Tokyo%2529%26date%3D2008%26volume%3D56%26spage%3D1126%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">Scouting human A<sub>3</sub> adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6596</span><span class="NLM_x">–</span> <span class="NLM_lpage">6606</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070852a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6596-6606&author=E.+Morizzoauthor=F.+Capelliauthor=O.+Lenziauthor=D.+Catarziauthor=F.+Varanoauthor=G.+Filacchioniauthor=F.+Vincenziauthor=K.+Varaniauthor=P.+A.+Boreaauthor=V.+Colottaauthor=S.+Moro&title=Scouting+human+A3+adenosine+receptor+antagonist+binding+mode+using+a+molecular+simplification+approach%3A+from+triazoloquinoxaline+to+a+pyrimidine+skeleton+as+a+key+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm070852a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070852a%26sid%3Dliteratum%253Aachs%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DCapelli%26aufirst%3DF.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DScouting%2520human%2520A3%2520adenosine%2520receptor%2520antagonist%2520binding%2520mode%2520using%2520a%2520molecular%2520simplification%2520approach%253A%2520from%2520triazoloquinoxaline%2520to%2520a%2520pyrimidine%2520skeleton%2520as%2520a%2520key%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6596%26epage%3D6606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Poli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">The identification of the 2-phenylphthalazin-1(2<i>H</i>)-one scaffold as a new decorable core skeleton for the design of potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2102</span><span class="NLM_x">–</span> <span class="NLM_lpage">2113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101328n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFersLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2102-2113&author=D.+Poliauthor=D.+Catarziauthor=V.+Colottaauthor=F.+Varanoauthor=G.+Filacchioniauthor=S.+Danieleauthor=L.+Trincavelliauthor=C.+Martiniauthor=S.+Paolettaauthor=S.+Moro&title=The+identification+of+the+2-phenylphthalazin-1%282H%29-one+scaffold+as+a+new+decorable+core+skeleton+for+the+design+of+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The Identification of the 2-Phenylphthalazin-1(2H)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Poli, Daniela; Catarzi, Daniela; Colotta, Vittoria; Varano, Flavia; Filacchioni, Guido; Daniele, Simona; Trincavelli, Letizia; Martini, Claudia; Paoletta, Silvia; Moro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2102-2113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Following a mol. simplification approach, we have identified the 2-phenylphthalazin-1(2H)-one (PHTZ) ring system as a new decorable core skeleton for the design of novel hA3 adenosine receptor (AR) antagonists.  Interest for this new series was driven by the structural similarity between the PHTZ skeleton and both the 2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one (TQX) and the 4-carboxamido-quinazoline (QZ) scaffolds extensively investigated in our previously reported studies.  Our attention was focused at position 4 of the phthalazine nucleus where different amido and ureido moieties were introduced (compds. 2-20).  Some of the new PHTZ compds. showed high hA3 AR affinity and selectivity, the 2,5-dimethoxyphenylphthalazin-1(2H)-one 18 being the most potent and selective hA3 AR antagonist among this series (Ki = 0.776 nM; hA1/hA3 and hA2A/hA3 > 12000).  Mol. docking studies on the PHTZ derivs. revealed for these compds. a binding mode similar to that of the previously reported TQX and QZ series, as was expected from the simplification approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Dzshyo5BRLVg90H21EOLACvtfcHk0lghxWYhzobn-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFersLo%253D&md5=0cb6019953c8ddca940f75d210400f81</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm101328n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101328n%26sid%3Dliteratum%253Aachs%26aulast%3DPoli%26aufirst%3DD.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DThe%2520identification%2520of%2520the%25202-phenylphthalazin-1%25282H%2529-one%2520scaffold%2520as%2520a%2520new%2520decorable%2520core%2520skeleton%2520for%2520the%2520design%2520of%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2102%26epage%3D2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Biagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbrini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nofal, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerni, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scartoni, V.</span><span> </span><span class="NLM_article-title">2,9-Disubstituted-<i>N</i><sup>6</sup>-(arylcarbamoyl)-8-azaadenines as new selective A<sub>3</sub> adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4679</span><span class="NLM_x">–</span> <span class="NLM_lpage">4693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4679-4693&author=G.+Biagiauthor=A.+M.+Bianucciauthor=A.+Coiauthor=B.+Costaauthor=L.+Fabbriniauthor=I.+Giorgiauthor=O.+Liviauthor=I.+Miccoauthor=F.+Pacchiniauthor=E.+Santiniauthor=M.+Leonardiauthor=F.+A.+Nofalauthor=O.+L.+Salerniauthor=V.+Scartoni&title=2%2C9-Disubstituted-N6-%28arylcarbamoyl%29-8-azaadenines+as+new+selective+A3+adenosine+receptor+antagonists%3A+synthesis%2C+biochemical+and+molecular+modelling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiagi%26aufirst%3DG.%26aulast%3DBianucci%26aufirst%3DA.%2BM.%26aulast%3DCoi%26aufirst%3DA.%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DFabbrini%26aufirst%3DL.%26aulast%3DGiorgi%26aufirst%3DI.%26aulast%3DLivi%26aufirst%3DO.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DPacchini%26aufirst%3DF.%26aulast%3DSantini%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DM.%26aulast%3DNofal%26aufirst%3DF.%2BA.%26aulast%3DSalerni%26aufirst%3DO.%2BL.%26aulast%3DScartoni%26aufirst%3DV.%26atitle%3D2%252C9-Disubstituted-N6-%2528arylcarbamoyl%2529-8-azaadenines%2520as%2520new%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%253A%2520synthesis%252C%2520biochemical%2520and%2520molecular%2520modelling%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D4679%26epage%3D4693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">Novel <i>N</i><sup>2</sup>-substituted pyrazolo[3,4-<i>d</i>]pyrimidine adenosine A<sub>3</sub> receptor antagonists: inhibition of A<sub>3</sub>-mediated human glioblastoma cell proliferation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3954</span><span class="NLM_x">–</span> <span class="NLM_lpage">3963</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901785w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3954-3963&author=S.+Talianiauthor=C.+La+Mottaauthor=L.+Mugnainiauthor=F.+Simoriniauthor=S.+Salernoauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=S.+Cosconatiauthor=B.+Cosimelliauthor=G.+Grecoauthor=V.+Limongelliauthor=L.+Marinelliauthor=E.+Novellinoauthor=O.+Ciampiauthor=S.+Danieleauthor=M.+L.+Trincavelliauthor=C.+Martini&title=Novel+N2-substituted+pyrazolo%5B3%2C4-d%5Dpyrimidine+adenosine+A3+receptor+antagonists%3A+inhibition+of+A3-mediated+human+glioblastoma+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm901785w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901785w%26sid%3Dliteratum%253Aachs%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DL.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DNovel%2520N2-substituted%2520pyrazolo%255B3%252C4-d%255Dpyrimidine%2520adenosine%2520A3%2520receptor%2520antagonists%253A%2520inhibition%2520of%2520A3-mediated%2520human%2520glioblastoma%2520cell%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3954%26epage%3D3963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">2-Phenylpyrazolo[4,3-<i>d</i>]pyrimidin-7-one as a new scaffold to obtain potent and selective human A<sub>3</sub> adenosine receptor antagonists: new insights into the receptor–antagonist recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7640</span><span class="NLM_x">–</span> <span class="NLM_lpage">7652</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900718w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7640-7652&author=O.+Lenziauthor=V.+Colottaauthor=D.+Catarziauthor=F.+Varanoauthor=D.+Poliauthor=G.+Filacchioniauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=S.+Paolettaauthor=E.+Morizzoauthor=S.+Moro&title=2-Phenylpyrazolo%5B4%2C3-d%5Dpyrimidin-7-one+as+a+new+scaffold+to+obtain+potent+and+selective+human+A3+adenosine+receptor+antagonists%3A+new+insights+into+the+receptor%E2%80%93antagonist+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm900718w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900718w%26sid%3Dliteratum%253Aachs%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DPoli%26aufirst%3DD.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3D2-Phenylpyrazolo%255B4%252C3-d%255Dpyrimidin-7-one%2520as%2520a%2520new%2520scaffold%2520to%2520obtain%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%253A%2520new%2520insights%2520into%2520the%2520receptor%25E2%2580%2593antagonist%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7640%26epage%3D7652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiesaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">New 2-arylpyrazolo[3,4-<i>c</i>]quinoline derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand–receptor modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4061</span><span class="NLM_x">–</span> <span class="NLM_lpage">4074</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070123v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4061-4074&author=V.+Colottaauthor=D.+Catarziauthor=F.+Varanoauthor=F.+Capelliauthor=O.+Lenziauthor=G.+Filacchioniauthor=C.+Martiniauthor=L.+Trincavelliauthor=O.+Ciampiauthor=A.+M.+Puglieseauthor=F.+Pedataauthor=A.+Schiesaroauthor=E.+Morizzoauthor=S.+Moro&title=New+2-arylpyrazolo%5B3%2C4-c%5Dquinoline+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists.+Synthesis%2C+pharmacological+evaluation%2C+and+ligand%E2%80%93receptor+modeling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm070123v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070123v%26sid%3Dliteratum%253Aachs%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DCapelli%26aufirst%3DF.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DPedata%26aufirst%3DF.%26aulast%3DSchiesaro%26aufirst%3DA.%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DNew%25202-arylpyrazolo%255B3%252C4-c%255Dquinoline%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists.%2520Synthesis%252C%2520pharmacological%2520evaluation%252C%2520and%2520ligand%25E2%2580%2593receptor%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4061%26epage%3D4074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span> </span><span class="NLM_article-title">Novel potent and highly selective human A<sub>3</sub> adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-<i>c</i>]quinoline series: molecular docking analysis and pharmacological studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=401-410&author=V.+Colottaauthor=F.+Capelliauthor=O.+Lenziauthor=D.+Catarziauthor=F.+Varanoauthor=D.+Poliauthor=F.+Vincenziauthor=K.+Varaniauthor=P.+A.+Boreaauthor=D.+Dal+Benauthor=R.+Volpiniauthor=G.+Cristalliauthor=G.+Filacchioni&title=Novel+potent+and+highly+selective+human+A3+adenosine+receptor+antagonists+belonging+to+the+4-amido-2-arylpyrazolo%5B3%2C4-c%5Dquinoline+series%3A+molecular+docking+analysis+and+pharmacological+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DCapelli%26aufirst%3DF.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DPoli%26aufirst%3DD.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DFilacchioni%26aufirst%3DG.%26atitle%3DNovel%2520potent%2520and%2520highly%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%2520belonging%2520to%2520the%25204-amido-2-arylpyrazolo%255B3%252C4-c%255Dquinoline%2520series%253A%2520molecular%2520docking%2520analysis%2520and%2520pharmacological%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D401%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaid, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New 2-arylpyrazolo[4,3-<i>c</i>]quinoline derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5001</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050125k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5001-5008&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=D.+Pretiauthor=A.+Boveroauthor=F.+Fruttaroloauthor=R.+Romagnoliauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=K.+Varaniauthor=P.+A.+Borea&title=New+2-arylpyrazolo%5B4%2C3-c%5Dquinoline+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm050125k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050125k%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBovero%26aufirst%3DA.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%25202-arylpyrazolo%255B4%252C3-c%255Dquinoline%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5001%26epage%3D5008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primofiore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergianni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">5-Amino-2-phenyl[1,2,3]triazolo[1,2-<i>a</i>][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A<sub>3</sub> adenosine receptor antagonistst</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5676</span><span class="NLM_x">–</span> <span class="NLM_lpage">5684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0708376" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5676-5684&author=F.+Da+Settimoauthor=G.+Primofioreauthor=S.+Talianiauthor=A.+M.+Mariniauthor=C.+La+Mottaauthor=F.+Simoriniauthor=S.+Salernoauthor=V.+Sergianniauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=B.+Cosimelliauthor=G.+Grecoauthor=E.+Novellinoauthor=O.+Ciampiauthor=M.+L.+Trincavelliauthor=C.+Martini&title=5-Amino-2-phenyl%5B1%2C2%2C3%5Dtriazolo%5B1%2C2-a%5D%5B1%2C2%2C4%5Dbenzotriazin-1-one%3A+a+versatile+scaffold+to+obtain+potent+and+selective+A3+adenosine+receptor+antagonistst"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm0708376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0708376%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DPrimofiore%26aufirst%3DG.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DSergianni%26aufirst%3DV.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3D5-Amino-2-phenyl%255B1%252C2%252C3%255Dtriazolo%255B1%252C2-a%255D%255B1%252C2%252C4%255Dbenzotriazin-1-one%253A%2520a%2520versatile%2520scaffold%2520to%2520obtain%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonistst%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5676%26epage%3D5684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>a</i>]pyrazin-1-one as a new scaffold to develop potent and selective human A<sub>3</sub> adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand–receptor modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2407</span><span class="NLM_x">–</span> <span class="NLM_lpage">2419</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014876" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2407-2419&author=V.+Colottaauthor=O.+Lenziauthor=D.+Catarziauthor=F.+Varanoauthor=G.+Filacchioniauthor=C.+Martiniauthor=L.+Trincavelliauthor=O.+Ciampiauthor=A.+M.+Puglieseauthor=C.+Trainiauthor=F.+Pedataauthor=E.+Morizzoauthor=S.+Moro&title=Pyrido%5B2%2C3-e%5D-1%2C2%2C4-triazolo%5B4%2C3-a%5Dpyrazin-1-one+as+a+new+scaffold+to+develop+potent+and+selective+human+A3+adenosine+receptor+antagonists.+Synthesis%2C+pharmacological+evaluation%2C+and+ligand%E2%80%93receptor+modeling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm8014876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014876%26sid%3Dliteratum%253Aachs%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DTraini%26aufirst%3DC.%26aulast%3DPedata%26aufirst%3DF.%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DPyrido%255B2%252C3-e%255D-1%252C2%252C4-triazolo%255B4%252C3-a%255Dpyrazin-1-one%2520as%2520a%2520new%2520scaffold%2520to%2520develop%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists.%2520Synthesis%252C%2520pharmacological%2520evaluation%252C%2520and%2520ligand%25E2%2580%2593receptor%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2407%26epage%3D2419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Cheong, S. L.; Venkatesan, G.; Paira, P.; Jothibasu, R.; Mandel, A. L.; Federico, S.; Spalluto, G.; Pastorin, G.</span><span> </span><span class="NLM_article-title">Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure–activity relationships</span>.  <span class="citation_source-journal">Int. J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1155/2011/480652</span> . Published Online: February 10,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1155%2F2011%2F480652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=25954519" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+L.+Cheong&author=G.+Venkatesan&author=P.+Paira&author=R.+Jothibasu&author=A.+L.+Mandel&author=S.+Federico&author=G.+Spalluto&author=G.+Pastorin&title=Pyrazolo+derivatives+as+potent+adenosine+receptor+antagonists%3A+an+overview+on+the+structure%E2%80%93activity+relationships&doi=10.1155%2F2011%2F480652"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1155%2F2011%2F480652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F480652%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26atitle%3DPyrazolo%2520derivatives%2520as%2520potent%2520adenosine%2520receptor%2520antagonists%253A%2520an%2520overview%2520on%2520the%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26doi%3D10.1155%2F2011%2F480652%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolcato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacilieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: a complete structure–activity profile</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=183-193&author=B.+Cacciariauthor=C.+Bolcatoauthor=G.+Spallutoauthor=K.+N.+Klotzauthor=M.+Bacilieriauthor=F.+Deflorianauthor=S.+Moro&title=Pyrazolo-triazolo-pyrimidines+as+adenosine+receptor+antagonists%3A+a+complete+structure%E2%80%93activity+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DBolcato%26aufirst%3DC.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DBacilieri%26aufirst%3DM.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DPyrazolo-triazolo-pyrimidines%2520as%2520adenosine%2520receptor%2520antagonists%253A%2520a%2520complete%2520structure%25E2%2580%2593activity%2520profile%26jtitle%3DPurinergic%2520Signalling%26date%3D2007%26volume%3D3%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Borea&title=Adenosine+receptor+antagonists%3A+translating+medicinal+chemistry+and+pharmacology+into+clinical+utility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Gessi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-263</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the chem. and pharmacol. of adenosine A1, A2A, A2B and A3 receptor antagonists and their therapeutic potential in clin. developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOXhQGKqAVLbVg90H21EOLACvtfcHk0lhEELD4zmCQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D&md5=1ae9e978507a1bbe7ab7aea0bdb33bb8</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptor%2520antagonists%253A%2520translating%2520medicinal%2520chemistry%2520and%2520pharmacology%2520into%2520clinical%2520utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D238%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Maconi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Ros, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A<sub>3</sub> adenosine receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3579</span><span class="NLM_x">–</span> <span class="NLM_lpage">3582</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020974x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3579-3582&author=A.+Maconiauthor=G.+Pastorinauthor=T.+Da+Rosauthor=G.+Spallutoauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=P.+G.+Baraldiauthor=B.+Cacciariauthor=K.+Varaniauthor=S.+Moroauthor=P.+A.+Borea&title=Synthesis%2C+biological+properties%2C+and+molecular+modeling+investigation+of+the+first+potent%2C+selective%2C+and+water-soluble+human+A3+adenosine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm020974x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020974x%26sid%3Dliteratum%253Aachs%26aulast%3DMaconi%26aufirst%3DA.%26aulast%3DPastorin%26aufirst%3DG.%26aulast%3DDa%2BRos%26aufirst%3DT.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%252C%2520biological%2520properties%252C%2520and%2520molecular%2520modeling%2520investigation%2520of%2520the%2520first%2520potent%252C%2520selective%252C%2520and%2520water-soluble%2520human%2520A3%2520adenosine%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3579%26epage%3D3582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Tafi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span> </span><span class="NLM_article-title">Pharmacophore based receptor modeling: the case of adenosine A<sub>3</sub> receptor antagonists. An approach to the optimization of protein models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051112%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4085-4097&author=A.+Tafiauthor=C.+Bernardiniauthor=M.+Bottaauthor=F.+Corelliauthor=M.+Andreiniauthor=A.+Martinelliauthor=G.+Ortoreauthor=P.+G.+Baraldiauthor=F.+Fruttaroloauthor=P.+A.+Boreaauthor=T.+Tuccinardi&title=Pharmacophore+based+receptor+modeling%3A+the+case+of+adenosine+A3+receptor+antagonists.+An+approach+to+the+optimization+of+protein+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm051112%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051112%252B%26sid%3Dliteratum%253Aachs%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DBernardini%26aufirst%3DC.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DOrtore%26aufirst%3DG.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DTuccinardi%26aufirst%3DT.%26atitle%3DPharmacophore%2520based%2520receptor%2520modeling%253A%2520the%2520case%2520of%2520adenosine%2520A3%2520receptor%2520antagonists.%2520An%2520approach%2520to%2520the%2520optimization%2520of%2520protein%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4085%26epage%3D4097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braiuca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span> </span><span class="NLM_article-title">Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A<sub>3</sub> adenosine receptor antagonists: pyrazolo[4,3-<i>e</i>]1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives as a key study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049662f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=152-162&author=S.+Moroauthor=P.+Braiucaauthor=F.+Deflorianauthor=C.+Ferrariauthor=G.+Pastorinauthor=B.+Cacciariauthor=P.+G.+Baraldiauthor=K.+Varaniauthor=P.+A.+Boreaauthor=G.+Spalluto&title=Combined+target-based+and+ligand-based+drug+design+approach+as+a+tool+to+define+a+novel+3D-pharmacophore+model+of+human+A3+adenosine+receptor+antagonists%3A+pyrazolo%5B4%2C3-e%5D1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives+as+a+key+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm049662f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049662f%26sid%3Dliteratum%253Aachs%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DBraiuca%26aufirst%3DP.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DFerrari%26aufirst%3DC.%26aulast%3DPastorin%26aufirst%3DG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DSpalluto%26aufirst%3DG.%26atitle%3DCombined%2520target-based%2520and%2520ligand-based%2520drug%2520design%2520approach%2520as%2520a%2520tool%2520to%2520define%2520a%2520novel%25203D-pharmacophore%2520model%2520of%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%253A%2520pyrazolo%255B4%252C3-e%255D1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%2520as%2520a%2520key%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D152%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Pran Kishore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghuram Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K.</span><span> </span><span class="NLM_article-title">QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives with human adenosine A<sub>3</sub>receptor subtype</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=818-823&author=D.+Pran+Kishoreauthor=C.+Balakumarauthor=A.+Raghuram+Raoauthor=P.+P.+Royauthor=K.+Roy&title=QSAR+of+adenosine+receptor+antagonists%3A+exploring+physicochemical+requirements+for+binding+of+pyrazolo%5B4%2C3-e%5D-1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives+with+human+adenosine+A3receptor+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPran%2BKishore%26aufirst%3DD.%26aulast%3DBalakumar%26aufirst%3DC.%26aulast%3DRaghuram%2BRao%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DP.%2BP.%26aulast%3DRoy%26aufirst%3DK.%26atitle%3DQSAR%2520of%2520adenosine%2520receptor%2520antagonists%253A%2520exploring%2520physicochemical%2520requirements%2520for%2520binding%2520of%2520pyrazolo%255B4%252C3-e%255D-1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%2520with%2520human%2520adenosine%2520A3receptor%2520subtype%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D818%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Cheong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA<sub>3</sub> adenosine receptors antagonists: new insights into structure–affinity relationship and receptor–antagonist recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3361</span><span class="NLM_x">–</span> <span class="NLM_lpage">3375</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100049f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3361-3375&author=S.+L.+Cheongauthor=A.+Dolzhenkoauthor=S.+Kachlerauthor=S.+Paolettaauthor=S.+Federicoauthor=B.+Cacciariauthor=A.+Dolzhenkoauthor=K.+N.+Klotzauthor=S.+Moroauthor=G.+Spallutoauthor=G.+Pastorin&title=The+significance+of+2-furyl+ring+substitution+with+a+2-%28para-substituted%29+aryl+group+in+a+new+series+of+pyrazolo-triazolo-pyrimidines+as+potent+and+highly+selective+hA3+adenosine+receptors+antagonists%3A+new+insights+into+structure%E2%80%93affinity+relationship+and+receptor%E2%80%93antagonist+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm100049f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100049f%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26aulast%3DDolzhenko%26aufirst%3DA.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DDolzhenko%26aufirst%3DA.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DThe%2520significance%2520of%25202-furyl%2520ring%2520substitution%2520with%2520a%25202-%2528para-substituted%2529%2520aryl%2520group%2520in%2520a%2520new%2520series%2520of%2520pyrazolo-triazolo-pyrimidines%2520as%2520potent%2520and%2520highly%2520selective%2520hA3%2520adenosine%2520receptors%2520antagonists%253A%2520new%2520insights%2520into%2520structure%25E2%2580%2593affinity%2520relationship%2520and%2520receptor%25E2%2580%2593antagonist%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3361%26epage%3D3375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Cheong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. P. R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">Does the combination of optimal substitutions at the <i>C</i><sup>2</sup>-, <i>N</i><sup>5</sup>- and <i>N</i><sup>8</sup>-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A<sub>3</sub> adenosine receptors?</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6120</span><span class="NLM_x">–</span> <span class="NLM_lpage">6134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6120-6134&author=S.+L.+Cheongauthor=A.+V.+Dolzhenkoauthor=S.+Paolettaauthor=E.+P.+R+Leeauthor=S.+Kachlerauthor=S.+Federicoauthor=K.+N.+Klotzauthor=A.+V.+Dolzhenkoauthor=G.+Spallutoauthor=S.+Moroauthor=G.+Pastorin&title=Does+the+combination+of+optimal+substitutions+at+the+C2-%2C+N5-+and+N8-positions+of+the+pyrazolo-triazolo-pyrimidine+scaffold+guarantee+selective+modulation+of+the+human+A3+adenosine+receptors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26aulast%3DDolzhenko%26aufirst%3DA.%2BV.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DE.%2BP.%2BR%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DDolzhenko%26aufirst%3DA.%2BV.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DDoes%2520the%2520combination%2520of%2520optimal%2520substitutions%2520at%2520the%2520C2-%252C%2520N5-%2520and%2520N8-positions%2520of%2520the%2520pyrazolo-triazolo-pyrimidine%2520scaffold%2520guarantee%2520selective%2520modulation%2520of%2520the%2520human%2520A3%2520adenosine%2520receptors%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6120%26epage%3D6134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Cheong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2898-2905&author=S.+L.+Cheongauthor=S.+Federicoauthor=G.+Venkatesanauthor=P.+Pairaauthor=Y.+M.+Shaoauthor=G.+Spallutoauthor=C.+W.+Yapauthor=G.+Pastorin&title=Pharmacophore+elucidation+for+a+new+series+of+2-aryl-pyrazolo-triazolo-pyrimidines+as+potent+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DVenkatesan%26aufirst%3DG.%26aulast%3DPaira%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DY.%2BM.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DYap%26aufirst%3DC.%2BW.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DPharmacophore%2520elucidation%2520for%2520a%2520new%2520series%2520of%25202-aryl-pyrazolo-triazolo-pyrimidines%2520as%2520potent%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2898%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span> </span><span class="NLM_article-title">Pyrrolo- and pyrazolo-[3,4-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidines as adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1046-1059&author=P.+G.+Baraldiauthor=G.+Saponaroauthor=M.+A.+Tabriziauthor=S.+Baraldiauthor=R.+Romagnoliauthor=A.+Moormanauthor=K.+Varaniauthor=P.+A.+Boreaauthor=D.+Preti&title=Pyrrolo-+and+pyrazolo-%5B3%2C4-e%5D%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dpyrimidines+as+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMoorman%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26atitle%3DPyrrolo-%2520and%2520pyrazolo-%255B3%252C4-e%255D%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-c%255Dpyrimidines%2520as%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1046%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurogi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiryu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagao, Y.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of adenosine A<sub>3</sub> receptor ligands: new potential therapy for the treatment of glaucoma</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3775</span><span class="NLM_x">–</span> <span class="NLM_lpage">3779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3775-3779&author=T.+Okamuraauthor=Y.+Kurogiauthor=K.+Hashimotoauthor=S.+Satoauthor=H.+Nishikawaauthor=K.+Kiryuauthor=Y.+Nagao&title=Structure%E2%80%93activity+relationships+of+adenosine+A3+receptor+ligands%3A+new+potential+therapy+for+the+treatment+of+glaucoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DKurogi%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DKiryu%26aufirst%3DK.%26aulast%3DNagao%26aufirst%3DY.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520adenosine%2520A3%2520receptor%2520ligands%253A%2520new%2520potential%2520therapy%2520for%2520the%2520treatment%2520of%2520glaucoma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3775%26epage%3D3779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurogi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagao, Y.</span><span> </span><span class="NLM_article-title">Facile synthesis of fused 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives as human adenosine A<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2443-2446&author=T.+Okamuraauthor=Y.+Kurogiauthor=K.+Hashimotoauthor=H.+Nishikawaauthor=Y.+Nagao&title=Facile+synthesis+of+fused+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives+as+human+adenosine+A3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DKurogi%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DNagao%26aufirst%3DY.%26atitle%3DFacile%2520synthesis%2520of%2520fused%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%2520as%2520human%2520adenosine%2520A3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2443%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Priego, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuenzel, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarasa, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Perez, M. J.</span><span> </span><span class="NLM_article-title">Pyrido[2,1-<i>f</i>]purine-2,4-dione derivatives as a novel class of highly potent human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3337</span><span class="NLM_x">–</span> <span class="NLM_lpage">3344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3337-3344&author=E.+M.+Priegoauthor=J.+V.+Kuenzelauthor=A.+P.+IJzermanauthor=M.+J.+Camarasaauthor=M.+J.+Perez-Perez&title=Pyrido%5B2%2C1-f%5Dpurine-2%2C4-dione+derivatives+as+a+novel+class+of+highly+potent+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm0208469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208469%26sid%3Dliteratum%253Aachs%26aulast%3DPriego%26aufirst%3DE.%2BM.%26aulast%3DKuenzel%26aufirst%3DJ.%2BV.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DPerez-Perez%26aufirst%3DM.%2BJ.%26atitle%3DPyrido%255B2%252C1-f%255Dpurine-2%252C4-dione%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520highly%2520potent%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3337%26epage%3D3344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Priego, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Perez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe Kuenzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarasa, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Santamaria, S.</span><span> </span><span class="NLM_article-title">Selective human adenosine A<sub>3</sub> antagonists based on pyrido[2,1-<i>f</i>]purine-2,4-diones: novel features of hA<sub>3</sub> antagonist binding</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=111-119&author=E.+M.+Priegoauthor=M.+J.+Perez-Perezauthor=J.+K.+von+Frijtag+Drabbe+Kuenzelauthor=H.+de+Vriesauthor=A.+P.+Ijzermanauthor=M.+J.+Camarasaauthor=S.+Martin-Santamaria&title=Selective+human+adenosine+A3+antagonists+based+on+pyrido%5B2%2C1-f%5Dpurine-2%2C4-diones%3A+novel+features+of+hA3+antagonist+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPriego%26aufirst%3DE.%2BM.%26aulast%3DPerez-Perez%26aufirst%3DM.%2BJ.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BKuenzel%26aufirst%3DJ.%2BK.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DMartin-Santamaria%26aufirst%3DS.%26atitle%3DSelective%2520human%2520adenosine%2520A3%2520antagonists%2520based%2520on%2520pyrido%255B2%252C1-f%255Dpurine-2%252C4-diones%253A%2520novel%2520features%2520of%2520hA3%2520antagonist%2520binding%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D111%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaid, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New pyrrolo[2,1-<i>f</i>]purine-2,4-dione and imidazo[2,1-<i>f</i>]purine-2,4-dione derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4697</span><span class="NLM_x">–</span> <span class="NLM_lpage">4701</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4697-4701&author=P.+G.+Baraldiauthor=D.+Pretiauthor=M.+A.+Tabriziauthor=F.+Fruttaroloauthor=R.+Romagnoliauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=S.+Merighiauthor=K.+Varaniauthor=P.+A.+Borea&title=New+pyrrolo%5B2%2C1-f%5Dpurine-2%2C4-dione+and+imidazo%5B2%2C1-f%5Dpurine-2%2C4-dione+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm058008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058008c%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%2520pyrrolo%255B2%252C1-f%255Dpurine-2%252C4-dione%2520and%2520imidazo%255B2%252C1-f%255Dpurine-2%252C4-dione%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4697%26epage%3D4701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tafi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of a new series of imidazo[2,1-<i>f</i>]purinones as potent and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">10281</span><span class="NLM_x">–</span> <span class="NLM_lpage">10294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=10281-10294&author=P.+G.+Baraldiauthor=D.+Pretiauthor=M.+A.+Tabriziauthor=R.+Romagnoliauthor=G.+Saponaroauthor=S.+Baraldiauthor=M.+Bottaauthor=C.+Bernardiniauthor=A.+Tafiauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=K.+Varaniauthor=P.+A.+Borea&title=Structure%E2%80%93activity+relationship+studies+of+a+new+series+of+imidazo%5B2%2C1-f%5Dpurinones+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBernardini%26aufirst%3DC.%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520a%2520new%2520series%2520of%2520imidazo%255B2%252C1-f%255Dpurinones%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D10281%26epage%3D10294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qurishi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Imidazo[2,1-<i>i</i>]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A<sub>2A</sub> and A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3440</span><span class="NLM_x">–</span> <span class="NLM_lpage">3450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm011093d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3440-3450&author=C.+E.+M%C3%BCllerauthor=M.+Thorandauthor=R.+Qurishiauthor=M.+Diekmannauthor=K.+A.+Jacobsonauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Imidazo%5B2%2C1-i%5Dpurin-5-ones+and+related+tricyclic+water-soluble+purine+derivatives%3A+potent+A2A+and+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm011093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011093d%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DQurishi%26aufirst%3DR.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DImidazo%255B2%252C1-i%255Dpurin-5-ones%2520and%2520related%2520tricyclic%2520water-soluble%2520purine%2520derivatives%253A%2520potent%2520A2A%2520and%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3440%26epage%3D3450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozola, V.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]8-Ethyl-4-methyl-2-phenyl-(8<i>R</i>)-4,5,7,8-tetrahydro-1<i>H</i>-imidazo[2,1-<i>i</i>]-purin-5-one ([<sup>3</sup>H]PSB-11), a novel high-affinity antagonist radioligand for human A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=501-503&author=C.+E.+M%C3%BCllerauthor=M.+Diekmannauthor=M.+Thorandauthor=V.+Ozola&title=%5B3H%5D8-Ethyl-4-methyl-2-phenyl-%288R%29-4%2C5%2C7%2C8-tetrahydro-1H-imidazo%5B2%2C1-i%5D-purin-5-one+%28%5B3H%5DPSB-11%29%2C+a+novel+high-affinity+antagonist+radioligand+for+human+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DOzola%26aufirst%3DV.%26atitle%3D%255B3H%255D8-Ethyl-4-methyl-2-phenyl-%25288R%2529-4%252C5%252C7%252C8-tetrahydro-1H-imidazo%255B2%252C1-i%255D-purin-5-one%2520%2528%255B3H%255DPSB-11%2529%252C%2520a%2520novel%2520high-affinity%2520antagonist%2520radioligand%2520for%2520human%2520A3%2520adenosine%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D501%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Ozola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qurishi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Műller, C. E.</span><span> </span><span class="NLM_article-title">2-Phenylimidazo[2,1-<i>i</i>]purin-5-ones: structure–activity relationships and characterization of potent and selective inverse agonists at human A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=347-356&author=V.+Ozolaauthor=M.+Thorandauthor=M.+Diekmannauthor=R.+Qurishiauthor=B.+Schumacherauthor=K.+A.+Jacobsonauthor=C.+E.+M%C5%B1ller&title=2-Phenylimidazo%5B2%2C1-i%5Dpurin-5-ones%3A+structure%E2%80%93activity+relationships+and+characterization+of+potent+and+selective+inverse+agonists+at+human+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOzola%26aufirst%3DV.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DQurishi%26aufirst%3DR.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C5%25B1ller%26aufirst%3DC.%2BE.%26atitle%3D2-Phenylimidazo%255B2%252C1-i%255Dpurin-5-ones%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520characterization%2520of%2520potent%2520and%2520selective%2520inverse%2520agonists%2520at%2520human%2520A3%2520adenosine%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D347%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Saki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimura, M.</span><span> </span><span class="NLM_article-title">KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1<i>H</i>-imidazo[2,1-<i>i</i>]purin-5(4<i>H</i>)-one dihydrochloride), a new potent and selective adenosine A<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0014-2999%2802%2901662-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12063073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVShsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2002&pages=133-141&author=M.+Sakiauthor=H.+Tsumukiauthor=H.+Nonakaauthor=J.+Shimadaauthor=M.+Ichimura&title=KF26777+%282-%284-bromophenyl%29-7%2C8-dihydro-4-propyl-1H-imidazo%5B2%2C1-i%5Dpurin-5%284H%29-one+dihydrochloride%29%2C+a+new+potent+and+selective+adenosine+A3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-onedihydrochloride), a new potent and selective adenosine A3 receptor antagonist</span></div><div class="casAuthors">Saki, Mayumi; Tsumuki, Hiroshi; Nonaka, Hiromi; Shimada, Junichi; Ichimura, Michio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-141</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The authors investigated the biochem. and pharmacol. properties of a new adenosine A3 receptor antagonist, KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-onedihydrochloride).  This compd. was characterized using N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide ([125I]AB-MECA) or [35S]guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding to membranes from human embryonic kidney 293 (HEK293) cells expressing human adenosine A3 receptors.  KF26777 showed a Ki value of 0.20±0.038 nM for human adenosine A3 receptors labeled with [125I]AB-MECA and possessed 9000-, 2350- and 3100-fold selectivity vs. human adenosine A1, A2A and A2B receptors, resp.  The inhibitory mode of binding was competitive.  KF26777 inhibited the binding of [35S]GTPγS stimulated by 1 μM 2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (Cl-IB-MECA).  The IC50 value was 270±85 nM; the compd. had no effect on basal activity.  Dexamethasone treatment for HL-60 cells, human promyelocytic leukemia, up-regulated functional adenosine A3 receptors expression, and resulted in the enhanced elevation of intracellular Ca2+ concn. ([Ca2+]i) via the adenosine A3 receptor.  KF26777 antagonized this [Ca2+]i mobilization induced by Cl-IB-MECA, with a KB value of 0.42±0.14 nM.  These results indicate that KF26777 is a highly potent and selective antagonist of the human adenosine A3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZsrhi-bkM17Vg90H21EOLACvtfcHk0liqTfLeVCtu2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVShsrw%253D&md5=215f410d4d628997269f964a173d0f46</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901662-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901662-X%26sid%3Dliteratum%253Aachs%26aulast%3DSaki%26aufirst%3DM.%26aulast%3DTsumuki%26aufirst%3DH.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DIchimura%26aufirst%3DM.%26atitle%3DKF26777%2520%25282-%25284-bromophenyl%2529-7%252C8-dihydro-4-propyl-1H-imidazo%255B2%252C1-i%255Dpurin-5%25284H%2529-one%2520dihydrochloride%2529%252C%2520a%2520new%2520potent%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D444%26spage%3D133%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaid, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New 2-heterocyclyl-imidazo[2,1-<i>i</i>]purin-5-one derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5205</span><span class="NLM_x">–</span> <span class="NLM_lpage">5220</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2004738" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5205-5220&author=P.+G.+Baraldiauthor=D.+Pretiauthor=A.+N.+Zaidauthor=G.+Saponaroauthor=M.+A.+Tabriziauthor=S.+Baraldiauthor=R.+Romagnoliauthor=A.+R.+Moormanauthor=K.+Varaniauthor=S.+Cosconatiauthor=S.+Di+Maroauthor=L.+Marinelliauthor=E.+Novellinoauthor=P.+A.+Borea&title=New+2-heterocyclyl-imidazo%5B2%2C1-i%5Dpurin-5-one+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm2004738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004738%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DZaid%26aufirst%3DA.%2BN.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%25202-heterocyclyl-imidazo%255B2%252C1-i%255Dpurin-5-one%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5205%26epage%3D5220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Purine derivatives as ligands for A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F156802605774463079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16305531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1275-1295&author=B.+V.+Joshiauthor=K.+A.+Jacobson&title=Purine+derivatives+as+ligands+for+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Purine derivatives as ligands for A3 adenosine receptors</span></div><div class="casAuthors">Joshi, Bhalchandra V.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1275-1295</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Selective agonists and antagonists for A3 adenosine receptors (ARs) are being explored for the treatment of a variety of disorders, including brain and heart ischemic conditions, cancer, and rheumatoid arthritis.  This review covers both the structure activity relationships of nucleoside agonist ligands and selected antagonists acting at this receptor and the routes of synthesis.  Highly selective agonists have been designed, using both empirical approaches and a semi-rational approach based on mol. modeling.  The prototypical A3 agonists IB-MECA 10 and the more receptor-subtype-selective Cl-IB-MECA 11, both of which have affinity in binding to the receptor of ∼ 1 nM, have been used widely as pharmacol. probes in the elucidation of the physiol. role of this receptor.  In addn. to the exploration of the effects of structural modification of the adenine and ribose moieties on A3AR affinity, the effects of these structural changes on the intrinsic efficacy have also been studied in a systematic fashion.  Key structural features detg. A3AR interaction include the N6-benzyl group, 2-position substitution such as halo, substitution of ribose (e.g., the (N)-methanocarba ring system, various 2'- and 3'-substitutions and 4'-thio substitution of oxygen).  Conformational studies of the ribose moiety and its equiv. indicate that the ring oxygen is not required and the North (N) ring conformation is preferred in binding to the A3AR.  Using these observations, a series of ring constrained (N)-methanocarba 5'-uronamide derivs. was recently reported to be highly selective A3AR agonists, the most notable amongst them was MRS3558 113 having a Ki value in binding to the human A3 receptor of 0.3 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZrtG1tbzNgrVg90H21EOLACvtfcHk0lhzSWnfIxg_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbbF&md5=5dc7a6be512eba8f69524644fad94192</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.2174%2F156802605774463079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605774463079%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DPurine%2520derivatives%2520as%2520ligands%2520for%2520A3%2520adenosine%2520receptors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1275%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Conversion of A<sub>3</sub> adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=596-601&author=Z.+G.+Gaoauthor=B.+V.+Joshiauthor=A.+M.+Klutzauthor=S.+K.+Kimauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Conversion+of+A3+adenosine+receptor+agonists+into+selective+antagonists+by+modification+of+the+5%E2%80%B2-ribofuran-uronamide+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DConversion%2520of%2520A3%2520adenosine%2520receptor%2520agonists%2520into%2520selective%2520antagonists%2520by%2520modification%2520of%2520the%25205%25E2%2580%25B2-ribofuran-uronamide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Koch, M.; Den Hartog, J. A. J.; Koomen, G. J.; Wanner, M. J.; Feenstra, R. W.</span><span> </span><span class="NLM_article-title">2-Substituted-6-trifluoromethyl Purine Derivatives with Adenosine-A<sub>3</sub> Antagonistic Activity</span>. WO 2006027365,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Koch&author=J.+A.+J.+Den+Hartog&author=G.+J.+Koomen&author=M.+J.+Wanner&author=R.+W.+Feenstra&title=2-Substituted-6-trifluoromethyl+Purine+Derivatives+with+Adenosine-A3+Antagonistic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DM.%26atitle%3D2-Substituted-6-trifluoromethyl%2520Purine%2520Derivatives%2520with%2520Adenosine-A3%2520Antagonistic%2520Activity%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Bevan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butchers, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span> </span><span class="NLM_article-title">Pharmacological characterisation and inhibitory effects of (2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2-(6-amino-2-{[(1<i>S</i>)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9<i>H</i>-purin-9-yl)-5-(2-ethyl-2<i>H</i>-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A<sub>2A</sub> receptor agonist and adenosine A<sub>3</sub> receptor antagonist activity</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">564</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.ejphar.2007.01.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17382926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=564&publication_year=2007&pages=219-225&author=N.+Bevanauthor=P.+R.+Butchersauthor=R.+Cousinsauthor=J.+Coatesauthor=E.+V.+Edgarauthor=V.+Morrisonauthor=M.+J.+Sheehanauthor=J.+Reevesauthor=D.+J.+Wilson&title=Pharmacological+characterisation+and+inhibitory+effects+of+%282R%2C3R%2C4S%2C5R%29-2-%286-amino-2-%7B%5B%281S%29-2-hydroxy-1-%28phenylmethyl%29ethyl%5Damino%7D-9H-purin-9-yl%29-5-%282-ethyl-2H-tetrazol-5-yl%29tetrahydro-3%2C4-furandiol%2C+a+novel+ligand+that+demonstrates+both+adenosine+A2A+receptor+agonist+and+adenosine+A3+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity</span></div><div class="casAuthors">Bevan, Nicola; Butchers, Peter R.; Cousins, Rick; Coates, Jill; Edgar, Emma V.; Morrison, Val; Sheehan, Michael J.; Reeves, Julian; Wilson, David J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">564</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">219-225</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pharmacol. properties of the novel ligand, (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol , at the human adenosine receptors were investigated using Chinese hamster ovary cell lines recombinantly expressing these receptors.  Functional studies were performed using a cAMP-coupled reporter gene system.  Binding studies were performed using membranes from these cells.  The effects of ligand were also detd. on functional responses of human neutrophils and eosinophils.  Ligand had a high affinity for the adenosine A2A receptor (pKi 7.8±0.2) and was a potent agonist at this receptor (pEC50 9.0±0.2).  Ligand had a similar affinity for the adenosine A3 receptor (pKi 7.8±0.1) but displayed no agonist activity, acting instead as a competitive antagonist (pA2 8.3±0.04).  Ligand had lower affinity for adenosine A1 and A2B receptors (pKi ≤ 6) and showed relatively weak agonist activity at these receptors (pEC50 7.1 at both receptors).  Ligand was a potent inhibitor of the generation of reactive oxygen species from human neutrophils and eosinophils (pEC50 9.7±0.1 and 9.4±0.2 resp.).  The inhibitory effect of ligand on the release of reactive oxygen species from neutrophils was antagonized competitively by the adenosine A2A receptor antagonist 9-chloro-2-(2-furanyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine (CGS15943) with a pA2 value (10.03 ± 0.44) consistent with an effect on adenosine A2A receptors.  Ligand also inhibited the release of granule proteins from neutrophils and eosinophils (pEC50 8.7 and 8.9 resp.), albeit less potently than as an inhibitor of reactive oxygen species generation.  In summary, ligand is a potent and selective agonist for the adenosine A2A receptor and a competitive antagonist at the adenosine A3 receptor.  Ligand has potent anti-inflammatory effects on human granulocytes in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt87YbjQuJ5rVg90H21EOLACvtfcHk0lhzSWnfIxg_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cit7c%253D&md5=b0f9d25b3b8cd087901f605fd12caacc</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.01.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.01.094%26sid%3Dliteratum%253Aachs%26aulast%3DBevan%26aufirst%3DN.%26aulast%3DButchers%26aufirst%3DP.%2BR.%26aulast%3DCousins%26aufirst%3DR.%26aulast%3DCoates%26aufirst%3DJ.%26aulast%3DEdgar%26aufirst%3DE.%2BV.%26aulast%3DMorrison%26aufirst%3DV.%26aulast%3DSheehan%26aufirst%3DM.%2BJ.%26aulast%3DReeves%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26atitle%3DPharmacological%2520characterisation%2520and%2520inhibitory%2520effects%2520of%2520%25282R%252C3R%252C4S%252C5R%2529-2-%25286-amino-2-%257B%255B%25281S%2529-2-hydroxy-1-%2528phenylmethyl%2529ethyl%255Damino%257D-9H-purin-9-yl%2529-5-%25282-ethyl-2H-tetrazol-5-yl%2529tetrahydro-3%252C4-furandiol%252C%2520a%2520novel%2520ligand%2520that%2520demonstrates%2520both%2520adenosine%2520A2A%2520receptor%2520agonist%2520and%2520adenosine%2520A3%2520receptor%2520antagonist%2520activity%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D564%26spage%3D219%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biadatti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structural determinants of A<sub>3</sub> adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4471</span><span class="NLM_x">–</span> <span class="NLM_lpage">4484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020211%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4471-4484&author=Z.+G.+Gaoauthor=S.+K.+Kimauthor=T.+Biadattiauthor=W.+Chenauthor=K.+Leeauthor=D.+Barakauthor=S.+G.+Kimauthor=C.+R.+Johnsonauthor=K.+A.+Jacobson&title=Structural+determinants+of+A3+adenosine+receptor+activation%3A+nucleoside+ligands+at+the+agonist%2Fantagonist+boundary"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants of A3 Adenosine Receptor Activation: Nucleoside Ligands at the Agonist/Antagonist Boundary</span></div><div class="casAuthors">Gao, Zhan-Guo; Kim, Soo-Kyung; Biadatti, Thibaud; Chen, Wangzhong; Lee, Kyeong; Barak, Dov; Kim, Seong Gon; Johnson, Carl R.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4471-4484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutagenesis of the human A3 adenosine receptor (AR) suggested that certain amino acid residues contributed differently to ligand binding and activation processes.  Here we demonstrated that various adenosine modifications, including adenine substitution and ribose ring constraints, also contributed differentially to these processes.  The ligand effects on cAMP prodn. in intact CHO cells expressing the A3AR and in receptor binding were compared.  Notably, the simple 2-fluoro group alone or 2-chloro in combination with N6-substitution dramatically diminished the efficacy of adenosine derivs., even converting agonist into antagonist.  Other affinity-increasing substitutions, including N6-(3-iodobenzyl) and the (Northern)-methanocarba, also reduced efficacy, except in combination with a flexible 5'-uronamide.  2-Cl-N6-(3-iodobenzyl) derivs., both in the (N)-methanocarba (i.e., of the Northern conformation) and riboside series were potent antagonists with little residual agonism.  Ring-constrained 2',3'-epoxide derivs. in both riboside and (N)-methanocarba series and a cyclized (spiral) 4',5'-uronamide deriv. were synthesized and found to be human A3AR antagonists.  The 4',5'-uronamide deriv. bound potently at both human (26 nM) and rat (49 nM) A3ARs.  A rhodopsin-based A3AR model, contg. all domains except the C-terminal region, indicated sep. structural requirements for receptor binding and activation for these adenosine analogs.  Ligand docking, taking into account binding of selected derivs. at mutant A3ARs, featured interactions of TM3 (His95) with the adenine moiety and TMs with the ribose 5'-region.  The 5'-OH group of antagonist N6-(3-iodobenzyl)-2-chloroadenosine formed a H-bond with N274 but not with S271.  The 5'-substituent of nucleoside antagonists moved toward TM7 and away from TM6.  The conserved Trp243 (6.48) side chain, involved in recognition of the classical (nonnucleoside) A3AR antagonists but not adenosine-derived ligands, displayed a characteristic movement exclusively upon docking of agonists.  Thus, A3AR activation appeared to require flexibility at the 5'- and 3'-positions, which was diminished in (N)-methanocarba, spiro, and epoxide analogs, and was characteristic of ribose interactions at TM6 and TM7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKyUix8ag2rrVg90H21EOLACvtfcHk0lhzSWnfIxg_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFSqurg%253D&md5=7055f590e03c6a7853225e3cb0f1de06</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm020211%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020211%252B%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DBiadatti%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DBarak%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520determinants%2520of%2520A3%2520adenosine%2520receptor%2520activation%253A%2520nucleoside%2520ligands%2520at%2520the%2520agonist%252Fantagonist%2520boundary%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4471%26epage%3D4484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson-Yantorno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coca-Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civan, M. M.</span><span> </span><span class="NLM_article-title">The cross-species A<sub>3</sub> adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure</span> <span class="citation_source-journal">Curr. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1080%2F02713680590953147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16146920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWitbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=747-754&author=H.+Yangauthor=M.+Y.+Avilaauthor=K.+Peterson-Yantornoauthor=M.+Coca-Pradosauthor=R.+A.+Stoneauthor=K.+A.+Jacobsonauthor=M.+M.+Civan&title=The+cross-species+A3+adenosine-receptor+antagonist+MRS+1292+inhibits+adenosine-triggered+human+nonpigmented+ciliary+epithelial+cell+fluid+release+and+reduces+mouse+intraocular+pressure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The Cross-Species A3 Adenosine-Receptor Antagonist MRS 1292 Inhibits Adenosine-Triggered Human Nonpigmented Ciliary Epithelial Cell Fluid Release and Reduces Mouse Intraocular Pressure</span></div><div class="casAuthors">Yang, Hui; Avila, Marcel Y.; Peterson-Yantorno, Kim; Coca-Prados, Miguel; Stone, Richard A.; Jacobson, Kenneth A.; Civan, Mortimer M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Eye Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">747-754</span>CODEN:
                <span class="NLM_cas:coden">CEYRDM</span>;
        ISSN:<span class="NLM_cas:issn">0271-3683</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Purpose: Antagonists to A3 adenosine receptors (ARs) lower mouse intraocular pressure (IOP), but extension to humans is limited by species variability.  We tested whether the specific A3AR antagonist MRS 1292, designed to cross species, mimics the effects of other A3AR antagonists on cultured human nonpigmented ciliary epithelial (NPE) cells and mouse IOP.  Methods: NPE cell vol. was monitored by electronic cell sorting.  Mouse IOP was measured with the Servo-Null Micropipette System.  Results: Adenosine triggered A3AR-mediated shrinkage of human NPE cells.  Shrinkage was blocked by MRS 1292 (IC50 = 42 ± 11 nM, p <0.01) and by another A3AR antagonist effective in this system, MRS 1191. Topical application of the A3AR agonist IB-MECA increased mouse IOP. MRS 1292 reduced IOP by 4.0 ± 0.8 mmHg at 25-μ M droplet concn. (n = 10, p <0.005). Conclusions: MRS 1292 inhibits A3AR-mediated shrinkage of human NPE cells and reduces mouse IOP, consistent with its putative action as a cross-species A3 antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-D1J3Cji3RbVg90H21EOLACvtfcHk0ljv8-8JkgveTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWitbnP&md5=47500e1a133d0580ae67ba4438ab96fd</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1080%2F02713680590953147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02713680590953147%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAvila%26aufirst%3DM.%2BY.%26aulast%3DPeterson-Yantorno%26aufirst%3DK.%26aulast%3DCoca-Prados%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DR.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DCivan%26aufirst%3DM.%2BM.%26atitle%3DThe%2520cross-species%2520A3%2520adenosine-receptor%2520antagonist%2520MRS%25201292%2520inhibits%2520adenosine-triggered%2520human%2520nonpigmented%2520ciliary%2520epithelial%2520cell%2520fluid%2520release%2520and%2520reduces%2520mouse%2520intraocular%2520pressure%26jtitle%3DCurr.%2520Eye%2520Res.%26date%3D2005%26volume%3D30%26spage%3D747%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Ravn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qvortrup, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbohm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5440</span><span class="NLM_x">–</span> <span class="NLM_lpage">5447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5440-5447&author=J.+Ravnauthor=K.+Qvortrupauthor=C.+Rosenbohmauthor=T.+Koch&title=Design%2C+synthesis%2C+and+biological+evaluation+of+LNA+nucleosides+as+adenosine+A3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavn%26aufirst%3DJ.%26aulast%3DQvortrup%26aufirst%3DK.%26aulast%3DRosenbohm%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520LNA%2520nucleosides%2520as%2520adenosine%2520A3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5440%26epage%3D5447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Ravn, J.; Rosenbohm, C.; Qvortrup, K.; Koch, T.</span><span> </span><span class="NLM_article-title">Adenosine Receptor Antagonists</span>. WO 2008006369,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Ravn&author=C.+Rosenbohm&author=K.+Qvortrup&author=T.+Koch&title=Adenosine+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRavn%26aufirst%3DJ.%26atitle%3DAdenosine%2520Receptor%2520Antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Docking studies of agonists and antagonists suggest an activation pathway of the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.jmgm.2006.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOhs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=562-577&author=S.+K.+Kimauthor=Z.+G.+Gaoauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Docking+studies+of+agonists+and+antagonists+suggest+an+activation+pathway+of+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor</span></div><div class="casAuthors">Kim, Soo-Kyung; Gao, Zhan-Guo; Jeong, Lak Shin; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">562-577</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Structural determinants of ligand efficacy in the human A3 adenosine receptor (AR) were studied using pharmacophore and docking analyses of various categories of A3 selective ligands: inverse agonist, neutral antagonist (nonnucleoside and nucleoside), and agonist (partial and full).  The homol. modeling of GPCRs was adapted to provide two templates: the rhodopsin-based resting state for antagonist binding and a putative Meta I state, conformationally altered at a key residue (W6.48), for agonist binding.  The preferential binding domains and/or local conformational changes assocd. with docking of three high affinity A3AR ligands were compared: inverse agonist PSB-11, neutral antagonist MRE-3008F20, and full agonist Cl-IB-MECA to define a distinct recognition mode for each.  Ribose-contg. agonists were more hydrophilic than nonnucleoside antagonists, and H-bonding ability at the ribose 3'- and 5'-positions was required for agonism.  From the receptor perspective, common requirements for activation included the destabilization of H-bond networks at W6.48 and H7.43, the specific interactions of the ribose moiety in its putative hydrophilic pocket at T3.36, S7.42, and H7.43, the stabilization of the complex by inward movement of F5.43, and the characteristic rotation of W6.48.  By analogy, outward rotation of the W6.48 side-chain upon activation of an internally-crosslinking mutant M3 muscarinic receptor was indicated by constrained mol. dynamics (MD).  The authors' results are consistent with an anti-clockwise rotation (from the extracellular view) of transmembrane domains 3, 5, 6, and 7, as proposed for other Family A GPCRs.  Thus, the putative conformational changes assocd. with A3AR activation indicate a shared mechanism of GPCR activation similar to rhodopsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWu8mjSrWoKLVg90H21EOLACvtfcHk0ljv8-8JkgveTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOhs7vL&md5=600d301ed714ecc352db9496f7109a7e</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2006.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2006.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DDocking%2520studies%2520of%2520agonists%2520and%2520antagonists%2520suggest%2520an%2520activation%2520pathway%2520of%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D562%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaniappan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Discovery of a new nucleoside template for human A<sub>3</sub> adenosine receptor ligands: <span class="smallcaps smallerCapital">d</span>-4′-thioadenosine derivatives without 4′-hydroxymethyl group as highly potent and selective antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3159</span><span class="NLM_x">–</span> <span class="NLM_lpage">3162</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070259t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1KrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3159-3162&author=L.+S.+Jeongauthor=S.+A.+Choeauthor=P.+Gunagaauthor=H.+O.+Kimauthor=H.+W.+Leeauthor=S.+K.+Leeauthor=D.+K.+Toshauthor=A.+Patelauthor=K.+K.+Palaniappanauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=H.+R.+Moon&title=Discovery+of+a+new+nucleoside+template+for+human+A3+adenosine+receptor+ligands%3A+d-4%E2%80%B2-thioadenosine+derivatives+without+4%E2%80%B2-hydroxymethyl+group+as+highly+potent+and+selective+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Nucleoside Template for Human A3 Adenosine Receptor Ligands: D-4'-Thioadenosine Derivatives without 4'-Hydroxymethyl Group as Highly Potent and Selective Antagonists</span></div><div class="casAuthors">Jeong, Lak Shin; Choe, Seung Ah; Gunaga, Prashantha; Kim, Hea Ok; Lee, Hyuk Woo; Lee, Sang Kook; Tosh, Dilip K.; Patel, Amit; Palaniappan, Krishnan K.; Gao, Zhan-Guo; Jacobson, Kenneth A.; Moon, Hyung Ryong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3159-3162</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Truncated D-4'-thioadenosine derivs. lacking the 4'-hydroxymethylene moiety were synthesized starting from D-mannose, using cyclization to the 4-thiosugar and one-step conversion of the diol to the acetate as key steps.  At the human A3 adenosine receptor (AR), N6-substituted purine analogs bound potently and selectively and acted as antagonists in a cAMP functional assay.  An N6-(3-chlorobenzyl)purine analog 9b displayed a Ki value of 1.66 nM at the human A3 AR.  Thus, truncated D-4'-thioadenosine is an excellent template for the design of novel A3 AR antagonists to act at both human and murine species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6WDstBT_FHLVg90H21EOLACvtfcHk0ljv8-8JkgveTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1KrtLk%253D&md5=353b81eacca2168e390fe048f75463c5</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm070259t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070259t%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DChoe%26aufirst%3DS.%2BA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPalaniappan%26aufirst%3DK.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520new%2520nucleoside%2520template%2520for%2520human%2520A3%2520adenosine%2520receptor%2520ligands%253A%2520d-4%25E2%2580%25B2-thioadenosine%2520derivatives%2520without%25204%25E2%2580%25B2-hydroxymethyl%2520group%2520as%2520highly%2520potent%2520and%2520selective%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3159%26epage%3D3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. D.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of 2-chloro-<i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-<i>N</i>,<i>N</i>-dialkyluronamides as human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1612-1616&author=L.+S.+Jeongauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=D.+K.+Toshauthor=S.+Palauthor=W.+J.+Choiauthor=Z.+G.+Gaoauthor=A.+R.+Patelauthor=W.+Williamsauthor=K.+A.+Jacobsonauthor=H.+D.+Kim&title=Structure%E2%80%93activity+relationships+of+2-chloro-N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-N%2CN-dialkyluronamides+as+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DPatel%26aufirst%3DA.%2BR.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DH.%2BD.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%25202-chloro-N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-N%252CN-dialkyluronamides%2520as%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1612%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Synthesis of 2-chloro-<i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-<i>N</i>,<i>N</i>-dialkyluronamides as potent and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Nucleic Acids Symp. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=645-646&author=W.+J.+Choiauthor=H.+W.+Leeauthor=X.+Houauthor=H.+O.+Kimauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Synthesis+of+2-chloro-N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-N%2CN-dialkyluronamides+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DSynthesis%2520of%25202-chloro-N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-N%252CN-dialkyluronamides%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DNucleic%2520Acids%2520Symp.%2520Ser.%26date%3D2008%26spage%3D645%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipnis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of truncated 4′-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists</span> <span class="citation_source-journal">Nucleic Acids Symp. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=641-642&author=X.+Houauthor=S.+Palauthor=W.+J.+Choiauthor=H.+O.+Kimauthor=A.+Tipnisauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Design+and+synthesis+of+truncated+4%E2%80%B2-thioadenosine+derivatives+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DTipnis%26aufirst%3DA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520truncated%25204%25E2%2580%25B2-thioadenosine%2520derivatives%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DNucleic%2520Acids%2520Symp.%2520Ser.%26date%3D2008%26spage%3D641%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of truncated <span class="smallcaps smallerCapital">d</span>- and l-4′-thioadenosine derivatives as species-independent A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6609</span><span class="NLM_x">–</span> <span class="NLM_lpage">6613</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6609-6613&author=L.+S.+Jeongauthor=S.+Palauthor=S.+A.+Choeauthor=W.+J.+Choiauthor=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=A.+M.+Klutzauthor=X.+Houauthor=H.+O.+Kimauthor=H.+W.+Leeauthor=S.+K.+Leeauthor=D.+K.+Toshauthor=H.+R.+Moon&title=Structure%E2%80%93activity+relationships+of+truncated+d-+and+l-4%E2%80%B2-thioadenosine+derivatives+as+species-independent+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm8008647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008647%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoe%26aufirst%3DS.%2BA.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520truncated%2520d-%2520and%2520l-4%25E2%2580%25B2-thioadenosine%2520derivatives%2520as%2520species-independent%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6609%26epage%3D6613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of truncated adenosine derivatives as highly potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3733</span><span class="NLM_x">–</span> <span class="NLM_lpage">3738</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3733-3738&author=S.+Palauthor=W.+J.+Choiauthor=S.+A.+Choeauthor=C.+L.+Hellerauthor=Z.+G.+Gaoauthor=M.+Chinnauthor=K.+A.+Jacobsonauthor=X.+Houauthor=S.+K.+Leeauthor=H.+O.+Kimauthor=L.+S.+Jeong&title=Structure%E2%80%93activity+relationships+of+truncated+adenosine+derivatives+as+highly+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DChoe%26aufirst%3DS.%2BA.%26aulast%3DHeller%26aufirst%3DC.%2BL.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520truncated%2520adenosine%2520derivatives%2520as%2520highly%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3733%26epage%3D3738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majik, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of truncated <i>C</i><sup>2</sup>- or <i>C</i><sup>8</sup>-substituted adenosine derivatives as dual acting A<sub>2A</sub> and A<sub>3</sub> adenosine receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201229j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=342-356&author=X.+Houauthor=M.+S.+Majikauthor=K.+Kimauthor=Y.+Pyeeauthor=Y.+Leeauthor=V.+Alexanderauthor=H.+Chungauthor=H.+W.+Leeauthor=G.+Chandraauthor=J.+H.+Leeauthor=S.+Parkauthor=W.+J.+Choiauthor=H.+O.+Kimauthor=K.+Phanauthor=Z.+Gaoauthor=K.+A.+Jacobsonauthor=S.+Choiauthor=S.+K.+Leeauthor=L.+S.+Jeong&title=Structure%E2%80%93activity+relationships+of+truncated+C2-+or+C8-substituted+adenosine+derivatives+as+dual+acting+A2A+and+A3+adenosine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fjm201229j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201229j%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMajik%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DPyee%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DAlexander%26aufirst%3DV.%26aulast%3DChung%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DChandra%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520truncated%2520C2-%2520or%2520C8-substituted%2520adenosine%2520derivatives%2520as%2520dual%2520acting%2520A2A%2520and%2520A3%2520adenosine%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D342%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Kiesewetter, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of [<sup>76</sup>Br]-labeled high-affinity A<sub>3</sub> adenosine receptor ligands for positron emission tomography</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.nucmedbio.2008.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19181263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=3-10&author=D.+O.+Kiesewetterauthor=L.+Langauthor=Y.+Maauthor=A.+K.+Bhattacharjeeauthor=Z.+G.+Gaoauthor=B.+V.+Joshiauthor=A.+Melmanauthor=S.+de+Castroauthor=K.+A.+Jacobson&title=Synthesis+and+characterization+of+%5B76Br%5D-labeled+high-affinity+A3+adenosine+receptor+ligands+for+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography</span></div><div class="casAuthors">Kiesewetter, Dale O.; Lang, Lixin; Ma, Ying; Bhattacharjee, Abesh Kumar; Gao, Zhan-Guo; Joshi, Bhalchandra V.; Melman, Artem; de Castro, Sonia; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Bromine-76-radiolabeled analogs of previously reported high-affinity A3 adenosine receptor (A3AR) nucleoside ligands have been prepd. as potential radiotracers for positron emission tomog.  Methods: The radiosyntheses were accomplished by oxidative radiobromination on the N 6-benzyl moiety of trimethyltin precursors.  Biodistribution studies of the kinetics of uptake were conducted in awake rats.  Results: We prepd. an agonist ligand {[76Br](1'S,2'R,3'S,4'R,5'S)-4'-{2-chloro-6-[(3-bromophenylmethyl)amino]purin-9-yl}-1'-(methylaminocarbonyl)bicyclo[3.1.0]hexane-2',3'-diol (MRS3581)} in 59% radiochem. yield with a specific activity of 19.5 GBq/μmol and an antagonist ligand {[76Br](1'R,2'R,3'S,4'R,5'S)-4'-(6-(3-bromobenzylamino)-2-chloro-9H-purin-9-yl)bicyclo[3.1.0]hexane-2',3'-diol (MRS5147)} in 65% radiochem. yield with a specific activity of 22 GBq/μmol.  The resultant products exhibited the expected high affinity (K i∼0.6 nM) and specific binding at the human A3AR in vitro.  Biodistribution studies in the rat showed uptake in the organs of excretion and metab.  The antagonist MRS5147 exhibited increasing uptake in testes, an organ that contains significant quantities of A3AR, over a 2-h time course, which suggests the presence of a specific A3AR retention mechanism.  Conclusion: We were able to compare uptake of the [76Br]-labeled antagonist MRS5147 to [76Br]agonist MRS3581.  The antagonist MRS5147 shows increasing uptake in the testes, an A3AR-rich tissue, suggesting that this ligand may have promise as a mol. imaging agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6t_hiYgrdbVg90H21EOLACvtfcHk0lis_HLvkO5BLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqt7w%253D&md5=46a59ff0fb2e096d3594e3c7c09e6929</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DKiesewetter%26aufirst%3DD.%2BO.%26aulast%3DLang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DBhattacharjee%26aufirst%3DA.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DMelman%26aufirst%3DA.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520%255B76Br%255D-labeled%2520high-affinity%2520A3%2520adenosine%2520receptor%2520ligands%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2009%26volume%3D36%26spage%3D3%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Selective A<sub>3</sub> adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8546</span><span class="NLM_x">–</span> <span class="NLM_lpage">8556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bmc.2008.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18752961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8546-8556&author=A.+Melmanauthor=B.+Wangauthor=B.+V.+Joshiauthor=Z.+G.+Gaoauthor=S.+Castroauthor=C.+L.+Hellerauthor=S.+K.+Kimauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Selective+A3+adenosine+receptor+antagonists+derived+from+nucleosides+containing+a+bicyclo%5B3.1.0%5Dhexane+ring+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Selective A3 adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span></div><div class="casAuthors">Melman, Artem; Wang, Ben; Joshi, Bhalchandra V.; Gao, Zhan-Guo; de Castro, Sonia; Heller, Cara L.; Kim, Soo-Kyung; Jeong, Lak Shin; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8546-8556</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have prepd. 5'-modified derivs. of adenosine and a corresponding (N)-methanocarba nucleoside series contg. a bicyclo[3.1.0]hexane ring system in place of the ribose moiety.  The compds. were examd. in binding assays at three subtypes of adenosine receptors (ARs) and in functional assays at the A3 AR.  The H-bonding ability of a group of 9-riboside derivs. contg. a 5'-uronamide moiety was reduced by modification of the NH; however these derivs. did not display the desired activity as selective A3 AR antagonists, as occurs with 5'-N,N-dimethyluronamides.  However, truncated (N)-methanocarba analogs lacking a 4'-hydroxymethyl group were highly potent and selective antagonists of the human A3 AR.  The compds. were synthesized from D-ribose using a reductive free radical decarboxylation of a 5'-carboxy intermediate.  A less efficient synthetic approach began with L-ribose, which was similar to the published synthesis of (N)-methanocarba A3AR agonists.  Compds. 33b-39b (N 6-3-halobenzyl and related arylalkyl derivs.) were potent A3AR antagonists with binding K i values of 0.7-1.4 nM.  In a functional assay of [35S]GTPγS binding, 33b (3-iodobenzyl) completely inhibited stimulation by NECA with a K B of 8.9 nM.  Thus, a highly potent and selective series of A3AR antagonists has been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCKshPwkRmvbVg90H21EOLACvtfcHk0lis_HLvkO5BLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K&md5=8f2e48da21c5e8a1f3f067d30b03fcae</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DCastro%26aufirst%3DS.%26aulast%3DHeller%26aufirst%3DC.%2BL.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSelective%2520A3%2520adenosine%2520receptor%2520antagonists%2520derived%2520from%2520nucleosides%2520containing%2520a%2520bicyclo%255B3.1.0%255Dhexane%2520ring%2520system%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8546%26epage%3D8556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of [<sup>125</sup>I]MRS5127, a high affinity, selective agonist radioligand for the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bcp.2009.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19917269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=967-973&author=J.+A.+Auchampachauthor=E.+T.+Gizewskiauthor=T.+C.+Wanauthor=S.+de+Castroauthor=G.+G.+Brownauthor=K.+A.+Jacobson&title=Synthesis+and+pharmacological+characterization+of+%5B125I%5DMRS5127%2C+a+high+affinity%2C+selective+agonist+radioligand+for+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor</span></div><div class="casAuthors">Auchampach, John A.; Gizewski, Elizabeth T.; Wan, Tina C.; de Castro, Sonia; Brown, Garth G.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">967-973</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A recently reported selective agonist of the human A3 adenosine receptor (hA3AR), MRS5127 (1'R,2'R,3'S,4'R,5'S)-4'-[2-chloro-6-(3-iodobenzylamino)-purine]-2',3'-O-dihydroxy-bicyclo-[3.1.0]hexane, was radioiodinated and characterized pharmacol.  It contains a rigid bicyclic ring system in place of a 5'-truncated ribose moiety, and was selected for radiolabeling due to its nanomolar binding affinity at both human and rat A3ARs.  The radioiodination of the N6-3-iodobenzyl substituent by iododestannylation of a 3-(trimethylstannyl)benzyl precursor was achieved in 73% yield, measured after purifn. by HPLC. [125I]MRS5127 bound to the human A3AR expressed in membranes of stably transfected HEK 293 cells.  Specific binding was saturable, competitive, and followed a one-site binding model, with a K d value of 5.74 ± 0.97 nM.  At a concn. equiv. to its Kd, non-specific binding comprised 27 ± 2% of total binding.  In kinetic studies, [125I]MRS5127 rapidly assocd. with the hA3AR (t 1/2 = 0.514 ± 0.014 min), and the affinity calcd. from assocn. and dissocn. rate consts. was 3.50 ± 1.46 nM.  The pharmacol. profile of ligands in competition expts. with [125I]MRS5127 was consistent with the known structure-activity-relationship profile of the hA3AR. [125I]MRS5127 bound with similar high affinity (K d, nM) to recombinant A3ARs from mouse (4.90 ± 0.77), rabbit (2.53 ± 0.11), and dog (3.35 ± 0.54).  For all of the species tested, MRS5127 exhibited A3AR agonist activity based on neg. coupling to cAMP prodn.  Thus, [125I]MRS5127 represents a new species-independent agonist radioligand for the A3AR.  The major advantage of [125I]MRS5127 compared with previously used A3AR radioligands is its high affinity, low degree of non-specific binding, and improved A3AR selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcLOUb60vR_bVg90H21EOLACvtfcHk0lis_HLvkO5BLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaisbo%253D&md5=d60f5c629a3955f18d8a912d5560445e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DGizewski%26aufirst%3DE.%2BT.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DG.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520%255B125I%255DMRS5127%252C%2520a%2520high%2520affinity%252C%2520selective%2520agonist%2520radioligand%2520for%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D967%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Choi, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Regio- and stereoselective synthesis of truncated 3′-aminocarbanucleosides and their binding affinity at the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">6955</span><span class="NLM_x">–</span> <span class="NLM_lpage">6962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=6955-6962&author=M.+J.+Choiauthor=G.+Chandraauthor=H.+W.+Leeauthor=X.+Houauthor=W.+J.+Choiauthor=K.+Phanauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Regio-+and+stereoselective+synthesis+of+truncated+3%E2%80%B2-aminocarbanucleosides+and+their+binding+affinity+at+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DM.%2BJ.%26aulast%3DChandra%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DRegio-%2520and%2520stereoselective%2520synthesis%2520of%2520truncated%25203%25E2%2580%25B2-aminocarbanucleosides%2520and%2520their%2520binding%2520affinity%2520at%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D6955%26epage%3D6962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span> </span><span class="NLM_article-title">Allosteric enhancers of A<sub>1</sub> adenosine receptors: state of the art and new horizons for drug development</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3488</span><span class="NLM_x">–</span> <span class="NLM_lpage">3502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F092986710792927831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20738250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3488-3502&author=R.+Romagnoliauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Boreaauthor=S.+Merighi&title=Allosteric+enhancers+of+A1+adenosine+receptors%3A+state+of+the+art+and+new+horizons+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development</span></div><div class="casAuthors">Romagnoli, R.; Baraldi, P. G.; Tabrizi, M. A.; Gessi, S.; Borea, P. A.; Merighi, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3488-3502</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine is an important autocoid, exerting its physiol. effects on the human body by activation of four different G-protein-coupled-receptors (GPCRs) classified as A1, A2A, A2B, and A3.  These receptors are coupled to secondary messenger systems including adenylate cyclase, inositol phosphate metab., and K+, KATP and Ca2+ channels.  Pharmacol. agents that increase the activation of A1 adenosine receptors in response to adenosine would be useful for treatment of cardiovascular, central nervous system, and inflammatory pathologies.  Compds. that are able to enhance the activity of the A1-adenosine receptors by the endogenous ligand within specific tissues may have potential therapeutic advantages over non-endogenous agonists.  Such an opportunity for intervention is provided by the concept of allosteric modulation of GPCRs.  Therefore the use of allosteric enhancers to increase the responsiveness of the A1 receptors to endogenous adenosine at sites of its prodn. is an appealing alternative to activation by exogenous agonists.  This approach minimizes side effects because allosteric enhancers amplify the action of the agonist by stabilizing the agonist-A1-receptor-G protein ternary complex.  The allosteric enhancement of the GABAA receptor by benzodiazepines is the most famous and successful example of this strategy.  The aim of this article is to give an overview of the results obtained in this field and discuss the opportunities and challenges that this class of ligands might offer for medicinal chem. and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokaKpRdjIL-bVg90H21EOLACvtfcHk0liBobuocBXKMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fE&md5=e4410b60b16f09593fd31fd6d3cec237</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.2174%2F092986710792927831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792927831%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26atitle%3DAllosteric%2520enhancers%2520of%2520A1%2520adenosine%2520receptors%253A%2520state%2520of%2520the%2520art%2520and%2520new%2520horizons%2520for%2520drug%2520development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3488%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Kiesman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span> </span><span class="NLM_article-title">A<sub>1</sub> adenosine receptor antagonists, agonists, and allosteric enhancers</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-3-540-89615-9_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19639278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2009&pages=25-58&author=W.+F.+Kiesmanauthor=E.+Elzeinauthor=J.+Zablocki&title=A1+adenosine+receptor+antagonists%2C+agonists%2C+and+allosteric+enhancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A1 adenosine receptor antagonists, agonists, and allosteric enhancers</span></div><div class="casAuthors">Kiesman, William F.; Elzein, Elfatih; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">25-58</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Intense efforts of many pharmaceutical companies and academicians in the A1 adenosine receptor (AR) field have led to the discovery of clin. candidates that are antagonists, agonists, and allosteric enhancers.  The A1AR antagonists currently in clin. development are KW3902, BG9928, and SLV320.  All three have high affinity for the human (h) A1AR subtype (hA1 Ki < 10 nM), > 200-fold selectivity over the hA2A subtype, and demonstrate renal protective effects in multiple animal models of disease and pharmacol. effects in human subjects.  In the A1AR agonist area, clin. candidates have been discovered for the following conditions: atrial arrhythmias (tecadenoson, selodenoson and PJ-875); Type II diabetes and insulin sensitizing agents (GR79236, ARA, RPR-749, and CVT-3619); and angina (BAY 68-4986).  The challenges assocd. with the development of any A1AR agonist are to obtain tissue-specific effects but avoid off-target tissue side effects and A1AR desensitization leading to tachyphylaxis.  For the IV antiarrhythmic agents that act as ventricular rate control agents, a selective response can be accomplished by careful IV dosing paradigms.  The treatment of type II diabetes using A1AR agonists in the clinic has met with limited success due to cardiovascular side effects and a well-defined desensitization of full agonists in human trials (GR79236, ARA, and RPR 749).  However, new partial A1AR agonists are in development, including CVT-3619 (hA1 AR Ki = 55 nM, hA2A:hA2B:hA3 > 200:1,000:20, CV Therapeutics), which have the potential to provide enhanced insulin sensitivity without cardiovascular side effects and tachyphylaxis.  The nonnucleosidic A1AR agonist BAY 68-4986 (capadenoson) represents a novel approach to angina wherein both animal studies and early human studies are promising.  T-62 is an A1AR allosteric enhancer that is currently being evaluated in clin. trials as a potential treatment for neuropathic pain.  The challenges assocd. with developing A1AR antagonists, agonists, or allosteric enhancers for therapeutic intervention are now well defined in humans.  Significant progress has been made in identifying A1AR antagonists for the treatment of edema assocd. with congestive heart failure (CHF), A1AR agonists for the treatment of atrial arrhythmias, type II diabetes and angina, and A1AR allosteric enhancers for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofCM7ufsD78rVg90H21EOLACvtfcHk0liBobuocBXKMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7K&md5=8aebbe66c1095ea8cbc94c58ce3849fd</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_2%26sid%3Dliteratum%253Aachs%26aulast%3DKiesman%26aufirst%3DW.%2BF.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DA1%2520adenosine%2520receptor%2520antagonists%252C%2520agonists%252C%2520and%2520allosteric%2520enhancers%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26volume%3D193%26spage%3D25%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Muijlwijk-Koezen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of A<sub>3</sub> adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1057-1063&author=Z.+G.+Gaoauthor=J.+E.+Van+Muijlwijk-Koezenauthor=A.+Chenauthor=C.+E.+M%C3%BCllerauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Allosteric+modulation+of+A3+adenosine+receptors+by+a+series+of+3-%282-pyridinyl%29isoquinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DVan%2BMuijlwijk-Koezen%26aufirst%3DJ.%2BE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAllosteric%2520modulation%2520of%2520A3%2520adenosine%2520receptors%2520by%2520a%2520series%2520of%25203-%25282-pyridinyl%2529isoquinoline%2520derivatives%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1057%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltysiak, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Selective allosteric enhancement of agonist binding and function at human A<sub>3</sub> adenosine receptors by a series of imidazoquinoline derivatives</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=81-89&author=Z.+G.+Gaoauthor=S.+G.+Kimauthor=K.+A.+Soltysiakauthor=N.+Melmanauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Selective+allosteric+enhancement+of+agonist+binding+and+function+at+human+A3+adenosine+receptors+by+a+series+of+imidazoquinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DSoltysiak%26aufirst%3DK.%2BA.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSelective%2520allosteric%2520enhancement%2520of%2520agonist%2520binding%2520and%2520function%2520at%2520human%2520A3%2520adenosine%2520receptors%2520by%2520a%2520series%2520of%2520imidazoquinoline%2520derivatives%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connestari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of new 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amine derivatives as allosteric enhancers of the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3354</span><span class="NLM_x">–</span> <span class="NLM_lpage">3361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060086s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3354-3361&author=A.+Goblyosauthor=Z.+G.+Gaoauthor=J.+Brusseeauthor=R.+Connestariauthor=S.+N.+Santiagoauthor=K.+Yeauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Structure%E2%80%93activity+relationships+of+new+1H-imidazo%5B4%2C5-c%5Dquinolin-4-amine+derivatives+as+allosteric+enhancers+of+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm060086s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060086s%26sid%3Dliteratum%253Aachs%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DConnestari%26aufirst%3DR.%26aulast%3DSantiago%26aufirst%3DS.%2BN.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520new%25201H-imidazo%255B4%252C5-c%255Dquinolin-4-amine%2520derivatives%2520as%2520allosteric%2520enhancers%2520of%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3354%26epage%3D3361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Flexible modulation of agonist efficacy at the human A<sub>3</sub> adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000</span> <span class="citation_source-journal">BMC Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1186%2F1471-2210-8-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19077268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FntFWhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=20&author=Z.+G.+Gaoauthor=K.+Yeauthor=A.+Goblyosauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Flexible+modulation+of+agonist+efficacy+at+the+human+A3+adenosine+receptor+by+the+imidazoquinoline+allosteric+enhancer+LUF6000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000</span></div><div class="casAuthors">Gao Zhan-Guo; Ye Kai; Goblyos Aniko; Ijzerman Adriaan P; Jacobson Kenneth A</div><div class="citationInfo"><span class="NLM_cas:title">BMC pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  A series of 1H-imidazo- [4,5-c]quinolin-4-amine derivatives, represented by LUF6000 (N-(3,4-dichloro-phenyl)-2-cyclohexyl-1H-imidazo [4,5-c]quinolin-4-amine), are allosteric modulators of the human A3 adenosine receptor (AR).  Here we studied the modulation by LUF6000 of the maximum effect (Emax) of structurally diverse agonists at the A3 AR stably expressed in CHO cells.  RESULTS:  In an assay of [35S]GTPgammaS binding, the Emax of the A3 AR agonist Cl-IB-MECA at the A3 AR was lower than that of the non-selective AR agonist NECA.  LUF6000 exerted an Emax-enhancing effect at a concentration of 0.1 microM or higher, and was shown to increase the Emax of Cl-IB-MECA and other low-efficacy agonists to a larger extent than that of the high-efficacy agonist NECA.  Interestingly, LUF6000 converted a nucleoside A3 AR antagonist MRS542, but not a non-nucleoside antagonist MRS1220, into an agonist.  LUF6000 alone did not show any effect.  Mathematical modeling was performed to explain the differential effects of LUF6000 on agonists with various Emax.  A simple explanation for the observation that LUF6000 has a much stronger effect on Cl-IB-MECA than on NECA derived from the mathematical modeling is that NECA has relatively strong intrinsic efficacy, such that the response is already close to the maximum response.  Therefore, LUF6000 cannot enhance Emax much further.  CONCLUSION:  LUF6000 was found to be an allosteric enhancer of Emax of structurally diverse agonists at the A3 AR, being more effective for low-Emax agonists than for high-Emax agonists.  LUF6000 was demonstrated to convert an antagonist into an agonist, which represents the first example in G protein-coupled receptors.  The observations from the present study are consistent with that predicted by mathematical modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3KsAoNyN66Z6KlWarZTAzfW6udTcc2eYWu4CJciI0-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FntFWhsw%253D%253D&md5=8e95b0d9112cb0979656c5808bac3aeb</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1186%2F1471-2210-8-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2210-8-20%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFlexible%2520modulation%2520of%2520agonist%2520efficacy%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%2520by%2520the%2520imidazoquinoline%2520allosteric%2520enhancer%2520LUF6000%26jtitle%3DBMC%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verzijl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Functionally biased modulation of A<sub>3</sub> adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=658-668&author=Z.+G.+Gaoauthor=D.+Verzijlauthor=A.+Zweemerauthor=K.+Yeauthor=A.+Goblyosauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Functionally+biased+modulation+of+A3+adenosine+receptor+agonist+efficacy+and+potency+by+imidazoquinolinamine+allosteric+enhancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DVerzijl%26aufirst%3DD.%26aulast%3DZweemer%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionally%2520biased%2520modulation%2520of%2520A3%2520adenosine%2520receptor%2520agonist%2520efficacy%2520and%2520potency%2520by%2520imidazoquinolinamine%2520allosteric%2520enhancers%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D658%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Novel 2- and 4-substituted 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amine derivatives as allosteric modulators of the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2098</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801659w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2098-2108&author=Y.+Kimauthor=S.+de+Castroauthor=Z.+G.+Gaoauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Novel+2-+and+4-substituted+1H-imidazo%5B4%2C5-c%5Dquinolin-4-amine+derivatives+as+allosteric+modulators+of+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm801659w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801659w%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DNovel%25202-%2520and%25204-substituted%25201H-imidazo%255B4%252C5-c%255Dquinolin-4-amine%2520derivatives%2520as%2520allosteric%2520modulators%2520of%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2098%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Veldhoven, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=926-931&author=L.+H.+Heitmanauthor=A.+Goblyosauthor=A.+M.+Zweemerauthor=R.+Bakkerauthor=T.+Mulder-Kriegerauthor=J.+P.+van+Veldhovenauthor=H.+de+Vriesauthor=J.+Brusseeauthor=A.+P.+Ijzerman&title=A+series+of+2%2C4-disubstituted+quinolines+as+a+new+class+of+allosteric+enhancers+of+the+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm8014052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014052%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DZweemer%26aufirst%3DA.%2BM.%26aulast%3DBakker%26aufirst%3DR.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3Dvan%2BVeldhoven%26aufirst%3DJ.%2BP.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DA%2520series%2520of%25202%252C4-disubstituted%2520quinolines%2520as%2520a%2520new%2520class%2520of%2520allosteric%2520enhancers%2520of%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D926%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beukers, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=48-56&author=J.+R.+Laneauthor=M.+W.+Beukersauthor=T.+Mulder-Kriegerauthor=A.+P.+Ijzerman&title=The+endocannabinoid+2-arachidonylglycerol+is+a+negative+allosteric+modulator+of+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DThe%2520endocannabinoid%25202-arachidonylglycerol%2520is%2520a%2520negative%2520allosteric%2520modulator%2520of%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D48%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span> </span><span class="NLM_article-title"><sup>125</sup>I-4-aminobenzyl-5′-<i>N</i>-methylcarboxamidoadenosine, a high affinity radioligand for the rat A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=978-982&author=M.+E.+Olahauthor=C.+Gallo-Rodriguezauthor=K.+A.+Jacobsonauthor=G.+L.+Stiles&title=125I-4-aminobenzyl-5%E2%80%B2-N-methylcarboxamidoadenosine%2C+a+high+affinity+radioligand+for+the+rat+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26atitle%3D125I-4-aminobenzyl-5%25E2%2580%25B2-N-methylcarboxamidoadenosine%252C%2520a%2520high%2520affinity%2520radioligand%2520for%2520the%2520rat%2520A3%2520adenosine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D978%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]HEMADO—a novel tritiated agonist selective for the human adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">556</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.ejphar.2006.10.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17126322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2007&pages=14-18&author=K.+N.+Klotzauthor=N.+Falgnerauthor=S.+Kachlerauthor=C.+Lambertucciauthor=S.+Vittoriauthor=R.+Volpiniauthor=G.+Cristalli&title=%5B3H%5DHEMADO%E2%80%94a+novel+tritiated+agonist+selective+for+the+human+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]HEMADO- a novel tritiated agonist selective for the human adenosine A3 receptor</span></div><div class="casAuthors">Klotz, Karl-Norbert; Falgner, Nico; Kachler, Sonja; Lambertucci, Catia; Vittori, Sauro; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">14-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A3 receptors are promising drug targets for a no. of conditions like inflammatory diseases including asthma, ischemic injury or certain types of cancer.  Consequently, intense efforts are dedicated to the development of selective A3 agonists and antagonists.  The only tritiated agonist that is available for radioligand binding is the nonselective [3H]5'-N-ethylcarboxamidoadenosine ([3H]NECA).  Based on a recently characterized series of 2-substituted adenosine receptor agonists we developed a tritiated selective A3 radioligand with high affinity.  From this series 2-hexyn-1-yl-N6-methyladenosine (HEMADO) with a Ki-value of 1.1 nM at the human A3 subtype was chosen.  HEMADO is 300-fold selective vs. the A1 subtype, and 1100-fold and more than 25,000-fold selective compared to the adenosine A2A and A2B receptors, resp.  The tritiated deriv. [3H]HEMADO exhibited the same affinity as the unlabeled precursor.  In concns. up to 10 nM no specific binding to adenosine A1, A2A or A2B receptors was obsd. confirming the high selectivity for adenosine A3 receptors.  Characterization of [3H]HEMADO in radioligand binding studies revealed reversible binding to the human adenosine A3 subtype.  In satn. binding studies for the A3 subtype a KD-value of 1.1 nM was detd.  Nonspecific binding at a radioligand concn. of 1 nM amounted to 1-2% of total binding.  Competition binding with a panel of adenosine receptor ligands clearly confirmed the correct A3 pharmacol. of the binding site labeled by [3H]HEMADO.  With [3H]HEMADO we present a tritiated agonist with high affinity and A3-selectivity and very low nonspecific binding.  [3H]HEMADO is a useful tool for specific screening for A3 receptor agonists and antagonists in improved radioligand binding assays with the human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWoJyAB1P49LVg90H21EOLACvtfcHk0lilcPQ05ZRH6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D&md5=91eb5e9810e75d1ca825a804c767929c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.10.048%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DFalgner%26aufirst%3DN.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D%255B3H%255DHEMADO%25E2%2580%2594a%2520novel%2520tritiated%2520agonist%2520selective%2520for%2520the%2520human%2520adenosine%2520A3%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D556%26spage%3D14%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Pharmacological and biochemical characterization of A<sub>3</sub> adenosine receptors in Jurkat T cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0704254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11522603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVyru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=116-126&author=S.+Gessiauthor=K.+Varaniauthor=S.+Merighiauthor=A.+Morelliauthor=D.+Ferrariauthor=E.+Leungauthor=P.+G.+Baraldiauthor=G.+Spallutoauthor=P.+A.+Borea&title=Pharmacological+and+biochemical+characterization+of+A3+adenosine+receptors+in+Jurkat+T+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells</span></div><div class="casAuthors">Gessi, Stefania; Varani, Katia; Merighi, Stefania; Morelli, Anna; Ferrari, Davide; Leung, Edward; Baraldi, Pier Giovanni; Spalluto, Giampiero; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The present work was devoted to the study of A3 adenosine receptors in Jurkat cells, a human leukemia line.  The A3 subtype was found by RT-PCR expts. and characterized by using the new A3 adenosine receptor antagonist [3H]-MRE 3008F20, the only A3 selective radioligand currently available.  Satn. expts. revealed a single high affinity binding site with KD of 1.9 nM and Bmax of 1.3 pmol mg-1 of protein.  The pharmacol. profile of [3H]-MRE 3008F20 binding on Jurkat cells was established using typical adenosine ligands which displayed a rank order of potency typical of the A3 subtype.  Thermodn. data indicated that [3H]-MRE 3008F20 binding to A3 subtype in Jurkat cells was entropy- and enthalpy-driven, according with that found in cells expressing the recombinant human A3 subtype.  In functional assays the high affinity A3 agonists Cl-IB-MECA and IB-MECA were able to inhibit cAMP accumulation and stimulate Ca2+ release from intracellular Ca2+ pools followed by Ca2+ influx.  The presence of the other adenosine subtypes was investigated in Jurkat cells.  A1 receptors were characterized using [3H]-DPCPX binding with a KD of 0.9 nM and Bmax of 42 fmol mg-1 of protein.  A2A receptors were studied with [3H]-SCH 58261 binding and revealed a KD of 2.5 nM and a Bmax of 1.4 pmol mg-1 of protein.  In conclusion, by the first antagonist radioligand [3H]-MRE 3008F20 the authors could demonstrate the existence of functional A3 receptors on Jurkat cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre39I_yLblZbVg90H21EOLACvtfcHk0ljUM-5wzK4iWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVyru7c%253D&md5=d06df41cebd7b0c84c51ada501b34c10</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704254%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DMorelli%26aufirst%3DA.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DPharmacological%2520and%2520biochemical%2520characterization%2520of%2520A3%2520adenosine%2520receptors%2520in%2520Jurkat%2520T%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D116%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulouglu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0704352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11704641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosl2qs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=1215-1226&author=S.+Merighiauthor=K.+Varaniauthor=S.+Gessiauthor=E.+Cattabrigaauthor=V.+Iannottaauthor=C.+Ulougluauthor=E.+Leungauthor=P.+A.+Borea&title=Pharmacological+and+biochemical+characterization+of+adenosine+receptors+in+the+human+malignant+melanoma+A375+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line</span></div><div class="casAuthors">Merighi, Stefania; Varani, Katia; Gessi, Stefania; Cattabriga, Elena; Iannotta, Valeria; Ulouglu, Canan; Leung, Edward; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1215-1226</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The present work characterizes, from a pharmacol. and biochem. point of view, adenosine receptors in the human malignant melanoma A375 cell line.  2 Adenosine receptors were detected by RT-PCR expts.  A1 receptors were characterized using [3H]-DPCPX binding with a KD of 1.9±0.2 nM and Bmax of 23±7 fmol mg-1 of protein.  A2A receptors were studied with [3H]-SCH 58261 binding and revealed a KD of 5.1±0.2 nM and a Bmax of 220±7 fmol mg-1 of protein.  A3 receptors were studied with the new A3 adenosine receptor antagonist [3H]-MRE 3008F20, the only A3 selective radioligand currently available.  Satn. expts. revealed a single high affinity binding site with KD of 3.3±0.7 nM and Bmax of 291±50 fmol mg-1 of protein.  3 The pharmacol. profile of radioligand binding on A375 cells was established using typical adenosine ligands which displayed a rank order of potency typical of the different adenosine receptor subtype.  4 Thermodn. data indicated that radioligand binding to adenosine receptor subtypes in A375 cells was entropy- and enthalpy-driven.  5 In functional assays the high affinity A2A agonists HE-NECA, CGS 21680 and A2A-A2B agonist NECA were able to increase cAMP accumulation in A375 cells whereas A3 agonists Cl-IB-MECA, IB-MECA and NECA were able to stimulate Ca2+ mobilization.  6 In conclusion, all these data indicate, for the first time, that adenosine receptors with a pharmacol. and biochem. profile typical of the A1, A2A, A2B and A3 receptor subtype are present on A375 melanoma cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiYQ1-tSi09LVg90H21EOLACvtfcHk0ljUM-5wzK4iWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosl2qs7Y%253D&md5=0f117370c5a46559fe00582fe657878d</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704352%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DIannotta%26aufirst%3DV.%26aulast%3DUlouglu%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DPharmacological%2520and%2520biochemical%2520characterization%2520of%2520adenosine%2520receptors%2520in%2520the%2520human%2520malignant%2520melanoma%2520A375%2520cell%2520line%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D1215%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=415-424&author=S.+Gessiauthor=K.+Varaniauthor=S.+Merighiauthor=E.+Cattabrigaauthor=V.+Iannottaauthor=E.+Leungauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=A3+adenosine+receptors+in+human+neutrophils+and+promyelocytic+HL60+cells%3A+a+pharmacological+and+biochemical+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DIannotta%26aufirst%3DV.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520adenosine%2520receptors%2520in%2520human%2520neutrophils%2520and%2520promyelocytic%2520HL60%2520cells%253A%2520a%2520pharmacological%2520and%2520biochemical%2520study%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D415%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2002&pages=923-933&author=S.+Merighiauthor=P.+Mirandolaauthor=D.+Milaniauthor=K.+Varaniauthor=S.+Gessiauthor=K.+N.+Klotzauthor=E.+Leungauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Adenosine+receptors+as+mediators+of+both+cell+proliferation+and+cell+death+of+cultured+human+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DMilani%26aufirst%3DD.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptors%2520as%2520mediators%2520of%2520both%2520cell%2520proliferation%2520and%2520cell%2520death%2520of%2520cultured%2520human%2520melanoma%2520cells%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2002%26volume%3D119%26spage%3D923%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980550w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=706-721&author=A.+H.+Liauthor=S.+Moroauthor=N.+Forsythauthor=N.+Melmanauthor=X.+D.+Jiauthor=K.+A.+Jacobson&title=Synthesis%2C+CoMFA+analysis%2C+and+receptor+docking+of+3%2C5-diacyl-2%2C4-dialkylpyridine+derivatives+as+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm980550w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980550w%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DForsyth%26aufirst%3DN.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%252C%2520CoMFA%2520analysis%252C%2520and%2520receptor%2520docking%2520of%25203%252C5-diacyl-2%252C4-dialkylpyridine%2520derivatives%2520as%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D706%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Wadsak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mien, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanab, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettlinger, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeusler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindelar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzenberger, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreitzer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viernstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudczak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kletter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitterhauser, M.</span><span> </span><span class="NLM_article-title">Preparation and first evaluation of [<sup>18</sup>F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="ffb9babfacaaafafa6">[email protected]</a>: a new PET tracer for the adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.nucmedbio.2007.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18158944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOlt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=61-66&author=W.+Wadsakauthor=L.+K.+Mienauthor=K.+Shanabauthor=D.+E.+Ettlingerauthor=D.+Haeuslerauthor=K.+Sindelarauthor=R.+R.+Lanzenbergerauthor=H.+Spreitzerauthor=H.+Viernsteinauthor=B.+K.+Kepplerauthor=R.+Dudczakauthor=K.+Kletterauthor=M.+Mitterhauser&title=Preparation+and+first+evaluation+of+%5B18F%5DFE%40SUPPY%3A+a+new+PET+tracer+for+the+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and first evaluation of [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="98deddd8cbcdc8c8c1">[email protected]</a>: a new PET tracer for the adenosine A3 receptor</span></div><div class="casAuthors">Wadsak, Wolfgang; Mien, Leonhard-Key; Shanab, Karem; Ettlinger, Dagmar E.; Haeusler, Daniela; Sindelar, Karoline; Lanzenberger, Rupert R.; Spreitzer, Helmut; Viernstein, Helmut; Keppler, Bernhard K.; Dudczak, Robert; Kletter, Kurt; Mitterhauser, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-66</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Changes of the adenosine A3 receptor subtype (A3AR) expression have been shown in a variety of pathologies, esp. neurol. and affective disorders, cardiac diseases and oncol. and inflammation processes.  Recently, 5-(2-fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="97d1d2d7c4c2c7c7ce">[email protected]</a>) was presented as a high-affinity ligand for the A3AR with good selectivity.  Our aims were the development of a suitable labeling precursor, the establishment of a reliable radiosynthesis for the fluorine-18-labeled analog [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bafcfffae9efeaeae3">[email protected]</a> and a first evaluation of [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b2f4f7f2e1e7e2e2eb">[email protected]</a> in rats.  Methods: [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="317774716264616168">[email protected]</a> was prepd. in a feasible and reliable manner by radiofluorination of the corresponding tosylated precursor.  Biodistribution was carried out in rats, and organs were removed and counted.  Autoradiog. was performed on rat brain slices in the presence or absence of 2-Cl-IB-MECA.  Results: Overall yields and radiochem. purity were sufficient for further preclin. and clin. applications.  The uptake pattern of [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7c3a393c2f292c2c25">[email protected]</a> found in rats mainly followed the described mRNA distribution pattern of the A3AR.  Specific uptake in brain was demonstrated by blocking with a selective A3AR agonist.  Conclusion: We conclude that [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="22646762717772727b">[email protected]</a> has the potential to serve as the first positron emission tomog. tracer for the A3AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaoNEK-xtqNLVg90H21EOLACvtfcHk0lh702MioJm6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOlt73M&md5=9b8b677896a8eb936de77ce643d27991</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DWadsak%26aufirst%3DW.%26aulast%3DMien%26aufirst%3DL.%2BK.%26aulast%3DShanab%26aufirst%3DK.%26aulast%3DEttlinger%26aufirst%3DD.%2BE.%26aulast%3DHaeusler%26aufirst%3DD.%26aulast%3DSindelar%26aufirst%3DK.%26aulast%3DLanzenberger%26aufirst%3DR.%2BR.%26aulast%3DSpreitzer%26aufirst%3DH.%26aulast%3DViernstein%26aufirst%3DH.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DDudczak%26aufirst%3DR.%26aulast%3DKletter%26aufirst%3DK.%26aulast%3DMitterhauser%26aufirst%3DM.%26atitle%3DPreparation%2520and%2520first%2520evaluation%2520of%2520%255B18F%255DFE%2540SUPPY%253A%2520a%2520new%2520PET%2520tracer%2520for%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D61%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Boison, D.</span><span> </span><span class="NLM_article-title">Adenosine as a modulator of brain activity</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1358%2Fdnp.2007.20.10.1181353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18301794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=607-611&author=D.+Boison&title=Adenosine+as+a+modulator+of+brain+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine as a modular of brain activity</span></div><div class="casAuthors">Boison, Detlev</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">607-611</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The endogenous neuromodulator adenosine controls and integrates a wide range of brain functions.  Consequently, dysfunction of the adenosine system is involved in pathologies ranging from epilepsy to neurodegenerative disorders and psychiatric conditions.  The adenosine system has therefore been recognized as a prime target for the development of new therapeutics for neurol. diseases.  This review covers the upstream and downstream targets of adenosinergic neurotransmission and provides the neurochem. rationale for the development of adenosine receptor modulating drugs (downstream) and inhibitors of adenosine kinase, the key upstream regulator of ambient levels of adenosine.  Due to the unique role of adenosine to integrate and fine-tune glutamatergic and dopaminergic neurotransmission, adenosine-regulating agents have the potential to modify a wide range of downstream effects.  Thus, adenosine-based therapies are rapidly evolving in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZopfDMF4u7Vg90H21EOLACvtfcHk0lh702MioJm6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVKntLg%253D&md5=204e175cb640e7bf9a229629722ceb56</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2007.20.10.1181353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2007.20.10.1181353%26sid%3Dliteratum%253Aachs%26aulast%3DBoison%26aufirst%3DD.%26atitle%3DAdenosine%2520as%2520a%2520modulator%2520of%2520brain%2520activity%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2007%26volume%3D20%26spage%3D607%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Boison, D.</span><span> </span><span class="NLM_article-title">The adenosine kinase hypothesis of epileptogenesis</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.pneurobio.2007.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18249058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlektbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=249-262&author=D.+Boison&title=The+adenosine+kinase+hypothesis+of+epileptogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The adenosine kinase hypothesis of epileptogenesis</span></div><div class="casAuthors">Boison, Detlev</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-262</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Current therapies for epilepsy are largely symptomatic and do not affect the underlying mechanisms of disease progression, i.e. epileptogenesis.  Given the large percentage of pharmacoresistant chronic epilepsies, novel approaches are needed to understand and modify the underlying pathogenetic mechanisms.  Although different types of brain injury (e.g. status epilepticus, traumatic brain injury, stroke) can trigger epileptogenesis, astrogliosis appears to be a homotypic response and hallmark of epilepsy.  Indeed, recent findings indicate that epilepsy might be a disease of astrocyte dysfunction.  This review focuses on the inhibitory neuromodulator and endogenous anticonvulsant adenosine, which is largely regulated by astrocytes and its key metabolic enzyme adenosine kinase (ADK).  Recent findings support the "ADK hypothesis of epileptogenesis": (i) Mouse models of epileptogenesis suggest a sequence of events leading from initial downregulation of ADK and elevation of ambient adenosine as an acute protective response, to changes in astrocytic adenosine receptor expression, to astrocyte proliferation and hypertrophy (i.e. astrogliosis), to consequential overexpression of ADK, reduced adenosine and - finally - to spontaneous focal seizure activity restricted to regions of astrogliotic overexpression of ADK.  (ii) Transgenic mice overexpressing ADK display increased sensitivity to brain injury and seizures.  (iii) Inhibition of ADK prevents seizures in a mouse model of pharmacoresistant epilepsy.  (iv) Intrahippocampal implants of stem cells engineered to lack ADK prevent epileptogenesis.  Thus, ADK emerges both as a diagnostic marker to predict, as well as a prime therapeutic target to prevent, epileptogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7IZTnq8B2ybVg90H21EOLACvtfcHk0lh702MioJm6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlektbc%253D&md5=e2d81d16911620ec424f38611dd211c7</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBoison%26aufirst%3DD.%26atitle%3DThe%2520adenosine%2520kinase%2520hypothesis%2520of%2520epileptogenesis%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D249%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Yoon, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. M.</span><span> </span><span class="NLM_article-title">Roles of adenosine receptor subtypes in the antinociceptive effect of intrathecal adenosine in a rat formalin test</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=21-26&author=M.+H.+Yoonauthor=H.+B.+Baeauthor=J.+I.+Choiauthor=S.+J.+Kimauthor=S.+T.+Chungauthor=C.+M.+Kim&title=Roles+of+adenosine+receptor+subtypes+in+the+antinociceptive+effect+of+intrathecal+adenosine+in+a+rat+formalin+test"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DM.%2BH.%26aulast%3DBae%26aufirst%3DH.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DChung%26aufirst%3DS.%2BT.%26aulast%3DKim%26aufirst%3DC.%2BM.%26atitle%3DRoles%2520of%2520adenosine%2520receptor%2520subtypes%2520in%2520the%2520antinociceptive%2520effect%2520of%2520intrathecal%2520adenosine%2520in%2520a%2520rat%2520formalin%2520test%26jtitle%3DPharmacology%26date%3D2006%26volume%3D78%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Brief, repeated, oxygen–glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0705442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12970092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2003&pages=305-314&author=A.+M.+Puglieseauthor=S.+Latiniauthor=R.+Corradettiauthor=F.+Pedata&title=Brief%2C+repeated%2C+oxygen%E2%80%93glucose+deprivation+episodes+protect+neurotransmission+from+a+longer+ischemic+episode+in+the+in+vitro+hippocampus%3A+role+of+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: Role of adenosine receptors</span></div><div class="casAuthors">Pugliese, Anna Maria; Latini, Serena; Corradetti, Renato; Pedata, Felicita</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-314</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ischemic preconditioning in the brain consists of reducing the sensitivity of neuronal tissue to further, more severe, ischemic insults.  We recorded field epsps (fepsps) extracellularly from hippocampal slices to develop a model of in vitro ischemic preconditioning and to evaluate the role of A1, A2A and A3 adenosine receptors in this phenomenon.  The application of an ischemic insult, obtained by glucose and oxygen deprivation for 7 min, produced an irreversible depression of synaptic transmission.  Ischemic preconditioning was induced by four ischemic insults (2 min each) sepd. by 13 min of normoxic conditions.  After 30 min, an ischemic insult of 7 min was applied.  This protocol substantially protected the tissue from the irreversible depression of synaptic activity.  The selective adenosine A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 100 nM), completely prevented the protective effect of preconditioning.  The selective adenosine A2A receptor antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5- ylamino]ethyl)phenol (ZM 241385, 100 nM) did not modify the magnitude of fepsp recovery compared to control slices.  The selective A3 adenosine receptor antagonists, 3-propyl-6-ethyl-5[ethyl(thio)carbonyl]-2-phenyl-4-propyl-3-pyridinecarboxylate (MRS 1523, 100 nM) significantly improved the recovery of fepsps after 7 min of ischemia.  Our results show that in vitro ischemic preconditioning allows CA1 hippocampal neurons to become resistant to prolonged exposure to ischemia.  Adenosine, by stimulating A1 receptors, plays a crucial role in eliciting the cell mechanisms underlying preconditioning; A2A receptors are not involved in this phenomenon, whereas A3 receptor activation is harmful to ischemic preconditioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC-wJjwyoc3bVg90H21EOLACvtfcHk0ljybOncqMpo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOmtr4%253D&md5=a552bfae90a6e88adf3e828f3f763934</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705442%26sid%3Dliteratum%253Aachs%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DCorradetti%26aufirst%3DR.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DBrief%252C%2520repeated%252C%2520oxygen%25E2%2580%2593glucose%2520deprivation%2520episodes%2520protect%2520neurotransmission%2520from%2520a%2520longer%2520ischemic%2520episode%2520in%2520the%2520in%2520vitro%2520hippocampus%253A%2520role%2520of%2520adenosine%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D140%26spage%3D305%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Role of adenosine A<sub>3</sub> receptors on CA1 hippocampal neurotransmission during oxygen–glucose deprivation episodes of different duration</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=768-779&author=A.+M.+Puglieseauthor=E.+Coppiauthor=R.+Volpiniauthor=G.+Cristalliauthor=R.+Corradettiauthor=L.+S.+Jeongauthor=K.+A.+Jacobsonauthor=F.+Pedata&title=Role+of+adenosine+A3+receptors+on+CA1+hippocampal+neurotransmission+during+oxygen%E2%80%93glucose+deprivation+episodes+of+different+duration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DCoppi%26aufirst%3DE.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DCorradetti%26aufirst%3DR.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DRole%2520of%2520adenosine%2520A3%2520receptors%2520on%2520CA1%2520hippocampal%2520neurotransmission%2520during%2520oxygen%25E2%2580%2593glucose%2520deprivation%2520episodes%2520of%2520different%2520duration%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D768%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Hammarberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3′-kinase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=129-134&author=C.+Hammarbergauthor=B.+B.+Fredholmauthor=G.+Schulte&title=Adenosine+A3+receptor-mediated+regulation+of+p38+and+extracellular-regulated+kinase+ERK1%2F2+via+phosphatidylinositol-3%E2%80%B2-kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHammarberg%26aufirst%3DC.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DSchulte%26aufirst%3DG.%26atitle%3DAdenosine%2520A3%2520receptor-mediated%2520regulation%2520of%2520p38%2520and%2520extracellular-regulated%2520kinase%2520ERK1%252F2%2520via%2520phosphatidylinositol-3%25E2%2580%25B2-kinase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">von Arnim, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoelgen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltan, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irizarry, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9913</span><span class="NLM_x">–</span> <span class="NLM_lpage">9922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1523%2FJNEUROSCI.2290-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17005855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9913-9922&author=C.+A.+von+Arnimauthor=R.+Spoelgenauthor=I.+D.+Peltanauthor=M.+Dengauthor=S.+Courchesneauthor=M.+Kokerauthor=T.+Matsuiauthor=H.+Kowaauthor=S.+F.+Lichtenthalerauthor=M.+C.+Irizarryauthor=B.+T.+Hyman&title=GGA1+acts+as+a+spatial+switch+altering+amyloid+precursor+protein+trafficking+and+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing</span></div><div class="casAuthors">von Arnim, Christine A. F.; Spoelgen, Robert; Peltan, Ithan D.; Deng, Meihua; Courchesne, Stephanie; Koker, Mirjam; Matsui, Toshifumi; Kowa, Hisatomo; Lichtenthaler, Stefan F.; Irizarry, Michael C.; Hyman, Bradley T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9913-9922</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The β-amyloid (Aβ) precursor protein (APP) is cleaved sequentially by β-site of APP-cleaving enzyme (BACE) and γ-secretase to release the Aβ peptides that accumulate in plaques in Alzheimer's disease (AD).  GGA1, a member of the Golgi-localized γ-ear-contg. ARF-binding (GGA) protein family, interacts with BACE and influences its subcellular distribution.  We now report that overexpression of GGA1 in cells increased the APP C-terminal fragment resulting from β-cleavage but surprisingly reduced Aβ.  GGA1 confined APP to the Golgi, in which fluorescence resonance energy transfer analyses suggest that the proteins come into close proximity.  GGA1 blunted only APP but not notch intracellular domain release.  These results suggest that GGA1 prevented APP β-cleavage products from becoming substrates for γ-secretase.  Direct binding of GGA1 to BACE was not required for these effects, but the integrity of the GAT (GGA1 and TOM) domain of GGA1 was.  GGA1 may act as a specific spatial switch influencing APP trafficking and processing, so that APP-GGA1 interactions may have pathophysiol. relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuxk8L3HXCj7Vg90H21EOLACvtfcHk0ljybOncqMpo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnJ&md5=e78bb9c66dcb40c997347da6a12314af</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2290-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2290-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BArnim%26aufirst%3DC.%2BA.%26aulast%3DSpoelgen%26aufirst%3DR.%26aulast%3DPeltan%26aufirst%3DI.%2BD.%26aulast%3DDeng%26aufirst%3DM.%26aulast%3DCourchesne%26aufirst%3DS.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DKowa%26aufirst%3DH.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DIrizarry%26aufirst%3DM.%2BC.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DGGA1%2520acts%2520as%2520a%2520spatial%2520switch%2520altering%2520amyloid%2520precursor%2520protein%2520trafficking%2520and%2520processing%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D9913%26epage%3D9922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Zhu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewlett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Colocalization and regulated physical association of presynaptic serotonin transporters with A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=458-465&author=C.+B.+Zhuauthor=K.+M.+Lindlerauthor=N.+G.+Campbellauthor=J.+S.+Sutcliffeauthor=W.+A.+Hewlettauthor=R.+D.+Blakely&title=Colocalization+and+regulated+physical+association+of+presynaptic+serotonin+transporters+with+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BB.%26aulast%3DLindler%26aufirst%3DK.%2BM.%26aulast%3DCampbell%26aufirst%3DN.%2BG.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BS.%26aulast%3DHewlett%26aufirst%3DW.%2BA.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DColocalization%2520and%2520regulated%2520physical%2520association%2520of%2520presynaptic%2520serotonin%2520transporters%2520with%2520A3%2520adenosine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D458%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casetta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granieri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=587-598&author=K.+Varaniauthor=F.+Vincenziauthor=A.+Tosiauthor=S.+Gessiauthor=I.+Casettaauthor=G.+Granieriauthor=P.+Fazioauthor=E.+Leungauthor=S.+MacLennanauthor=E.+Granieriauthor=P.+A.+Borea&title=A2A+adenosine+receptor+overexpression+and+functionality%2C+as+well+as+TNF-alpha+levels%2C+correlate+with+motor+symptoms+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTosi%26aufirst%3DA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DCasetta%26aufirst%3DI.%26aulast%3DGranieri%26aufirst%3DG.%26aulast%3DFazio%26aufirst%3DP.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMacLennan%26aufirst%3DS.%26aulast%3DGranieri%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA2A%2520adenosine%2520receptor%2520overexpression%2520and%2520functionality%252C%2520as%2520well%2520as%2520TNF-alpha%2520levels%252C%2520correlate%2520with%2520motor%2520symptoms%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D587%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Shryock, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span> </span><span class="NLM_article-title">Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1997&pages=2-10&author=J.+C.+Shryockauthor=L.+Belardinelli&title=Adenosine+and+adenosine+receptors+in+the+cardiovascular+system%3A+biochemistry%2C+physiology%2C+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26aulast%3DBelardinelli%26aufirst%3DL.%26atitle%3DAdenosine%2520and%2520adenosine%2520receptors%2520in%2520the%2520cardiovascular%2520system%253A%2520biochemistry%252C%2520physiology%252C%2520and%2520pharmacology%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D1997%26volume%3D79%26spage%3D2%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Gardner, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadley, K. J.</span><span> </span><span class="NLM_article-title">Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in guinea-pig atria and papillary muscles</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=358-368&author=N.+M.+Gardnerauthor=L.+Yatesauthor=K.+J.+Broadley&title=Effects+of+endogenous+adenosine+and+adenosine+receptor+agonists+on+hypoxia-induced+myocardial+stunning+in+guinea-pig+atria+and+papillary+muscles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DN.%2BM.%26aulast%3DYates%26aufirst%3DL.%26aulast%3DBroadley%26aufirst%3DK.%2BJ.%26atitle%3DEffects%2520of%2520endogenous%2520adenosine%2520and%2520adenosine%2520receptor%2520agonists%2520on%2520hypoxia-induced%2520myocardial%2520stunning%2520in%2520guinea-pig%2520atria%2520and%2520papillary%2520muscles%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2004%26volume%3D43%26spage%3D358%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Zhao, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukreja, R. C.</span><span> </span><span class="NLM_article-title">Late preconditioning elicited by activation of adenosine A<sub>3</sub> receptor in heart: role of NF-kappa B, iNOS and mitochondrial K(ATP) channel</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1006%2Fjmcc.2001.1510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11945020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1yht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=263-277&author=T.+C.+Zhaoauthor=R.+C.+Kukreja&title=Late+preconditioning+elicited+by+activation+of+adenosine+A3+receptor+in+heart%3A+role+of+NF-kappa+B%2C+iNOS+and+mitochondrial+K%28ATP%29+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Late Preconditioning Elicited by Activation of Adenosine A3 Receptor in Heart: Role of NF-κB, iNOS and Mitochondrial KATP Channel</span></div><div class="casAuthors">Zhao, Ting C.; Kukreja, Rakesh C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-277</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Activation of adenosine A3 receptor (A3AR) protects against ischemia/reperfusion injury in the heart.  However, the downstream signaling mechanisms leading to its delayed anti-ischemic effects remain unclear.  The authors hypothesized that A3AR stimulation protects the heart via activation of nuclear transcription factor κ B (NF-κB) and synthesis of inducible nitric oxide synthase (iNOS).  Mice were treated with selective A3AR agonist, N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA).  Twenty-four h later, hearts were perfused in Langendorff mode and subjected to 30 min of global ischemia and 30 min of reperfusion.  IB-MECA caused post-ischemic redn. in necrosis and improvement in myocardial performance which was abolished by A3AR antagonist, MRS1191.  Electrophoretic mobility shift assay demonstrated increased NF-κB binding in nuclear exts. following A3AR stimulation, which was diminished by MRS1191 and NF-κB inhibitor, pyrrolidinediethyldithiocarbamate (PDTC).  The cardioprotection was abrogated by PDTC and targeted ablation of p50 subunit of NF-κB in mice.  The inhibition of iNOS with S-methylisothiourea and targeted disruption of the iNOS gene also abolished the protective effect of A3AR stimulation.  Expression of iNOS mRNA and NO prodn. were enhanced after 6 and 24 h resp. of IB-MECA treatment.  MRS1191 and PDTC blocked IB-MECA induced NO prodn. after A3AR stimulation.  MitoKATP channel blocker, 5-hydroxydecanoate abolished the protective effect of A3AR.  For the first time, the authors have provided direct evidence of an essential role of NF-κB activation and iNOS in A3AR-induced late preconditioning.  Selective activation of A3AR with IB-MECA can be used to trigger long-lasting ischemic protection in the heart.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ7K3bjiY_x7Vg90H21EOLACvtfcHk0lhxR45JYGI_0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1yht7Y%253D&md5=10f350aeeec0aa6800ddd39b22a2eba0</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2001.1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2001.1510%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DT.%2BC.%26aulast%3DKukreja%26aufirst%3DR.%2BC.%26atitle%3DLate%2520preconditioning%2520elicited%2520by%2520activation%2520of%2520adenosine%2520A3%2520receptor%2520in%2520heart%253A%2520role%2520of%2520NF-kappa%2520B%252C%2520iNOS%2520and%2520mitochondrial%2520K%2528ATP%2529%2520channel%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2002%26volume%3D34%26spage%3D263%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Talukder, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S. J.</span><span> </span><span class="NLM_article-title">Targeted deletion of adenosine A<sub>3</sub> receptors augments adenosine-induced coronary flow in isolated mouse heart</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">H2183</span><span class="NLM_x">–</span> <span class="NLM_lpage">H2189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2002&pages=H2183-H2189&author=M.+A.+Talukderauthor=R.+R.+Morrisonauthor=M.+A.+Jacobsonauthor=K.+A.+Jacobsonauthor=C.+Ledentauthor=S.+J.+Mustafa&title=Targeted+deletion+of+adenosine+A3+receptors+augments+adenosine-induced+coronary+flow+in+isolated+mouse+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalukder%26aufirst%3DM.%2BA.%26aulast%3DMorrison%26aufirst%3DR.%2BR.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DMustafa%26aufirst%3DS.%2BJ.%26atitle%3DTargeted%2520deletion%2520of%2520adenosine%2520A3%2520receptors%2520augments%2520adenosine-induced%2520coronary%2520flow%2520in%2520isolated%2520mouse%2520heart%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D282%26spage%3DH2183%26epage%3DH2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Maddock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocanu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellon, D. M.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> receptor activation protects the myocardium from reperfusion/reoxygenation injury</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">H1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">H1313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2002&pages=H1307-H1313&author=H.+L.+Maddockauthor=M.+M.+Mocanuauthor=D.+M.+Yellon&title=Adenosine+A3+receptor+activation+protects+the+myocardium+from+reperfusion%2Freoxygenation+injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaddock%26aufirst%3DH.%2BL.%26aulast%3DMocanu%26aufirst%3DM.%2BM.%26aulast%3DYellon%26aufirst%3DD.%2BM.%26atitle%3DAdenosine%2520A3%2520receptor%2520activation%2520protects%2520the%2520myocardium%2520from%2520reperfusion%252Freoxygenation%2520injury%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D283%26spage%3DH1307%26epage%3DH1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Zhai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciarretta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeotti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadoshima, J.</span><span> </span><span class="NLM_article-title">Differential roles of GSK-3beta during myocardial ischemia and ischemia/reperfusion</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2011&pages=502-511&author=P.+Zhaiauthor=S.+Sciarrettaauthor=J.+Galeottiauthor=M.+Volpeauthor=J.+Sadoshima&title=Differential+roles+of+GSK-3beta+during+myocardial+ischemia+and+ischemia%2Freperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhai%26aufirst%3DP.%26aulast%3DSciarretta%26aufirst%3DS.%26aulast%3DGaleotti%26aufirst%3DJ.%26aulast%3DVolpe%26aufirst%3DM.%26aulast%3DSadoshima%26aufirst%3DJ.%26atitle%3DDifferential%2520roles%2520of%2520GSK-3beta%2520during%2520myocardial%2520ischemia%2520and%2520ischemia%252Freperfusion%26jtitle%3DCirc.%2520Res.%26date%3D2011%26volume%3D109%26spage%3D502%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Maddock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadley, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bril, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandoudi, N.</span><span> </span><span class="NLM_article-title">Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1211%2F0022357021779041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12079003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2hur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=859-867&author=H.+L.+Maddockauthor=K.+J.+Broadleyauthor=A.+Brilauthor=N.+Khandoudi&title=Effects+of+adenosine+receptor+agonists+on+guinea-pig+isolated+working+hearts+and+the+role+of+endothelium+and+NO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO</span></div><div class="casAuthors">Maddock, Helen L.; Broadley, Kenneth J.; Bril, Antoine; Khandoudi, Nassirah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">859-867</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">The hypothesis that the coronary vasodilator effects of adenosine receptor agonists are independent of the vascular endothelium or mediators derived therefrom was examd. in guinea-pig isolated working hearts.  Adenosine receptor agonists, 5'-(N-ethylcarboxamido)-adenosine (NECA; two-fold selective for A2 over A1 receptors), 2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680; A2A selective), N6-cyclopentyl-adenosine (CPA; A1 selective) and N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA; A3 selective), were infused (3×10-7 M) after endothelium removal by passing oxygen through the coronary circulation.  In spontaneously beating hearts, CGS21680 and NECA increased, while CPA decreased, coronary flow.  NECA and CPA reduced heart rate, left ventricular pressure and aortic output.  The nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine (L-NOARG; 3×10-5 M) abolished the vasodilatation by NECA but not CGS21680, indicating that nitric oxide (NO) of a non-endothelial source mediated the NECA response.  Coronary vasodilatation by CGS21680 was inhibited by the A2A receptor antagonist, 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM241385).  Indometacin (10-6 M) attenuated the coronary vasodilatation to CGS21680, suggesting a partial role for cyclooxygenase products.  IB-MECA had no effect, indicating no A3 receptor involvement.  In paced working hearts, the responses were similar except CPA had no effect on coronary flow or aortic output and CGS21680 increased left ventricular pressure and the max. rate of ventricular pressure rise.  This study has demonstrated functionally effective removal of the endothelium by a novel method of passing oxygen through the coronary vasculature.  A coronary vasodilator action of adenosine receptor agonists mediated via A2A receptors is endothelium- and NO-independent, but partially involves cyclooxygenase products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2b_uZbbVhrVg90H21EOLACvtfcHk0lhxR45JYGI_0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2hur0%253D&md5=f5f5b9e55b17f080267b1494b86328f5</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1211%2F0022357021779041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357021779041%26sid%3Dliteratum%253Aachs%26aulast%3DMaddock%26aufirst%3DH.%2BL.%26aulast%3DBroadley%26aufirst%3DK.%2BJ.%26aulast%3DBril%26aufirst%3DA.%26aulast%3DKhandoudi%26aufirst%3DN.%26atitle%3DEffects%2520of%2520adenosine%2520receptor%2520agonists%2520on%2520guinea-pig%2520isolated%2520working%2520hearts%2520and%2520the%2520role%2520of%2520endothelium%2520and%2520NO%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2002%26volume%3D54%26spage%3D859%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Tilley, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagoner, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span> </span><span class="NLM_article-title">Adenosine and inosine increase cutaneous vasopermeability by activating A<sub>3</sub> receptors on mast cells</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=361-367&author=S.+L.+Tilleyauthor=V.+A.+Wagonerauthor=C.+A.+Salvatoreauthor=M.+A.+Jacobsonauthor=B.+H.+Koller&title=Adenosine+and+inosine+increase+cutaneous+vasopermeability+by+activating+A3+receptors+on+mast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DWagoner%26aufirst%3DV.%2BA.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26atitle%3DAdenosine%2520and%2520inosine%2520increase%2520cutaneous%2520vasopermeability%2520by%2520activating%2520A3%2520receptors%2520on%2520mast%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D361%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simioni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=395-406&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=C.+Simioniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Caffeine+inhibits+adenosine-induced+accumulation+of+hypoxia-inducible+factor-1alpha%2C+vascular+endothelial+growth+factor%2C+and+interleukin-8+expression+in+hypoxic+human+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DSimioni%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DCaffeine%2520inhibits%2520adenosine-induced%2520accumulation%2520of%2520hypoxia-inducible%2520factor-1alpha%252C%2520vascular%2520endothelial%2520growth%2520factor%252C%2520and%2520interleukin-8%2520expression%2520in%2520hypoxic%2520human%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D395%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Blaisdell, F. W.</span><span> </span><span class="NLM_article-title">The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review</span> <span class="citation_source-journal">Cardiovasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0967-2109%2802%2900070-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12453699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD38npt1agsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=620-630&author=F.+W.+Blaisdell&title=The+pathophysiology+of+skeletal+muscle+ischemia+and+the+reperfusion+syndrome%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review</span></div><div class="casAuthors">Blaisdell F William</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular surgery (London, England)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-30</span>
        ISSN:<span class="NLM_cas:issn">0967-2109</span>.
    </div><div class="casAbstract">There are two components to the reperfusion syndrome, which follows extremity ischemia.  The local response, which follows reperfusion, consists of limb swelling with its potential for aggravating tissue injury and the systemic response, which results in multiple organ failure and death.  It is apparent that skeletal muscle is the predominant tissue in the limb but also the tissue that is most vulnerable to ischemia.  Physiological and anatomical studies show that irreversible muscle cell damage starts after 3 h of ischemia and is nearly complete at 6 h.  These muscle changes are paralleled by progressive microvascular damage.  Microvascular changes appear to follow rather than precede skeletal muscle damage as the tolerance of capillaries to ischemia vary with the tissue being reperfused.  The more severe the cellular damage the greater the microvascular changes and with death of tissue microvascular flow ceases within a few hours-the no reflow phenomenon.  At this point tissue swelling ceases.  The inflammatory responses following reperfusion varies greatly.  When muscle tissue death is uniform, as would follow tourniquet ischemia or limb replantation, little inflammatory response results.  In most instances of reperfusion, which follows thrombotic or embolic occlusion, there will be a variable degree of ischemic damage in the zone where collateral blood flow is possible.  The extent of this region will determine the magnitude of the inflammatory response, whether local or systemic.  Only in this region will therapy be of any benefit, whether fasciotomy to prevent pressure occlusion of the microcirculation, or anticoagulation to prevent further microvascular thrombosis.  Since many of the inflammatory mediators are generated by the act of clotting, anticoagulation will have additional benefit by decreasing the inflammatory response.  In instances in which the process involves the bulk of the lower extremity, amputation rather than attempts at revascularization may be the most prudent course to prevent the toxic product in the ischemic limb from entering the systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVCoETDdEvYbP3FVUi_gf8fW6udTcc2eahAailWF0_cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38npt1agsA%253D%253D&md5=8a201f37f276cf60ecf954e3729ee2a4</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0967-2109%2802%2900070-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0967-2109%252802%252900070-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlaisdell%26aufirst%3DF.%2BW.%26atitle%3DThe%2520pathophysiology%2520of%2520skeletal%2520muscle%2520ischemia%2520and%2520the%2520reperfusion%2520syndrome%253A%2520a%2520review%26jtitle%3DCardiovasc.%2520Surg.%26date%3D2002%26volume%3D10%26spage%3D620%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Lusis, A. J.</span><span> </span><span class="NLM_article-title">Atherosclerosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2F35025203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11001066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=233-241&author=A.+J.+Lusis&title=Atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Atherosclerosis</span></div><div class="casAuthors">Lusis, Aldons J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">233-241</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 72 refs.  Atherosclerosis, a disease of the large arteries, is the primary cause of heart disease and stroke.  In Westernized societies, it is the underlying cause of about 50% of all deaths.  Epidemiol. studies have revealed several important environmental and genetic risk factors assocd. with atherosclerosis.  Progress in defining the cellular and mol. interactions involved, however, has been hindered by the disease's etiol. complexity.  Over the past decade, the availability of new investigative tools, including genetically modified mouse models of disease, has resulted in a clearer understanding of the mol. mechanisms that connect altered cholesterol metab. and other risk factors to the development of atherosclerotic plaque.  It is now clear that atherosclerosis is not simply an inevitable degenerative consequence of aging, but rather a chronic inflammatory condition that can be converted into an acute clin. event by plaque rupture and thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAqrsjtqIWmLVg90H21EOLACvtfcHk0lgd8v5ftcQrOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSlsrk%253D&md5=b0484eda002d326a1f2678e7e295b737</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2F35025203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025203%26sid%3Dliteratum%253Aachs%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26atitle%3DAtherosclerosis%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D233%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1161%2FATVBAHA.109.194902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19834107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFensbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=90-97&author=S.+Gessiauthor=E.+Fogliauthor=V.+Sacchettoauthor=S.+Merighiauthor=K.+Varaniauthor=D.+Pretiauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=Adenosine+modulates+HIF-1%7Balpha%7D%2C+VEGF%2C+IL-8%2C+and+foam+cell+formation+in+a+human+model+of+hypoxic+foam+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Modulates HIF-1α, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells</span></div><div class="casAuthors">Gessi, Stefania; Fogli, Eleonora; Sacchetto, Valeria; Merighi, Stefania; Varani, Katia; Preti, Delia; Leung, Edward; MacLennan, Stephen; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-97</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Foam cell (FC) formation by oxidized low-d. lipoprotein (oxLDL) accumulation in macrophages is crucial for development of atherosclerosis.  Hypoxia was demonstrated in atherosclerosis and hypoxia-inducible factor-1 (HIF-1) was shown to promote intraplaque angiogenesis and FC development.  As hypoxia induces HIF-1α stabilization and adenosine (ado) accumulation, we investigated whether this nucleoside regulates HIF-1α in FCs.  Ado, under hypoxia, stimulates HIF-1α accumulation by activating all adenosine receptors (ARs).  HIF-1α modulation involved extracellular signal-regulated kinase 1/2 (ERK 1/2), p38 mitogen-activated protein kinase (p38 MAPK), and protein kinase B (Akt) phosphorylation in the case of A1, A2A, A2B, and ERK 1/2 phosphorylation in the case of A3 receptors.  Ado, through the activation of A3 and A2B receptors, stimulates vascular endothelial growth factor (VEGF) secretion in a HIF-1α-dependent way.  Furthermore, ado, through the A2B subtype, induces an increase of Interleukin-8 (IL-8) secretion in a ERK 1/2, p38, and Akt kinase-dependent but not HIF-1α-mediated way.  Finally, ado stimulates FC formation, and this effect is strongly reduced by A3 and A2B blockers and by HIF-1α silencing.  This study provides the 1st evidence that A3, A2B, or mixed A3/A2B antagonists may be useful to block important steps in the atherosclerotic plaque development ado-induced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyeXTmBu7HTLVg90H21EOLACvtfcHk0lgd8v5ftcQrOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFensbbL&md5=600257df25d93873b67d2046c57e8f9b</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.194902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.194902%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DFogli%26aufirst%3DE.%26aulast%3DSacchetto%26aufirst%3DV.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520modulates%2520HIF-1%257Balpha%257D%252C%2520VEGF%252C%2520IL-8%252C%2520and%2520foam%2520cell%2520formation%2520in%2520a%2520human%2520model%2520of%2520hypoxic%2520foam%2520cells%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D90%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">van der Hoeven, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span> </span><span class="NLM_article-title">Activation of the A<sub>3</sub> adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=685-696&author=D.+van+der+Hoevenauthor=T.+C.+Wanauthor=J.+A.+Auchampach&title=Activation+of+the+A3+adenosine+receptor+suppresses+superoxide+production+and+chemotaxis+of+mouse+bone+marrow+neutrophils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BHoeven%26aufirst%3DD.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26atitle%3DActivation%2520of%2520the%2520A3%2520adenosine%2520receptor%2520suppresses%2520superoxide%2520production%2520and%2520chemotaxis%2520of%2520mouse%2520bone%2520marrow%2520neutrophils%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D685%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=76-82&author=Z.+Gaoauthor=B.+S.+Liauthor=Y.+J.+Dayauthor=J.+Linden&title=A3+adenosine+receptor+activation+triggers+phosphorylation+of+protein+kinase+B+and+protects+rat+basophilic+leukemia+2H3+mast+cells+from+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%2BS.%26aulast%3DDay%26aufirst%3DY.%2BJ.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520triggers%2520phosphorylation%2520of%2520protein%2520kinase%2520B%2520and%2520protects%2520rat%2520basophilic%2520leukemia%25202H3%2520mast%2520cells%2520from%2520apoptosis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D76%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latour, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Disruption of the A<sub>3</sub> adenosine receptor gene in mice and its effect on stimulated inflammatory cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1074%2Fjbc.275.6.4429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=10660615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=4429-4434&author=C.+A.+Salvatoreauthor=S.+L.+Tilleyauthor=A.+M.+Latourauthor=D.+S.+Fletcherauthor=B.+H.+Kollerauthor=M.+A.+Jacobson&title=Disruption+of+the+A3+adenosine+receptor+gene+in+mice+and+its+effect+on+stimulated+inflammatory+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the A3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells</span></div><div class="casAuthors">Salvatore, Christopher A.; Tilley, Stephen L.; Latour, Anne M.; Fletcher, Daniel S.; Koller, Beverly H.; Jacobson, Marlene A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4429-4434</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The A3 adenosine receptor (A3AR) is one of four receptor subtypes for adenosine and is expressed in a broad spectrum of tissues.  In order to study the function of A3AR, a mouse line carrying a mutant A3 allele was generated.  Mice homozygous for targeted disruption of the A3AR gene, A3AR-/-, are fertile and visually and histol. indistinguishable from wild type mice.  The lack of a functional receptor in the A3AR-/- mice was confirmed by mol. and pharmacol. analyses.  The absence of A3AR protein expression in the A3AR-/- mice was demonstrated by lack of N6-(4-amino-3-[125I]iodobenzyl)adenosine binding to bone marrow-derived mast cell membranes that were found to express high levels of A3AR in wild type mice.  In A3AR-/- mice, the d. of A1 and A2A adenosine receptor subtypes was the same as in A3AR+/+ mice as detd. by radioligand binding to brain membranes.  Addnl., A2B receptor transcript expression was not affected by ablation of the A3AR gene.  A3AR-/- mice have basal heart rates and arterial blood pressures indistinguishable from A3AR+/+ mice.  Functionally, in contrast to wild type mice, adenosine and the A3AR-specific agonist, 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide (2-Cl-IB-MECA), elicit no potentiation of antigen-dependent degranulation of bone marrow-derived mast cells from A3AR-/- mice as measured by hexosaminidase release.  Also, the ability of 2Cl-IB-MECA to inhibit lipopolysaccharide-induced tumor necrosis factor-α prodn. in vivo was decreased in A3AR-/- mice in comparison to A3AR+/+ mice.  The A2A adenosine receptor agonist, 2-p-((2-carboxyethyl)phenylamino)-5'-N-ethylcarboxamidoadenosine, produced inhibition of lipopolysaccharide-stimulated tumor necrosis factor-α prodn. in both A3AR-/- and A3AR+/+ mice.  These results show that the inhibition in vivo can be mediated by multiple subtypes, specifically the A3 and A2A adenosine receptors, and A3AR activation plays an important role in both pro- and anti-inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBq9Cr_xCk7Vg90H21EOLACvtfcHk0lh5S38-jptwGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12nsr4%253D&md5=9ec8c0ab7f724af692ab2b4f132557bc</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.6.4429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.6.4429%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DLatour%26aufirst%3DA.%2BM.%26aulast%3DFletcher%26aufirst%3DD.%2BS.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDisruption%2520of%2520the%2520A3%2520adenosine%2520receptor%2520gene%2520in%2520mice%2520and%2520its%2520effect%2520on%2520stimulated%2520inflammatory%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D4429%26epage%3D4434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Zhong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlykov, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, M. R.</span><span> </span><span class="NLM_article-title">Activation of murine lung mast cells by the adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2003&pages=338-345&author=H.+Zhongauthor=S.+G.+Shlykovauthor=J.+G.+Molinaauthor=B.+M.+Sanbornauthor=M.+A.+Jacobsonauthor=S.+L.+Tilleyauthor=M.+R.+Blackburn&title=Activation+of+murine+lung+mast+cells+by+the+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DShlykov%26aufirst%3DS.%2BG.%26aulast%3DMolina%26aufirst%3DJ.%2BG.%26aulast%3DSanborn%26aufirst%3DB.%2BM.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26atitle%3DActivation%2520of%2520murine%2520lung%2520mast%2520cells%2520by%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D171%26spage%3D338%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Young, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, M. R.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=1380-1389&author=H.+W.+Youngauthor=J.+G.+Molinaauthor=D.+Diminaauthor=H.+Zhongauthor=M.+Jacobsonauthor=L.+N.+Chanauthor=T.+S.+Chanauthor=J.+J.+Leeauthor=M.+R.+Blackburn&title=A3+adenosine+receptor+signaling+contributes+to+airway+inflammation+and+mucus+production+in+adenosine+deaminase-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DH.%2BW.%26aulast%3DMolina%26aufirst%3DJ.%2BG.%26aulast%3DDimina%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DL.%2BN.%26aulast%3DChan%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26atitle%3DA3%2520adenosine%2520receptor%2520signaling%2520contributes%2520to%2520airway%2520inflammation%2520and%2520mucus%2520production%2520in%2520adenosine%2520deaminase-deficient%2520mice%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D1380%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Morschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volmer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohsenin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kheradmand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, M. R.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor signaling influences pulmonary inflammation and fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1165%2Frcmb.2007-0419OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18587054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1cjivVyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=697-705&author=E.+Morschlauthor=J.+G.+Molinaauthor=J.+B.+Volmerauthor=A.+Mohseninauthor=R.+S.+Peroauthor=J.+S.+Hongauthor=F.+Kheradmandauthor=J.+J.+Leeauthor=M.+R.+Blackburn&title=A3+adenosine+receptor+signaling+influences+pulmonary+inflammation+and+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis</span></div><div class="casAuthors">Morschl Eva; Molina Jose G; Volmer Jonathan B; Mohsenin Amir; Pero Ralph S; Hong Jeong-Soo; Kheradmand Farrah; Lee James J; Blackburn Michael R</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory cell and molecular biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">697-705</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adenosine is a signaling molecule produced during conditions that cause cellular stress or damage.  This signaling pathway is implicated in the regulation of pulmonary disorders through the selective engagement of adenosine receptors.  The goal of this study was to examine the involvement of the A(3) adenosine receptor (A(3)R) in a bleomycin model of pulmonary inflammation and fibrosis.  Results demonstrated that A(3)R-deficient mice exhibit enhanced pulmonary inflammation that included an increase in eosinophils.  Accordingly, there was a selective up-regulation of eosinophil-related chemokines and cytokines in the lungs of A(3)R-deficient mice exposed to bleomycin.  This increase in eosinophil numbers was accompanied by a decrease in the amount of extracellular eosinophil peroxidase activity in lavage fluid from A(3)R-deficient mice exposed to bleomycin, an observation suggesting that the A(3)R is necessary for eosinophil degranulation in this model.  Despite an increase in inflammatory metrics associated with A(3)R-deficient mice treated with bleomycin, there was little difference in the degree of pulmonary fibrosis.  Examination of fibrotic mediators demonstrated enhanced transforming growth factor (TGF)-beta1 expression, but not a concomitant increase in TGF-beta1 activity.  This was associated with the loss of expression of matrix metalloprotease 9, an activator of TGF-beta1, in alveolar macrophages and airway mast cells in the lungs of A(3)R-deficient mice.  Together, these results suggest that the A(3)R serves antiinflammatory functions in the bleomycin model, and is also involved in regulating the production of mediators that can impact fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlrd0OmnFWJIhLSh9fo81bfW6udTcc2eY3N5YDgJmNzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjivVyjtw%253D%253D&md5=370062d095bda3317b9bd7dbc905ed9d</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2007-0419OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2007-0419OC%26sid%3Dliteratum%253Aachs%26aulast%3DMorschl%26aufirst%3DE.%26aulast%3DMolina%26aufirst%3DJ.%2BG.%26aulast%3DVolmer%26aufirst%3DJ.%2BB.%26aulast%3DMohsenin%26aufirst%3DA.%26aulast%3DPero%26aufirst%3DR.%2BS.%26aulast%3DHong%26aufirst%3DJ.%2BS.%26aulast%3DKheradmand%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26atitle%3DA3%2520adenosine%2520receptor%2520signaling%2520influences%2520pulmonary%2520inflammation%2520and%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2008%26volume%3D39%26spage%3D697%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Reeves, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butchers, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, M. J.</span><span> </span><span class="NLM_article-title">Studies on the effects of adenosine A<sub>3</sub> receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2Fs000110050644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11211916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslGmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=666-672&author=J.+J.+Reevesauthor=C.+A.+Harrisauthor=B.+P.+Hayesauthor=P.+R.+Butchersauthor=M.+J.+Sheehan&title=Studies+on+the+effects+of+adenosine+A3+receptor+stimulation+on+human+eosinophils+isolated+from+non-asthmatic+or+asthmatic+donors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the effects of adenosine A3 receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors</span></div><div class="casAuthors">Reeves, J. J.; Harris, C. A.; Hayes, B. P.; Butchers, P. R.; Sheehan, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">666-672</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Objective: This study was designed to demonstrate the presence of adenosine A3 receptors on human peripheral blood eosinophils, and to investigate the effect of A3 receptor stimulation on eosinophil function.  Material: Eosinophils from either non-asthmatic or asthmatic donors.  Methods: Eosinophils were isolated from peripheral venous blood by discontinuous gradient centrifugation and neg. immunoselection.  Receptor localisation was investigated by immunoblotting and by immunocytochem. using a novel antibody specific for the human A3 receptor.  Two pharmacol. responses were studied: elevation of intracellular calcium in single eosinophils, measured by microfluorimetry, and hydrogen peroxide generation in cell suspensions.  Results: The expression of A3 receptors by eosinophils was confirmed using the selective antibody.  Addn. of the A3 receptor selective agonist, IB-MECA (100 nM), produced increases in intracellular calcium in less than 10% of the eosinophils isolated from non-asthmatic donors.  These responses were only partially attenuated with the A3 receptor antagonist, I-ABOPX.  IB-MECA (0.001 - 1000 nM) did not stimulate hydrogen peroxide (H2O2) generation, nor did it enhance fMLP- or C5a-stimulated generation of H2O2.  In fact high concns. of IB-MECA inhibited the generation of H2O2 (when stimulated by fMLP or C5a), an effect probably mediated by A2 receptors.  Similar results were obtained using eosinophils from asthmatic donors.  Conclusions: Stimulation of adenosine A3 receptors does not appear to be a prime mechanism for free radical generation by human peripheral blood eosinophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-iVS_QUrRrVg90H21EOLACvtfcHk0liAMfwzIdqINQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslGmt7k%253D&md5=f0682082ffb4e0169d135a420ea8c783</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1007%2Fs000110050644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000110050644%26sid%3Dliteratum%253Aachs%26aulast%3DReeves%26aufirst%3DJ.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BA.%26aulast%3DHayes%26aufirst%3DB.%2BP.%26aulast%3DButchers%26aufirst%3DP.%2BR.%26aulast%3DSheehan%26aufirst%3DM.%2BJ.%26atitle%3DStudies%2520on%2520the%2520effects%2520of%2520adenosine%2520A3%2520receptor%2520stimulation%2520on%2520human%2520eosinophils%2520isolated%2520from%2520non-asthmatic%2520or%2520asthmatic%2520donors%26jtitle%3DInflammation%2520Res.%26date%3D2000%26volume%3D49%26spage%3D666%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Kay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. S.</span><span> </span><span class="NLM_article-title">A role for eosinophils in airway remodelling in asthma</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.it.2004.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15324740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFWmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=477-482&author=A.+B.+Kayauthor=S.+Phippsauthor=D.+S.+Robinson&title=A+role+for+eosinophils+in+airway+remodelling+in+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">A role for eosinophils in airway remodelling in asthma</span></div><div class="casAuthors">Kay, A. Barry; Phipps, Simon; Robinson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the years, the role of the eosinophil in asthma and allergic processes has been disputed.  Recent human expts. using a humanized monoclonal antibody to interleukin-5 (IL-5), and animal studies involving specific IL-5 gene deletion, indicates that eosinophils might control downstream repair and remodelling processes.  Eosinophils are a rich source of fibrogenic factors, particularly transforming growth factor-β (TGF-β), the latent form of which is activated by epithelial-cell expression of the integrin αvβ6.  The emerging role for the eosinophil in airway remodelling might be important in future anti-asthma strategies.  However, more effective eosinophil-depleting agents than anti-IL-5 are required before the definitive role of this cell type in asthma airway pathophysiol. can be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogri2K-7lQrrVg90H21EOLACvtfcHk0liAMfwzIdqINQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFWmu70%253D&md5=ca49cd95134e9b00d3e2c34f73f2d6ae</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2004.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2004.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DKay%26aufirst%3DA.%2BB.%26aulast%3DPhipps%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%2BS.%26atitle%3DA%2520role%2520for%2520eosinophils%2520in%2520airway%2520remodelling%2520in%2520asthma%26jtitle%3DTrends%2520Immunol.%26date%3D2004%26volume%3D25%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casolari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1164%2Frccm.200506-869OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16322645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=398-406&author=K.+Varaniauthor=G.+Caramoriauthor=F.+Vincenziauthor=I.+Adcockauthor=P.+Casolariauthor=E.+Leungauthor=S.+Maclennanauthor=S.+Gessiauthor=S.+Morelloauthor=P.+J.+Barnesauthor=K.+Itoauthor=K.+F.+Chungauthor=G.+Cavallescoauthor=G.+Azzenaauthor=A.+Papiauthor=P.+A.+Borea&title=Alteration+of+adenosine+receptors+in+patients+with+chronic+obstructive+pulmonary+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease</span></div><div class="casAuthors">Varani, Katia; Caramori, Gaetano; Vincenzi, Fabrizio; Adcock, Ian; Casolari, Paolo; Leung, Edward; MacLennan, Stephen; Gessi, Stefania; Morello, Silvania; Barnes, Peter J.; Ito, Kazuhiro; Chung, Kian Fan; Cavallesco, Giorgio; Azzena, Gianfranco; Papi, Alberto; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">398-406</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality worldwide.  Adenosine is an inflammatory regulator that acts through four distinct receptors to mediate pro- and antiinflammatory effects.  Objectives: The primary aim of this study was to investigate the expression, affinity, and d. of adenosine receptors in peripheral lung parenchyma from age-matched smokers with COPD (n = 14) and smokers with normal lung function (control group; n = 20).  Methods: Adenosine receptors were analyzed by immunohistochem. and satn. binding assays using typical antagonist radioligands.  Results: A1, A2A, A2B, and A3 receptors were expressed in different cells in peripheral lung parenchyma.  The affinity of A1, A2A, and A3 receptors was significantly decreased in patients with COPD compared with the control group (KD[A1] = 3.15 ± 0.19 vs. 1.70 ± 0.14 nM; KD[A2A] = 7.88 ± 0.68 vs. 1.87 ± 0.09 nM; KD[A3] = 9.34 ± 0.27 vs. 4.41 ± 0.25 nM; p < 0.01), whereas their d. was increased (Bmax[A1] = 53 ± 4 vs. 32 ± 3 fmol/mg protein; Bmax[A2A] = 852 ± 50 vs. 302 ± 12 fmol/mg protein; Bmax[A3] = 2,078 ± 108 vs. 770 ± 34 fmol/mg protein; p < 0.01).  The affinity of A2B receptors was not altered, but the d. was significantly decreased in patients with COPD compared with the control group (Bmax = 66 ± 5 vs. 189 ± 16 fmol/mg protein; p < 0.01).  A significant correlation was found between the affinity and d. of the adenosine receptors and the FEV1/FVC ratio.  Conclusions: This is the first report showing the presence of adenosine receptors in lung parenchyma in subjects with COPD compared with control smokers.  These novel findings strengthen the hypothesis of a potential role played by adenosine receptors in the pathogenesis of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBVPEVprddDbVg90H21EOLACvtfcHk0liAMfwzIdqINQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSlu78%253D&md5=0c6087812da1f8adad7ac5e9ac9defee</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1164%2Frccm.200506-869OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200506-869OC%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DCaramori%26aufirst%3DG.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DAdcock%26aufirst%3DI.%26aulast%3DCasolari%26aufirst%3DP.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMorello%26aufirst%3DS.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DChung%26aufirst%3DK.%2BF.%26aulast%3DCavallesco%26aufirst%3DG.%26aulast%3DAzzena%26aufirst%3DG.%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAlteration%2520of%2520adenosine%2520receptors%2520in%2520patients%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D398%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">The role of adenosine receptors in rheumatoid arthritis</span> <span class="citation_source-journal">Autoimmun. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.autrev.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20691813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGitrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=61-64&author=K.+Varaniauthor=M.+Padovanauthor=M.+Govoniauthor=F.+Vincenziauthor=F.+Trottaauthor=P.+A.+Borea&title=The+role+of+adenosine+receptors+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The role of adenosine receptors in rheumatoid arthritis</span></div><div class="casAuthors">Varani, Katia; Padovan, Melissa; Govoni, Marcello; Vincenzi, Fabrizio; Trotta, Francesco; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Autoimmunity Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">ARUEBU</span>;
        ISSN:<span class="NLM_cas:issn">1568-9972</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA), is the most common inflammatory musculoskeletal disease inducing diminished quality-of-life in the affected individuals and having major impact on society due to decrease work ability.  Early diagnosis and immediate, effective therapy are crucial in order to prevent unfavorable outcome.  Treatment of RA has progressed during the past two decades thanks to the advent of a large no. of new agents targeting different specific mols. and pathways involved in the modulation of the inflammation.  In this scenario an important role is covered by adenosine, a purine nucleoside released from a variety of cells in response to metabolic and inflammatory stress, which is considered to be a potent endogenous regulator acting through its interaction with 4 cell surface receptors named as A1, A2A, A2B and A3.  Adenosine receptor stimulation has complex effects on the release of pro-inflammatory cytokines depending on selective receptor engagement.  Recent data show the involvement of adenosine pathways in RA and its potential therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTwfn8Nqugi7Vg90H21EOLACvtfcHk0libriiT0IV6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGitrvJ&md5=094c178f1225b285f9ce2873ae859c8a</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.autrev.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autrev.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DPadovan%26aufirst%3DM.%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DThe%2520role%2520of%2520adenosine%2520receptors%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAutoimmun.%2520Rev.%26date%3D2010%26volume%3D10%26spage%3D61%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The anti-inflammatory effect of A<sub>3</sub> adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1613</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=1601-1613&author=S.+Bar-Yehudaauthor=M.+H.+Silvermanauthor=W.+D.+Kernsauthor=A.+Ochaionauthor=S.+Cohenauthor=P.+Fishman&title=The+anti-inflammatory+effect+of+A3+adenosine+receptor+agonists%3A+a+novel+targeted+therapy+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DKerns%26aufirst%3DW.%2BD.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520anti-inflammatory%2520effect%2520of%2520A3%2520adenosine%2520receptor%2520agonists%253A%2520a%2520novel%2520targeted%2520therapy%2520for%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D1601%26epage%3D1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markovits, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozenbaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mader, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adawi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tishler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langevitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman-Furman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farbstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yehuda, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Clinical evidence for utilization of the A<sub>3</sub> adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18050382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslyltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=41-48&author=M.+H.+Silvermanauthor=V.+Strandauthor=D.+Markovitsauthor=M.+Nahirauthor=T.+Reitblatauthor=Y.+Moladauthor=I.+Rosnerauthor=M.+Rozenbaumauthor=R.+Maderauthor=M.+Adawiauthor=D.+Caspiauthor=M.+Tishlerauthor=P.+Langevitzauthor=A.+Rubinowauthor=J.+Friedmanauthor=L.+Greenauthor=A.+Tanayauthor=A.+Ochaionauthor=S.+Cohenauthor=W.+D.+Kernsauthor=I.+Cohnauthor=S.+Fishman-Furmanauthor=M.+Farbsteinauthor=S.+B.+Yehudaauthor=P.+Fishman&title=Clinical+evidence+for+utilization+of+the+A3+adenosine+receptor+as+a+target+to+treat+rheumatoid+arthritis%3A+data+from+a+phase+II+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial</span></div><div class="casAuthors">Silverman, Michael H.; Strand, Vibeke; Markovits, Doron; Nahir, Menachem; Reitblat, Tatiana; Molad, Yair; Rosner, Itzhak; Rozenbaum, Michael; Mader, Reuven; Adawi, Muhamad; Caspi, Dan; Tishler, Moshe; Langevitz, Pnina; Rubinow, Alan; Friedman, Joshua; Green, Lesly; Tanay, Amir; Ochaion, Avivit; Cohen, Shira; Kerns, William D.; Cohn, Ilan; Fishman-Furman, Sari; Farbstein, Motti; Yehuda, Sara Bar; Fishman, Pnina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">Objective: Adenosine exerts antiinflammatory effects via activation of the A3 adenosine receptor (A3AR), a Gi protein-assocd. cell-surface receptor, overexpressed in synovial tissue and peripheral blood mononuclear cells (PBMC) in patients with active rheumatoid arthritis (RA).  CF101 is a highly specific orally bioavailable A3AR agonist.  Methods: This was a multicenter study, blinded to dose, designed to assess the clin. activity and safety of CF101 in active RA.  Seventy-four patients were randomized to receive 0.1, 1.0, or 4.0 mg CF101 bid for 12 wk.  The primary efficacy endpoint was American College of Rheumatol. 20% response (ACR20) at Week 12.  A3AR expression levels were analyzed in PBMC from 18 patients.  Results: Maximal responses were obsd. with 1.0 mg bid, lower at 0.1 and 4.0 mg bid.  At 12 wk, 55.6%, 33.3%, and 11.5% of the patients receiving 1.0 mg CF101 achieved ACR20%, 50%, and 70% responses, resp.  CF101 was generally well tolerated, with mild headache (4.1%), nausea (2.7%), and rash (2.7%) being the most common treatment-related adverse events.  Statistically significant correlations between A3AR overexpression at baseline and ACR50 and ACR70 responses were obsd.  Conclusion: CF101 administered bid for 12 wk resulted in improvement in signs and symptoms of RA that did not achieve statistical significance, and was safe and well tolerated.  The expression level of A3AR was directly correlated with patient responses to CF101, suggesting its utilization as a biomarker for the pharmacodynamic and therapeutic effects of this novel agent.  These findings require confirmation in a double-blind randomized placebo-controlled trial, currently under way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp76np_8qRetbVg90H21EOLACvtfcHk0libriiT0IV6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslyltLc%253D&md5=4f99e853bdbd82daca708a0d0cf2de2a</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DStrand%26aufirst%3DV.%26aulast%3DMarkovits%26aufirst%3DD.%26aulast%3DNahir%26aufirst%3DM.%26aulast%3DReitblat%26aufirst%3DT.%26aulast%3DMolad%26aufirst%3DY.%26aulast%3DRosner%26aufirst%3DI.%26aulast%3DRozenbaum%26aufirst%3DM.%26aulast%3DMader%26aufirst%3DR.%26aulast%3DAdawi%26aufirst%3DM.%26aulast%3DCaspi%26aufirst%3DD.%26aulast%3DTishler%26aufirst%3DM.%26aulast%3DLangevitz%26aufirst%3DP.%26aulast%3DRubinow%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DTanay%26aufirst%3DA.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DKerns%26aufirst%3DW.%2BD.%26aulast%3DCohn%26aufirst%3DI.%26aulast%3DFishman-Furman%26aufirst%3DS.%26aulast%3DFarbstein%26aufirst%3DM.%26aulast%3DYehuda%26aufirst%3DS.%2BB.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DClinical%2520evidence%2520for%2520utilization%2520of%2520the%2520A3%2520adenosine%2520receptor%2520as%2520a%2520target%2520to%2520treat%2520rheumatoid%2520arthritis%253A%2520data%2520from%2520a%2520phase%2520II%2520clinical%2520trial%26jtitle%3DJ.%2520Rheumatol.%26date%3D2008%26volume%3D35%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Normalization of A<sub>2A</sub> and A<sub>3</sub> adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2880</span><span class="NLM_x">–</span> <span class="NLM_lpage">2891</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fart.24794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19790066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=2880-2891&author=K.+Varaniauthor=A.+Massaraauthor=F.+Vincenziauthor=A.+Tosiauthor=M.+Padovanauthor=F.+Trottaauthor=P.+A.+Borea&title=Normalization+of+A2A+and+A3+adenosine+receptor+up-regulation+in+rheumatoid+arthritis+patients+by+treatment+with+anti-tumor+necrosis+factor+alpha+but+not+methotrexate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate</span></div><div class="casAuthors">Varani, Katia; Massara, Alfonso; Vincenzi, Fabrizio; Tosi, Alice; Padovan, Melissa; Trotta, Francesco; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2880-2891</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To investigate A1, A2A, A2B, and A3 adenosine receptors in lymphocytes and neutrophils from patients with early rheumatoid arthritis (ERA) as well as from RA patients treated with methotrexate (MTX) or anti-tumor necrosis factor a (anti-TNFα), as compared with those in age-matched healthy controls, and to examine correlations between the status and functionality of adenosine receptors and TNFα release and NF-κB activation.  Adenosine receptors were analyzed by satn. binding assays and Western blot analyses.  We investigated the potency of typical A2A and A3 agonists in the prodn. of cAMP in control subjects, ERA patients, and RA patients treated with MTX or anti-TNFα.  In a sep. cohort of RA patients, TNFα release and NF-κB activation were evaluated in plasma and nuclear exts., resp.  In ERA patients, we found a high d. and altered functionality of A2A and A3 receptors.  The binding and functional parameters of A2A and A3 receptors normalized after anti-TNFα, but not MTX, treatment.  TNFα release was increased in ERA patients and in MTX-treated RA patients, whereas in anti-TNFα-treated RA patients, release was comparable to that in the controls.  NF-κB activation was elevated in ERA patients and in MTX-treated RA patients.  Anti-TNFα treatment mediated decreased levels of NF-κB activation.  A2A and A3 receptor up-regulation in ERA patients and in MTX-treated RA patients was assocd. with high levels of TNFα and NF-κB activation.  Treatment with anti-TNFα normalized A2A and A3 receptor expression and functionality.  This new evidence of A2A and A3 receptor involvement opens the possibility of exploiting their potential role in human diseases characterized by a marked inflammatory component.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplvCWYa5vOBLVg90H21EOLACvtfcHk0libriiT0IV6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbnL&md5=74fac99076140b3e18569353f6568119</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1002%2Fart.24794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24794%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMassara%26aufirst%3DA.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTosi%26aufirst%3DA.%26aulast%3DPadovan%26aufirst%3DM.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNormalization%2520of%2520A2A%2520and%2520A3%2520adenosine%2520receptor%2520up-regulation%2520in%2520rheumatoid%2520arthritis%2520patients%2520by%2520treatment%2520with%2520anti-tumor%2520necrosis%2520factor%2520alpha%2520but%2520not%2520methotrexate%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D2880%26epage%3D2891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pina-Oviedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Liz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3061</span><span class="NLM_x">–</span> <span class="NLM_lpage">3071</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fart.24817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19790055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=3061-3071&author=S.+Bar-Yehudaauthor=L.+Rath-Wolfsonauthor=L.+Del+Valleauthor=A.+Ochaionauthor=S.+Cohenauthor=R.+Patokaauthor=G.+Zozulyaauthor=F.+Barerauthor=E.+Atarauthor=S.+Pina-Oviedoauthor=G.+Perez-Lizauthor=D.+Castelauthor=P.+Fishman&title=Induction+of+an+antiinflammatory+effect+and+prevention+of+cartilage+damage+in+rat+knee+osteoarthritis+by+CF101+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment</span></div><div class="casAuthors">Bar-Yehuda, S.; Rath-Wolfson, L.; Del Valle, L.; Ochaion, A.; Cohen, S.; Patoka, R.; Zozulya, G.; Barer, F.; Atar, E.; Pina-Oviedo, S.; Perez-Liz, G.; Castel, D.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3061-3071</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Studies have suggested that rheumatoid arthritis (RA) and osteoarthritis (OA) share common characteristics.  The highly selective A3 adenosine receptor agonist CF101 was recently defined as a potent antiinflammatory agent for the treatment of RA.  The purpose of this study was to examine the effects of CF101 on the clin. and pathol. manifestations of OA in an exptl. animal model.  OA was induced in rats by monosodium iodoacetate, and upon disease onset, oral treatment with CF101 (100 μg/kg given twice daily) was initiated.  The A3 adenosine receptor antagonist MRS1220 (100 μg/kg given twice daily) was administered orally, 30 min before CF101 treatment.  The OA clin. score was monitored by knee diam. measurements and by radiog. analyses.  Histol. analyses were performed following staining with hematoxylin and eosin, Safranin O-fast green, or toluidine blue, and histol. changes were scored according to a modified Mankin system.  Signaling proteins were assayed by Western blotting; apoptosis was detected via immunohistochem. and TUNEL analyses.  CF101 induced a marked decrease in knee diam. and improved the changes noted on radiographs.  Administration of MRS1220 counteracted the effects of CF101.  CF101 prevented cartilage damage, osteoclast/osteophyte formation, and bone destruction.  In addn., CF101 markedly reduced pannus formation and lymphocyte infiltration.  Mechanistically, CF101 induced deregulation of the NF-κB signaling pathway, resulting in down-regulation of tumor necrosis factor α.  Consequently, CF101 induced apoptosis of inflammatory cells that had infiltrated the knee joints; however, it prevented apoptosis of chondrocytes.  CF101 deregulated the NF-κB signaling pathway involved in the pathogenesis of OA.  CF101 induced apoptosis of inflammatory cells and acted as a cartilage protective agent, which suggests that it would be a suitable candidate drug for the treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp41AroCeGD0bVg90H21EOLACvtfcHk0lhtaR1IY63s0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbfI&md5=8933df5c22e08667ceb823b21b52f01c</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1002%2Fart.24817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24817%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DZozulya%26aufirst%3DG.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DAtar%26aufirst%3DE.%26aulast%3DPina-Oviedo%26aufirst%3DS.%26aulast%3DPerez-Liz%26aufirst%3DG.%26aulast%3DCastel%26aufirst%3DD.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DInduction%2520of%2520an%2520antiinflammatory%2520effect%2520and%2520prevention%2520of%2520cartilage%2520damage%2520in%2520rat%2520knee%2520osteoarthritis%2520by%2520CF101%2520treatment%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D3061%26epage%3D3071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amital, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ophir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konfino, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowers, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Horin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The anti-inflammatory target A<sub>3</sub> adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.cellimm.2009.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19426966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotF2nsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=2009&pages=115-122&author=A.+Ochaionauthor=S.+Bar-Yehudaauthor=S.+Cohenauthor=F.+Barerauthor=R.+Patokaauthor=H.+Amitalauthor=T.+Reitblatauthor=A.+Reitblatauthor=J.+Ophirauthor=I.+Konfinoauthor=Y.+Chowersauthor=S.+Ben-Horinauthor=P.+Fishman&title=The+anti-inflammatory+target+A3+adenosine+receptor+is+over-expressed+in+rheumatoid+arthritis%2C+psoriasis+and+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease</span></div><div class="casAuthors">Ochaion, A.; Bar-Yehuda, S.; Cohen, S.; Barer, F.; Patoka, R.; Amital, H.; Reitblat, T.; Reitblat, A.; Ophir, J.; Konfino, I.; Chowers, Y.; Ben-Horin, S.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-122</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Gi protein assocd. A3 adenosine receptor (A3AR) was recently defined as a novel anti-inflammatory target.  The aim of this study was to look at A3AR expression levels in peripheral blood mononuclear cells (PBMCs) of patients with autoimmune inflammatory diseases and to explore transcription factors involved receptor expression.  Over-expression of A3AR was found in PBMCs derived from patients with rheumatoid arthritis (RA), psoriasis and Crohn's disease compared with PBMCs from healthy subjects.  Bioinformatics anal. demonstrated the presence of DNA binding sites for nuclear factor-κB (NF-κB) and cAMP-responsive element binding protein (CREB) in the A3AR gene promoter.  Up-regulation of NF-κB and CREB was found in the PBMCs from patients with RA, psoriasis and Crohn's disease.  The PI3K-PKB/Akt signaling pathway, known to regulate both the NF-κB and CREB, was also up-regulated in the patients' PBMCs.  Taken together, NF-κB and CREB are involved with the over-expression of A3AR in patients with autoimmune inflammatory diseases.  The receptor may be considered as a specific target to combat inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqMTkoYZq2irVg90H21EOLACvtfcHk0lhtaR1IY63s0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotF2nsrg%253D&md5=66aa4dafe7588bb0e43a988dba9ef43d</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2009.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2009.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DAmital%26aufirst%3DH.%26aulast%3DReitblat%26aufirst%3DT.%26aulast%3DReitblat%26aufirst%3DA.%26aulast%3DOphir%26aufirst%3DJ.%26aulast%3DKonfino%26aufirst%3DI.%26aulast%3DChowers%26aufirst%3DY.%26aulast%3DBen-Horin%26aufirst%3DS.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520anti-inflammatory%2520target%2520A3%2520adenosine%2520receptor%2520is%2520over-expressed%2520in%2520rheumatoid%2520arthritis%252C%2520psoriasis%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DCell.%2520Immunol.%26date%3D2009%26volume%3D258%26spage%3D115%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Morovic-Vergles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamulin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culo, F.</span><span> </span><span class="NLM_article-title">Cyclic adenosine 5′-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients</span> <span class="citation_source-journal">Rheumatol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2Fs00296-008-0663-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18695981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSktb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=167-171&author=J.+Morovic-Verglesauthor=M.+I.+Culoauthor=S.+Gamulinauthor=F.+Culo&title=Cyclic+adenosine+5%E2%80%B2-monophosphate+in+synovial+fluid+of+rheumatoid+arthritis+and+osteoarthritis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients</span></div><div class="casAuthors">Morovic-Vergles, Jadranka; Culo, Melanie Ivana; Gamulin, Stjepan; Culo, Filip</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-171</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The relationship between synovial fluid (SF) cAMP level and IL-18 and PGE2 SF levels in rheumatoid arthritis (RA) and osteoarthritis (OA) patients, and between SF cAMP level and disease as well as inflammatory activity in RA were investigated in 17 RA and 19 OA patients.  Erythrocyte sedimentation rate (ESR), serum (S) C-reactive protein (CRP) level and SF IL-18 level were higher in RA than in OA patients.  SF PGE2 level was similar in both groups.  SF cAMP level was higher in OA than in RA patients.  In RA patients, SF cAMP level showed neg. correlation with Disease Activity Score including a 28-joint count and S CRP, ESR and SF IL-18 level.  The results suggest that cAMP promotes anti-inflammatory response in RA and OA patients, which is higher in the latter.  Promotion of anti-inflammatory response by cAMP elevating agents might be useful in the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQEHUYNnbD7Vg90H21EOLACvtfcHk0lhtaR1IY63s0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSktb3N&md5=ef529d45964d08c1af7d4900ab93a264</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1007%2Fs00296-008-0663-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-008-0663-z%26sid%3Dliteratum%253Aachs%26aulast%3DMorovic-Vergles%26aufirst%3DJ.%26aulast%3DCulo%26aufirst%3DM.%2BI.%26aulast%3DGamulin%26aufirst%3DS.%26aulast%3DCulo%26aufirst%3DF.%26atitle%3DCyclic%2520adenosine%25205%25E2%2580%25B2-monophosphate%2520in%2520synovial%2520fluid%2520of%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%2520patients%26jtitle%3DRheumatol.%2520Int.%26date%3D2008%26volume%3D29%26spage%3D167%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabutti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">IB-MECA, an A<sub>3</sub> adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16956430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD28rjt1eitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=400-406&author=L.+Rath-Wolfsonauthor=S.+Bar-Yehudaauthor=L.+Madiauthor=A.+Ochaionauthor=S.+Cohenauthor=A.+Zabuttiauthor=P.+Fishman&title=IB-MECA%2C+an+A3+adenosine+receptor+agonist+prevents+bone+resorption+in+rats+with+adjuvant+induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis</span></div><div class="casAuthors">Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental rheumatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-6</span>
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">OBJECTIVES:  The anti-inflammatory effect of adenosine is partially mediated via the A3 adenosine receptor (A3AR), a Gi protein associated cell surface receptor.  The highly selective A3AR agonist, IB-MECA was earlier shown to prevent the clinical and pathological manifestations of arthritis in experimental animal models of collagen and adjuvant induced arthritis (AIA).  In this study we tested the effect of IB-MECA on the prevention of bone resorption in AIA rats and looked at the molecular mechanism of action.  METHODS:  Rats with AIA were treated orally twice daily with IB-MECA starting upon onset of disease and the clinical score was evaluated every other day.  At study termination the foot, knee and hip region of both vehicle and IB-MECA treated animals were subjected to histomorphometric analysis.  Western blot analysis was carried out on paw protein extracts.  RESULTS:  IB-MECA ameliorated the clinical manifestations of the disease and reduced pannus and fibrosis formation, attenuated cartilage and bone destruction and decreased the number of osteoclasts.  In cell protein extracts derived from paw of AIA rats, A3AR was highly expressed in comparison to naive animals.  In paw extracts derived from IB-MECA treated AIA rats, down-regulation of the A3AR protein expression level was noted.  PI3K, PKB/Akt, IKK, NF-kappaB, TNF-alpha and RANKL were down-regulated whereas caspase 3 was up-regulated.  CONCLUSION:  IB-MECA, a small highly bioavailable molecule, induces modulation of proteins which control survival and apoptosis resulting in the amelioration of the inflammatory process and the preservation of bone mass in AIA rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo7I9kIwFbFtenUz0lpNqnfW6udTcc2ea3py19Y_SdR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rjt1eitQ%253D%253D&md5=f2625d62981a0d6d42267862fee23742</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DZabutti%26aufirst%3DA.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DIB-MECA%252C%2520an%2520A3%2520adenosine%2520receptor%2520agonist%2520prevents%2520bone%2520resorption%2520in%2520rats%2520with%2520adjuvant%2520induced%2520arthritis%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D2006%26volume%3D24%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amital, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Liz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2008&pages=482-494&author=A.+Ochaionauthor=S.+Bar-Yehudaauthor=S.+Cohenauthor=H.+Amitalauthor=K.+A.+Jacobsonauthor=B.+V.+Joshiauthor=Z.+G.+Gaoauthor=F.+Barerauthor=R.+Patokaauthor=L.+Del+Valleauthor=G.+Perez-Lizauthor=P.+Fishman&title=The+A3+adenosine+receptor+agonist+CF502+inhibits+the+PI3K%2C+PKB%2FAkt+and+NF-kappaB+signaling+pathway+in+synoviocytes+from+rheumatoid+arthritis+patients+and+in+adjuvant-induced+arthritis+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DAmital%26aufirst%3DH.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DPerez-Liz%26aufirst%3DG.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520agonist%2520CF502%2520inhibits%2520the%2520PI3K%252C%2520PKB%252FAkt%2520and%2520NF-kappaB%2520signaling%2520pathway%2520in%2520synoviocytes%2520from%2520rheumatoid%2520arthritis%2520patients%2520and%2520in%2520adjuvant-induced%2520arthritis%2520rats%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D76%26spage%3D482%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> and A<sub>3</sub> adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">R197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=R197&author=K.+Varaniauthor=M.+Padovanauthor=F.+Vincenziauthor=M.+Targaauthor=F.+Trottaauthor=M.+Govoniauthor=P.+A.+Borea&title=A2A+and+A3+adenosine+receptor+expression+in+rheumatoid+arthritis%3A+upregulation%2C+inverse+correlation+with+disease+activity+score+and+suppression+of+inflammatory+cytokine+and+metalloproteinase+release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DPadovan%26aufirst%3DM.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTarga%26aufirst%3DM.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA2A%2520and%2520A3%2520adenosine%2520receptor%2520expression%2520in%2520rheumatoid%2520arthritis%253A%2520upregulation%252C%2520inverse%2520correlation%2520with%2520disease%2520activity%2520score%2520and%2520suppression%2520of%2520inflammatory%2520cytokine%2520and%2520metalloproteinase%2520release%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2011%26volume%3D13%26spage%3DR197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierma-Zeinstra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmander, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugwell, P.</span><span> </span><span class="NLM_article-title">OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.joca.2007.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18279766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1c7it12itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=137-162&author=W.+Zhangauthor=R.+W.+Moskowitzauthor=G.+Nukiauthor=S.+Abramsonauthor=R.+D.+Altmanauthor=N.+Ardenauthor=S.+Bierma-Zeinstraauthor=K.+D.+Brandtauthor=P.+Croftauthor=M.+Dohertyauthor=M.+Dougadosauthor=M.+Hochbergauthor=D.+J.+Hunterauthor=K.+Kwohauthor=L.+S.+Lohmanderauthor=P.+Tugwell&title=OARSI+recommendations+for+the+management+of+hip+and+knee+osteoarthritis.+Part+II%3A+OARSI+evidence-based%2C+expert+consensus+guidelines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines</span></div><div class="casAuthors">Zhang W; Moskowitz R W; Nuki G; Abramson S; Altman R D; Arden N; Bierma-Zeinstra S; Brandt K D; Croft P; Doherty M; Dougados M; Hochberg M; Hunter D J; Kwoh K; Lohmander L S; Tugwell P</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-62</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">PURPOSE:  To develop concise, patient-focussed, up to date, evidence-based, expert consensus recommendations for the management of hip and knee osteoarthritis (OA), which are adaptable and designed to assist physicians and allied health care professionals in general and specialist practise throughout the world.  METHODS:  Sixteen experts from four medical disciplines (primary care, rheumatology, orthopaedics and evidence-based medicine), two continents and six countries (USA, UK, France, Netherlands, Sweden and Canada) formed the guidelines development team.  A systematic review of existing guidelines for the management of hip and knee OA published between 1945 and January 2006 was undertaken using the validated appraisal of guidelines research and evaluation (AGREE) instrument.  A core set of management modalities was generated based on the agreement between guidelines.  Evidence before 2002 was based on a systematic review conducted by European League Against Rheumatism and evidence after 2002 was updated using MEDLINE, EMBASE, CINAHL, AMED, the Cochrane Library and HTA reports.  The quality of evidence was evaluated, and where possible, effect size (ES), number needed to treat, relative risk or odds ratio and cost per quality-adjusted life years gained were estimated.  Consensus recommendations were produced following a Delphi exercise and the strength of recommendation (SOR) for propositions relating to each modality was determined using a visual analogue scale.  RESULTS:  Twenty-three treatment guidelines for the management of hip and knee OA were identified from the literature search, including six opinion-based, five evidence-based and 12 based on both expert opinion and research evidence.  Twenty out of 51 treatment modalities addressed by these guidelines were universally recommended.  ES for pain relief varied from treatment to treatment.  Overall there was no statistically significant difference between non-pharmacological therapies [0.25, 95% confidence interval (CI) 0.16, 0.34] and pharmacological therapies (ES=0.39, 95% CI 0.31, 0.47).  Following feedback from Osteoarthritis Research International members on the draft guidelines and six Delphi rounds consensus was reached on 25 carefully worded recommendations.  Optimal management of patients with OA hip or knee requires a combination of non-pharmacological and pharmacological modalities of therapy.  Recommendations cover the use of 12 non-pharmacological modalities: education and self-management, regular telephone contact, referral to a physical therapist, aerobic, muscle strengthening and water-based exercises, weight reduction, walking aids, knee braces, footwear and insoles, thermal modalities, transcutaneous electrical nerve stimulation and acupuncture.  Eight recommendations cover pharmacological modalities of treatment including acetaminophen, cyclooxygenase-2 (COX-2) non-selective and selective oral non-steroidal anti-inflammatory drugs (NSAIDs), topical NSAIDs and capsaicin, intra-articular injections of corticosteroids and hyaluronates, glucosamine and/or chondroitin sulphate for symptom relief; glucosamine sulphate, chondroitin sulphate and diacerein for possible structure-modifying effects and the use of opioid analgesics for the treatment of refractory pain.  There are recommendations covering five surgical modalities: total joint replacements, unicompartmental knee replacement, osteotomy and joint preserving surgical procedures; joint lavage and arthroscopic debridement in knee OA, and joint fusion as a salvage procedure when joint replacement had failed.  Strengths of recommendation and 95% CIs are provided.  CONCLUSION:  Twenty-five carefully worded recommendations have been generated based on a critical appraisal of existing guidelines, a systematic review of research evidence and the consensus opinions of an international, multidisciplinary group of experts.  The recommendations may be adapted for use in different countries or regions according to the availability of treatment modalities and SOR for each modality of therapy.  These recommendations will be revised regularly following systematic review of new research evidence as this becomes available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxS93cdmmxmczK395ZObgVfW6udTcc2ea3py19Y_SdR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7it12itg%253D%253D&md5=63c6f1489b42ee342207fb1afca90d3d</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2007.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2007.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMoskowitz%26aufirst%3DR.%2BW.%26aulast%3DNuki%26aufirst%3DG.%26aulast%3DAbramson%26aufirst%3DS.%26aulast%3DAltman%26aufirst%3DR.%2BD.%26aulast%3DArden%26aufirst%3DN.%26aulast%3DBierma-Zeinstra%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DK.%2BD.%26aulast%3DCroft%26aufirst%3DP.%26aulast%3DDoherty%26aufirst%3DM.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DHochberg%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DKwoh%26aufirst%3DK.%26aulast%3DLohmander%26aufirst%3DL.%2BS.%26aulast%3DTugwell%26aufirst%3DP.%26atitle%3DOARSI%2520recommendations%2520for%2520the%2520management%2520of%2520hip%2520and%2520knee%2520osteoarthritis.%2520Part%2520II%253A%2520OARSI%2520evidence-based%252C%2520expert%2520consensus%2520guidelines%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2008%26volume%3D16%26spage%3D137%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Westra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, P. C.</span><span> </span><span class="NLM_article-title">p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=867-874&author=J.+Westraauthor=P.+C.+Limburg&title=p38+mitogen-activated+protein+kinase+%28MAPK%29+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestra%26aufirst%3DJ.%26aulast%3DLimburg%26aufirst%3DP.%2BC.%26atitle%3Dp38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520in%2520rheumatoid%2520arthritis%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D867%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mattei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadossi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.joca.2007.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17698373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1c7msVWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=292-304&author=K.+Varaniauthor=M.+De+Matteiauthor=F.+Vincenziauthor=S.+Gessiauthor=S.+Merighiauthor=A.+Pellatiauthor=A.+Ongaroauthor=A.+Carusoauthor=R.+Cadossiauthor=P.+A.+Borea&title=Characterization+of+adenosine+receptors+in+bovine+chondrocytes+and+fibroblast-like+synoviocytes+exposed+to+low+frequency+low+energy+pulsed+electromagnetic+fields"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields</span></div><div class="casAuthors">Varani K; De Mattei M; Vincenzi F; Gessi S; Merighi S; Pellati A; Ongaro A; Caruso A; Cadossi R; Borea P A</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-304</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  The present study describes the presence and binding parameters of the A1, A2A, A2B and A3 adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes.  The effect of low frequency low energy pulsed electromagnetic fields (PEMFs) on the adenosine receptor affinity and density was studied.  METHODS:  Saturation, competition binding experiments and Western blotting assays in the absence and in the presence of PEMFs on the adenosine receptors in bovine chondrocytes or fibroblast-like synoviocytes were performed.  Thermodynamic analysis of the A2A or A3 binding was studied to investigate the forces driving drug-receptor coupling.  In the adenylyl cyclase and proliferation assays the potency of typical high-affinity A2A or A3 agonists in the absence and in the presence of PEMFs was evaluated.  RESULTS:  Bovine chondrocytes and fibroblast-like synoviocytes expressed all adenosine receptors.  PEMFs evoked an up-regulation of A2A and A3 receptors and thermodynamic parameters indicate that adenosine binding is enthalpy and entropy driven.  In PEMF-treated cells the potency of typical A2A or A3 agonists on cyclic AMP assays was significantly increased when compared with the untreated cells.  PEMFs potentiated the effect of A2A or A3 agonists on cell proliferation in both cell types.  CONCLUSIONS:  PEMFs mediate an up-regulation of A2A and A3 receptors related to an increase of their functional activities in bovine chondrocytes and fibroblast-like synoviocytes.  No differences are present in adenosine affinity and in the drug-receptor interactions.  Our data could be used as a trigger to future studies addressed to PEMFs and adenosine therapeutic intervention in inflammatory joint diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6VKfLEWgjMULxIEhxUjPfW6udTcc2eZ_DQ-0gr0ejLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7msVWhtg%253D%253D&md5=b76a11de8271f2396feee9bb4e0caeea</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2007.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2007.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DDe%2BMattei%26aufirst%3DM.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DPellati%26aufirst%3DA.%26aulast%3DOngaro%26aufirst%3DA.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DCadossi%26aufirst%3DR.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DCharacterization%2520of%2520adenosine%2520receptors%2520in%2520bovine%2520chondrocytes%2520and%2520fibroblast-like%2520synoviocytes%2520exposed%2520to%2520low%2520frequency%2520low%2520energy%2520pulsed%2520electromagnetic%2520fields%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2008%26volume%3D16%26spage%3D292%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">De Mattei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masieri, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadossi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span> </span><span class="NLM_article-title">Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.joca.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18640059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1M7itlWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=252-262&author=M.+De+Matteiauthor=K.+Varaniauthor=F.+F.+Masieriauthor=A.+Pellatiauthor=A.+Ongaroauthor=M.+Finiauthor=R.+Cadossiauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=A.+Caruso&title=Adenosine+analogs+and+electromagnetic+fields+inhibit+prostaglandin+E2+release+in+bovine+synovial+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts</span></div><div class="casAuthors">De Mattei M; Varani K; Masieri F F; Pellati A; Ongaro A; Fini M; Cadossi R; Vincenzi F; Borea P A; Caruso A</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">252-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the role of adenosine analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE(2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).  METHODS:  SFs isolated from synovia were cultured in monolayer.  Saturation and binding experiments were performed by using typical adenosine agonists: N6-cyclohexyladenosine (CHA, A(1)), 2-[p-(2-carboxyethyl)-phenetyl-amino]-5'-N-ethylcarboxamidoadenosine (CGS 21680, A(2A)), 5'-N-ethylcarboxamidoadenosine (NECA, non-selective), N6-(3-iodobenzyl)2-chloroadenosine-5'-N-methyluronamide (Cl-IB-MECA, A(3)).  SFs were treated with TNF-alpha (10 ng/ml) and lipopolysaccharide (LPS) (1 microg/ml) to activate inflammatory response.  Adenosine analogs were added to control and TNF-alpha- or LPS-treated cultures both in the absence and in the presence of adenosine deaminase (ADA) which is used to deplete endogenous adenosine.  Parallel cultures were exposed to EMFs (75 Hz, 1.5 mT) during the period in culture (24h).  PGE(2) release was measured by immunoassay.  COX-2 expression was evaluated by RT-PCR.  RESULTS:  TNF-alpha and LPS stimulated PGE(2) release.  All adenosine agonists, except for Cl-IB-MECA, significantly inhibited PGE(2) production.  EMFs inhibited PGE(2) production in the absence of adenosine agonists and increased the effects of CHA, CGS 21680 and NECA.  In ADA, the inhibition on PGE(2) release induced by CHA, CGS and NECA was stronger than in the absence of ADA and the EMF-inhibitory effect was lost.  Changes in PGE(2) levels were associated to modification of COX-2 expression.  CONCLUSIONS:  This study supports anti-inflammatory activities of A(1) and A(2A) adenosine receptors and EMFs in bovine SFs.  EMF activity appears mediated by an EMF-induced up-regulation of A(2A) receptors.  Biophysical and/or pharmacological modulation of adenosine pathways may play an important role to control joint inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo5l1BUkNhuvtos8R3JUhXfW6udTcc2eZ_DQ-0gr0ejLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7itlWntw%253D%253D&md5=8b1c1e43b386ea01e0323c38ddff752f</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMattei%26aufirst%3DM.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMasieri%26aufirst%3DF.%2BF.%26aulast%3DPellati%26aufirst%3DA.%26aulast%3DOngaro%26aufirst%3DA.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DCadossi%26aufirst%3DR.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DCaruso%26aufirst%3DA.%26atitle%3DAdenosine%2520analogs%2520and%2520electromagnetic%2520fields%2520inhibit%2520prostaglandin%2520E2%2520release%2520in%2520bovine%2520synovial%2520fibroblasts%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2009%26volume%3D17%26spage%3D252%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masieri, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mattei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1111%2Fj.1476-5381.2010.00667.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20331607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslyqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=101-115&author=K.+Varaniauthor=F.+Vincenziauthor=A.+Tosiauthor=M.+Targaauthor=F.+F.+Masieriauthor=A.+Ongaroauthor=M.+De+Matteiauthor=L.+Massariauthor=P.+A.+Borea&title=Expression+and+functional+role+of+adenosine+receptors+in+regulating+inflammatory+responses+in+human+synoviocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes</span></div><div class="casAuthors">Varani, K.; Vincenzi, F.; Tosi, A.; Targa, M.; Masieri, F. F.; Ongaro, A.; De Mattei, M.; Massari, L.; Borea, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Adenosine is an endogenous modulator, interacting with four G-protein coupled receptors (A1, A2A, A2B and A3) and acts as a potent inhibitor of inflammatory processes in several tissues.  So far, the functional effects modulated by adenosine receptors on human synoviocytes have not been investigated in detail.  We evaluated mRNA, the protein levels, the functional role of adenosine receptors and their pharmacol. modulation in human synoviocytes.  Exptl. approach: mRNA, Western blotting, satn. and competition binding expts., cAMP, p38 mitogen-activated protein kinases (MAPKs) and nuclear factor (NF)-κB activation, tumor necrosis factor α (TNF-α) and interleukin-8 (IL-8) release were assessed in human synoviocytes isolated from patients with osteoarthritis.  Key results: mRNA and protein for A1, A2A, A2B and A3 adenosine receptors are expressed in human synoviocytes.  Std. adenosine agonists and antagonists showed affinity values in the nanomolar range and were coupled to stimulation or inhibition of adenylyl cyclase.  Activation of A2A and A3 adenosine receptors inhibited p38 MAPK and NF-κB pathways, an effect abolished by selective adenosine antagonists.  A2A and A3 receptor agonists decreased TNF-α and IL-8 prodn.  The phosphoinositide 3-kinase or Gs pathways were involved in the functional responses of A3 or A2A adenosine receptors.  Synoviocyte A1 and A2B adenosine receptors were not implicated in the inflammatory process whereas stimulation of A2A and A3 adenosine receptors was closely assocd. with a down-regulation of the inflammatory status.  Conclusions and implications: These results indicate that A2A and A3 adenosine receptors may represent a potential target in therapeutic modulation of joint inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9MuYpPfxgV7Vg90H21EOLACvtfcHk0ljiiIqBBUWMVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslyqtLo%253D&md5=42afea5cf3468e67b3c87c05b1f6986e</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00667.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00667.x%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTosi%26aufirst%3DA.%26aulast%3DTarga%26aufirst%3DM.%26aulast%3DMasieri%26aufirst%3DF.%2BF.%26aulast%3DOngaro%26aufirst%3DA.%26aulast%3DDe%2BMattei%26aufirst%3DM.%26aulast%3DMassari%26aufirst%3DL.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520and%2520functional%2520role%2520of%2520adenosine%2520receptors%2520in%2520regulating%2520inflammatory%2520responses%2520in%2520human%2520synoviocytes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26spage%3D101%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Hanauer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Present, D. H.</span><span> </span><span class="NLM_article-title">The state of the art in the management of inflammatory bowel disease</span> <span class="citation_source-journal">Rev. Gastroenterol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12776005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD3s3lt1eqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=81-92&author=S.+B.+Hanauerauthor=D.+H.+Present&title=The+state+of+the+art+in+the+management+of+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">The state of the art in the management of inflammatory bowel disease</span></div><div class="casAuthors">Hanauer Stephen B; Present Daniel H</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in gastroenterological disorders</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-92</span>
        ISSN:<span class="NLM_cas:issn">1533-001X</span>.
    </div><div class="casAbstract">Ulcerative colitis (UC) and Crohn's disease (CD), collectively known as inflammatory bowel disease (IBD), afflict an estimated one million Americans and produce symptoms that impair quality of life and ability to function.  Progress in IBD management strategies has led to optimized approaches for achieving the two primary clinical goals of therapy: induction and maintenance of remission.  Although surgery is indicated to treat refractory disease or specific complications, pharmacotherapy is the cornerstone of IBD management.  The efficacy of aminosalicylates for induction of remission in mild to moderate UC and CD is well established, as is their role for maintenance of remission in UC.  The sulfa-free mesalamine formulation offers an adverse effect profile similar to that of placebo, enabling the administration of higher, more effective doses.  Although corticosteroids provide potent anti-inflammatory effects, their benefits are countermanded by the risk of intolerable and serious adverse effects, and they are ineffective for maintenance therapy.  Other agents effective in inducing or maintaining remission are azathioprine, 6-mercaptopurine, infliximab, cyclosporine, methotrexate, and antibiotics.  Ongoing clinical trials of experimental therapies will generate new tools for IBD treatment.  Currently, a broad range of options allows physicians to tailor treatment to each patient's needs and preferences.  Such considerations are essential for maximizing adherence to therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSpqiFqxFUSCCEBeYuoi7AfW6udTcc2ea3NiKnmcsbcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3lt1eqtQ%253D%253D&md5=eb66b991df88380c6443d958f96ca571</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26aulast%3DPresent%26aufirst%3DD.%2BH.%26atitle%3DThe%2520state%2520of%2520the%2520art%2520in%2520the%2520management%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DRev.%2520Gastroenterol.%2520Disord.%26date%3D2003%26volume%3D3%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">De Schepper, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Man, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreels, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelckmans, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, B. Y.</span><span> </span><span class="NLM_article-title">Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease: clinical relevance and pathophysiological mechanisms</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1111%2Fj.1365-2036.2008.03624.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18221407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1c7pt1Crsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=621-637&author=H.+U.+De+Schepperauthor=J.+G.+De+Manauthor=T.+G.+Moreelsauthor=P.+A.+Pelckmansauthor=B.+Y.+De+Winter&title=Review+article%3A+gastrointestinal+sensory+and+motor+disturbances+in+inflammatory+bowel+disease%3A+clinical+relevance+and+pathophysiological+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms</span></div><div class="casAuthors">De Schepper H U; De Man J G; Moreels T G; Pelckmans P A; De Winter B Y</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">621-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  It is well known that inflammation has a profound impact on the neuromuscular apparatus of the gastrointestinal tract during the inflammatory insult and in periods of remission, at the site of inflammation and at distance from this site.  The importance of this interaction is illustrated by the higher prevalence of functional gut disorders in patients with inflammatory bowel disease.  AIMS:  To document the epidemiological and clinical significance of functional alterations of gut motility and sensitivity in patients with inflammatory bowel disease and to formulate potential pathophysiological mechanisms.  RESULTS AND CONCLUSIONS:  Functional gut disorders occur frequently in patients with inflammatory bowel disease, both during inflammatory episodes and in periods of remission, and have a major impact on their quality of life.  The clinical manifestations of these motility and sensitivity disorders vary and are often difficult to treat, mainly because therapeutic guidelines and specific diagnostic tests to distinguish inflammatory bowel disease from functional gut disorders are lacking.  Chronic bowel inflammation results in a complicated interaction between neuroendocrine serotonin-predominant cells of the mucosa, inflammatory cells (particularly mast cells) in the submucosa, the intrinsic and extrinsic innervation and the muscular apparatus including the interstitial cells of Cajal.  The outcome of this interaction is a perturbation of gastrointestinal motor function, both locally and at distance from the site of inflammation and during both acute inflammation and remission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQiU0cGL1MsqYHWj6b1v8uTfW6udTcc2ea3NiKnmcsbcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7pt1Crsg%253D%253D&md5=a70e229d159088cc5c3f004996467750</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2008.03624.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2008.03624.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSchepper%26aufirst%3DH.%2BU.%26aulast%3DDe%2BMan%26aufirst%3DJ.%2BG.%26aulast%3DMoreels%26aufirst%3DT.%2BG.%26aulast%3DPelckmans%26aufirst%3DP.%2BA.%26aulast%3DDe%2BWinter%26aufirst%3DB.%2BY.%26atitle%3DReview%2520article%253A%2520gastrointestinal%2520sensory%2520and%2520motor%2520disturbances%2520in%2520inflammatory%2520bowel%2520disease%253A%2520clinical%2520relevance%2520and%2520pathophysiological%2520mechanisms%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D27%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Mabley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, C.</span><span> </span><span class="NLM_article-title">The adenosine A<sub>3</sub> receptor agonist, <i>N</i><sup>6</sup>-(3-iodobenzyl)-adenosine-5′-<i>N</i>-methyluronamide, is protective in two murine models of colitis</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0014-2999%2803%2901570-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12694816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisleltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2003&pages=323-329&author=J.+Mableyauthor=F.+Sorianoauthor=P.+Pacherauthor=G.+Haskoauthor=A.+Martonauthor=R.+Wallaceauthor=A.+Salzmanauthor=C.+Szabo&title=The+adenosine+A3+receptor+agonist%2C+N6-%283-iodobenzyl%29-adenosine-5%E2%80%B2-N-methyluronamide%2C+is+protective+in+two+murine+models+of+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis</span></div><div class="casAuthors">Mabley, Jon; Soriano, Francisco; Pacher, Pal; Hasko, Gyorgy; Marton, Anita; Wallace, Rebecca; Salzman, Andrew; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-329</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">This study evaluated the effects of the adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA), in two murine models of colitis, the dextran sodium sulfate-induced colitis and the spontaneous colitis found in interleukin-10 gene deficient mice.  IB-MECA was given orally twice a day at a dose of either 1 or 3 mg/kg/day.  Evaluation of colon damage and inflammation was detd. grossly (body wt., rectal bleeding) and biochem. (colon levels of myeloperoxidase, malondialdehyde, chemokines and cytokines).  There was significantly increased inflammatory cell infiltration into the colon assocd. with an increase in colon levels of cytokines and chemokines; with subsequent free radical related damage in both dextran sodium sulfate-induced colitis and 10-wk-old interleukin-10-/- mice.  IB-MECA protected in both models against the colitis induced inflammatory cell infiltration and damage and attenuated the increases in colon inflammatory cytokine and chemokine levels.  Thus activation of the adenosine A3 receptor is effective in protecting against colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0kJSY66IJrVg90H21EOLACvtfcHk0ljEyo8t-6ng5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisleltrc%253D&md5=4cd64ff64f3f07f3bee4d10e9158ec6e</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901570-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901570-X%26sid%3Dliteratum%253Aachs%26aulast%3DMabley%26aufirst%3DJ.%26aulast%3DSoriano%26aufirst%3DF.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DHasko%26aufirst%3DG.%26aulast%3DMarton%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DR.%26aulast%3DSalzman%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DThe%2520adenosine%2520A3%2520receptor%2520agonist%252C%2520N6-%25283-iodobenzyl%2529-adenosine-5%25E2%2580%25B2-N-methyluronamide%252C%2520is%2520protective%2520in%2520two%2520murine%2520models%2520of%2520colitis%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D466%26spage%3D323%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Bastia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span> </span><span class="NLM_article-title">Effects of A<sub>1</sub> and A<sub>2A</sub> adenosine receptor ligands in mouse acute models of pain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2002&pages=241-244&author=E.+Bastiaauthor=K.+Varaniauthor=A.+Monopoliauthor=R.+Bertorelli&title=Effects+of+A1+and+A2A+adenosine+receptor+ligands+in+mouse+acute+models+of+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBastia%26aufirst%3DE.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DBertorelli%26aufirst%3DR.%26atitle%3DEffects%2520of%2520A1%2520and%2520A2A%2520adenosine%2520receptor%2520ligands%2520in%2520mouse%2520acute%2520models%2520of%2520pain%26jtitle%3DNeurosci.%2520Lett.%26date%3D2002%26volume%3D328%26spage%3D241%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Lee, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emala, C. W.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">R959</span><span class="NLM_x">–</span> <span class="NLM_lpage">R969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2006&pages=R959-R969&author=H.+T.+Leeauthor=M.+Kimauthor=J.+D.+Jooauthor=G.+Gallosauthor=J.+F.+Chenauthor=C.+W.+Emala&title=A3+adenosine+receptor+activation+decreases+mortality+and+renal+and+hepatic+injury+in+murine+septic+peritonitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DJoo%26aufirst%3DJ.%2BD.%26aulast%3DGallos%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEmala%26aufirst%3DC.%2BW.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520decreases%2520mortality%2520and%2520renal%2520and%2520hepatic%2520injury%2520in%2520murine%2520septic%2520peritonitis%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2006%26volume%3D291%26spage%3DR959%26epage%3DR969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Lee, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota-Setlik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agati, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emala, C. W.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">F267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=F267-273&author=H.+T.+Leeauthor=A.+Ota-Setlikauthor=H.+Xuauthor=V.+D.+D%E2%80%99Agatiauthor=M.+A.+Jacobsonauthor=C.+W.+Emala&title=A3+adenosine+receptor+knockout+mice+are+protected+against+ischemia-+and+myoglobinuria-induced+renal+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DOta-Setlik%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Agati%26aufirst%3DV.%2BD.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DEmala%26aufirst%3DC.%2BW.%26atitle%3DA3%2520adenosine%2520receptor%2520knockout%2520mice%2520are%2520protected%2520against%2520ischemia-%2520and%2520myoglobinuria-induced%2520renal%2520failure%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2003%26volume%3D284%26spage%3DF267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Lee, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emala, C. W.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">R959</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2006&pages=R959-969&author=H.+T.+Leeauthor=M.+Kimauthor=J.+D.+Jooauthor=G.+Gallosauthor=J.+F.+Chenauthor=C.+W.+Emala&title=A3+adenosine+receptor+activation+decreases+mortality+and+renal+and+hepatic+injury+in+murine+septic+peritonitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DJoo%26aufirst%3DJ.%2BD.%26aulast%3DGallos%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEmala%26aufirst%3DC.%2BW.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520decreases%2520mortality%2520and%2520renal%2520and%2520hepatic%2520injury%2520in%2520murine%2520septic%2520peritonitis%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2006%26volume%3D291%26spage%3DR959%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson-Yantorno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civan, M. M.</span><span> </span><span class="NLM_article-title">Nucleoside-derived antagonists to A<sub>3</sub> adenosine receptors lower mouse intraocular pressure and act across species</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.exer.2009.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19878673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFantbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=146-154&author=Z.+Wangauthor=C.+W.+Doauthor=M.+Y.+Avilaauthor=K.+Peterson-Yantornoauthor=R.+A.+Stoneauthor=Z.+G.+Gaoauthor=B.+Joshiauthor=P.+Besadaauthor=L.+S.+Jeongauthor=K.+A.+Jacobsonauthor=M.+M.+Civan&title=Nucleoside-derived+antagonists+to+A3+adenosine+receptors+lower+mouse+intraocular+pressure+and+act+across+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species</span></div><div class="casAuthors">Wang, Zhao; Do, Chi-Wai; Avila, Marcel Y.; Peterson-Yantorno, Kim; Stone, Richard A.; Gao, Zhan-Guo; Joshi, Bhalchandra; Besada, Pedro; Jeong, Lak-Shin; Jacobson, Kenneth A.; Civan, Mortimer M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of the study was to det. whether novel, selective antagonists of human A3 adenosine receptors (ARs) derived from the A3-selective agonist Cl-IB-MECA lower intraocular pressure (IOP) and act across species.  IOP was measured invasively with a micropipette by the Servo-Null Micropipette System (SNMS) and by non-invasive pneumotonometry during topical drug application.  Antagonist efficacy was also assayed by measuring inhibition of adenosine-triggered shrinkage of native bovine nonpigmented ciliary epithelial (NPE) cells.  Five agonist-based A3AR antagonists lowered mouse IOP measured with SNMS tonometry by 3-5 mm Hg within minutes of topical application.  Of the 5 agonist derivs., LJ 1251 was the only antagonist to lower IOP measured by pneumotonometry.  No effect was detected pneumotonometrically over 30 min following application of the other 4 compds., consonant with slower, smaller responses previously measured non-invasively following topical application of A3AR agonists and the dihydropyridine A3AR antagonist MRS 1191.  Latanoprost similarly lowered SNMS-measured IOP, but not IOP measured non-invasively over 30 min.  Like MRS 1191, agonist-based A3AR antagonists applied to native bovine NPE cells inhibited adenosine-triggered shrinkage.  In summary, the results indicate that antagonists of human A3ARs derived from the potent, selective A3 agonist Cl-IB-MECA display efficacy in mouse and bovine cells, as well.  When intraocular delivery was enhanced by measuring mouse IOP invasively, 5 derivs. of the A3AR agonist Cl-IB-MECA lowered IOP but only one rapidly reduced IOP measured non-invasively after topical application.  We conclude that derivs. of the highly-selective A3AR agonist Cl-IB-MECA can reduce IOP upon reaching their intraocular target, and that nucleoside-based derivs. are promising A3 antagonists for study in multiple animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodKko5nfHoMLVg90H21EOLACvtfcHk0lh76GqR7n4mIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFantbjM&md5=3d11d9a34194272b31e203a158609fd8</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2009.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2009.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDo%26aufirst%3DC.%2BW.%26aulast%3DAvila%26aufirst%3DM.%2BY.%26aulast%3DPeterson-Yantorno%26aufirst%3DK.%26aulast%3DStone%26aufirst%3DR.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJoshi%26aufirst%3DB.%26aulast%3DBesada%26aufirst%3DP.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DCivan%26aufirst%3DM.%2BM.%26atitle%3DNucleoside-derived%2520antagonists%2520to%2520A3%2520adenosine%2520receptors%2520lower%2520mouse%2520intraocular%2520pressure%2520and%2520act%2520across%2520species%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2010%26volume%3D90%26spage%3D146%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Schlotzer-Schrehardt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decking, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coca-Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumann, G. O.</span><span> </span><span class="NLM_article-title">Selective upregulation of the A<sub>3</sub> adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=2023-2034&author=U.+Schlotzer-Schrehardtauthor=M.+Zenkelauthor=U.+Deckingauthor=D.+Haubsauthor=F.+E.+Kruseauthor=A.+Junemannauthor=M.+Coca-Pradosauthor=G.+O.+Naumann&title=Selective+upregulation+of+the+A3+adenosine+receptor+in+eyes+with+pseudoexfoliation+syndrome+and+glaucoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlotzer-Schrehardt%26aufirst%3DU.%26aulast%3DZenkel%26aufirst%3DM.%26aulast%3DDecking%26aufirst%3DU.%26aulast%3DHaubs%26aufirst%3DD.%26aulast%3DKruse%26aufirst%3DF.%2BE.%26aulast%3DJunemann%26aufirst%3DA.%26aulast%3DCoca-Prados%26aufirst%3DM.%26aulast%3DNaumann%26aufirst%3DG.%2BO.%26atitle%3DSelective%2520upregulation%2520of%2520the%2520A3%2520adenosine%2520receptor%2520in%2520eyes%2520with%2520pseudoexfoliation%2520syndrome%2520and%2520glaucoma%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2005%26volume%3D46%26spage%3D2023%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eysteinsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laties, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, C. H.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.neuint.2009.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19723551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=35-41&author=M.+Zhangauthor=H.+L.+Huauthor=X.+L.+Zhangauthor=W.+N.+Luauthor=J.+Limauthor=T.+Eysteinssonauthor=K.+A.+Jacobsonauthor=A.+M.+Latiesauthor=C.+H.+Mitchell&title=The+A3+adenosine+receptor+attenuates+the+calcium+rise+triggered+by+NMDA+receptors+in+retinal+ganglion+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells</span></div><div class="casAuthors">Zhang, Mei; Hu, Huiling; Zhang, Xiulan; Lu, Wennan; Lim, Jason; Eysteinsson, Thor; Jacobson, Kenneth A.; Laties, Alan M.; Mitchell, Claire H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-41</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The A3 adenosine receptor is emerging as an important regulator of neuronal signaling, and in some situations receptor stimulation can limit excitability.  As the NMDA receptor frequently contributes to neuronal excitability, this study examd. whether A3 receptor activation could alter the calcium rise accompanying NMDA receptor stimulation.  Calcium levels were detd. from fura-2 imaging of isolated rat retinal ganglion cells as these neurons possess both receptor types.  Brief application of glutamate or NMDA led to repeatable and reversible elevations of intracellular calcium.  The A3 agonist Cl-IB-MECA reduced the response to both glutamate and NMDA.  While adenosine mimicked the effect of Cl-IB-MECA, the A3 receptor antagonist MRS 1191 impeded the block by adenosine, implicating a role for the A3 receptor in response to the natural agonist.  The A1 receptor antagonist DPCPX provided addnl. inhibition, implying a contribution from both A1 and A3 adenosine receptors.  The novel A3 agonist MRS 3558 (1'S,2'R,3'S,4'R,5'S)-4-(2-chloro-6-(3-chlorobenzylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo [3.1.0] hexane-1-carboxamide and mixed A1/A3 agonist MRS 3630 (1'S,2'R,3'S,4'R,5'S)-4-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo [3.1.0] hexane-1-carboxamide also inhibited the calcium rise induced by NMDA.  Low levels of MRS 3558 were particularly effective, with an IC50 of 400 pM.  In all cases, A3 receptor stimulation inhibited only 30-50% of the calcium rise.  In summary, stimulation of the A3 adenosine receptor by either endogenous or synthesized agonists can limit the calcium rise accompanying NMDA receptor activation.  It remains to be detd. if partial block of the calcium rise by A3 agonists can modify downstream responses to NMDA receptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5IWJWU87-HLVg90H21EOLACvtfcHk0lh76GqR7n4mIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlehug%253D%253D&md5=d0b4e34e8994756b0bbf9b6eb56ea5d8</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DH.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DLu%26aufirst%3DW.%2BN.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DEysteinsson%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLaties%26aufirst%3DA.%2BM.%26aulast%3DMitchell%26aufirst%3DC.%2BH.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520attenuates%2520the%2520calcium%2520rise%2520triggered%2520by%2520NMDA%2520receptors%2520in%2520retinal%2520ganglion%2520cells%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D56%26spage%3D35%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patokaa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Morales, J. M. G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Inhibition of experimental auto-immune uveitis by the A<sub>3</sub> adenosine receptor agonist CF101</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21887476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleku7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=727-731&author=S.+Bar-Yehudaauthor=D.+Lugerauthor=A.+Ochaionauthor=S.+Cohenauthor=R.+Patokaaauthor=G.+Zozulyaauthor=P.+B.+Silverauthor=J.+M.+G.+R.+De+Moralesauthor=R.+R.+Caspiauthor=P.+Fishman&title=Inhibition+of+experimental+auto-immune+uveitis+by+the+A3+adenosine+receptor+agonist+CF101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101</span></div><div class="casAuthors">Bar-Yehuda, Sara; Luger, Dror; Ochaion, Avivit; Cohen, Shira; Patokaa, Renana; Zozulya, Galina; Silver, Phyllis B.; Ruiz De Morales, Jose Maria Garcia; Caspi, Rachel R.; Fishman, Pnina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">727-731</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">Uveitis is an inflammation of the middle layer of the eye with a high risk of blindness.  The Gi protein assocd. A3 adenosine receptor (A3AR) is highly expressed in inflammatory cells whereas low expression is found in normal cells.  CF101 is a highly specific agonist at the A3AR known to induce a robust anti-inflammatory effect in different exptl. animal models.  The CF101 mechanism of action entails down-regulation of the NF-κB-TNF-α signaling pathway, resulting in inhibition of pro-inflammatory cytokine prodn. and apoptosis of inflammatory cells.  In this study the effect of CF101 on the development of retinal antigen interphotoreceptor retinoid-binding protein (IRBP)-induced exptl. autoimmune uveitis (EAU) was assessed.  Oral treatment with CF101 (10 μg/kg, twice daily), initiated upon disease onset, improved uveitis clin. score measured by fundoscopy and ameliorated the pathol. manifestations of the disease.  Shortly after treatment with CF101 A3AR expression levels were down-regulated in the lymph node and spleen cells pointing towards receptor activation.  Downstream events included a decrease in PI3K and STAT-1 and proliferation inhibition of IRPB auto-reactive T cells ex vivo.  Inhibition of interleukin-2, tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) prodn. and up-regulation of interleukin-10 was found in cultured splenocytes derived from CF101-treated animals.  Overall, the present study data point towards a marked anti-inflammatory effect of CF101 in EAU and support further exploration of this small mol. drug for the treatment of uveitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqe7symGDucrVg90H21EOLACvtfcHk0lg5CMu1HV6S3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleku7jJ&md5=a7fbc0827e3fc86c09198456614ecef5</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DLuger%26aufirst%3DD.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DPatokaa%26aufirst%3DR.%26aulast%3DZozulya%26aufirst%3DG.%26aulast%3DSilver%26aufirst%3DP.%2BB.%26aulast%3DDe%2BMorales%26aufirst%3DJ.%2BM.%2BG.%2BR.%26aulast%3DCaspi%26aufirst%3DR.%2BR.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520experimental%2520auto-immune%2520uveitis%2520by%2520the%2520A3%2520adenosine%2520receptor%2520agonist%2520CF101%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2011%26volume%3D28%26spage%3D727%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Multani, A. S.</span><span> </span><span class="NLM_article-title">Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Eur. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=1452-1458&author=P.+Fishmanauthor=S.+Bar-Yehudaauthor=G.+Ohanaauthor=S.+Pathakauthor=L.+Wassermanauthor=F.+Barerauthor=A.+S.+Multani&title=Adenosine+acts+as+an+inhibitor+of+lymphoma+cell+growth%3A+a+major+role+for+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DOhana%26aufirst%3DG.%26aulast%3DPathak%26aufirst%3DS.%26aulast%3DWasserman%26aufirst%3DL.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DMultani%26aufirst%3DA.%2BS.%26atitle%3DAdenosine%2520acts%2520as%2520an%2520inhibitor%2520of%2520lymphoma%2520cell%2520growth%253A%2520a%2520major%2520role%2520for%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DEur.%2520J.%2520Cancer.%26date%3D2000%26volume%3D36%26spage%3D1452%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Suh, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. T.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0704218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11522605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=132-142&author=B.+C.+Suhauthor=T.+D.+Kimauthor=J.+U.+Leeauthor=J.+K.+Seongauthor=K.+T.+Kim&title=Pharmacological+characterization+of+adenosine+receptors+in+PGT-beta+mouse+pineal+gland+tumour+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of adenosine receptors in PGT-β mouse pineal gland tumour cells</span></div><div class="casAuthors">Suh, Byung-Chang; Kim, Tae-Don; Lee, Jung-Uek; Seong, Je-Kyung; Kim, Kyong-Tai</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adenosine receptor in mouse pinealocytes was identified and characterized using pharmacol. and physiol. approaches.  Expression of the two adenosine receptor subtypes A2B and A3 was detected in mouse pineal glands and PGT-β cells by polymerase chain reaction and nucleotide sequencing.  Adenosine and 5'-N-ethylcarboxamidoadenosine (NECA) evoked cAMP generation but the A2A-selective agonist 2-(4-(2-carboxyethyl)phenylethylamino)adenosine-5'-N-ethylcarboxamideadenosine (CGS 21680) and the A1-specific agonists R-N6-(2-phenylisopropyl)adenosine (R-PIA) and N6-cyclopentyladenosine (CPA) had little effect on intracellular cAMP levels.  The A2B receptor selective antagonists alloxazine and enprofylline completely blocked NECA-mediated cAMP accumulation.  Treatment of cells with the A3-selective agonist N6-(3-iodobenzyl)-5'-(N-methylcarbamoyl)adenosine (IB-MECA) inhibited the elevation of the cAMP level induced by NECA or isoproterenol in a concn.-dependent manner with maximal inhibition of 40-50%.  These responses were blocked by the specific A3 adenosine receptor antagonist MRS 1191.  Pretreatment of the cells with pertussis toxin attenuated the IB-MECA-induced responses, suggesting that this effect occurred via the pertussis toxin-sensitive inhibitory G proteins.  IB-MECA also caused a concn.-dependent elevation in [Ca2+]i and IP3 content.  Both the responses induced by IB-MECA were attenuated by treatment with U73122 or phorbol 12-myristate 13-acetate.  These data suggest the presence of both A2B and A3 adenosine receptors in mouse pineal tumor cells and that the A2B receptor is pos. coupled to adenylyl cyclase, whereas the A3 receptor is neg. coupled to adenylyl cyclase and also coupled to phospholipase C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYzMFEwx6NR7Vg90H21EOLACvtfcHk0lg5CMu1HV6S3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVyqsr0%253D&md5=33a7e2ecb87ce7181db9a65de82bdf0a</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704218%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DT.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BU.%26aulast%3DSeong%26aufirst%3DJ.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BT.%26atitle%3DPharmacological%2520characterization%2520of%2520adenosine%2520receptors%2520in%2520PGT-beta%2520mouse%2520pineal%2520gland%2520tumour%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D132%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1483</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1483-1495&author=S.+Gessiauthor=V.+Sacchettoauthor=E.+Fogliauthor=S.+Merighiauthor=K.+Varaniauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=Modulation+of+metalloproteinase-9+in+U87MG+glioblastoma+cells+by+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DSacchetto%26aufirst%3DV.%26aulast%3DFogli%26aufirst%3DE.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DModulation%2520of%2520metalloproteinase-9%2520in%2520U87MG%2520glioblastoma%2520cells%2520by%2520A3%2520adenosine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1483%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=19-31&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=Adenosine+modulates+vascular+endothelial+growth+factor+expression+via+hypoxia-inducible+factor-1+in+human+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520modulates%2520vascular%2520endothelial%2520growth%2520factor%2520expression%2520via%2520hypoxia-inducible%2520factor-1%2520in%2520human%2520glioblastoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D19%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Jajoo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramkumar, V.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1132-1145&author=S.+Jajooauthor=D.+Mukherjeaauthor=K.+Watabeauthor=V.+Ramkumar&title=Adenosine+A3+receptor+suppresses+prostate+cancer+metastasis+by+inhibiting+NADPH+oxidase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJajoo%26aufirst%3DS.%26aulast%3DMukherjea%26aufirst%3DD.%26aulast%3DWatabe%26aufirst%3DK.%26aulast%3DRamkumar%26aufirst%3DV.%26atitle%3DAdenosine%2520A3%2520receptor%2520suppresses%2520prostate%2520cancer%2520metastasis%2520by%2520inhibiting%2520NADPH%2520oxidase%2520activity%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D1132%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A<sub>3</sub> adenosine subtype</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fjcp.20994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17348028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFKlt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2007&pages=826-836&author=S.+Gessiauthor=S.+Merighiauthor=K.+Varaniauthor=E.+Cattabrigaauthor=A.+Beniniauthor=P.+Mirandolaauthor=E.+Leungauthor=S.+Mac+Lennanauthor=C.+Feoauthor=S.+Baraldiauthor=P.+A.+Borea&title=Adenosine+receptors+in+colon+carcinoma+tissues+and+colon+tumoral+cell+lines%3A+focus+on+the+A3+adenosine+subtype"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in colon carcinoma tissue and colon tumor cell lines: focus on the A3 adenosine subtype</span></div><div class="casAuthors">Gessi, Stefania; Merighi, Stefania; Varani, Katia; Cattabriga, Elena; Benini, Annalisa; Mirandola, Prisco; Leung, Edward; MacLennan, Stephen; Feo, Carlo; Baraldi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">826-836</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Adenosine may affect several pathophysiol. processes, including cell proliferation, through interaction with A1, A2A, A2B, and A3 receptors.  In this study the authors characterized adenosine receptors in human colon cancer tissues and in colon cancer cell lines Caco-2, DLD-1, HT-29. mRNA of all adenosine subtypes was detected in cancer tissues and cell lines.  The mRNAs of all adenosine subtypes were detected in cancer tissues and cell lines.  At protein level, low amts. of A1, A2A, and A2B receptors were detected, whereas the A3 receptor was the most abundant subtype in both cancer tissue and the cell lines.  All the receptors were coupled to stimulation/inhibition of adenylate cyclase in cancer cells, with the exception of the A1 subtype.  Adenosine increased cell proliferation with an EC50 of 3-12 μM in cancer cells.  This effect was not essentially reduced by adenosine receptor antagonists.  However dipyridamole, an adenosine transport inhibitor, increased the stimulatory effect induced by adenosine, suggesting an action at the cell surface.  Addn. of adenosine deaminase makes the A3 agonist 2-chloro-N6-(3-iodobenzyl)-N-methyl-5'-carbamoyladenosine (CI-IB-MECA) able to stimulate cell proliferation with an EC50 of 0.5-0.9 nM in cancer cells, suggesting a tonic proliferative effect induced by endogenous adenosine.  This effect was antagonized by 5-N-(4-methoxyphenyl-carbamoyl)amino-8-propyl-2(2furyl)-pyrazolo-[4,3e]-1,2,4-triazolo [1,5-c] pyrimidine (MRE 3008F20) 10 nM.  CI-IB-MECA-stimulated cell proliferation involved extracellular-signal-regulated-kinases (ERK 1/2) pathway, as demonstrated by redn. of proliferation with 1,4-diamino-2,3-dicyano-1,4-bis-2[-amino-phenylthio]-butadiene (U0126) and by ERK 1/2 phosphorylation.  In conclusion this study indicates for the first time that in colon cancer cell lines endogenous adenosine, through the interaction with A3 receptors, mediates a tonic proliferative effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv93CBiqqqa7Vg90H21EOLACvtfcHk0liJMyTf8GwLmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFKlt7o%253D&md5=456c5a736491c462b862075d1ba52ac3</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1002%2Fjcp.20994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.20994%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac%2BLennan%26aufirst%3DS.%26aulast%3DFeo%26aufirst%3DC.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptors%2520in%2520colon%2520carcinoma%2520tissues%2520and%2520colon%2520tumoral%2520cell%2520lines%253A%2520focus%2520on%2520the%2520A3%2520adenosine%2520subtype%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2007%26volume%3D211%26spage%3D826%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span> </span><span class="NLM_article-title">An agonist to the A<sub>3</sub> adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2465</span><span class="NLM_x">–</span> <span class="NLM_lpage">2471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2465-2471&author=P.+Fishmanauthor=S.+Bar-Yehudaauthor=G.+Ohanaauthor=F.+Barerauthor=A.+Ochaionauthor=A.+Erlangerauthor=L.+Madi&title=An+agonist+to+the+A3+adenosine+receptor+inhibits+colon+carcinoma+growth+in+mice+via+modulation+of+GSK-3+beta+and+NF-kappa+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DOhana%26aufirst%3DG.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DErlanger%26aufirst%3DA.%26aulast%3DMadi%26aufirst%3DL.%26atitle%3DAn%2520agonist%2520to%2520the%2520A3%2520adenosine%2520receptor%2520inhibits%2520colon%2520carcinoma%2520growth%2520in%2520mice%2520via%2520modulation%2520of%2520GSK-3%2520beta%2520and%2520NF-kappa%2520B%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2465%26epage%3D2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Aghaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panjehpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karami-Tehrani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salami, S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of A<sub>3</sub> adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway</span> <span class="citation_source-journal">J. Cancer Res. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2011&pages=1511-1523&author=M.+Aghaeiauthor=M.+Panjehpourauthor=F.+Karami-Tehraniauthor=S.+Salami&title=Molecular+mechanisms+of+A3+adenosine+receptor-induced+G1+cell+cycle+arrest+and+apoptosis+in+androgen-dependent+and+independent+prostate+cancer+cell+lines%3A+involvement+of+intrinsic+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAghaei%26aufirst%3DM.%26aulast%3DPanjehpour%26aufirst%3DM.%26aulast%3DKarami-Tehrani%26aufirst%3DF.%26aulast%3DSalami%26aufirst%3DS.%26atitle%3DMolecular%2520mechanisms%2520of%2520A3%2520adenosine%2520receptor-induced%2520G1%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520androgen-dependent%2520and%2520independent%2520prostate%2520cancer%2520cell%2520lines%253A%2520involvement%2520of%2520intrinsic%2520pathway%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D137%26spage%3D1511%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinozuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, M.</span><span> </span><span class="NLM_article-title">Antitumor effect of cordycepin (3′-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A<sub>3</sub> receptor stimulation</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16475677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ahsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=43-47&author=K.+Nakamuraauthor=N.+Yoshikawaauthor=Y.+Yamaguchiauthor=S.+Kagotaauthor=K.+Shinozukaauthor=M.+Kunitomo&title=Antitumor+effect+of+cordycepin+%283%E2%80%B2-deoxyadenosine%29+on+mouse+melanoma+and+lung+carcinoma+cells+involves+adenosine+A3+receptor+stimulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation</span></div><div class="casAuthors">Nakamura, Kazuki; Yoshikawa, Noriko; Yamaguchi, Yu; Kagota, Satomi; Shinozuka, Kazumasa; Kunitomo, Masaru</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">43-47</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">An attempt was made to elucidate the mol. target for the antitumor effects of cordycepin (3'-deoxyadenosine) using non-selective and selective adenosine A1, A2a, A2b and A3 receptor agonists and antagonists.  Although adenosine and 2'-deoxyadenosine (up to 100 μM) had no effect, cordycepin showed remarkable inhibitory effects on the growth curves of B16-BL6 mouse melanoma (IC50=39 μM) and mouse Lewis lung carcinoma (IC50=48 μM) cell lines in vitro.  Among the adenosine receptor agonists and antagonists used (up to 100 μM), only 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (Cl-IB-MECA), a selective adenosine A3 receptor agonist, notably inhibited the growth of both mouse tumor cell lines (B16-BL6; IC50=5 μM, LLC; 14 μM).  In addn., the tumor growth inhibitory effect of cordycepin was antagonized by 3-Et 5-benzyl 2-methyl-6-phenyl-4-phenylethynyl-1,4-(±)-dihydropyridine-3,5-dicarboxylate (MRS1191), a selective adenosine A3 receptor antagonist.  These results suggest that cordycepin exerts inhibitory effects on the growth of mouse melanoma and lung carcinoma cells by stimulating adenosine A3 receptors on tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4h5j66E8iKLVg90H21EOLACvtfcHk0liJMyTf8GwLmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ahsbs%253D&md5=765439863391ececd07e01261bd0eca1</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYoshikawa%26aufirst%3DN.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DKagota%26aufirst%3DS.%26aulast%3DShinozuka%26aufirst%3DK.%26aulast%3DKunitomo%26aufirst%3DM.%26atitle%3DAntitumor%2520effect%2520of%2520cordycepin%2520%25283%25E2%2580%25B2-deoxyadenosine%2529%2520on%2520mouse%2520melanoma%2520and%2520lung%2520carcinoma%2520cells%2520involves%2520adenosine%2520A3%2520receptor%2520stimulation%26jtitle%3DAnticancer%2520Res.%26date%3D2006%26volume%3D26%26spage%3D43%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, K.</span><span> </span><span class="NLM_article-title">An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6413</span><span class="NLM_x">–</span> <span class="NLM_lpage">6423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6413-6423&author=J.+Luauthor=A.+Pierronauthor=K.+Ravid&title=An+adenosine+analogue%2C+IB-MECA%2C+down-regulates+estrogen+receptor+alpha+and+suppresses+human+breast+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPierron%26aufirst%3DA.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DAn%2520adenosine%2520analogue%252C%2520IB-MECA%252C%2520down-regulates%2520estrogen%2520receptor%2520alpha%2520and%2520suppresses%2520human%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6413%26epage%3D6423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=894-903&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+MacLennanauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=A3+adenosine+receptors+modulate+hypoxia-inducible+factor-1alpha+expression+in+human+A375+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMacLennan%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520adenosine%2520receptors%2520modulate%2520hypoxia-inducible%2520factor-1alpha%2520expression%2520in%2520human%2520A375%2520melanoma%2520cells%26jtitle%3DNeoplasia%26date%3D2005%26volume%3D7%26spage%3D894%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gafa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavazzini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liboni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac-Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Elevated expression of A<sub>3</sub> adenosine receptors in human colorectal cancer is reflected in peripheral blood cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5895</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1158%2F1078-0432.CCR-1134-03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15355922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlyjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=5895-5901&author=S.+Gessiauthor=E.+Cattabrigaauthor=A.+Avitabileauthor=R.+Gafaauthor=G.+Lanzaauthor=L.+Cavazziniauthor=N.+Bianchiauthor=R.+Gambariauthor=C.+Feoauthor=A.+Liboniauthor=S.+Gulliniauthor=E.+Leungauthor=S.+Mac-Lennanauthor=P.+A.+Borea&title=Elevated+expression+of+A3+adenosine+receptors+in+human+colorectal+cancer+is+reflected+in+peripheral+blood+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells</span></div><div class="casAuthors">Gessi, Stefania; Cattabriga, Elena; Avitabile, Arianna; Gafa', Roberta; Lanza, Giovanni; Cavazzini, Luigi; Bianchi, Nicoletta; Gambari, Roberto; Feo, Carlo; Liboni, Alberto; Gullini, Sergio; Leung, Edward; Mac-Lennan, Stephen; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5895-5901</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Adenosine is a ubiquitous nucleoside that accumulates at high levels in hypoxic regions of solid tumors, and A3 adenosine receptors have been recently demonstrated to play a pivotal role in the adenosine-mediated inhibition of tumor cell proliferation.  In the present work, the authors addressed the question of the putative relevance of A3 subtypes in colorectal adenocarcinomas.  Seventy-three paired samples of tumor and surrounding peritumoral normal mucosa at a distance of 2 and 10 cm from the tumor and blood samples obtained from a cohort of 30 patients with colorectal cancer were investigated to det. the presence of A3 receptors by means of binding, immunocytochem., and real-time reverse transcription-polymerase chain reaction studies.  As measured by receptor binding assays, the d. of A3 receptor was higher in colon carcinomas as compared with normal mucosa originating from the same individuals (P < 0.05).  Overexpression of A3 receptors at the protein level was confirmed by immunohistochem. studies, whereas no changes in A3 mRNA accumulation in tumors as compared with the corresponding normal tissue were revealed.  The overexpression of A3 receptors in tumors was reflected in peripheral blood cells, where the d. was approx. 3-fold higher compared with healthy subjects (P < 0.01).  In a cohort of 10 patients studied longitudinally, expression of A3 receptors in circulating blood cells returned to normal after surgical resection for colorectal cancer.  This study provides the first evidence that A3 receptor plays a role in colon tumorigenesis and, more importantly, can potentially be used as a diagnostic marker or a therapeutic target for colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj5SEyiih0ZLVg90H21EOLACvtfcHk0lgeFVC6grorag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlyjtrY%253D&md5=90cd0af97ab52479832caad67e7f74f1</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-1134-03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-1134-03%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DAvitabile%26aufirst%3DA.%26aulast%3DGafa%26aufirst%3DR.%26aulast%3DLanza%26aufirst%3DG.%26aulast%3DCavazzini%26aufirst%3DL.%26aulast%3DBianchi%26aufirst%3DN.%26aulast%3DGambari%26aufirst%3DR.%26aulast%3DFeo%26aufirst%3DC.%26aulast%3DLiboni%26aufirst%3DA.%26aulast%3DGullini%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac-Lennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DElevated%2520expression%2520of%2520A3%2520adenosine%2520receptors%2520in%2520human%2520colorectal%2520cancer%2520is%2520reflected%2520in%2520peripheral%2520blood%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D5895%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Morello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, A.</span><span> </span><span class="NLM_article-title">Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells</span> <span class="citation_source-journal">J. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fjcp.21863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19562684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGrsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2009&pages=378-386&author=S.+Morelloauthor=R.+Sorrentinoauthor=A.+Portaauthor=G.+Forteauthor=A.+Popoloauthor=A.+Petrellaauthor=A.+Pinto&title=Cl-IB-MECA+enhances+TRAIL-induced+apoptosis+via+the+modulation+of+NF-kappaB+signalling+pathway+in+thyroid+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-κB signalling pathway in thyroid cancer cells</span></div><div class="casAuthors">Morello, Silvana; Sorrentino, Rosalinda; Porta, Amalia; Forte, Giovanni; Popolo, Ada; Petrella, Antonello; Pinto, Aldo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">378-386</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Apoptosis is an endogenous process that can be a useful anti-cancer tool.  This study aimed to investigate the effect of Cl-IB-MECA, adenosine receptor A3 agonist, on TRAIL-induced apoptosis of thyroid carcinoma cells.  Cl-IB-MECA enhanced TRAIL-mediated apoptosis in FRO but not in ARO cells.  This effect was correlated to higher expression levels of DR5 on FRO than ARO cells, that instead presented higher levels of decoy receptors, DcR1 and DcR2.  To understand the cross-talk between the effect of Cl-IB-MECA and TRAIL, we evaluated the nuclear translocation of p65 and c-Rel.  Since the dependency by NF-κB, TRAIL promoted the nuclear translocation of both p65 and c-Rel subunits.  However, the addn. of Cl-IB-MECA led to the predominant translocation of c-Rel after TRAIL addn.  Furthermore, Bcl-2, cFLIP and pAkt were lower induced than caspase-3 and -9 in FRO cells.  To discriminate a specific effect of TRAIL, we used tumor necrosis factor-alpha (TNF-α) with Cl-IB-MECA.  In this case, no synergism was obsd.  In addn., the effect of Cl-IB-MECA was not A3 receptor-dependent since its antagonists, MRS1191 and FA385, failed to block Cl-IB-MECA activity on TRAIL-treated FRO cells.  In conclusion, Cl-IB-MECA enhanced TRAIL-mediated apoptosis via NF-κB/c-Rel activation and DR5-dependent manner.  This study may shed light on a potential drug cocktail that may prove useful as anti-cancer in an in vivo animal model.  J. Cell. Physiol. 221: 378-386, 2009. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUyksL_rDp3LVg90H21EOLACvtfcHk0ljJ1bqsjR1Nlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGrsrrO&md5=82bbf12e3658f7f5634ef7faff8d4e8e</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21863%26sid%3Dliteratum%253Aachs%26aulast%3DMorello%26aufirst%3DS.%26aulast%3DSorrentino%26aufirst%3DR.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DForte%26aufirst%3DG.%26aulast%3DPopolo%26aufirst%3DA.%26aulast%3DPetrella%26aufirst%3DA.%26aulast%3DPinto%26aufirst%3DA.%26atitle%3DCl-IB-MECA%2520enhances%2520TRAIL-induced%2520apoptosis%2520via%2520the%2520modulation%2520of%2520NF-kappaB%2520signalling%2520pathway%2520in%2520thyroid%2520cancer%2520cells%26jtitle%3DJ.%2520Cell%2520Physiol.%26date%3D2009%26volume%3D221%26spage%3D378%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">CF102 an A<sub>3</sub> adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver</span> <span class="citation_source-journal">J. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">2438</span><span class="NLM_x">–</span> <span class="NLM_lpage">2447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fjcp.22593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21660967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Kqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=2438-2447&author=S.+Cohenauthor=S.+M.+Stemmerauthor=G.+Zozulyaauthor=A.+Ochaionauthor=R.+Patokaauthor=F.+Barerauthor=S.+Bar-Yehudaauthor=L.+Rath-Wolfsonauthor=K.+A.+Jacobsonauthor=P.+Fishman&title=CF102+an+A3+adenosine+receptor+agonist+mediates+anti-tumor+and+anti-inflammatory+effects+in+the+liver"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver</span></div><div class="casAuthors">Cohen, S.; Stemmer, S. M.; Zozulya, G.; Ochaion, A.; Patoka, R.; Barer, F.; Bar-Yehuda, S.; Rath-Wolfson, L.; Jacobson, K. A.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2438-2447</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Gi protein-assocd. A3 adenosine receptor (A3AR) is a member of the adenosine receptor family.  Selective agonists at the A3AR, such as CF101 and CF102 were found to induce anti-inflammatory and anti-cancer effects.  In this study, we examd. the differential effect of CF102 in pathol. conditions of the liver.  The anti-inflammatory protective effect of CF101 was tested in a model of liver inflammation induced by Con A (Con. A) and the anti-cancer effect of CF102 was examd. in vitro and in a xenograft animal model utilizing Hep-3B hepatocellular carcinoma (HCC) cells.  The mechanism of action was explored by following the expression levels of key signaling proteins in the inflamed and tumor liver tissues, utilizing Western blot (WB) anal.  In the liver inflammation model, CF102 (100 μg/kg) markedly reduced the secretion of serum glutamic oxaloacetic transaminase and serum glutamic pyruvic transaminase in comparison to the vehicle-treated group.  Mechanistically, CF102 treatment decreased the expression level of phosphorylated glycogen synthase kinase-3β, NF-κB, and TNF-α and prevented apoptosis in the liver.  This was demonstrated by decreased expression levels of Fas receptor (FasR) and of the pro-apoptotic proteins Bax and Bad in liver tissues.  In addn., CF102-induced apoptosis of Hep-3B cells both in vitro and in vivo via de-regulation of the PI3K-NF-κB signaling pathway, resulting in up-regulation of pro-apoptotic proteins.  Taken together, CF102 acts as a protective agent in liver inflammation and inhibits HCC tumor growth.  These results suggest that CF102 through its differential effect is a potential drug candidate to treat various pathol. liver conditions.  J. Cell. Physiol. 226: 2438-2447, 2011. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhxRxOl8p-VbVg90H21EOLACvtfcHk0ljJ1bqsjR1Nlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Kqtbk%253D&md5=944e3cf29e0de7903e62dd378c9c2aa4</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22593%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DStemmer%26aufirst%3DS.%2BM.%26aulast%3DZozulya%26aufirst%3DG.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DCF102%2520an%2520A3%2520adenosine%2520receptor%2520agonist%2520mediates%2520anti-tumor%2520and%2520anti-inflammatory%2520effects%2520in%2520the%2520liver%26jtitle%3DJ.%2520Cell%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D2438%26epage%3D2447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniscalco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tognon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via akt/nuclear factor-kappa b pathway</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1164%2Frccm.201006-0980OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20870754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslCku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2011&pages=522-530&author=K.+Varaniauthor=S.+Manieroauthor=F.+Vincenziauthor=M.+Targaauthor=A.+Stefanelliauthor=P.+Maniscalcoauthor=F.+Martiniauthor=M.+Tognonauthor=P.+A.+Borea&title=A3+receptors+are+overexpressed+in+pleura+from+patients+with+mesothelioma+and+reduce+cell+growth+via+akt%2Fnuclear+factor-kappa+b+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">A3 receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway</span></div><div class="casAuthors">Varani, Katia; Maniero, Stefania; Vincenzi, Fabrizio; Targa, Martina; Stefanelli, Angela; Maniscalco, Pio; Martini, Fernanda; Tognon, Mauro; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-530</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: A strong link has been established between exposure to asbestos and increased risk for pleural malignant mesothelioma (MM).  Adenosine plays a key role in inflammatory processes and cancer, where it is involved in the regulation of cell death and proliferation.  Objectives: The primary aim of this study was to investigate the presence of adenosine receptors (ARs) in human MM pleura (MMP) and healthy mesothelial pleura (HMP).  To shed some light on the interaction between adenosine and MM, the presence and functionality of ARs were explored in human healthy mesothelial cells (HMC) and in malignant mesothelioma cells (MMC).  Methods: ARs were analyzed by using reverse transcriptase-polymerase chain reaction, Western blotting, and satn. binding assays.  HMC were treated with crocidolite asbestos, which is the principal risk factor for MM.  The role of A3ARs on these cellular models, evaluating cAMP prodn., Akt phosphorylation, and nuclear factor (NF)-κB activation, was investigated.  The dual effect of A3AR stimulation on healthy and cancer cell growth was studied by means of proliferation, apoptosis, and cytotoxicity assays.  Measurements and Main Results: A3AR was up-regulated by 2.5-fold (P < 0.01) in MMP when compared with HMP.  Stimulation of A3ARs decreased proliferation and exerted a cytotoxic and proapoptotic effect on MMC and on HMC exposed to asbestos and tumor necrosis factor-α, but not on HMC with an involvement of the deregulation of Akt/NF-κB cell survival pathway.  Conclusions: These new findings suggest that A3AR could represent a pharmacol. target to prevent tumor development after asbestos exposure and to treat full-blown MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphUHRpPoSZerVg90H21EOLACvtfcHk0ljJ1bqsjR1Nlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslCku7o%253D&md5=cb4b02a5159c8083fe049a2d5deef55c</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1164%2Frccm.201006-0980OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201006-0980OC%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DManiero%26aufirst%3DS.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTarga%26aufirst%3DM.%26aulast%3DStefanelli%26aufirst%3DA.%26aulast%3DManiscalco%26aufirst%3DP.%26aulast%3DMartini%26aufirst%3DF.%26aulast%3DTognon%26aufirst%3DM.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520receptors%2520are%2520overexpressed%2520in%2520pleura%2520from%2520patients%2520with%2520mesothelioma%2520and%2520reduce%2520cell%2520growth%2520via%2520akt%252Fnuclear%2520factor-kappa%2520b%2520pathway%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2011%26volume%3D183%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of novel A<sub>3</sub> adenosine receptor-selective antagonists</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=1157-1165&author=K.+A.+Jacobsonauthor=K.+S.+Parkauthor=J.+L.+Jiangauthor=Y.+C.+Kimauthor=M.+E.+Olahauthor=G.+L.+Stilesauthor=X.+D.+Ji&title=Pharmacological+characterization+of+novel+A3+adenosine+receptor-selective+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DJiang%26aufirst%3DJ.%2BL.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJi%26aufirst%3DX.%2BD.%26atitle%3DPharmacological%2520characterization%2520of%2520novel%2520A3%2520adenosine%2520receptor-selective%2520antagonists%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D1157%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Molfino, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, P. K.</span><span> </span><span class="NLM_article-title">Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.pupt.2006.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16798034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFylu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=462-472&author=N.+A.+Molfinoauthor=P.+K.+Jeffery&title=Chronic+obstructive+pulmonary+disease%3A+histopathology%2C+inflammation+and+potential+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapies</span></div><div class="casAuthors">Molfino, Nestor A.; Jeffery, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">462-472</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic obstructive pulmonary disease (COPD) is a major worldwide health burden with increasing morbidity, mortality and health care cost.  It is a slowly progressive chronic inflammatory condition that affects the conducting airways (both large and small) and lung parenchyma.  In COPD, inflammation is evident early on even in mild disease and increases with disease severity.  Recent advances in our knowledge demonstrate, by comparison with asthma, the distinctive, "abnormal" or exaggerated inflammatory processes involved in the pathogenesis of COPD and thus identify novel therapeutic targets that could potentially impact on disease progression.  The present review will focus on what is known of the abnormal inflammatory response of COPD in different regions of the conducting airways and lung.  Novel, potentially promising approaches to therapy are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-my6d1XFKB7Vg90H21EOLACvtfcHk0ljqN7Awv3lp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFylu7c%253D&md5=ffe793aec2129444427c6ac3204b0cb2</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2006.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2006.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMolfino%26aufirst%3DN.%2BA.%26aulast%3DJeffery%26aufirst%3DP.%2BK.%26atitle%3DChronic%2520obstructive%2520pulmonary%2520disease%253A%2520histopathology%252C%2520inflammation%2520and%2520potential%2520therapies%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D20%26spage%3D462%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">David, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadurina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gospodinov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlotsky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yankova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzeva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial</span> <span class="citation_source-journal">J. Eur. Acad. Dermatol. Venereol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1111%2Fj.1468-3083.2011.04078.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21504485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2rtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=361-367&author=M.+Davidauthor=L.+Akermanauthor=M.+Zivauthor=M.+Kadurinaauthor=D.+Gospodinovauthor=F.+Pavlotskyauthor=R.+Yankovaauthor=V.+Kouzevaauthor=M.+Ramonauthor=M.+Silvermanauthor=P.+Fishman&title=Treatment+of+plaque-type+psoriasis+with+oral+CF101%3A+data+from+an+exploratory+randomized+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial</span></div><div class="casAuthors">David, M.; Akerman, L.; Ziv, M.; Kadurina, M.; Gospodinov, D.; Pavlotsky, F.; Yankova, R.; Kouzeva, V.; Ramon, M.; Silverman, M. H.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the European Academy of Dermatology and Venereology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-367</span>CODEN:
                <span class="NLM_cas:coden">JEAVEQ</span>;
        ISSN:<span class="NLM_cas:issn">1468-3083</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims CF101 demonstrated a marked anti-inflammatory effect in Phase 2 studies conducted in patients with rheumatoid arthritis and dry eye syndrome.  The aim of this study was to evaluate the safety and efficacy of CF101 for the treatment of patients with moderate to severe plaque-type psoriasis.  Materials and methods This was a phase 2, multicentre, randomized, double-blind, dose-ranging, placebo-controlled study.  Seventy five patients with moderate to severe plaque-type psoriasis were enrolled, randomized and treated with CF101 (1, 2, or 4 mg) or placebo administered orally twice daily for 12 wk.  Safety and change from base line of Psoriasis Area and Severity Index (PASI) score and physician's global assessment (PGA) score over 12 wk.  Results In the 2 mg CF101-treated group, a progressive improvement in the mean change from baseline in the PASI score vs. placebo throughout the study period was obsd., with a statistically significant difference on weeks 8 and 12 (P = 0.047; P = 0.031, resp.).  In this group, 35.3% of the patients achieved PASI ≥50 response, and 23.5% of the patients achieved a PGA score of 0 or 1.  CF101 was safe and well tolerated.  Conclusions CF101 was well tolerated and demonstrated clear evidence of efficacy in patients with moderate to severe plaque psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt2cC_yV2sT7Vg90H21EOLACvtfcHk0ljqN7Awv3lp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2rtrw%253D&md5=a1223babba9d6115871e97952e3b7ab2</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-3083.2011.04078.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-3083.2011.04078.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DM.%26aulast%3DAkerman%26aufirst%3DL.%26aulast%3DZiv%26aufirst%3DM.%26aulast%3DKadurina%26aufirst%3DM.%26aulast%3DGospodinov%26aufirst%3DD.%26aulast%3DPavlotsky%26aufirst%3DF.%26aulast%3DYankova%26aufirst%3DR.%26aulast%3DKouzeva%26aufirst%3DV.%26aulast%3DRamon%26aufirst%3DM.%26aulast%3DSilverman%26aufirst%3DM.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DTreatment%2520of%2520plaque-type%2520psoriasis%2520with%2520oral%2520CF101%253A%2520data%2520from%2520an%2520exploratory%2520randomized%2520phase%25202%2520clinical%2520trial%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2012%26volume%3D26%26spage%3D361%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Avni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzozi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barequet, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segev, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varssano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetrit, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadok, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomkins, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farbstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yehuda, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial</span> <span class="citation_source-journal">Ophthalmology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">1287</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2010&pages=1287-1293&author=I.+Avniauthor=H.+J.+Garzoziauthor=I.+S.+Barequetauthor=F.+Segevauthor=D.+Varssanoauthor=G.+Sartaniauthor=N.+Chetritauthor=E.+Bakshiauthor=D.+Zadokauthor=O.+Tomkinsauthor=G.+Litvinauthor=K.+A.+Jacobsonauthor=S.+Fishmanauthor=Z.+Harpazauthor=M.+Farbsteinauthor=S.+B.+Yehudaauthor=M.+H.+Silvermanauthor=W.+D.+Kernsauthor=D.+R.+Bristolauthor=I.+Cohnauthor=P.+Fishman&title=Treatment+of+dry+eye+syndrome+with+orally+administered+CF101%3A+data+from+a+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvni%26aufirst%3DI.%26aulast%3DGarzozi%26aufirst%3DH.%2BJ.%26aulast%3DBarequet%26aufirst%3DI.%2BS.%26aulast%3DSegev%26aufirst%3DF.%26aulast%3DVarssano%26aufirst%3DD.%26aulast%3DSartani%26aufirst%3DG.%26aulast%3DChetrit%26aufirst%3DN.%26aulast%3DBakshi%26aufirst%3DE.%26aulast%3DZadok%26aufirst%3DD.%26aulast%3DTomkins%26aufirst%3DO.%26aulast%3DLitvin%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DFishman%26aufirst%3DS.%26aulast%3DHarpaz%26aufirst%3DZ.%26aulast%3DFarbstein%26aufirst%3DM.%26aulast%3DYehuda%26aufirst%3DS.%2BB.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DKerns%26aufirst%3DW.%2BD.%26aulast%3DBristol%26aufirst%3DD.%2BR.%26aulast%3DCohn%26aufirst%3DI.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DTreatment%2520of%2520dry%2520eye%2520syndrome%2520with%2520orally%2520administered%2520CF101%253A%2520data%2520from%2520a%2520phase%25202%2520clinical%2520trial%26jtitle%3DOphthalmology%26date%3D2010%26volume%3D117%26spage%3D1287%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Pharmacological and therapeutic effects of A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.drudis.2011.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=22033198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=359-366&author=P.+Fishmanauthor=S.+Bar-Yehudaauthor=B.+T.+Liangauthor=K.+A.+Jacobson&title=Pharmacological+and+therapeutic+effects+of+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and therapeutic effects of A3 adenosine receptor agonists</span></div><div class="casAuthors">Fishman, Pnina; Bar-Yehuda, Sara; Liang, Bruce T.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">359-366</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The A3 adenosine receptor (A3AR) coupled to Gi (inhibitory regulative guanine nucleotide-binding protein) mediates anti-inflammatory, anticancer and anti-ischemic protective effects.  The receptor is overexpressed in inflammatory and cancer cells, while low expression is found in normal cells, rendering the A3AR as a potential therapeutic target.  Highly selective A3AR agonists have been synthesized and mol. recognition in the binding site has been characterized.  In this article, we summarize preclin. and clin. human studies that demonstrate that A3AR agonists induce specific anti-inflammatory and anticancer effects through a mol. mechanism that entails modulation of the Wnt and the NF-κB signal transduction pathways.  At present, A3AR agonists are being developed for the treatment of inflammatory diseases, including rheumatoid arthritis (RA) and psoriasis; ophthalmic diseases such as dry eye syndrome and glaucoma; liver diseases such as hepatocellular carcinoma and hepatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBCdToPXU4m7Vg90H21EOLACvtfcHk0ljqN7Awv3lp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2isbw%253D&md5=b7278bf446f320ca621a93dff383ca13</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DB.%2BT.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DPharmacological%2520and%2520therapeutic%2520effects%2520of%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D359%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Ohana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreznick, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slosman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Inhibition of primary colon carcinoma growth and liver metastasis by the A<sub>3</sub> adenosine receptor agonist CF101</span> <span class="citation_source-journal">Br. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1552</span><span class="NLM_x">–</span> <span class="NLM_lpage">1558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjc.6601315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=14562031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFeksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2003&pages=1552-1558&author=G.+Ohanaauthor=S.+Bar-Yehudaauthor=A.+Arichauthor=L.+Madiauthor=Z.+Dreznickauthor=L.+Rath-Wolfsonauthor=D.+Silbermanauthor=G.+Slosmanauthor=P.+Fishman&title=Inhibition+of+primary+colon+carcinoma+growth+and+liver+metastasis+by+the+A3+adenosine+receptor+agonist+CF101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101</span></div><div class="casAuthors">Ohana, G.; Bar-Yehuda, S.; Arich, A.; Madi, L.; Dreznick, Z.; Rath-Wolfson, L.; Silberman, D.; Slosman, G.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1552-1558</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine is a purine nucleoside that acts as a regulatory mol. by binding to specific G-protein-coupled A1, A2A, A2B, and A3 cell surface receptors.  We have recently demonstrated that adenosine inhibits tumor cell growth and concomitantly stimulates bone marrow cell proliferation via activation of the A3 adenosine receptor (A3AR).  In the present study, we show that a synthetic agonist to the A3AR, CF101, at the low nanomolar concn. range, inhibits HCT-116 human colon carcinoma cell growth.  This effect was reversed by the selective A3AR antagonist MRS1523, demonstrating the specificity of the response.  CF101 (given orally) was efficacious in inhibiting the development of primary tumors in xenograft and syngeneic models in which mice were inoculated s.c. with human HCT-116 or murine CT-26 colon carcinoma cells, resp.  Moreover, CF101 suppressed (50%, P<0.01) colon cancer liver metastases in syngeneic mice inoculated to the spleen with CT-26 cells.  The mechanism of action entailed upregulation of interleukin-12 prodn. in the CF101-treated groups and potentiation of NK cell activity.  In the HCT-116 xenograft model in which a combined therapy of CF101 and 5-fluorouracil (5-FU) was examd., an additive antitumor effect was demonstrated.  Moreover, CF101 prevented the 5-FU-induced myelotoxicity, resulting in normal values of white blood cell and neutrophil counts.  We conclude that the A3AR agonist CF101, a small orally bioavailable mol., exerts systemic anticancer, antimetastatic, and myeloprotective effects in colon carcinoma-bearing mice, and may serve as an adjuvant treatment to enhance the chemotherapeutic index and prevent myelotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnpNJyI8jnaLVg90H21EOLACvtfcHk0lgHlyQqYHCoXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFeksbY%253D&md5=b3be6d639812d415184b7c6b7806dc28</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601315%26sid%3Dliteratum%253Aachs%26aulast%3DOhana%26aufirst%3DG.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DArich%26aufirst%3DA.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DDreznick%26aufirst%3DZ.%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DSilberman%26aufirst%3DD.%26aulast%3DSlosman%26aufirst%3DG.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520primary%2520colon%2520carcinoma%2520growth%2520and%2520liver%2520metastasis%2520by%2520the%2520A3%2520adenosine%2520receptor%2520agonist%2520CF101%26jtitle%3DBr.%2520J.%2520Cancer.%26date%3D2003%26volume%3D89%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shkapenuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">CF101, an agonist to the A<sub>3</sub> adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=85-90&author=S.+Bar-Yehudaauthor=L.+Madiauthor=D.+Silbermanauthor=S.+Geryauthor=M.+Shkapenukauthor=P.+Fishman&title=CF101%2C+an+agonist+to+the+A3+adenosine+receptor%2C+enhances+the+chemotherapeutic+effect+of+5-fluorouracil+in+a+colon+carcinoma+murine+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DSilberman%26aufirst%3DD.%26aulast%3DGery%26aufirst%3DS.%26aulast%3DShkapenuk%26aufirst%3DM.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DCF101%252C%2520an%2520agonist%2520to%2520the%2520A3%2520adenosine%2520receptor%252C%2520enhances%2520the%2520chemotherapeutic%2520effect%2520of%25205-fluorouracil%2520in%2520a%2520colon%2520carcinoma%2520murine%2520model%26jtitle%3DNeoplasia%26date%3D2005%26volume%3D7%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabutti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Liz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18636149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2lsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=287-295&author=S.+Bar-Yehudaauthor=S.+M.+Stemmerauthor=L.+Madiauthor=D.+Castelauthor=A.+Ochaionauthor=S.+Cohenauthor=F.+Barerauthor=A.+Zabuttiauthor=G.+Perez-Lizauthor=L.+Del+Valleauthor=P.+Fishman&title=The+A3+adenosine+receptor+agonist+CF102+induces+apoptosis+of+hepatocellular+carcinoma+via+de-regulation+of+the+Wnt+and+NF-kappaB+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-κB signal transduction pathways</span></div><div class="casAuthors">Bar-Yehuda, S.; Stemmer, S. M.; Madi, L.; Castel, D.; Ochaion, A.; Cohen, S.; Barer, F.; Zabutti, A.; Perez-Liz, G.; del Valle, L.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-295</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">The A3 adenosine receptor (A3AR) is highly expressed in tumors and was suggested as a target for cancer treatment.  In this study, we show that A3AR is highly expressed in tumor tissues and in peripheral blood mononuclear cells (PBMCs) derived from patients with HCC, as well as from HCC tumor-bearing rats.  The high expression level of the receptor was directly correlated to overexpression of NF-κB, known as a transcription factor of A3AR.  CF102, a synthetic highly selective agonist to A3AR induced a marked dose response inhibition of tumor growth in N1S1 HCC tumor rats, via de-regulation of the NF-κB and the Wnt signal transduction pathways, resulting in apoptosis of tumor cells.  Taken together, A3AR is highly expressed in tumors and PBMCs of HCC patients and tumor-bearing rats.  CF102 induced apoptosis and tumor growth inhibition.  These data suggest A3AR as a novel targeted therapy to treat HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9mAZahYskg7Vg90H21EOLACvtfcHk0lgHlyQqYHCoXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2lsbzE&md5=2a49857cc99edefa8cb69f62c7cf484e</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DStemmer%26aufirst%3DS.%2BM.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DCastel%26aufirst%3DD.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DZabutti%26aufirst%3DA.%26aulast%3DPerez-Liz%26aufirst%3DG.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520agonist%2520CF102%2520induces%2520apoptosis%2520of%2520hepatocellular%2520carcinoma%2520via%2520de-regulation%2520of%2520the%2520Wnt%2520and%2520NF-kappaB%2520signal%2520transduction%2520pathways%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2008%26volume%3D33%26spage%3D287%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 5944-5978. <a href="https://doi.org/10.1021/acs.jmedchem.8b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeted%252BTreatments%252Bfor%252BChronic%252BObstructive%252BPulmonary%252BDisease%252B%252528COPD%252529%252BUsing%252BLow-Molecular-Weight%252BDrugs%252B%252528LMWDs%252529%26aulast%3DTi%26aufirst%3DHuihui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30092018%26date%3D12022019%26date%3D25012019%26volume%3D62%26issue%3D13%26spage%3D5944%26epage%3D5978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jhonny  Azuaje</span>, <span class="hlFld-ContribAuthor ">Willem  Jespers</span>, <span class="hlFld-ContribAuthor ">Vicente  Yaziji</span>, <span class="hlFld-ContribAuthor ">Ana  Mallo</span>, <span class="hlFld-ContribAuthor ">María  Majellaro</span>, <span class="hlFld-ContribAuthor ">Olga  Caamaño</span>, <span class="hlFld-ContribAuthor ">María I.  Loza</span>, <span class="hlFld-ContribAuthor ">María I.  Cadavid</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">Johan  Åqvist</span>, <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>, and <span class="hlFld-ContribAuthor ">Hugo  Gutiérrez-de-Terán</span>  . </span><span class="cited-content_cbyCitation_article-title">Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7502-7511. <a href="https://doi.org/10.1021/acs.jmedchem.7b00860" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00860%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffect%252Bof%252BNitrogen%252BAtom%252BSubstitution%252Bin%252BA3%252BAdenosine%252BReceptor%252BBinding%25253A%252BN-%2525284%25252C6-Diarylpyridin-2-yl%252529acetamides%252Bas%252BPotent%252Band%252BSelective%252BAntagonists%26aulast%3DAzuaje%26aufirst%3DJhonny%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13062017%26date%3D21082017%26date%3D14092017%26date%3D09082017%26volume%3D60%26issue%3D17%26spage%3D7502%26epage%3D7511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lizi  Xia</span>, <span class="hlFld-ContribAuthor ">Wessel A. C.  Burger</span>, <span class="hlFld-ContribAuthor ">Jacobus P. D.  van Veldhoven</span>, <span class="hlFld-ContribAuthor ">Boaz J.  Kuiper</span>, <span class="hlFld-ContribAuthor ">Tirsa T.  van Duijl</span>, <span class="hlFld-ContribAuthor ">Eelke B.  Lenselink</span>, <span class="hlFld-ContribAuthor ">Ellen  Paasman</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>, and <span class="hlFld-ContribAuthor ">Adriaan P.  IJzerman</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7555-7568. <a href="https://doi.org/10.1021/acs.jmedchem.7b00950" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00950%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Affinity%252BRelationships%252Band%252BStructure%2525E2%252580%252593Kinetics%252BRelationships%252Bof%252BPyrido%25255B2%25252C1-f%25255Dpurine-2%25252C4-dione%252BDerivatives%252Bas%252BHuman%252BAdenosine%252BA3%252BReceptor%252BAntagonists%26aulast%3DXia%26aufirst%3DLizi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28062017%26date%3D30082017%26date%3D14092017%26date%3D14082017%26volume%3D60%26issue%3D17%26spage%3D7555%26epage%3D7568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinha  Yu</span>, <span class="hlFld-ContribAuthor ">Long Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Jongmi  Park</span>, <span class="hlFld-ContribAuthor ">Hyuk Woo  Lee</span>, <span class="hlFld-ContribAuthor ">Pramod K.  Sahu</span>, <span class="hlFld-ContribAuthor ">Minghua  Cui</span>, <span class="hlFld-ContribAuthor ">Steven M.  Moss</span>, <span class="hlFld-ContribAuthor ">Eva  Hammes</span>, <span class="hlFld-ContribAuthor ">Eugene  Warnick</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Minsoo  Noh</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Hee-Chul  Ahn</span>, <span class="hlFld-ContribAuthor ">Jungwon  Choi</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, and <span class="hlFld-ContribAuthor ">Lak Shin  Jeong</span>  . </span><span class="cited-content_cbyCitation_article-title">N6-Substituted 5′-N-Methylcarbamoyl-4′-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (8)
                                     , 3422-3437. <a href="https://doi.org/10.1021/acs.jmedchem.7b00241" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00241%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN6-Substituted%252B5%2525E2%252580%2525B2-N-Methylcarbamoyl-4%2525E2%252580%2525B2-selenoadenosines%252Bas%252BPotent%252Band%252BSelective%252BA3%252BAdenosine%252BReceptor%252BAgonists%252Bwith%252BUnusual%252BSugar%252BPuckering%252Band%252BNucleobase%252BOrientation%26aulast%3DYu%26aufirst%3DJinha%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14022017%26date%3D19042017%26date%3D27042017%26date%3D05042017%26volume%3D60%26issue%3D8%26spage%3D3422%26epage%3D3437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Stefania  Baraldi</span>, <span class="hlFld-ContribAuthor ">Giulia  Saponaro</span>, <span class="hlFld-ContribAuthor ">Mojgan  Aghazadeh Tabrizi</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Emanuela  Ruggiero</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, and <span class="hlFld-ContribAuthor ">Katia  Varani</span>  . </span><span class="cited-content_cbyCitation_article-title">One-Pot Reaction To Obtain N,N′-Disubstituted Guanidines of Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold as Human A3 Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (13)
                                     , 5355-5360. <a href="https://doi.org/10.1021/acs.jmedchem.5b00551" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00551%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOne-Pot%252BReaction%252BTo%252BObtain%252BN%25252CN%2525E2%252580%2525B2-Disubstituted%252BGuanidines%252Bof%252BPyrazolo%25255B4%25252C3-e%25255D%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-c%25255Dpyrimidine%252BScaffold%252Bas%252BHuman%252BA3%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DBaraldi%26aufirst%3DPier%2BGiovanni%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08042015%26date%3D17062015%26date%3D09072015%26date%3D05062015%26volume%3D58%26issue%3D13%26spage%3D5355%26epage%3D5360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshata  Nayak</span>, <span class="hlFld-ContribAuthor ">Girish  Chandra</span>, <span class="hlFld-ContribAuthor ">Inah  Hwang</span>, <span class="hlFld-ContribAuthor ">Kyunglim  Kim</span>, <span class="hlFld-ContribAuthor ">Xiyan  Hou</span>, <span class="hlFld-ContribAuthor ">Hea Ok  Kim</span>, <span class="hlFld-ContribAuthor ">Pramod K.  Sahu</span>, <span class="hlFld-ContribAuthor ">Kuldeep K.  Roy</span>, <span class="hlFld-ContribAuthor ">Jakyung  Yoo</span>, <span class="hlFld-ContribAuthor ">Yoonji  Lee</span>, <span class="hlFld-ContribAuthor ">Minghua  Cui</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Steven M.  Moss</span>, <span class="hlFld-ContribAuthor ">Khai  Phan</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Hunjoo  Ha</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, and <span class="hlFld-ContribAuthor ">Lak Shin  Jeong</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-Renal Fibrosis Activity of Conformationally Locked Truncated 2-Hexynyl-N6-Substituted-(N)-Methanocarba-nucleosides as A3 Adenosine Receptor Antagonists and Partial Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1344-1354. <a href="https://doi.org/10.1021/jm4015313" title="DOI URL">https://doi.org/10.1021/jm4015313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4015313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4015313%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnti-Renal%252BFibrosis%252BActivity%252Bof%252BConformationally%252BLocked%252BTruncated%252B2-Hexynyl-N6-Substituted-%252528N%252529-Methanocarba-nucleosides%252Bas%252BA3%252BAdenosine%252BReceptor%252BAntagonists%252Band%252BPartial%252BAgonists%26aulast%3DNayak%26aufirst%3DAkshata%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D02102013%26date%3D05022014%26date%3D27022014%26date%3D24012014%26volume%3D57%26issue%3D4%26spage%3D1344%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Approaches to Ligands for G-Protein-Coupled Adenosine and P2Y Receptors, from Small Molecules to Nanoconjugates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3749-3767. <a href="https://doi.org/10.1021/jm400422s" title="DOI URL">https://doi.org/10.1021/jm400422s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400422s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400422s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BApproaches%252Bto%252BLigands%252Bfor%252BG-Protein-Coupled%252BAdenosine%252Band%252BP2Y%252BReceptors%25252C%252Bfrom%252BSmall%252BMolecules%252Bto%252BNanoconjugates%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22032013%26date%3D09052013%26date%3D23052013%26date%3D18042013%26volume%3D56%26issue%3D10%26spage%3D3749%26epage%3D3767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiwin Is  Effendi</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Nagano</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Nishimura</span>. </span><span class="cited-content_cbyCitation_article-title">Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     , 785. <a href="https://doi.org/10.3390/cells9030785" title="DOI URL">https://doi.org/10.3390/cells9030785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9030785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9030785%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DFocusing%252Bon%252BAdenosine%252BReceptors%252Bas%252Ba%252BPotential%252BTargeted%252BTherapy%252Bin%252BHuman%252BDiseases%26aulast%3DEffendi%26aufirst%3DWiwin%2BIs%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D3%26spage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christa E.  Müller</span>, <span class="hlFld-ContribAuthor ">Younis  Baqi</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>. </span><span class="cited-content_cbyCitation_article-title">Agonists and Antagonists for Purinergic Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 45-64. <a href="https://doi.org/10.1007/978-1-4939-9717-6_3" title="DOI URL">https://doi.org/10.1007/978-1-4939-9717-6_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9717-6_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9717-6_3%26sid%3Dliteratum%253Aachs%26atitle%3DAgonists%252Band%252BAntagonists%252Bfor%252BPurinergic%252BReceptors%26aulast%3DM%25C3%25BCller%26aufirst%3DChrista%2BE.%26date%3D2020%26date%3D2019%26spage%3D45%26epage%3D64%26pub%3DSpringer%2520New%2520York%26atitle%3DPurinergic%252BSignaling%26aulast%3DPelegr%25C3%25ADn%26aufirst%3DPablo%26date%3D2020%26volume%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pabitra Narayan  Samanta</span>, <span class="hlFld-ContribAuthor ">Supratik  Kar</span>, <span class="hlFld-ContribAuthor ">Jerzy  Leszczynski</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (7)
                                     , 750-773. <a href="https://doi.org/10.2174/1381612825666190304123545" title="DOI URL">https://doi.org/10.2174/1381612825666190304123545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190304123545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190304123545%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DRecent%252BAdvances%252Bof%252BIn-Silico%252BModeling%252Bof%252BPotent%252BAntagonists%252Bfor%252Bthe%252BAdenosine%252BReceptors%26aulast%3DSamanta%26aufirst%3DPabitra%2BNarayan%26date%3D2019%26volume%3D25%26issue%3D7%26spage%3D750%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flavia  Varano</span>, <span class="hlFld-ContribAuthor ">Daniela  Catarzi</span>, <span class="hlFld-ContribAuthor ">Matteo  Falsini</span>, <span class="hlFld-ContribAuthor ">Diego  Dal Ben</span>, <span class="hlFld-ContribAuthor ">Michela  Buccioni</span>, <span class="hlFld-ContribAuthor ">Gabriella  Marucci</span>, <span class="hlFld-ContribAuthor ">Rosaria  Volpini</span>, <span class="hlFld-ContribAuthor ">Vittoria  Colotta</span>. </span><span class="cited-content_cbyCitation_article-title">Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 563-569. <a href="https://doi.org/10.1016/j.bmcl.2018.12.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bhuman%252Badenosine%252Breceptor%252Bantagonists%252Bbased%252Bon%252Bthe%252B7-amino-thiazolo%25255B5%25252C4-d%25255Dpyrimidine%252Bscaffold.%252BStructural%252Binvestigations%252Bat%252Bthe%252B2-%25252C%252B5-%252Band%252B7-positions%252Bto%252Benhance%252Baffinity%252Band%252Btune%252Bselectivity%26aulast%3DVarano%26aufirst%3DFlavia%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D563%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jolien  Storme</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Christophe P.  Stove</span>. </span><span class="cited-content_cbyCitation_article-title">Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>158 </em>, 103-113. <a href="https://doi.org/10.1016/j.bcp.2018.10.003" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DProbing%252Bstructure-activity%252Brelationship%252Bin%252B%2525CE%2525B2-arrestin2%252Brecruitment%252Bof%252Bdiversely%252Bsubstituted%252Badenosine%252Bderivatives%26aulast%3DStorme%26aufirst%3DJolien%26date%3D2018%26volume%3D158%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Stefania  Merighi</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Stefania  Baraldi</span>, <span class="hlFld-ContribAuthor ">Mojgan  Aghazadeh Tabrizi</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Stefania  Gessi</span>. </span><span class="cited-content_cbyCitation_article-title">A
              3
              Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (4)
                                     , 1031-1072. <a href="https://doi.org/10.1002/med.21456" title="DOI URL">https://doi.org/10.1002/med.21456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21456%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DA%252B3%252BAdenosine%252BReceptors%252Bas%252BModulators%252Bof%252BInflammation%25253A%252BFrom%252BMedicinal%252BChemistry%252Bto%252BTherapy%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D1031%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bidisha  Sarkar</span>, <span class="hlFld-ContribAuthor ">Santanu  Maiti</span>, <span class="hlFld-ContribAuthor ">Gajanan Raosaheb  Jadhav</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzothiazolylquinoline conjugates as novel human A
              3
              receptor antagonists: biological evaluations and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Royal Society Open Science</span><span> <strong>2018,</strong> <em>5 </em>
                                    (2)
                                     , 171622. <a href="https://doi.org/10.1098/rsos.171622" title="DOI URL">https://doi.org/10.1098/rsos.171622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsos.171622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsos.171622%26sid%3Dliteratum%253Aachs%26jtitle%3DRoyal%2520Society%2520Open%2520Science%26atitle%3DDiscovery%252Bof%252Bbenzothiazolylquinoline%252Bconjugates%252Bas%252Bnovel%252Bhuman%252BA%252B3%252Breceptor%252Bantagonists%25253A%252Bbiological%252Bevaluations%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DSarkar%26aufirst%3DBidisha%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D2%26spage%3D171622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefania  Baraldi</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Paola  Oliva</span>, <span class="hlFld-ContribAuthor ">Kiran S.  Toti</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">A2A Adenosine Receptor: Structures, Modeling, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 91-136. <a href="https://doi.org/10.1007/978-3-319-90808-3_5" title="DOI URL">https://doi.org/10.1007/978-3-319-90808-3_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-90808-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-90808-3_5%26sid%3Dliteratum%253Aachs%26atitle%3DA2A%252BAdenosine%252BReceptor%25253A%252BStructures%25252C%252BModeling%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBaraldi%26aufirst%3DStefania%26date%3D2018%26date%3D2018%26spage%3D91%26epage%3D136%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BAdenosine%252BReceptors%26aulast%3DBorea%26aufirst%3DPier%2BAndrea%26date%3D2018%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Willem  Jespers</span>, <span class="hlFld-ContribAuthor ">Ana  Oliveira</span>, <span class="hlFld-ContribAuthor ">Rubén  Prieto-Díaz</span>, <span class="hlFld-ContribAuthor ">María  Majellaro</span>, <span class="hlFld-ContribAuthor ">Johan  Åqvist</span>, <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>, <span class="hlFld-ContribAuthor ">Hugo  Gutiérrez-de-Terán</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1945. <a href="https://doi.org/10.3390/molecules22111945" title="DOI URL">https://doi.org/10.3390/molecules22111945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22111945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22111945%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BDesign%252Bof%252BPotent%252Band%252BSelective%252BLigands%252Bat%252Bthe%252BFour%252BAdenosine%252BReceptors%26aulast%3DJespers%26aufirst%3DWillem%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Schmidt</span>, <span class="hlFld-ContribAuthor ">Polonca  Ferk</span>. </span><span class="cited-content_cbyCitation_article-title">Safety issues of compounds acting on adenosinergic signalling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2017,</strong> <em>69 </em>
                                    (7)
                                     , 790-806. <a href="https://doi.org/10.1111/jphp.12720" title="DOI URL">https://doi.org/10.1111/jphp.12720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.12720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.12720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DSafety%252Bissues%252Bof%252Bcompounds%252Bacting%252Bon%252Badenosinergic%252Bsignalling%26aulast%3DSchmidt%26aufirst%3DJan%26date%3D2017%26date%3D2017%26volume%3D69%26issue%3D7%26spage%3D790%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Oyarzún</span>, <span class="hlFld-ContribAuthor ">Wallys  Garrido</span>, <span class="hlFld-ContribAuthor ">Sebastián  Alarcón</span>, <span class="hlFld-ContribAuthor ">Alejandro  Yáñez</span>, <span class="hlFld-ContribAuthor ">Luis  Sobrevia</span>, <span class="hlFld-ContribAuthor ">Claudia  Quezada</span>, <span class="hlFld-ContribAuthor ">Rody  San Martín</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine contribution to normal renal physiology and chronic kidney disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Aspects of Medicine</span><span> <strong>2017,</strong> <em>55 </em>, 75-89. <a href="https://doi.org/10.1016/j.mam.2017.01.004" title="DOI URL">https://doi.org/10.1016/j.mam.2017.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mam.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mam.2017.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Aspects%2520of%2520Medicine%26atitle%3DAdenosine%252Bcontribution%252Bto%252Bnormal%252Brenal%252Bphysiology%252Band%252Bchronic%252Bkidney%252Bdisease%26aulast%3DOyarz%25C3%25BAn%26aufirst%3DCarlos%26date%3D2017%26volume%3D55%26spage%3D75%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasarao  Allu</span>, <span class="hlFld-ContribAuthor ">Manjula  Ravi</span>, <span class="hlFld-ContribAuthor ">K. C.  Kumara Swamy</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalysed Carbenoid C(sp
              2
              )-H Functionalisation of Aniline Substrates with α-Diazo Esters: Formation of Oxindoles and Characterisation/Utility of an Intermediate-Like Rhodacycle. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (34)
                                     , 5697-5705. <a href="https://doi.org/10.1002/ejoc.201600968" title="DOI URL">https://doi.org/10.1002/ejoc.201600968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600968%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRhodium%252528III%252529-Catalysed%252BCarbenoid%252BC%252528sp%252B2%252B%252529-H%252BFunctionalisation%252Bof%252BAniline%252BSubstrates%252Bwith%252B%2525CE%2525B1-Diazo%252BEsters%25253A%252BFormation%252Bof%252BOxindoles%252Band%252BCharacterisation%25252FUtility%252Bof%252Ban%252BIntermediate-Like%252BRhodacycle%26aulast%3DAllu%26aufirst%3DSrinivasarao%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D34%26spage%3D5697%26epage%3D5705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Squarcialupi</span>, <span class="hlFld-ContribAuthor ">Daniela  Catarzi</span>, <span class="hlFld-ContribAuthor ">Flavia  Varano</span>, <span class="hlFld-ContribAuthor ">Marco  Betti</span>, <span class="hlFld-ContribAuthor ">Matteo  Falsini</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Annalisa  Ravani</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Vittoria  Colotta</span>. </span><span class="cited-content_cbyCitation_article-title">Structural refinement of pyrazolo[4,3- d ]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A 3 adenosine receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 117-133. <a href="https://doi.org/10.1016/j.ejmech.2015.11.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Brefinement%252Bof%252Bpyrazolo%25255B4%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Bto%252Bobtain%252Bhighly%252Bpotent%252Band%252Bselective%252Bantagonists%252Bfor%252Bthe%252Bhuman%252BA%252B3%252Badenosine%252Breceptor%26aulast%3DSquarcialupi%26aufirst%3DLucia%26date%3D2016%26volume%3D108%26spage%3D117%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth J.  Broadley</span>, <span class="hlFld-ContribAuthor ">Erica  Burnell</span>, <span class="hlFld-ContribAuthor ">Robin H.  Davies</span>, <span class="hlFld-ContribAuthor ">Alan T. L.  Lee</span>, <span class="hlFld-ContribAuthor ">Stephen  Snee</span>, <span class="hlFld-ContribAuthor ">Eric J.  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of a series of adenosine A
              3
              receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (15)
                                     , 3765-3781. <a href="https://doi.org/10.1039/C6OB00244G" title="DOI URL">https://doi.org/10.1039/C6OB00244G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00244G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00244G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Bof%252Ba%252Bseries%252Bof%252Badenosine%252BA%252B3%252Breceptor%252Bagonists%26aulast%3DBroadley%26aufirst%3DKenneth%2BJ.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D15%26spage%3D3765%26epage%3D3781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Preti</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Allan R.  Moorman</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>. </span><span class="cited-content_cbyCitation_article-title">History and Perspectives of A
              2A
              Adenosine Receptor Antagonists as Potential Therapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (4)
                                     , 790-848. <a href="https://doi.org/10.1002/med.21344" title="DOI URL">https://doi.org/10.1002/med.21344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21344%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistory%252Band%252BPerspectives%252Bof%252BA%252B2A%252BAdenosine%252BReceptor%252BAntagonists%252Bas%252BPotential%252BTherapeutic%252BAgents%26aulast%3DPreti%26aufirst%3DDelia%26date%3D2015%26date%3D2015%26volume%3D35%26issue%3D4%26spage%3D790%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen'kii</span>, <span class="hlFld-ContribAuthor ">Yu B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 193-363. <a href="https://doi.org/10.1016/bs.aihch.2015.04.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.04.002%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXIII%25252C%252B2012%2525E2%252580%2525932013%26aulast%3DBelen%2527kii%26aufirst%3DLeonid%2BI.%26date%3D2015%26spage%3D193%26epage%3D363%26pub%3DElsevier%26date%3D2015%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Evgeny  Kiselev</span>, <span class="hlFld-ContribAuthor ">Saibal  Chakraborty</span>, <span class="hlFld-ContribAuthor ">P. Suresh  Jayasekara</span>, <span class="hlFld-ContribAuthor ">Ramachandran  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>. </span><span class="cited-content_cbyCitation_article-title">John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2015,</strong> <em>13 </em>, 286-298. <a href="https://doi.org/10.1016/j.csbj.2014.10.004" title="DOI URL">https://doi.org/10.1016/j.csbj.2014.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2014.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2014.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DJohn%252BDaly%252BLecture%25253A%252BStructure-guided%252BDrug%252BDesign%252Bfor%252BAdenosine%252Band%252BP2Y%252BReceptors%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2015%26volume%3D13%26spage%3D286%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.  Cagide</span>, <span class="hlFld-ContribAuthor ">A.  Gaspar</span>, <span class="hlFld-ContribAuthor ">J.  Reis</span>, <span class="hlFld-ContribAuthor ">D.  Chavarria</span>, <span class="hlFld-ContribAuthor ">S.  Vilar</span>, <span class="hlFld-ContribAuthor ">G.  Hripcsak</span>, <span class="hlFld-ContribAuthor ">E.  Uriarte</span>, <span class="hlFld-ContribAuthor ">S.  Kachler</span>, <span class="hlFld-ContribAuthor ">K. N.  Klotz</span>, <span class="hlFld-ContribAuthor ">F.  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">Navigating in chromone chemical space: discovery of novel and distinct A
              3
              adenosine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (96)
                                     , 78572-78585. <a href="https://doi.org/10.1039/C5RA14988F" title="DOI URL">https://doi.org/10.1039/C5RA14988F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA14988F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA14988F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DNavigating%252Bin%252Bchromone%252Bchemical%252Bspace%25253A%252Bdiscovery%252Bof%252Bnovel%252Band%252Bdistinct%252BA%252B3%252Badenosine%252Breceptor%252Bligands%26aulast%3DCagide%26aufirst%3DF.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D96%26spage%3D78572%26epage%3D78585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Mojgan Aghazadeh  Tabrizi</span>, <span class="hlFld-ContribAuthor ">Stefania  Merighi</span>, <span class="hlFld-ContribAuthor ">Stefania  Gessi</span>, . </span><span class="cited-content_cbyCitation_article-title">The A
              3
              Adenosine Receptor: History and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2015,</strong> <em>67 </em>
                                    (1)
                                     , 74-102. <a href="https://doi.org/10.1124/pr.113.008540" title="DOI URL">https://doi.org/10.1124/pr.113.008540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.113.008540%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DThe%252BA%252B3%252BAdenosine%252BReceptor%25253A%252BHistory%252Band%252BPerspectives%26aulast%3DBorea%26aufirst%3DPier%2BAndrea%26date%3D2015%26date%3D2014%26volume%3D67%26issue%3D1%26spage%3D74%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Zhoumou  Chen</span>, <span class="hlFld-ContribAuthor ">Steven M.  Moss</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Daniela  Salvemini</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Extended N6 substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (15)
                                     , 3302-3306. <a href="https://doi.org/10.1016/j.bmcl.2014.06.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExtended%252BN6%252Bsubstitution%252Bof%252Brigid%252BC2-arylethynyl%252Bnucleosides%252Bfor%252Bexploring%252Bthe%252Brole%252Bof%252Bextracellular%252Bloops%252Bin%252Bligand%252Brecognition%252Bat%252Bthe%252BA3%252Badenosine%252Breceptor%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2014%26volume%3D24%26issue%3D15%26spage%3D3302%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Antonioli</span>, <span class="hlFld-ContribAuthor ">Balázs  Csóka</span>, <span class="hlFld-ContribAuthor ">Matteo  Fornai</span>, <span class="hlFld-ContribAuthor ">Rocchina  Colucci</span>, <span class="hlFld-ContribAuthor ">Endre  Kókai</span>, <span class="hlFld-ContribAuthor ">Corrado  Blandizzi</span>, <span class="hlFld-ContribAuthor ">György  Haskó</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine and inflammation: what's new on the horizon?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (8)
                                     , 1051-1068. <a href="https://doi.org/10.1016/j.drudis.2014.02.010" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAdenosine%252Band%252Binflammation%25253A%252Bwhat%252527s%252Bnew%252Bon%252Bthe%252Bhorizon%25253F%26aulast%3DAntonioli%26aufirst%3DLuca%26date%3D2014%26volume%3D19%26issue%3D8%26spage%3D1051%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiaorong  Han</span>, <span class="hlFld-ContribAuthor ">Yuliang  Jiang</span>, <span class="hlFld-ContribAuthor ">Can  Jin</span>, <span class="hlFld-ContribAuthor ">Shanshan  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Wang</span>, <span class="hlFld-ContribAuthor ">Bingxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Hyperbranched polyester nanorods with pyrrolo[2,1-a]isoquinoline end groups for fluorescent recognition of Fe
              3+. </span><span class="cited-content_cbyCitation_journal-name">Polym. Chem.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (20)
                                     , 5900-5905. <a href="https://doi.org/10.1039/C4PY00787E" title="DOI URL">https://doi.org/10.1039/C4PY00787E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4PY00787E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4PY00787E%26sid%3Dliteratum%253Aachs%26jtitle%3DPolym.%2520Chem.%26atitle%3DHyperbranched%252Bpolyester%252Bnanorods%252Bwith%252Bpyrrolo%25255B2%25252C1-a%25255Disoquinoline%252Bend%252Bgroups%252Bfor%252Bfluorescent%252Brecognition%252Bof%252BFe%252B3%25252B%26aulast%3DHan%26aufirst%3DQiaorong%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D20%26spage%3D5900%26epage%3D5905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Maryška</span>, <span class="hlFld-ContribAuthor ">Naděžda  Chudíková</span>, <span class="hlFld-ContribAuthor ">Vladislav  Kotek</span>, <span class="hlFld-ContribAuthor ">Dalimil  Dvořák</span>, <span class="hlFld-ContribAuthor ">Tomáš  Tobrman</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective and efficient synthesis of N 7-substituted adenines, guanines, and 6-mercaptopurines. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2013,</strong> <em>144 </em>
                                    (4)
                                     , 501-507. <a href="https://doi.org/10.1007/s00706-012-0899-x" title="DOI URL">https://doi.org/10.1007/s00706-012-0899-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-012-0899-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-012-0899-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DRegioselective%252Band%252Befficient%252Bsynthesis%252Bof%252BN%252B7-substituted%252Badenines%25252C%252Bguanines%25252C%252Band%252B6-mercaptopurines%26aulast%3DMary%25C5%25A1ka%26aufirst%3DMichal%26date%3D2013%26date%3D2013%26volume%3D144%26issue%3D4%26spage%3D501%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang-Fan  Chen</span>, <span class="hlFld-ContribAuthor ">Holger K.  Eltzschig</span>, <span class="hlFld-ContribAuthor ">Bertil B.  Fredholm</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine receptors as drug targets — what are the challenges?. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2013,</strong> <em>12 </em>
                                    (4)
                                     , 265-286. <a href="https://doi.org/10.1038/nrd3955" title="DOI URL">https://doi.org/10.1038/nrd3955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd3955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd3955%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DAdenosine%252Breceptors%252Bas%252Bdrug%252Btargets%252B%2525E2%252580%252594%252Bwhat%252Bare%252Bthe%252Bchallenges%25253F%26aulast%3DChen%26aufirst%3DJiang-Fan%26date%3D2013%26date%3D2013%26volume%3D12%26issue%3D4%26spage%3D265%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vicente  Yaziji</span>, <span class="hlFld-ContribAuthor ">David  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Alberto  Coelho</span>, <span class="hlFld-ContribAuthor ">Xerardo  García-Mera</span>, <span class="hlFld-ContribAuthor ">Abdelaziz  El Maatougui</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">María Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">María Isabel  Cadavid</span>, <span class="hlFld-ContribAuthor ">Hugo  Gutiérrez-de-Terán</span>, <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>59 </em>, 235-242. <a href="https://doi.org/10.1016/j.ejmech.2012.11.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Band%252Bpotent%252Badenosine%252BA3%252Breceptor%252Bantagonists%252Bby%252Bmethoxyaryl%252Bsubstitution%252Bon%252Bthe%252BN-%2525282%25252C6-diarylpyrimidin-4-yl%252529acetamide%252Bscaffold%26aulast%3DYaziji%26aufirst%3DVicente%26date%3D2013%26volume%3D59%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Methanocarba ring as a ribose modification in ligands of G protein-coupled purine and pyrimidine receptors: synthetic approaches. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (4)
                                     , 619. <a href="https://doi.org/10.1039/c2md20348k" title="DOI URL">https://doi.org/10.1039/c2md20348k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20348k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20348k%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DMethanocarba%252Bring%252Bas%252Ba%252Bribose%252Bmodification%252Bin%252Bligands%252Bof%252BG%252Bprotein-coupled%252Bpurine%252Band%252Bpyrimidine%252Breceptors%25253A%252Bsynthetic%252Bapproaches%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton V.  Dolzhenko</span>, <span class="hlFld-ContribAuthor ">Svetlana A.  Kalinina</span>, <span class="hlFld-ContribAuthor ">Dmitrii V.  Kalinin</span>. </span><span class="cited-content_cbyCitation_article-title">A novel multicomponent microwave-assisted synthesis of 5-aza-adenines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (36)
                                     , 15850. <a href="https://doi.org/10.1039/c3ra41932k" title="DOI URL">https://doi.org/10.1039/c3ra41932k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra41932k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra41932k%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bnovel%252Bmulticomponent%252Bmicrowave-assisted%252Bsynthesis%252Bof%252B5-aza-adenines%26aulast%3DDolzhenko%26aufirst%3DAnton%2BV.%26date%3D2013%26volume%3D3%26issue%3D36%26spage%3D15850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Kolb</span>, <span class="hlFld-ContribAuthor ">Khai  Phan</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Adam C.  Marko</span>, <span class="hlFld-ContribAuthor ">Andrej  Sali</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, . </span><span class="cited-content_cbyCitation_article-title">Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A1 Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2012,</strong> <em>7 </em>
                                    (11)
                                     , e49910. <a href="https://doi.org/10.1371/journal.pone.0049910" title="DOI URL">https://doi.org/10.1371/journal.pone.0049910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0049910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0049910%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DLimits%252Bof%252BLigand%252BSelectivity%252Bfrom%252BDocking%252Bto%252BModels%25253A%252BIn%252BSilico%252BScreening%252Bfor%252BA1%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DKolb%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D11%26spage%3De49910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of signaling pathways mediated by A<sub>3</sub>AR activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic diagram illustrating the functional role of A<sub>3</sub>ARs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative collection of <i>N</i><sup>6</sup>-substituted (<b>2</b>, <b>3</b>), <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup>-disubstituted (<b>4</b>, <b>5</b>), <i>N</i><sup>6</sup>-5′-disubstituted (<b>6a</b>, <b>7</b>–<b>9</b>), and <i>C</i><sup>2</sup>-<i>N</i><sup>6</sup>-5′-trisubstituted (<b>6b</b>, <b>10</b>–<b>15</b>) adenosine derivatives as A<sub>3</sub>AR agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative collection of 3′-OH (<b>16</b>) or ribose (<b>17</b>–<b>22</b>) modified adenosine derivatives, nonadenine nucleosides (<b>23</b>), and non-nucleosides (<b>24</b>) as A<sub>3</sub>AR agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Monocyclic systems as A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bicyclic systems as A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative collection of tricyclic systems as A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Fused xanthine derivatives as tricyclic antagonists of A<sub>3</sub>ARs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Nucleoside-derived A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Nucleoside-derived A<sub>3</sub>AR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/medium/jm-2012-00087j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. A<sub>3</sub>AR allosteric modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300087j/production/images/large/jm-2012-00087j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300087j&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 217 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Adenosine receptors as drug targets</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.yexcr.2010.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20153317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2010&pages=1284-1288&author=B.+B.+Fredholm&title=Adenosine+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as drug targets</span></div><div class="casAuthors">Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1284-1288</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  There are four adenosine receptors, A1, A2A, A2B and A3, together forming a defined subgroup of G protein coupled receptors.  They are well conserved and widely expressed.  The endogenous agonist, adenosine, has a minimal concn. in body fluids (20-200 nM) that is sufficient to slightly activate the receptors where they are very highly expressed-as in the basal ganglia, on fat cells and in the kidney.  Here adenosine can play a physiol. role and here antagonists such as caffeine can have effects in healthy individuals.  Adenosine levels rise in stress and distress (up to 30 μM in ischemia) and tend to minimize the risk for adverse outcomes by increasing energy supply and decreasing cellular work, by stimulating angiogenesis, mediating preconditioning and having multiple effects on immune competent cells.  These pathophysiol. roles of adenosine also offer some potential drug targets, but the fact that adenosine receptors are involved in so many processes does not simplify drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_KHHZKnJX2bVg90H21EOLACvtfcHk0lgKHAtg9l9luQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVart7c%253D&md5=cc440c9c77ef88aa88406c337f9bd666</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2010.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2010.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520receptors%2520as%2520drug%2520targets%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2010%26volume%3D316%26spage%3D1284%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New potent and selective human adenosine A<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=456-459&author=P.+G.+Baraldiauthor=P.+A.+Borea&title=New+potent+and+selective+human+adenosine+A3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%2520potent%2520and%2520selective%2520human%2520adenosine%2520A3%2520receptor%2520antagonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2000%26volume%3D21%26spage%3D456%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhratsky, A.</span><span> </span><span class="NLM_article-title">Adenosine and ATP receptors in the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F156802611795347627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21401499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=973-1011&author=G.+Burnstockauthor=B.+B.+Fredholmauthor=A.+Verkhratsky&title=Adenosine+and+ATP+receptors+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine and ATP receptors in the brain</span></div><div class="casAuthors">Burnstock, Geoffrey; Fredholm, Bertil B.; Verkhratsky, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">973-1011</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  There is a widespread presence of both adenosine (P1) and P2 nucleotide receptors in the brain on both neurons and glial cells.  Adenosine receptors play a major role in presynaptic neuromodulation, while P2X receptors are involved in fast synaptic transmission and synaptic plasticity.  P2Y receptors largely mediate presynaptic activities.  Both P1 and P2 receptors participate in neuron-glia interactions.  Purinergic signaling is involved in control of cerebral vascular tone and remodelling.  Examples of the roles of purinoceptors in neuropathol. involve: A2A receptors in Parkinson's disease and epilepsy, P2 receptors in trauma, ischemia, neuroinflammatory and neuropsychiatric disorders, and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNffIkJPOinbVg90H21EOLACvtfcHk0linxrOLM_uqpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyktLg%253D&md5=c7d41568ebcb97044b145db17f9c76ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802611795347627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795347627%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DVerkhratsky%26aufirst%3DA.%26atitle%3DAdenosine%2520and%2520ATP%2520receptors%2520in%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D973%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptor targeting in health and disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1591-1609&author=S.+Gessiauthor=S.+Merighiauthor=D.+Fazziauthor=A.+Stefanelliauthor=K.+Varaniauthor=P.+A.+Borea&title=Adenosine+receptor+targeting+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DFazzi%26aufirst%3DD.%26aulast%3DStefanelli%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptor%2520targeting%2520in%2520health%2520and%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs.%26date%3D2011%26volume%3D20%26spage%3D1591%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AP, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1124%2Fpr.110.003285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21303899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1-34&author=B.+B.+Fredholmauthor=I.+J.+APauthor=K.+A.+Jacobsonauthor=J.+Lindenauthor=C.+E.+M%C3%BCller&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXI.+Nomenclature+and+classification+of+adenosine+receptors-an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Linden, Joel; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-34</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In the 10 years since our previous International Union of Basic and Clin. Pharmacol. report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations.  However, there have been so many other developments that an update is needed.  The fact that the structure of one of the adenosine receptors has recently been solved has already led to new ways of in silico screening of ligands.  The evidence that adenosine receptors can form homo- and hetero-multimers has accumulated, but the functional significance of such complexes remains unclear.  The availability of mice with genetic modification of all the adenosine receptors has led to a clarification of the functional roles of adenosine, and to excellent means to study the specificity of drugs.  There are also interesting assocns. between disease and structural variants in one or more of the adenosine receptors.  Several new selective agonists and antagonists have become available.  They provide improved possibilities for receptor classification.  There are also developments hinting at the usefulness of allosteric modulators.  Many drugs targeting adenosine receptors are in clin. trials, but the established therapeutic use is still very limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqbDC-UZ5sbVg90H21EOLACvtfcHk0linxrOLM_uqpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D&md5=e184c127e06b800bbcf15402ed27f02a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003285%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DAP%26aufirst%3DI.%2BJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXI.%2520Nomenclature%2520and%2520classification%2520of%2520adenosine%2520receptors-an%2520update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D1%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor: pharmacology and role in disease</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-3-540-89615-9_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19639286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2009&pages=297-327&author=P.+A.+Boreaauthor=S.+Gessiauthor=S.+Bar-Yehudaauthor=P.+Fishman&title=A3+adenosine+receptor%3A+pharmacology+and+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A3 adenosine receptor: pharmacology and role in disease</span></div><div class="casAuthors">Borea, P. A.; Gessi, S.; Bar-Yehuda, S.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">297-327</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The study of the A3 adenosine receptor (A3AR) represents a rapidly growing and intense area of research in the adenosine field.  The present chapter will provide an overview of the expression patterns, mol. pharmacol. and functional role of this A3AR subtype under pathophysiol. conditions.  Through studies utilizing selective A3AR agonists and antagonists, or A3AR knockout mice, it is now clear that this receptor plays a crit. role in the modulation of ischemic diseases as well as in inflammatory and autoimmune pathologies.  Therefore, the potential therapeutic use of agonists and antagonists will also be described.  The discussion will principally address the use of such compds. in the treatment of brain and heart ischemia, asthma, sepsis and glaucoma.  The final part concs. on the mol. basis of A3ARs in autoimmune diseases such as rheumatoid arthritis, and includes a description of clin. trials with the selective agonist CF101.  Based on this chapter, it is evident that continued research to discover agonists and antagonists for the A3AR subtype is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnDJBH5xASa7Vg90H21EOLACvtfcHk0linxrOLM_uqpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FF&md5=3f891ac8c418f8d1050a2c341d53a24e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_10%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DA3%2520adenosine%2520receptor%253A%2520pharmacology%2520and%2520role%2520in%2520disease%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26volume%3D193%26spage%3D297%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cheong, S. L.; Federico, S.; Venkatesan, G.; Mandel, A. L.; Shao, Y. M.; Moro, S.; Spalluto, G.; Pastorin, G.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches</span>.  <span class="citation_source-journal">Med. Res. Rev.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1002/med.20254</span> . Published Online: November 16,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fmed.20254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=22095687" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+L.+Cheong&author=S.+Federico&author=G.+Venkatesan&author=A.+L.+Mandel&author=Y.+M.+Shao&author=S.+Moro&author=G.+Spalluto&author=G.+Pastorin&title=The+A3+adenosine+receptor+as+multifaceted+therapeutic+target%3A+pharmacology%2C+medicinal+chemistry%2C+and+in+silico+approaches&doi=10.1002%2Fmed.20254"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmed.20254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20254%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520as%2520multifaceted%2520therapeutic%2520target%253A%2520pharmacology%252C%2520medicinal%2520chemistry%252C%2520and%2520in%2520silico%2520approaches%26jtitle%3DMed.%2520Res.%2520Rev.%26doi%3D10.1002%2Fmed.20254%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=627-632&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Modulation+of+the+Akt%2FRas%2FRaf%2FMEK%2FERK+pathway+by+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DModulation%2520of%2520the%2520Akt%252FRas%252FRaf%252FMEK%252FERK%2520pathway%2520by%2520A3%2520adenosine%2520receptor%26jtitle%3DPurinergic%2520Signalling%26date%3D2006%26volume%3D2%26spage%3D627%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">19516</span><span class="NLM_x">–</span> <span class="NLM_lpage">19526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19516-19526&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=A3+adenosine+receptor+activation+inhibits+cell+proliferation+via+phosphatidylinositol+3-kinase%2FAkt-dependent+inhibition+of+the+extracellular+signal-regulated+kinase+1%2F2+phosphorylation+in+A375+human+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520inhibits%2520cell%2520proliferation%2520via%2520phosphatidylinositol%25203-kinase%252FAkt-dependent%2520inhibition%2520of%2520the%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520phosphorylation%2520in%2520A375%2520human%2520melanoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19516%26epage%3D19526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuscano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falleni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremigni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabeni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1373</span><span class="NLM_x">–</span> <span class="NLM_lpage">1384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1373-1384&author=M.+L.+Trincavelliauthor=D.+Tuscanoauthor=M.+Marroniauthor=A.+Falleniauthor=V.+Gremigniauthor=S.+Cerutiauthor=M.+P.+Abbracchioauthor=K.+A.+Jacobsonauthor=F.+Cattabeniauthor=C.+Martini&title=A3+adenosine+receptors+in+human+astrocytoma+cells%3A+agonist-mediated+desensitization%2C+internalization%2C+and+down-regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DTuscano%26aufirst%3DD.%26aulast%3DMarroni%26aufirst%3DM.%26aulast%3DFalleni%26aufirst%3DA.%26aulast%3DGremigni%26aufirst%3DV.%26aulast%3DCeruti%26aufirst%3DS.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DCattabeni%26aufirst%3DF.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DA3%2520adenosine%2520receptors%2520in%2520human%2520astrocytoma%2520cells%253A%2520agonist-mediated%2520desensitization%252C%2520internalization%252C%2520and%2520down-regulation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D1373%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuscano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucacchini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">Involvement of mitogen protein kinase cascade in agonist-mediated human A<sub>3</sub> adenosine receptor regulation</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1591</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1591&publication_year=2002&pages=55-62&author=M.+L.+Trincavelliauthor=D.+Tuscanoauthor=M.+Marroniauthor=K.+N.+Klotzauthor=A.+Lucacchiniauthor=C.+Martini&title=Involvement+of+mitogen+protein+kinase+cascade+in+agonist-mediated+human+A3+adenosine+receptor+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DTuscano%26aufirst%3DD.%26aulast%3DMarroni%26aufirst%3DM.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLucacchini%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DInvolvement%2520of%2520mitogen%2520protein%2520kinase%2520cascade%2520in%2520agonist-mediated%2520human%2520A3%2520adenosine%2520receptor%2520regulation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1591%26spage%3D55%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arslan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, W.</span><span> </span><span class="NLM_article-title">Structure and function of adenosine receptors and their genes</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2Fs002100000313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11111830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFCru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2000&pages=364-374&author=B.+B.+Fredholmauthor=G.+Arslanauthor=L.+Halldnerauthor=B.+Kullauthor=G.+Schulteauthor=W.+Wasserman&title=Structure+and+function+of+adenosine+receptors+and+their+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of adenosine receptors and their genes</span></div><div class="casAuthors">Fredholm, Bertil B.; Arslan, Giulia; Halldner, Linda; Kull, Bjorn; Schulte, Gunnar; Wasserman, Wyeth</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">364-374</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review with 130 refs.  Four adenosine receptors have been cloned from many mammalian and some non-mammalian species.  In each case the translated part of the receptor is encoded by two sep. exons.  Two sep. promoters regulate the A1 receptor expression, and a similar situation may pertain also for the other receptors.  The receptors are expressed in a cell and tissue specific manner, even though A1 and A2B receptors are found in many different cell types.  Emerging data indicate that the receptor protein is targeted to specific parts of the cell.  A1 and A3 receptors activate the Gi family of G proteins, whereas A2A and A2B receptors activate the Gs family.  However, other G proteins can also be activated even though the physiol. significance of this is unknown.  Following the activation of G proteins several cellular effector pathways can be affected.  Signaling via adenosine receptors is also known to interact in functionally important ways with signaling initiated via other receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqi7IPIpeDOLVg90H21EOLACvtfcHk0ljF_iwpkcH3XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFCru7g%253D&md5=26a3b7f257b3748da01ab4ef33a81953</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs002100000313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000313%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DArslan%26aufirst%3DG.%26aulast%3DHalldner%26aufirst%3DL.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DSchulte%26aufirst%3DG.%26aulast%3DWasserman%26aufirst%3DW.%26atitle%3DStructure%2520and%2520function%2520of%2520adenosine%2520receptors%2520and%2520their%2520genes%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D362%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zhou, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of an adenosine receptor: the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">7432</span><span class="NLM_x">–</span> <span class="NLM_lpage">7436</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=7432-7436&author=Q.+Y.+Zhouauthor=C.+Liauthor=M.+E.+Olahauthor=R.+A.+Johnsonauthor=G.+L.+Stilesauthor=O.+Civelli&title=Molecular+cloning+and+characterization+of+an+adenosine+receptor%3A+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520an%2520adenosine%2520receptor%253A%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1992%26volume%3D89%26spage%3D7432%26epage%3D7436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. G.</span><span> </span><span class="NLM_article-title">Molecular-cloning and characterization of the human-A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">10365</span><span class="NLM_x">–</span> <span class="NLM_lpage">10369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=10365-10369&author=C.+A.+Salvatoreauthor=M.+A.+Jacobsonauthor=H.+E.+Taylorauthor=J.+Lindenauthor=R.+G.+Johnson&title=Molecular-cloning+and+characterization+of+the+human-A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DTaylor%26aufirst%3DH.%2BE.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26atitle%3DMolecular-cloning%2520and%2520characterization%2520of%2520the%2520human-A3%2520adenosine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D10365%26epage%3D10369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor: an enigmatic player in cell biology</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.pharmthera.2007.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18029023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=123-140&author=S.+Gessiauthor=S.+Merighiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Mac+Lennanauthor=P.+A.+Borea&title=The+A3+adenosine+receptor%3A+an+enigmatic+player+in+cell+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: An enigmatic player in cell biology</span></div><div class="casAuthors">Gessi, Stefania; Merighi, Stefania; Varani, Katia; Leung, Edward; Mac Lennan, Stephen; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-140</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adenosine is a primordial signaling mol. present in every cell of the human body that mediates its physiol. functions by interacting with 4 subtypes of G-protein-coupled receptors, termed A1, A2A, A2B and A3.  The A3 subtype is perhaps the most enigmatic among adenosine receptors since, although several studies have been performed in the years to elucidate its physiol. function, it still presents in several cases a double nature in different pathophysiol. conditions.  The 2 personalities of A3 often come into direct conflict, e.g., in ischemia, inflammation and cancer, rendering this receptor as a single entity behaving in 2 different ways.  This review focuses on the most relevant aspects of A3 adenosine subtype activation and summarizes the pharmacol. evidence as the basis of the dichotomy of this receptor in different therapeutic fields.  Although much is still to be learned about the function of the A3 receptor and in spite of its duality, at the present time it can be speculated that A3 receptor selective ligands might show utility in the treatment of ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature.  The biggest and most intriguing challenge for the future is therefore to understand whether and where selective A3 agonists or antagonists are the best choice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DycIR5fBxbVg90H21EOLACvtfcHk0lj-JA_j8cHAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtLzF&md5=fbdc6b555110a56c3724cab8a116a9ea</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac%2BLennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%253A%2520an%2520enigmatic%2520player%2520in%2520cell%2520biology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D123%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=10779381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVegurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=968-975&author=K.+Varaniauthor=S.+Merighiauthor=S.+Gessiauthor=K.+N.+Klotzauthor=E.+Leungauthor=P.+G.+Baraldiauthor=B.+Cacciariauthor=R.+Romagnoliauthor=G.+Spallutoauthor=P.+A.+Borea&title=%5B3H%5DMRE+3008F20%3A+a+novel+antagonist+radioligand+for+the+pharmacological+and+biochemical+characterization+of+human+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors</span></div><div class="casAuthors">Varani, Katia; Merighi, Stefania; Gessi, Stefania; Klotz, Karl-Norbert; Lfung, Edward; Baraldi, Pier Giovanni; Cacciari, Barbara; Romagnoli, Romeo; Spalluto, Giampiero; Borfa, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-975</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The lack of a radiolabeled selective A3 adenosine receptor antagonist is a major drawback for an adequate characterization of this receptor subtype.  This paper describes the pharmacol. and biochem. characterization of the tritiated form of a new potent A3 adenosine receptor antagonist, the pyrazolo triazolo pyrimidine deriv. [3H]5N-(4-methoxyphenylcarbamoyl)amino-8-propyl-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine ([3H]MRE 3008F20).  [3H]MRE 3008F20 bound specifically to the human adenosine A3 receptor expressed in CHO cells (hA3CHO), and satn. anal. revealed a single high affinity binding site, KD = 0.80 nM, with a Bmax = 300 fmol/mg protein.  This new ligand displayed high selectivity (1294-, 165-, and 2471-fold) in binding assay to human A3 vs. A1, A2A, and A2B receptors, resp., and binds to the rat A3 receptors with a Ki >10 μM.  The pharmacol. profile of [3H]MRE 3008F20 binding to hA3CHO cells was evaluated using known adenosine receptor agonists and antagonists with a rank order of potency consistent with that typically found for interactions with the A3 adenosine receptors.  In the adenylyl cyclase assay the same compds. exhibited a rank order of potency identical with that obsd. in binding expts.  Thermodn. data indicated that [3H]MRE 3008F20 binding to hA3CHO is entropy- and enthalpy-driven in agreement with the typical behavior of other adenosine antagonists to A1 and A2A receptors.  These results show that [3H]MRE 3008F20 is the first antagonist radioligand with high affinity and selectivity for the human A3 adenosine receptor and may be used to investigate the physiopathol. role of A3 adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLUtXnI9zeCbVg90H21EOLACvtfcHk0lj-JA_j8cHAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVegurc%253D&md5=f8856e23ba8e4ac4a17eedc9b21dcf5f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3D%255B3H%255DMRE%25203008F20%253A%2520a%2520novel%2520antagonist%2520radioligand%2520for%2520the%2520pharmacological%2520and%2520biochemical%2520characterization%2520of%2520human%2520A3%2520adenosine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D968%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavioli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Expression of A<sub>3</sub> adenosine receptors in human lymphocytes: up-regulation in T cell activation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=711-719&author=S.+Gessiauthor=K.+Varaniauthor=S.+Merighiauthor=E.+Cattabrigaauthor=A.+Avitabileauthor=R.+Gavioliauthor=C.+Fortiniauthor=E.+Leungauthor=S.+Mac+Lennanauthor=P.+A.+Borea&title=Expression+of+A3+adenosine+receptors+in+human+lymphocytes%3A+up-regulation+in+T+cell+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DAvitabile%26aufirst%3DA.%26aulast%3DGavioli%26aufirst%3DR.%26aulast%3DFortini%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac%2BLennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520A3%2520adenosine%2520receptors%2520in%2520human%2520lymphocytes%253A%2520up-regulation%2520in%2520T%2520cell%2520activation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D711%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A glance at adenosine receptors: novel target for antitumor therapy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0163-7258%2803%2900084-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=14550503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=31-48&author=S.+Merighiauthor=P.+Mirandolaauthor=K.+Varaniauthor=S.+Gessiauthor=E.+Leungauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=P.+A.+Borea&title=A+glance+at+adenosine+receptors%3A+novel+target+for+antitumor+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A glance at adenosine receptors: novel target for antitumor therapy</span></div><div class="casAuthors">Merighi, Stefania; Mirandola, Prisco; Varani, Katia; Gessi, Stefania; Leung, Edward; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-48</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Adenosine can be released from a variety of cells throughout the body, as the result of increased metabolic rates, in concns. that can have a profound impact on the vasculature, immunoescaping, and growth of tumor masses.  It is recognized that the concns. of this nucleoside are increased in cancer tissues.  Therefore, it is not surprising that adenosine has been shown to be a crucial factor in detg. the cell progression pathway, either during apoptosis or during cytostatic state.  From the perspective of cancer, the most important question then may be "Can activation and/or blockade of the pathways downstream of the adenosine receptor contribute to tumor development".  Rigorous examns. of the role of adenosine in in vivo and in vitro systems need to be investigated.  The present review therefore proposes multiple adenosine-sustained ways that could prime tumor development together with the crit. combinatorial role played by adenosine receptors in taking a choice between proliferation and death.  This review proposes that adenosine acts as a potent regulator of normal and tumor cell growth.  It is hypothesized that this effect is dependent on extracellular adenosine concns., cell surface expression of different adenosine receptor subtypes, and signal transduction mechanisms activated following the binding of specific agonists.  We venture to suggest that the clarification of the role of adenosine and its receptors in cancer development may hold great promise for the treatment of chemotherapy in patients affected by malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhMpzNAaZAUbVg90H21EOLACvtfcHk0lgn7sCQwTc4fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVOgsLY%253D&md5=98ba1341e13fb77842485b69c4e3ada3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900084-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900084-6%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA%2520glance%2520at%2520adenosine%2520receptors%253A%2520novel%2520target%2520for%2520antitumor%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D100%26spage%3D31%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor ligands: history and perspectives</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C103%3A%3AAID-MED1%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=10723024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=103-128&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=R.+Romagnoliauthor=S.+Merighiauthor=K.+Varaniauthor=P.+A.+Boreaauthor=G.+Spalluto&title=A3+adenosine+receptor+ligands%3A+history+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A3 adenosine receptor ligands: history and perspectives</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Cacciari, Barbara; Romagnoli, Romeo; Merighi, Stefania; Varani, Katia; Borea, Pier Andrea; Spalluto, Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-128</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 92 refs.  Adenosine regulates many physiol. functions through specific cell membrane receptors.  On the basis of pharmacol. studies and mol. cloning, four different adenosine receptors have been identified and classified as A1, A2A, A2B, and A3.  These adenosine receptors are members of the G-protein-coupled receptor family.  While adenosine A1 and A2A receptor subtypes have been pharmacol. characterized through the use of selective ligands, the A3 adenosine receptor subtype is presently under study to better understand its physio-pathol. functions.  Activation of adenosine A3 receptors has been shown to stimulate phospholipase C and D and to inhibit adenylate cyclase.  Activation of A3 adenosine receptors also causes the release of inflammatory mediators such as histamine from mast cells.  These mediators are responsible for processes such as inflammation and hypotension.  It has also been suggested that the A3 receptor plays an important role in brain ischemia, immunosuppression, and bronchospasm in several animal models.  Based on these results, highly selective A3 adenosine receptor agonists and/or antagonists have been indicated as potential drugs for the treatment of asthma and inflammation, while highly selective agonists have been shown to possess cardioprotective effects.  The updated material related to this field of research has been rationalized and arranged to offer an overview of the topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKZMvY-RWf3bVg90H21EOLACvtfcHk0lgn7sCQwTc4fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVeisL0%253D&md5=afc7dbccbfd5273cddd9009bb22c49a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200003%2920%3A2%3C103%3A%3AAID-MED1%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200003%252920%253A2%253C103%253A%253AAID-MED1%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DSpalluto%26aufirst%3DG.%26atitle%3DA3%2520adenosine%2520receptor%2520ligands%253A%2520history%2520and%2520perspectives%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D103%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuzzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Full and partial agonistic behaviour and thermodynamic binding parameters of adenosine A<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2F0922-4106%2894%2990224-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=8206130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1994&pages=55-61&author=P.+A.+Boreaauthor=K.+Varaniauthor=A.+Dalpiazauthor=A.+Capuzzoauthor=E.+Fabbriauthor=A.+P.+Ijzerman&title=Full+and+partial+agonistic+behaviour+and+thermodynamic+binding+parameters+of+adenosine+A1+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Full and partial agonistic behavior and thermodynamic binding parameters of adenosine A1 receptor ligands</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Dalpiaz, Alessandro; Capuzzo, Antonio; Fabbri, Elena; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The inhibitory effect of forskolin-stimulated 3',5'-cyclic monophosphate (cAMP) synthesis in isolated rat adipocytes has been measured for eight typical adenosine receptor agonists.  The percent inhibition was evaluated using concns. of each compd. corresponding to 100 times their Ki, inhibitory binding consts., detd. in parallel by [3H]N6-cyclohexyladenosine binding to adenosine A1 receptors on rat adipocyte membranes which guaranteed full receptor occupancy.  Some drugs were able to inhibit the forskolin-induced c-AMP accumulation by 100% (full agonists, intrinsic activity = 1) but others only to a lesser extent, ranging from 80% to 50% (partial agonists, intrinsic activities in the 0.8-0.5 interval).  These efficacy data were correlated with the thermodn. binding parameters (free energy, enthalpy and entropy) obtained in rat brain membranes by equil. const. measurements and Van't Hoff plots in the 0-30° range.  The pos. correlation between intrinsic activity and entropy changes (r = 0.88) points to the possibility of obtaining information about the full spectrum of activities of adenosine analogs from in vitro binding assays and suggests some considerations on the possible drug-receptor interaction mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhPGGODVxAvbVg90H21EOLACvtfcHk0lgn7sCQwTc4fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKrsLg%253D&md5=09ea8bc79ba54c2c76cac153fdf475ff</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990224-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990224-0%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DCapuzzo%26aufirst%3DA.%26aulast%3DFabbri%26aufirst%3DE.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DFull%2520and%2520partial%2520agonistic%2520behaviour%2520and%2520thermodynamic%2520binding%2520parameters%2520of%2520adenosine%2520A1%2520receptor%2520ligands%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D267%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilli, G.</span><span> </span><span class="NLM_article-title">Binding thermodynamics of adenosine A<sub>2A</sub> receptor ligands</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=461-469&author=P.+A.+Boreaauthor=A.+Dalpiazauthor=K.+Varaniauthor=L.+Guerraauthor=G.+Gilli&title=Binding+thermodynamics+of+adenosine+A2A+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGuerra%26aufirst%3DL.%26aulast%3DGilli%26aufirst%3DG.%26atitle%3DBinding%2520thermodynamics%2520of%2520adenosine%2520A2A%2520receptor%2520ligands%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26spage%3D461%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilli, G.</span><span> </span><span class="NLM_article-title">Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=1549-1556&author=P.+A.+Boreaauthor=A.+Dalpiazauthor=K.+Varaniauthor=P.+Gilliauthor=G.+Gilli&title=Can+thermodynamic+measurements+of+receptor+binding+yield+information+on+drug+affinity+and+efficacy%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGilli%26aufirst%3DP.%26aulast%3DGilli%26aufirst%3DG.%26atitle%3DCan%2520thermodynamic%2520measurements%2520of%2520receptor%2520binding%2520yield%2520information%2520on%2520drug%2520affinity%2520and%2520efficacy%253F%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2000%26volume%3D60%26spage%3D1549%26epage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Binding thermodynamics at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=157-161&author=S.+Merighiauthor=K.+Varaniauthor=S.+Gessiauthor=K.+N.+Klotzauthor=E.+Leungauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Binding+thermodynamics+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DBinding%2520thermodynamics%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D63%26spage%3D157%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliesi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> receptor ligands: past, present and future trends</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F156802610791293109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20370658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFaqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=942-975&author=S.+Talianiauthor=I.+Pugliesiauthor=M.+Bellandiauthor=C.+La+Mottaauthor=F.+Da+Settimo&title=A3+receptor+ligands%3A+past%2C+present+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A3 receptor ligands: past, present and future trends</span></div><div class="casAuthors">Taliani, S.; Pugliesi, I.; Bellandi, M.; La Motta, C.; Da Settimo, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">942-975</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The A3 adenosine receptors (A3 ARs), belonging to the adenosine receptor family of G-protein-coupled receptors (GPCRs), are ubiquitously expressed in a wide variety of tissues in human body, with high levels in peripheral organs and low levels in the brain.  The A3 ARs are involved in a variety of important patho-physiol. processes, including modulation of cerebral and cardiac ischemic damage, inflammation, modulation of intraocular pressure, regulation of normal and tumor cell growth, and immunosuppression.  Consequently, A3 AR selective ligands may represent important pharmacol. tools in the treatment of a variety of diseases.  Indeed, the development of potent and selective A3 AR ligands has been the subject of medicinal chem. research for more than two decades.  Although to date a considerable no. of selective A3 AR agonists and antagonists have been discovered, much is still to be learned about the exact function of this subtype, due to its enigmatic role in several physiol. processes.  In the last two decades, numerous medicinal chem. groups have made intense efforts in searching for ideal ligands for the A3 AR subtype.  The purpose of this review is to summarize the most recent developments made in the field of selective A3 AR ligands, which have been subdivided on the basis of their main chem. structural features.  For each chem. class, attention has been focused on the SARs which det. ligand affinity and selectivity for the target subtype, and on eventually available preclin. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVkLMsN7bZBbVg90H21EOLACvtfcHk0livTzWONcUiBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFaqs7c%253D&md5=2dca84481eee08b7a00308ef8818d11f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F156802610791293109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791293109%26sid%3Dliteratum%253Aachs%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DPugliesi%26aufirst%3DI.%26aulast%3DBellandi%26aufirst%3DM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26atitle%3DA3%2520receptor%2520ligands%253A%2520past%252C%2520present%2520and%2520future%2520trends%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D942%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine receptor ligands and their potential as novel drugs</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1808</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1290-1308&author=C.+E.+M%C3%BCllerauthor=K.+A.+Jacobson&title=Recent+developments+in+adenosine+receptor+ligands+and+their+potential+as+novel+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520receptor%2520ligands%2520and%2520their%2520potential%2520as%2520novel%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1808%26spage%3D1290%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of the A<sub>3</sub> adenosine receptor: agonists, antagonists, and receptor engineering</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-3-540-89615-9_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19639281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=123-159&author=K.+A.+Jacobsonauthor=A.+M.+Klutzauthor=D.+K.+Toshauthor=A.+A.+Ivanovauthor=D.+Pretiauthor=P.+G.+Baraldi&title=Medicinal+chemistry+of+the+A3+adenosine+receptor%3A+agonists%2C+antagonists%2C+and+receptor+engineering"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering</span></div><div class="casAuthors">Jacobson, Kenneth A.; Klutz, Athena M.; Tosh, Dilip K.; Ivanov, Andrei A.; Preti, Delia; Baraldi, Pier Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">123-159</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A3 adenosine receptor (A3AR) ligands have been modified to optimize their interaction with the A3AR.  Most of these modifications have been made to the N6 and C2 positions of adenine as well as the ribose moiety, and using a combination of these substitutions leads to the most efficacious, selective, and potent ligands.  A3AR agonists such as IB-MECA and Cl-IB-MECA are now advancing into Phase II clin. trials for treatments targeting diseases such as cancer, arthritis, and psoriasis.  Also, a wide no. of compds. exerting high potency and selectivity in antagonizing the human (h)A3AR have been discovered.  These mols. are generally characterized by a notable structural diversity, taking into account that arom. nitrogen-contg. monocyclic (thiazoles and thiadiazoles), bicyclic (isoquinoline, quinozalines, (aza)adenines), tricyclic systems (pyrazoloquinolines, triazoloquinoxalines, pyrazolotriazolopyrimidines, triazolopurines, tricyclic xanthines) and nucleoside derivs. have been identified as potent and selective A3AR antagonists.  Probably due to the "enigmatic" physiol. role of A3AR, whose activation may produce opposite effects (for example, concerning tissue protection in inflammatory and cancer cells) and may produce effects that are species dependent, only a few mols. have reached preclin. investigation.  Indeed, the most advanced A3AR antagonists remain in preclin. testing.  Among the antagonists described above, compd. OT-7999 is expected to enter clin. trials for the treatment of glaucoma, while several thiazole derivs. are in development as antiallergic, antiasthmatic and/or antiinflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1HYJjr1FNxrVg90H21EOLACvtfcHk0livTzWONcUiBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr%252FM&md5=56f7d3226341b1e49ffe359e7ab81f78</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_5%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26atitle%3DMedicinal%2520chemistry%2520of%2520the%2520A3%2520adenosine%2520receptor%253A%2520agonists%252C%2520antagonists%252C%2520and%2520receptor%2520engineering%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26spage%3D123%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaustein, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=1675-1684&author=Z.+G.+Gaoauthor=J.+B.+Blausteinauthor=A.+S.+Grossauthor=N.+Melmanauthor=K.+A.+Jacobson&title=N-6-Substituted+adenosine+derivatives%3A+selectivity%2C+efficacy%2C+and+species+differences+at+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DBlaustein%26aufirst%3DJ.%2BB.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DN-6-Substituted%2520adenosine%2520derivatives%253A%2520selectivity%252C%2520efficacy%252C%2520and%2520species%2520differences%2520at%2520A3%2520adenosine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D1675%26epage%3D1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rompaey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K.</span><span> </span><span class="NLM_article-title">Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2995</span><span class="NLM_x">–</span> <span class="NLM_lpage">3007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2995-3007&author=M.+Ohnoauthor=Z.+Gaoauthor=P.+Van+Rompaeyauthor=S.+Tchilibonauthor=S.+Kimauthor=B.+A.+Harrisauthor=A.+S.+Grossauthor=H.+T.+Duongauthor=S.+Van+Calenberghauthor=K.+Jacobson&title=Modulation+of+adenosine+receptor+affinity+and+intrinsic+efficacy+in+adenine+nucleosides+substituted+at+the+2-position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DVan%2BRompaey%26aufirst%3DP.%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%26atitle%3DModulation%2520of%2520adenosine%2520receptor%2520affinity%2520and%2520intrinsic%2520efficacy%2520in%2520adenine%2520nucleosides%2520substituted%2520at%2520the%25202-position%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2995%26epage%3D3007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaustein, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Exploring distal regions of the A<sub>3</sub> adenosine receptor binding site: sterically constrained <i>N</i><sup>6</sup>-(2-phenylethyl)adenosine derivatives as potent ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2021-2034&author=S.+Tchilibonauthor=S.+K.+Kimauthor=Z.+G.+Gaoauthor=B.+A.+Harrisauthor=J.+B.+Blausteinauthor=A.+S.+Grossauthor=H.+T.+Duongauthor=N.+Melmanauthor=K.+A.+Jacobson&title=Exploring+distal+regions+of+the+A3+adenosine+receptor+binding+site%3A+sterically+constrained+N6-%282-phenylethyl%29adenosine+derivatives+as+potent+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DBlaustein%26aufirst%3DJ.%2BB.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DExploring%2520distal%2520regions%2520of%2520the%2520A3%2520adenosine%2520receptor%2520binding%2520site%253A%2520sterically%2520constrained%2520N6-%25282-phenylethyl%2529adenosine%2520derivatives%2520as%2520potent%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2021%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maa, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span> </span><span class="NLM_article-title">2-Pyrazolyl-<i>N</i><sup>6</sup>-substituted adenosine derivatives as high affinity and selective adenosine A<sub>3</sub> receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4766</span><span class="NLM_x">–</span> <span class="NLM_lpage">4773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049682h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4766-4773&author=E.+Elzeinauthor=V.+Palleauthor=Y.+Z.+Wuauthor=T.+N.+Maaauthor=D.+W.+Zengauthor=J.+Zablocki&title=2-Pyrazolyl-N6-substituted+adenosine+derivatives+as+high+affinity+and+selective+adenosine+A3+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm049682h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049682h%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DY.%2BZ.%26aulast%3DMaa%26aufirst%3DT.%2BN.%26aulast%3DZeng%26aufirst%3DD.%2BW.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3D2-Pyrazolyl-N6-substituted%2520adenosine%2520derivatives%2520as%2520high%2520affinity%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4766%26epage%3D4773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Elzein, E.; Palle, V.; Varkhedkar, V.; Zablocki, J.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> Receptor Agonists</span>. WO 2003014137,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=E.+Elzein&author=V.+Palle&author=V.+Varkhedkar&author=J.+Zablocki&title=Adenosine+A3+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26atitle%3DAdenosine%2520A3%2520Receptor%2520Agonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegman, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Galen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of <i>N</i><sup>6</sup>-benzyladenosine-5′-uronamides as A<sub>3</sub>-selective adenosine agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00031a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=636-646&author=C.+Gallo-Rodriguezauthor=X.+D.+Jiauthor=N.+Melmanauthor=B.+D.+Siegmanauthor=L.+H.+Sandersauthor=J.+Orlinaauthor=B.+Fischerauthor=Q.+Puauthor=M.+E.+Olahauthor=P.+J.+van+Galenauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=Structure%E2%80%93activity+relationships+of+N6-benzyladenosine-5%E2%80%B2-uronamides+as+A3-selective+adenosine+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm00031a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00031a014%26sid%3Dliteratum%253Aachs%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DSiegman%26aufirst%3DB.%2BD.%26aulast%3DSanders%26aufirst%3DL.%2BH.%26aulast%3DOrlina%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DPu%26aufirst%3DQ.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3Dvan%2BGalen%26aufirst%3DP.%2BJ.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520N6-benzyladenosine-5%25E2%2580%25B2-uronamides%2520as%2520A3-selective%2520adenosine%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D636%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Novel <i>N</i><sup>6</sup>-(substituted-phenylcarbamoyl)adenosine-5′-uronamides as potent agonists for A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950518r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=802-806&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=G.+Spallutoauthor=X.+D.+Jiauthor=M.+E.+Olahauthor=G.+Stilesauthor=S.+Dionisottiauthor=C.+Zocchiauthor=E.+Onginiauthor=K.+A.+Jacobson&title=Novel+N6-%28substituted-phenylcarbamoyl%29adenosine-5%E2%80%B2-uronamides+as+potent+agonists+for+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm950518r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950518r%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DNovel%2520N6-%2528substituted-phenylcarbamoyl%2529adenosine-5%25E2%2580%25B2-uronamides%2520as%2520potent%2520agonists%2520for%2520A3%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D802%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda de Las Infantas, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of a new series of <i>N</i><sup>6</sup>-arylcarbamoyl, 2-(Ar)alkynyl-<i>N</i>-arylcarbamoyl, and <i>N</i><sup>6</sup>-carboxamido derivatives of adenosine-5′-<i>N</i>-ethyluronamide as A<sub>1</sub> and A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3174</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980147p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3174-3185&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=M.+J.+Pineda+de+Las+Infantasauthor=R.+Romagnoliauthor=G.+Spallutoauthor=R.+Volpiniauthor=S.+Costanziauthor=S.+Vittoriauthor=G.+Cristalliauthor=N.+Melmanauthor=K.+S.+Parkauthor=X.+D.+Jiauthor=K.+A.+Jacobson&title=Synthesis+and+biological+activity+of+a+new+series+of+N6-arylcarbamoyl%2C+2-%28Ar%29alkynyl-N-arylcarbamoyl%2C+and+N6-carboxamido+derivatives+of+adenosine-5%E2%80%B2-N-ethyluronamide+as+A1+and+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm980147p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980147p%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DPineda%2Bde%2BLas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520a%2520new%2520series%2520of%2520N6-arylcarbamoyl%252C%25202-%2528Ar%2529alkynyl-N-arylcarbamoyl%252C%2520and%2520N6-carboxamido%2520derivatives%2520of%2520adenosine-5%25E2%2580%25B2-N-ethyluronamide%2520as%2520A1%2520and%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3174%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda de Las Infantas, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel <i>N</i><sup>6</sup>-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5′-uronamides as A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5535</span><span class="NLM_x">–</span> <span class="NLM_lpage">5540</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0408161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5535-5540&author=P.+G.+Baraldiauthor=F.+Fruttaroloauthor=M.+A.+Tabriziauthor=R.+Romagnoliauthor=D.+Pretiauthor=A.+Boveroauthor=M.+J.+Pineda+de+Las+Infantasauthor=A.+Moormanauthor=K.+Varaniauthor=P.+A.+Borea&title=Synthesis+and+biological+evaluation+of+novel+N6-%5B4-%28substituted%29sulfonamidophenylcarbamoyl%5Dadenosine-5%E2%80%B2-uronamides+as+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0408161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0408161%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBovero%26aufirst%3DA.%26aulast%3DPineda%2Bde%2BLas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DMoorman%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520N6-%255B4-%2528substituted%2529sulfonamidophenylcarbamoyl%255Dadenosine-5%25E2%2580%25B2-uronamides%2520as%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5535%26epage%3D5540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Devine, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urmaliya, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouton, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottle, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of new <i>N</i><sup>6</sup>-substituted adenosine-5′-<i>N</i>-methylcarboxamides as A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3078</span><span class="NLM_x">–</span> <span class="NLM_lpage">3087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3078-3087&author=S.+M.+Devineauthor=A.+Greggauthor=H.+Figlerauthor=K.+McIntoshauthor=V.+Urmaliyaauthor=J.+Lindenauthor=C.+W.+Poutonauthor=P.+J.+Whiteauthor=S.+E.+Bottleauthor=P.+J.+Scammells&title=Synthesis+and+evaluation+of+new+N6-substituted+adenosine-5%E2%80%B2-N-methylcarboxamides+as+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DGregg%26aufirst%3DA.%26aulast%3DFigler%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DK.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DPouton%26aufirst%3DC.%2BW.%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DBottle%26aufirst%3DS.%2BE.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520new%2520N6-substituted%2520adenosine-5%25E2%2580%25B2-N-methylcarboxamides%2520as%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3078%26epage%3D3087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">2-Substitution of <i>N</i><sup>6</sup>-benzyladenosine-5′-uromamides enhances selectivity for A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3614</span><span class="NLM_x">–</span> <span class="NLM_lpage">3621</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00047a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3614-3621&author=H.+O.+Kimauthor=X.+D.+Jiauthor=S.+M.+Siddiqiauthor=M.+E.+Olahauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=2-Substitution+of+N6-benzyladenosine-5%E2%80%B2-uromamides+enhances+selectivity+for+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00047a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00047a018%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DSiddiqi%26aufirst%3DS.%2BM.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D2-Substitution%2520of%2520N6-benzyladenosine-5%25E2%2580%25B2-uromamides%2520enhances%2520selectivity%2520for%2520A3%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3614%26epage%3D3621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Design of (N)-methanocarba adenosine 5′-uronamides as species-independent A<sub>3</sub> receptor-selective agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2813-2819&author=A.+Melmanauthor=Z.+G.+Gaoauthor=D.+Kumarauthor=T.+C.+Wanauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=K.+A.+Jacobson&title=Design+of+%28N%29-methanocarba+adenosine+5%E2%80%B2-uronamides+as+species-independent+A3+receptor-selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DDesign%2520of%2520%2528N%2529-methanocarba%2520adenosine%25205%25E2%2580%25B2-uronamides%2520as%2520species-independent%2520A3%2520receptor-selective%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2813%26epage%3D2819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2285</span><span class="NLM_x">–</span> <span class="NLM_lpage">2298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F1381612023392856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12369946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Crurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2285-2298&author=R.+Volpiniauthor=S.+Costanziauthor=C.+Lambertucciauthor=S.+Vittoriauthor=G.+Cristalli&title=Purine+nucleosides+bearing+1-alkynyl+chains+as+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists</span></div><div class="casAuthors">Volpini, Rosaria; Costanzi, Stefano; Lambertucci, Catia; Vittori, Sauro; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2285-2298</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  The synthesis and the pharmacol. activity of alkynyl derivs. of adenosine (Ado) and N-ethylcarboxamidoadenosine (NECA), that have been tested on adenosine receptors from different sources, have been reviewed.  Most of compds. have been characterized in the last ten years by using radioligand binding assays on rat brain membranes and functional studies on different animal models.  More recently, the four human adenosine receptor subtypes have been stably transfected into Chinese hamster ovary (CHO) cells allowing for comparative studies in a similar cellular background, utilizing radioligand binding studies (A1, A2A, A3) or adenylate cyclase activity assays (A2B).  From the whole pattern of studies the following structure-activity relationships have been drawn:.  -The activities of 2-alkynylAdos resulted slightly higher at A1 and lower at A3 and A2B subtypes than the corresponding NECA derivs., whereas the affinities at A2A subtype are similar for the two series of nucleosides.  -The presence of a Me group on N6 of the 2-alkynyladenosines, inducing a contemporary increase in affinity at the human A3 receptor and a decrease at the other subtypes, resulted in a relevant increase in A3 selectivity.  In particular, 2-phenylethynyl-N6-methylAdo showed an A3 affinity in the low nanomolar range (Ki A3 = 3.4 nM), and about 500 fold A1/A3 and about 2500 fold A2A/A3 selectivity.  -The presence of a hydroxyl group in some alkynyl side chains led to potent inhibitors of platelet aggregation induced by ADP.  -Introduction of particular substituents, such as the racemic 2-phenylhydroxypropynyl group, both in adenosine and in NECA analogs, led to highly potent, non selective agonists at all the four subtypes.  -For the potency at A2B receptor it seems to be very important the type of alkynyl chain in 2-position and the presence of the carboxyamido group on the sugar; in fact, the (S)-2-phenylhydroxypropynylNECA [(S)-PHPNECA, EC50 A2B = 220 nM] proved to be one of the most potent A2B agonist reported so far.  -The introduction of alkynyl chain in 8-position of adenosine led to very selective ligands for the A3 receptor subtype.  These nucleosides behave as adenosine antagonists, since they do not stimulate basal [35S]GTPγS binding, but inhibit NECA-stimulated binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNgPJDW6MTF7Vg90H21EOLACvtfcHk0lgMgX92fAUN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Crurc%253D&md5=c777034885bf8337a9ff09de609d60b4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F1381612023392856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023392856%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DPurine%2520nucleosides%2520bearing%25201-alkynyl%2520chains%2520as%2520adenosine%2520receptor%2520agonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2285%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramadori, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 2-alkynyl-<i>N</i><sup>6</sup>-methyl-5′-<i>N</i>-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7897</span><span class="NLM_x">–</span> <span class="NLM_lpage">7900</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900754g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7897-7900&author=R.+Volpiniauthor=M.+Buccioniauthor=D.+Dal+Benauthor=C.+Lambertucciauthor=C.+Lammiauthor=G.+Marucciauthor=A.+T.+Ramadoriauthor=K.+N.+Klotzauthor=G.+Cristalli&title=Synthesis+and+biological+evaluation+of+2-alkynyl-N6-methyl-5%E2%80%B2-N-methylcarboxamidoadenosine+derivatives+as+potent+and+highly+selective+agonists+for+the+human+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm900754g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900754g%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DLammi%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DRamadori%26aufirst%3DA.%2BT.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25202-alkynyl-N6-methyl-5%25E2%2580%25B2-N-methylcarboxamidoadenosine%2520derivatives%2520as%2520potent%2520and%2520highly%2520selective%2520agonists%2520for%2520the%2520human%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7897%26epage%3D7900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>6</sup>-Methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1230</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060963u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1222-1230&author=R.+Volpiniauthor=D.+Dal+Benauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=K.+N.+Klotzauthor=G.+Cristalli&title=N6-Methoxy-2-alkynyladenosine+derivatives+as+highly+potent+and+selective+ligands+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060963u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060963u%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DN6-Methoxy-2-alkynyladenosine%2520derivatives%2520as%2520highly%2520potent%2520and%2520selective%2520ligands%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1222%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">Molecular modeling study on potent and selective adenosine A<sub>3</sub> receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7923</span><span class="NLM_x">–</span> <span class="NLM_lpage">7930</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bmc.2010.09.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20943397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKrsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7923-7930&author=D.+Dal+Benauthor=M.+Buccioniauthor=C.+Lambertucciauthor=G.+Marucciauthor=A.+Thomasauthor=R.+Volpiniauthor=G.+Cristalli&title=Molecular+modeling+study+on+potent+and+selective+adenosine+A3+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling study on potent and selective adenosine A3 receptor agonists</span></div><div class="casAuthors">Dal Ben, Diego; Buccioni, Michela; Lambertucci, Catia; Marucci, Gabriella; Thomas, Ajiroghene; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7923-7930</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A3 receptor (A3AR) is involved in a variety of key physio-pathol. processes and its agonists are potential therapeutic agents for the treatment of rheumatoid arthritis, dry eye disorders, asthma, as anti-inflammatory agents, and in cancer therapy.  Recently reported MECA (5'-N-methylcarboxamidoadenosine) derivs. bearing a Me group in N6-position and an arylethynyl substituent in 2-position demonstrated to possess sub-nanomolar affinity and remarkable selectivity for the human A3AR, behaving as full agonists of this receptor.  In this study, we made an attempt to get a rationalization of the high affinities and selectivities of these mols. for the human A3AR, by using adenosine receptor (AR) structural models based on the A2AAR crystal structure and mol. docking anal.  Post-docking anal. allowed to evaluate the ability of modeling tools in predicting AA3R affinity and in providing interpretation of compd. substituents effect on the A3AR affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprTrcS5ra1x7Vg90H21EOLACvtfcHk0licz0IvSPg3Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKrsr%252FE&md5=09d41ebd1533011c05bd28f6afda270e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DMolecular%2520modeling%2520study%2520on%2520potent%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7923%26epage%3D7930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>6</sup>-Ethyl-2-alkynyl NECAs, selective human A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2416-2418&author=R.+Zhuauthor=C.+R.+Frazierauthor=J.+Lindenauthor=T.+L.+Macdonald&title=N6-Ethyl-2-alkynyl+NECAs%2C+selective+human+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DFrazier%26aufirst%3DC.%2BR.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DN6-Ethyl-2-alkynyl%2520NECAs%252C%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2416%26epage%3D2418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Cosyn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaniappan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span> </span><span class="NLM_article-title">2-Triazole-substituted adenosines: a new class of selective A<sub>3</sub> adenosine receptor agonists, partial agonists, and antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7373</span><span class="NLM_x">–</span> <span class="NLM_lpage">7383</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7373-7383&author=L.+Cosynauthor=K.+K.+Palaniappanauthor=S.+K.+Kimauthor=H.+T.+Duongauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=S.+Van+Calenbergh&title=2-Triazole-substituted+adenosines%3A+a+new+class+of+selective+A3+adenosine+receptor+agonists%2C+partial+agonists%2C+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0608208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608208%26sid%3Dliteratum%253Aachs%26aulast%3DCosyn%26aufirst%3DL.%26aulast%3DPalaniappan%26aufirst%3DK.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26atitle%3D2-Triazole-substituted%2520adenosines%253A%2520a%2520new%2520class%2520of%2520selective%2520A3%2520adenosine%2520receptor%2520agonists%252C%2520partial%2520agonists%252C%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7373%26epage%3D7383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Design, synthesis and binding affinity of 3′-fluoro analogues of Cl-IB-MECA as adenosine A<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=817-820&author=M.+H.+Limauthor=H.+O.+Kimauthor=H.+R.+Moonauthor=S.+J.+Leeauthor=M.+W.+Chunauthor=Z.+G.+Gaoauthor=N.+Melmanauthor=K.+A.+Jacobsonauthor=J.+H.+Kimauthor=L.+S.+Jeong&title=Design%2C+synthesis+and+binding+affinity+of+3%E2%80%B2-fluoro+analogues+of+Cl-IB-MECA+as+adenosine+A3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520binding%2520affinity%2520of%25203%25E2%2580%25B2-fluoro%2520analogues%2520of%2520Cl-IB-MECA%2520as%2520adenosine%2520A3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D817%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elhalem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamedova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structural determinants of efficacy at A<sub>3</sub> adenosine receptors: modification of the ribose moiety</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bcp.2003.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15104242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFWmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=893-901&author=Z.+G.+Gaoauthor=L.+S.+Jeongauthor=H.+R.+Moonauthor=H.+O.+Kimauthor=W.+J.+Choiauthor=D.+H.+Shinauthor=E.+Elhalemauthor=M.+J.+Cominauthor=N.+Melmanauthor=L.+Mamedovaauthor=A.+S.+Grossauthor=J.+B.+Rodriguezauthor=K.+A.+Jacobson&title=Structural+determinants+of+efficacy+at+A3+adenosine+receptors%3A+modification+of+the+ribose+moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety</span></div><div class="casAuthors">Gao, Zhan-Guo; Jeong, Lak Shin; Moon, Hyung Ryong; Kim, Hea Ok; Choi, Won Jun; Shin, Dae Hong; Elhalem, Eleonora; Comin, Maria J.; Melman, Neli; Mamedova, Liaman; Gross, Ariel S.; Rodriguez, Juan B.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">893-901</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The authors have found previously that structural features of adenosine derivs., particularly at the N6- and 2-positions of adenine, det. the intrinsic efficacy as A3 adenosine receptor (AR) agonists.  Here, the authors have probed this phenomenon with respect to the ribose moiety using a series of ribose-modified adenosine derivs., examg. binding affinity and activation of the human A3 AR expressed in CHO cells.  Both 2'- and 3'-hydroxyl groups in the ribose moiety contribute to A3 AR binding and activation, with 2'-OH being more essential.  Thus, the 2'-fluoro substitution eliminated both binding and activation, while a 3'-fluoro substitution led to only a partial redn. of potency and efficacy at the A3 AR.  A 5'-uronamide group, known to restore full efficacy in other derivs., failed to fully overcome the diminished efficacy of 3'-fluoro derivs.  The 4'-thio substitution, which generally enhanced A3 AR potency and selectivity, resulted in 5'-CH2OH analogs which were partial agonists of the A3 AR.  Interestingly, the shifting of the N6-(3-iodobenzyl)adenine moiety from the 1'- to 4'-position had a minor influence on A3 AR selectivity, but transformed one analog into a potent antagonist.  This antagonist antagonized human A3 AR agonist-induced inhibition of cAMP with a KB value of 3.0 nM.  A novel apio analog of neplanocin A, was a full A3 AR agonist.  The affinities of selected, novel analogs at rat ARs were examd., revealing species differences.  In summary, crit. structural determinants for human A3 AR activation have been identified, which should prove useful for further understanding the mechanism of receptor activation and development of more potent and selective full agonists, partial agonists and antagonists for A3 ARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAMN3ntd9aerVg90H21EOLACvtfcHk0licz0IvSPg3Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFWmt74%253D&md5=7463b27f1eb62e0eb7c8dfa9bb301d0c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2003.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2003.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DElhalem%26aufirst%3DE.%26aulast%3DComin%26aufirst%3DM.%2BJ.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DMamedova%26aufirst%3DL.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DJ.%2BB.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520determinants%2520of%2520efficacy%2520at%2520A3%2520adenosine%2520receptors%253A%2520modification%2520of%2520the%2520ribose%2520moiety%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D893%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">DeNinno, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamune, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiRico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etienne, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleynek, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span> </span><span class="NLM_article-title">3′-Aminoadenosine-5′-uronamides: discovery of the first highly selective agonist at the human adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0255724" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=353-355&author=M.+P.+DeNinnoauthor=H.+Masamuneauthor=L.+K.+Chenardauthor=K.+J.+DiRicoauthor=C.+Ellerauthor=J.+B.+Etienneauthor=J.+E.+Ticknerauthor=S.+P.+Kennedyauthor=D.+R.+Knightauthor=J.+Kongauthor=J.+J.+Oleynekauthor=W.+R.+Traceyauthor=R.+J.+Hill&title=3%E2%80%B2-Aminoadenosine-5%E2%80%B2-uronamides%3A+discovery+of+the+first+highly+selective+agonist+at+the+human+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm0255724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255724%26sid%3Dliteratum%253Aachs%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DMasamune%26aufirst%3DH.%26aulast%3DChenard%26aufirst%3DL.%2BK.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DEller%26aufirst%3DC.%26aulast%3DEtienne%26aufirst%3DJ.%2BB.%26aulast%3DTickner%26aufirst%3DJ.%2BE.%26aulast%3DKennedy%26aufirst%3DS.%2BP.%26aulast%3DKnight%26aufirst%3DD.%2BR.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DOleynek%26aufirst%3DJ.%2BJ.%26aulast%3DTracey%26aufirst%3DW.%2BR.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26atitle%3D3%25E2%2580%25B2-Aminoadenosine-5%25E2%2580%25B2-uronamides%253A%2520discovery%2520of%2520the%2520first%2520highly%2520selective%2520agonist%2520at%2520the%2520human%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D353%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Synthesis of 3′-acetamidoadenosine derivatives as potential A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1080%2F15257770801944436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18404574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFSit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=408-420&author=M.+W.+Chunauthor=S.+W.+Choiauthor=T.+K.+Kangauthor=W.+J.+Choiauthor=H.+O.+Kimauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Synthesis+of+3%E2%80%B2-acetamidoadenosine+derivatives+as+potential+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3'-Acetamidoadenosine Derivatives as Potential A3 Adenosine Receptor Agonists</span></div><div class="casAuthors">Chun, Moon Woo; Choi, Sung Wook; Kang, Tae Kyung; Choi, Won Jun; Kim, Hea Ok; Gao, Zhan-Guo; Jacobson, Kenneth A.; Jeong, Lak Shin</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">408-420</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">On the basis of high binding affinity of 3'-aminoadenosine derivs. at the human A3 adenosine receptor (AR), 3'-acetamidoadenosine derivs., e.g. I, were synthesized from 1,2:5,6-di-O-isopropylidene-D-glucose via stereoselective hydroboration as a key step.  Although all synthesized compds. were totally devoid of binding affinity at the human A3AR, our results revealed that 3'-position of adenosine can only be tolerated with small size of a hydrogen bonding donor like hydroxyl or amino group in the binding site of human A3AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfXXuFZXY_F7Vg90H21EOLACvtfcHk0lijalRO-FsdEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFSit78%253D&md5=6c7d2f2ef80bf1b3d005aefbaa20f836</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1080%2F15257770801944436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770801944436%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DChoi%26aufirst%3DS.%2BW.%26aulast%3DKang%26aufirst%3DT.%2BK.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DSynthesis%2520of%25203%25E2%2580%25B2-acetamidoadenosine%2520derivatives%2520as%2520potential%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2008%26volume%3D27%26spage%3D408%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>6</sup>-Substituted <span class="smallcaps smallerCapital">d</span>-4′-thioadenosine-5′-methyluronamides: potent and selective agonists at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3775</span><span class="NLM_x">–</span> <span class="NLM_lpage">3777</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3775-3777&author=L.+S.+Jeongauthor=D.+Z.+Jinauthor=H.+O.+Kimauthor=D.+H.+Shinauthor=H.+R.+Moonauthor=P.+Gunagaauthor=M.+W.+Chunauthor=Y.+C.+Kimauthor=N.+Melmanauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=N6-Substituted+d-4%E2%80%B2-thioadenosine-5%E2%80%B2-methyluronamides%3A+potent+and+selective+agonists+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm034098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034098e%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJin%26aufirst%3DD.%2BZ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DN6-Substituted%2520d-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-methyluronamides%253A%2520potent%2520and%2520selective%2520agonists%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3775%26epage%3D3777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of 2-chloro-<i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-uronamides as highly potent and selective agonists at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050595e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=273-281&author=L.+S.+Jeongauthor=H.+W.+Leeauthor=K.+A.+Jacobsonauthor=H.+O.+Kimauthor=D.+H.+Shinauthor=J.+A.+Leeauthor=Z.+G.+Gaoauthor=C.+Luauthor=H.+T.+Duongauthor=P.+Gunagaauthor=S.+K.+Leeauthor=D.+Z.+Jinauthor=M.+W.+Chunauthor=H.+R.+Moon&title=Structure%E2%80%93activity+relationships+of+2-chloro-N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-uronamides+as+highly+potent+and+selective+agonists+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm050595e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050595e%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DD.%2BZ.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%25202-chloro-N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-uronamides%2520as%2520highly%2520potent%2520and%2520selective%2520agonists%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of <i>N</i><sup>6</sup>-substituted-4′-thioadenosines at the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4718</span><span class="NLM_x">–</span> <span class="NLM_lpage">4730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4718-4730&author=L.+S.+Jeongauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=J.+Y.+Jungauthor=Z.+G.+Gaoauthor=H.+T.+Duongauthor=S.+Raoauthor=K.+A.+Jacobsonauthor=D.+H.+Shinauthor=J.+A.+Leeauthor=P.+Gunagaauthor=S.+K.+Leeauthor=D.+Z.+Jinauthor=M.+W.+Chunauthor=H.+R.+Moon&title=Design%2C+synthesis%2C+and+biological+activity+of+N6-substituted-4%E2%80%B2-thioadenosines+at+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJung%26aufirst%3DJ.%2BY.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DD.%2BZ.%26aulast%3DChun%26aufirst%3DM.%2BW.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520N6-substituted-4%25E2%2580%25B2-thioadenosines%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4718%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Lee, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span> </span><span class="NLM_article-title">A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=918-924&author=E.+J.+Leeauthor=H.+Y.+Minauthor=H.+J.+Chungauthor=E.+J.+Parkauthor=D.+H.+Shinauthor=L.+S.+Jeongauthor=S.+K.+Lee&title=A+novel+adenosine+analog%2C+thio-Cl-IB-MECA%2C+induces+G0%2FG1+cell+cycle+arrest+and+apoptosis+in+human+promyelocytic+leukemia+HL-60+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BJ.%26aulast%3DMin%26aufirst%3DH.%2BY.%26aulast%3DChung%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BK.%26atitle%3DA%2520novel%2520adenosine%2520analog%252C%2520thio-Cl-IB-MECA%252C%2520induces%2520G0%252FG1%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520human%2520promyelocytic%2520leukemia%2520HL-60%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D918%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Chung, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, G.</span><span> </span><span class="NLM_article-title">The anti-tumor effect of LJ-529, a novel agonist to A<sub>3</sub> adenosine receptor, in estrogen receptor-negative human breast cancer cells via inactivation of Akt and Wnt pathways</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1158%2F1535-7163.MCT-05-0245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16546983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitl2lurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=685-692&author=H.+Y.+Chungauthor=S.+D.+Choauthor=H.+J.+Kimauthor=D.+H.+Shinauthor=L.+S.+Jeongauthor=G.+Kong&title=The+anti-tumor+effect+of+LJ-529%2C+a+novel+agonist+to+A3+adenosine+receptor%2C+in+estrogen+receptor-negative+human+breast+cancer+cells+via+inactivation+of+Akt+and+Wnt+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers</span></div><div class="casAuthors">Chung, Heekyoung; Jung, Ji-Youn; Cho, Sung-Dae; Hong, Kyung-A.; Kim, Hyun-Jun; Shin, Dong-Hui; Kim, Hwan; Kim, Hea Ok; Shin, Dae Hong; Lee, Hyuk Woo; Jeong, Lak Shin; Kong, Gu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Agonists to A3 adenosine receptor (A3AR) have been reported to inhibit cell growth and/or induce apoptosis in various tumors.  We tested the effect of a novel A3AR agonist generically known as LJ-529 in breast cancer cells.  Anchorage-dependent cell growth and in vivo tumor growth were attenuated by LJ-529, independently of its estrogen receptor (ER) α status.  In addn., apoptosis was induced as evidenced by the activation of caspase-3 and c-poly(ADP)ribose polymerase.  Furthermore, the Wnt signaling pathway was down-regulated and p27kip was induced by LJ-529.  In ER-pos. cells, the expression of ER was down-regulated by LJ-529, which might have addnl. contributed to attenuated cell proliferation.  In ER-neg., c-ErbB2-overexpressing SK-BR-3 cells, the expression of c-ErbB2 and its downstream extracellular signal-regulated kinase pathway were down-regulated by LJ-529.  However, such effect of LJ-529 acted independently of its receptor because no A3AR was detected by reverse transcription-PCR in all four cell lines tested.  In conclusion, our novel findings open the possibility of LJ-529 as an effective therapeutic agent against both ER-pos. and ER-neg. breast cancers, particularly against the more aggressive ER-neg., c-ErbB2-overexpressing types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbNhzalVi2rVg90H21EOLACvtfcHk0lhxmpOhFs6usg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitl2lurw%253D&md5=4bdab4daedb42542c195f008ce10f2be</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0245%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DH.%2BY.%26aulast%3DCho%26aufirst%3DS.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DKong%26aufirst%3DG.%26atitle%3DThe%2520anti-tumor%2520effect%2520of%2520LJ-529%252C%2520a%2520novel%2520agonist%2520to%2520A3%2520adenosine%2520receptor%252C%2520in%2520estrogen%2520receptor-negative%2520human%2520breast%2520cancer%2520cells%2520via%2520inactivation%2520of%2520Akt%2520and%2520Wnt%2520pathways%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of <i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-uronamides as potent and selective human A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">8003</span><span class="NLM_x">–</span> <span class="NLM_lpage">8011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8003-8011&author=W.+J.+Choiauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=M.+Chinnauthor=Z.+G.+Gaoauthor=A.+Patelauthor=K.+A.+Jacobsonauthor=H.+R.+Moonauthor=Y.+H.+Jungauthor=L.+S.+Jeong&title=Design+and+synthesis+of+N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-uronamides+as+potent+and+selective+human+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26aulast%3DJung%26aufirst%3DY.%2BH.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-uronamides%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8003%26epage%3D8011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, R. G.</span><span> </span><span class="NLM_article-title">Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2196</span><span class="NLM_x">–</span> <span class="NLM_lpage">2203</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9905965" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFKiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2196-2203&author=K.+A.+Jacobsonauthor=X.+Jiauthor=A.+H.+Liauthor=N.+Melmanauthor=M.+A.+Siddiqiauthor=K.+J.+Shinauthor=V.+E.+Marquezauthor=R.+G.+Ravi&title=Methanocarba+analogues+of+purine+nucleosides+as+potent+and+selective+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Methanocarba Analogues of Purine Nucleosides as Potent and Selective Adenosine Receptor Agonists</span></div><div class="casAuthors">Jacobson, Kenneth A.; Ji, Xiao-duo; Li, An-Hu; Melman, Neli; Siddiqui, Maqbool A.; Shin, Kye-Jung; Marquez, Victor E.; Ravi, R. Gnana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2196-2203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine receptor agonists have cardioprotective, cerebroprotective, and antiinflammatory properties.  The authors report that a carbocyclic modification of the ribose moiety incorporating ring constraints is a general approach for the design of A1 and A3 receptor agonists having favorable pharmacodynamic properties.  While simple carbocyclic substitution of adenosine agonists greatly diminishes potency, methanocarba-adenosine analogs have now defined the role of sugar puckering in stabilizing the active adenosine receptor-bound conformation and thereby have allowed identification of a favored isomer.  In such analogs a fused cyclopropane moiety constrains the pseudosugar ring of the nucleoside to either a Northern (N) or Southern (S) conformation, as defined in the pseudorotational cycle.  In binding assays at A1, A2A, and A3 receptors, (N)-methanocarba-adenosine was of higher affinity than the (S)-analog, particularly at the human A3 receptor (N/S affinity ratio of 150).  (N)-methanocarba analogs of various N6-substituted adenosine derivs., including cyclopentyl and 3-iodobenzyl, in which the parent compds. are potent agonists at either A1 or A3 receptors, resp., were synthesized.  The N6-cyclopentyl derivs. were A1 receptor-selective and maintained high efficacy at recombinant human but not rat brain A1 receptors, as indicated by stimulation of binding of [35S]GTP-γ-S.  The (N)-methanocarba-N6-(3-iodobenzyl)adenosine and its 2-chloro deriv. had Ki values of 4.1 and 2.2 nM at A3 receptors, resp., and were highly selective partial agonists.  Partial agonism combined with high functional potency at A3 receptors (EC50 < 1 nM) may produce tissue selectivity.  In conclusion, as for P2Y1 receptors, at least three adenosine receptors favor the ribose (N)-conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyofQbUPWTtbVg90H21EOLACvtfcHk0lhxmpOhFs6usg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFKiu78%253D&md5=e6ea09c4de935777d080f2d48a4f8e8c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm9905965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9905965%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DSiddiqi%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DK.%2BJ.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DRavi%26aufirst%3DR.%2BG.%26atitle%3DMethanocarba%2520analogues%2520of%2520purine%2520nucleosides%2520as%2520potent%2520and%2520selective%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2196%26epage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">(N)-Methanocarba 2,<i>N</i><sup>6</sup>-disubstituted adenine nucleosides as highly potent and selective A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1745</span><span class="NLM_x">–</span> <span class="NLM_lpage">1758</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049580r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1745-1758&author=S.+Tchilibonauthor=B.+V.+Joshiauthor=S.+K.+Kimauthor=H.+T.+Duongauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=%28N%29-Methanocarba+2%2CN6-disubstituted+adenine+nucleosides+as+highly+potent+and+selective+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm049580r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049580r%26sid%3Dliteratum%253Aachs%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D%2528N%2529-Methanocarba%25202%252CN6-disubstituted%2520adenine%2520nucleosides%2520as%2520highly%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1745%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Matot, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiniger, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion</span> <span class="citation_source-journal">Crit. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=R65&author=I.+Matotauthor=C.+F.+Weinigerauthor=E.+Zeiraauthor=E.+Galunauthor=B.+V.+Joshiauthor=K.+A.+Jacobson&title=A3+adenosine+receptors+and+mitogen-activated+protein+kinases+in+lung+injury+following+in+vivo+reperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatot%26aufirst%3DI.%26aulast%3DWeiniger%26aufirst%3DC.%2BF.%26aulast%3DZeira%26aufirst%3DE.%26aulast%3DGalun%26aufirst%3DE.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA3%2520adenosine%2520receptors%2520and%2520mitogen-activated%2520protein%2520kinases%2520in%2520lung%2520injury%2520following%2520in%2520vivo%2520reperfusion%26jtitle%3DCrit.%2520Care%26date%3D2006%26volume%3D10%26spage%3DR65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of [<sup>125</sup>I]-MRS1898, a high-affinity, selective radioligand for the rat A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=31-37&author=Z.+Gaoauthor=B.+Tengauthor=H.+Wuauthor=B.+V.+Joshiauthor=G.+L.+Griffithsauthor=K.+A.+Jacobson&title=Synthesis+and+pharmacological+characterization+of+%5B125I%5D-MRS1898%2C+a+high-affinity%2C+selective+radioligand+for+the+rat+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DTeng%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGriffiths%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520%255B125I%255D-MRS1898%252C%2520a%2520high-affinity%252C%2520selective%2520radioligand%2520for%2520the%2520rat%2520A3%2520adenosine%2520receptor%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D31%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Functionalized congeners of A<sub>3</sub> adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7580</span><span class="NLM_x">–</span> <span class="NLM_lpage">7592</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900426g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7580-7592&author=D.+K.+Toshauthor=M.+Chinnauthor=A.+A.+Ivanovauthor=A.+M.+Klutzauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=Functionalized+congeners+of+A3+adenosine+receptor-selective+nucleosides+containing+a+bicyclo%5B3.1.0%5Dhexane+ring+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm900426g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900426g%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionalized%2520congeners%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%2520containing%2520a%2520bicyclo%255B3.1.0%255Dhexane%2520ring%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7580%26epage%3D7592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">2-Dialkynyl derivatives of (N)-methanocarba nucleosides: “clickable” A<sub>3</sub> adenosine receptor-selective agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=508-517&author=D.+K.+Toshauthor=M.+Chinnauthor=L.+S.+Yooauthor=D.+W.+Kangauthor=H.+Lueckeauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=2-Dialkynyl+derivatives+of+%28N%29-methanocarba+nucleosides%3A+%E2%80%9Cclickable%E2%80%9D+A3+adenosine+receptor-selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DYoo%26aufirst%3DL.%2BS.%26aulast%3DKang%26aufirst%3DD.%2BW.%26aulast%3DLuecke%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D2-Dialkynyl%2520derivatives%2520of%2520%2528N%2529-methanocarba%2520nucleosides%253A%2520%25E2%2580%259Cclickable%25E2%2580%259D%2520A3%2520adenosine%2520receptor-selective%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D508%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Chang, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Frijtag Drabbe Kuenzel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanjersberg, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Hout, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beukers, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A.</span><span> </span><span class="NLM_article-title">A series of ligands displaying a remarkable agonistic–antagonistic profile at the adenosine A<sub>1</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2045</span><span class="NLM_x">–</span> <span class="NLM_lpage">2053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049597%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2045-2053&author=L.+C.+Changauthor=J.+Von+Frijtag+Drabbe+Kuenzelauthor=T.+Mulderauthor=R.+F.+Spanjersbergauthor=G.+Van+den+Houtauthor=M.+W.+Beukersauthor=J.+Brusseeauthor=A.+IJzerman&title=A+series+of+ligands+displaying+a+remarkable+agonistic%E2%80%93antagonistic+profile+at+the+adenosine+A1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm049597%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049597%252B%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%2BC.%26aulast%3DVon%2BFrijtag%2BDrabbe%2BKuenzel%26aufirst%3DJ.%26aulast%3DMulder%26aufirst%3DT.%26aulast%3DSpanjersberg%26aufirst%3DR.%2BF.%26aulast%3DVan%2Bden%2BHout%26aufirst%3DG.%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%26atitle%3DA%2520series%2520of%2520ligands%2520displaying%2520a%2520remarkable%2520agonistic%25E2%2580%2593antagonistic%2520profile%2520at%2520the%2520adenosine%2520A1%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2045%26epage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Baraldi, P. G.; Romagnoli, R.; Saponaro, G.; Baraldi, S.; Tabrizi, M. A.; Preti, D.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> Adenosine Receptor Antagonists: History and Future Perspectives</span>. In  <span class="citation_source-book">A<sub>3</sub> Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics</span>; <span class="NLM_contrib-group">Borea, P. A.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-90-481-3144-0_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=121-147&author=P.+G.+Baraldi&author=R.+Romagnoli&author=G.+Saponaro&author=S.+Baraldi&author=M.+A.+Tabrizi&author=D.+Pretiauthor=P.+A.+Borea&title=A3+Adenosine+Receptors+from+Cell+Biology+to+Pharmacology+and+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2F978-90-481-3144-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-90-481-3144-0_7%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26atitle%3DA3%2520Adenosine%2520Receptor%2520Antagonists%253A%2520History%2520and%2520Future%2520Perspectives%26btitle%3DA3%2520Adenosine%2520Receptors%2520from%2520Cell%2520Biology%2520to%2520Pharmacology%2520and%2520Therapeutics%26aulast%3DBorea%26aufirst%3DP.%2BA.%26pub%3DSpringer%26date%3D2010%26spage%3D121%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Cosimelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1764</span><span class="NLM_x">–</span> <span class="NLM_lpage">1770</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701159t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1764-1770&author=B.+Cosimelliauthor=G.+Grecoauthor=M.+Ehlardoauthor=E.+Novellinoauthor=F.+Da+Settimoauthor=S.+Talianiauthor=C.+La+Mottaauthor=M.+Bellandiauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=O.+Ciampiauthor=M.+L.+Trincavelliauthor=C.+Martini&title=Derivatives+of+4-amino-6-hydroxy-2-mercaptopyrimidine+as+novel%2C+potent%2C+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm701159t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701159t%26sid%3Dliteratum%253Aachs%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DEhlardo%26aufirst%3DM.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DBellandi%26aufirst%3DM.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DDerivatives%2520of%25204-amino-6-hydroxy-2-mercaptopyrimidine%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1764%26epage%3D1770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Yaziji, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Maatougui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Mera, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotelo, E.</span><span> </span><span class="NLM_article-title">Divergent solution-phase synthesis of diarylpyrimidine libraries as selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc900044k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVentr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=519-522&author=V.+Yazijiauthor=A.+Coelhoauthor=A.+El+Maatouguiauthor=J.+Breaauthor=M.+I.+Lozaauthor=X.+Garcia-Meraauthor=E.+Sotelo&title=Divergent+solution-phase+synthesis+of+diarylpyrimidine+libraries+as+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent Solution-Phase Synthesis of Diarylpyrimidine Libraries as Selective A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Yaziji, Vicente; Coelho, Alberto; El Maatougui, Abdelaziz; Brea, Jose; Loza, M. Isabel; Garcia-Mera, Xerardo; Sotelo, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">519-522</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical and divergent soln.-phase synthetic strategy has been optimized to prep. a highly diverse library of 2,4-diaryl- and 2,6-diarylpyrimidines.  Structural elaboration of the starting heterocyclic scaffolds was accomplished by exploiting the potential for diversity offered by the Suzuki-Miyaura cross-coupling reaction.  These studies enabled the identification of structurally simple, highly potent, and selective A3 adenosine receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5JPXnvRZwQbVg90H21EOLACvtfcHk0lg9_H-hwvRVdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVentr8%253D&md5=14c0f81a8aa0b82138a743dd9d538e40</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fcc900044k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc900044k%26sid%3Dliteratum%253Aachs%26aulast%3DYaziji%26aufirst%3DV.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DEl%2BMaatougui%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DGarcia-Mera%26aufirst%3DX.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DDivergent%2520solution-phase%2520synthesis%2520of%2520diarylpyrimidine%2520libraries%2520as%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2009%26volume%3D11%26spage%3D519%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Yaziji, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez-de-Teran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caamano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Mera, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadavid, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotelo, E.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives as potent and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100843z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=457-471&author=V.+Yazijiauthor=D.+Rodriguezauthor=H.+Gutierrez-de-Teranauthor=A.+Coelhoauthor=O.+Caamanoauthor=X.+Garcia-Meraauthor=J.+Breaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=E.+Sotelo&title=Pyrimidine+derivatives+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm100843z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100843z%26sid%3Dliteratum%253Aachs%26aulast%3DYaziji%26aufirst%3DV.%26aulast%3DRodriguez%26aufirst%3DD.%26aulast%3DGutierrez-de-Teran%26aufirst%3DH.%26aulast%3DCoelho%26aufirst%3DA.%26aulast%3DCaamano%26aufirst%3DO.%26aulast%3DGarcia-Mera%26aufirst%3DX.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DPyrimidine%2520derivatives%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D457%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Jung, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=613-623&author=K.+Y.+Jungauthor=S.+K.+Kimauthor=Z.+G.+Gaoauthor=A.+S.+Grossauthor=N.+Melmanauthor=K.+A.+Jacobsonauthor=Y.+C.+Kim&title=Structure%E2%80%93activity+relationships+of+thiazole+and+thiadiazole+derivatives+as+potent+and+selective+human+adenosine+A3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520thiazole%2520and%2520thiadiazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520adenosine%2520A3%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D613%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Press, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span> </span><span class="NLM_article-title">New highly potent and selective adenosine A<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F1568026043451023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15078217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVeju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=863-870&author=N.+J.+Pressauthor=T.+H.+Kellerauthor=P.+Tranterauthor=D.+Beerauthor=K.+Jonesauthor=A.+Faesslerauthor=R.+Hengauthor=C.+Lewisauthor=T.+Howeauthor=P.+Gedeckauthor=L.+Mazzoniauthor=J.+R.+Fozard&title=New+highly+potent+and+selective+adenosine+A3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">New highly potent and selective adenosine A3 receptor antagonists</span></div><div class="casAuthors">Press, Neil J.; Keller, Thomas H.; Tranter, Pamela; Beer, David; Jones, Ken; Faessler, Alexander; Heng, Richard; Lewis, Christine; Howe, Trevor; Gedeck, Peter; Mazzoni, Lazzaro; Fozard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">863-870</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A class of potent, selective adenosine A3 receptor antagonists was obtained via optimization of the screening hit N-[4-(4-methoxyphenyl)-thiazol-2-yl]-acetamide.  Structural modifications of this hit revealed very quickly that a 5-(pyridin-4-yl) substituent on the 2-aminothiazole ring was optimal for high potency at the adenosine A3 receptor.  Structure activity relationship studies led to both potent and selective A3 receptor antagonists, including N-[5-pyridin-4-yl-4-(3,4,5-trimethoxyphenyl)-thiazol-2-yl]-acetamide, a highly potent adenosine A3 receptor antagonist with greater than 100- fold selectivity against the related adenosine receptors.  As well as demonstrating selective in vitro binding on the human A3 adenosine receptor, this compd. was also shown to selectively block the rat A3 receptor in vivo.  This important new compd. can be readily synthesized in four steps from com. available starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoswZrH027jH7Vg90H21EOLACvtfcHk0liAW_PP05yPJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVeju7Y%253D&md5=f3bd9305aa069ae9fae80ccb93205530</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F1568026043451023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043451023%26sid%3Dliteratum%253Aachs%26aulast%3DPress%26aufirst%3DN.%2BJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DTranter%26aufirst%3DP.%26aulast%3DBeer%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DFaessler%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DMazzoni%26aufirst%3DL.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26atitle%3DNew%2520highly%2520potent%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D863%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Miwatashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawa, S.</span><span> </span><span class="NLM_article-title">Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A<sub>3</sub> antagonists</span> <span class="citation_source-journal">Chem. Pharm. Bull. (Tokyo)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1126</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=1126-1137&author=S.+Miwatashiauthor=Y.+Arikawaauthor=T.+Matsumotoauthor=K.+Ugaauthor=N.+Kanzakiauthor=Y.+N.+Imaiauthor=S.+Ohkawa&title=Synthesis+and+biological+activities+of+4-phenyl-5-pyridyl-1%2C3-thiazole+derivatives+as+selective+adenosine+A3+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiwatashi%26aufirst%3DS.%26aulast%3DArikawa%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DImai%26aufirst%3DY.%2BN.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%25204-phenyl-5-pyridyl-1%252C3-thiazole%2520derivatives%2520as%2520selective%2520adenosine%2520A3%2520antagonists%26jtitle%3DChem.%2520Pharm.%2520Bull.%2520%2528Tokyo%2529%26date%3D2008%26volume%3D56%26spage%3D1126%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">Scouting human A<sub>3</sub> adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6596</span><span class="NLM_x">–</span> <span class="NLM_lpage">6606</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070852a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6596-6606&author=E.+Morizzoauthor=F.+Capelliauthor=O.+Lenziauthor=D.+Catarziauthor=F.+Varanoauthor=G.+Filacchioniauthor=F.+Vincenziauthor=K.+Varaniauthor=P.+A.+Boreaauthor=V.+Colottaauthor=S.+Moro&title=Scouting+human+A3+adenosine+receptor+antagonist+binding+mode+using+a+molecular+simplification+approach%3A+from+triazoloquinoxaline+to+a+pyrimidine+skeleton+as+a+key+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm070852a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070852a%26sid%3Dliteratum%253Aachs%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DCapelli%26aufirst%3DF.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DScouting%2520human%2520A3%2520adenosine%2520receptor%2520antagonist%2520binding%2520mode%2520using%2520a%2520molecular%2520simplification%2520approach%253A%2520from%2520triazoloquinoxaline%2520to%2520a%2520pyrimidine%2520skeleton%2520as%2520a%2520key%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6596%26epage%3D6606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Poli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">The identification of the 2-phenylphthalazin-1(2<i>H</i>)-one scaffold as a new decorable core skeleton for the design of potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2102</span><span class="NLM_x">–</span> <span class="NLM_lpage">2113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101328n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFersLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2102-2113&author=D.+Poliauthor=D.+Catarziauthor=V.+Colottaauthor=F.+Varanoauthor=G.+Filacchioniauthor=S.+Danieleauthor=L.+Trincavelliauthor=C.+Martiniauthor=S.+Paolettaauthor=S.+Moro&title=The+identification+of+the+2-phenylphthalazin-1%282H%29-one+scaffold+as+a+new+decorable+core+skeleton+for+the+design+of+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The Identification of the 2-Phenylphthalazin-1(2H)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Poli, Daniela; Catarzi, Daniela; Colotta, Vittoria; Varano, Flavia; Filacchioni, Guido; Daniele, Simona; Trincavelli, Letizia; Martini, Claudia; Paoletta, Silvia; Moro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2102-2113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Following a mol. simplification approach, we have identified the 2-phenylphthalazin-1(2H)-one (PHTZ) ring system as a new decorable core skeleton for the design of novel hA3 adenosine receptor (AR) antagonists.  Interest for this new series was driven by the structural similarity between the PHTZ skeleton and both the 2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one (TQX) and the 4-carboxamido-quinazoline (QZ) scaffolds extensively investigated in our previously reported studies.  Our attention was focused at position 4 of the phthalazine nucleus where different amido and ureido moieties were introduced (compds. 2-20).  Some of the new PHTZ compds. showed high hA3 AR affinity and selectivity, the 2,5-dimethoxyphenylphthalazin-1(2H)-one 18 being the most potent and selective hA3 AR antagonist among this series (Ki = 0.776 nM; hA1/hA3 and hA2A/hA3 > 12000).  Mol. docking studies on the PHTZ derivs. revealed for these compds. a binding mode similar to that of the previously reported TQX and QZ series, as was expected from the simplification approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Dzshyo5BRLVg90H21EOLACvtfcHk0ljToJiRRp71-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFersLo%253D&md5=0cb6019953c8ddca940f75d210400f81</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm101328n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101328n%26sid%3Dliteratum%253Aachs%26aulast%3DPoli%26aufirst%3DD.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DThe%2520identification%2520of%2520the%25202-phenylphthalazin-1%25282H%2529-one%2520scaffold%2520as%2520a%2520new%2520decorable%2520core%2520skeleton%2520for%2520the%2520design%2520of%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2102%26epage%3D2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Biagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbrini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nofal, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerni, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scartoni, V.</span><span> </span><span class="NLM_article-title">2,9-Disubstituted-<i>N</i><sup>6</sup>-(arylcarbamoyl)-8-azaadenines as new selective A<sub>3</sub> adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4679</span><span class="NLM_x">–</span> <span class="NLM_lpage">4693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4679-4693&author=G.+Biagiauthor=A.+M.+Bianucciauthor=A.+Coiauthor=B.+Costaauthor=L.+Fabbriniauthor=I.+Giorgiauthor=O.+Liviauthor=I.+Miccoauthor=F.+Pacchiniauthor=E.+Santiniauthor=M.+Leonardiauthor=F.+A.+Nofalauthor=O.+L.+Salerniauthor=V.+Scartoni&title=2%2C9-Disubstituted-N6-%28arylcarbamoyl%29-8-azaadenines+as+new+selective+A3+adenosine+receptor+antagonists%3A+synthesis%2C+biochemical+and+molecular+modelling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiagi%26aufirst%3DG.%26aulast%3DBianucci%26aufirst%3DA.%2BM.%26aulast%3DCoi%26aufirst%3DA.%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DFabbrini%26aufirst%3DL.%26aulast%3DGiorgi%26aufirst%3DI.%26aulast%3DLivi%26aufirst%3DO.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DPacchini%26aufirst%3DF.%26aulast%3DSantini%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DM.%26aulast%3DNofal%26aufirst%3DF.%2BA.%26aulast%3DSalerni%26aufirst%3DO.%2BL.%26aulast%3DScartoni%26aufirst%3DV.%26atitle%3D2%252C9-Disubstituted-N6-%2528arylcarbamoyl%2529-8-azaadenines%2520as%2520new%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%253A%2520synthesis%252C%2520biochemical%2520and%2520molecular%2520modelling%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D4679%26epage%3D4693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">Novel <i>N</i><sup>2</sup>-substituted pyrazolo[3,4-<i>d</i>]pyrimidine adenosine A<sub>3</sub> receptor antagonists: inhibition of A<sub>3</sub>-mediated human glioblastoma cell proliferation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3954</span><span class="NLM_x">–</span> <span class="NLM_lpage">3963</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901785w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3954-3963&author=S.+Talianiauthor=C.+La+Mottaauthor=L.+Mugnainiauthor=F.+Simoriniauthor=S.+Salernoauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=S.+Cosconatiauthor=B.+Cosimelliauthor=G.+Grecoauthor=V.+Limongelliauthor=L.+Marinelliauthor=E.+Novellinoauthor=O.+Ciampiauthor=S.+Danieleauthor=M.+L.+Trincavelliauthor=C.+Martini&title=Novel+N2-substituted+pyrazolo%5B3%2C4-d%5Dpyrimidine+adenosine+A3+receptor+antagonists%3A+inhibition+of+A3-mediated+human+glioblastoma+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm901785w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901785w%26sid%3Dliteratum%253Aachs%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DL.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3DNovel%2520N2-substituted%2520pyrazolo%255B3%252C4-d%255Dpyrimidine%2520adenosine%2520A3%2520receptor%2520antagonists%253A%2520inhibition%2520of%2520A3-mediated%2520human%2520glioblastoma%2520cell%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3954%26epage%3D3963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">2-Phenylpyrazolo[4,3-<i>d</i>]pyrimidin-7-one as a new scaffold to obtain potent and selective human A<sub>3</sub> adenosine receptor antagonists: new insights into the receptor–antagonist recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7640</span><span class="NLM_x">–</span> <span class="NLM_lpage">7652</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900718w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7640-7652&author=O.+Lenziauthor=V.+Colottaauthor=D.+Catarziauthor=F.+Varanoauthor=D.+Poliauthor=G.+Filacchioniauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=S.+Paolettaauthor=E.+Morizzoauthor=S.+Moro&title=2-Phenylpyrazolo%5B4%2C3-d%5Dpyrimidin-7-one+as+a+new+scaffold+to+obtain+potent+and+selective+human+A3+adenosine+receptor+antagonists%3A+new+insights+into+the+receptor%E2%80%93antagonist+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm900718w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900718w%26sid%3Dliteratum%253Aachs%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DPoli%26aufirst%3DD.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3D2-Phenylpyrazolo%255B4%252C3-d%255Dpyrimidin-7-one%2520as%2520a%2520new%2520scaffold%2520to%2520obtain%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%253A%2520new%2520insights%2520into%2520the%2520receptor%25E2%2580%2593antagonist%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7640%26epage%3D7652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiesaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">New 2-arylpyrazolo[3,4-<i>c</i>]quinoline derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand–receptor modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4061</span><span class="NLM_x">–</span> <span class="NLM_lpage">4074</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070123v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4061-4074&author=V.+Colottaauthor=D.+Catarziauthor=F.+Varanoauthor=F.+Capelliauthor=O.+Lenziauthor=G.+Filacchioniauthor=C.+Martiniauthor=L.+Trincavelliauthor=O.+Ciampiauthor=A.+M.+Puglieseauthor=F.+Pedataauthor=A.+Schiesaroauthor=E.+Morizzoauthor=S.+Moro&title=New+2-arylpyrazolo%5B3%2C4-c%5Dquinoline+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists.+Synthesis%2C+pharmacological+evaluation%2C+and+ligand%E2%80%93receptor+modeling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm070123v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070123v%26sid%3Dliteratum%253Aachs%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DCapelli%26aufirst%3DF.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DPedata%26aufirst%3DF.%26aulast%3DSchiesaro%26aufirst%3DA.%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DNew%25202-arylpyrazolo%255B3%252C4-c%255Dquinoline%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists.%2520Synthesis%252C%2520pharmacological%2520evaluation%252C%2520and%2520ligand%25E2%2580%2593receptor%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4061%26epage%3D4074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span> </span><span class="NLM_article-title">Novel potent and highly selective human A<sub>3</sub> adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-<i>c</i>]quinoline series: molecular docking analysis and pharmacological studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=401-410&author=V.+Colottaauthor=F.+Capelliauthor=O.+Lenziauthor=D.+Catarziauthor=F.+Varanoauthor=D.+Poliauthor=F.+Vincenziauthor=K.+Varaniauthor=P.+A.+Boreaauthor=D.+Dal+Benauthor=R.+Volpiniauthor=G.+Cristalliauthor=G.+Filacchioni&title=Novel+potent+and+highly+selective+human+A3+adenosine+receptor+antagonists+belonging+to+the+4-amido-2-arylpyrazolo%5B3%2C4-c%5Dquinoline+series%3A+molecular+docking+analysis+and+pharmacological+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DCapelli%26aufirst%3DF.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DPoli%26aufirst%3DD.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DFilacchioni%26aufirst%3DG.%26atitle%3DNovel%2520potent%2520and%2520highly%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%2520belonging%2520to%2520the%25204-amido-2-arylpyrazolo%255B3%252C4-c%255Dquinoline%2520series%253A%2520molecular%2520docking%2520analysis%2520and%2520pharmacological%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D401%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaid, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New 2-arylpyrazolo[4,3-<i>c</i>]quinoline derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5001</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050125k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5001-5008&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=D.+Pretiauthor=A.+Boveroauthor=F.+Fruttaroloauthor=R.+Romagnoliauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=K.+Varaniauthor=P.+A.+Borea&title=New+2-arylpyrazolo%5B4%2C3-c%5Dquinoline+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm050125k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050125k%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBovero%26aufirst%3DA.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%25202-arylpyrazolo%255B4%252C3-c%255Dquinoline%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5001%26epage%3D5008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primofiore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergianni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span> </span><span class="NLM_article-title">5-Amino-2-phenyl[1,2,3]triazolo[1,2-<i>a</i>][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A<sub>3</sub> adenosine receptor antagonistst</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5676</span><span class="NLM_x">–</span> <span class="NLM_lpage">5684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0708376" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5676-5684&author=F.+Da+Settimoauthor=G.+Primofioreauthor=S.+Talianiauthor=A.+M.+Mariniauthor=C.+La+Mottaauthor=F.+Simoriniauthor=S.+Salernoauthor=V.+Sergianniauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=B.+Cosimelliauthor=G.+Grecoauthor=E.+Novellinoauthor=O.+Ciampiauthor=M.+L.+Trincavelliauthor=C.+Martini&title=5-Amino-2-phenyl%5B1%2C2%2C3%5Dtriazolo%5B1%2C2-a%5D%5B1%2C2%2C4%5Dbenzotriazin-1-one%3A+a+versatile+scaffold+to+obtain+potent+and+selective+A3+adenosine+receptor+antagonistst"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm0708376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0708376%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DPrimofiore%26aufirst%3DG.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DSergianni%26aufirst%3DV.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCosimelli%26aufirst%3DB.%26aulast%3DGreco%26aufirst%3DG.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DTrincavelli%26aufirst%3DM.%2BL.%26aulast%3DMartini%26aufirst%3DC.%26atitle%3D5-Amino-2-phenyl%255B1%252C2%252C3%255Dtriazolo%255B1%252C2-a%255D%255B1%252C2%252C4%255Dbenzotriazin-1-one%253A%2520a%2520versatile%2520scaffold%2520to%2520obtain%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonistst%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5676%26epage%3D5684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Colotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciampi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>a</i>]pyrazin-1-one as a new scaffold to develop potent and selective human A<sub>3</sub> adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand–receptor modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2407</span><span class="NLM_x">–</span> <span class="NLM_lpage">2419</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014876" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2407-2419&author=V.+Colottaauthor=O.+Lenziauthor=D.+Catarziauthor=F.+Varanoauthor=G.+Filacchioniauthor=C.+Martiniauthor=L.+Trincavelliauthor=O.+Ciampiauthor=A.+M.+Puglieseauthor=C.+Trainiauthor=F.+Pedataauthor=E.+Morizzoauthor=S.+Moro&title=Pyrido%5B2%2C3-e%5D-1%2C2%2C4-triazolo%5B4%2C3-a%5Dpyrazin-1-one+as+a+new+scaffold+to+develop+potent+and+selective+human+A3+adenosine+receptor+antagonists.+Synthesis%2C+pharmacological+evaluation%2C+and+ligand%E2%80%93receptor+modeling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm8014876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014876%26sid%3Dliteratum%253Aachs%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DCiampi%26aufirst%3DO.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DTraini%26aufirst%3DC.%26aulast%3DPedata%26aufirst%3DF.%26aulast%3DMorizzo%26aufirst%3DE.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DPyrido%255B2%252C3-e%255D-1%252C2%252C4-triazolo%255B4%252C3-a%255Dpyrazin-1-one%2520as%2520a%2520new%2520scaffold%2520to%2520develop%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists.%2520Synthesis%252C%2520pharmacological%2520evaluation%252C%2520and%2520ligand%25E2%2580%2593receptor%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2407%26epage%3D2419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Cheong, S. L.; Venkatesan, G.; Paira, P.; Jothibasu, R.; Mandel, A. L.; Federico, S.; Spalluto, G.; Pastorin, G.</span><span> </span><span class="NLM_article-title">Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure–activity relationships</span>.  <span class="citation_source-journal">Int. J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1155/2011/480652</span> . Published Online: February 10,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1155%2F2011%2F480652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=25954519" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+L.+Cheong&author=G.+Venkatesan&author=P.+Paira&author=R.+Jothibasu&author=A.+L.+Mandel&author=S.+Federico&author=G.+Spalluto&author=G.+Pastorin&title=Pyrazolo+derivatives+as+potent+adenosine+receptor+antagonists%3A+an+overview+on+the+structure%E2%80%93activity+relationships&doi=10.1155%2F2011%2F480652"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1155%2F2011%2F480652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F480652%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26atitle%3DPyrazolo%2520derivatives%2520as%2520potent%2520adenosine%2520receptor%2520antagonists%253A%2520an%2520overview%2520on%2520the%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26doi%3D10.1155%2F2011%2F480652%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolcato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacilieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: a complete structure–activity profile</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=183-193&author=B.+Cacciariauthor=C.+Bolcatoauthor=G.+Spallutoauthor=K.+N.+Klotzauthor=M.+Bacilieriauthor=F.+Deflorianauthor=S.+Moro&title=Pyrazolo-triazolo-pyrimidines+as+adenosine+receptor+antagonists%3A+a+complete+structure%E2%80%93activity+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DBolcato%26aufirst%3DC.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DBacilieri%26aufirst%3DM.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DPyrazolo-triazolo-pyrimidines%2520as%2520adenosine%2520receptor%2520antagonists%253A%2520a%2520complete%2520structure%25E2%2580%2593activity%2520profile%26jtitle%3DPurinergic%2520Signalling%26date%3D2007%26volume%3D3%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Borea&title=Adenosine+receptor+antagonists%3A+translating+medicinal+chemistry+and+pharmacology+into+clinical+utility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Gessi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-263</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the chem. and pharmacol. of adenosine A1, A2A, A2B and A3 receptor antagonists and their therapeutic potential in clin. developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOXhQGKqAVLbVg90H21EOLACvtfcHk0lg6GiE3n5V8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D&md5=1ae9e978507a1bbe7ab7aea0bdb33bb8</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptor%2520antagonists%253A%2520translating%2520medicinal%2520chemistry%2520and%2520pharmacology%2520into%2520clinical%2520utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D238%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Maconi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Ros, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A<sub>3</sub> adenosine receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3579</span><span class="NLM_x">–</span> <span class="NLM_lpage">3582</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020974x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3579-3582&author=A.+Maconiauthor=G.+Pastorinauthor=T.+Da+Rosauthor=G.+Spallutoauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=P.+G.+Baraldiauthor=B.+Cacciariauthor=K.+Varaniauthor=S.+Moroauthor=P.+A.+Borea&title=Synthesis%2C+biological+properties%2C+and+molecular+modeling+investigation+of+the+first+potent%2C+selective%2C+and+water-soluble+human+A3+adenosine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm020974x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020974x%26sid%3Dliteratum%253Aachs%26aulast%3DMaconi%26aufirst%3DA.%26aulast%3DPastorin%26aufirst%3DG.%26aulast%3DDa%2BRos%26aufirst%3DT.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%252C%2520biological%2520properties%252C%2520and%2520molecular%2520modeling%2520investigation%2520of%2520the%2520first%2520potent%252C%2520selective%252C%2520and%2520water-soluble%2520human%2520A3%2520adenosine%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3579%26epage%3D3582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Tafi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span> </span><span class="NLM_article-title">Pharmacophore based receptor modeling: the case of adenosine A<sub>3</sub> receptor antagonists. An approach to the optimization of protein models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051112%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4085-4097&author=A.+Tafiauthor=C.+Bernardiniauthor=M.+Bottaauthor=F.+Corelliauthor=M.+Andreiniauthor=A.+Martinelliauthor=G.+Ortoreauthor=P.+G.+Baraldiauthor=F.+Fruttaroloauthor=P.+A.+Boreaauthor=T.+Tuccinardi&title=Pharmacophore+based+receptor+modeling%3A+the+case+of+adenosine+A3+receptor+antagonists.+An+approach+to+the+optimization+of+protein+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm051112%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051112%252B%26sid%3Dliteratum%253Aachs%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DBernardini%26aufirst%3DC.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DOrtore%26aufirst%3DG.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DTuccinardi%26aufirst%3DT.%26atitle%3DPharmacophore%2520based%2520receptor%2520modeling%253A%2520the%2520case%2520of%2520adenosine%2520A3%2520receptor%2520antagonists.%2520An%2520approach%2520to%2520the%2520optimization%2520of%2520protein%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4085%26epage%3D4097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braiuca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span> </span><span class="NLM_article-title">Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A<sub>3</sub> adenosine receptor antagonists: pyrazolo[4,3-<i>e</i>]1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives as a key study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049662f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=152-162&author=S.+Moroauthor=P.+Braiucaauthor=F.+Deflorianauthor=C.+Ferrariauthor=G.+Pastorinauthor=B.+Cacciariauthor=P.+G.+Baraldiauthor=K.+Varaniauthor=P.+A.+Boreaauthor=G.+Spalluto&title=Combined+target-based+and+ligand-based+drug+design+approach+as+a+tool+to+define+a+novel+3D-pharmacophore+model+of+human+A3+adenosine+receptor+antagonists%3A+pyrazolo%5B4%2C3-e%5D1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives+as+a+key+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm049662f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049662f%26sid%3Dliteratum%253Aachs%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DBraiuca%26aufirst%3DP.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DFerrari%26aufirst%3DC.%26aulast%3DPastorin%26aufirst%3DG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DSpalluto%26aufirst%3DG.%26atitle%3DCombined%2520target-based%2520and%2520ligand-based%2520drug%2520design%2520approach%2520as%2520a%2520tool%2520to%2520define%2520a%2520novel%25203D-pharmacophore%2520model%2520of%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%253A%2520pyrazolo%255B4%252C3-e%255D1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%2520as%2520a%2520key%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D152%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Pran Kishore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghuram Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K.</span><span> </span><span class="NLM_article-title">QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives with human adenosine A<sub>3</sub>receptor subtype</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=818-823&author=D.+Pran+Kishoreauthor=C.+Balakumarauthor=A.+Raghuram+Raoauthor=P.+P.+Royauthor=K.+Roy&title=QSAR+of+adenosine+receptor+antagonists%3A+exploring+physicochemical+requirements+for+binding+of+pyrazolo%5B4%2C3-e%5D-1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives+with+human+adenosine+A3receptor+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPran%2BKishore%26aufirst%3DD.%26aulast%3DBalakumar%26aufirst%3DC.%26aulast%3DRaghuram%2BRao%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DP.%2BP.%26aulast%3DRoy%26aufirst%3DK.%26atitle%3DQSAR%2520of%2520adenosine%2520receptor%2520antagonists%253A%2520exploring%2520physicochemical%2520requirements%2520for%2520binding%2520of%2520pyrazolo%255B4%252C3-e%255D-1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%2520with%2520human%2520adenosine%2520A3receptor%2520subtype%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D818%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Cheong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA<sub>3</sub> adenosine receptors antagonists: new insights into structure–affinity relationship and receptor–antagonist recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3361</span><span class="NLM_x">–</span> <span class="NLM_lpage">3375</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100049f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3361-3375&author=S.+L.+Cheongauthor=A.+Dolzhenkoauthor=S.+Kachlerauthor=S.+Paolettaauthor=S.+Federicoauthor=B.+Cacciariauthor=A.+Dolzhenkoauthor=K.+N.+Klotzauthor=S.+Moroauthor=G.+Spallutoauthor=G.+Pastorin&title=The+significance+of+2-furyl+ring+substitution+with+a+2-%28para-substituted%29+aryl+group+in+a+new+series+of+pyrazolo-triazolo-pyrimidines+as+potent+and+highly+selective+hA3+adenosine+receptors+antagonists%3A+new+insights+into+structure%E2%80%93affinity+relationship+and+receptor%E2%80%93antagonist+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm100049f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100049f%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26aulast%3DDolzhenko%26aufirst%3DA.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DDolzhenko%26aufirst%3DA.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DThe%2520significance%2520of%25202-furyl%2520ring%2520substitution%2520with%2520a%25202-%2528para-substituted%2529%2520aryl%2520group%2520in%2520a%2520new%2520series%2520of%2520pyrazolo-triazolo-pyrimidines%2520as%2520potent%2520and%2520highly%2520selective%2520hA3%2520adenosine%2520receptors%2520antagonists%253A%2520new%2520insights%2520into%2520structure%25E2%2580%2593affinity%2520relationship%2520and%2520receptor%25E2%2580%2593antagonist%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3361%26epage%3D3375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Cheong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. P. R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolzhenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">Does the combination of optimal substitutions at the <i>C</i><sup>2</sup>-, <i>N</i><sup>5</sup>- and <i>N</i><sup>8</sup>-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A<sub>3</sub> adenosine receptors?</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6120</span><span class="NLM_x">–</span> <span class="NLM_lpage">6134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6120-6134&author=S.+L.+Cheongauthor=A.+V.+Dolzhenkoauthor=S.+Paolettaauthor=E.+P.+R+Leeauthor=S.+Kachlerauthor=S.+Federicoauthor=K.+N.+Klotzauthor=A.+V.+Dolzhenkoauthor=G.+Spallutoauthor=S.+Moroauthor=G.+Pastorin&title=Does+the+combination+of+optimal+substitutions+at+the+C2-%2C+N5-+and+N8-positions+of+the+pyrazolo-triazolo-pyrimidine+scaffold+guarantee+selective+modulation+of+the+human+A3+adenosine+receptors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26aulast%3DDolzhenko%26aufirst%3DA.%2BV.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DE.%2BP.%2BR%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DDolzhenko%26aufirst%3DA.%2BV.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DDoes%2520the%2520combination%2520of%2520optimal%2520substitutions%2520at%2520the%2520C2-%252C%2520N5-%2520and%2520N8-positions%2520of%2520the%2520pyrazolo-triazolo-pyrimidine%2520scaffold%2520guarantee%2520selective%2520modulation%2520of%2520the%2520human%2520A3%2520adenosine%2520receptors%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6120%26epage%3D6134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Cheong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2898-2905&author=S.+L.+Cheongauthor=S.+Federicoauthor=G.+Venkatesanauthor=P.+Pairaauthor=Y.+M.+Shaoauthor=G.+Spallutoauthor=C.+W.+Yapauthor=G.+Pastorin&title=Pharmacophore+elucidation+for+a+new+series+of+2-aryl-pyrazolo-triazolo-pyrimidines+as+potent+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DS.%2BL.%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DVenkatesan%26aufirst%3DG.%26aulast%3DPaira%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DY.%2BM.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DYap%26aufirst%3DC.%2BW.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DPharmacophore%2520elucidation%2520for%2520a%2520new%2520series%2520of%25202-aryl-pyrazolo-triazolo-pyrimidines%2520as%2520potent%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2898%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span> </span><span class="NLM_article-title">Pyrrolo- and pyrazolo-[3,4-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidines as adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1046-1059&author=P.+G.+Baraldiauthor=G.+Saponaroauthor=M.+A.+Tabriziauthor=S.+Baraldiauthor=R.+Romagnoliauthor=A.+Moormanauthor=K.+Varaniauthor=P.+A.+Boreaauthor=D.+Preti&title=Pyrrolo-+and+pyrazolo-%5B3%2C4-e%5D%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dpyrimidines+as+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMoorman%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26atitle%3DPyrrolo-%2520and%2520pyrazolo-%255B3%252C4-e%255D%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-c%255Dpyrimidines%2520as%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1046%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurogi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiryu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagao, Y.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of adenosine A<sub>3</sub> receptor ligands: new potential therapy for the treatment of glaucoma</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3775</span><span class="NLM_x">–</span> <span class="NLM_lpage">3779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3775-3779&author=T.+Okamuraauthor=Y.+Kurogiauthor=K.+Hashimotoauthor=S.+Satoauthor=H.+Nishikawaauthor=K.+Kiryuauthor=Y.+Nagao&title=Structure%E2%80%93activity+relationships+of+adenosine+A3+receptor+ligands%3A+new+potential+therapy+for+the+treatment+of+glaucoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DKurogi%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DKiryu%26aufirst%3DK.%26aulast%3DNagao%26aufirst%3DY.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520adenosine%2520A3%2520receptor%2520ligands%253A%2520new%2520potential%2520therapy%2520for%2520the%2520treatment%2520of%2520glaucoma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3775%26epage%3D3779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurogi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagao, Y.</span><span> </span><span class="NLM_article-title">Facile synthesis of fused 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives as human adenosine A<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2443-2446&author=T.+Okamuraauthor=Y.+Kurogiauthor=K.+Hashimotoauthor=H.+Nishikawaauthor=Y.+Nagao&title=Facile+synthesis+of+fused+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives+as+human+adenosine+A3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DKurogi%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DNagao%26aufirst%3DY.%26atitle%3DFacile%2520synthesis%2520of%2520fused%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%2520as%2520human%2520adenosine%2520A3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2443%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Priego, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuenzel, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarasa, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Perez, M. J.</span><span> </span><span class="NLM_article-title">Pyrido[2,1-<i>f</i>]purine-2,4-dione derivatives as a novel class of highly potent human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3337</span><span class="NLM_x">–</span> <span class="NLM_lpage">3344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3337-3344&author=E.+M.+Priegoauthor=J.+V.+Kuenzelauthor=A.+P.+IJzermanauthor=M.+J.+Camarasaauthor=M.+J.+Perez-Perez&title=Pyrido%5B2%2C1-f%5Dpurine-2%2C4-dione+derivatives+as+a+novel+class+of+highly+potent+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm0208469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208469%26sid%3Dliteratum%253Aachs%26aulast%3DPriego%26aufirst%3DE.%2BM.%26aulast%3DKuenzel%26aufirst%3DJ.%2BV.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DPerez-Perez%26aufirst%3DM.%2BJ.%26atitle%3DPyrido%255B2%252C1-f%255Dpurine-2%252C4-dione%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520highly%2520potent%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3337%26epage%3D3344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Priego, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Perez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe Kuenzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarasa, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Santamaria, S.</span><span> </span><span class="NLM_article-title">Selective human adenosine A<sub>3</sub> antagonists based on pyrido[2,1-<i>f</i>]purine-2,4-diones: novel features of hA<sub>3</sub> antagonist binding</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=111-119&author=E.+M.+Priegoauthor=M.+J.+Perez-Perezauthor=J.+K.+von+Frijtag+Drabbe+Kuenzelauthor=H.+de+Vriesauthor=A.+P.+Ijzermanauthor=M.+J.+Camarasaauthor=S.+Martin-Santamaria&title=Selective+human+adenosine+A3+antagonists+based+on+pyrido%5B2%2C1-f%5Dpurine-2%2C4-diones%3A+novel+features+of+hA3+antagonist+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPriego%26aufirst%3DE.%2BM.%26aulast%3DPerez-Perez%26aufirst%3DM.%2BJ.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BKuenzel%26aufirst%3DJ.%2BK.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DMartin-Santamaria%26aufirst%3DS.%26atitle%3DSelective%2520human%2520adenosine%2520A3%2520antagonists%2520based%2520on%2520pyrido%255B2%252C1-f%255Dpurine-2%252C4-diones%253A%2520novel%2520features%2520of%2520hA3%2520antagonist%2520binding%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D111%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttarolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaid, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New pyrrolo[2,1-<i>f</i>]purine-2,4-dione and imidazo[2,1-<i>f</i>]purine-2,4-dione derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4697</span><span class="NLM_x">–</span> <span class="NLM_lpage">4701</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4697-4701&author=P.+G.+Baraldiauthor=D.+Pretiauthor=M.+A.+Tabriziauthor=F.+Fruttaroloauthor=R.+Romagnoliauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=S.+Merighiauthor=K.+Varaniauthor=P.+A.+Borea&title=New+pyrrolo%5B2%2C1-f%5Dpurine-2%2C4-dione+and+imidazo%5B2%2C1-f%5Dpurine-2%2C4-dione+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm058008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058008c%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%2520pyrrolo%255B2%252C1-f%255Dpurine-2%252C4-dione%2520and%2520imidazo%255B2%252C1-f%255Dpurine-2%252C4-dione%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4697%26epage%3D4701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tafi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of a new series of imidazo[2,1-<i>f</i>]purinones as potent and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">10281</span><span class="NLM_x">–</span> <span class="NLM_lpage">10294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=10281-10294&author=P.+G.+Baraldiauthor=D.+Pretiauthor=M.+A.+Tabriziauthor=R.+Romagnoliauthor=G.+Saponaroauthor=S.+Baraldiauthor=M.+Bottaauthor=C.+Bernardiniauthor=A.+Tafiauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=K.+Varaniauthor=P.+A.+Borea&title=Structure%E2%80%93activity+relationship+studies+of+a+new+series+of+imidazo%5B2%2C1-f%5Dpurinones+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBernardini%26aufirst%3DC.%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520a%2520new%2520series%2520of%2520imidazo%255B2%252C1-f%255Dpurinones%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D10281%26epage%3D10294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qurishi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Imidazo[2,1-<i>i</i>]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A<sub>2A</sub> and A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3440</span><span class="NLM_x">–</span> <span class="NLM_lpage">3450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm011093d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3440-3450&author=C.+E.+M%C3%BCllerauthor=M.+Thorandauthor=R.+Qurishiauthor=M.+Diekmannauthor=K.+A.+Jacobsonauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Imidazo%5B2%2C1-i%5Dpurin-5-ones+and+related+tricyclic+water-soluble+purine+derivatives%3A+potent+A2A+and+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm011093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011093d%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DQurishi%26aufirst%3DR.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DImidazo%255B2%252C1-i%255Dpurin-5-ones%2520and%2520related%2520tricyclic%2520water-soluble%2520purine%2520derivatives%253A%2520potent%2520A2A%2520and%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3440%26epage%3D3450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozola, V.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]8-Ethyl-4-methyl-2-phenyl-(8<i>R</i>)-4,5,7,8-tetrahydro-1<i>H</i>-imidazo[2,1-<i>i</i>]-purin-5-one ([<sup>3</sup>H]PSB-11), a novel high-affinity antagonist radioligand for human A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=501-503&author=C.+E.+M%C3%BCllerauthor=M.+Diekmannauthor=M.+Thorandauthor=V.+Ozola&title=%5B3H%5D8-Ethyl-4-methyl-2-phenyl-%288R%29-4%2C5%2C7%2C8-tetrahydro-1H-imidazo%5B2%2C1-i%5D-purin-5-one+%28%5B3H%5DPSB-11%29%2C+a+novel+high-affinity+antagonist+radioligand+for+human+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DOzola%26aufirst%3DV.%26atitle%3D%255B3H%255D8-Ethyl-4-methyl-2-phenyl-%25288R%2529-4%252C5%252C7%252C8-tetrahydro-1H-imidazo%255B2%252C1-i%255D-purin-5-one%2520%2528%255B3H%255DPSB-11%2529%252C%2520a%2520novel%2520high-affinity%2520antagonist%2520radioligand%2520for%2520human%2520A3%2520adenosine%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D501%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Ozola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diekmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qurishi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Műller, C. E.</span><span> </span><span class="NLM_article-title">2-Phenylimidazo[2,1-<i>i</i>]purin-5-ones: structure–activity relationships and characterization of potent and selective inverse agonists at human A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=347-356&author=V.+Ozolaauthor=M.+Thorandauthor=M.+Diekmannauthor=R.+Qurishiauthor=B.+Schumacherauthor=K.+A.+Jacobsonauthor=C.+E.+M%C5%B1ller&title=2-Phenylimidazo%5B2%2C1-i%5Dpurin-5-ones%3A+structure%E2%80%93activity+relationships+and+characterization+of+potent+and+selective+inverse+agonists+at+human+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOzola%26aufirst%3DV.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DQurishi%26aufirst%3DR.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C5%25B1ller%26aufirst%3DC.%2BE.%26atitle%3D2-Phenylimidazo%255B2%252C1-i%255Dpurin-5-ones%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520characterization%2520of%2520potent%2520and%2520selective%2520inverse%2520agonists%2520at%2520human%2520A3%2520adenosine%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D347%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Saki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimura, M.</span><span> </span><span class="NLM_article-title">KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1<i>H</i>-imidazo[2,1-<i>i</i>]purin-5(4<i>H</i>)-one dihydrochloride), a new potent and selective adenosine A<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0014-2999%2802%2901662-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12063073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVShsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2002&pages=133-141&author=M.+Sakiauthor=H.+Tsumukiauthor=H.+Nonakaauthor=J.+Shimadaauthor=M.+Ichimura&title=KF26777+%282-%284-bromophenyl%29-7%2C8-dihydro-4-propyl-1H-imidazo%5B2%2C1-i%5Dpurin-5%284H%29-one+dihydrochloride%29%2C+a+new+potent+and+selective+adenosine+A3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-onedihydrochloride), a new potent and selective adenosine A3 receptor antagonist</span></div><div class="casAuthors">Saki, Mayumi; Tsumuki, Hiroshi; Nonaka, Hiromi; Shimada, Junichi; Ichimura, Michio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-141</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The authors investigated the biochem. and pharmacol. properties of a new adenosine A3 receptor antagonist, KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-onedihydrochloride).  This compd. was characterized using N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide ([125I]AB-MECA) or [35S]guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding to membranes from human embryonic kidney 293 (HEK293) cells expressing human adenosine A3 receptors.  KF26777 showed a Ki value of 0.20±0.038 nM for human adenosine A3 receptors labeled with [125I]AB-MECA and possessed 9000-, 2350- and 3100-fold selectivity vs. human adenosine A1, A2A and A2B receptors, resp.  The inhibitory mode of binding was competitive.  KF26777 inhibited the binding of [35S]GTPγS stimulated by 1 μM 2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (Cl-IB-MECA).  The IC50 value was 270±85 nM; the compd. had no effect on basal activity.  Dexamethasone treatment for HL-60 cells, human promyelocytic leukemia, up-regulated functional adenosine A3 receptors expression, and resulted in the enhanced elevation of intracellular Ca2+ concn. ([Ca2+]i) via the adenosine A3 receptor.  KF26777 antagonized this [Ca2+]i mobilization induced by Cl-IB-MECA, with a KB value of 0.42±0.14 nM.  These results indicate that KF26777 is a highly potent and selective antagonist of the human adenosine A3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZsrhi-bkM17Vg90H21EOLACvtfcHk0lgZIIfndsoCRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVShsrw%253D&md5=215f410d4d628997269f964a173d0f46</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901662-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901662-X%26sid%3Dliteratum%253Aachs%26aulast%3DSaki%26aufirst%3DM.%26aulast%3DTsumuki%26aufirst%3DH.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DIchimura%26aufirst%3DM.%26atitle%3DKF26777%2520%25282-%25284-bromophenyl%2529-7%252C8-dihydro-4-propyl-1H-imidazo%255B2%252C1-i%255Dpurin-5%25284H%2529-one%2520dihydrochloride%2529%252C%2520a%2520new%2520potent%2520and%2520selective%2520adenosine%2520A3%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D444%26spage%3D133%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaid, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">New 2-heterocyclyl-imidazo[2,1-<i>i</i>]purin-5-one derivatives as potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5205</span><span class="NLM_x">–</span> <span class="NLM_lpage">5220</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2004738" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5205-5220&author=P.+G.+Baraldiauthor=D.+Pretiauthor=A.+N.+Zaidauthor=G.+Saponaroauthor=M.+A.+Tabriziauthor=S.+Baraldiauthor=R.+Romagnoliauthor=A.+R.+Moormanauthor=K.+Varaniauthor=S.+Cosconatiauthor=S.+Di+Maroauthor=L.+Marinelliauthor=E.+Novellinoauthor=P.+A.+Borea&title=New+2-heterocyclyl-imidazo%5B2%2C1-i%5Dpurin-5-one+derivatives+as+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm2004738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004738%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DZaid%26aufirst%3DA.%2BN.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%25202-heterocyclyl-imidazo%255B2%252C1-i%255Dpurin-5-one%2520derivatives%2520as%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5205%26epage%3D5220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Purine derivatives as ligands for A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F156802605774463079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16305531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1275-1295&author=B.+V.+Joshiauthor=K.+A.+Jacobson&title=Purine+derivatives+as+ligands+for+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Purine derivatives as ligands for A3 adenosine receptors</span></div><div class="casAuthors">Joshi, Bhalchandra V.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1275-1295</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Selective agonists and antagonists for A3 adenosine receptors (ARs) are being explored for the treatment of a variety of disorders, including brain and heart ischemic conditions, cancer, and rheumatoid arthritis.  This review covers both the structure activity relationships of nucleoside agonist ligands and selected antagonists acting at this receptor and the routes of synthesis.  Highly selective agonists have been designed, using both empirical approaches and a semi-rational approach based on mol. modeling.  The prototypical A3 agonists IB-MECA 10 and the more receptor-subtype-selective Cl-IB-MECA 11, both of which have affinity in binding to the receptor of ∼ 1 nM, have been used widely as pharmacol. probes in the elucidation of the physiol. role of this receptor.  In addn. to the exploration of the effects of structural modification of the adenine and ribose moieties on A3AR affinity, the effects of these structural changes on the intrinsic efficacy have also been studied in a systematic fashion.  Key structural features detg. A3AR interaction include the N6-benzyl group, 2-position substitution such as halo, substitution of ribose (e.g., the (N)-methanocarba ring system, various 2'- and 3'-substitutions and 4'-thio substitution of oxygen).  Conformational studies of the ribose moiety and its equiv. indicate that the ring oxygen is not required and the North (N) ring conformation is preferred in binding to the A3AR.  Using these observations, a series of ring constrained (N)-methanocarba 5'-uronamide derivs. was recently reported to be highly selective A3AR agonists, the most notable amongst them was MRS3558 113 having a Ki value in binding to the human A3 receptor of 0.3 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZrtG1tbzNgrVg90H21EOLACvtfcHk0lgZIIfndsoCRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegsbbF&md5=5dc7a6be512eba8f69524644fad94192</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.2174%2F156802605774463079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605774463079%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DPurine%2520derivatives%2520as%2520ligands%2520for%2520A3%2520adenosine%2520receptors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1275%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Conversion of A<sub>3</sub> adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=596-601&author=Z.+G.+Gaoauthor=B.+V.+Joshiauthor=A.+M.+Klutzauthor=S.+K.+Kimauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Conversion+of+A3+adenosine+receptor+agonists+into+selective+antagonists+by+modification+of+the+5%E2%80%B2-ribofuran-uronamide+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DConversion%2520of%2520A3%2520adenosine%2520receptor%2520agonists%2520into%2520selective%2520antagonists%2520by%2520modification%2520of%2520the%25205%25E2%2580%25B2-ribofuran-uronamide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Koch, M.; Den Hartog, J. A. J.; Koomen, G. J.; Wanner, M. J.; Feenstra, R. W.</span><span> </span><span class="NLM_article-title">2-Substituted-6-trifluoromethyl Purine Derivatives with Adenosine-A<sub>3</sub> Antagonistic Activity</span>. WO 2006027365,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Koch&author=J.+A.+J.+Den+Hartog&author=G.+J.+Koomen&author=M.+J.+Wanner&author=R.+W.+Feenstra&title=2-Substituted-6-trifluoromethyl+Purine+Derivatives+with+Adenosine-A3+Antagonistic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DM.%26atitle%3D2-Substituted-6-trifluoromethyl%2520Purine%2520Derivatives%2520with%2520Adenosine-A3%2520Antagonistic%2520Activity%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Bevan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butchers, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span> </span><span class="NLM_article-title">Pharmacological characterisation and inhibitory effects of (2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2-(6-amino-2-{[(1<i>S</i>)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9<i>H</i>-purin-9-yl)-5-(2-ethyl-2<i>H</i>-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A<sub>2A</sub> receptor agonist and adenosine A<sub>3</sub> receptor antagonist activity</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">564</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.ejphar.2007.01.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17382926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=564&publication_year=2007&pages=219-225&author=N.+Bevanauthor=P.+R.+Butchersauthor=R.+Cousinsauthor=J.+Coatesauthor=E.+V.+Edgarauthor=V.+Morrisonauthor=M.+J.+Sheehanauthor=J.+Reevesauthor=D.+J.+Wilson&title=Pharmacological+characterisation+and+inhibitory+effects+of+%282R%2C3R%2C4S%2C5R%29-2-%286-amino-2-%7B%5B%281S%29-2-hydroxy-1-%28phenylmethyl%29ethyl%5Damino%7D-9H-purin-9-yl%29-5-%282-ethyl-2H-tetrazol-5-yl%29tetrahydro-3%2C4-furandiol%2C+a+novel+ligand+that+demonstrates+both+adenosine+A2A+receptor+agonist+and+adenosine+A3+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity</span></div><div class="casAuthors">Bevan, Nicola; Butchers, Peter R.; Cousins, Rick; Coates, Jill; Edgar, Emma V.; Morrison, Val; Sheehan, Michael J.; Reeves, Julian; Wilson, David J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">564</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">219-225</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pharmacol. properties of the novel ligand, (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol , at the human adenosine receptors were investigated using Chinese hamster ovary cell lines recombinantly expressing these receptors.  Functional studies were performed using a cAMP-coupled reporter gene system.  Binding studies were performed using membranes from these cells.  The effects of ligand were also detd. on functional responses of human neutrophils and eosinophils.  Ligand had a high affinity for the adenosine A2A receptor (pKi 7.8±0.2) and was a potent agonist at this receptor (pEC50 9.0±0.2).  Ligand had a similar affinity for the adenosine A3 receptor (pKi 7.8±0.1) but displayed no agonist activity, acting instead as a competitive antagonist (pA2 8.3±0.04).  Ligand had lower affinity for adenosine A1 and A2B receptors (pKi ≤ 6) and showed relatively weak agonist activity at these receptors (pEC50 7.1 at both receptors).  Ligand was a potent inhibitor of the generation of reactive oxygen species from human neutrophils and eosinophils (pEC50 9.7±0.1 and 9.4±0.2 resp.).  The inhibitory effect of ligand on the release of reactive oxygen species from neutrophils was antagonized competitively by the adenosine A2A receptor antagonist 9-chloro-2-(2-furanyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine (CGS15943) with a pA2 value (10.03 ± 0.44) consistent with an effect on adenosine A2A receptors.  Ligand also inhibited the release of granule proteins from neutrophils and eosinophils (pEC50 8.7 and 8.9 resp.), albeit less potently than as an inhibitor of reactive oxygen species generation.  In summary, ligand is a potent and selective agonist for the adenosine A2A receptor and a competitive antagonist at the adenosine A3 receptor.  Ligand has potent anti-inflammatory effects on human granulocytes in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt87YbjQuJ5rVg90H21EOLACvtfcHk0li2S8azSL_H1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cit7c%253D&md5=b0f9d25b3b8cd087901f605fd12caacc</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.01.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.01.094%26sid%3Dliteratum%253Aachs%26aulast%3DBevan%26aufirst%3DN.%26aulast%3DButchers%26aufirst%3DP.%2BR.%26aulast%3DCousins%26aufirst%3DR.%26aulast%3DCoates%26aufirst%3DJ.%26aulast%3DEdgar%26aufirst%3DE.%2BV.%26aulast%3DMorrison%26aufirst%3DV.%26aulast%3DSheehan%26aufirst%3DM.%2BJ.%26aulast%3DReeves%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26atitle%3DPharmacological%2520characterisation%2520and%2520inhibitory%2520effects%2520of%2520%25282R%252C3R%252C4S%252C5R%2529-2-%25286-amino-2-%257B%255B%25281S%2529-2-hydroxy-1-%2528phenylmethyl%2529ethyl%255Damino%257D-9H-purin-9-yl%2529-5-%25282-ethyl-2H-tetrazol-5-yl%2529tetrahydro-3%252C4-furandiol%252C%2520a%2520novel%2520ligand%2520that%2520demonstrates%2520both%2520adenosine%2520A2A%2520receptor%2520agonist%2520and%2520adenosine%2520A3%2520receptor%2520antagonist%2520activity%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D564%26spage%3D219%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biadatti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structural determinants of A<sub>3</sub> adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4471</span><span class="NLM_x">–</span> <span class="NLM_lpage">4484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020211%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4471-4484&author=Z.+G.+Gaoauthor=S.+K.+Kimauthor=T.+Biadattiauthor=W.+Chenauthor=K.+Leeauthor=D.+Barakauthor=S.+G.+Kimauthor=C.+R.+Johnsonauthor=K.+A.+Jacobson&title=Structural+determinants+of+A3+adenosine+receptor+activation%3A+nucleoside+ligands+at+the+agonist%2Fantagonist+boundary"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants of A3 Adenosine Receptor Activation: Nucleoside Ligands at the Agonist/Antagonist Boundary</span></div><div class="casAuthors">Gao, Zhan-Guo; Kim, Soo-Kyung; Biadatti, Thibaud; Chen, Wangzhong; Lee, Kyeong; Barak, Dov; Kim, Seong Gon; Johnson, Carl R.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4471-4484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutagenesis of the human A3 adenosine receptor (AR) suggested that certain amino acid residues contributed differently to ligand binding and activation processes.  Here we demonstrated that various adenosine modifications, including adenine substitution and ribose ring constraints, also contributed differentially to these processes.  The ligand effects on cAMP prodn. in intact CHO cells expressing the A3AR and in receptor binding were compared.  Notably, the simple 2-fluoro group alone or 2-chloro in combination with N6-substitution dramatically diminished the efficacy of adenosine derivs., even converting agonist into antagonist.  Other affinity-increasing substitutions, including N6-(3-iodobenzyl) and the (Northern)-methanocarba, also reduced efficacy, except in combination with a flexible 5'-uronamide.  2-Cl-N6-(3-iodobenzyl) derivs., both in the (N)-methanocarba (i.e., of the Northern conformation) and riboside series were potent antagonists with little residual agonism.  Ring-constrained 2',3'-epoxide derivs. in both riboside and (N)-methanocarba series and a cyclized (spiral) 4',5'-uronamide deriv. were synthesized and found to be human A3AR antagonists.  The 4',5'-uronamide deriv. bound potently at both human (26 nM) and rat (49 nM) A3ARs.  A rhodopsin-based A3AR model, contg. all domains except the C-terminal region, indicated sep. structural requirements for receptor binding and activation for these adenosine analogs.  Ligand docking, taking into account binding of selected derivs. at mutant A3ARs, featured interactions of TM3 (His95) with the adenine moiety and TMs with the ribose 5'-region.  The 5'-OH group of antagonist N6-(3-iodobenzyl)-2-chloroadenosine formed a H-bond with N274 but not with S271.  The 5'-substituent of nucleoside antagonists moved toward TM7 and away from TM6.  The conserved Trp243 (6.48) side chain, involved in recognition of the classical (nonnucleoside) A3AR antagonists but not adenosine-derived ligands, displayed a characteristic movement exclusively upon docking of agonists.  Thus, A3AR activation appeared to require flexibility at the 5'- and 3'-positions, which was diminished in (N)-methanocarba, spiro, and epoxide analogs, and was characteristic of ribose interactions at TM6 and TM7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKyUix8ag2rrVg90H21EOLACvtfcHk0li2S8azSL_H1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFSqurg%253D&md5=7055f590e03c6a7853225e3cb0f1de06</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm020211%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020211%252B%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DBiadatti%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DBarak%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520determinants%2520of%2520A3%2520adenosine%2520receptor%2520activation%253A%2520nucleoside%2520ligands%2520at%2520the%2520agonist%252Fantagonist%2520boundary%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4471%26epage%3D4484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson-Yantorno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coca-Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civan, M. M.</span><span> </span><span class="NLM_article-title">The cross-species A<sub>3</sub> adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure</span> <span class="citation_source-journal">Curr. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1080%2F02713680590953147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16146920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWitbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=747-754&author=H.+Yangauthor=M.+Y.+Avilaauthor=K.+Peterson-Yantornoauthor=M.+Coca-Pradosauthor=R.+A.+Stoneauthor=K.+A.+Jacobsonauthor=M.+M.+Civan&title=The+cross-species+A3+adenosine-receptor+antagonist+MRS+1292+inhibits+adenosine-triggered+human+nonpigmented+ciliary+epithelial+cell+fluid+release+and+reduces+mouse+intraocular+pressure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The Cross-Species A3 Adenosine-Receptor Antagonist MRS 1292 Inhibits Adenosine-Triggered Human Nonpigmented Ciliary Epithelial Cell Fluid Release and Reduces Mouse Intraocular Pressure</span></div><div class="casAuthors">Yang, Hui; Avila, Marcel Y.; Peterson-Yantorno, Kim; Coca-Prados, Miguel; Stone, Richard A.; Jacobson, Kenneth A.; Civan, Mortimer M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Eye Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">747-754</span>CODEN:
                <span class="NLM_cas:coden">CEYRDM</span>;
        ISSN:<span class="NLM_cas:issn">0271-3683</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Purpose: Antagonists to A3 adenosine receptors (ARs) lower mouse intraocular pressure (IOP), but extension to humans is limited by species variability.  We tested whether the specific A3AR antagonist MRS 1292, designed to cross species, mimics the effects of other A3AR antagonists on cultured human nonpigmented ciliary epithelial (NPE) cells and mouse IOP.  Methods: NPE cell vol. was monitored by electronic cell sorting.  Mouse IOP was measured with the Servo-Null Micropipette System.  Results: Adenosine triggered A3AR-mediated shrinkage of human NPE cells.  Shrinkage was blocked by MRS 1292 (IC50 = 42 ± 11 nM, p <0.01) and by another A3AR antagonist effective in this system, MRS 1191. Topical application of the A3AR agonist IB-MECA increased mouse IOP. MRS 1292 reduced IOP by 4.0 ± 0.8 mmHg at 25-μ M droplet concn. (n = 10, p <0.005). Conclusions: MRS 1292 inhibits A3AR-mediated shrinkage of human NPE cells and reduces mouse IOP, consistent with its putative action as a cross-species A3 antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-D1J3Cji3RbVg90H21EOLACvtfcHk0li2S8azSL_H1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWitbnP&md5=47500e1a133d0580ae67ba4438ab96fd</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1080%2F02713680590953147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02713680590953147%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAvila%26aufirst%3DM.%2BY.%26aulast%3DPeterson-Yantorno%26aufirst%3DK.%26aulast%3DCoca-Prados%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DR.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DCivan%26aufirst%3DM.%2BM.%26atitle%3DThe%2520cross-species%2520A3%2520adenosine-receptor%2520antagonist%2520MRS%25201292%2520inhibits%2520adenosine-triggered%2520human%2520nonpigmented%2520ciliary%2520epithelial%2520cell%2520fluid%2520release%2520and%2520reduces%2520mouse%2520intraocular%2520pressure%26jtitle%3DCurr.%2520Eye%2520Res.%26date%3D2005%26volume%3D30%26spage%3D747%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Ravn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qvortrup, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbohm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A<sub>3</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5440</span><span class="NLM_x">–</span> <span class="NLM_lpage">5447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5440-5447&author=J.+Ravnauthor=K.+Qvortrupauthor=C.+Rosenbohmauthor=T.+Koch&title=Design%2C+synthesis%2C+and+biological+evaluation+of+LNA+nucleosides+as+adenosine+A3+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavn%26aufirst%3DJ.%26aulast%3DQvortrup%26aufirst%3DK.%26aulast%3DRosenbohm%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520LNA%2520nucleosides%2520as%2520adenosine%2520A3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5440%26epage%3D5447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Ravn, J.; Rosenbohm, C.; Qvortrup, K.; Koch, T.</span><span> </span><span class="NLM_article-title">Adenosine Receptor Antagonists</span>. WO 2008006369,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Ravn&author=C.+Rosenbohm&author=K.+Qvortrup&author=T.+Koch&title=Adenosine+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRavn%26aufirst%3DJ.%26atitle%3DAdenosine%2520Receptor%2520Antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Docking studies of agonists and antagonists suggest an activation pathway of the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.jmgm.2006.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOhs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=562-577&author=S.+K.+Kimauthor=Z.+G.+Gaoauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Docking+studies+of+agonists+and+antagonists+suggest+an+activation+pathway+of+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor</span></div><div class="casAuthors">Kim, Soo-Kyung; Gao, Zhan-Guo; Jeong, Lak Shin; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">562-577</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Structural determinants of ligand efficacy in the human A3 adenosine receptor (AR) were studied using pharmacophore and docking analyses of various categories of A3 selective ligands: inverse agonist, neutral antagonist (nonnucleoside and nucleoside), and agonist (partial and full).  The homol. modeling of GPCRs was adapted to provide two templates: the rhodopsin-based resting state for antagonist binding and a putative Meta I state, conformationally altered at a key residue (W6.48), for agonist binding.  The preferential binding domains and/or local conformational changes assocd. with docking of three high affinity A3AR ligands were compared: inverse agonist PSB-11, neutral antagonist MRE-3008F20, and full agonist Cl-IB-MECA to define a distinct recognition mode for each.  Ribose-contg. agonists were more hydrophilic than nonnucleoside antagonists, and H-bonding ability at the ribose 3'- and 5'-positions was required for agonism.  From the receptor perspective, common requirements for activation included the destabilization of H-bond networks at W6.48 and H7.43, the specific interactions of the ribose moiety in its putative hydrophilic pocket at T3.36, S7.42, and H7.43, the stabilization of the complex by inward movement of F5.43, and the characteristic rotation of W6.48.  By analogy, outward rotation of the W6.48 side-chain upon activation of an internally-crosslinking mutant M3 muscarinic receptor was indicated by constrained mol. dynamics (MD).  The authors' results are consistent with an anti-clockwise rotation (from the extracellular view) of transmembrane domains 3, 5, 6, and 7, as proposed for other Family A GPCRs.  Thus, the putative conformational changes assocd. with A3AR activation indicate a shared mechanism of GPCR activation similar to rhodopsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWu8mjSrWoKLVg90H21EOLACvtfcHk0lhq2xIPu6Nj4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOhs7vL&md5=600d301ed714ecc352db9496f7109a7e</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2006.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2006.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DDocking%2520studies%2520of%2520agonists%2520and%2520antagonists%2520suggest%2520an%2520activation%2520pathway%2520of%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D562%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaniappan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Discovery of a new nucleoside template for human A<sub>3</sub> adenosine receptor ligands: <span class="smallcaps smallerCapital">d</span>-4′-thioadenosine derivatives without 4′-hydroxymethyl group as highly potent and selective antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3159</span><span class="NLM_x">–</span> <span class="NLM_lpage">3162</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070259t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1KrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3159-3162&author=L.+S.+Jeongauthor=S.+A.+Choeauthor=P.+Gunagaauthor=H.+O.+Kimauthor=H.+W.+Leeauthor=S.+K.+Leeauthor=D.+K.+Toshauthor=A.+Patelauthor=K.+K.+Palaniappanauthor=Z.+G.+Gaoauthor=K.+A.+Jacobsonauthor=H.+R.+Moon&title=Discovery+of+a+new+nucleoside+template+for+human+A3+adenosine+receptor+ligands%3A+d-4%E2%80%B2-thioadenosine+derivatives+without+4%E2%80%B2-hydroxymethyl+group+as+highly+potent+and+selective+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a New Nucleoside Template for Human A3 Adenosine Receptor Ligands: D-4'-Thioadenosine Derivatives without 4'-Hydroxymethyl Group as Highly Potent and Selective Antagonists</span></div><div class="casAuthors">Jeong, Lak Shin; Choe, Seung Ah; Gunaga, Prashantha; Kim, Hea Ok; Lee, Hyuk Woo; Lee, Sang Kook; Tosh, Dilip K.; Patel, Amit; Palaniappan, Krishnan K.; Gao, Zhan-Guo; Jacobson, Kenneth A.; Moon, Hyung Ryong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3159-3162</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Truncated D-4'-thioadenosine derivs. lacking the 4'-hydroxymethylene moiety were synthesized starting from D-mannose, using cyclization to the 4-thiosugar and one-step conversion of the diol to the acetate as key steps.  At the human A3 adenosine receptor (AR), N6-substituted purine analogs bound potently and selectively and acted as antagonists in a cAMP functional assay.  An N6-(3-chlorobenzyl)purine analog 9b displayed a Ki value of 1.66 nM at the human A3 AR.  Thus, truncated D-4'-thioadenosine is an excellent template for the design of novel A3 AR antagonists to act at both human and murine species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6WDstBT_FHLVg90H21EOLACvtfcHk0lhq2xIPu6Nj4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1KrtLk%253D&md5=353b81eacca2168e390fe048f75463c5</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm070259t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070259t%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DChoe%26aufirst%3DS.%2BA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPalaniappan%26aufirst%3DK.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520new%2520nucleoside%2520template%2520for%2520human%2520A3%2520adenosine%2520receptor%2520ligands%253A%2520d-4%25E2%2580%25B2-thioadenosine%2520derivatives%2520without%25204%25E2%2580%25B2-hydroxymethyl%2520group%2520as%2520highly%2520potent%2520and%2520selective%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3159%26epage%3D3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. D.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of 2-chloro-<i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-<i>N</i>,<i>N</i>-dialkyluronamides as human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1612-1616&author=L.+S.+Jeongauthor=H.+W.+Leeauthor=H.+O.+Kimauthor=D.+K.+Toshauthor=S.+Palauthor=W.+J.+Choiauthor=Z.+G.+Gaoauthor=A.+R.+Patelauthor=W.+Williamsauthor=K.+A.+Jacobsonauthor=H.+D.+Kim&title=Structure%E2%80%93activity+relationships+of+2-chloro-N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-N%2CN-dialkyluronamides+as+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DPatel%26aufirst%3DA.%2BR.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DH.%2BD.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%25202-chloro-N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-N%252CN-dialkyluronamides%2520as%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1612%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Synthesis of 2-chloro-<i>N</i><sup>6</sup>-substituted-4′-thioadenosine-5′-<i>N</i>,<i>N</i>-dialkyluronamides as potent and selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Nucleic Acids Symp. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=645-646&author=W.+J.+Choiauthor=H.+W.+Leeauthor=X.+Houauthor=H.+O.+Kimauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Synthesis+of+2-chloro-N6-substituted-4%E2%80%B2-thioadenosine-5%E2%80%B2-N%2CN-dialkyluronamides+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DSynthesis%2520of%25202-chloro-N6-substituted-4%25E2%2580%25B2-thioadenosine-5%25E2%2580%25B2-N%252CN-dialkyluronamides%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DNucleic%2520Acids%2520Symp.%2520Ser.%26date%3D2008%26spage%3D645%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipnis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of truncated 4′-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists</span> <span class="citation_source-journal">Nucleic Acids Symp. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=641-642&author=X.+Houauthor=S.+Palauthor=W.+J.+Choiauthor=H.+O.+Kimauthor=A.+Tipnisauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Design+and+synthesis+of+truncated+4%E2%80%B2-thioadenosine+derivatives+as+potent+and+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DTipnis%26aufirst%3DA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520truncated%25204%25E2%2580%25B2-thioadenosine%2520derivatives%2520as%2520potent%2520and%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DNucleic%2520Acids%2520Symp.%2520Ser.%26date%3D2008%26spage%3D641%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, H. R.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of truncated <span class="smallcaps smallerCapital">d</span>- and l-4′-thioadenosine derivatives as species-independent A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6609</span><span class="NLM_x">–</span> <span class="NLM_lpage">6613</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6609-6613&author=L.+S.+Jeongauthor=S.+Palauthor=S.+A.+Choeauthor=W.+J.+Choiauthor=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=A.+M.+Klutzauthor=X.+Houauthor=H.+O.+Kimauthor=H.+W.+Leeauthor=S.+K.+Leeauthor=D.+K.+Toshauthor=H.+R.+Moon&title=Structure%E2%80%93activity+relationships+of+truncated+d-+and+l-4%E2%80%B2-thioadenosine+derivatives+as+species-independent+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm8008647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008647%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoe%26aufirst%3DS.%2BA.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DMoon%26aufirst%3DH.%2BR.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520truncated%2520d-%2520and%2520l-4%25E2%2580%25B2-thioadenosine%2520derivatives%2520as%2520species-independent%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6609%26epage%3D6613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of truncated adenosine derivatives as highly potent and selective human A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3733</span><span class="NLM_x">–</span> <span class="NLM_lpage">3738</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=3733-3738&author=S.+Palauthor=W.+J.+Choiauthor=S.+A.+Choeauthor=C.+L.+Hellerauthor=Z.+G.+Gaoauthor=M.+Chinnauthor=K.+A.+Jacobsonauthor=X.+Houauthor=S.+K.+Leeauthor=H.+O.+Kimauthor=L.+S.+Jeong&title=Structure%E2%80%93activity+relationships+of+truncated+adenosine+derivatives+as+highly+potent+and+selective+human+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DChoe%26aufirst%3DS.%2BA.%26aulast%3DHeller%26aufirst%3DC.%2BL.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DChinn%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520truncated%2520adenosine%2520derivatives%2520as%2520highly%2520potent%2520and%2520selective%2520human%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D3733%26epage%3D3738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majik, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of truncated <i>C</i><sup>2</sup>- or <i>C</i><sup>8</sup>-substituted adenosine derivatives as dual acting A<sub>2A</sub> and A<sub>3</sub> adenosine receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201229j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=342-356&author=X.+Houauthor=M.+S.+Majikauthor=K.+Kimauthor=Y.+Pyeeauthor=Y.+Leeauthor=V.+Alexanderauthor=H.+Chungauthor=H.+W.+Leeauthor=G.+Chandraauthor=J.+H.+Leeauthor=S.+Parkauthor=W.+J.+Choiauthor=H.+O.+Kimauthor=K.+Phanauthor=Z.+Gaoauthor=K.+A.+Jacobsonauthor=S.+Choiauthor=S.+K.+Leeauthor=L.+S.+Jeong&title=Structure%E2%80%93activity+relationships+of+truncated+C2-+or+C8-substituted+adenosine+derivatives+as+dual+acting+A2A+and+A3+adenosine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fjm201229j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201229j%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMajik%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DPyee%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DAlexander%26aufirst%3DV.%26aulast%3DChung%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DChandra%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520truncated%2520C2-%2520or%2520C8-substituted%2520adenosine%2520derivatives%2520as%2520dual%2520acting%2520A2A%2520and%2520A3%2520adenosine%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D342%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Kiesewetter, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of [<sup>76</sup>Br]-labeled high-affinity A<sub>3</sub> adenosine receptor ligands for positron emission tomography</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.nucmedbio.2008.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19181263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=3-10&author=D.+O.+Kiesewetterauthor=L.+Langauthor=Y.+Maauthor=A.+K.+Bhattacharjeeauthor=Z.+G.+Gaoauthor=B.+V.+Joshiauthor=A.+Melmanauthor=S.+de+Castroauthor=K.+A.+Jacobson&title=Synthesis+and+characterization+of+%5B76Br%5D-labeled+high-affinity+A3+adenosine+receptor+ligands+for+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography</span></div><div class="casAuthors">Kiesewetter, Dale O.; Lang, Lixin; Ma, Ying; Bhattacharjee, Abesh Kumar; Gao, Zhan-Guo; Joshi, Bhalchandra V.; Melman, Artem; de Castro, Sonia; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Bromine-76-radiolabeled analogs of previously reported high-affinity A3 adenosine receptor (A3AR) nucleoside ligands have been prepd. as potential radiotracers for positron emission tomog.  Methods: The radiosyntheses were accomplished by oxidative radiobromination on the N 6-benzyl moiety of trimethyltin precursors.  Biodistribution studies of the kinetics of uptake were conducted in awake rats.  Results: We prepd. an agonist ligand {[76Br](1'S,2'R,3'S,4'R,5'S)-4'-{2-chloro-6-[(3-bromophenylmethyl)amino]purin-9-yl}-1'-(methylaminocarbonyl)bicyclo[3.1.0]hexane-2',3'-diol (MRS3581)} in 59% radiochem. yield with a specific activity of 19.5 GBq/μmol and an antagonist ligand {[76Br](1'R,2'R,3'S,4'R,5'S)-4'-(6-(3-bromobenzylamino)-2-chloro-9H-purin-9-yl)bicyclo[3.1.0]hexane-2',3'-diol (MRS5147)} in 65% radiochem. yield with a specific activity of 22 GBq/μmol.  The resultant products exhibited the expected high affinity (K i∼0.6 nM) and specific binding at the human A3AR in vitro.  Biodistribution studies in the rat showed uptake in the organs of excretion and metab.  The antagonist MRS5147 exhibited increasing uptake in testes, an organ that contains significant quantities of A3AR, over a 2-h time course, which suggests the presence of a specific A3AR retention mechanism.  Conclusion: We were able to compare uptake of the [76Br]-labeled antagonist MRS5147 to [76Br]agonist MRS3581.  The antagonist MRS5147 shows increasing uptake in the testes, an A3AR-rich tissue, suggesting that this ligand may have promise as a mol. imaging agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6t_hiYgrdbVg90H21EOLACvtfcHk0lgjJFe4nu1y7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqt7w%253D&md5=46a59ff0fb2e096d3594e3c7c09e6929</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DKiesewetter%26aufirst%3DD.%2BO.%26aulast%3DLang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DBhattacharjee%26aufirst%3DA.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DMelman%26aufirst%3DA.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520%255B76Br%255D-labeled%2520high-affinity%2520A3%2520adenosine%2520receptor%2520ligands%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2009%26volume%3D36%26spage%3D3%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Selective A<sub>3</sub> adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8546</span><span class="NLM_x">–</span> <span class="NLM_lpage">8556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bmc.2008.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18752961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8546-8556&author=A.+Melmanauthor=B.+Wangauthor=B.+V.+Joshiauthor=Z.+G.+Gaoauthor=S.+Castroauthor=C.+L.+Hellerauthor=S.+K.+Kimauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Selective+A3+adenosine+receptor+antagonists+derived+from+nucleosides+containing+a+bicyclo%5B3.1.0%5Dhexane+ring+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Selective A3 adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span></div><div class="casAuthors">Melman, Artem; Wang, Ben; Joshi, Bhalchandra V.; Gao, Zhan-Guo; de Castro, Sonia; Heller, Cara L.; Kim, Soo-Kyung; Jeong, Lak Shin; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8546-8556</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have prepd. 5'-modified derivs. of adenosine and a corresponding (N)-methanocarba nucleoside series contg. a bicyclo[3.1.0]hexane ring system in place of the ribose moiety.  The compds. were examd. in binding assays at three subtypes of adenosine receptors (ARs) and in functional assays at the A3 AR.  The H-bonding ability of a group of 9-riboside derivs. contg. a 5'-uronamide moiety was reduced by modification of the NH; however these derivs. did not display the desired activity as selective A3 AR antagonists, as occurs with 5'-N,N-dimethyluronamides.  However, truncated (N)-methanocarba analogs lacking a 4'-hydroxymethyl group were highly potent and selective antagonists of the human A3 AR.  The compds. were synthesized from D-ribose using a reductive free radical decarboxylation of a 5'-carboxy intermediate.  A less efficient synthetic approach began with L-ribose, which was similar to the published synthesis of (N)-methanocarba A3AR agonists.  Compds. 33b-39b (N 6-3-halobenzyl and related arylalkyl derivs.) were potent A3AR antagonists with binding K i values of 0.7-1.4 nM.  In a functional assay of [35S]GTPγS binding, 33b (3-iodobenzyl) completely inhibited stimulation by NECA with a K B of 8.9 nM.  Thus, a highly potent and selective series of A3AR antagonists has been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCKshPwkRmvbVg90H21EOLACvtfcHk0lhJ63MiSSy6Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K&md5=8f2e48da21c5e8a1f3f067d30b03fcae</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DCastro%26aufirst%3DS.%26aulast%3DHeller%26aufirst%3DC.%2BL.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSelective%2520A3%2520adenosine%2520receptor%2520antagonists%2520derived%2520from%2520nucleosides%2520containing%2520a%2520bicyclo%255B3.1.0%255Dhexane%2520ring%2520system%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8546%26epage%3D8556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of [<sup>125</sup>I]MRS5127, a high affinity, selective agonist radioligand for the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.bcp.2009.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19917269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=967-973&author=J.+A.+Auchampachauthor=E.+T.+Gizewskiauthor=T.+C.+Wanauthor=S.+de+Castroauthor=G.+G.+Brownauthor=K.+A.+Jacobson&title=Synthesis+and+pharmacological+characterization+of+%5B125I%5DMRS5127%2C+a+high+affinity%2C+selective+agonist+radioligand+for+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor</span></div><div class="casAuthors">Auchampach, John A.; Gizewski, Elizabeth T.; Wan, Tina C.; de Castro, Sonia; Brown, Garth G.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">967-973</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A recently reported selective agonist of the human A3 adenosine receptor (hA3AR), MRS5127 (1'R,2'R,3'S,4'R,5'S)-4'-[2-chloro-6-(3-iodobenzylamino)-purine]-2',3'-O-dihydroxy-bicyclo-[3.1.0]hexane, was radioiodinated and characterized pharmacol.  It contains a rigid bicyclic ring system in place of a 5'-truncated ribose moiety, and was selected for radiolabeling due to its nanomolar binding affinity at both human and rat A3ARs.  The radioiodination of the N6-3-iodobenzyl substituent by iododestannylation of a 3-(trimethylstannyl)benzyl precursor was achieved in 73% yield, measured after purifn. by HPLC. [125I]MRS5127 bound to the human A3AR expressed in membranes of stably transfected HEK 293 cells.  Specific binding was saturable, competitive, and followed a one-site binding model, with a K d value of 5.74 ± 0.97 nM.  At a concn. equiv. to its Kd, non-specific binding comprised 27 ± 2% of total binding.  In kinetic studies, [125I]MRS5127 rapidly assocd. with the hA3AR (t 1/2 = 0.514 ± 0.014 min), and the affinity calcd. from assocn. and dissocn. rate consts. was 3.50 ± 1.46 nM.  The pharmacol. profile of ligands in competition expts. with [125I]MRS5127 was consistent with the known structure-activity-relationship profile of the hA3AR. [125I]MRS5127 bound with similar high affinity (K d, nM) to recombinant A3ARs from mouse (4.90 ± 0.77), rabbit (2.53 ± 0.11), and dog (3.35 ± 0.54).  For all of the species tested, MRS5127 exhibited A3AR agonist activity based on neg. coupling to cAMP prodn.  Thus, [125I]MRS5127 represents a new species-independent agonist radioligand for the A3AR.  The major advantage of [125I]MRS5127 compared with previously used A3AR radioligands is its high affinity, low degree of non-specific binding, and improved A3AR selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcLOUb60vR_bVg90H21EOLACvtfcHk0lhJ63MiSSy6Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaisbo%253D&md5=d60f5c629a3955f18d8a912d5560445e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DGizewski%26aufirst%3DE.%2BT.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DG.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520%255B125I%255DMRS5127%252C%2520a%2520high%2520affinity%252C%2520selective%2520agonist%2520radioligand%2520for%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D967%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Choi, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span> </span><span class="NLM_article-title">Regio- and stereoselective synthesis of truncated 3′-aminocarbanucleosides and their binding affinity at the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">6955</span><span class="NLM_x">–</span> <span class="NLM_lpage">6962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=6955-6962&author=M.+J.+Choiauthor=G.+Chandraauthor=H.+W.+Leeauthor=X.+Houauthor=W.+J.+Choiauthor=K.+Phanauthor=K.+A.+Jacobsonauthor=L.+S.+Jeong&title=Regio-+and+stereoselective+synthesis+of+truncated+3%E2%80%B2-aminocarbanucleosides+and+their+binding+affinity+at+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DM.%2BJ.%26aulast%3DChandra%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DW.%2BJ.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26atitle%3DRegio-%2520and%2520stereoselective%2520synthesis%2520of%2520truncated%25203%25E2%2580%25B2-aminocarbanucleosides%2520and%2520their%2520binding%2520affinity%2520at%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D6955%26epage%3D6962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span> </span><span class="NLM_article-title">Allosteric enhancers of A<sub>1</sub> adenosine receptors: state of the art and new horizons for drug development</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3488</span><span class="NLM_x">–</span> <span class="NLM_lpage">3502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.2174%2F092986710792927831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20738250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3488-3502&author=R.+Romagnoliauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Boreaauthor=S.+Merighi&title=Allosteric+enhancers+of+A1+adenosine+receptors%3A+state+of+the+art+and+new+horizons+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development</span></div><div class="casAuthors">Romagnoli, R.; Baraldi, P. G.; Tabrizi, M. A.; Gessi, S.; Borea, P. A.; Merighi, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3488-3502</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine is an important autocoid, exerting its physiol. effects on the human body by activation of four different G-protein-coupled-receptors (GPCRs) classified as A1, A2A, A2B, and A3.  These receptors are coupled to secondary messenger systems including adenylate cyclase, inositol phosphate metab., and K+, KATP and Ca2+ channels.  Pharmacol. agents that increase the activation of A1 adenosine receptors in response to adenosine would be useful for treatment of cardiovascular, central nervous system, and inflammatory pathologies.  Compds. that are able to enhance the activity of the A1-adenosine receptors by the endogenous ligand within specific tissues may have potential therapeutic advantages over non-endogenous agonists.  Such an opportunity for intervention is provided by the concept of allosteric modulation of GPCRs.  Therefore the use of allosteric enhancers to increase the responsiveness of the A1 receptors to endogenous adenosine at sites of its prodn. is an appealing alternative to activation by exogenous agonists.  This approach minimizes side effects because allosteric enhancers amplify the action of the agonist by stabilizing the agonist-A1-receptor-G protein ternary complex.  The allosteric enhancement of the GABAA receptor by benzodiazepines is the most famous and successful example of this strategy.  The aim of this article is to give an overview of the results obtained in this field and discuss the opportunities and challenges that this class of ligands might offer for medicinal chem. and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokaKpRdjIL-bVg90H21EOLACvtfcHk0lhJ63MiSSy6Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWrt7fE&md5=e4410b60b16f09593fd31fd6d3cec237</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.2174%2F092986710792927831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792927831%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26atitle%3DAllosteric%2520enhancers%2520of%2520A1%2520adenosine%2520receptors%253A%2520state%2520of%2520the%2520art%2520and%2520new%2520horizons%2520for%2520drug%2520development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3488%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Kiesman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span> </span><span class="NLM_article-title">A<sub>1</sub> adenosine receptor antagonists, agonists, and allosteric enhancers</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2F978-3-540-89615-9_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19639278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2009&pages=25-58&author=W.+F.+Kiesmanauthor=E.+Elzeinauthor=J.+Zablocki&title=A1+adenosine+receptor+antagonists%2C+agonists%2C+and+allosteric+enhancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A1 adenosine receptor antagonists, agonists, and allosteric enhancers</span></div><div class="casAuthors">Kiesman, William F.; Elzein, Elfatih; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">25-58</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Intense efforts of many pharmaceutical companies and academicians in the A1 adenosine receptor (AR) field have led to the discovery of clin. candidates that are antagonists, agonists, and allosteric enhancers.  The A1AR antagonists currently in clin. development are KW3902, BG9928, and SLV320.  All three have high affinity for the human (h) A1AR subtype (hA1 Ki < 10 nM), > 200-fold selectivity over the hA2A subtype, and demonstrate renal protective effects in multiple animal models of disease and pharmacol. effects in human subjects.  In the A1AR agonist area, clin. candidates have been discovered for the following conditions: atrial arrhythmias (tecadenoson, selodenoson and PJ-875); Type II diabetes and insulin sensitizing agents (GR79236, ARA, RPR-749, and CVT-3619); and angina (BAY 68-4986).  The challenges assocd. with the development of any A1AR agonist are to obtain tissue-specific effects but avoid off-target tissue side effects and A1AR desensitization leading to tachyphylaxis.  For the IV antiarrhythmic agents that act as ventricular rate control agents, a selective response can be accomplished by careful IV dosing paradigms.  The treatment of type II diabetes using A1AR agonists in the clinic has met with limited success due to cardiovascular side effects and a well-defined desensitization of full agonists in human trials (GR79236, ARA, and RPR 749).  However, new partial A1AR agonists are in development, including CVT-3619 (hA1 AR Ki = 55 nM, hA2A:hA2B:hA3 > 200:1,000:20, CV Therapeutics), which have the potential to provide enhanced insulin sensitivity without cardiovascular side effects and tachyphylaxis.  The nonnucleosidic A1AR agonist BAY 68-4986 (capadenoson) represents a novel approach to angina wherein both animal studies and early human studies are promising.  T-62 is an A1AR allosteric enhancer that is currently being evaluated in clin. trials as a potential treatment for neuropathic pain.  The challenges assocd. with developing A1AR antagonists, agonists, or allosteric enhancers for therapeutic intervention are now well defined in humans.  Significant progress has been made in identifying A1AR antagonists for the treatment of edema assocd. with congestive heart failure (CHF), A1AR agonists for the treatment of atrial arrhythmias, type II diabetes and angina, and A1AR allosteric enhancers for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofCM7ufsD78rVg90H21EOLACvtfcHk0lgP4Fp14E2HVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7K&md5=8aebbe66c1095ea8cbc94c58ce3849fd</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_2%26sid%3Dliteratum%253Aachs%26aulast%3DKiesman%26aufirst%3DW.%2BF.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DA1%2520adenosine%2520receptor%2520antagonists%252C%2520agonists%252C%2520and%2520allosteric%2520enhancers%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26volume%3D193%26spage%3D25%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Muijlwijk-Koezen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of A<sub>3</sub> adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1057-1063&author=Z.+G.+Gaoauthor=J.+E.+Van+Muijlwijk-Koezenauthor=A.+Chenauthor=C.+E.+M%C3%BCllerauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Allosteric+modulation+of+A3+adenosine+receptors+by+a+series+of+3-%282-pyridinyl%29isoquinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DVan%2BMuijlwijk-Koezen%26aufirst%3DJ.%2BE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAllosteric%2520modulation%2520of%2520A3%2520adenosine%2520receptors%2520by%2520a%2520series%2520of%25203-%25282-pyridinyl%2529isoquinoline%2520derivatives%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1057%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltysiak, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Selective allosteric enhancement of agonist binding and function at human A<sub>3</sub> adenosine receptors by a series of imidazoquinoline derivatives</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=81-89&author=Z.+G.+Gaoauthor=S.+G.+Kimauthor=K.+A.+Soltysiakauthor=N.+Melmanauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Selective+allosteric+enhancement+of+agonist+binding+and+function+at+human+A3+adenosine+receptors+by+a+series+of+imidazoquinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DSoltysiak%26aufirst%3DK.%2BA.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSelective%2520allosteric%2520enhancement%2520of%2520agonist%2520binding%2520and%2520function%2520at%2520human%2520A3%2520adenosine%2520receptors%2520by%2520a%2520series%2520of%2520imidazoquinoline%2520derivatives%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connestari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of new 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amine derivatives as allosteric enhancers of the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3354</span><span class="NLM_x">–</span> <span class="NLM_lpage">3361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060086s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3354-3361&author=A.+Goblyosauthor=Z.+G.+Gaoauthor=J.+Brusseeauthor=R.+Connestariauthor=S.+N.+Santiagoauthor=K.+Yeauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Structure%E2%80%93activity+relationships+of+new+1H-imidazo%5B4%2C5-c%5Dquinolin-4-amine+derivatives+as+allosteric+enhancers+of+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm060086s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060086s%26sid%3Dliteratum%253Aachs%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DConnestari%26aufirst%3DR.%26aulast%3DSantiago%26aufirst%3DS.%2BN.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520new%25201H-imidazo%255B4%252C5-c%255Dquinolin-4-amine%2520derivatives%2520as%2520allosteric%2520enhancers%2520of%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3354%26epage%3D3361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Flexible modulation of agonist efficacy at the human A<sub>3</sub> adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000</span> <span class="citation_source-journal">BMC Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1186%2F1471-2210-8-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19077268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FntFWhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=20&author=Z.+G.+Gaoauthor=K.+Yeauthor=A.+Goblyosauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Flexible+modulation+of+agonist+efficacy+at+the+human+A3+adenosine+receptor+by+the+imidazoquinoline+allosteric+enhancer+LUF6000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000</span></div><div class="casAuthors">Gao Zhan-Guo; Ye Kai; Goblyos Aniko; Ijzerman Adriaan P; Jacobson Kenneth A</div><div class="citationInfo"><span class="NLM_cas:title">BMC pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  A series of 1H-imidazo- [4,5-c]quinolin-4-amine derivatives, represented by LUF6000 (N-(3,4-dichloro-phenyl)-2-cyclohexyl-1H-imidazo [4,5-c]quinolin-4-amine), are allosteric modulators of the human A3 adenosine receptor (AR).  Here we studied the modulation by LUF6000 of the maximum effect (Emax) of structurally diverse agonists at the A3 AR stably expressed in CHO cells.  RESULTS:  In an assay of [35S]GTPgammaS binding, the Emax of the A3 AR agonist Cl-IB-MECA at the A3 AR was lower than that of the non-selective AR agonist NECA.  LUF6000 exerted an Emax-enhancing effect at a concentration of 0.1 microM or higher, and was shown to increase the Emax of Cl-IB-MECA and other low-efficacy agonists to a larger extent than that of the high-efficacy agonist NECA.  Interestingly, LUF6000 converted a nucleoside A3 AR antagonist MRS542, but not a non-nucleoside antagonist MRS1220, into an agonist.  LUF6000 alone did not show any effect.  Mathematical modeling was performed to explain the differential effects of LUF6000 on agonists with various Emax.  A simple explanation for the observation that LUF6000 has a much stronger effect on Cl-IB-MECA than on NECA derived from the mathematical modeling is that NECA has relatively strong intrinsic efficacy, such that the response is already close to the maximum response.  Therefore, LUF6000 cannot enhance Emax much further.  CONCLUSION:  LUF6000 was found to be an allosteric enhancer of Emax of structurally diverse agonists at the A3 AR, being more effective for low-Emax agonists than for high-Emax agonists.  LUF6000 was demonstrated to convert an antagonist into an agonist, which represents the first example in G protein-coupled receptors.  The observations from the present study are consistent with that predicted by mathematical modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3KsAoNyN66Z6KlWarZTAzfW6udTcc2eZd3SAHOOXKLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FntFWhsw%253D%253D&md5=8e95b0d9112cb0979656c5808bac3aeb</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1186%2F1471-2210-8-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2210-8-20%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFlexible%2520modulation%2520of%2520agonist%2520efficacy%2520at%2520the%2520human%2520A3%2520adenosine%2520receptor%2520by%2520the%2520imidazoquinoline%2520allosteric%2520enhancer%2520LUF6000%26jtitle%3DBMC%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verzijl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Functionally biased modulation of A<sub>3</sub> adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=658-668&author=Z.+G.+Gaoauthor=D.+Verzijlauthor=A.+Zweemerauthor=K.+Yeauthor=A.+Goblyosauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Functionally+biased+modulation+of+A3+adenosine+receptor+agonist+efficacy+and+potency+by+imidazoquinolinamine+allosteric+enhancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DVerzijl%26aufirst%3DD.%26aulast%3DZweemer%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionally%2520biased%2520modulation%2520of%2520A3%2520adenosine%2520receptor%2520agonist%2520efficacy%2520and%2520potency%2520by%2520imidazoquinolinamine%2520allosteric%2520enhancers%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D658%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Novel 2- and 4-substituted 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amine derivatives as allosteric modulators of the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2098</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801659w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2098-2108&author=Y.+Kimauthor=S.+de+Castroauthor=Z.+G.+Gaoauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Novel+2-+and+4-substituted+1H-imidazo%5B4%2C5-c%5Dquinolin-4-amine+derivatives+as+allosteric+modulators+of+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm801659w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801659w%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DNovel%25202-%2520and%25204-substituted%25201H-imidazo%255B4%252C5-c%255Dquinolin-4-amine%2520derivatives%2520as%2520allosteric%2520modulators%2520of%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2098%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Veldhoven, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=926-931&author=L.+H.+Heitmanauthor=A.+Goblyosauthor=A.+M.+Zweemerauthor=R.+Bakkerauthor=T.+Mulder-Kriegerauthor=J.+P.+van+Veldhovenauthor=H.+de+Vriesauthor=J.+Brusseeauthor=A.+P.+Ijzerman&title=A+series+of+2%2C4-disubstituted+quinolines+as+a+new+class+of+allosteric+enhancers+of+the+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm8014052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014052%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DZweemer%26aufirst%3DA.%2BM.%26aulast%3DBakker%26aufirst%3DR.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3Dvan%2BVeldhoven%26aufirst%3DJ.%2BP.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DA%2520series%2520of%25202%252C4-disubstituted%2520quinolines%2520as%2520a%2520new%2520class%2520of%2520allosteric%2520enhancers%2520of%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D926%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beukers, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=48-56&author=J.+R.+Laneauthor=M.+W.+Beukersauthor=T.+Mulder-Kriegerauthor=A.+P.+Ijzerman&title=The+endocannabinoid+2-arachidonylglycerol+is+a+negative+allosteric+modulator+of+the+human+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DThe%2520endocannabinoid%25202-arachidonylglycerol%2520is%2520a%2520negative%2520allosteric%2520modulator%2520of%2520the%2520human%2520A3%2520adenosine%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D48%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span> </span><span class="NLM_article-title"><sup>125</sup>I-4-aminobenzyl-5′-<i>N</i>-methylcarboxamidoadenosine, a high affinity radioligand for the rat A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=978-982&author=M.+E.+Olahauthor=C.+Gallo-Rodriguezauthor=K.+A.+Jacobsonauthor=G.+L.+Stiles&title=125I-4-aminobenzyl-5%E2%80%B2-N-methylcarboxamidoadenosine%2C+a+high+affinity+radioligand+for+the+rat+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26atitle%3D125I-4-aminobenzyl-5%25E2%2580%25B2-N-methylcarboxamidoadenosine%252C%2520a%2520high%2520affinity%2520radioligand%2520for%2520the%2520rat%2520A3%2520adenosine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D978%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]HEMADO—a novel tritiated agonist selective for the human adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">556</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.ejphar.2006.10.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17126322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2007&pages=14-18&author=K.+N.+Klotzauthor=N.+Falgnerauthor=S.+Kachlerauthor=C.+Lambertucciauthor=S.+Vittoriauthor=R.+Volpiniauthor=G.+Cristalli&title=%5B3H%5DHEMADO%E2%80%94a+novel+tritiated+agonist+selective+for+the+human+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]HEMADO- a novel tritiated agonist selective for the human adenosine A3 receptor</span></div><div class="casAuthors">Klotz, Karl-Norbert; Falgner, Nico; Kachler, Sonja; Lambertucci, Catia; Vittori, Sauro; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">14-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A3 receptors are promising drug targets for a no. of conditions like inflammatory diseases including asthma, ischemic injury or certain types of cancer.  Consequently, intense efforts are dedicated to the development of selective A3 agonists and antagonists.  The only tritiated agonist that is available for radioligand binding is the nonselective [3H]5'-N-ethylcarboxamidoadenosine ([3H]NECA).  Based on a recently characterized series of 2-substituted adenosine receptor agonists we developed a tritiated selective A3 radioligand with high affinity.  From this series 2-hexyn-1-yl-N6-methyladenosine (HEMADO) with a Ki-value of 1.1 nM at the human A3 subtype was chosen.  HEMADO is 300-fold selective vs. the A1 subtype, and 1100-fold and more than 25,000-fold selective compared to the adenosine A2A and A2B receptors, resp.  The tritiated deriv. [3H]HEMADO exhibited the same affinity as the unlabeled precursor.  In concns. up to 10 nM no specific binding to adenosine A1, A2A or A2B receptors was obsd. confirming the high selectivity for adenosine A3 receptors.  Characterization of [3H]HEMADO in radioligand binding studies revealed reversible binding to the human adenosine A3 subtype.  In satn. binding studies for the A3 subtype a KD-value of 1.1 nM was detd.  Nonspecific binding at a radioligand concn. of 1 nM amounted to 1-2% of total binding.  Competition binding with a panel of adenosine receptor ligands clearly confirmed the correct A3 pharmacol. of the binding site labeled by [3H]HEMADO.  With [3H]HEMADO we present a tritiated agonist with high affinity and A3-selectivity and very low nonspecific binding.  [3H]HEMADO is a useful tool for specific screening for A3 receptor agonists and antagonists in improved radioligand binding assays with the human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWoJyAB1P49LVg90H21EOLACvtfcHk0lgq_kJDBKnBcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D&md5=91eb5e9810e75d1ca825a804c767929c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.10.048%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DFalgner%26aufirst%3DN.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D%255B3H%255DHEMADO%25E2%2580%2594a%2520novel%2520tritiated%2520agonist%2520selective%2520for%2520the%2520human%2520adenosine%2520A3%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D556%26spage%3D14%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Pharmacological and biochemical characterization of A<sub>3</sub> adenosine receptors in Jurkat T cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0704254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11522603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVyru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=116-126&author=S.+Gessiauthor=K.+Varaniauthor=S.+Merighiauthor=A.+Morelliauthor=D.+Ferrariauthor=E.+Leungauthor=P.+G.+Baraldiauthor=G.+Spallutoauthor=P.+A.+Borea&title=Pharmacological+and+biochemical+characterization+of+A3+adenosine+receptors+in+Jurkat+T+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells</span></div><div class="casAuthors">Gessi, Stefania; Varani, Katia; Merighi, Stefania; Morelli, Anna; Ferrari, Davide; Leung, Edward; Baraldi, Pier Giovanni; Spalluto, Giampiero; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The present work was devoted to the study of A3 adenosine receptors in Jurkat cells, a human leukemia line.  The A3 subtype was found by RT-PCR expts. and characterized by using the new A3 adenosine receptor antagonist [3H]-MRE 3008F20, the only A3 selective radioligand currently available.  Satn. expts. revealed a single high affinity binding site with KD of 1.9 nM and Bmax of 1.3 pmol mg-1 of protein.  The pharmacol. profile of [3H]-MRE 3008F20 binding on Jurkat cells was established using typical adenosine ligands which displayed a rank order of potency typical of the A3 subtype.  Thermodn. data indicated that [3H]-MRE 3008F20 binding to A3 subtype in Jurkat cells was entropy- and enthalpy-driven, according with that found in cells expressing the recombinant human A3 subtype.  In functional assays the high affinity A3 agonists Cl-IB-MECA and IB-MECA were able to inhibit cAMP accumulation and stimulate Ca2+ release from intracellular Ca2+ pools followed by Ca2+ influx.  The presence of the other adenosine subtypes was investigated in Jurkat cells.  A1 receptors were characterized using [3H]-DPCPX binding with a KD of 0.9 nM and Bmax of 42 fmol mg-1 of protein.  A2A receptors were studied with [3H]-SCH 58261 binding and revealed a KD of 2.5 nM and a Bmax of 1.4 pmol mg-1 of protein.  In conclusion, by the first antagonist radioligand [3H]-MRE 3008F20 the authors could demonstrate the existence of functional A3 receptors on Jurkat cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre39I_yLblZbVg90H21EOLACvtfcHk0lgq_kJDBKnBcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVyru7c%253D&md5=d06df41cebd7b0c84c51ada501b34c10</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704254%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DMorelli%26aufirst%3DA.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DPharmacological%2520and%2520biochemical%2520characterization%2520of%2520A3%2520adenosine%2520receptors%2520in%2520Jurkat%2520T%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D116%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulouglu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0704352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11704641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosl2qs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=1215-1226&author=S.+Merighiauthor=K.+Varaniauthor=S.+Gessiauthor=E.+Cattabrigaauthor=V.+Iannottaauthor=C.+Ulougluauthor=E.+Leungauthor=P.+A.+Borea&title=Pharmacological+and+biochemical+characterization+of+adenosine+receptors+in+the+human+malignant+melanoma+A375+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line</span></div><div class="casAuthors">Merighi, Stefania; Varani, Katia; Gessi, Stefania; Cattabriga, Elena; Iannotta, Valeria; Ulouglu, Canan; Leung, Edward; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1215-1226</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The present work characterizes, from a pharmacol. and biochem. point of view, adenosine receptors in the human malignant melanoma A375 cell line.  2 Adenosine receptors were detected by RT-PCR expts.  A1 receptors were characterized using [3H]-DPCPX binding with a KD of 1.9±0.2 nM and Bmax of 23±7 fmol mg-1 of protein.  A2A receptors were studied with [3H]-SCH 58261 binding and revealed a KD of 5.1±0.2 nM and a Bmax of 220±7 fmol mg-1 of protein.  A3 receptors were studied with the new A3 adenosine receptor antagonist [3H]-MRE 3008F20, the only A3 selective radioligand currently available.  Satn. expts. revealed a single high affinity binding site with KD of 3.3±0.7 nM and Bmax of 291±50 fmol mg-1 of protein.  3 The pharmacol. profile of radioligand binding on A375 cells was established using typical adenosine ligands which displayed a rank order of potency typical of the different adenosine receptor subtype.  4 Thermodn. data indicated that radioligand binding to adenosine receptor subtypes in A375 cells was entropy- and enthalpy-driven.  5 In functional assays the high affinity A2A agonists HE-NECA, CGS 21680 and A2A-A2B agonist NECA were able to increase cAMP accumulation in A375 cells whereas A3 agonists Cl-IB-MECA, IB-MECA and NECA were able to stimulate Ca2+ mobilization.  6 In conclusion, all these data indicate, for the first time, that adenosine receptors with a pharmacol. and biochem. profile typical of the A1, A2A, A2B and A3 receptor subtype are present on A375 melanoma cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiYQ1-tSi09LVg90H21EOLACvtfcHk0lhEDQHqh_H4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosl2qs7Y%253D&md5=0f117370c5a46559fe00582fe657878d</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704352%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DIannotta%26aufirst%3DV.%26aulast%3DUlouglu%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DPharmacological%2520and%2520biochemical%2520characterization%2520of%2520adenosine%2520receptors%2520in%2520the%2520human%2520malignant%2520melanoma%2520A375%2520cell%2520line%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D1215%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=415-424&author=S.+Gessiauthor=K.+Varaniauthor=S.+Merighiauthor=E.+Cattabrigaauthor=V.+Iannottaauthor=E.+Leungauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=A3+adenosine+receptors+in+human+neutrophils+and+promyelocytic+HL60+cells%3A+a+pharmacological+and+biochemical+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DIannotta%26aufirst%3DV.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520adenosine%2520receptors%2520in%2520human%2520neutrophils%2520and%2520promyelocytic%2520HL60%2520cells%253A%2520a%2520pharmacological%2520and%2520biochemical%2520study%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D415%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2002&pages=923-933&author=S.+Merighiauthor=P.+Mirandolaauthor=D.+Milaniauthor=K.+Varaniauthor=S.+Gessiauthor=K.+N.+Klotzauthor=E.+Leungauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Adenosine+receptors+as+mediators+of+both+cell+proliferation+and+cell+death+of+cultured+human+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DMilani%26aufirst%3DD.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptors%2520as%2520mediators%2520of%2520both%2520cell%2520proliferation%2520and%2520cell%2520death%2520of%2520cultured%2520human%2520melanoma%2520cells%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2002%26volume%3D119%26spage%3D923%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A<sub>3</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980550w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=706-721&author=A.+H.+Liauthor=S.+Moroauthor=N.+Forsythauthor=N.+Melmanauthor=X.+D.+Jiauthor=K.+A.+Jacobson&title=Synthesis%2C+CoMFA+analysis%2C+and+receptor+docking+of+3%2C5-diacyl-2%2C4-dialkylpyridine+derivatives+as+selective+A3+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm980550w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980550w%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DForsyth%26aufirst%3DN.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%252C%2520CoMFA%2520analysis%252C%2520and%2520receptor%2520docking%2520of%25203%252C5-diacyl-2%252C4-dialkylpyridine%2520derivatives%2520as%2520selective%2520A3%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D706%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Wadsak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mien, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanab, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettlinger, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeusler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindelar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzenberger, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreitzer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viernstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudczak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kletter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitterhauser, M.</span><span> </span><span class="NLM_article-title">Preparation and first evaluation of [<sup>18</sup>F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="98deddd8cbcdc8c8c1">[email protected]</a>: a new PET tracer for the adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.nucmedbio.2007.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18158944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOlt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=61-66&author=W.+Wadsakauthor=L.+K.+Mienauthor=K.+Shanabauthor=D.+E.+Ettlingerauthor=D.+Haeuslerauthor=K.+Sindelarauthor=R.+R.+Lanzenbergerauthor=H.+Spreitzerauthor=H.+Viernsteinauthor=B.+K.+Kepplerauthor=R.+Dudczakauthor=K.+Kletterauthor=M.+Mitterhauser&title=Preparation+and+first+evaluation+of+%5B18F%5DFE%40SUPPY%3A+a+new+PET+tracer+for+the+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and first evaluation of [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6d2b282d3e383d3d34">[email protected]</a>: a new PET tracer for the adenosine A3 receptor</span></div><div class="casAuthors">Wadsak, Wolfgang; Mien, Leonhard-Key; Shanab, Karem; Ettlinger, Dagmar E.; Haeusler, Daniela; Sindelar, Karoline; Lanzenberger, Rupert R.; Spreitzer, Helmut; Viernstein, Helmut; Keppler, Bernhard K.; Dudczak, Robert; Kletter, Kurt; Mitterhauser, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-66</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Changes of the adenosine A3 receptor subtype (A3AR) expression have been shown in a variety of pathologies, esp. neurol. and affective disorders, cardiac diseases and oncol. and inflammation processes.  Recently, 5-(2-fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="adebe8edfef8fdfdf4">[email protected]</a>) was presented as a high-affinity ligand for the A3AR with good selectivity.  Our aims were the development of a suitable labeling precursor, the establishment of a reliable radiosynthesis for the fluorine-18-labeled analog [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="216764617274717178">[email protected]</a> and a first evaluation of [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="9fd9dadfcccacfcfc6">[email protected]</a> in rats.  Methods: [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="783e3d382b2d282821">[email protected]</a> was prepd. in a feasible and reliable manner by radiofluorination of the corresponding tosylated precursor.  Biodistribution was carried out in rats, and organs were removed and counted.  Autoradiog. was performed on rat brain slices in the presence or absence of 2-Cl-IB-MECA.  Results: Overall yields and radiochem. purity were sufficient for further preclin. and clin. applications.  The uptake pattern of [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c6808386959396969f">[email protected]</a> found in rats mainly followed the described mRNA distribution pattern of the A3AR.  Specific uptake in brain was demonstrated by blocking with a selective A3AR agonist.  Conclusion: We conclude that [18F]<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="65232025363035353c">[email protected]</a> has the potential to serve as the first positron emission tomog. tracer for the A3AR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaoNEK-xtqNLVg90H21EOLACvtfcHk0lhEDQHqh_H4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOlt73M&md5=9b8b677896a8eb936de77ce643d27991</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DWadsak%26aufirst%3DW.%26aulast%3DMien%26aufirst%3DL.%2BK.%26aulast%3DShanab%26aufirst%3DK.%26aulast%3DEttlinger%26aufirst%3DD.%2BE.%26aulast%3DHaeusler%26aufirst%3DD.%26aulast%3DSindelar%26aufirst%3DK.%26aulast%3DLanzenberger%26aufirst%3DR.%2BR.%26aulast%3DSpreitzer%26aufirst%3DH.%26aulast%3DViernstein%26aufirst%3DH.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DDudczak%26aufirst%3DR.%26aulast%3DKletter%26aufirst%3DK.%26aulast%3DMitterhauser%26aufirst%3DM.%26atitle%3DPreparation%2520and%2520first%2520evaluation%2520of%2520%255B18F%255DFE%2540SUPPY%253A%2520a%2520new%2520PET%2520tracer%2520for%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D61%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Boison, D.</span><span> </span><span class="NLM_article-title">Adenosine as a modulator of brain activity</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1358%2Fdnp.2007.20.10.1181353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18301794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=607-611&author=D.+Boison&title=Adenosine+as+a+modulator+of+brain+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine as a modular of brain activity</span></div><div class="casAuthors">Boison, Detlev</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">607-611</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The endogenous neuromodulator adenosine controls and integrates a wide range of brain functions.  Consequently, dysfunction of the adenosine system is involved in pathologies ranging from epilepsy to neurodegenerative disorders and psychiatric conditions.  The adenosine system has therefore been recognized as a prime target for the development of new therapeutics for neurol. diseases.  This review covers the upstream and downstream targets of adenosinergic neurotransmission and provides the neurochem. rationale for the development of adenosine receptor modulating drugs (downstream) and inhibitors of adenosine kinase, the key upstream regulator of ambient levels of adenosine.  Due to the unique role of adenosine to integrate and fine-tune glutamatergic and dopaminergic neurotransmission, adenosine-regulating agents have the potential to modify a wide range of downstream effects.  Thus, adenosine-based therapies are rapidly evolving in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZopfDMF4u7Vg90H21EOLACvtfcHk0lhshy0leAQqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVKntLg%253D&md5=204e175cb640e7bf9a229629722ceb56</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2007.20.10.1181353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2007.20.10.1181353%26sid%3Dliteratum%253Aachs%26aulast%3DBoison%26aufirst%3DD.%26atitle%3DAdenosine%2520as%2520a%2520modulator%2520of%2520brain%2520activity%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2007%26volume%3D20%26spage%3D607%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Boison, D.</span><span> </span><span class="NLM_article-title">The adenosine kinase hypothesis of epileptogenesis</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.pneurobio.2007.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18249058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlektbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=249-262&author=D.+Boison&title=The+adenosine+kinase+hypothesis+of+epileptogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The adenosine kinase hypothesis of epileptogenesis</span></div><div class="casAuthors">Boison, Detlev</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-262</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Current therapies for epilepsy are largely symptomatic and do not affect the underlying mechanisms of disease progression, i.e. epileptogenesis.  Given the large percentage of pharmacoresistant chronic epilepsies, novel approaches are needed to understand and modify the underlying pathogenetic mechanisms.  Although different types of brain injury (e.g. status epilepticus, traumatic brain injury, stroke) can trigger epileptogenesis, astrogliosis appears to be a homotypic response and hallmark of epilepsy.  Indeed, recent findings indicate that epilepsy might be a disease of astrocyte dysfunction.  This review focuses on the inhibitory neuromodulator and endogenous anticonvulsant adenosine, which is largely regulated by astrocytes and its key metabolic enzyme adenosine kinase (ADK).  Recent findings support the "ADK hypothesis of epileptogenesis": (i) Mouse models of epileptogenesis suggest a sequence of events leading from initial downregulation of ADK and elevation of ambient adenosine as an acute protective response, to changes in astrocytic adenosine receptor expression, to astrocyte proliferation and hypertrophy (i.e. astrogliosis), to consequential overexpression of ADK, reduced adenosine and - finally - to spontaneous focal seizure activity restricted to regions of astrogliotic overexpression of ADK.  (ii) Transgenic mice overexpressing ADK display increased sensitivity to brain injury and seizures.  (iii) Inhibition of ADK prevents seizures in a mouse model of pharmacoresistant epilepsy.  (iv) Intrahippocampal implants of stem cells engineered to lack ADK prevent epileptogenesis.  Thus, ADK emerges both as a diagnostic marker to predict, as well as a prime therapeutic target to prevent, epileptogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7IZTnq8B2ybVg90H21EOLACvtfcHk0lhshy0leAQqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlektbc%253D&md5=e2d81d16911620ec424f38611dd211c7</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBoison%26aufirst%3DD.%26atitle%3DThe%2520adenosine%2520kinase%2520hypothesis%2520of%2520epileptogenesis%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D249%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Yoon, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. M.</span><span> </span><span class="NLM_article-title">Roles of adenosine receptor subtypes in the antinociceptive effect of intrathecal adenosine in a rat formalin test</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=21-26&author=M.+H.+Yoonauthor=H.+B.+Baeauthor=J.+I.+Choiauthor=S.+J.+Kimauthor=S.+T.+Chungauthor=C.+M.+Kim&title=Roles+of+adenosine+receptor+subtypes+in+the+antinociceptive+effect+of+intrathecal+adenosine+in+a+rat+formalin+test"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DM.%2BH.%26aulast%3DBae%26aufirst%3DH.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DChung%26aufirst%3DS.%2BT.%26aulast%3DKim%26aufirst%3DC.%2BM.%26atitle%3DRoles%2520of%2520adenosine%2520receptor%2520subtypes%2520in%2520the%2520antinociceptive%2520effect%2520of%2520intrathecal%2520adenosine%2520in%2520a%2520rat%2520formalin%2520test%26jtitle%3DPharmacology%26date%3D2006%26volume%3D78%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Brief, repeated, oxygen–glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0705442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12970092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2003&pages=305-314&author=A.+M.+Puglieseauthor=S.+Latiniauthor=R.+Corradettiauthor=F.+Pedata&title=Brief%2C+repeated%2C+oxygen%E2%80%93glucose+deprivation+episodes+protect+neurotransmission+from+a+longer+ischemic+episode+in+the+in+vitro+hippocampus%3A+role+of+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: Role of adenosine receptors</span></div><div class="casAuthors">Pugliese, Anna Maria; Latini, Serena; Corradetti, Renato; Pedata, Felicita</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-314</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ischemic preconditioning in the brain consists of reducing the sensitivity of neuronal tissue to further, more severe, ischemic insults.  We recorded field epsps (fepsps) extracellularly from hippocampal slices to develop a model of in vitro ischemic preconditioning and to evaluate the role of A1, A2A and A3 adenosine receptors in this phenomenon.  The application of an ischemic insult, obtained by glucose and oxygen deprivation for 7 min, produced an irreversible depression of synaptic transmission.  Ischemic preconditioning was induced by four ischemic insults (2 min each) sepd. by 13 min of normoxic conditions.  After 30 min, an ischemic insult of 7 min was applied.  This protocol substantially protected the tissue from the irreversible depression of synaptic activity.  The selective adenosine A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 100 nM), completely prevented the protective effect of preconditioning.  The selective adenosine A2A receptor antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5- ylamino]ethyl)phenol (ZM 241385, 100 nM) did not modify the magnitude of fepsp recovery compared to control slices.  The selective A3 adenosine receptor antagonists, 3-propyl-6-ethyl-5[ethyl(thio)carbonyl]-2-phenyl-4-propyl-3-pyridinecarboxylate (MRS 1523, 100 nM) significantly improved the recovery of fepsps after 7 min of ischemia.  Our results show that in vitro ischemic preconditioning allows CA1 hippocampal neurons to become resistant to prolonged exposure to ischemia.  Adenosine, by stimulating A1 receptors, plays a crucial role in eliciting the cell mechanisms underlying preconditioning; A2A receptors are not involved in this phenomenon, whereas A3 receptor activation is harmful to ischemic preconditioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC-wJjwyoc3bVg90H21EOLACvtfcHk0lhshy0leAQqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOmtr4%253D&md5=a552bfae90a6e88adf3e828f3f763934</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705442%26sid%3Dliteratum%253Aachs%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DCorradetti%26aufirst%3DR.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DBrief%252C%2520repeated%252C%2520oxygen%25E2%2580%2593glucose%2520deprivation%2520episodes%2520protect%2520neurotransmission%2520from%2520a%2520longer%2520ischemic%2520episode%2520in%2520the%2520in%2520vitro%2520hippocampus%253A%2520role%2520of%2520adenosine%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D140%26spage%3D305%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Pugliese, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Role of adenosine A<sub>3</sub> receptors on CA1 hippocampal neurotransmission during oxygen–glucose deprivation episodes of different duration</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=768-779&author=A.+M.+Puglieseauthor=E.+Coppiauthor=R.+Volpiniauthor=G.+Cristalliauthor=R.+Corradettiauthor=L.+S.+Jeongauthor=K.+A.+Jacobsonauthor=F.+Pedata&title=Role+of+adenosine+A3+receptors+on+CA1+hippocampal+neurotransmission+during+oxygen%E2%80%93glucose+deprivation+episodes+of+different+duration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DCoppi%26aufirst%3DE.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DCorradetti%26aufirst%3DR.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DRole%2520of%2520adenosine%2520A3%2520receptors%2520on%2520CA1%2520hippocampal%2520neurotransmission%2520during%2520oxygen%25E2%2580%2593glucose%2520deprivation%2520episodes%2520of%2520different%2520duration%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D768%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Hammarberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3′-kinase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=129-134&author=C.+Hammarbergauthor=B.+B.+Fredholmauthor=G.+Schulte&title=Adenosine+A3+receptor-mediated+regulation+of+p38+and+extracellular-regulated+kinase+ERK1%2F2+via+phosphatidylinositol-3%E2%80%B2-kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHammarberg%26aufirst%3DC.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DSchulte%26aufirst%3DG.%26atitle%3DAdenosine%2520A3%2520receptor-mediated%2520regulation%2520of%2520p38%2520and%2520extracellular-regulated%2520kinase%2520ERK1%252F2%2520via%2520phosphatidylinositol-3%25E2%2580%25B2-kinase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">von Arnim, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoelgen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltan, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irizarry, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9913</span><span class="NLM_x">–</span> <span class="NLM_lpage">9922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1523%2FJNEUROSCI.2290-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17005855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9913-9922&author=C.+A.+von+Arnimauthor=R.+Spoelgenauthor=I.+D.+Peltanauthor=M.+Dengauthor=S.+Courchesneauthor=M.+Kokerauthor=T.+Matsuiauthor=H.+Kowaauthor=S.+F.+Lichtenthalerauthor=M.+C.+Irizarryauthor=B.+T.+Hyman&title=GGA1+acts+as+a+spatial+switch+altering+amyloid+precursor+protein+trafficking+and+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing</span></div><div class="casAuthors">von Arnim, Christine A. F.; Spoelgen, Robert; Peltan, Ithan D.; Deng, Meihua; Courchesne, Stephanie; Koker, Mirjam; Matsui, Toshifumi; Kowa, Hisatomo; Lichtenthaler, Stefan F.; Irizarry, Michael C.; Hyman, Bradley T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9913-9922</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The β-amyloid (Aβ) precursor protein (APP) is cleaved sequentially by β-site of APP-cleaving enzyme (BACE) and γ-secretase to release the Aβ peptides that accumulate in plaques in Alzheimer's disease (AD).  GGA1, a member of the Golgi-localized γ-ear-contg. ARF-binding (GGA) protein family, interacts with BACE and influences its subcellular distribution.  We now report that overexpression of GGA1 in cells increased the APP C-terminal fragment resulting from β-cleavage but surprisingly reduced Aβ.  GGA1 confined APP to the Golgi, in which fluorescence resonance energy transfer analyses suggest that the proteins come into close proximity.  GGA1 blunted only APP but not notch intracellular domain release.  These results suggest that GGA1 prevented APP β-cleavage products from becoming substrates for γ-secretase.  Direct binding of GGA1 to BACE was not required for these effects, but the integrity of the GAT (GGA1 and TOM) domain of GGA1 was.  GGA1 may act as a specific spatial switch influencing APP trafficking and processing, so that APP-GGA1 interactions may have pathophysiol. relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuxk8L3HXCj7Vg90H21EOLACvtfcHk0ljjRIUkubi7Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnJ&md5=e78bb9c66dcb40c997347da6a12314af</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2290-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2290-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BArnim%26aufirst%3DC.%2BA.%26aulast%3DSpoelgen%26aufirst%3DR.%26aulast%3DPeltan%26aufirst%3DI.%2BD.%26aulast%3DDeng%26aufirst%3DM.%26aulast%3DCourchesne%26aufirst%3DS.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DKowa%26aufirst%3DH.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DIrizarry%26aufirst%3DM.%2BC.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DGGA1%2520acts%2520as%2520a%2520spatial%2520switch%2520altering%2520amyloid%2520precursor%2520protein%2520trafficking%2520and%2520processing%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D9913%26epage%3D9922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Zhu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewlett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Colocalization and regulated physical association of presynaptic serotonin transporters with A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=458-465&author=C.+B.+Zhuauthor=K.+M.+Lindlerauthor=N.+G.+Campbellauthor=J.+S.+Sutcliffeauthor=W.+A.+Hewlettauthor=R.+D.+Blakely&title=Colocalization+and+regulated+physical+association+of+presynaptic+serotonin+transporters+with+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BB.%26aulast%3DLindler%26aufirst%3DK.%2BM.%26aulast%3DCampbell%26aufirst%3DN.%2BG.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BS.%26aulast%3DHewlett%26aufirst%3DW.%2BA.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DColocalization%2520and%2520regulated%2520physical%2520association%2520of%2520presynaptic%2520serotonin%2520transporters%2520with%2520A3%2520adenosine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D458%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casetta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granieri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=587-598&author=K.+Varaniauthor=F.+Vincenziauthor=A.+Tosiauthor=S.+Gessiauthor=I.+Casettaauthor=G.+Granieriauthor=P.+Fazioauthor=E.+Leungauthor=S.+MacLennanauthor=E.+Granieriauthor=P.+A.+Borea&title=A2A+adenosine+receptor+overexpression+and+functionality%2C+as+well+as+TNF-alpha+levels%2C+correlate+with+motor+symptoms+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTosi%26aufirst%3DA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DCasetta%26aufirst%3DI.%26aulast%3DGranieri%26aufirst%3DG.%26aulast%3DFazio%26aufirst%3DP.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMacLennan%26aufirst%3DS.%26aulast%3DGranieri%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA2A%2520adenosine%2520receptor%2520overexpression%2520and%2520functionality%252C%2520as%2520well%2520as%2520TNF-alpha%2520levels%252C%2520correlate%2520with%2520motor%2520symptoms%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D587%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Shryock, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span> </span><span class="NLM_article-title">Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1997&pages=2-10&author=J.+C.+Shryockauthor=L.+Belardinelli&title=Adenosine+and+adenosine+receptors+in+the+cardiovascular+system%3A+biochemistry%2C+physiology%2C+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26aulast%3DBelardinelli%26aufirst%3DL.%26atitle%3DAdenosine%2520and%2520adenosine%2520receptors%2520in%2520the%2520cardiovascular%2520system%253A%2520biochemistry%252C%2520physiology%252C%2520and%2520pharmacology%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D1997%26volume%3D79%26spage%3D2%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Gardner, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadley, K. J.</span><span> </span><span class="NLM_article-title">Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in guinea-pig atria and papillary muscles</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=358-368&author=N.+M.+Gardnerauthor=L.+Yatesauthor=K.+J.+Broadley&title=Effects+of+endogenous+adenosine+and+adenosine+receptor+agonists+on+hypoxia-induced+myocardial+stunning+in+guinea-pig+atria+and+papillary+muscles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DN.%2BM.%26aulast%3DYates%26aufirst%3DL.%26aulast%3DBroadley%26aufirst%3DK.%2BJ.%26atitle%3DEffects%2520of%2520endogenous%2520adenosine%2520and%2520adenosine%2520receptor%2520agonists%2520on%2520hypoxia-induced%2520myocardial%2520stunning%2520in%2520guinea-pig%2520atria%2520and%2520papillary%2520muscles%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2004%26volume%3D43%26spage%3D358%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Zhao, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukreja, R. C.</span><span> </span><span class="NLM_article-title">Late preconditioning elicited by activation of adenosine A<sub>3</sub> receptor in heart: role of NF-kappa B, iNOS and mitochondrial K(ATP) channel</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1006%2Fjmcc.2001.1510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11945020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1yht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=263-277&author=T.+C.+Zhaoauthor=R.+C.+Kukreja&title=Late+preconditioning+elicited+by+activation+of+adenosine+A3+receptor+in+heart%3A+role+of+NF-kappa+B%2C+iNOS+and+mitochondrial+K%28ATP%29+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Late Preconditioning Elicited by Activation of Adenosine A3 Receptor in Heart: Role of NF-κB, iNOS and Mitochondrial KATP Channel</span></div><div class="casAuthors">Zhao, Ting C.; Kukreja, Rakesh C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-277</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Activation of adenosine A3 receptor (A3AR) protects against ischemia/reperfusion injury in the heart.  However, the downstream signaling mechanisms leading to its delayed anti-ischemic effects remain unclear.  The authors hypothesized that A3AR stimulation protects the heart via activation of nuclear transcription factor κ B (NF-κB) and synthesis of inducible nitric oxide synthase (iNOS).  Mice were treated with selective A3AR agonist, N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA).  Twenty-four h later, hearts were perfused in Langendorff mode and subjected to 30 min of global ischemia and 30 min of reperfusion.  IB-MECA caused post-ischemic redn. in necrosis and improvement in myocardial performance which was abolished by A3AR antagonist, MRS1191.  Electrophoretic mobility shift assay demonstrated increased NF-κB binding in nuclear exts. following A3AR stimulation, which was diminished by MRS1191 and NF-κB inhibitor, pyrrolidinediethyldithiocarbamate (PDTC).  The cardioprotection was abrogated by PDTC and targeted ablation of p50 subunit of NF-κB in mice.  The inhibition of iNOS with S-methylisothiourea and targeted disruption of the iNOS gene also abolished the protective effect of A3AR stimulation.  Expression of iNOS mRNA and NO prodn. were enhanced after 6 and 24 h resp. of IB-MECA treatment.  MRS1191 and PDTC blocked IB-MECA induced NO prodn. after A3AR stimulation.  MitoKATP channel blocker, 5-hydroxydecanoate abolished the protective effect of A3AR.  For the first time, the authors have provided direct evidence of an essential role of NF-κB activation and iNOS in A3AR-induced late preconditioning.  Selective activation of A3AR with IB-MECA can be used to trigger long-lasting ischemic protection in the heart.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ7K3bjiY_x7Vg90H21EOLACvtfcHk0ljjRIUkubi7Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1yht7Y%253D&md5=10f350aeeec0aa6800ddd39b22a2eba0</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2001.1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2001.1510%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DT.%2BC.%26aulast%3DKukreja%26aufirst%3DR.%2BC.%26atitle%3DLate%2520preconditioning%2520elicited%2520by%2520activation%2520of%2520adenosine%2520A3%2520receptor%2520in%2520heart%253A%2520role%2520of%2520NF-kappa%2520B%252C%2520iNOS%2520and%2520mitochondrial%2520K%2528ATP%2529%2520channel%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2002%26volume%3D34%26spage%3D263%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Talukder, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S. J.</span><span> </span><span class="NLM_article-title">Targeted deletion of adenosine A<sub>3</sub> receptors augments adenosine-induced coronary flow in isolated mouse heart</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">H2183</span><span class="NLM_x">–</span> <span class="NLM_lpage">H2189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2002&pages=H2183-H2189&author=M.+A.+Talukderauthor=R.+R.+Morrisonauthor=M.+A.+Jacobsonauthor=K.+A.+Jacobsonauthor=C.+Ledentauthor=S.+J.+Mustafa&title=Targeted+deletion+of+adenosine+A3+receptors+augments+adenosine-induced+coronary+flow+in+isolated+mouse+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalukder%26aufirst%3DM.%2BA.%26aulast%3DMorrison%26aufirst%3DR.%2BR.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DMustafa%26aufirst%3DS.%2BJ.%26atitle%3DTargeted%2520deletion%2520of%2520adenosine%2520A3%2520receptors%2520augments%2520adenosine-induced%2520coronary%2520flow%2520in%2520isolated%2520mouse%2520heart%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D282%26spage%3DH2183%26epage%3DH2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Maddock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocanu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellon, D. M.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> receptor activation protects the myocardium from reperfusion/reoxygenation injury</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">H1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">H1313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2002&pages=H1307-H1313&author=H.+L.+Maddockauthor=M.+M.+Mocanuauthor=D.+M.+Yellon&title=Adenosine+A3+receptor+activation+protects+the+myocardium+from+reperfusion%2Freoxygenation+injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaddock%26aufirst%3DH.%2BL.%26aulast%3DMocanu%26aufirst%3DM.%2BM.%26aulast%3DYellon%26aufirst%3DD.%2BM.%26atitle%3DAdenosine%2520A3%2520receptor%2520activation%2520protects%2520the%2520myocardium%2520from%2520reperfusion%252Freoxygenation%2520injury%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D283%26spage%3DH1307%26epage%3DH1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Zhai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciarretta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeotti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadoshima, J.</span><span> </span><span class="NLM_article-title">Differential roles of GSK-3beta during myocardial ischemia and ischemia/reperfusion</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2011&pages=502-511&author=P.+Zhaiauthor=S.+Sciarrettaauthor=J.+Galeottiauthor=M.+Volpeauthor=J.+Sadoshima&title=Differential+roles+of+GSK-3beta+during+myocardial+ischemia+and+ischemia%2Freperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhai%26aufirst%3DP.%26aulast%3DSciarretta%26aufirst%3DS.%26aulast%3DGaleotti%26aufirst%3DJ.%26aulast%3DVolpe%26aufirst%3DM.%26aulast%3DSadoshima%26aufirst%3DJ.%26atitle%3DDifferential%2520roles%2520of%2520GSK-3beta%2520during%2520myocardial%2520ischemia%2520and%2520ischemia%252Freperfusion%26jtitle%3DCirc.%2520Res.%26date%3D2011%26volume%3D109%26spage%3D502%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Maddock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadley, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bril, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandoudi, N.</span><span> </span><span class="NLM_article-title">Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1211%2F0022357021779041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12079003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2hur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=859-867&author=H.+L.+Maddockauthor=K.+J.+Broadleyauthor=A.+Brilauthor=N.+Khandoudi&title=Effects+of+adenosine+receptor+agonists+on+guinea-pig+isolated+working+hearts+and+the+role+of+endothelium+and+NO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO</span></div><div class="casAuthors">Maddock, Helen L.; Broadley, Kenneth J.; Bril, Antoine; Khandoudi, Nassirah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">859-867</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">The hypothesis that the coronary vasodilator effects of adenosine receptor agonists are independent of the vascular endothelium or mediators derived therefrom was examd. in guinea-pig isolated working hearts.  Adenosine receptor agonists, 5'-(N-ethylcarboxamido)-adenosine (NECA; two-fold selective for A2 over A1 receptors), 2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680; A2A selective), N6-cyclopentyl-adenosine (CPA; A1 selective) and N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA; A3 selective), were infused (3×10-7 M) after endothelium removal by passing oxygen through the coronary circulation.  In spontaneously beating hearts, CGS21680 and NECA increased, while CPA decreased, coronary flow.  NECA and CPA reduced heart rate, left ventricular pressure and aortic output.  The nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine (L-NOARG; 3×10-5 M) abolished the vasodilatation by NECA but not CGS21680, indicating that nitric oxide (NO) of a non-endothelial source mediated the NECA response.  Coronary vasodilatation by CGS21680 was inhibited by the A2A receptor antagonist, 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM241385).  Indometacin (10-6 M) attenuated the coronary vasodilatation to CGS21680, suggesting a partial role for cyclooxygenase products.  IB-MECA had no effect, indicating no A3 receptor involvement.  In paced working hearts, the responses were similar except CPA had no effect on coronary flow or aortic output and CGS21680 increased left ventricular pressure and the max. rate of ventricular pressure rise.  This study has demonstrated functionally effective removal of the endothelium by a novel method of passing oxygen through the coronary vasculature.  A coronary vasodilator action of adenosine receptor agonists mediated via A2A receptors is endothelium- and NO-independent, but partially involves cyclooxygenase products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2b_uZbbVhrVg90H21EOLACvtfcHk0lhT24WSlnk45Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2hur0%253D&md5=f5f5b9e55b17f080267b1494b86328f5</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1211%2F0022357021779041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357021779041%26sid%3Dliteratum%253Aachs%26aulast%3DMaddock%26aufirst%3DH.%2BL.%26aulast%3DBroadley%26aufirst%3DK.%2BJ.%26aulast%3DBril%26aufirst%3DA.%26aulast%3DKhandoudi%26aufirst%3DN.%26atitle%3DEffects%2520of%2520adenosine%2520receptor%2520agonists%2520on%2520guinea-pig%2520isolated%2520working%2520hearts%2520and%2520the%2520role%2520of%2520endothelium%2520and%2520NO%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2002%26volume%3D54%26spage%3D859%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Tilley, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagoner, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span> </span><span class="NLM_article-title">Adenosine and inosine increase cutaneous vasopermeability by activating A<sub>3</sub> receptors on mast cells</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=361-367&author=S.+L.+Tilleyauthor=V.+A.+Wagonerauthor=C.+A.+Salvatoreauthor=M.+A.+Jacobsonauthor=B.+H.+Koller&title=Adenosine+and+inosine+increase+cutaneous+vasopermeability+by+activating+A3+receptors+on+mast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DWagoner%26aufirst%3DV.%2BA.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26atitle%3DAdenosine%2520and%2520inosine%2520increase%2520cutaneous%2520vasopermeability%2520by%2520activating%2520A3%2520receptors%2520on%2520mast%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D361%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simioni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=395-406&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=C.+Simioniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=Caffeine+inhibits+adenosine-induced+accumulation+of+hypoxia-inducible+factor-1alpha%2C+vascular+endothelial+growth+factor%2C+and+interleukin-8+expression+in+hypoxic+human+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DSimioni%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DCaffeine%2520inhibits%2520adenosine-induced%2520accumulation%2520of%2520hypoxia-inducible%2520factor-1alpha%252C%2520vascular%2520endothelial%2520growth%2520factor%252C%2520and%2520interleukin-8%2520expression%2520in%2520hypoxic%2520human%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D395%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Blaisdell, F. W.</span><span> </span><span class="NLM_article-title">The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review</span> <span class="citation_source-journal">Cardiovasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0967-2109%2802%2900070-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12453699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD38npt1agsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=620-630&author=F.+W.+Blaisdell&title=The+pathophysiology+of+skeletal+muscle+ischemia+and+the+reperfusion+syndrome%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review</span></div><div class="casAuthors">Blaisdell F William</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular surgery (London, England)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-30</span>
        ISSN:<span class="NLM_cas:issn">0967-2109</span>.
    </div><div class="casAbstract">There are two components to the reperfusion syndrome, which follows extremity ischemia.  The local response, which follows reperfusion, consists of limb swelling with its potential for aggravating tissue injury and the systemic response, which results in multiple organ failure and death.  It is apparent that skeletal muscle is the predominant tissue in the limb but also the tissue that is most vulnerable to ischemia.  Physiological and anatomical studies show that irreversible muscle cell damage starts after 3 h of ischemia and is nearly complete at 6 h.  These muscle changes are paralleled by progressive microvascular damage.  Microvascular changes appear to follow rather than precede skeletal muscle damage as the tolerance of capillaries to ischemia vary with the tissue being reperfused.  The more severe the cellular damage the greater the microvascular changes and with death of tissue microvascular flow ceases within a few hours-the no reflow phenomenon.  At this point tissue swelling ceases.  The inflammatory responses following reperfusion varies greatly.  When muscle tissue death is uniform, as would follow tourniquet ischemia or limb replantation, little inflammatory response results.  In most instances of reperfusion, which follows thrombotic or embolic occlusion, there will be a variable degree of ischemic damage in the zone where collateral blood flow is possible.  The extent of this region will determine the magnitude of the inflammatory response, whether local or systemic.  Only in this region will therapy be of any benefit, whether fasciotomy to prevent pressure occlusion of the microcirculation, or anticoagulation to prevent further microvascular thrombosis.  Since many of the inflammatory mediators are generated by the act of clotting, anticoagulation will have additional benefit by decreasing the inflammatory response.  In instances in which the process involves the bulk of the lower extremity, amputation rather than attempts at revascularization may be the most prudent course to prevent the toxic product in the ischemic limb from entering the systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVCoETDdEvYbP3FVUi_gf8fW6udTcc2eY2UQU4yAfBvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38npt1agsA%253D%253D&md5=8a201f37f276cf60ecf954e3729ee2a4</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0967-2109%2802%2900070-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0967-2109%252802%252900070-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlaisdell%26aufirst%3DF.%2BW.%26atitle%3DThe%2520pathophysiology%2520of%2520skeletal%2520muscle%2520ischemia%2520and%2520the%2520reperfusion%2520syndrome%253A%2520a%2520review%26jtitle%3DCardiovasc.%2520Surg.%26date%3D2002%26volume%3D10%26spage%3D620%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Lusis, A. J.</span><span> </span><span class="NLM_article-title">Atherosclerosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2F35025203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11001066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=233-241&author=A.+J.+Lusis&title=Atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Atherosclerosis</span></div><div class="casAuthors">Lusis, Aldons J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">233-241</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 72 refs.  Atherosclerosis, a disease of the large arteries, is the primary cause of heart disease and stroke.  In Westernized societies, it is the underlying cause of about 50% of all deaths.  Epidemiol. studies have revealed several important environmental and genetic risk factors assocd. with atherosclerosis.  Progress in defining the cellular and mol. interactions involved, however, has been hindered by the disease's etiol. complexity.  Over the past decade, the availability of new investigative tools, including genetically modified mouse models of disease, has resulted in a clearer understanding of the mol. mechanisms that connect altered cholesterol metab. and other risk factors to the development of atherosclerotic plaque.  It is now clear that atherosclerosis is not simply an inevitable degenerative consequence of aging, but rather a chronic inflammatory condition that can be converted into an acute clin. event by plaque rupture and thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAqrsjtqIWmLVg90H21EOLACvtfcHk0ljAjVyLvqLb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSlsrk%253D&md5=b0484eda002d326a1f2678e7e295b737</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2F35025203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025203%26sid%3Dliteratum%253Aachs%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26atitle%3DAtherosclerosis%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D233%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1161%2FATVBAHA.109.194902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19834107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFensbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=90-97&author=S.+Gessiauthor=E.+Fogliauthor=V.+Sacchettoauthor=S.+Merighiauthor=K.+Varaniauthor=D.+Pretiauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=Adenosine+modulates+HIF-1%7Balpha%7D%2C+VEGF%2C+IL-8%2C+and+foam+cell+formation+in+a+human+model+of+hypoxic+foam+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Modulates HIF-1α, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells</span></div><div class="casAuthors">Gessi, Stefania; Fogli, Eleonora; Sacchetto, Valeria; Merighi, Stefania; Varani, Katia; Preti, Delia; Leung, Edward; MacLennan, Stephen; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-97</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Foam cell (FC) formation by oxidized low-d. lipoprotein (oxLDL) accumulation in macrophages is crucial for development of atherosclerosis.  Hypoxia was demonstrated in atherosclerosis and hypoxia-inducible factor-1 (HIF-1) was shown to promote intraplaque angiogenesis and FC development.  As hypoxia induces HIF-1α stabilization and adenosine (ado) accumulation, we investigated whether this nucleoside regulates HIF-1α in FCs.  Ado, under hypoxia, stimulates HIF-1α accumulation by activating all adenosine receptors (ARs).  HIF-1α modulation involved extracellular signal-regulated kinase 1/2 (ERK 1/2), p38 mitogen-activated protein kinase (p38 MAPK), and protein kinase B (Akt) phosphorylation in the case of A1, A2A, A2B, and ERK 1/2 phosphorylation in the case of A3 receptors.  Ado, through the activation of A3 and A2B receptors, stimulates vascular endothelial growth factor (VEGF) secretion in a HIF-1α-dependent way.  Furthermore, ado, through the A2B subtype, induces an increase of Interleukin-8 (IL-8) secretion in a ERK 1/2, p38, and Akt kinase-dependent but not HIF-1α-mediated way.  Finally, ado stimulates FC formation, and this effect is strongly reduced by A3 and A2B blockers and by HIF-1α silencing.  This study provides the 1st evidence that A3, A2B, or mixed A3/A2B antagonists may be useful to block important steps in the atherosclerotic plaque development ado-induced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyeXTmBu7HTLVg90H21EOLACvtfcHk0ljAjVyLvqLb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFensbbL&md5=600257df25d93873b67d2046c57e8f9b</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.194902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.194902%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DFogli%26aufirst%3DE.%26aulast%3DSacchetto%26aufirst%3DV.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520modulates%2520HIF-1%257Balpha%257D%252C%2520VEGF%252C%2520IL-8%252C%2520and%2520foam%2520cell%2520formation%2520in%2520a%2520human%2520model%2520of%2520hypoxic%2520foam%2520cells%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D90%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">van der Hoeven, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span> </span><span class="NLM_article-title">Activation of the A<sub>3</sub> adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=685-696&author=D.+van+der+Hoevenauthor=T.+C.+Wanauthor=J.+A.+Auchampach&title=Activation+of+the+A3+adenosine+receptor+suppresses+superoxide+production+and+chemotaxis+of+mouse+bone+marrow+neutrophils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BHoeven%26aufirst%3DD.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26atitle%3DActivation%2520of%2520the%2520A3%2520adenosine%2520receptor%2520suppresses%2520superoxide%2520production%2520and%2520chemotaxis%2520of%2520mouse%2520bone%2520marrow%2520neutrophils%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D685%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=76-82&author=Z.+Gaoauthor=B.+S.+Liauthor=Y.+J.+Dayauthor=J.+Linden&title=A3+adenosine+receptor+activation+triggers+phosphorylation+of+protein+kinase+B+and+protects+rat+basophilic+leukemia+2H3+mast+cells+from+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%2BS.%26aulast%3DDay%26aufirst%3DY.%2BJ.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520triggers%2520phosphorylation%2520of%2520protein%2520kinase%2520B%2520and%2520protects%2520rat%2520basophilic%2520leukemia%25202H3%2520mast%2520cells%2520from%2520apoptosis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D76%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latour, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Disruption of the A<sub>3</sub> adenosine receptor gene in mice and its effect on stimulated inflammatory cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1074%2Fjbc.275.6.4429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=10660615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=4429-4434&author=C.+A.+Salvatoreauthor=S.+L.+Tilleyauthor=A.+M.+Latourauthor=D.+S.+Fletcherauthor=B.+H.+Kollerauthor=M.+A.+Jacobson&title=Disruption+of+the+A3+adenosine+receptor+gene+in+mice+and+its+effect+on+stimulated+inflammatory+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the A3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells</span></div><div class="casAuthors">Salvatore, Christopher A.; Tilley, Stephen L.; Latour, Anne M.; Fletcher, Daniel S.; Koller, Beverly H.; Jacobson, Marlene A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4429-4434</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The A3 adenosine receptor (A3AR) is one of four receptor subtypes for adenosine and is expressed in a broad spectrum of tissues.  In order to study the function of A3AR, a mouse line carrying a mutant A3 allele was generated.  Mice homozygous for targeted disruption of the A3AR gene, A3AR-/-, are fertile and visually and histol. indistinguishable from wild type mice.  The lack of a functional receptor in the A3AR-/- mice was confirmed by mol. and pharmacol. analyses.  The absence of A3AR protein expression in the A3AR-/- mice was demonstrated by lack of N6-(4-amino-3-[125I]iodobenzyl)adenosine binding to bone marrow-derived mast cell membranes that were found to express high levels of A3AR in wild type mice.  In A3AR-/- mice, the d. of A1 and A2A adenosine receptor subtypes was the same as in A3AR+/+ mice as detd. by radioligand binding to brain membranes.  Addnl., A2B receptor transcript expression was not affected by ablation of the A3AR gene.  A3AR-/- mice have basal heart rates and arterial blood pressures indistinguishable from A3AR+/+ mice.  Functionally, in contrast to wild type mice, adenosine and the A3AR-specific agonist, 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide (2-Cl-IB-MECA), elicit no potentiation of antigen-dependent degranulation of bone marrow-derived mast cells from A3AR-/- mice as measured by hexosaminidase release.  Also, the ability of 2Cl-IB-MECA to inhibit lipopolysaccharide-induced tumor necrosis factor-α prodn. in vivo was decreased in A3AR-/- mice in comparison to A3AR+/+ mice.  The A2A adenosine receptor agonist, 2-p-((2-carboxyethyl)phenylamino)-5'-N-ethylcarboxamidoadenosine, produced inhibition of lipopolysaccharide-stimulated tumor necrosis factor-α prodn. in both A3AR-/- and A3AR+/+ mice.  These results show that the inhibition in vivo can be mediated by multiple subtypes, specifically the A3 and A2A adenosine receptors, and A3AR activation plays an important role in both pro- and anti-inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBq9Cr_xCk7Vg90H21EOLACvtfcHk0ljn7kUI3QvbyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12nsr4%253D&md5=9ec8c0ab7f724af692ab2b4f132557bc</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.6.4429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.6.4429%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DLatour%26aufirst%3DA.%2BM.%26aulast%3DFletcher%26aufirst%3DD.%2BS.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDisruption%2520of%2520the%2520A3%2520adenosine%2520receptor%2520gene%2520in%2520mice%2520and%2520its%2520effect%2520on%2520stimulated%2520inflammatory%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D4429%26epage%3D4434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Zhong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlykov, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, M. R.</span><span> </span><span class="NLM_article-title">Activation of murine lung mast cells by the adenosine A<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2003&pages=338-345&author=H.+Zhongauthor=S.+G.+Shlykovauthor=J.+G.+Molinaauthor=B.+M.+Sanbornauthor=M.+A.+Jacobsonauthor=S.+L.+Tilleyauthor=M.+R.+Blackburn&title=Activation+of+murine+lung+mast+cells+by+the+adenosine+A3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DShlykov%26aufirst%3DS.%2BG.%26aulast%3DMolina%26aufirst%3DJ.%2BG.%26aulast%3DSanborn%26aufirst%3DB.%2BM.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DTilley%26aufirst%3DS.%2BL.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26atitle%3DActivation%2520of%2520murine%2520lung%2520mast%2520cells%2520by%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D171%26spage%3D338%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Young, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, M. R.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=1380-1389&author=H.+W.+Youngauthor=J.+G.+Molinaauthor=D.+Diminaauthor=H.+Zhongauthor=M.+Jacobsonauthor=L.+N.+Chanauthor=T.+S.+Chanauthor=J.+J.+Leeauthor=M.+R.+Blackburn&title=A3+adenosine+receptor+signaling+contributes+to+airway+inflammation+and+mucus+production+in+adenosine+deaminase-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DH.%2BW.%26aulast%3DMolina%26aufirst%3DJ.%2BG.%26aulast%3DDimina%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DL.%2BN.%26aulast%3DChan%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26atitle%3DA3%2520adenosine%2520receptor%2520signaling%2520contributes%2520to%2520airway%2520inflammation%2520and%2520mucus%2520production%2520in%2520adenosine%2520deaminase-deficient%2520mice%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D1380%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Morschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volmer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohsenin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kheradmand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, M. R.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor signaling influences pulmonary inflammation and fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1165%2Frcmb.2007-0419OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18587054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1cjivVyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=697-705&author=E.+Morschlauthor=J.+G.+Molinaauthor=J.+B.+Volmerauthor=A.+Mohseninauthor=R.+S.+Peroauthor=J.+S.+Hongauthor=F.+Kheradmandauthor=J.+J.+Leeauthor=M.+R.+Blackburn&title=A3+adenosine+receptor+signaling+influences+pulmonary+inflammation+and+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis</span></div><div class="casAuthors">Morschl Eva; Molina Jose G; Volmer Jonathan B; Mohsenin Amir; Pero Ralph S; Hong Jeong-Soo; Kheradmand Farrah; Lee James J; Blackburn Michael R</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory cell and molecular biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">697-705</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adenosine is a signaling molecule produced during conditions that cause cellular stress or damage.  This signaling pathway is implicated in the regulation of pulmonary disorders through the selective engagement of adenosine receptors.  The goal of this study was to examine the involvement of the A(3) adenosine receptor (A(3)R) in a bleomycin model of pulmonary inflammation and fibrosis.  Results demonstrated that A(3)R-deficient mice exhibit enhanced pulmonary inflammation that included an increase in eosinophils.  Accordingly, there was a selective up-regulation of eosinophil-related chemokines and cytokines in the lungs of A(3)R-deficient mice exposed to bleomycin.  This increase in eosinophil numbers was accompanied by a decrease in the amount of extracellular eosinophil peroxidase activity in lavage fluid from A(3)R-deficient mice exposed to bleomycin, an observation suggesting that the A(3)R is necessary for eosinophil degranulation in this model.  Despite an increase in inflammatory metrics associated with A(3)R-deficient mice treated with bleomycin, there was little difference in the degree of pulmonary fibrosis.  Examination of fibrotic mediators demonstrated enhanced transforming growth factor (TGF)-beta1 expression, but not a concomitant increase in TGF-beta1 activity.  This was associated with the loss of expression of matrix metalloprotease 9, an activator of TGF-beta1, in alveolar macrophages and airway mast cells in the lungs of A(3)R-deficient mice.  Together, these results suggest that the A(3)R serves antiinflammatory functions in the bleomycin model, and is also involved in regulating the production of mediators that can impact fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlrd0OmnFWJIhLSh9fo81bfW6udTcc2eYAcZznFJKY87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjivVyjtw%253D%253D&md5=370062d095bda3317b9bd7dbc905ed9d</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2007-0419OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2007-0419OC%26sid%3Dliteratum%253Aachs%26aulast%3DMorschl%26aufirst%3DE.%26aulast%3DMolina%26aufirst%3DJ.%2BG.%26aulast%3DVolmer%26aufirst%3DJ.%2BB.%26aulast%3DMohsenin%26aufirst%3DA.%26aulast%3DPero%26aufirst%3DR.%2BS.%26aulast%3DHong%26aufirst%3DJ.%2BS.%26aulast%3DKheradmand%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26atitle%3DA3%2520adenosine%2520receptor%2520signaling%2520influences%2520pulmonary%2520inflammation%2520and%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2008%26volume%3D39%26spage%3D697%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Reeves, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butchers, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, M. J.</span><span> </span><span class="NLM_article-title">Studies on the effects of adenosine A<sub>3</sub> receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2Fs000110050644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11211916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslGmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=666-672&author=J.+J.+Reevesauthor=C.+A.+Harrisauthor=B.+P.+Hayesauthor=P.+R.+Butchersauthor=M.+J.+Sheehan&title=Studies+on+the+effects+of+adenosine+A3+receptor+stimulation+on+human+eosinophils+isolated+from+non-asthmatic+or+asthmatic+donors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the effects of adenosine A3 receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors</span></div><div class="casAuthors">Reeves, J. J.; Harris, C. A.; Hayes, B. P.; Butchers, P. R.; Sheehan, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">666-672</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Objective: This study was designed to demonstrate the presence of adenosine A3 receptors on human peripheral blood eosinophils, and to investigate the effect of A3 receptor stimulation on eosinophil function.  Material: Eosinophils from either non-asthmatic or asthmatic donors.  Methods: Eosinophils were isolated from peripheral venous blood by discontinuous gradient centrifugation and neg. immunoselection.  Receptor localisation was investigated by immunoblotting and by immunocytochem. using a novel antibody specific for the human A3 receptor.  Two pharmacol. responses were studied: elevation of intracellular calcium in single eosinophils, measured by microfluorimetry, and hydrogen peroxide generation in cell suspensions.  Results: The expression of A3 receptors by eosinophils was confirmed using the selective antibody.  Addn. of the A3 receptor selective agonist, IB-MECA (100 nM), produced increases in intracellular calcium in less than 10% of the eosinophils isolated from non-asthmatic donors.  These responses were only partially attenuated with the A3 receptor antagonist, I-ABOPX.  IB-MECA (0.001 - 1000 nM) did not stimulate hydrogen peroxide (H2O2) generation, nor did it enhance fMLP- or C5a-stimulated generation of H2O2.  In fact high concns. of IB-MECA inhibited the generation of H2O2 (when stimulated by fMLP or C5a), an effect probably mediated by A2 receptors.  Similar results were obtained using eosinophils from asthmatic donors.  Conclusions: Stimulation of adenosine A3 receptors does not appear to be a prime mechanism for free radical generation by human peripheral blood eosinophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-iVS_QUrRrVg90H21EOLACvtfcHk0ljn7kUI3QvbyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslGmt7k%253D&md5=f0682082ffb4e0169d135a420ea8c783</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1007%2Fs000110050644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000110050644%26sid%3Dliteratum%253Aachs%26aulast%3DReeves%26aufirst%3DJ.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BA.%26aulast%3DHayes%26aufirst%3DB.%2BP.%26aulast%3DButchers%26aufirst%3DP.%2BR.%26aulast%3DSheehan%26aufirst%3DM.%2BJ.%26atitle%3DStudies%2520on%2520the%2520effects%2520of%2520adenosine%2520A3%2520receptor%2520stimulation%2520on%2520human%2520eosinophils%2520isolated%2520from%2520non-asthmatic%2520or%2520asthmatic%2520donors%26jtitle%3DInflammation%2520Res.%26date%3D2000%26volume%3D49%26spage%3D666%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Kay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. S.</span><span> </span><span class="NLM_article-title">A role for eosinophils in airway remodelling in asthma</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.it.2004.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15324740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFWmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=477-482&author=A.+B.+Kayauthor=S.+Phippsauthor=D.+S.+Robinson&title=A+role+for+eosinophils+in+airway+remodelling+in+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">A role for eosinophils in airway remodelling in asthma</span></div><div class="casAuthors">Kay, A. Barry; Phipps, Simon; Robinson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the years, the role of the eosinophil in asthma and allergic processes has been disputed.  Recent human expts. using a humanized monoclonal antibody to interleukin-5 (IL-5), and animal studies involving specific IL-5 gene deletion, indicates that eosinophils might control downstream repair and remodelling processes.  Eosinophils are a rich source of fibrogenic factors, particularly transforming growth factor-β (TGF-β), the latent form of which is activated by epithelial-cell expression of the integrin αvβ6.  The emerging role for the eosinophil in airway remodelling might be important in future anti-asthma strategies.  However, more effective eosinophil-depleting agents than anti-IL-5 are required before the definitive role of this cell type in asthma airway pathophysiol. can be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogri2K-7lQrrVg90H21EOLACvtfcHk0lj9WAtnKfd3dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFWmu70%253D&md5=ca49cd95134e9b00d3e2c34f73f2d6ae</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2004.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2004.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DKay%26aufirst%3DA.%2BB.%26aulast%3DPhipps%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%2BS.%26atitle%3DA%2520role%2520for%2520eosinophils%2520in%2520airway%2520remodelling%2520in%2520asthma%26jtitle%3DTrends%2520Immunol.%26date%3D2004%26volume%3D25%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casolari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1164%2Frccm.200506-869OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16322645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=398-406&author=K.+Varaniauthor=G.+Caramoriauthor=F.+Vincenziauthor=I.+Adcockauthor=P.+Casolariauthor=E.+Leungauthor=S.+Maclennanauthor=S.+Gessiauthor=S.+Morelloauthor=P.+J.+Barnesauthor=K.+Itoauthor=K.+F.+Chungauthor=G.+Cavallescoauthor=G.+Azzenaauthor=A.+Papiauthor=P.+A.+Borea&title=Alteration+of+adenosine+receptors+in+patients+with+chronic+obstructive+pulmonary+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease</span></div><div class="casAuthors">Varani, Katia; Caramori, Gaetano; Vincenzi, Fabrizio; Adcock, Ian; Casolari, Paolo; Leung, Edward; MacLennan, Stephen; Gessi, Stefania; Morello, Silvania; Barnes, Peter J.; Ito, Kazuhiro; Chung, Kian Fan; Cavallesco, Giorgio; Azzena, Gianfranco; Papi, Alberto; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">398-406</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of mortality worldwide.  Adenosine is an inflammatory regulator that acts through four distinct receptors to mediate pro- and antiinflammatory effects.  Objectives: The primary aim of this study was to investigate the expression, affinity, and d. of adenosine receptors in peripheral lung parenchyma from age-matched smokers with COPD (n = 14) and smokers with normal lung function (control group; n = 20).  Methods: Adenosine receptors were analyzed by immunohistochem. and satn. binding assays using typical antagonist radioligands.  Results: A1, A2A, A2B, and A3 receptors were expressed in different cells in peripheral lung parenchyma.  The affinity of A1, A2A, and A3 receptors was significantly decreased in patients with COPD compared with the control group (KD[A1] = 3.15 ± 0.19 vs. 1.70 ± 0.14 nM; KD[A2A] = 7.88 ± 0.68 vs. 1.87 ± 0.09 nM; KD[A3] = 9.34 ± 0.27 vs. 4.41 ± 0.25 nM; p < 0.01), whereas their d. was increased (Bmax[A1] = 53 ± 4 vs. 32 ± 3 fmol/mg protein; Bmax[A2A] = 852 ± 50 vs. 302 ± 12 fmol/mg protein; Bmax[A3] = 2,078 ± 108 vs. 770 ± 34 fmol/mg protein; p < 0.01).  The affinity of A2B receptors was not altered, but the d. was significantly decreased in patients with COPD compared with the control group (Bmax = 66 ± 5 vs. 189 ± 16 fmol/mg protein; p < 0.01).  A significant correlation was found between the affinity and d. of the adenosine receptors and the FEV1/FVC ratio.  Conclusions: This is the first report showing the presence of adenosine receptors in lung parenchyma in subjects with COPD compared with control smokers.  These novel findings strengthen the hypothesis of a potential role played by adenosine receptors in the pathogenesis of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBVPEVprddDbVg90H21EOLACvtfcHk0lj9WAtnKfd3dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSlu78%253D&md5=0c6087812da1f8adad7ac5e9ac9defee</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1164%2Frccm.200506-869OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200506-869OC%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DCaramori%26aufirst%3DG.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DAdcock%26aufirst%3DI.%26aulast%3DCasolari%26aufirst%3DP.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMorello%26aufirst%3DS.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DChung%26aufirst%3DK.%2BF.%26aulast%3DCavallesco%26aufirst%3DG.%26aulast%3DAzzena%26aufirst%3DG.%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAlteration%2520of%2520adenosine%2520receptors%2520in%2520patients%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D398%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">The role of adenosine receptors in rheumatoid arthritis</span> <span class="citation_source-journal">Autoimmun. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.autrev.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20691813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGitrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=61-64&author=K.+Varaniauthor=M.+Padovanauthor=M.+Govoniauthor=F.+Vincenziauthor=F.+Trottaauthor=P.+A.+Borea&title=The+role+of+adenosine+receptors+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The role of adenosine receptors in rheumatoid arthritis</span></div><div class="casAuthors">Varani, Katia; Padovan, Melissa; Govoni, Marcello; Vincenzi, Fabrizio; Trotta, Francesco; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Autoimmunity Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">ARUEBU</span>;
        ISSN:<span class="NLM_cas:issn">1568-9972</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA), is the most common inflammatory musculoskeletal disease inducing diminished quality-of-life in the affected individuals and having major impact on society due to decrease work ability.  Early diagnosis and immediate, effective therapy are crucial in order to prevent unfavorable outcome.  Treatment of RA has progressed during the past two decades thanks to the advent of a large no. of new agents targeting different specific mols. and pathways involved in the modulation of the inflammation.  In this scenario an important role is covered by adenosine, a purine nucleoside released from a variety of cells in response to metabolic and inflammatory stress, which is considered to be a potent endogenous regulator acting through its interaction with 4 cell surface receptors named as A1, A2A, A2B and A3.  Adenosine receptor stimulation has complex effects on the release of pro-inflammatory cytokines depending on selective receptor engagement.  Recent data show the involvement of adenosine pathways in RA and its potential therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTwfn8Nqugi7Vg90H21EOLACvtfcHk0lj9WAtnKfd3dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGitrvJ&md5=094c178f1225b285f9ce2873ae859c8a</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.autrev.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autrev.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DPadovan%26aufirst%3DM.%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DThe%2520role%2520of%2520adenosine%2520receptors%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAutoimmun.%2520Rev.%26date%3D2010%26volume%3D10%26spage%3D61%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The anti-inflammatory effect of A<sub>3</sub> adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1613</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=1601-1613&author=S.+Bar-Yehudaauthor=M.+H.+Silvermanauthor=W.+D.+Kernsauthor=A.+Ochaionauthor=S.+Cohenauthor=P.+Fishman&title=The+anti-inflammatory+effect+of+A3+adenosine+receptor+agonists%3A+a+novel+targeted+therapy+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DKerns%26aufirst%3DW.%2BD.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520anti-inflammatory%2520effect%2520of%2520A3%2520adenosine%2520receptor%2520agonists%253A%2520a%2520novel%2520targeted%2520therapy%2520for%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D1601%26epage%3D1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markovits, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozenbaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mader, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adawi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tishler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langevitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman-Furman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farbstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yehuda, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Clinical evidence for utilization of the A<sub>3</sub> adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18050382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslyltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=41-48&author=M.+H.+Silvermanauthor=V.+Strandauthor=D.+Markovitsauthor=M.+Nahirauthor=T.+Reitblatauthor=Y.+Moladauthor=I.+Rosnerauthor=M.+Rozenbaumauthor=R.+Maderauthor=M.+Adawiauthor=D.+Caspiauthor=M.+Tishlerauthor=P.+Langevitzauthor=A.+Rubinowauthor=J.+Friedmanauthor=L.+Greenauthor=A.+Tanayauthor=A.+Ochaionauthor=S.+Cohenauthor=W.+D.+Kernsauthor=I.+Cohnauthor=S.+Fishman-Furmanauthor=M.+Farbsteinauthor=S.+B.+Yehudaauthor=P.+Fishman&title=Clinical+evidence+for+utilization+of+the+A3+adenosine+receptor+as+a+target+to+treat+rheumatoid+arthritis%3A+data+from+a+phase+II+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial</span></div><div class="casAuthors">Silverman, Michael H.; Strand, Vibeke; Markovits, Doron; Nahir, Menachem; Reitblat, Tatiana; Molad, Yair; Rosner, Itzhak; Rozenbaum, Michael; Mader, Reuven; Adawi, Muhamad; Caspi, Dan; Tishler, Moshe; Langevitz, Pnina; Rubinow, Alan; Friedman, Joshua; Green, Lesly; Tanay, Amir; Ochaion, Avivit; Cohen, Shira; Kerns, William D.; Cohn, Ilan; Fishman-Furman, Sari; Farbstein, Motti; Yehuda, Sara Bar; Fishman, Pnina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">Objective: Adenosine exerts antiinflammatory effects via activation of the A3 adenosine receptor (A3AR), a Gi protein-assocd. cell-surface receptor, overexpressed in synovial tissue and peripheral blood mononuclear cells (PBMC) in patients with active rheumatoid arthritis (RA).  CF101 is a highly specific orally bioavailable A3AR agonist.  Methods: This was a multicenter study, blinded to dose, designed to assess the clin. activity and safety of CF101 in active RA.  Seventy-four patients were randomized to receive 0.1, 1.0, or 4.0 mg CF101 bid for 12 wk.  The primary efficacy endpoint was American College of Rheumatol. 20% response (ACR20) at Week 12.  A3AR expression levels were analyzed in PBMC from 18 patients.  Results: Maximal responses were obsd. with 1.0 mg bid, lower at 0.1 and 4.0 mg bid.  At 12 wk, 55.6%, 33.3%, and 11.5% of the patients receiving 1.0 mg CF101 achieved ACR20%, 50%, and 70% responses, resp.  CF101 was generally well tolerated, with mild headache (4.1%), nausea (2.7%), and rash (2.7%) being the most common treatment-related adverse events.  Statistically significant correlations between A3AR overexpression at baseline and ACR50 and ACR70 responses were obsd.  Conclusion: CF101 administered bid for 12 wk resulted in improvement in signs and symptoms of RA that did not achieve statistical significance, and was safe and well tolerated.  The expression level of A3AR was directly correlated with patient responses to CF101, suggesting its utilization as a biomarker for the pharmacodynamic and therapeutic effects of this novel agent.  These findings require confirmation in a double-blind randomized placebo-controlled trial, currently under way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp76np_8qRetbVg90H21EOLACvtfcHk0lhXAuOlwb_GQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslyltLc%253D&md5=4f99e853bdbd82daca708a0d0cf2de2a</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DStrand%26aufirst%3DV.%26aulast%3DMarkovits%26aufirst%3DD.%26aulast%3DNahir%26aufirst%3DM.%26aulast%3DReitblat%26aufirst%3DT.%26aulast%3DMolad%26aufirst%3DY.%26aulast%3DRosner%26aufirst%3DI.%26aulast%3DRozenbaum%26aufirst%3DM.%26aulast%3DMader%26aufirst%3DR.%26aulast%3DAdawi%26aufirst%3DM.%26aulast%3DCaspi%26aufirst%3DD.%26aulast%3DTishler%26aufirst%3DM.%26aulast%3DLangevitz%26aufirst%3DP.%26aulast%3DRubinow%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DTanay%26aufirst%3DA.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DKerns%26aufirst%3DW.%2BD.%26aulast%3DCohn%26aufirst%3DI.%26aulast%3DFishman-Furman%26aufirst%3DS.%26aulast%3DFarbstein%26aufirst%3DM.%26aulast%3DYehuda%26aufirst%3DS.%2BB.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DClinical%2520evidence%2520for%2520utilization%2520of%2520the%2520A3%2520adenosine%2520receptor%2520as%2520a%2520target%2520to%2520treat%2520rheumatoid%2520arthritis%253A%2520data%2520from%2520a%2520phase%2520II%2520clinical%2520trial%26jtitle%3DJ.%2520Rheumatol.%26date%3D2008%26volume%3D35%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Normalization of A<sub>2A</sub> and A<sub>3</sub> adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2880</span><span class="NLM_x">–</span> <span class="NLM_lpage">2891</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fart.24794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19790066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=2880-2891&author=K.+Varaniauthor=A.+Massaraauthor=F.+Vincenziauthor=A.+Tosiauthor=M.+Padovanauthor=F.+Trottaauthor=P.+A.+Borea&title=Normalization+of+A2A+and+A3+adenosine+receptor+up-regulation+in+rheumatoid+arthritis+patients+by+treatment+with+anti-tumor+necrosis+factor+alpha+but+not+methotrexate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate</span></div><div class="casAuthors">Varani, Katia; Massara, Alfonso; Vincenzi, Fabrizio; Tosi, Alice; Padovan, Melissa; Trotta, Francesco; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2880-2891</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To investigate A1, A2A, A2B, and A3 adenosine receptors in lymphocytes and neutrophils from patients with early rheumatoid arthritis (ERA) as well as from RA patients treated with methotrexate (MTX) or anti-tumor necrosis factor a (anti-TNFα), as compared with those in age-matched healthy controls, and to examine correlations between the status and functionality of adenosine receptors and TNFα release and NF-κB activation.  Adenosine receptors were analyzed by satn. binding assays and Western blot analyses.  We investigated the potency of typical A2A and A3 agonists in the prodn. of cAMP in control subjects, ERA patients, and RA patients treated with MTX or anti-TNFα.  In a sep. cohort of RA patients, TNFα release and NF-κB activation were evaluated in plasma and nuclear exts., resp.  In ERA patients, we found a high d. and altered functionality of A2A and A3 receptors.  The binding and functional parameters of A2A and A3 receptors normalized after anti-TNFα, but not MTX, treatment.  TNFα release was increased in ERA patients and in MTX-treated RA patients, whereas in anti-TNFα-treated RA patients, release was comparable to that in the controls.  NF-κB activation was elevated in ERA patients and in MTX-treated RA patients.  Anti-TNFα treatment mediated decreased levels of NF-κB activation.  A2A and A3 receptor up-regulation in ERA patients and in MTX-treated RA patients was assocd. with high levels of TNFα and NF-κB activation.  Treatment with anti-TNFα normalized A2A and A3 receptor expression and functionality.  This new evidence of A2A and A3 receptor involvement opens the possibility of exploiting their potential role in human diseases characterized by a marked inflammatory component.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplvCWYa5vOBLVg90H21EOLACvtfcHk0lhXAuOlwb_GQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbnL&md5=74fac99076140b3e18569353f6568119</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1002%2Fart.24794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24794%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMassara%26aufirst%3DA.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTosi%26aufirst%3DA.%26aulast%3DPadovan%26aufirst%3DM.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNormalization%2520of%2520A2A%2520and%2520A3%2520adenosine%2520receptor%2520up-regulation%2520in%2520rheumatoid%2520arthritis%2520patients%2520by%2520treatment%2520with%2520anti-tumor%2520necrosis%2520factor%2520alpha%2520but%2520not%2520methotrexate%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D2880%26epage%3D2891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pina-Oviedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Liz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3061</span><span class="NLM_x">–</span> <span class="NLM_lpage">3071</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fart.24817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19790055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=3061-3071&author=S.+Bar-Yehudaauthor=L.+Rath-Wolfsonauthor=L.+Del+Valleauthor=A.+Ochaionauthor=S.+Cohenauthor=R.+Patokaauthor=G.+Zozulyaauthor=F.+Barerauthor=E.+Atarauthor=S.+Pina-Oviedoauthor=G.+Perez-Lizauthor=D.+Castelauthor=P.+Fishman&title=Induction+of+an+antiinflammatory+effect+and+prevention+of+cartilage+damage+in+rat+knee+osteoarthritis+by+CF101+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment</span></div><div class="casAuthors">Bar-Yehuda, S.; Rath-Wolfson, L.; Del Valle, L.; Ochaion, A.; Cohen, S.; Patoka, R.; Zozulya, G.; Barer, F.; Atar, E.; Pina-Oviedo, S.; Perez-Liz, G.; Castel, D.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3061-3071</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Studies have suggested that rheumatoid arthritis (RA) and osteoarthritis (OA) share common characteristics.  The highly selective A3 adenosine receptor agonist CF101 was recently defined as a potent antiinflammatory agent for the treatment of RA.  The purpose of this study was to examine the effects of CF101 on the clin. and pathol. manifestations of OA in an exptl. animal model.  OA was induced in rats by monosodium iodoacetate, and upon disease onset, oral treatment with CF101 (100 μg/kg given twice daily) was initiated.  The A3 adenosine receptor antagonist MRS1220 (100 μg/kg given twice daily) was administered orally, 30 min before CF101 treatment.  The OA clin. score was monitored by knee diam. measurements and by radiog. analyses.  Histol. analyses were performed following staining with hematoxylin and eosin, Safranin O-fast green, or toluidine blue, and histol. changes were scored according to a modified Mankin system.  Signaling proteins were assayed by Western blotting; apoptosis was detected via immunohistochem. and TUNEL analyses.  CF101 induced a marked decrease in knee diam. and improved the changes noted on radiographs.  Administration of MRS1220 counteracted the effects of CF101.  CF101 prevented cartilage damage, osteoclast/osteophyte formation, and bone destruction.  In addn., CF101 markedly reduced pannus formation and lymphocyte infiltration.  Mechanistically, CF101 induced deregulation of the NF-κB signaling pathway, resulting in down-regulation of tumor necrosis factor α.  Consequently, CF101 induced apoptosis of inflammatory cells that had infiltrated the knee joints; however, it prevented apoptosis of chondrocytes.  CF101 deregulated the NF-κB signaling pathway involved in the pathogenesis of OA.  CF101 induced apoptosis of inflammatory cells and acted as a cartilage protective agent, which suggests that it would be a suitable candidate drug for the treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp41AroCeGD0bVg90H21EOLACvtfcHk0lhXAuOlwb_GQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOmtbfI&md5=8933df5c22e08667ceb823b21b52f01c</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1002%2Fart.24817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24817%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DZozulya%26aufirst%3DG.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DAtar%26aufirst%3DE.%26aulast%3DPina-Oviedo%26aufirst%3DS.%26aulast%3DPerez-Liz%26aufirst%3DG.%26aulast%3DCastel%26aufirst%3DD.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DInduction%2520of%2520an%2520antiinflammatory%2520effect%2520and%2520prevention%2520of%2520cartilage%2520damage%2520in%2520rat%2520knee%2520osteoarthritis%2520by%2520CF101%2520treatment%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D3061%26epage%3D3071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amital, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitblat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ophir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konfino, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowers, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Horin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The anti-inflammatory target A<sub>3</sub> adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.cellimm.2009.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19426966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotF2nsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=2009&pages=115-122&author=A.+Ochaionauthor=S.+Bar-Yehudaauthor=S.+Cohenauthor=F.+Barerauthor=R.+Patokaauthor=H.+Amitalauthor=T.+Reitblatauthor=A.+Reitblatauthor=J.+Ophirauthor=I.+Konfinoauthor=Y.+Chowersauthor=S.+Ben-Horinauthor=P.+Fishman&title=The+anti-inflammatory+target+A3+adenosine+receptor+is+over-expressed+in+rheumatoid+arthritis%2C+psoriasis+and+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease</span></div><div class="casAuthors">Ochaion, A.; Bar-Yehuda, S.; Cohen, S.; Barer, F.; Patoka, R.; Amital, H.; Reitblat, T.; Reitblat, A.; Ophir, J.; Konfino, I.; Chowers, Y.; Ben-Horin, S.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-122</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Gi protein assocd. A3 adenosine receptor (A3AR) was recently defined as a novel anti-inflammatory target.  The aim of this study was to look at A3AR expression levels in peripheral blood mononuclear cells (PBMCs) of patients with autoimmune inflammatory diseases and to explore transcription factors involved receptor expression.  Over-expression of A3AR was found in PBMCs derived from patients with rheumatoid arthritis (RA), psoriasis and Crohn's disease compared with PBMCs from healthy subjects.  Bioinformatics anal. demonstrated the presence of DNA binding sites for nuclear factor-κB (NF-κB) and cAMP-responsive element binding protein (CREB) in the A3AR gene promoter.  Up-regulation of NF-κB and CREB was found in the PBMCs from patients with RA, psoriasis and Crohn's disease.  The PI3K-PKB/Akt signaling pathway, known to regulate both the NF-κB and CREB, was also up-regulated in the patients' PBMCs.  Taken together, NF-κB and CREB are involved with the over-expression of A3AR in patients with autoimmune inflammatory diseases.  The receptor may be considered as a specific target to combat inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqMTkoYZq2irVg90H21EOLACvtfcHk0lgA-dQPU9R6tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotF2nsrg%253D&md5=66aa4dafe7588bb0e43a988dba9ef43d</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2009.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2009.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DAmital%26aufirst%3DH.%26aulast%3DReitblat%26aufirst%3DT.%26aulast%3DReitblat%26aufirst%3DA.%26aulast%3DOphir%26aufirst%3DJ.%26aulast%3DKonfino%26aufirst%3DI.%26aulast%3DChowers%26aufirst%3DY.%26aulast%3DBen-Horin%26aufirst%3DS.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520anti-inflammatory%2520target%2520A3%2520adenosine%2520receptor%2520is%2520over-expressed%2520in%2520rheumatoid%2520arthritis%252C%2520psoriasis%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DCell.%2520Immunol.%26date%3D2009%26volume%3D258%26spage%3D115%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Morovic-Vergles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamulin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culo, F.</span><span> </span><span class="NLM_article-title">Cyclic adenosine 5′-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients</span> <span class="citation_source-journal">Rheumatol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1007%2Fs00296-008-0663-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18695981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSktb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=167-171&author=J.+Morovic-Verglesauthor=M.+I.+Culoauthor=S.+Gamulinauthor=F.+Culo&title=Cyclic+adenosine+5%E2%80%B2-monophosphate+in+synovial+fluid+of+rheumatoid+arthritis+and+osteoarthritis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients</span></div><div class="casAuthors">Morovic-Vergles, Jadranka; Culo, Melanie Ivana; Gamulin, Stjepan; Culo, Filip</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-171</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The relationship between synovial fluid (SF) cAMP level and IL-18 and PGE2 SF levels in rheumatoid arthritis (RA) and osteoarthritis (OA) patients, and between SF cAMP level and disease as well as inflammatory activity in RA were investigated in 17 RA and 19 OA patients.  Erythrocyte sedimentation rate (ESR), serum (S) C-reactive protein (CRP) level and SF IL-18 level were higher in RA than in OA patients.  SF PGE2 level was similar in both groups.  SF cAMP level was higher in OA than in RA patients.  In RA patients, SF cAMP level showed neg. correlation with Disease Activity Score including a 28-joint count and S CRP, ESR and SF IL-18 level.  The results suggest that cAMP promotes anti-inflammatory response in RA and OA patients, which is higher in the latter.  Promotion of anti-inflammatory response by cAMP elevating agents might be useful in the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQEHUYNnbD7Vg90H21EOLACvtfcHk0lgA-dQPU9R6tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSktb3N&md5=ef529d45964d08c1af7d4900ab93a264</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1007%2Fs00296-008-0663-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-008-0663-z%26sid%3Dliteratum%253Aachs%26aulast%3DMorovic-Vergles%26aufirst%3DJ.%26aulast%3DCulo%26aufirst%3DM.%2BI.%26aulast%3DGamulin%26aufirst%3DS.%26aulast%3DCulo%26aufirst%3DF.%26atitle%3DCyclic%2520adenosine%25205%25E2%2580%25B2-monophosphate%2520in%2520synovial%2520fluid%2520of%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%2520patients%26jtitle%3DRheumatol.%2520Int.%26date%3D2008%26volume%3D29%26spage%3D167%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabutti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">IB-MECA, an A<sub>3</sub> adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16956430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD28rjt1eitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=400-406&author=L.+Rath-Wolfsonauthor=S.+Bar-Yehudaauthor=L.+Madiauthor=A.+Ochaionauthor=S.+Cohenauthor=A.+Zabuttiauthor=P.+Fishman&title=IB-MECA%2C+an+A3+adenosine+receptor+agonist+prevents+bone+resorption+in+rats+with+adjuvant+induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis</span></div><div class="casAuthors">Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental rheumatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-6</span>
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">OBJECTIVES:  The anti-inflammatory effect of adenosine is partially mediated via the A3 adenosine receptor (A3AR), a Gi protein associated cell surface receptor.  The highly selective A3AR agonist, IB-MECA was earlier shown to prevent the clinical and pathological manifestations of arthritis in experimental animal models of collagen and adjuvant induced arthritis (AIA).  In this study we tested the effect of IB-MECA on the prevention of bone resorption in AIA rats and looked at the molecular mechanism of action.  METHODS:  Rats with AIA were treated orally twice daily with IB-MECA starting upon onset of disease and the clinical score was evaluated every other day.  At study termination the foot, knee and hip region of both vehicle and IB-MECA treated animals were subjected to histomorphometric analysis.  Western blot analysis was carried out on paw protein extracts.  RESULTS:  IB-MECA ameliorated the clinical manifestations of the disease and reduced pannus and fibrosis formation, attenuated cartilage and bone destruction and decreased the number of osteoclasts.  In cell protein extracts derived from paw of AIA rats, A3AR was highly expressed in comparison to naive animals.  In paw extracts derived from IB-MECA treated AIA rats, down-regulation of the A3AR protein expression level was noted.  PI3K, PKB/Akt, IKK, NF-kappaB, TNF-alpha and RANKL were down-regulated whereas caspase 3 was up-regulated.  CONCLUSION:  IB-MECA, a small highly bioavailable molecule, induces modulation of proteins which control survival and apoptosis resulting in the amelioration of the inflammatory process and the preservation of bone mass in AIA rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo7I9kIwFbFtenUz0lpNqnfW6udTcc2eaiWfBqFM3SxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rjt1eitQ%253D%253D&md5=f2625d62981a0d6d42267862fee23742</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DZabutti%26aufirst%3DA.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DIB-MECA%252C%2520an%2520A3%2520adenosine%2520receptor%2520agonist%2520prevents%2520bone%2520resorption%2520in%2520rats%2520with%2520adjuvant%2520induced%2520arthritis%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D2006%26volume%3D24%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amital, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Liz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2008&pages=482-494&author=A.+Ochaionauthor=S.+Bar-Yehudaauthor=S.+Cohenauthor=H.+Amitalauthor=K.+A.+Jacobsonauthor=B.+V.+Joshiauthor=Z.+G.+Gaoauthor=F.+Barerauthor=R.+Patokaauthor=L.+Del+Valleauthor=G.+Perez-Lizauthor=P.+Fishman&title=The+A3+adenosine+receptor+agonist+CF502+inhibits+the+PI3K%2C+PKB%2FAkt+and+NF-kappaB+signaling+pathway+in+synoviocytes+from+rheumatoid+arthritis+patients+and+in+adjuvant-induced+arthritis+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DAmital%26aufirst%3DH.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DPerez-Liz%26aufirst%3DG.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520agonist%2520CF502%2520inhibits%2520the%2520PI3K%252C%2520PKB%252FAkt%2520and%2520NF-kappaB%2520signaling%2520pathway%2520in%2520synoviocytes%2520from%2520rheumatoid%2520arthritis%2520patients%2520and%2520in%2520adjuvant-induced%2520arthritis%2520rats%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D76%26spage%3D482%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> and A<sub>3</sub> adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">R197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=R197&author=K.+Varaniauthor=M.+Padovanauthor=F.+Vincenziauthor=M.+Targaauthor=F.+Trottaauthor=M.+Govoniauthor=P.+A.+Borea&title=A2A+and+A3+adenosine+receptor+expression+in+rheumatoid+arthritis%3A+upregulation%2C+inverse+correlation+with+disease+activity+score+and+suppression+of+inflammatory+cytokine+and+metalloproteinase+release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DPadovan%26aufirst%3DM.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTarga%26aufirst%3DM.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA2A%2520and%2520A3%2520adenosine%2520receptor%2520expression%2520in%2520rheumatoid%2520arthritis%253A%2520upregulation%252C%2520inverse%2520correlation%2520with%2520disease%2520activity%2520score%2520and%2520suppression%2520of%2520inflammatory%2520cytokine%2520and%2520metalloproteinase%2520release%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2011%26volume%3D13%26spage%3DR197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierma-Zeinstra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmander, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugwell, P.</span><span> </span><span class="NLM_article-title">OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.joca.2007.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18279766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1c7it12itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=137-162&author=W.+Zhangauthor=R.+W.+Moskowitzauthor=G.+Nukiauthor=S.+Abramsonauthor=R.+D.+Altmanauthor=N.+Ardenauthor=S.+Bierma-Zeinstraauthor=K.+D.+Brandtauthor=P.+Croftauthor=M.+Dohertyauthor=M.+Dougadosauthor=M.+Hochbergauthor=D.+J.+Hunterauthor=K.+Kwohauthor=L.+S.+Lohmanderauthor=P.+Tugwell&title=OARSI+recommendations+for+the+management+of+hip+and+knee+osteoarthritis.+Part+II%3A+OARSI+evidence-based%2C+expert+consensus+guidelines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines</span></div><div class="casAuthors">Zhang W; Moskowitz R W; Nuki G; Abramson S; Altman R D; Arden N; Bierma-Zeinstra S; Brandt K D; Croft P; Doherty M; Dougados M; Hochberg M; Hunter D J; Kwoh K; Lohmander L S; Tugwell P</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-62</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">PURPOSE:  To develop concise, patient-focussed, up to date, evidence-based, expert consensus recommendations for the management of hip and knee osteoarthritis (OA), which are adaptable and designed to assist physicians and allied health care professionals in general and specialist practise throughout the world.  METHODS:  Sixteen experts from four medical disciplines (primary care, rheumatology, orthopaedics and evidence-based medicine), two continents and six countries (USA, UK, France, Netherlands, Sweden and Canada) formed the guidelines development team.  A systematic review of existing guidelines for the management of hip and knee OA published between 1945 and January 2006 was undertaken using the validated appraisal of guidelines research and evaluation (AGREE) instrument.  A core set of management modalities was generated based on the agreement between guidelines.  Evidence before 2002 was based on a systematic review conducted by European League Against Rheumatism and evidence after 2002 was updated using MEDLINE, EMBASE, CINAHL, AMED, the Cochrane Library and HTA reports.  The quality of evidence was evaluated, and where possible, effect size (ES), number needed to treat, relative risk or odds ratio and cost per quality-adjusted life years gained were estimated.  Consensus recommendations were produced following a Delphi exercise and the strength of recommendation (SOR) for propositions relating to each modality was determined using a visual analogue scale.  RESULTS:  Twenty-three treatment guidelines for the management of hip and knee OA were identified from the literature search, including six opinion-based, five evidence-based and 12 based on both expert opinion and research evidence.  Twenty out of 51 treatment modalities addressed by these guidelines were universally recommended.  ES for pain relief varied from treatment to treatment.  Overall there was no statistically significant difference between non-pharmacological therapies [0.25, 95% confidence interval (CI) 0.16, 0.34] and pharmacological therapies (ES=0.39, 95% CI 0.31, 0.47).  Following feedback from Osteoarthritis Research International members on the draft guidelines and six Delphi rounds consensus was reached on 25 carefully worded recommendations.  Optimal management of patients with OA hip or knee requires a combination of non-pharmacological and pharmacological modalities of therapy.  Recommendations cover the use of 12 non-pharmacological modalities: education and self-management, regular telephone contact, referral to a physical therapist, aerobic, muscle strengthening and water-based exercises, weight reduction, walking aids, knee braces, footwear and insoles, thermal modalities, transcutaneous electrical nerve stimulation and acupuncture.  Eight recommendations cover pharmacological modalities of treatment including acetaminophen, cyclooxygenase-2 (COX-2) non-selective and selective oral non-steroidal anti-inflammatory drugs (NSAIDs), topical NSAIDs and capsaicin, intra-articular injections of corticosteroids and hyaluronates, glucosamine and/or chondroitin sulphate for symptom relief; glucosamine sulphate, chondroitin sulphate and diacerein for possible structure-modifying effects and the use of opioid analgesics for the treatment of refractory pain.  There are recommendations covering five surgical modalities: total joint replacements, unicompartmental knee replacement, osteotomy and joint preserving surgical procedures; joint lavage and arthroscopic debridement in knee OA, and joint fusion as a salvage procedure when joint replacement had failed.  Strengths of recommendation and 95% CIs are provided.  CONCLUSION:  Twenty-five carefully worded recommendations have been generated based on a critical appraisal of existing guidelines, a systematic review of research evidence and the consensus opinions of an international, multidisciplinary group of experts.  The recommendations may be adapted for use in different countries or regions according to the availability of treatment modalities and SOR for each modality of therapy.  These recommendations will be revised regularly following systematic review of new research evidence as this becomes available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxS93cdmmxmczK395ZObgVfW6udTcc2eaQ7Ol64QN36rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7it12itg%253D%253D&md5=63c6f1489b42ee342207fb1afca90d3d</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2007.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2007.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMoskowitz%26aufirst%3DR.%2BW.%26aulast%3DNuki%26aufirst%3DG.%26aulast%3DAbramson%26aufirst%3DS.%26aulast%3DAltman%26aufirst%3DR.%2BD.%26aulast%3DArden%26aufirst%3DN.%26aulast%3DBierma-Zeinstra%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DK.%2BD.%26aulast%3DCroft%26aufirst%3DP.%26aulast%3DDoherty%26aufirst%3DM.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DHochberg%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DKwoh%26aufirst%3DK.%26aulast%3DLohmander%26aufirst%3DL.%2BS.%26aulast%3DTugwell%26aufirst%3DP.%26atitle%3DOARSI%2520recommendations%2520for%2520the%2520management%2520of%2520hip%2520and%2520knee%2520osteoarthritis.%2520Part%2520II%253A%2520OARSI%2520evidence-based%252C%2520expert%2520consensus%2520guidelines%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2008%26volume%3D16%26spage%3D137%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Westra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, P. C.</span><span> </span><span class="NLM_article-title">p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=867-874&author=J.+Westraauthor=P.+C.+Limburg&title=p38+mitogen-activated+protein+kinase+%28MAPK%29+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestra%26aufirst%3DJ.%26aulast%3DLimburg%26aufirst%3DP.%2BC.%26atitle%3Dp38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520in%2520rheumatoid%2520arthritis%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D867%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mattei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadossi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.joca.2007.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17698373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1c7msVWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=292-304&author=K.+Varaniauthor=M.+De+Matteiauthor=F.+Vincenziauthor=S.+Gessiauthor=S.+Merighiauthor=A.+Pellatiauthor=A.+Ongaroauthor=A.+Carusoauthor=R.+Cadossiauthor=P.+A.+Borea&title=Characterization+of+adenosine+receptors+in+bovine+chondrocytes+and+fibroblast-like+synoviocytes+exposed+to+low+frequency+low+energy+pulsed+electromagnetic+fields"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields</span></div><div class="casAuthors">Varani K; De Mattei M; Vincenzi F; Gessi S; Merighi S; Pellati A; Ongaro A; Caruso A; Cadossi R; Borea P A</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-304</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  The present study describes the presence and binding parameters of the A1, A2A, A2B and A3 adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes.  The effect of low frequency low energy pulsed electromagnetic fields (PEMFs) on the adenosine receptor affinity and density was studied.  METHODS:  Saturation, competition binding experiments and Western blotting assays in the absence and in the presence of PEMFs on the adenosine receptors in bovine chondrocytes or fibroblast-like synoviocytes were performed.  Thermodynamic analysis of the A2A or A3 binding was studied to investigate the forces driving drug-receptor coupling.  In the adenylyl cyclase and proliferation assays the potency of typical high-affinity A2A or A3 agonists in the absence and in the presence of PEMFs was evaluated.  RESULTS:  Bovine chondrocytes and fibroblast-like synoviocytes expressed all adenosine receptors.  PEMFs evoked an up-regulation of A2A and A3 receptors and thermodynamic parameters indicate that adenosine binding is enthalpy and entropy driven.  In PEMF-treated cells the potency of typical A2A or A3 agonists on cyclic AMP assays was significantly increased when compared with the untreated cells.  PEMFs potentiated the effect of A2A or A3 agonists on cell proliferation in both cell types.  CONCLUSIONS:  PEMFs mediate an up-regulation of A2A and A3 receptors related to an increase of their functional activities in bovine chondrocytes and fibroblast-like synoviocytes.  No differences are present in adenosine affinity and in the drug-receptor interactions.  Our data could be used as a trigger to future studies addressed to PEMFs and adenosine therapeutic intervention in inflammatory joint diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6VKfLEWgjMULxIEhxUjPfW6udTcc2eaQ7Ol64QN36rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7msVWhtg%253D%253D&md5=b76a11de8271f2396feee9bb4e0caeea</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2007.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2007.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DDe%2BMattei%26aufirst%3DM.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DPellati%26aufirst%3DA.%26aulast%3DOngaro%26aufirst%3DA.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DCadossi%26aufirst%3DR.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DCharacterization%2520of%2520adenosine%2520receptors%2520in%2520bovine%2520chondrocytes%2520and%2520fibroblast-like%2520synoviocytes%2520exposed%2520to%2520low%2520frequency%2520low%2520energy%2520pulsed%2520electromagnetic%2520fields%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2008%26volume%3D16%26spage%3D292%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">De Mattei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masieri, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadossi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span> </span><span class="NLM_article-title">Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.joca.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18640059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1M7itlWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=252-262&author=M.+De+Matteiauthor=K.+Varaniauthor=F.+F.+Masieriauthor=A.+Pellatiauthor=A.+Ongaroauthor=M.+Finiauthor=R.+Cadossiauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=A.+Caruso&title=Adenosine+analogs+and+electromagnetic+fields+inhibit+prostaglandin+E2+release+in+bovine+synovial+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts</span></div><div class="casAuthors">De Mattei M; Varani K; Masieri F F; Pellati A; Ongaro A; Fini M; Cadossi R; Vincenzi F; Borea P A; Caruso A</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">252-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the role of adenosine analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE(2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).  METHODS:  SFs isolated from synovia were cultured in monolayer.  Saturation and binding experiments were performed by using typical adenosine agonists: N6-cyclohexyladenosine (CHA, A(1)), 2-[p-(2-carboxyethyl)-phenetyl-amino]-5'-N-ethylcarboxamidoadenosine (CGS 21680, A(2A)), 5'-N-ethylcarboxamidoadenosine (NECA, non-selective), N6-(3-iodobenzyl)2-chloroadenosine-5'-N-methyluronamide (Cl-IB-MECA, A(3)).  SFs were treated with TNF-alpha (10 ng/ml) and lipopolysaccharide (LPS) (1 microg/ml) to activate inflammatory response.  Adenosine analogs were added to control and TNF-alpha- or LPS-treated cultures both in the absence and in the presence of adenosine deaminase (ADA) which is used to deplete endogenous adenosine.  Parallel cultures were exposed to EMFs (75 Hz, 1.5 mT) during the period in culture (24h).  PGE(2) release was measured by immunoassay.  COX-2 expression was evaluated by RT-PCR.  RESULTS:  TNF-alpha and LPS stimulated PGE(2) release.  All adenosine agonists, except for Cl-IB-MECA, significantly inhibited PGE(2) production.  EMFs inhibited PGE(2) production in the absence of adenosine agonists and increased the effects of CHA, CGS 21680 and NECA.  In ADA, the inhibition on PGE(2) release induced by CHA, CGS and NECA was stronger than in the absence of ADA and the EMF-inhibitory effect was lost.  Changes in PGE(2) levels were associated to modification of COX-2 expression.  CONCLUSIONS:  This study supports anti-inflammatory activities of A(1) and A(2A) adenosine receptors and EMFs in bovine SFs.  EMF activity appears mediated by an EMF-induced up-regulation of A(2A) receptors.  Biophysical and/or pharmacological modulation of adenosine pathways may play an important role to control joint inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo5l1BUkNhuvtos8R3JUhXfW6udTcc2eZh2rYeDiFmYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7itlWntw%253D%253D&md5=8b1c1e43b386ea01e0323c38ddff752f</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMattei%26aufirst%3DM.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMasieri%26aufirst%3DF.%2BF.%26aulast%3DPellati%26aufirst%3DA.%26aulast%3DOngaro%26aufirst%3DA.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DCadossi%26aufirst%3DR.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DCaruso%26aufirst%3DA.%26atitle%3DAdenosine%2520analogs%2520and%2520electromagnetic%2520fields%2520inhibit%2520prostaglandin%2520E2%2520release%2520in%2520bovine%2520synovial%2520fibroblasts%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2009%26volume%3D17%26spage%3D252%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masieri, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mattei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1111%2Fj.1476-5381.2010.00667.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20331607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslyqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=101-115&author=K.+Varaniauthor=F.+Vincenziauthor=A.+Tosiauthor=M.+Targaauthor=F.+F.+Masieriauthor=A.+Ongaroauthor=M.+De+Matteiauthor=L.+Massariauthor=P.+A.+Borea&title=Expression+and+functional+role+of+adenosine+receptors+in+regulating+inflammatory+responses+in+human+synoviocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes</span></div><div class="casAuthors">Varani, K.; Vincenzi, F.; Tosi, A.; Targa, M.; Masieri, F. F.; Ongaro, A.; De Mattei, M.; Massari, L.; Borea, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Adenosine is an endogenous modulator, interacting with four G-protein coupled receptors (A1, A2A, A2B and A3) and acts as a potent inhibitor of inflammatory processes in several tissues.  So far, the functional effects modulated by adenosine receptors on human synoviocytes have not been investigated in detail.  We evaluated mRNA, the protein levels, the functional role of adenosine receptors and their pharmacol. modulation in human synoviocytes.  Exptl. approach: mRNA, Western blotting, satn. and competition binding expts., cAMP, p38 mitogen-activated protein kinases (MAPKs) and nuclear factor (NF)-κB activation, tumor necrosis factor α (TNF-α) and interleukin-8 (IL-8) release were assessed in human synoviocytes isolated from patients with osteoarthritis.  Key results: mRNA and protein for A1, A2A, A2B and A3 adenosine receptors are expressed in human synoviocytes.  Std. adenosine agonists and antagonists showed affinity values in the nanomolar range and were coupled to stimulation or inhibition of adenylyl cyclase.  Activation of A2A and A3 adenosine receptors inhibited p38 MAPK and NF-κB pathways, an effect abolished by selective adenosine antagonists.  A2A and A3 receptor agonists decreased TNF-α and IL-8 prodn.  The phosphoinositide 3-kinase or Gs pathways were involved in the functional responses of A3 or A2A adenosine receptors.  Synoviocyte A1 and A2B adenosine receptors were not implicated in the inflammatory process whereas stimulation of A2A and A3 adenosine receptors was closely assocd. with a down-regulation of the inflammatory status.  Conclusions and implications: These results indicate that A2A and A3 adenosine receptors may represent a potential target in therapeutic modulation of joint inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9MuYpPfxgV7Vg90H21EOLACvtfcHk0lgSUPF6DoqShw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslyqtLo%253D&md5=42afea5cf3468e67b3c87c05b1f6986e</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00667.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00667.x%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTosi%26aufirst%3DA.%26aulast%3DTarga%26aufirst%3DM.%26aulast%3DMasieri%26aufirst%3DF.%2BF.%26aulast%3DOngaro%26aufirst%3DA.%26aulast%3DDe%2BMattei%26aufirst%3DM.%26aulast%3DMassari%26aufirst%3DL.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520and%2520functional%2520role%2520of%2520adenosine%2520receptors%2520in%2520regulating%2520inflammatory%2520responses%2520in%2520human%2520synoviocytes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26spage%3D101%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Hanauer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Present, D. H.</span><span> </span><span class="NLM_article-title">The state of the art in the management of inflammatory bowel disease</span> <span class="citation_source-journal">Rev. Gastroenterol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12776005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD3s3lt1eqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=81-92&author=S.+B.+Hanauerauthor=D.+H.+Present&title=The+state+of+the+art+in+the+management+of+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">The state of the art in the management of inflammatory bowel disease</span></div><div class="casAuthors">Hanauer Stephen B; Present Daniel H</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in gastroenterological disorders</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-92</span>
        ISSN:<span class="NLM_cas:issn">1533-001X</span>.
    </div><div class="casAbstract">Ulcerative colitis (UC) and Crohn's disease (CD), collectively known as inflammatory bowel disease (IBD), afflict an estimated one million Americans and produce symptoms that impair quality of life and ability to function.  Progress in IBD management strategies has led to optimized approaches for achieving the two primary clinical goals of therapy: induction and maintenance of remission.  Although surgery is indicated to treat refractory disease or specific complications, pharmacotherapy is the cornerstone of IBD management.  The efficacy of aminosalicylates for induction of remission in mild to moderate UC and CD is well established, as is their role for maintenance of remission in UC.  The sulfa-free mesalamine formulation offers an adverse effect profile similar to that of placebo, enabling the administration of higher, more effective doses.  Although corticosteroids provide potent anti-inflammatory effects, their benefits are countermanded by the risk of intolerable and serious adverse effects, and they are ineffective for maintenance therapy.  Other agents effective in inducing or maintaining remission are azathioprine, 6-mercaptopurine, infliximab, cyclosporine, methotrexate, and antibiotics.  Ongoing clinical trials of experimental therapies will generate new tools for IBD treatment.  Currently, a broad range of options allows physicians to tailor treatment to each patient's needs and preferences.  Such considerations are essential for maximizing adherence to therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSpqiFqxFUSCCEBeYuoi7AfW6udTcc2eZh2rYeDiFmYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3lt1eqtQ%253D%253D&md5=eb66b991df88380c6443d958f96ca571</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26aulast%3DPresent%26aufirst%3DD.%2BH.%26atitle%3DThe%2520state%2520of%2520the%2520art%2520in%2520the%2520management%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DRev.%2520Gastroenterol.%2520Disord.%26date%3D2003%26volume%3D3%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">De Schepper, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Man, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreels, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelckmans, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, B. Y.</span><span> </span><span class="NLM_article-title">Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease: clinical relevance and pathophysiological mechanisms</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1111%2Fj.1365-2036.2008.03624.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18221407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A280%3ADC%252BD1c7pt1Crsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=621-637&author=H.+U.+De+Schepperauthor=J.+G.+De+Manauthor=T.+G.+Moreelsauthor=P.+A.+Pelckmansauthor=B.+Y.+De+Winter&title=Review+article%3A+gastrointestinal+sensory+and+motor+disturbances+in+inflammatory+bowel+disease%3A+clinical+relevance+and+pathophysiological+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms</span></div><div class="casAuthors">De Schepper H U; De Man J G; Moreels T G; Pelckmans P A; De Winter B Y</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">621-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  It is well known that inflammation has a profound impact on the neuromuscular apparatus of the gastrointestinal tract during the inflammatory insult and in periods of remission, at the site of inflammation and at distance from this site.  The importance of this interaction is illustrated by the higher prevalence of functional gut disorders in patients with inflammatory bowel disease.  AIMS:  To document the epidemiological and clinical significance of functional alterations of gut motility and sensitivity in patients with inflammatory bowel disease and to formulate potential pathophysiological mechanisms.  RESULTS AND CONCLUSIONS:  Functional gut disorders occur frequently in patients with inflammatory bowel disease, both during inflammatory episodes and in periods of remission, and have a major impact on their quality of life.  The clinical manifestations of these motility and sensitivity disorders vary and are often difficult to treat, mainly because therapeutic guidelines and specific diagnostic tests to distinguish inflammatory bowel disease from functional gut disorders are lacking.  Chronic bowel inflammation results in a complicated interaction between neuroendocrine serotonin-predominant cells of the mucosa, inflammatory cells (particularly mast cells) in the submucosa, the intrinsic and extrinsic innervation and the muscular apparatus including the interstitial cells of Cajal.  The outcome of this interaction is a perturbation of gastrointestinal motor function, both locally and at distance from the site of inflammation and during both acute inflammation and remission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQiU0cGL1MsqYHWj6b1v8uTfW6udTcc2eaAc226JasjELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7pt1Crsg%253D%253D&md5=a70e229d159088cc5c3f004996467750</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2008.03624.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2008.03624.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSchepper%26aufirst%3DH.%2BU.%26aulast%3DDe%2BMan%26aufirst%3DJ.%2BG.%26aulast%3DMoreels%26aufirst%3DT.%2BG.%26aulast%3DPelckmans%26aufirst%3DP.%2BA.%26aulast%3DDe%2BWinter%26aufirst%3DB.%2BY.%26atitle%3DReview%2520article%253A%2520gastrointestinal%2520sensory%2520and%2520motor%2520disturbances%2520in%2520inflammatory%2520bowel%2520disease%253A%2520clinical%2520relevance%2520and%2520pathophysiological%2520mechanisms%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D27%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Mabley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, C.</span><span> </span><span class="NLM_article-title">The adenosine A<sub>3</sub> receptor agonist, <i>N</i><sup>6</sup>-(3-iodobenzyl)-adenosine-5′-<i>N</i>-methyluronamide, is protective in two murine models of colitis</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2FS0014-2999%2803%2901570-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=12694816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisleltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2003&pages=323-329&author=J.+Mableyauthor=F.+Sorianoauthor=P.+Pacherauthor=G.+Haskoauthor=A.+Martonauthor=R.+Wallaceauthor=A.+Salzmanauthor=C.+Szabo&title=The+adenosine+A3+receptor+agonist%2C+N6-%283-iodobenzyl%29-adenosine-5%E2%80%B2-N-methyluronamide%2C+is+protective+in+two+murine+models+of+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis</span></div><div class="casAuthors">Mabley, Jon; Soriano, Francisco; Pacher, Pal; Hasko, Gyorgy; Marton, Anita; Wallace, Rebecca; Salzman, Andrew; Szabo, Csaba</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-329</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">This study evaluated the effects of the adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA), in two murine models of colitis, the dextran sodium sulfate-induced colitis and the spontaneous colitis found in interleukin-10 gene deficient mice.  IB-MECA was given orally twice a day at a dose of either 1 or 3 mg/kg/day.  Evaluation of colon damage and inflammation was detd. grossly (body wt., rectal bleeding) and biochem. (colon levels of myeloperoxidase, malondialdehyde, chemokines and cytokines).  There was significantly increased inflammatory cell infiltration into the colon assocd. with an increase in colon levels of cytokines and chemokines; with subsequent free radical related damage in both dextran sodium sulfate-induced colitis and 10-wk-old interleukin-10-/- mice.  IB-MECA protected in both models against the colitis induced inflammatory cell infiltration and damage and attenuated the increases in colon inflammatory cytokine and chemokine levels.  Thus activation of the adenosine A3 receptor is effective in protecting against colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0kJSY66IJrVg90H21EOLACvtfcHk0lg7CBwOrJiWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisleltrc%253D&md5=4cd64ff64f3f07f3bee4d10e9158ec6e</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901570-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901570-X%26sid%3Dliteratum%253Aachs%26aulast%3DMabley%26aufirst%3DJ.%26aulast%3DSoriano%26aufirst%3DF.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DHasko%26aufirst%3DG.%26aulast%3DMarton%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DR.%26aulast%3DSalzman%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DThe%2520adenosine%2520A3%2520receptor%2520agonist%252C%2520N6-%25283-iodobenzyl%2529-adenosine-5%25E2%2580%25B2-N-methyluronamide%252C%2520is%2520protective%2520in%2520two%2520murine%2520models%2520of%2520colitis%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D466%26spage%3D323%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Bastia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span> </span><span class="NLM_article-title">Effects of A<sub>1</sub> and A<sub>2A</sub> adenosine receptor ligands in mouse acute models of pain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2002&pages=241-244&author=E.+Bastiaauthor=K.+Varaniauthor=A.+Monopoliauthor=R.+Bertorelli&title=Effects+of+A1+and+A2A+adenosine+receptor+ligands+in+mouse+acute+models+of+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBastia%26aufirst%3DE.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DBertorelli%26aufirst%3DR.%26atitle%3DEffects%2520of%2520A1%2520and%2520A2A%2520adenosine%2520receptor%2520ligands%2520in%2520mouse%2520acute%2520models%2520of%2520pain%26jtitle%3DNeurosci.%2520Lett.%26date%3D2002%26volume%3D328%26spage%3D241%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Lee, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emala, C. W.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">R959</span><span class="NLM_x">–</span> <span class="NLM_lpage">R969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2006&pages=R959-R969&author=H.+T.+Leeauthor=M.+Kimauthor=J.+D.+Jooauthor=G.+Gallosauthor=J.+F.+Chenauthor=C.+W.+Emala&title=A3+adenosine+receptor+activation+decreases+mortality+and+renal+and+hepatic+injury+in+murine+septic+peritonitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DJoo%26aufirst%3DJ.%2BD.%26aulast%3DGallos%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEmala%26aufirst%3DC.%2BW.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520decreases%2520mortality%2520and%2520renal%2520and%2520hepatic%2520injury%2520in%2520murine%2520septic%2520peritonitis%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2006%26volume%3D291%26spage%3DR959%26epage%3DR969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Lee, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota-Setlik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agati, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emala, C. W.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">F267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=F267-273&author=H.+T.+Leeauthor=A.+Ota-Setlikauthor=H.+Xuauthor=V.+D.+D%E2%80%99Agatiauthor=M.+A.+Jacobsonauthor=C.+W.+Emala&title=A3+adenosine+receptor+knockout+mice+are+protected+against+ischemia-+and+myoglobinuria-induced+renal+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DOta-Setlik%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Agati%26aufirst%3DV.%2BD.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DEmala%26aufirst%3DC.%2BW.%26atitle%3DA3%2520adenosine%2520receptor%2520knockout%2520mice%2520are%2520protected%2520against%2520ischemia-%2520and%2520myoglobinuria-induced%2520renal%2520failure%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2003%26volume%3D284%26spage%3DF267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Lee, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emala, C. W.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">R959</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2006&pages=R959-969&author=H.+T.+Leeauthor=M.+Kimauthor=J.+D.+Jooauthor=G.+Gallosauthor=J.+F.+Chenauthor=C.+W.+Emala&title=A3+adenosine+receptor+activation+decreases+mortality+and+renal+and+hepatic+injury+in+murine+septic+peritonitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DJoo%26aufirst%3DJ.%2BD.%26aulast%3DGallos%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEmala%26aufirst%3DC.%2BW.%26atitle%3DA3%2520adenosine%2520receptor%2520activation%2520decreases%2520mortality%2520and%2520renal%2520and%2520hepatic%2520injury%2520in%2520murine%2520septic%2520peritonitis%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2006%26volume%3D291%26spage%3DR959%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson-Yantorno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civan, M. M.</span><span> </span><span class="NLM_article-title">Nucleoside-derived antagonists to A<sub>3</sub> adenosine receptors lower mouse intraocular pressure and act across species</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.exer.2009.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19878673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFantbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=146-154&author=Z.+Wangauthor=C.+W.+Doauthor=M.+Y.+Avilaauthor=K.+Peterson-Yantornoauthor=R.+A.+Stoneauthor=Z.+G.+Gaoauthor=B.+Joshiauthor=P.+Besadaauthor=L.+S.+Jeongauthor=K.+A.+Jacobsonauthor=M.+M.+Civan&title=Nucleoside-derived+antagonists+to+A3+adenosine+receptors+lower+mouse+intraocular+pressure+and+act+across+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species</span></div><div class="casAuthors">Wang, Zhao; Do, Chi-Wai; Avila, Marcel Y.; Peterson-Yantorno, Kim; Stone, Richard A.; Gao, Zhan-Guo; Joshi, Bhalchandra; Besada, Pedro; Jeong, Lak-Shin; Jacobson, Kenneth A.; Civan, Mortimer M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of the study was to det. whether novel, selective antagonists of human A3 adenosine receptors (ARs) derived from the A3-selective agonist Cl-IB-MECA lower intraocular pressure (IOP) and act across species.  IOP was measured invasively with a micropipette by the Servo-Null Micropipette System (SNMS) and by non-invasive pneumotonometry during topical drug application.  Antagonist efficacy was also assayed by measuring inhibition of adenosine-triggered shrinkage of native bovine nonpigmented ciliary epithelial (NPE) cells.  Five agonist-based A3AR antagonists lowered mouse IOP measured with SNMS tonometry by 3-5 mm Hg within minutes of topical application.  Of the 5 agonist derivs., LJ 1251 was the only antagonist to lower IOP measured by pneumotonometry.  No effect was detected pneumotonometrically over 30 min following application of the other 4 compds., consonant with slower, smaller responses previously measured non-invasively following topical application of A3AR agonists and the dihydropyridine A3AR antagonist MRS 1191.  Latanoprost similarly lowered SNMS-measured IOP, but not IOP measured non-invasively over 30 min.  Like MRS 1191, agonist-based A3AR antagonists applied to native bovine NPE cells inhibited adenosine-triggered shrinkage.  In summary, the results indicate that antagonists of human A3ARs derived from the potent, selective A3 agonist Cl-IB-MECA display efficacy in mouse and bovine cells, as well.  When intraocular delivery was enhanced by measuring mouse IOP invasively, 5 derivs. of the A3AR agonist Cl-IB-MECA lowered IOP but only one rapidly reduced IOP measured non-invasively after topical application.  We conclude that derivs. of the highly-selective A3AR agonist Cl-IB-MECA can reduce IOP upon reaching their intraocular target, and that nucleoside-based derivs. are promising A3 antagonists for study in multiple animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodKko5nfHoMLVg90H21EOLACvtfcHk0lhGydVgIB6PZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFantbjM&md5=3d11d9a34194272b31e203a158609fd8</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2009.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2009.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDo%26aufirst%3DC.%2BW.%26aulast%3DAvila%26aufirst%3DM.%2BY.%26aulast%3DPeterson-Yantorno%26aufirst%3DK.%26aulast%3DStone%26aufirst%3DR.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJoshi%26aufirst%3DB.%26aulast%3DBesada%26aufirst%3DP.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DCivan%26aufirst%3DM.%2BM.%26atitle%3DNucleoside-derived%2520antagonists%2520to%2520A3%2520adenosine%2520receptors%2520lower%2520mouse%2520intraocular%2520pressure%2520and%2520act%2520across%2520species%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2010%26volume%3D90%26spage%3D146%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Schlotzer-Schrehardt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decking, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coca-Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumann, G. O.</span><span> </span><span class="NLM_article-title">Selective upregulation of the A<sub>3</sub> adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=2023-2034&author=U.+Schlotzer-Schrehardtauthor=M.+Zenkelauthor=U.+Deckingauthor=D.+Haubsauthor=F.+E.+Kruseauthor=A.+Junemannauthor=M.+Coca-Pradosauthor=G.+O.+Naumann&title=Selective+upregulation+of+the+A3+adenosine+receptor+in+eyes+with+pseudoexfoliation+syndrome+and+glaucoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlotzer-Schrehardt%26aufirst%3DU.%26aulast%3DZenkel%26aufirst%3DM.%26aulast%3DDecking%26aufirst%3DU.%26aulast%3DHaubs%26aufirst%3DD.%26aulast%3DKruse%26aufirst%3DF.%2BE.%26aulast%3DJunemann%26aufirst%3DA.%26aulast%3DCoca-Prados%26aufirst%3DM.%26aulast%3DNaumann%26aufirst%3DG.%2BO.%26atitle%3DSelective%2520upregulation%2520of%2520the%2520A3%2520adenosine%2520receptor%2520in%2520eyes%2520with%2520pseudoexfoliation%2520syndrome%2520and%2520glaucoma%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2005%26volume%3D46%26spage%3D2023%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eysteinsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laties, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, C. H.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.neuint.2009.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19723551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=35-41&author=M.+Zhangauthor=H.+L.+Huauthor=X.+L.+Zhangauthor=W.+N.+Luauthor=J.+Limauthor=T.+Eysteinssonauthor=K.+A.+Jacobsonauthor=A.+M.+Latiesauthor=C.+H.+Mitchell&title=The+A3+adenosine+receptor+attenuates+the+calcium+rise+triggered+by+NMDA+receptors+in+retinal+ganglion+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells</span></div><div class="casAuthors">Zhang, Mei; Hu, Huiling; Zhang, Xiulan; Lu, Wennan; Lim, Jason; Eysteinsson, Thor; Jacobson, Kenneth A.; Laties, Alan M.; Mitchell, Claire H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-41</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The A3 adenosine receptor is emerging as an important regulator of neuronal signaling, and in some situations receptor stimulation can limit excitability.  As the NMDA receptor frequently contributes to neuronal excitability, this study examd. whether A3 receptor activation could alter the calcium rise accompanying NMDA receptor stimulation.  Calcium levels were detd. from fura-2 imaging of isolated rat retinal ganglion cells as these neurons possess both receptor types.  Brief application of glutamate or NMDA led to repeatable and reversible elevations of intracellular calcium.  The A3 agonist Cl-IB-MECA reduced the response to both glutamate and NMDA.  While adenosine mimicked the effect of Cl-IB-MECA, the A3 receptor antagonist MRS 1191 impeded the block by adenosine, implicating a role for the A3 receptor in response to the natural agonist.  The A1 receptor antagonist DPCPX provided addnl. inhibition, implying a contribution from both A1 and A3 adenosine receptors.  The novel A3 agonist MRS 3558 (1'S,2'R,3'S,4'R,5'S)-4-(2-chloro-6-(3-chlorobenzylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo [3.1.0] hexane-1-carboxamide and mixed A1/A3 agonist MRS 3630 (1'S,2'R,3'S,4'R,5'S)-4-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo [3.1.0] hexane-1-carboxamide also inhibited the calcium rise induced by NMDA.  Low levels of MRS 3558 were particularly effective, with an IC50 of 400 pM.  In all cases, A3 receptor stimulation inhibited only 30-50% of the calcium rise.  In summary, stimulation of the A3 adenosine receptor by either endogenous or synthesized agonists can limit the calcium rise accompanying NMDA receptor activation.  It remains to be detd. if partial block of the calcium rise by A3 agonists can modify downstream responses to NMDA receptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5IWJWU87-HLVg90H21EOLACvtfcHk0lhGydVgIB6PZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlehug%253D%253D&md5=d0b4e34e8994756b0bbf9b6eb56ea5d8</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DH.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DLu%26aufirst%3DW.%2BN.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DEysteinsson%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLaties%26aufirst%3DA.%2BM.%26aulast%3DMitchell%26aufirst%3DC.%2BH.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520attenuates%2520the%2520calcium%2520rise%2520triggered%2520by%2520NMDA%2520receptors%2520in%2520retinal%2520ganglion%2520cells%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D56%26spage%3D35%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patokaa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Morales, J. M. G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Inhibition of experimental auto-immune uveitis by the A<sub>3</sub> adenosine receptor agonist CF101</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21887476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleku7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=727-731&author=S.+Bar-Yehudaauthor=D.+Lugerauthor=A.+Ochaionauthor=S.+Cohenauthor=R.+Patokaaauthor=G.+Zozulyaauthor=P.+B.+Silverauthor=J.+M.+G.+R.+De+Moralesauthor=R.+R.+Caspiauthor=P.+Fishman&title=Inhibition+of+experimental+auto-immune+uveitis+by+the+A3+adenosine+receptor+agonist+CF101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101</span></div><div class="casAuthors">Bar-Yehuda, Sara; Luger, Dror; Ochaion, Avivit; Cohen, Shira; Patokaa, Renana; Zozulya, Galina; Silver, Phyllis B.; Ruiz De Morales, Jose Maria Garcia; Caspi, Rachel R.; Fishman, Pnina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">727-731</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">Uveitis is an inflammation of the middle layer of the eye with a high risk of blindness.  The Gi protein assocd. A3 adenosine receptor (A3AR) is highly expressed in inflammatory cells whereas low expression is found in normal cells.  CF101 is a highly specific agonist at the A3AR known to induce a robust anti-inflammatory effect in different exptl. animal models.  The CF101 mechanism of action entails down-regulation of the NF-κB-TNF-α signaling pathway, resulting in inhibition of pro-inflammatory cytokine prodn. and apoptosis of inflammatory cells.  In this study the effect of CF101 on the development of retinal antigen interphotoreceptor retinoid-binding protein (IRBP)-induced exptl. autoimmune uveitis (EAU) was assessed.  Oral treatment with CF101 (10 μg/kg, twice daily), initiated upon disease onset, improved uveitis clin. score measured by fundoscopy and ameliorated the pathol. manifestations of the disease.  Shortly after treatment with CF101 A3AR expression levels were down-regulated in the lymph node and spleen cells pointing towards receptor activation.  Downstream events included a decrease in PI3K and STAT-1 and proliferation inhibition of IRPB auto-reactive T cells ex vivo.  Inhibition of interleukin-2, tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) prodn. and up-regulation of interleukin-10 was found in cultured splenocytes derived from CF101-treated animals.  Overall, the present study data point towards a marked anti-inflammatory effect of CF101 in EAU and support further exploration of this small mol. drug for the treatment of uveitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqe7symGDucrVg90H21EOLACvtfcHk0lhGydVgIB6PZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleku7jJ&md5=a7fbc0827e3fc86c09198456614ecef5</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DLuger%26aufirst%3DD.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DPatokaa%26aufirst%3DR.%26aulast%3DZozulya%26aufirst%3DG.%26aulast%3DSilver%26aufirst%3DP.%2BB.%26aulast%3DDe%2BMorales%26aufirst%3DJ.%2BM.%2BG.%2BR.%26aulast%3DCaspi%26aufirst%3DR.%2BR.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520experimental%2520auto-immune%2520uveitis%2520by%2520the%2520A3%2520adenosine%2520receptor%2520agonist%2520CF101%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2011%26volume%3D28%26spage%3D727%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Multani, A. S.</span><span> </span><span class="NLM_article-title">Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A<sub>3</sub> adenosine receptor</span> <span class="citation_source-journal">Eur. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=1452-1458&author=P.+Fishmanauthor=S.+Bar-Yehudaauthor=G.+Ohanaauthor=S.+Pathakauthor=L.+Wassermanauthor=F.+Barerauthor=A.+S.+Multani&title=Adenosine+acts+as+an+inhibitor+of+lymphoma+cell+growth%3A+a+major+role+for+the+A3+adenosine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DOhana%26aufirst%3DG.%26aulast%3DPathak%26aufirst%3DS.%26aulast%3DWasserman%26aufirst%3DL.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DMultani%26aufirst%3DA.%2BS.%26atitle%3DAdenosine%2520acts%2520as%2520an%2520inhibitor%2520of%2520lymphoma%2520cell%2520growth%253A%2520a%2520major%2520role%2520for%2520the%2520A3%2520adenosine%2520receptor%26jtitle%3DEur.%2520J.%2520Cancer.%26date%3D2000%26volume%3D36%26spage%3D1452%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Suh, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. T.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjp.0704218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=11522605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=132-142&author=B.+C.+Suhauthor=T.+D.+Kimauthor=J.+U.+Leeauthor=J.+K.+Seongauthor=K.+T.+Kim&title=Pharmacological+characterization+of+adenosine+receptors+in+PGT-beta+mouse+pineal+gland+tumour+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of adenosine receptors in PGT-β mouse pineal gland tumour cells</span></div><div class="casAuthors">Suh, Byung-Chang; Kim, Tae-Don; Lee, Jung-Uek; Seong, Je-Kyung; Kim, Kyong-Tai</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adenosine receptor in mouse pinealocytes was identified and characterized using pharmacol. and physiol. approaches.  Expression of the two adenosine receptor subtypes A2B and A3 was detected in mouse pineal glands and PGT-β cells by polymerase chain reaction and nucleotide sequencing.  Adenosine and 5'-N-ethylcarboxamidoadenosine (NECA) evoked cAMP generation but the A2A-selective agonist 2-(4-(2-carboxyethyl)phenylethylamino)adenosine-5'-N-ethylcarboxamideadenosine (CGS 21680) and the A1-specific agonists R-N6-(2-phenylisopropyl)adenosine (R-PIA) and N6-cyclopentyladenosine (CPA) had little effect on intracellular cAMP levels.  The A2B receptor selective antagonists alloxazine and enprofylline completely blocked NECA-mediated cAMP accumulation.  Treatment of cells with the A3-selective agonist N6-(3-iodobenzyl)-5'-(N-methylcarbamoyl)adenosine (IB-MECA) inhibited the elevation of the cAMP level induced by NECA or isoproterenol in a concn.-dependent manner with maximal inhibition of 40-50%.  These responses were blocked by the specific A3 adenosine receptor antagonist MRS 1191.  Pretreatment of the cells with pertussis toxin attenuated the IB-MECA-induced responses, suggesting that this effect occurred via the pertussis toxin-sensitive inhibitory G proteins.  IB-MECA also caused a concn.-dependent elevation in [Ca2+]i and IP3 content.  Both the responses induced by IB-MECA were attenuated by treatment with U73122 or phorbol 12-myristate 13-acetate.  These data suggest the presence of both A2B and A3 adenosine receptors in mouse pineal tumor cells and that the A2B receptor is pos. coupled to adenylyl cyclase, whereas the A3 receptor is neg. coupled to adenylyl cyclase and also coupled to phospholipase C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYzMFEwx6NR7Vg90H21EOLACvtfcHk0ljvUBQ_dDQUAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVyqsr0%253D&md5=33a7e2ecb87ce7181db9a65de82bdf0a</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704218%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DT.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BU.%26aulast%3DSeong%26aufirst%3DJ.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BT.%26atitle%3DPharmacological%2520characterization%2520of%2520adenosine%2520receptors%2520in%2520PGT-beta%2520mouse%2520pineal%2520gland%2520tumour%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D132%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A<sub>3</sub> adenosine receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1483</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1483-1495&author=S.+Gessiauthor=V.+Sacchettoauthor=E.+Fogliauthor=S.+Merighiauthor=K.+Varaniauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=Modulation+of+metalloproteinase-9+in+U87MG+glioblastoma+cells+by+A3+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DSacchetto%26aufirst%3DV.%26aulast%3DFogli%26aufirst%3DE.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DModulation%2520of%2520metalloproteinase-9%2520in%2520U87MG%2520glioblastoma%2520cells%2520by%2520A3%2520adenosine%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1483%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=19-31&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+Maclennanauthor=P.+A.+Borea&title=Adenosine+modulates+vascular+endothelial+growth+factor+expression+via+hypoxia-inducible+factor-1+in+human+glioblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMaclennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520modulates%2520vascular%2520endothelial%2520growth%2520factor%2520expression%2520via%2520hypoxia-inducible%2520factor-1%2520in%2520human%2520glioblastoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D19%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Jajoo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramkumar, V.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>3</sub> receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1132-1145&author=S.+Jajooauthor=D.+Mukherjeaauthor=K.+Watabeauthor=V.+Ramkumar&title=Adenosine+A3+receptor+suppresses+prostate+cancer+metastasis+by+inhibiting+NADPH+oxidase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJajoo%26aufirst%3DS.%26aulast%3DMukherjea%26aufirst%3DD.%26aulast%3DWatabe%26aufirst%3DK.%26aulast%3DRamkumar%26aufirst%3DV.%26atitle%3DAdenosine%2520A3%2520receptor%2520suppresses%2520prostate%2520cancer%2520metastasis%2520by%2520inhibiting%2520NADPH%2520oxidase%2520activity%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D1132%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A<sub>3</sub> adenosine subtype</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fjcp.20994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=17348028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFKlt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2007&pages=826-836&author=S.+Gessiauthor=S.+Merighiauthor=K.+Varaniauthor=E.+Cattabrigaauthor=A.+Beniniauthor=P.+Mirandolaauthor=E.+Leungauthor=S.+Mac+Lennanauthor=C.+Feoauthor=S.+Baraldiauthor=P.+A.+Borea&title=Adenosine+receptors+in+colon+carcinoma+tissues+and+colon+tumoral+cell+lines%3A+focus+on+the+A3+adenosine+subtype"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in colon carcinoma tissue and colon tumor cell lines: focus on the A3 adenosine subtype</span></div><div class="casAuthors">Gessi, Stefania; Merighi, Stefania; Varani, Katia; Cattabriga, Elena; Benini, Annalisa; Mirandola, Prisco; Leung, Edward; MacLennan, Stephen; Feo, Carlo; Baraldi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">826-836</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Adenosine may affect several pathophysiol. processes, including cell proliferation, through interaction with A1, A2A, A2B, and A3 receptors.  In this study the authors characterized adenosine receptors in human colon cancer tissues and in colon cancer cell lines Caco-2, DLD-1, HT-29. mRNA of all adenosine subtypes was detected in cancer tissues and cell lines.  The mRNAs of all adenosine subtypes were detected in cancer tissues and cell lines.  At protein level, low amts. of A1, A2A, and A2B receptors were detected, whereas the A3 receptor was the most abundant subtype in both cancer tissue and the cell lines.  All the receptors were coupled to stimulation/inhibition of adenylate cyclase in cancer cells, with the exception of the A1 subtype.  Adenosine increased cell proliferation with an EC50 of 3-12 μM in cancer cells.  This effect was not essentially reduced by adenosine receptor antagonists.  However dipyridamole, an adenosine transport inhibitor, increased the stimulatory effect induced by adenosine, suggesting an action at the cell surface.  Addn. of adenosine deaminase makes the A3 agonist 2-chloro-N6-(3-iodobenzyl)-N-methyl-5'-carbamoyladenosine (CI-IB-MECA) able to stimulate cell proliferation with an EC50 of 0.5-0.9 nM in cancer cells, suggesting a tonic proliferative effect induced by endogenous adenosine.  This effect was antagonized by 5-N-(4-methoxyphenyl-carbamoyl)amino-8-propyl-2(2furyl)-pyrazolo-[4,3e]-1,2,4-triazolo [1,5-c] pyrimidine (MRE 3008F20) 10 nM.  CI-IB-MECA-stimulated cell proliferation involved extracellular-signal-regulated-kinases (ERK 1/2) pathway, as demonstrated by redn. of proliferation with 1,4-diamino-2,3-dicyano-1,4-bis-2[-amino-phenylthio]-butadiene (U0126) and by ERK 1/2 phosphorylation.  In conclusion this study indicates for the first time that in colon cancer cell lines endogenous adenosine, through the interaction with A3 receptors, mediates a tonic proliferative effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv93CBiqqqa7Vg90H21EOLACvtfcHk0ljvUBQ_dDQUAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFKlt7o%253D&md5=456c5a736491c462b862075d1ba52ac3</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1002%2Fjcp.20994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.20994%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac%2BLennan%26aufirst%3DS.%26aulast%3DFeo%26aufirst%3DC.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptors%2520in%2520colon%2520carcinoma%2520tissues%2520and%2520colon%2520tumoral%2520cell%2520lines%253A%2520focus%2520on%2520the%2520A3%2520adenosine%2520subtype%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2007%26volume%3D211%26spage%3D826%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span> </span><span class="NLM_article-title">An agonist to the A<sub>3</sub> adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2465</span><span class="NLM_x">–</span> <span class="NLM_lpage">2471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2465-2471&author=P.+Fishmanauthor=S.+Bar-Yehudaauthor=G.+Ohanaauthor=F.+Barerauthor=A.+Ochaionauthor=A.+Erlangerauthor=L.+Madi&title=An+agonist+to+the+A3+adenosine+receptor+inhibits+colon+carcinoma+growth+in+mice+via+modulation+of+GSK-3+beta+and+NF-kappa+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DOhana%26aufirst%3DG.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DErlanger%26aufirst%3DA.%26aulast%3DMadi%26aufirst%3DL.%26atitle%3DAn%2520agonist%2520to%2520the%2520A3%2520adenosine%2520receptor%2520inhibits%2520colon%2520carcinoma%2520growth%2520in%2520mice%2520via%2520modulation%2520of%2520GSK-3%2520beta%2520and%2520NF-kappa%2520B%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2465%26epage%3D2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Aghaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panjehpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karami-Tehrani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salami, S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of A<sub>3</sub> adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway</span> <span class="citation_source-journal">J. Cancer Res. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2011&pages=1511-1523&author=M.+Aghaeiauthor=M.+Panjehpourauthor=F.+Karami-Tehraniauthor=S.+Salami&title=Molecular+mechanisms+of+A3+adenosine+receptor-induced+G1+cell+cycle+arrest+and+apoptosis+in+androgen-dependent+and+independent+prostate+cancer+cell+lines%3A+involvement+of+intrinsic+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAghaei%26aufirst%3DM.%26aulast%3DPanjehpour%26aufirst%3DM.%26aulast%3DKarami-Tehrani%26aufirst%3DF.%26aulast%3DSalami%26aufirst%3DS.%26atitle%3DMolecular%2520mechanisms%2520of%2520A3%2520adenosine%2520receptor-induced%2520G1%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520androgen-dependent%2520and%2520independent%2520prostate%2520cancer%2520cell%2520lines%253A%2520involvement%2520of%2520intrinsic%2520pathway%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D137%26spage%3D1511%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinozuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, M.</span><span> </span><span class="NLM_article-title">Antitumor effect of cordycepin (3′-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A<sub>3</sub> receptor stimulation</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16475677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ahsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=43-47&author=K.+Nakamuraauthor=N.+Yoshikawaauthor=Y.+Yamaguchiauthor=S.+Kagotaauthor=K.+Shinozukaauthor=M.+Kunitomo&title=Antitumor+effect+of+cordycepin+%283%E2%80%B2-deoxyadenosine%29+on+mouse+melanoma+and+lung+carcinoma+cells+involves+adenosine+A3+receptor+stimulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation</span></div><div class="casAuthors">Nakamura, Kazuki; Yoshikawa, Noriko; Yamaguchi, Yu; Kagota, Satomi; Shinozuka, Kazumasa; Kunitomo, Masaru</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">43-47</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">An attempt was made to elucidate the mol. target for the antitumor effects of cordycepin (3'-deoxyadenosine) using non-selective and selective adenosine A1, A2a, A2b and A3 receptor agonists and antagonists.  Although adenosine and 2'-deoxyadenosine (up to 100 μM) had no effect, cordycepin showed remarkable inhibitory effects on the growth curves of B16-BL6 mouse melanoma (IC50=39 μM) and mouse Lewis lung carcinoma (IC50=48 μM) cell lines in vitro.  Among the adenosine receptor agonists and antagonists used (up to 100 μM), only 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (Cl-IB-MECA), a selective adenosine A3 receptor agonist, notably inhibited the growth of both mouse tumor cell lines (B16-BL6; IC50=5 μM, LLC; 14 μM).  In addn., the tumor growth inhibitory effect of cordycepin was antagonized by 3-Et 5-benzyl 2-methyl-6-phenyl-4-phenylethynyl-1,4-(±)-dihydropyridine-3,5-dicarboxylate (MRS1191), a selective adenosine A3 receptor antagonist.  These results suggest that cordycepin exerts inhibitory effects on the growth of mouse melanoma and lung carcinoma cells by stimulating adenosine A3 receptors on tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4h5j66E8iKLVg90H21EOLACvtfcHk0li1D0xdO8_Kjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ahsbs%253D&md5=765439863391ececd07e01261bd0eca1</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYoshikawa%26aufirst%3DN.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DKagota%26aufirst%3DS.%26aulast%3DShinozuka%26aufirst%3DK.%26aulast%3DKunitomo%26aufirst%3DM.%26atitle%3DAntitumor%2520effect%2520of%2520cordycepin%2520%25283%25E2%2580%25B2-deoxyadenosine%2529%2520on%2520mouse%2520melanoma%2520and%2520lung%2520carcinoma%2520cells%2520involves%2520adenosine%2520A3%2520receptor%2520stimulation%26jtitle%3DAnticancer%2520Res.%26date%3D2006%26volume%3D26%26spage%3D43%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, K.</span><span> </span><span class="NLM_article-title">An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6413</span><span class="NLM_x">–</span> <span class="NLM_lpage">6423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6413-6423&author=J.+Luauthor=A.+Pierronauthor=K.+Ravid&title=An+adenosine+analogue%2C+IB-MECA%2C+down-regulates+estrogen+receptor+alpha+and+suppresses+human+breast+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPierron%26aufirst%3DA.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DAn%2520adenosine%2520analogue%252C%2520IB-MECA%252C%2520down-regulates%2520estrogen%2520receptor%2520alpha%2520and%2520suppresses%2520human%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6413%26epage%3D6423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirandola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=894-903&author=S.+Merighiauthor=A.+Beniniauthor=P.+Mirandolaauthor=S.+Gessiauthor=K.+Varaniauthor=E.+Leungauthor=S.+MacLennanauthor=P.+G.+Baraldiauthor=P.+A.+Borea&title=A3+adenosine+receptors+modulate+hypoxia-inducible+factor-1alpha+expression+in+human+A375+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBenini%26aufirst%3DA.%26aulast%3DMirandola%26aufirst%3DP.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMacLennan%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520adenosine%2520receptors%2520modulate%2520hypoxia-inducible%2520factor-1alpha%2520expression%2520in%2520human%2520A375%2520melanoma%2520cells%26jtitle%3DNeoplasia%26date%3D2005%26volume%3D7%26spage%3D894%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattabriga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gafa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavazzini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liboni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac-Lennan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Elevated expression of A<sub>3</sub> adenosine receptors in human colorectal cancer is reflected in peripheral blood cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5895</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1158%2F1078-0432.CCR-1134-03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=15355922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlyjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=5895-5901&author=S.+Gessiauthor=E.+Cattabrigaauthor=A.+Avitabileauthor=R.+Gafaauthor=G.+Lanzaauthor=L.+Cavazziniauthor=N.+Bianchiauthor=R.+Gambariauthor=C.+Feoauthor=A.+Liboniauthor=S.+Gulliniauthor=E.+Leungauthor=S.+Mac-Lennanauthor=P.+A.+Borea&title=Elevated+expression+of+A3+adenosine+receptors+in+human+colorectal+cancer+is+reflected+in+peripheral+blood+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells</span></div><div class="casAuthors">Gessi, Stefania; Cattabriga, Elena; Avitabile, Arianna; Gafa', Roberta; Lanza, Giovanni; Cavazzini, Luigi; Bianchi, Nicoletta; Gambari, Roberto; Feo, Carlo; Liboni, Alberto; Gullini, Sergio; Leung, Edward; Mac-Lennan, Stephen; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5895-5901</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Adenosine is a ubiquitous nucleoside that accumulates at high levels in hypoxic regions of solid tumors, and A3 adenosine receptors have been recently demonstrated to play a pivotal role in the adenosine-mediated inhibition of tumor cell proliferation.  In the present work, the authors addressed the question of the putative relevance of A3 subtypes in colorectal adenocarcinomas.  Seventy-three paired samples of tumor and surrounding peritumoral normal mucosa at a distance of 2 and 10 cm from the tumor and blood samples obtained from a cohort of 30 patients with colorectal cancer were investigated to det. the presence of A3 receptors by means of binding, immunocytochem., and real-time reverse transcription-polymerase chain reaction studies.  As measured by receptor binding assays, the d. of A3 receptor was higher in colon carcinomas as compared with normal mucosa originating from the same individuals (P < 0.05).  Overexpression of A3 receptors at the protein level was confirmed by immunohistochem. studies, whereas no changes in A3 mRNA accumulation in tumors as compared with the corresponding normal tissue were revealed.  The overexpression of A3 receptors in tumors was reflected in peripheral blood cells, where the d. was approx. 3-fold higher compared with healthy subjects (P < 0.01).  In a cohort of 10 patients studied longitudinally, expression of A3 receptors in circulating blood cells returned to normal after surgical resection for colorectal cancer.  This study provides the first evidence that A3 receptor plays a role in colon tumorigenesis and, more importantly, can potentially be used as a diagnostic marker or a therapeutic target for colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj5SEyiih0ZLVg90H21EOLACvtfcHk0li1D0xdO8_Kjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlyjtrY%253D&md5=90cd0af97ab52479832caad67e7f74f1</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-1134-03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-1134-03%26sid%3Dliteratum%253Aachs%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DCattabriga%26aufirst%3DE.%26aulast%3DAvitabile%26aufirst%3DA.%26aulast%3DGafa%26aufirst%3DR.%26aulast%3DLanza%26aufirst%3DG.%26aulast%3DCavazzini%26aufirst%3DL.%26aulast%3DBianchi%26aufirst%3DN.%26aulast%3DGambari%26aufirst%3DR.%26aulast%3DFeo%26aufirst%3DC.%26aulast%3DLiboni%26aufirst%3DA.%26aulast%3DGullini%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DMac-Lennan%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DElevated%2520expression%2520of%2520A3%2520adenosine%2520receptors%2520in%2520human%2520colorectal%2520cancer%2520is%2520reflected%2520in%2520peripheral%2520blood%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D5895%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Morello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, A.</span><span> </span><span class="NLM_article-title">Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells</span> <span class="citation_source-journal">J. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fjcp.21863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=19562684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGrsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2009&pages=378-386&author=S.+Morelloauthor=R.+Sorrentinoauthor=A.+Portaauthor=G.+Forteauthor=A.+Popoloauthor=A.+Petrellaauthor=A.+Pinto&title=Cl-IB-MECA+enhances+TRAIL-induced+apoptosis+via+the+modulation+of+NF-kappaB+signalling+pathway+in+thyroid+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-κB signalling pathway in thyroid cancer cells</span></div><div class="casAuthors">Morello, Silvana; Sorrentino, Rosalinda; Porta, Amalia; Forte, Giovanni; Popolo, Ada; Petrella, Antonello; Pinto, Aldo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">378-386</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Apoptosis is an endogenous process that can be a useful anti-cancer tool.  This study aimed to investigate the effect of Cl-IB-MECA, adenosine receptor A3 agonist, on TRAIL-induced apoptosis of thyroid carcinoma cells.  Cl-IB-MECA enhanced TRAIL-mediated apoptosis in FRO but not in ARO cells.  This effect was correlated to higher expression levels of DR5 on FRO than ARO cells, that instead presented higher levels of decoy receptors, DcR1 and DcR2.  To understand the cross-talk between the effect of Cl-IB-MECA and TRAIL, we evaluated the nuclear translocation of p65 and c-Rel.  Since the dependency by NF-κB, TRAIL promoted the nuclear translocation of both p65 and c-Rel subunits.  However, the addn. of Cl-IB-MECA led to the predominant translocation of c-Rel after TRAIL addn.  Furthermore, Bcl-2, cFLIP and pAkt were lower induced than caspase-3 and -9 in FRO cells.  To discriminate a specific effect of TRAIL, we used tumor necrosis factor-alpha (TNF-α) with Cl-IB-MECA.  In this case, no synergism was obsd.  In addn., the effect of Cl-IB-MECA was not A3 receptor-dependent since its antagonists, MRS1191 and FA385, failed to block Cl-IB-MECA activity on TRAIL-treated FRO cells.  In conclusion, Cl-IB-MECA enhanced TRAIL-mediated apoptosis via NF-κB/c-Rel activation and DR5-dependent manner.  This study may shed light on a potential drug cocktail that may prove useful as anti-cancer in an in vivo animal model.  J. Cell. Physiol. 221: 378-386, 2009. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUyksL_rDp3LVg90H21EOLACvtfcHk0lgm-QHVkmpiFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGrsrrO&md5=82bbf12e3658f7f5634ef7faff8d4e8e</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21863%26sid%3Dliteratum%253Aachs%26aulast%3DMorello%26aufirst%3DS.%26aulast%3DSorrentino%26aufirst%3DR.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DForte%26aufirst%3DG.%26aulast%3DPopolo%26aufirst%3DA.%26aulast%3DPetrella%26aufirst%3DA.%26aulast%3DPinto%26aufirst%3DA.%26atitle%3DCl-IB-MECA%2520enhances%2520TRAIL-induced%2520apoptosis%2520via%2520the%2520modulation%2520of%2520NF-kappaB%2520signalling%2520pathway%2520in%2520thyroid%2520cancer%2520cells%26jtitle%3DJ.%2520Cell%2520Physiol.%26date%3D2009%26volume%3D221%26spage%3D378%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">CF102 an A<sub>3</sub> adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver</span> <span class="citation_source-journal">J. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">2438</span><span class="NLM_x">–</span> <span class="NLM_lpage">2447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1002%2Fjcp.22593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21660967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Kqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=2438-2447&author=S.+Cohenauthor=S.+M.+Stemmerauthor=G.+Zozulyaauthor=A.+Ochaionauthor=R.+Patokaauthor=F.+Barerauthor=S.+Bar-Yehudaauthor=L.+Rath-Wolfsonauthor=K.+A.+Jacobsonauthor=P.+Fishman&title=CF102+an+A3+adenosine+receptor+agonist+mediates+anti-tumor+and+anti-inflammatory+effects+in+the+liver"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver</span></div><div class="casAuthors">Cohen, S.; Stemmer, S. M.; Zozulya, G.; Ochaion, A.; Patoka, R.; Barer, F.; Bar-Yehuda, S.; Rath-Wolfson, L.; Jacobson, K. A.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2438-2447</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Gi protein-assocd. A3 adenosine receptor (A3AR) is a member of the adenosine receptor family.  Selective agonists at the A3AR, such as CF101 and CF102 were found to induce anti-inflammatory and anti-cancer effects.  In this study, we examd. the differential effect of CF102 in pathol. conditions of the liver.  The anti-inflammatory protective effect of CF101 was tested in a model of liver inflammation induced by Con A (Con. A) and the anti-cancer effect of CF102 was examd. in vitro and in a xenograft animal model utilizing Hep-3B hepatocellular carcinoma (HCC) cells.  The mechanism of action was explored by following the expression levels of key signaling proteins in the inflamed and tumor liver tissues, utilizing Western blot (WB) anal.  In the liver inflammation model, CF102 (100 μg/kg) markedly reduced the secretion of serum glutamic oxaloacetic transaminase and serum glutamic pyruvic transaminase in comparison to the vehicle-treated group.  Mechanistically, CF102 treatment decreased the expression level of phosphorylated glycogen synthase kinase-3β, NF-κB, and TNF-α and prevented apoptosis in the liver.  This was demonstrated by decreased expression levels of Fas receptor (FasR) and of the pro-apoptotic proteins Bax and Bad in liver tissues.  In addn., CF102-induced apoptosis of Hep-3B cells both in vitro and in vivo via de-regulation of the PI3K-NF-κB signaling pathway, resulting in up-regulation of pro-apoptotic proteins.  Taken together, CF102 acts as a protective agent in liver inflammation and inhibits HCC tumor growth.  These results suggest that CF102 through its differential effect is a potential drug candidate to treat various pathol. liver conditions.  J. Cell. Physiol. 226: 2438-2447, 2011. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhxRxOl8p-VbVg90H21EOLACvtfcHk0lgm-QHVkmpiFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Kqtbk%253D&md5=944e3cf29e0de7903e62dd378c9c2aa4</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22593%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DStemmer%26aufirst%3DS.%2BM.%26aulast%3DZozulya%26aufirst%3DG.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DPatoka%26aufirst%3DR.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DCF102%2520an%2520A3%2520adenosine%2520receptor%2520agonist%2520mediates%2520anti-tumor%2520and%2520anti-inflammatory%2520effects%2520in%2520the%2520liver%26jtitle%3DJ.%2520Cell%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D2438%26epage%3D2447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniscalco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tognon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">A<sub>3</sub> receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via akt/nuclear factor-kappa b pathway</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1164%2Frccm.201006-0980OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=20870754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslCku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2011&pages=522-530&author=K.+Varaniauthor=S.+Manieroauthor=F.+Vincenziauthor=M.+Targaauthor=A.+Stefanelliauthor=P.+Maniscalcoauthor=F.+Martiniauthor=M.+Tognonauthor=P.+A.+Borea&title=A3+receptors+are+overexpressed+in+pleura+from+patients+with+mesothelioma+and+reduce+cell+growth+via+akt%2Fnuclear+factor-kappa+b+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">A3 receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway</span></div><div class="casAuthors">Varani, Katia; Maniero, Stefania; Vincenzi, Fabrizio; Targa, Martina; Stefanelli, Angela; Maniscalco, Pio; Martini, Fernanda; Tognon, Mauro; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-530</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: A strong link has been established between exposure to asbestos and increased risk for pleural malignant mesothelioma (MM).  Adenosine plays a key role in inflammatory processes and cancer, where it is involved in the regulation of cell death and proliferation.  Objectives: The primary aim of this study was to investigate the presence of adenosine receptors (ARs) in human MM pleura (MMP) and healthy mesothelial pleura (HMP).  To shed some light on the interaction between adenosine and MM, the presence and functionality of ARs were explored in human healthy mesothelial cells (HMC) and in malignant mesothelioma cells (MMC).  Methods: ARs were analyzed by using reverse transcriptase-polymerase chain reaction, Western blotting, and satn. binding assays.  HMC were treated with crocidolite asbestos, which is the principal risk factor for MM.  The role of A3ARs on these cellular models, evaluating cAMP prodn., Akt phosphorylation, and nuclear factor (NF)-κB activation, was investigated.  The dual effect of A3AR stimulation on healthy and cancer cell growth was studied by means of proliferation, apoptosis, and cytotoxicity assays.  Measurements and Main Results: A3AR was up-regulated by 2.5-fold (P < 0.01) in MMP when compared with HMP.  Stimulation of A3ARs decreased proliferation and exerted a cytotoxic and proapoptotic effect on MMC and on HMC exposed to asbestos and tumor necrosis factor-α, but not on HMC with an involvement of the deregulation of Akt/NF-κB cell survival pathway.  Conclusions: These new findings suggest that A3AR could represent a pharmacol. target to prevent tumor development after asbestos exposure and to treat full-blown MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphUHRpPoSZerVg90H21EOLACvtfcHk0lgm-QHVkmpiFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslCku7o%253D&md5=cb4b02a5159c8083fe049a2d5deef55c</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1164%2Frccm.201006-0980OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201006-0980OC%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DManiero%26aufirst%3DS.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DTarga%26aufirst%3DM.%26aulast%3DStefanelli%26aufirst%3DA.%26aulast%3DManiscalco%26aufirst%3DP.%26aulast%3DMartini%26aufirst%3DF.%26aulast%3DTognon%26aufirst%3DM.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DA3%2520receptors%2520are%2520overexpressed%2520in%2520pleura%2520from%2520patients%2520with%2520mesothelioma%2520and%2520reduce%2520cell%2520growth%2520via%2520akt%252Fnuclear%2520factor-kappa%2520b%2520pathway%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2011%26volume%3D183%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. D.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of novel A<sub>3</sub> adenosine receptor-selective antagonists</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=1157-1165&author=K.+A.+Jacobsonauthor=K.+S.+Parkauthor=J.+L.+Jiangauthor=Y.+C.+Kimauthor=M.+E.+Olahauthor=G.+L.+Stilesauthor=X.+D.+Ji&title=Pharmacological+characterization+of+novel+A3+adenosine+receptor-selective+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DJiang%26aufirst%3DJ.%2BL.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJi%26aufirst%3DX.%2BD.%26atitle%3DPharmacological%2520characterization%2520of%2520novel%2520A3%2520adenosine%2520receptor-selective%2520antagonists%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D1157%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Molfino, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, P. K.</span><span> </span><span class="NLM_article-title">Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.pupt.2006.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=16798034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFylu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=462-472&author=N.+A.+Molfinoauthor=P.+K.+Jeffery&title=Chronic+obstructive+pulmonary+disease%3A+histopathology%2C+inflammation+and+potential+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapies</span></div><div class="casAuthors">Molfino, Nestor A.; Jeffery, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">462-472</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic obstructive pulmonary disease (COPD) is a major worldwide health burden with increasing morbidity, mortality and health care cost.  It is a slowly progressive chronic inflammatory condition that affects the conducting airways (both large and small) and lung parenchyma.  In COPD, inflammation is evident early on even in mild disease and increases with disease severity.  Recent advances in our knowledge demonstrate, by comparison with asthma, the distinctive, "abnormal" or exaggerated inflammatory processes involved in the pathogenesis of COPD and thus identify novel therapeutic targets that could potentially impact on disease progression.  The present review will focus on what is known of the abnormal inflammatory response of COPD in different regions of the conducting airways and lung.  Novel, potentially promising approaches to therapy are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-my6d1XFKB7Vg90H21EOLACvtfcHk0ljYT_t143rkTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFylu7c%253D&md5=ffe793aec2129444427c6ac3204b0cb2</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2006.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2006.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMolfino%26aufirst%3DN.%2BA.%26aulast%3DJeffery%26aufirst%3DP.%2BK.%26atitle%3DChronic%2520obstructive%2520pulmonary%2520disease%253A%2520histopathology%252C%2520inflammation%2520and%2520potential%2520therapies%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D20%26spage%3D462%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">David, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadurina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gospodinov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlotsky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yankova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzeva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial</span> <span class="citation_source-journal">J. Eur. Acad. Dermatol. Venereol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1111%2Fj.1468-3083.2011.04078.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=21504485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2rtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=361-367&author=M.+Davidauthor=L.+Akermanauthor=M.+Zivauthor=M.+Kadurinaauthor=D.+Gospodinovauthor=F.+Pavlotskyauthor=R.+Yankovaauthor=V.+Kouzevaauthor=M.+Ramonauthor=M.+Silvermanauthor=P.+Fishman&title=Treatment+of+plaque-type+psoriasis+with+oral+CF101%3A+data+from+an+exploratory+randomized+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial</span></div><div class="casAuthors">David, M.; Akerman, L.; Ziv, M.; Kadurina, M.; Gospodinov, D.; Pavlotsky, F.; Yankova, R.; Kouzeva, V.; Ramon, M.; Silverman, M. H.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the European Academy of Dermatology and Venereology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-367</span>CODEN:
                <span class="NLM_cas:coden">JEAVEQ</span>;
        ISSN:<span class="NLM_cas:issn">1468-3083</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims CF101 demonstrated a marked anti-inflammatory effect in Phase 2 studies conducted in patients with rheumatoid arthritis and dry eye syndrome.  The aim of this study was to evaluate the safety and efficacy of CF101 for the treatment of patients with moderate to severe plaque-type psoriasis.  Materials and methods This was a phase 2, multicentre, randomized, double-blind, dose-ranging, placebo-controlled study.  Seventy five patients with moderate to severe plaque-type psoriasis were enrolled, randomized and treated with CF101 (1, 2, or 4 mg) or placebo administered orally twice daily for 12 wk.  Safety and change from base line of Psoriasis Area and Severity Index (PASI) score and physician's global assessment (PGA) score over 12 wk.  Results In the 2 mg CF101-treated group, a progressive improvement in the mean change from baseline in the PASI score vs. placebo throughout the study period was obsd., with a statistically significant difference on weeks 8 and 12 (P = 0.047; P = 0.031, resp.).  In this group, 35.3% of the patients achieved PASI ≥50 response, and 23.5% of the patients achieved a PGA score of 0 or 1.  CF101 was safe and well tolerated.  Conclusions CF101 was well tolerated and demonstrated clear evidence of efficacy in patients with moderate to severe plaque psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt2cC_yV2sT7Vg90H21EOLACvtfcHk0ljYT_t143rkTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2rtrw%253D&md5=a1223babba9d6115871e97952e3b7ab2</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-3083.2011.04078.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-3083.2011.04078.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DM.%26aulast%3DAkerman%26aufirst%3DL.%26aulast%3DZiv%26aufirst%3DM.%26aulast%3DKadurina%26aufirst%3DM.%26aulast%3DGospodinov%26aufirst%3DD.%26aulast%3DPavlotsky%26aufirst%3DF.%26aulast%3DYankova%26aufirst%3DR.%26aulast%3DKouzeva%26aufirst%3DV.%26aulast%3DRamon%26aufirst%3DM.%26aulast%3DSilverman%26aufirst%3DM.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DTreatment%2520of%2520plaque-type%2520psoriasis%2520with%2520oral%2520CF101%253A%2520data%2520from%2520an%2520exploratory%2520randomized%2520phase%25202%2520clinical%2520trial%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2012%26volume%3D26%26spage%3D361%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Avni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzozi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barequet, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segev, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varssano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetrit, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadok, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomkins, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farbstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yehuda, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial</span> <span class="citation_source-journal">Ophthalmology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">1287</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2010&pages=1287-1293&author=I.+Avniauthor=H.+J.+Garzoziauthor=I.+S.+Barequetauthor=F.+Segevauthor=D.+Varssanoauthor=G.+Sartaniauthor=N.+Chetritauthor=E.+Bakshiauthor=D.+Zadokauthor=O.+Tomkinsauthor=G.+Litvinauthor=K.+A.+Jacobsonauthor=S.+Fishmanauthor=Z.+Harpazauthor=M.+Farbsteinauthor=S.+B.+Yehudaauthor=M.+H.+Silvermanauthor=W.+D.+Kernsauthor=D.+R.+Bristolauthor=I.+Cohnauthor=P.+Fishman&title=Treatment+of+dry+eye+syndrome+with+orally+administered+CF101%3A+data+from+a+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvni%26aufirst%3DI.%26aulast%3DGarzozi%26aufirst%3DH.%2BJ.%26aulast%3DBarequet%26aufirst%3DI.%2BS.%26aulast%3DSegev%26aufirst%3DF.%26aulast%3DVarssano%26aufirst%3DD.%26aulast%3DSartani%26aufirst%3DG.%26aulast%3DChetrit%26aufirst%3DN.%26aulast%3DBakshi%26aufirst%3DE.%26aulast%3DZadok%26aufirst%3DD.%26aulast%3DTomkins%26aufirst%3DO.%26aulast%3DLitvin%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DFishman%26aufirst%3DS.%26aulast%3DHarpaz%26aufirst%3DZ.%26aulast%3DFarbstein%26aufirst%3DM.%26aulast%3DYehuda%26aufirst%3DS.%2BB.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DKerns%26aufirst%3DW.%2BD.%26aulast%3DBristol%26aufirst%3DD.%2BR.%26aulast%3DCohn%26aufirst%3DI.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DTreatment%2520of%2520dry%2520eye%2520syndrome%2520with%2520orally%2520administered%2520CF101%253A%2520data%2520from%2520a%2520phase%25202%2520clinical%2520trial%26jtitle%3DOphthalmology%26date%3D2010%26volume%3D117%26spage%3D1287%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Pharmacological and therapeutic effects of A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1016%2Fj.drudis.2011.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=22033198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=359-366&author=P.+Fishmanauthor=S.+Bar-Yehudaauthor=B.+T.+Liangauthor=K.+A.+Jacobson&title=Pharmacological+and+therapeutic+effects+of+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and therapeutic effects of A3 adenosine receptor agonists</span></div><div class="casAuthors">Fishman, Pnina; Bar-Yehuda, Sara; Liang, Bruce T.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">359-366</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The A3 adenosine receptor (A3AR) coupled to Gi (inhibitory regulative guanine nucleotide-binding protein) mediates anti-inflammatory, anticancer and anti-ischemic protective effects.  The receptor is overexpressed in inflammatory and cancer cells, while low expression is found in normal cells, rendering the A3AR as a potential therapeutic target.  Highly selective A3AR agonists have been synthesized and mol. recognition in the binding site has been characterized.  In this article, we summarize preclin. and clin. human studies that demonstrate that A3AR agonists induce specific anti-inflammatory and anticancer effects through a mol. mechanism that entails modulation of the Wnt and the NF-κB signal transduction pathways.  At present, A3AR agonists are being developed for the treatment of inflammatory diseases, including rheumatoid arthritis (RA) and psoriasis; ophthalmic diseases such as dry eye syndrome and glaucoma; liver diseases such as hepatocellular carcinoma and hepatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBCdToPXU4m7Vg90H21EOLACvtfcHk0ljYT_t143rkTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2isbw%253D&md5=b7278bf446f320ca621a93dff383ca13</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DB.%2BT.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DPharmacological%2520and%2520therapeutic%2520effects%2520of%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D359%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Ohana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreznick, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath-Wolfson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slosman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">Inhibition of primary colon carcinoma growth and liver metastasis by the A<sub>3</sub> adenosine receptor agonist CF101</span> <span class="citation_source-journal">Br. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1552</span><span class="NLM_x">–</span> <span class="NLM_lpage">1558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Fjm300087j&amp;key=10.1038%2Fsj.bjc.6601315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=14562031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFeksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2003&pages=1552-1558&author=G.+Ohanaauthor=S.+Bar-Yehudaauthor=A.+Arichauthor=L.+Madiauthor=Z.+Dreznickauthor=L.+Rath-Wolfsonauthor=D.+Silbermanauthor=G.+Slosmanauthor=P.+Fishman&title=Inhibition+of+primary+colon+carcinoma+growth+and+liver+metastasis+by+the+A3+adenosine+receptor+agonist+CF101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101</span></div><div class="casAuthors">Ohana, G.; Bar-Yehuda, S.; Arich, A.; Madi, L.; Dreznick, Z.; Rath-Wolfson, L.; Silberman, D.; Slosman, G.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1552-1558</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine is a purine nucleoside that acts as a regulatory mol. by binding to specific G-protein-coupled A1, A2A, A2B, and A3 cell surface receptors.  We have recently demonstrated that adenosine inhibits tumor cell growth and concomitantly stimulates bone marrow cell proliferation via activation of the A3 adenosine receptor (A3AR).  In the present study, we show that a synthetic agonist to the A3AR, CF101, at the low nanomolar concn. range, inhibits HCT-116 human colon carcinoma cell growth.  This effect was reversed by the selective A3AR antagonist MRS1523, demonstrating the specificity of the response.  CF101 (given orally) was efficacious in inhibiting the development of primary tumors in xenograft and syngeneic models in which mice were inoculated s.c. with human HCT-116 or murine CT-26 colon carcinoma cells, resp.  Moreover, CF101 suppressed (50%, P<0.01) colon cancer liver metastases in syngeneic mice inoculated to the spleen with CT-26 cells.  The mechanism of action entailed upregulation of interleukin-12 prodn. in the CF101-treated groups and potentiation of NK cell activity.  In the HCT-116 xenograft model in which a combined therapy of CF101 and 5-fluorouracil (5-FU) was examd., an additive antitumor effect was demonstrated.  Moreover, CF101 prevented the 5-FU-induced myelotoxicity, resulting in normal values of white blood cell and neutrophil counts.  We conclude that the A3AR agonist CF101, a small orally bioavailable mol., exerts systemic anticancer, antimetastatic, and myeloprotective effects in colon carcinoma-bearing mice, and may serve as an adjuvant treatment to enhance the chemotherapeutic index and prevent myelotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnpNJyI8jnaLVg90H21EOLACvtfcHk0lgFtVSZQ27LWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFeksbY%253D&md5=b3be6d639812d415184b7c6b7806dc28</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601315%26sid%3Dliteratum%253Aachs%26aulast%3DOhana%26aufirst%3DG.%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DArich%26aufirst%3DA.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DDreznick%26aufirst%3DZ.%26aulast%3DRath-Wolfson%26aufirst%3DL.%26aulast%3DSilberman%26aufirst%3DD.%26aulast%3DSlosman%26aufirst%3DG.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520primary%2520colon%2520carcinoma%2520growth%2520and%2520liver%2520metastasis%2520by%2520the%2520A3%2520adenosine%2520receptor%2520agonist%2520CF101%26jtitle%3DBr.%2520J.%2520Cancer.%26date%3D2003%26volume%3D89%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shkapenuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">CF101, an agonist to the A<sub>3</sub> adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=85-90&author=S.+Bar-Yehudaauthor=L.+Madiauthor=D.+Silbermanauthor=S.+Geryauthor=M.+Shkapenukauthor=P.+Fishman&title=CF101%2C+an+agonist+to+the+A3+adenosine+receptor%2C+enhances+the+chemotherapeutic+effect+of+5-fluorouracil+in+a+colon+carcinoma+murine+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DSilberman%26aufirst%3DD.%26aulast%3DGery%26aufirst%3DS.%26aulast%3DShkapenuk%26aufirst%3DM.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DCF101%252C%2520an%2520agonist%2520to%2520the%2520A3%2520adenosine%2520receptor%252C%2520enhances%2520the%2520chemotherapeutic%2520effect%2520of%25205-fluorouracil%2520in%2520a%2520colon%2520carcinoma%2520murine%2520model%26jtitle%3DNeoplasia%26date%3D2005%26volume%3D7%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group">Bar-Yehuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochaion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabutti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Liz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, P.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Fjm300087j&amp;key=18636149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Fjm300087j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2lsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=287-295&author=S.+Bar-Yehudaauthor=S.+M.+Stemmerauthor=L.+Madiauthor=D.+Castelauthor=A.+Ochaionauthor=S.+Cohenauthor=F.+Barerauthor=A.+Zabuttiauthor=G.+Perez-Lizauthor=L.+Del+Valleauthor=P.+Fishman&title=The+A3+adenosine+receptor+agonist+CF102+induces+apoptosis+of+hepatocellular+carcinoma+via+de-regulation+of+the+Wnt+and+NF-kappaB+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-κB signal transduction pathways</span></div><div class="casAuthors">Bar-Yehuda, S.; Stemmer, S. M.; Madi, L.; Castel, D.; Ochaion, A.; Cohen, S.; Barer, F.; Zabutti, A.; Perez-Liz, G.; del Valle, L.; Fishman, P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-295</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">The A3 adenosine receptor (A3AR) is highly expressed in tumors and was suggested as a target for cancer treatment.  In this study, we show that A3AR is highly expressed in tumor tissues and in peripheral blood mononuclear cells (PBMCs) derived from patients with HCC, as well as from HCC tumor-bearing rats.  The high expression level of the receptor was directly correlated to overexpression of NF-κB, known as a transcription factor of A3AR.  CF102, a synthetic highly selective agonist to A3AR induced a marked dose response inhibition of tumor growth in N1S1 HCC tumor rats, via de-regulation of the NF-κB and the Wnt signal transduction pathways, resulting in apoptosis of tumor cells.  Taken together, A3AR is highly expressed in tumors and PBMCs of HCC patients and tumor-bearing rats.  CF102 induced apoptosis and tumor growth inhibition.  These data suggest A3AR as a novel targeted therapy to treat HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9mAZahYskg7Vg90H21EOLACvtfcHk0lgFtVSZQ27LWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2lsbzE&md5=2a49857cc99edefa8cb69f62c7cf484e</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Yehuda%26aufirst%3DS.%26aulast%3DStemmer%26aufirst%3DS.%2BM.%26aulast%3DMadi%26aufirst%3DL.%26aulast%3DCastel%26aufirst%3DD.%26aulast%3DOchaion%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DBarer%26aufirst%3DF.%26aulast%3DZabutti%26aufirst%3DA.%26aulast%3DPerez-Liz%26aufirst%3DG.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DFishman%26aufirst%3DP.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520agonist%2520CF102%2520induces%2520apoptosis%2520of%2520hepatocellular%2520carcinoma%2520via%2520de-regulation%2520of%2520the%2520Wnt%2520and%2520NF-kappaB%2520signal%2520transduction%2520pathways%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2008%26volume%3D33%26spage%3D287%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300087j&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm300087j%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-12%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300087j" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679939f02a7e3cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
